Patient ID	Treatment type	Type of ICI treatment	Age at diagnosis	Sex	Cancer type	Year of diagnosis	Stage at diagnosis	Days between diagnosis and MSK-IMPACT sample	TMB (mutations/Mb)	MSI status	Temozolomide treatment prior to MSK-IMPACT sample	Chemotherapy or Radiotherapy prior to MSK-IMPACT sample	Dominant mutational signature	Mutations in DNA damage repair pathways	Only 1 line of therapy received	Vital status	OS	ICB.binary	MMRmut_canon	MMRmut_any	ARID1Amut
1	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2016	III	46	34.2		No	No	Signature.7	ARID1A | MRE11A | RAD50	No	0	34.6	0	no	no	yes
2	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	15	9.8	Stable	No	No	Signature.4	MRE11A	No	1	2.2	0	no	no	no
3	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	6.9	Stable	No	Yes or Unknown			No	1	5.82	0	no	no	no
4	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	25.63	0	no	no	no
5	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	34	0.9	Stable	No	No			Yes	0	16.62	0	no	no	no
6	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	20	0.9		No	No			Yes	0	37.03	0	no	no	no
7	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	56	12.8		No	No	Signature.29		Yes	0	37.75	0	no	no	no
8	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	I	286	0	Stable	No	Yes or Unknown			Yes	0	18.76	0	no	no	no
9	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	I	61	32.5	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA2 | FANCC | MSH2	Yes	0	42.91	0	no	no	no
10	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	0	4.4	Stable	No	No		BRCA2	No	0	26.02	0	no	no	no
11	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	1	Stable	No	No			No	0	54.31	0	no	no	no
12	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2016	IV	903	7	Stable	No	No	Signature.1	ATR	No	0	38.83	0	no	no	no
13	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	9	1.8		No	No			Yes	0	32	0	no	no	no
14	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	19	1.8	Stable	No	Yes or Unknown			No	0	24.11	0	no	no	no
15	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	221	7.9	Stable	No	Yes or Unknown	Signature.3	BLM	No	0	11.7	0	no	no	no
16	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	120	31.6	Stable	No	Yes or Unknown	Signature.4	ATR | SLX4	No	0	28.81	0	no	no	no
17	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	35	11.8	Stable	No	No	Signature.4		No	0	34.04	0	no	no	no
18	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	106	1.8	Stable	No	No			Yes	0	28.09	0	no	no	no
19	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	623	2.6	Stable	No	Yes or Unknown			No	0	36.93	0	no	no	no
20	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	38	0.9	Stable	No	Yes or Unknown	Signature.6		Yes	0	17.51	0	no	no	no
21	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	63	0.9	Stable	No	Yes or Unknown			Yes	0	27.79	0	no	no	no
22	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	2.6		No	No			No	0	32.16	0	no	no	no
23	Non-ICI treated	Never received ICI	86 - 90	Female	Breast	2016	IV	41	4.9	Stable	No	Yes or Unknown			Yes	1	4.01	0	no	no	no
24	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	IV	0	6.1	Stable	No	Yes or Unknown			No	1	8.34	0	no	no	no
25	Non-ICI treated	Never received ICI	86 - 90	Male	Breast	2016	II	41	1	Stable	No	No			Yes	0	19.32	0	no	no	no
26	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	47	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	19.12	0	no	no	yes
27	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	43	19.7	Stable	No	No	Signature.4	RAD50	No	0	42.64	0	no	no	no
28	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		23	7.9		Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | PMS1	No	1	19.38	0	no	no	yes
29	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	55	3.5		No	Yes or Unknown			Yes	0	39.39	0	no	no	no
30	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	III	31	31.6	Unstable	No	No	Signature.6	BRCA2 | MSH3 | PALB2	No	1	21.03	0	other-MMRd	mut-MMRd	no
31	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	0	23.69	0	no	no	no
32	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	48	7	Stable	No	No	Signature.1	ARID1A | ERCC2	No	0	15.93	0	no	no	yes
33	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	2.6	Stable	No	No			No	0	28.48	0	no	no	no
34	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	6.1	Stable	No	Yes or Unknown			No	0	28.68	0	no	no	no
35	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	35	5.3		No	Yes or Unknown			No	0	38.44	0	no	no	no
36	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	21	6.9	Stable	No	No	Signature.4	RAD50	No	0	21.91	0	no	no	no
37	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3.5	Stable	No	No		BRCA2	No	0	36.17	0	no	no	no
38	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	38	382.7	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | MSH3 | MSH6 | NBN | PALB2 | PARP1 | RAD52 | SLX4 | TP53BP1	No	0	8.94	0	no	no	yes
39	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown	Signature.30		Yes	0	10.78	0	no	no	no
40	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	51	0.9		No	No			No	0	36.37	0	no	no	no
41	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	I	0	7.9	Indeterminate	No	No	Signature.16		Yes	0	11.24	0	no	no	no
42	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	0	1.8		No	No			No	0	33.31	0	no	no	no
43	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	0	45.3	Indeterminate	No	Yes or Unknown	Signature.1	ERCC5 | MSH6 | PMS2 | RAD50	No	0	43.89	0	no	no	no
44	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	30	0	Stable	No	No			No	0	16.79	0	no	no	no
45	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	454	1.8	Stable	No	No			No	0	30.88	0	no	no	no
46	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	0	0.9	Stable	No	No		CHEK2	No	1	17.38	0	no	no	no
47	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	I	79	57.1	Unstable	No	No	Signature.6	ARID1A | CHEK1 | MLH1 | MSH3 | NBN | PALB2 | XRCC2	No	0	15.41	0	mut-MMRd	mut-MMRd	yes
48	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	77	0.9	Stable	No	No		BRCA2	No	0	22.21	0	no	no	no
49	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	71	1.8	Stable	No	No			Yes	0	14.09	0	no	no	no
50	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	20	4.4	Stable	No	Yes or Unknown			No	0	27.99	0	no	no	no
51	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	III	161	0	Stable	No	Yes or Unknown			No	0	48.36	0	no	no	no
52	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	0	12.3	Stable	No	No	Signature.7	TP53BP1	Yes	0	13.4	0	no	no	no
53	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	33	2.6		No	No			No	0	4.04	0	no	no	no
54	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	II	1277	4.4	Stable	No	Yes or Unknown			No	1	42.71	0	no	no	no
55	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2016	IV	40	7.9		No	No		ARID1A	No	1	25.53	0	no	no	yes
56	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	18.66	0	no	no	no
57	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	II	0	1	Stable	No	No			No	0	38.6	0	no	no	no
58	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	I	851	2.6	Stable	No	Yes or Unknown			No	1	46.36	0	no	no	no
59	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	IV	23	0.9		No	No			No	0	18.04	0	no	no	no
60	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	35	0.9		No	No			Yes	0	34	0	no	no	no
61	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016		944	29	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ERCC2	Yes	0	39.03	0	other-MMRd	mut-MMRd	yes
62	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	0	4.9	Stable	No	No			No	0	42.48	0	no	no	no
63	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	II	31	4.4	Stable	No	No			Yes	0	13.14	0	no	no	no
64	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2018	I	122	0	Stable	No	Yes or Unknown			Yes	0	10.41	0	no	no	no
65	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	III	53	1.8		No	No		BRCA2	Yes	0	41.66	0	no	no	no
66	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	16	5.3	Stable	No	No	Signature.8	ATM	No	0	20.9	0	no	no	no
67	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	33	2.6		No	No			No	0	32.23	0	no	no	no
68	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	16	7		No	No	Signature.10		No	0	32.56	0	no	no	no
69	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	31	3.5	Stable	No	No		BRCA2	No	0	14.32	0	no	no	no
70	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	23	9.8		No	No	Signature.13		No	0	26.55	0	no	no	no
71	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	22	2.6		No	Yes or Unknown			No	0	24.74	0	no	no	no
72	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2016	I	0	2.6		No	No			No	0	23	0	no	no	no
73	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	22.93	0	no	no	no
74	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	389	4.4		No	Yes or Unknown	Signature.2		Yes	1	18.1	0	no	no	no
75	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	23	8.8	Stable	No	No		ARID1A	No	0	27.73	0	no	no	yes
76	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	4.4	Stable	No	No		MUTYH	No	0	38.41	0	no	no	no
77	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	1183	5.3	Stable	No	Yes or Unknown			No	0	40.41	0	no	no	no
78	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	21	2.6	Stable	No	No			No	0	13.54	0	no	no	no
79	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	8	3.5		No	No	Signature.6	NBN	Yes	0	27.07	0	no	no	no
80	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	64	0	Stable	No	No			Yes	0	38.28	0	no	no	no
81	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	10	4.4		No	No			Yes	0	28.75	0	no	no	no
82	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	II	40	21.9	Unstable	No	No	Signature.26	ARID1A | NBN | PMS2	No	0	27.53	0	mut-MMRd	mut-MMRd	yes
83	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	40	3.5	Stable	No	No			Yes	0	48.07	0	no	no	no
84	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	13	79	Stable	No	No	Signature.10	ATM | ATR | BRCA1 | BRCA2 | ERCC4 | FANCA | MSH2 | NBN | PALB2	No	0	26.51	0	no	no	no
85	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	I	116	0.9	Stable	No	Yes or Unknown			Yes	0	42.78	0	no	no	no
86	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	868	4.4	Stable	No	Yes or Unknown		NTHL1	No	0	43.96	0	no	no	no
87	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	2	Stable	No	No			No	0	46.62	0	no	no	no
88	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	30	4.4	Stable	No	No			Yes	0	22.54	0	no	no	no
89	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	IV	98	2	Stable	No	Yes or Unknown			No	1	29.11	0	no	no	no
90	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	0	27.37	0	no	no	no
91	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	35	8.8		No	No	Signature.24		No	0	10.35	0	no	no	no
92	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	III	0	3.9	Stable	No	No			No	0	38.31	0	no	no	no
93	Non-ICI treated	Never received ICI	81 - 85	Female	Bladder	2018		227	12.3	Stable	No	No	Signature.13	BRCA2	No	0	13.11	0	no	no	no
94	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.34	0	no	no	no
95	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	0	3.5	Stable	No	No	Signature.1		No	0	19.75	0	no	no	no
96	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	553	1.8	Stable	No	Yes or Unknown			No	0	21.19	0	no	no	no
97	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	7	6.9	Stable	No	No		ATR	No	1	12.35	0	no	no	no
98	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	8	7	Stable	No	No			No	0	22.21	0	no	no	no
99	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	37	2		No	Yes or Unknown			Yes	0	30.39	0	no	no	no
100	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	17	8.8		No	No	Signature.13	ARID1A | FANCA	Yes	0	30.69	0	no	no	yes
101	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2018		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.25	0	no	no	no
102	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	13	4.4	Stable	No	No	Signature.1		No	0	12.35	0	no	no	no
103	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	298	0		No	Yes or Unknown	Signature.5		No	0	18.99	0	no	no	no
104	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	46	4.4	Stable	No	No			No	0	21.29	0	no	no	no
105	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2018	III	8	1.8	Stable	No	No			Yes	0	16.07	0	no	no	no
106	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	0	16.53	0	no	no	no
107	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	18	3.5	Stable	No	No			Yes	0	22.97	0	no	no	no
108	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	36	3.5	Stable	No	No	Signature.2		Yes	0	13.37	0	no	no	no
109	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	19	0.9	Stable	No	Yes or Unknown			No	0	34.96	0	no	no	no
110	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	32	80.7	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | BRIP1 | CHEK2 | ERCC5 | MRE11A | MSH2 | MSH3 | MSH6 | MUTYH | SLX4 | TP53BP1	Yes	0	26.41	0	no	no	yes
111	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	17	1.8	Stable	No	No			Yes	0	9.53	0	no	no	no
112	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	6.9	Stable	No	No	Signature.4		No	0	39.29	0	no	no	no
113	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	18	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	21.32	0	no	no	no
114	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	29	2.6	Stable	No	No			No	0	16.62	0	no	no	no
115	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	17	1.8		No	Yes or Unknown		BRCA2	No	0	31.57	0	no	no	no
116	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	2.6	Stable	No	No			No	0	28.25	0	no	no	no
117	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	56	5.3	Stable	No	No			No	0	11.2	0	no	no	no
118	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	6	5.3	Stable	No	No			No	0	27.93	0	no	no	no
119	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	2.6		No	No			Yes	0	30.03	0	no	no	no
120	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	7	Stable	No	Yes or Unknown	Signature.13	MRE11A	No	0	40.71	0	no	no	no
121	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	0	4.4		No	No	Signature.3		No	0	35.65	0	no	no	no
122	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	37	4.9	Stable	No	Yes or Unknown			No	0	49.74	0	no	no	no
123	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	55	1	Stable	No	No			Yes	0	15.01	0	no	no	no
124	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	I	71	9.7	Stable	No	Yes or Unknown		ARID1A	Yes	0	35.68	0	no	no	yes
125	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	30	2.6	Stable	No	Yes or Unknown	Signature.1		Yes	0	18.89	0	no	no	no
126	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	II	23	2	Stable	No	No			No	1	32.1	0	no	no	no
127	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	48	6.1	Stable	No	No	Signature.1	ARID1A	Yes	0	18.07	0	no	no	yes
128	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	7	3	Stable	No	No	Signature.4		No	0	41.46	0	no	no	no
129	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			No	0	2.4	0	no	no	no
130	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	II	55	4.4	Stable	No	No			No	0	27.5	0	no	no	no
131	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	I	0	8.9	Stable	No	No	Signature.13		No	1	19.09	0	no	no	no
132	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	61	1.8	Stable	No	Yes or Unknown		ERCC2	Yes	0	26.12	0	no	no	no
133	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2018		0	3.5	Stable	No	No			No	1	1.74	0	no	no	no
134	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	IV	140	2		No	Yes or Unknown		PALB2	No	1	12.62	0	no	no	no
135	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	24	1.8	Stable	No	No			Yes	0	20.17	0	no	no	no
136	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	17	8.9	Stable	No	No	Signature.3		Yes	1	1.51	0	no	no	no
137	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	39	15.8	Stable	No	No	Signature.2		No	1	33.48	0	no	no	no
138	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	30	0.9	Stable	No	No			No	0	22.51	0	no	no	no
139	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	25	4.9	Stable	No	Yes or Unknown			No	0	42.71	0	no	no	no
140	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	375	6.1	Stable	No	Yes or Unknown	Signature.18		No	1	6.97	0	no	no	no
141	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	I	0	7	Stable	No	Yes or Unknown		MSH2	No	0	20.96	0	no	no	no
142	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	8	1	Stable	No	No			No	0	47.44	0	no	no	no
143	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	49	2.6		No	No			Yes	0	40.34	0	no	no	no
144	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		0	7		No	No		ERCC5	No	1	12.98	0	no	no	no
145	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	21	4.4	Stable	No	Yes or Unknown		ARID1A	No	1	22.08	0	no	no	yes
146	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	3.9	Stable	No	No		CHEK2	No	0	35.68	0	no	no	no
147	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	20	7.9	Stable	No	No	Signature.2	PARP1 | RAD50	No	0	21.68	0	no	no	no
148	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2017	II	17	5.3	Stable	No	No			No	1	12.98	0	no	no	no
149	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2018	I	0	5.3	Stable	No	No			Yes	0	17.25	0	no	no	no
150	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	I	22	7.9		No	No	Signature.3		No	0	25.49	0	no	no	no
151	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	16	5.9	Stable	No	No	Signature.13	PARP1	No	1	10.81	0	no	no	no
152	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	55	3	Stable	No	No			Yes	0	38.24	0	no	no	no
153	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	16	0.9	Stable	No	Yes or Unknown			Yes	0	23.39	0	no	no	no
154	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	9.8	Stable	No	No		ARID1A | ATM	Yes	1	2.4	0	no	no	yes
155	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	29	4.9	Stable	No	Yes or Unknown			No	0	37.26	0	no	no	no
156	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	17	2.6	Stable	No	No			No	0	25.99	0	no	no	no
157	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0.9		No	No			No	0	29.67	0	no	no	no
158	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	II	0	1.8		No	No		ARID1A	Yes	0	33.48	0	no	no	yes
159	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	2	Stable	No	No			Yes	0	39.03	0	no	no	no
160	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	36	1.8	Stable	No	No			Yes	0	25.63	0	no	no	no
161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	6.1		No	No		RAD51C	No	0	35.45	0	no	no	no
162	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	8.8		No	No	Signature.6		No	0	7.75	0	no	no	no
163	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	III	90	0.9	Stable	No	No			No	0	46.92	0	no	no	no
164	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	99	14	Stable	No	Yes or Unknown	Signature.4	ATR | MSH6	Yes	0	20.86	0	no	no	no
165	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	41	1.8		No	No			Yes	0	33.05	0	no	no	no
166	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	0	9.8	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	16.16	0	no	no	yes
167	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	3.9	Stable	No	No			Yes	1	11.79	0	no	no	no
168	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	20	48.3	Unstable	No	No	Signature.6	ARID1A | BRCA2 | MLH1 | MSH2	No	0	13.14	0	mut-MMRd	mut-MMRd	yes
169	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	908	0.9	Stable	No	Yes or Unknown			No	0	37.49	0	no	no	no
170	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	24	1.8		No	No		BRCA2	No	0	26.78	0	no	no	no
171	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	89	1.8	Stable	No	No			No	0	25.95	0	no	no	no
172	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	57	13.2	Stable	No	No	Signature.4	XRCC2	No	0	12.52	0	no	no	no
173	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	13.7	0	no	no	no
174	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	44	4.4		No	Yes or Unknown			No	0	35.68	0	no	no	no
175	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	51	3.5	Stable	No	Yes or Unknown			No	0	14.09	0	no	no	no
176	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	IV	61	3.9	Stable	No	Yes or Unknown			No	1	3.61	0	no	no	no
177	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	30	0		No	Yes or Unknown			Yes	0	29.93	0	no	no	no
178	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	17	2	Stable	No	No			No	0	40.54	0	no	no	no
179	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	0	3.5	Stable	No	No	Signature.8	BRCA1 | ERCC4	No	0	10.32	0	no	no	no
180	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	30	1.8		No	Yes or Unknown			Yes	0	36.3	0	no	no	no
181	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	1273	5.3	Stable	No	Yes or Unknown	Signature.8		No	0	47.97	0	no	no	no
182	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	8	12.3		No	Yes or Unknown	Signature.4		No	1	1.41	0	no	no	no
183	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	III	355	2.6	Stable	No	Yes or Unknown			No	1	22.28	0	no	no	no
184	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	I	32	26.6	Unstable	No	No	Signature.6	ARID1A	Yes	0	46.39	0	other-MMRd	mut-MMRd	yes
185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	52	0.9	Stable	No	Yes or Unknown			Yes	0	36.07	0	no	no	no
186	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	II	0	0		No	No			Yes	0	48.13	0	no	no	no
187	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	18	1	Stable	No	No			Yes	0	34.96	0	no	no	no
188	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	6	5.9	Stable	No	No			No	1	20.57	0	no	no	no
189	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	15	12.3		No	No	Signature.5	BRCA2 | MRE11A | MSH2	Yes	0	3.38	0	no	no	no
190	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	20	1	Stable	No	No			Yes	0	35.19	0	no	no	no
191	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	5.3	Stable	No	No		BRCA2 | MSH2	Yes	0	24.34	0	no	no	no
192	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	57	3.9	Stable	No	No			No	0	26.25	0	no	no	no
193	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	IV	9	6.1	Stable	No	No			No	1	6.51	0	no	no	no
194	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	22	1.8		No	No			No	0	28.29	0	no	no	no
195	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	II	8	1.8	Stable	No	No			No	0	32.2	0	no	no	no
196	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	44	4.4		No	No	Signature.1		No	0	13.63	0	no	no	no
197	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	0	10.8	Stable	No	Yes or Unknown	Signature.20	BRCA2	Yes	0	26.09	0	no	no	no
198	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	61	1.8		No	No	Signature.30		Yes	0	32.2	0	no	no	no
199	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	14	1	Stable	No	No			No	1	20.93	0	no	no	no
200	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	0	0.9	Stable	No	No			No	0	16.3	0	no	no	no
201	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	0	4.4	Stable	No	Yes or Unknown			No	1	33.94	0	no	no	no
202	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	I	11	1.8	Stable	No	No			No	1	8.74	0	no	no	no
203	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		7	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	0	27.5	0	no	no	yes
204	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	0	15.8	Stable	No	No	Signature.13	ERCC2	No	0	19.45	0	no	no	no
205	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	IV	11	3.5	Stable	No	No	Signature.5		No	0	47.84	0	no	no	no
206	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	26	11.8	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	6.28	0	no	no	no
207	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	20	5.3	Stable	No	No	Signature.2	ATM	No	0	18.3	0	no	no	no
208	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	0	7.9	Stable	No	No			No	0	9.95	0	no	no	no
209	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	54	1.8		No	Yes or Unknown			Yes	0	27.47	0	no	no	no
210	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2015	IV	1	10.5		No	No	Signature.2	ARID1A | FANCA	Yes	0	43.89	0	no	no	yes
211	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	27	0.9	Stable	No	No			No	0	13.9	0	no	no	no
212	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	0	4.4	Stable	No	No		BLM | BRCA2 | BRIP1	No	0	18.14	0	no	no	no
213	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	5	6.1	Stable	No	No		ARID1A	Yes	0	1.28	0	no	no	yes
214	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	II	196	4.4	Stable	No	Yes or Unknown			No	0	11.89	0	no	no	no
215	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	I	47	7.9	Stable	No	No			No	1	7.03	0	no	no	no
216	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	IV	66	2	Stable	No	No	Signature.5		No	1	5.49	0	no	no	no
217	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	33	24.6	Unstable	No	No	Signature.6	ARID1A	No	0	41.89	0	other-MMRd	mut-MMRd	yes
218	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	4.4	Stable	No	No		CHEK2	No	0	10.55	0	no	no	no
219	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	28	5.9	Stable	No	No			Yes	1	15.08	0	no	no	no
220	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	32	3.9		No	Yes or Unknown			No	0	22.57	0	no	no	no
221	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	1.8		No	No			Yes	0	30.55	0	no	no	no
222	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	48	3.5	Indeterminate	No	No			No	0	32.62	0	no	no	no
223	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	III	21	65.9	Unstable	No	No	Signature.6	ATM | BLM | FANCA | FANCC | MSH6 | MUTYH	Yes	0	25.63	0	mut-MMRd	mut-MMRd	no
224	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	18	2.6	Stable	No	No			Yes	0	16.26	0	no	no	no
225	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2015	II	0	6.1		No	Yes or Unknown		ARID1A	No	1	25.63	0	no	no	yes
226	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	6.1		No	No	Signature.4		No	0	34.89	0	no	no	no
227	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	975	3.5		No	Yes or Unknown	Signature.1		No	0	42.87	0	no	no	no
228	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	13	1		No	No			Yes	0	30.85	0	no	no	no
229	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	29	6.1		No	No			No	0	38.28	0	no	no	no
230	Non-ICI treated	Never received ICI	91 - 95	Female	Ovarian	2015	IV	13	4.4	Stable	No	No		ERCC5	No	0	30.16	0	no	no	no
231	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	5.3	Stable	No	No		ERCC3	Yes	0	19.22	0	no	no	no
232	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	0	3		No	No			No	0	19.84	0	no	no	no
233	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	73	3	Stable	No	No			No	1	15.77	0	no	no	no
234	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	0	9.7	Indeterminate	No	No	Signature.3	MUTYH	No	0	20.5	0	no	no	no
235	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	0	6.1	Stable	No	Yes or Unknown			No	1	18.14	0	no	no	no
236	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2015	IV	184	7.9	Stable	No	Yes or Unknown	Signature.7		No	1	14.62	0	no	no	no
237	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	14	2.6	Stable	No	No			No	0	21.85	0	no	no	no
238	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	74	3.5	Stable	No	No	Signature.2		No	0	38.37	0	no	no	no
239	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	64	1.8	Stable	No	No			No	0	5.75	0	no	no	no
240	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	I	1382	3.5	Stable	No	No			No	0	52.34	0	no	no	no
241	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	19	2.6		No	Yes or Unknown		BRCA2	No	0	34.96	0	no	no	no
242	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	260	2.6	Stable	No	No			Yes	0	24.71	0	no	no	no
243	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	30	5.3	Stable	No	No			No	0	6.83	0	no	no	no
244	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	16	5.9		No	No			No	0	36.8	0	no	no	no
245	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	18	2	Stable	No	No			No	1	13.01	0	no	no	no
246	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	0	0	Stable	No	No			Yes	0	22.44	0	no	no	no
247	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2015	II	857	0	Stable	No	Yes or Unknown			No	0	54.74	0	no	no	no
248	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	154	19.3	Stable	No	Yes or Unknown	Signature.4	ARID1A | ATM	No	0	18.2	0	no	no	yes
249	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	14	5.9	Stable	No	No			No	1	42.41	0	no	no	no
250	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	20	0.9	Stable	No	No			Yes	0	22.31	0	no	no	no
251	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	22	2.6		No	No			No	0	46.29	0	no	no	no
252	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	70	0.9	Stable	No	Yes or Unknown			No	0	15.67	0	no	no	no
253	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	36	1.8	Stable	No	Yes or Unknown			No	0	26.02	0	no	no	no
254	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	II	0	2.6	Stable	No	No		ARID1A	Yes	0	18.89	0	no	no	yes
255	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	II	0	4.4	Stable	No	No			No	0	12.62	0	no	no	no
256	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	39	7		No	Yes or Unknown			No	0	45.8	0	no	no	no
257	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	125	10.5	Stable	No	No	Signature.13	PMS2	No	1	9.2	0	no	no	no
258	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	112	3	Stable	No	Yes or Unknown			No	0	40.44	0	no	no	no
259	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	17	0.9	Stable	No	Yes or Unknown			Yes	0	6.31	0	no	no	no
260	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2018	IV	120	0	Stable	No	Yes or Unknown			Yes	0	10.78	0	no	no	no
261	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	22	8.9	Stable	No	No		ATM	Yes	0	41.59	0	no	no	no
262	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	57	12.8	Indeterminate	No	No	Signature.4		No	1	3.71	0	no	no	no
263	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	36	13.2	Stable	No	No	Signature.1		No	0	2.46	0	no	no	no
264	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	II	10	8.8	Stable	No	No	Signature.29	ARID1A	Yes	0	11.79	0	no	no	yes
265	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	122	1.8	Stable	No	No			Yes	0	18.04	0	no	no	no
266	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	26	0.9	Stable	No	No		ARID1A	No	0	17.74	0	no	no	yes
267	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	85	3		No	No			No	0	38.01	0	no	no	no
268	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	8	2.6	Stable	No	Yes or Unknown			No	1	6.41	0	no	no	no
269	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	IV	0	74.6	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | ERCC2 | ERCC5 | MLH1 | MSH3	No	0	21.39	0	mut-MMRd	mut-MMRd	yes
270	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	16	3.9	Stable	No	No			No	0	40.25	0	no	no	no
271	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	125	0.9	Stable	No	Yes or Unknown			No	1	16.82	0	no	no	no
272	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	19	5.9	Stable	No	No			No	0	41.95	0	no	no	no
273	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2018	III	0	43	Unstable	No	No	Signature.6	ATM | MSH3 | XRCC2	Yes	0	16.53	0	other-MMRd	mut-MMRd	no
274	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.45	0	no	no	no
275	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	2.6	Stable	No	No			No	0	29.24	0	no	no	no
276	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	236	4.4	Stable	No	Yes or Unknown			No	0	20.6	0	no	no	no
277	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	33	3.5		No	No		ARID1A	No	0	37.49	0	no	no	yes
278	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	25	3.5		No	No			No	0	37.88	0	no	no	no
279	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	36	3.5	Stable	No	No			Yes	0	25.59	0	no	no	no
280	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2017	I	0	0	Stable	No	No			No	0	18.66	0	no	no	no
281	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	82	0	Stable	No	No			No	0	47.18	0	no	no	no
282	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	1	11.76	0	no	no	no
283	Non-ICI treated	Never received ICI	51 - 55	Female	Bladder	2017	II	0	8.8	Stable	No	No	Signature.3		Yes	0	29.83	0	no	no	no
284	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	36	5.3	Stable	No	No			Yes	0	27.37	0	no	no	no
285	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2015		81	11.8	Stable	No	No	Signature.13		Yes	0	42.18	0	no	no	no
286	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	II	12	49.2	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | PMS1 | RAD50 | RAD52	No	0	43.66	0	other-MMRd	mut-MMRd	yes
287	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	I	23	2.6		No	No			No	0	39.82	0	no	no	no
288	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	54	4.9	Stable	No	No		RAD50	No	0	50.27	0	no	no	no
289	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2017	I	0	5.3	Stable	No	No		CHEK2	No	0	19.81	0	no	no	no
290	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	7	Stable	No	No			No	1	7.72	0	no	no	no
291	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018	II	30	0	Stable	No	Yes or Unknown			No	0	9.89	0	no	no	no
292	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	98	0		No	No			No	0	35.12	0	no	no	no
293	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	42	4.4	Stable	No	No			No	0	38.9	0	no	no	no
294	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	36	10.5	Stable	No	No	Signature.4		No	0	23.33	0	no	no	no
295	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	III	38	7.9	Stable	No	No			No	1	4.67	0	no	no	no
296	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	IV	28	3.5	Stable	No	Yes or Unknown			No	0	48.95	0	no	no	no
297	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	56	0		No	No			No	0	29.27	0	no	no	no
298	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	12	2.6		No	No			Yes	0	15.34	0	no	no	no
299	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		47	3	Stable	No	No			No	0	50.3	0	no	no	no
300	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		176	0	Stable	No	No	Signature.3		No	0	18.1	0	no	no	no
301	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	5	3	Stable	No	No			Yes	0	38.18	0	no	no	no
302	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	26	3.9	Stable	No	No		FANCA	No	0	49.91	0	no	no	no
303	Non-ICI treated	Never received ICI	91 - 95	Male	SCLC	2016	II	44	5.9	Stable	No	No	Signature.27		No	1	35.48	0	no	no	no
304	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	10	5.3	Stable	No	No		PMS2	No	0	22.57	0	no	no	no
305	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	157	0.9	Stable	No	Yes or Unknown			No	0	30.42	0	no	no	no
306	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	12	0.9		No	Yes or Unknown			No	0	25.4	0	no	no	no
307	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	18	24.6	Stable	No	No	Signature.4		No	1	12.71	0	no	no	no
308	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	34	1	Stable	No	Yes or Unknown			No	0	37.85	0	no	no	no
309	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	49	1.8	Stable	No	Yes or Unknown			No	0	19.98	0	no	no	no
310	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	II	65	4.9	Stable	No	Yes or Unknown		ERCC4	No	0	39.36	0	no	no	no
311	Non-ICI treated	Never received ICI	31 - 35	Male	Esophageal	2016	III	0	3.9	Stable	No	No			Yes	0	39.06	0	no	no	no
312	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	III	16	1.8	Stable	No	No			No	1	16.43	0	no	no	no
313	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	13	5.9	Stable	No	No			No	1	31.74	0	no	no	no
314	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		No	1	10.84	0	no	no	no
315	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	3.9	Stable	No	No			Yes	0	39.39	0	no	no	no
316	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	0	0	Stable	No	No			Yes	0	34.56	0	no	no	no
317	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	I	164	1.8	Stable	No	Yes or Unknown		CHEK2	No	1	31.57	0	no	no	no
318	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2015	III	80	0	Stable	No	Yes or Unknown			Yes	0	49.81	0	no	no	no
319	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		BLM	No	0	24.38	0	no	no	no
320	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	24.34	0	no	no	no
321	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	197	10.5		No	No	Signature.4	SLX4	No	0	31.51	0	no	no	no
322	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	I	16	0.9	Stable	No	No			No	0	7.39	0	no	no	no
323	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	II	46	1.8		No	No			No	0	42.02	0	no	no	no
324	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	570	1.8	Stable	No	Yes or Unknown			No	0	41.2	0	no	no	no
325	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	8	0.9	Stable	No	No			No	1	17.94	0	no	no	no
326	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	25	2.6	Stable	No	No			No	0	27.56	0	no	no	no
327	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	III	252	7.9		No	Yes or Unknown	Signature.5	CHEK2	Yes	0	21.88	0	no	no	no
328	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	34	1.8	Stable	No	No		BRCA1 | CHEK2	No	0	12.94	0	no	no	no
329	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	2	Stable	No	No			No	0	38.37	0	no	no	no
330	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	147	2.6	Stable	No	Yes or Unknown			No	0	25.86	0	no	no	no
331	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	I	20	0.9	Stable	No	No			No	0	20.9	0	no	no	no
332	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2016	III	412	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A | BLM	Yes	1	32	0	no	no	yes
333	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	46	0	Stable	No	No			No	0	36.04	0	no	no	no
334	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	15	3	Stable	No	No			No	0	7.29	0	no	no	no
335	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	55	0.9	Stable	No	No			No	0	33.97	0	no	no	no
336	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	19	3.5	Stable	No	No			Yes	0	7.79	0	no	no	no
337	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	48	5.9	Stable	No	No	Signature.4		No	1	31.9	0	no	no	no
338	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	6	9.7		No	No	Signature.4	BRIP1	Yes	1	6.47	0	no	no	no
339	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	2	Stable	No	No			Yes	0	28.19	0	no	no	no
340	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	114	6.1	Stable	No	Yes or Unknown			Yes	0	37.29	0	no	no	no
341	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	8	6.1	Stable	No	No	Signature.3	BRCA1	No	0	6.9	0	no	no	no
342	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	32	2.6	Stable	No	Yes or Unknown	Signature.5		No	0	9.53	0	no	no	no
343	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	131	1.8	Stable	No	Yes or Unknown		BRIP1	No	0	12.55	0	no	no	no
344	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	14	1.8	Stable	No	No			No	0	10.25	0	no	no	no
345	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	IV	159	6.1		No	Yes or Unknown	Signature.17	ARID1A	No	1	9	0	no	no	yes
346	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	22	0.9		No	No			Yes	0	26.38	0	no	no	no
347	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	20	2.6	Stable	No	No			Yes	0	24.57	0	no	no	no
348	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2015	II	55	0	Stable	No	No			No	0	49.02	0	no	no	no
349	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	4.4	0	no	no	no
350	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	14	4.4	Stable	No	No			Yes	0	14.72	0	no	no	no
351	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	III	0	3.5	Stable	No	No		ARID1A	Yes	0	39.29	0	no	no	yes
352	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	26	6.1	Stable	No	No	Signature.4	MRE11A	No	0	16.69	0	no	no	no
353	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	24	3.5		No	No			No	0	33.35	0	no	no	no
354	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	11	5.9	Stable	No	No			No	1	8.15	0	no	no	no
355	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	III	0	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	16.82	0	no	no	no
356	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	50	2.6		No	No			No	0	29.7	0	no	no	no
357	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	I	37	56.2	Unstable	No	No	Signature.6	ARID1A | MLH1 | MRE11A | MSH3 | RAD50	No	0	12.91	0	mut-MMRd	mut-MMRd	yes
358	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2016	IV	0	7.9	Stable	No	No	Signature.5		Yes	0	37.82	0	no	no	no
359	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	24	5.3	Stable	No	No			No	0	36.21	0	no	no	no
360	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	34	2	Stable	No	No			No	0	38.8	0	no	no	no
361	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	6.1	Stable	No	No	Signature.1		No	1	27.4	0	no	no	no
362	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		0	5.3		No	No			No	1	11.63	0	no	no	no
363	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	22	12.8	Stable	No	No	Signature.1	ARID1A	No	0	37.45	0	no	no	yes
364	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017		11	3.5	Stable	No	No			No	1	7.82	0	no	no	no
365	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	21	4.4		No	No	Signature.29		No	1	1.51	0	no	no	no
366	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	III	6	7	Stable	No	No	Signature.3	MUTYH | SLX4	No	0	9.82	0	no	no	no
367	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	113	12.3	Stable	No	Yes or Unknown	Signature.30	NTHL1	Yes	0	10.58	0	no	no	no
368	Non-ICI treated	Never received ICI	46 - 50	Female	Renal	2016	I	3	0.9	Stable	No	No			No	0	24.15	0	no	no	no
369	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		1	4.9	Stable	No	Yes or Unknown			No	1	17.22	0	no	no	no
370	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	27	5.3	Stable	No	Yes or Unknown		SLX4	Yes	0	7.82	0	no	no	no
371	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		57	0		No	No			No	0	23.23	0	no	no	no
372	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	I	24	0.9	Stable	No	No			No	0	13.47	0	no	no	no
373	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	14	3.5	Stable	No	No			No	1	12.42	0	no	no	no
374	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2016	III	0	1.8	Stable	No	No			No	1	11.96	0	no	no	no
375	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	2.6	Stable	No	No		BRCA1	No	0	17.94	0	no	no	no
376	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	3.5		No	No		CHEK2 | TP53BP1	No	0	31.77	0	no	no	no
377	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	100	0	Stable	No	No			No	0	6.93	0	no	no	no
378	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	II	47	7	Stable	No	No	Signature.1		No	0	25.33	0	no	no	no
379	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	0	4.4	Stable	No	No	Signature.3	RAD54L	No	0	27.5	0	no	no	no
380	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	I	22	1	Stable	No	Yes or Unknown			No	0	47.84	0	no	no	no
381	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	9	3.5	Stable	No	Yes or Unknown	Signature.1		No	0	13.54	0	no	no	no
382	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	2.6	Stable	No	Yes or Unknown			No	0	24.74	0	no	no	no
383	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	I	42	6.1	Stable	No	No			No	0	12.91	0	no	no	no
384	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	18	1.8	Stable	No	No			No	0	30.92	0	no	no	no
385	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	IV	0	3.5		No	No	Signature.1		No	1	5.72	0	no	no	no
386	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	I	22	3.5		No	No		ARID1A	No	0	34.2	0	no	no	yes
387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	59	1.8	Stable	No	No		BRCA1 | BRCA2	No	0	32.2	0	no	no	no
388	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	207	1.8		No	Yes or Unknown			No	1	30.92	0	no	no	no
389	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	1	0.9	Stable	No	No			Yes	1	2.4	0	no	no	no
390	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	26	3.5	Stable	No	No			Yes	0	23.36	0	no	no	no
391	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	62	6.1	Stable	No	No	Signature.3	BRCA2	No	0	25.49	0	no	no	no
392	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	29	2.6	Stable	No	Yes or Unknown		ATM	No	0	26.64	0	no	no	no
393	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	14	2	Stable	No	No		ATM	No	0	39.59	0	no	no	no
394	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	3.9		No	Yes or Unknown			No	0	36.27	0	no	no	no
395	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	27	3.5	Stable	No	No			No	0	25.59	0	no	no	no
396	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	III	0	1	Stable	No	No			No	0	40.44	0	no	no	no
397	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	I	3	3.5	Stable	No	No		MSH3	Yes	0	15.18	0	no	no	no
398	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	49	0.9	Stable	No	No			No	0	16.95	0	no	no	no
399	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	5.3	Stable	No	Yes or Unknown		RAD50	No	0	12.12	0	no	no	no
400	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	29	0.9		No	No			No	0	29.44	0	no	no	no
401	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	21	4.4	Stable	No	No			No	0	6.67	0	no	no	no
402	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	35	15.8	Stable	No	No	Signature.4	ATR	No	0	24.15	0	no	no	no
403	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	22	1	Stable	No	No			Yes	0	35.45	0	no	no	no
404	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	13	3.9	Stable	No	No			Yes	0	36.8	0	no	no	no
405	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	27	4.4	Stable	No	Yes or Unknown			No	0	28.91	0	no	no	no
406	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	IV	113	4.9	Stable	No	Yes or Unknown			No	1	17.12	0	no	no	no
407	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	13	1	Stable	No	Yes or Unknown			Yes	0	12.62	0	no	no	no
408	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	9	4.9	Stable	No	No			No	1	47.87	0	no	no	no
409	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	1.8	Stable	No	No			Yes	0	10.12	0	no	no	no
410	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	12	3	Stable	No	No			No	1	40.84	0	no	no	no
411	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2018	IV	0	4.4	Stable	No	No		BLM | SLX4	No	0	7.69	0	no	no	no
412	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	0	24.6		No	Yes or Unknown	Signature.4		No	1	31.74	0	no	no	no
413	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	31	1.8	Stable	No	No			Yes	0	24.21	0	no	no	no
414	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	10	2	Stable	No	No		BRCA2	Yes	1	1.84	0	no	no	no
415	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	I	0	0		No	No			No	0	36.21	0	no	no	no
416	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016		0	3	Stable	No	No			Yes	0	32.85	0	no	no	no
417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	2		No	No			No	0	34.92	0	no	no	no
418	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	6.1	Stable	No	No		BRCA2	No	0	31.8	0	no	no	no
419	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	24	1.8	Stable	No	No			Yes	0	25.03	0	no	no	no
420	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	18	5.3		No	No	Signature.2		Yes	0	30.85	0	no	no	no
421	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	69	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	22.41	0	no	no	yes
422	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	1324	7	Stable	No	Yes or Unknown	Signature.29		No	0	52.7	0	no	no	no
423	Non-ICI treated	Never received ICI	91 - 95	Male	Pancreatic	2017	IV	18	4.4	Stable	No	No	Signature.3	BRCA1 | MRE11A	No	0	3.22	0	no	no	no
424	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	2.6	Stable	No	No		ARID1A	No	0	10.51	0	no	no	yes
425	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	IV	0	4.4	Stable	No	No			No	1	6.05	0	no	no	no
426	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	9	6.1		No	No		ATM	No	1	19.94	0	no	no	no
427	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016		0	0.9		No	No			Yes	0	32.89	0	no	no	no
428	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2018		19	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	14.09	0	no	no	no
429	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	41	5.9	Stable	No	No			Yes	0	39.56	0	no	no	no
430	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	29	1	Stable	No	No			No	0	47.44	0	no	no	no
431	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	1500	4.4	Stable	No	No			No	0	50.83	0	no	no	no
432	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	28	9.7	Stable	No	No	Signature.1		No	0	29.86	0	no	no	no
433	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	26.78	0	no	no	no
434	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	10	5.3	Stable	No	No		ARID1A	No	0	20.86	0	no	no	yes
435	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	28	3.5	Stable	No	No		PMS1	Yes	0	24.54	0	no	no	no
436	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	41	0.9	Stable	No	No	Signature.1		Yes	0	16.53	0	no	no	no
437	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	156	5.3	Stable	No	Yes or Unknown		RAD52	No	0	22.24	0	no	no	no
438	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	0	4.9		No	No			Yes	1	7	0	no	no	no
439	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	II	27	0	Stable	No	No			Yes	0	48.23	0	no	no	no
440	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	56	31.6	Unstable	No	No	Signature.1	ERCC5	No	0	35.35	0	other-MMRd	mut-MMRd	no
441	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	10	1.8	Stable	No	No			No	0	20.37	0	no	no	no
442	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	36	14.9	Stable	No	No	Signature.10	ATM | MSH3	Yes	0	32.26	0	no	no	no
443	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	27	5.3		No	No	Signature.3	PMS1	No	0	35.42	0	no	no	no
444	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	13	4.4	Stable	No	No	Signature.1		No	0	15.61	0	no	no	no
445	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		0	1	Stable	No	No			No	0	48.46	0	no	no	no
446	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	33	3.5	Stable	No	Yes or Unknown			No	0	13.31	0	no	no	no
447	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	III	133	2.6		No	Yes or Unknown			No	1	10.81	0	no	no	no
448	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	23	0.9	Stable	No	No			No	0	36.07	0	no	no	no
449	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2018	IV	19	2.6	Stable	No	No	Signature.30	BRCA2	No	0	15.77	0	no	no	no
450	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	643	3.5	Stable	No	Yes or Unknown			No	0	49.51	0	no	no	no
451	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	87	5.3	Stable	No	No			Yes	0	16	0	no	no	no
452	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	257	4.9		No	Yes or Unknown	Signature.5	PALB2	Yes	0	43.24	0	no	no	no
453	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	20	3.5	Stable	No	No			Yes	0	40.77	0	no	no	no
454	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	26	37.4	Unstable	No	No	Signature.15	ARID1A | ATM | MLH1 | MUTYH	No	1	9.3	0	mut-MMRd	mut-MMRd	yes
455	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	I	19	6.1		No	Yes or Unknown			No	0	36.47	0	no	no	no
456	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	II	1249	1.8	Stable	No	No			No	0	43.73	0	no	no	no
457	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	28	9.7	Stable	No	No	Signature.1		No	1	7.49	0	no	no	no
458	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	15	2.6		No	No			No	0	34.73	0	no	no	no
459	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4	Stable	No	No			No	0	23.43	0	no	no	no
460	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	7	Stable	No	No		ARID1A	Yes	0	30.42	0	no	no	yes
461	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	33	2.6	Stable	No	Yes or Unknown			No	0	21.09	0	no	no	no
462	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	I	18	6.9	Stable	No	No	Signature.1	ERCC3 | MUTYH	No	0	46.92	0	no	no	no
463	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	52.7	0	no	no	no
464	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	0	6.1	Stable	No	No	Signature.29		No	1	19.19	0	no	no	no
465	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	0	2.6	Stable	No	No			Yes	1	10.09	0	no	no	no
466	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	15	2.6	Stable	No	No			Yes	0	15.74	0	no	no	no
467	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	34	0	Stable	No	No			No	0	9.17	0	no	no	no
468	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	23	5.3	Stable	No	Yes or Unknown			No	0	27.17	0	no	no	no
469	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	15	0	Stable	No	No			No	0	8.25	0	no	no	no
470	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	50	2.6	Stable	No	No			No	0	17.05	0	no	no	no
471	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	10.09	0	no	no	no
472	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2017	I	514	1.8	Stable	No	No			No	0	27.7	0	no	no	no
473	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	0	6.1	Stable	No	No	Signature.13	BRCA2	No	0	25.49	0	no	no	no
474	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	8	5.3	Stable	No	Yes or Unknown			No	1	21.72	0	no	no	no
475	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	34	3.5		No	No			Yes	0	30.92	0	no	no	no
476	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	37	1.8	Stable	No	No			Yes	0	12.39	0	no	no	no
477	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2015	I	1171	0.9	Stable	No	No			No	0	44.65	0	no	no	no
478	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	60	4.9	Stable	No	No		ARID1A	No	0	22.08	0	no	no	yes
479	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	40	2	Stable	No	No			Yes	1	7.2	0	no	no	no
480	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	20	0		No	No			Yes	0	30.55	0	no	no	no
481	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	27	1.8	Stable	No	No			No	0	41.23	0	no	no	no
482	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	III	0	3.9	Stable	No	No			No	0	36.73	0	no	no	no
483	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	52	13.8		No	No	Signature.4	ATM | NBN	No	1	27.07	0	no	no	no
484	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	12	4.9	Stable	No	Yes or Unknown		ATM | BRCA1	No	1	27.33	0	no	no	no
485	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	III	0	0		No	No			No	0	33.74	0	no	no	no
486	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	38	6.9	Stable	No	No	Signature.4	MSH2	Yes	1	15.18	0	no	no	no
487	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	36	2.6	Stable	No	Yes or Unknown			No	0	13.14	0	no	no	no
488	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	4.9	Stable	No	No	Signature.13		Yes	1	3.48	0	no	no	no
489	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	185	8.8	Stable	No	Yes or Unknown		FANCA	No	0	19.19	0	no	no	no
490	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	10	10.8	Indeterminate	No	No	Signature.4	BRIP1	No	1	1.05	0	no	no	no
491	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	III	0	2.6		No	No	Signature.4		No	0	34.92	0	no	no	no
492	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.1	BRCA2 | RAD50	No	0	7.62	0	no	no	no
493	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	9	7	Stable	No	No	Signature.30		No	1	9.07	0	no	no	no
494	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	2	12.3		No	No	Signature.4	FANCA	No	1	4.73	0	no	no	no
495	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	20	0.9	Stable	No	No			Yes	0	38.64	0	no	no	no
496	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	9	4.4	Stable	No	No		TP53BP1	No	0	22.18	0	no	no	no
497	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		0	3	Stable	No	No			No	1	12.29	0	no	no	no
498	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	10	7.9	Stable	No	No			No	0	17.12	0	no	no	no
499	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	27	1.8		No	No			Yes	0	45.86	0	no	no	no
500	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2015		158	4.9	Stable	No	No			No	1	6.51	0	no	no	no
501	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	2.6	Stable	No	No		PALB2	Yes	0	9.86	0	no	no	no
502	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	1		No	No			No	0	31.97	0	no	no	no
503	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	II	42	0.9	Stable	No	No			No	0	49.15	0	no	no	no
504	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	II	43	10.5	Stable	No	No	Signature.4		Yes	0	10.15	0	no	no	no
505	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	8	29		No	No	Signature.4	BRCA2 | ERCC3 | TP53BP1	No	0	24.15	0	no	no	no
506	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	193	2	Stable	No	Yes or Unknown		BRCA2	No	0	49.35	0	no	no	no
507	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	III	0	14.9		No	No	Signature.13	ARID1A	No	1	21.45	0	no	no	yes
508	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	24	10.5	Stable	No	No	Signature.1		No	0	10.09	0	no	no	no
509	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	29	2	Stable	No	No			No	0	36.57	0	no	no	no
510	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	II	0	6.1		No	Yes or Unknown	Signature.3		No	0	38.18	0	no	no	no
511	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	18	1.8	Stable	No	No			No	0	18.96	0	no	no	no
512	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	0	0		No	No			No	0	6.18	0	no	no	no
513	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2017	III	0	5.3	Stable	No	No	Signature.2		Yes	0	24.9	0	no	no	no
514	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	9	7.9	Stable	No	No	Signature.13		Yes	1	43.6	0	no	no	no
515	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		208	12.8	Stable	No	No		ARID1A | BRCA2 | FANCA	No	0	51.68	0	no	no	yes
516	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015		733	4.4	Stable	No	No			Yes	0	51.91	0	no	no	no
517	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	III	292	3.5	Stable	No	No			Yes	0	26.58	0	no	no	no
518	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	II	12	0	Stable	No	No			No	0	13.77	0	no	no	no
519	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	7.03	0	no	no	no
520	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	81	1	Stable	No	No			No	0	50.96	0	no	no	no
521	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	32	6.1	Stable	No	No		ARID1A	No	0	14.72	0	no	no	yes
522	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	19	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	39.23	0	no	no	no
523	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	III	0	5.9	Stable	No	No	Signature.3	ERCC5 | PARP1	No	0	48.72	0	no	no	no
524	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	11.01	0	no	no	no
525	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	10	11.4	Stable	No	No	Signature.1		Yes	0	10.25	0	no	no	no
526	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	33	1.8	Stable	No	No			Yes	0	50.76	0	no	no	no
527	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	II	29	3	Stable	No	No		BRCA2	No	1	11.83	0	no	no	no
528	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	I	0	5.3	Stable	No	No			No	0	17.54	0	no	no	no
529	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2018	IV	0	7.9	Stable	No	No			No	0	14.19	0	no	no	no
530	Non-ICI treated	Never received ICI	76 - 80	Male	Renal	2015	III	0	0	Stable	No	No			No	0	55.16	0	no	no	no
531	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	III	43	0	Stable	No	No			No	0	51.71	0	no	no	no
532	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	44	6.1	Stable	No	No	Signature.26		No	0	28.35	0	no	no	no
533	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	II	1100	0.9	Stable	No	Yes or Unknown			No	0	54.83	0	no	no	no
534	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	0	4.9	Stable	No	No			No	1	8.57	0	no	no	no
535	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	0	3.5	Stable	No	Yes or Unknown			Yes	1	8.64	0	no	no	no
536	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		1551	1.8	Stable	No	No			No	0	55.03	0	no	no	no
537	Non-ICI treated	Never received ICI	46 - 50	Male	Ovarian	2017		548	4.4	Stable	No	Yes or Unknown			No	0	27.6	0	no	no	no
538	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	832	4.4	Stable	No	No			No	0	52.47	0	no	no	no
539	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		0	3.9	Stable	No	No			Yes	0	9.86	0	no	no	no
540	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	10	2	Stable	No	No			Yes	0	54.41	0	no	no	no
541	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2015	III	43	3	Stable	No	No			No	0	53.49	0	no	no	no
542	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	7	Stable	No	No	Signature.1		No	1	43.73	0	no	no	no
543	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	III	0	3.9	Stable	No	No			No	1	22.93	0	no	no	no
544	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	0	0	Stable	No	Yes or Unknown			No	1	15.08	0	no	no	no
545	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2015	I	0	1	Stable	No	No			No	1	18.27	0	no	no	no
546	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.35	0	no	no	no
547	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	0	3	Stable	No	No	Signature.1		Yes	1	11.5	0	no	no	no
548	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	615	6.1	Stable	No	Yes or Unknown			No	0	55.06	0	no	no	no
549	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	87	0	Stable	No	Yes or Unknown			No	0	54.41	0	no	no	no
550	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	0	6.9	Stable	No	No	Signature.1	ERCC2	Yes	0	54.97	0	no	no	no
551	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	0	3	Stable	No	No			No	0	49.05	0	no	no	no
552	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	12	3	Stable	No	No			No	1	8.64	0	no	no	no
553	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	0	3	Indeterminate	No	No	Signature.13		No	1	8.97	0	no	no	no
554	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	1084	3.5	Stable	No	No			No	0	47.93	0	no	no	no
555	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	35	19.7	Stable	No	No	Signature.4	BRIP1	No	0	48.13	0	no	no	no
556	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	III	1457	5.3	Stable	No	Yes or Unknown			No	0	55.2	0	no	no	no
557	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	II	0	0	Stable	No	No			No	0	51.91	0	no	no	no
558	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	18	2	Stable	No	Yes or Unknown			No	1	27.14	0	no	no	no
559	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	18	3	Stable	No	No			No	1	54.37	0	no	no	no
560	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	12	6.9	Stable	No	No			No	0	54.9	0	no	no	no
561	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	36	2	Stable	No	No			No	0	49.28	0	no	no	no
562	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1470	12.3	Stable	No	Yes or Unknown	Signature.2		No	0	54.24	0	no	no	no
563	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	22	4.9	Stable	No	No			Yes	0	52.24	0	no	no	no
564	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	IV	0	6.9	Stable	No	Yes or Unknown	Signature.5		No	1	16.76	0	no	no	no
565	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2015	I	0	2.6		No	No			No	0	48.95	0	no	no	no
566	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.94	0	no	no	no
567	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	15	4.9	Stable	No	Yes or Unknown			No	1	39.49	0	no	no	no
568	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	4.9	Stable	No	No	Signature.4	ATR | ERCC3	Yes	1	3.15	0	no	no	no
569	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	IV	39	11.8	Stable	No	No	Signature.2	ARID1A | BRCA1 | MDC1	Yes	1	23.23	0	no	no	yes
570	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	35	5.3	Stable	No	Yes or Unknown	Signature.7		Yes	0	9.43	0	no	no	no
571	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2015	III	599	2.6	Stable	No	Yes or Unknown	Signature.24		No	1	40.05	0	no	no	no
572	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2015	I	0	3	Stable	No	No			No	0	47.87	0	no	no	no
573	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	II	0	3.9	Stable	No	Yes or Unknown		ARID1A	No	1	10.28	0	no	no	yes
574	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	85	3.9	Stable	No	Yes or Unknown			No	1	7.69	0	no	no	no
575	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	6	4.4	Stable	No	No		ARID1A	No	0	29.17	0	no	no	yes
576	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	150	15.7	Stable	No	Yes or Unknown	Signature.8		No	1	5.65	0	no	no	no
577	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	11	3.9	Stable	No	No			No	1	23.39	0	no	no	no
578	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	1649	0.9	Stable	No	Yes or Unknown			No	0	54.51	0	no	no	no
579	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	30	2	Stable	No	No		ARID1A	No	0	27.7	0	no	no	yes
580	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	III	13	5.3	Stable	No	Yes or Unknown			No	0	55.16	0	no	no	no
581	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	16	4.9	Stable	No	Yes or Unknown		BRCA1	No	1	31.01	0	no	no	no
582	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	0	3	Stable	No	No		ARID1A | CHEK2	No	1	19.45	0	no	no	yes
583	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2015	I	7	1	Stable	No	No			No	0	50.79	0	no	no	no
584	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1359	0	Stable	No	Yes or Unknown	Signature.30		No	0	54.11	0	no	no	no
585	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	52	0.9		No	Yes or Unknown	Signature.1		No	1	53.68	0	no	no	no
586	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	0	3	Stable	No	Yes or Unknown			No	1	5.95	0	no	no	no
587	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	45	3.9	Stable	No	No		ERCC4	Yes	0	50.1	0	no	no	no
588	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	47	3	Stable	No	No			No	0	11.73	0	no	no	no
589	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	I	49	3.5	Stable	No	No			No	0	55.23	0	no	no	no
590	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	I	0	1.8	Stable	No	No			Yes	0	55.16	0	no	no	no
591	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	III	0	7.9		No	No	Signature.5	BRCA2 | MSH6	No	0	29.7	0	no	no	no
592	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	0	4.4	Stable	No	No			No	1	26.61	0	no	no	no
593	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	5	7.9	Stable	No	Yes or Unknown	Signature.9		No	0	42.81	0	no	no	no
594	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	0	4.9	Stable	No	No	Signature.3	BRCA2	No	1	19.25	0	no	no	no
595	Non-ICI treated	Never received ICI	36 - 40	Female	Gastric	2015	I	61	0		No	No			Yes	0	51.09	0	no	no	no
596	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	27	18.7	Stable	No	No	Signature.4	RAD50	No	0	44.94	0	no	no	no
597	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2015	IV	29	3	Stable	No	Yes or Unknown			No	0	53.98	0	no	no	no
598	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	7	0	Stable	No	Yes or Unknown		CHEK2	No	1	30.92	0	no	no	no
599	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	26	0	Stable	No	No			No	1	32.56	0	no	no	no
600	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	0	5.9	Stable	No	No	Signature.1		No	0	18.6	0	no	no	no
601	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	III	26	1.8	Stable	No	No			No	1	51.68	0	no	no	no
602	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	32	7.9	Stable	No	No	Signature.4		Yes	1	12.45	0	no	no	no
603	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	140	5.9	Stable	No	Yes or Unknown	Signature.1		No	0	11.24	0	no	no	no
604	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	25	3.9	Stable	No	Yes or Unknown			No	1	16.79	0	no	no	no
605	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015		0	0	Stable	No	No			Yes	0	33.97	0	no	no	no
606	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	544	3		No	Yes or Unknown			No	1	20.96	0	no	no	no
607	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	IV	38	8.9	Stable	No	No	Signature.13	BRCA2	Yes	1	4.83	0	no	no	no
608	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	3	1	Stable	No	Yes or Unknown			No	1	29.86	0	no	no	no
609	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	18.79	0	no	no	no
610	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	IV	0	0	Stable	No	No			No	0	54.44	0	no	no	no
611	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	0	32.5	Stable	No	No	Signature.4	ARID1A | MRE11A	No	1	6.18	0	no	no	yes
612	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	0	1.8		No	No			No	0	26.51	0	no	no	no
613	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	46	2	Stable	No	No			No	0	54.8	0	no	no	no
614	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	19	13.8	Stable	No	No	Signature.1	ATM	No	1	49.68	0	no	no	no
615	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	II	83	2	Stable	No	No			Yes	0	51.55	0	no	no	no
616	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	235	1.8	Stable	No	Yes or Unknown			No	0	53.26	0	no	no	no
617	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2015	III	243	3	Stable	No	Yes or Unknown			Yes	0	49.64	0	no	no	no
618	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	4.9	Stable	No	No			Yes	0	53.62	0	no	no	no
619	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	910	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	54.34	0	no	no	no
620	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2015	I	69	2	Stable	No	No			No	0	45.96	0	no	no	no
621	Non-ICI treated	Never received ICI	66 - 70	Female	Head & Neck	2015	IV	773	3.5	Stable	No	Yes or Unknown		MSH2	No	0	54.28	0	no	no	no
622	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	127	1		No	Yes or Unknown			No	1	43.73	0	no	no	no
623	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	67	0	Stable	No	No			Yes	0	54.87	0	no	no	no
624	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	33	14.8	Stable	No	No	Signature.7		Yes	0	51.91	0	no	no	no
625	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	41	13.2		No	No	Signature.11	FANCA	No	0	51.58	0	no	no	no
626	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	49	2	Stable	No	Yes or Unknown			Yes	0	53.13	0	no	no	no
627	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2015		10	3	Stable	Yes or Unknown	Yes or Unknown			No	0	9.36	0	no	no	no
628	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	8.9	Stable	No	No	Signature.1		No	1	9.53	0	no	no	no
629	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	464	4.4		No	Yes or Unknown		NBN	No	1	40.67	0	no	no	no
630	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	182	3	Stable	No	Yes or Unknown			No	0	50.33	0	no	no	no
631	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	56	9.8	Stable	No	No	Signature.29		No	1	12.06	0	no	no	no
632	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	III	2	4.9	Stable	No	No			No	1	14.82	0	no	no	no
633	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	78	0.9		No	No			No	0	53.49	0	no	no	no
634	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	III	1254	1.8	Stable	No	No	Signature.3		No	0	43.66	0	no	no	no
635	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	8	11.8	Stable	No	No	Signature.4	BRCA1	No	1	4.01	0	no	no	no
636	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		2	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	25.63	0	no	no	no
637	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	39	4.9	Stable	No	No			No	0	22.11	0	no	no	no
638	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	40	33.4	Stable	No	Yes or Unknown	Signature.4		Yes	0	26.35	0	no	no	no
639	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	131	3.9	Stable	No	No		ATM	Yes	0	52.67	0	no	no	no
640	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	II	170	0	Stable	No	Yes or Unknown		BRCA1	No	1	32.79	0	no	no	no
641	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	1	Stable	No	No			No	0	50.83	0	no	no	no
642	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	75	4.4	Stable	No	No		MDC1	No	1	51.65	0	no	no	no
643	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	68	1	Stable	No	Yes or Unknown			No	0	54.41	0	no	no	no
644	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	24	9.8	Stable	No	No	Signature.4	CHEK2	No	0	6.77	0	no	no	no
645	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	1156	0.9	Stable	No	No			No	0	49.91	0	no	no	no
646	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	42	8.9	Stable	No	No	Signature.13	BLM | PALB2	Yes	0	40.8	0	no	no	no
647	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	II	108	0	Stable	No	No			No	0	38.01	0	no	no	no
648	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	1288	3.5	Stable	No	Yes or Unknown		PALB2	No	0	50.37	0	no	no	no
649	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	35	0	Stable	No	No			Yes	1	6.01	0	no	no	no
650	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015		7	3	Stable	No	No			Yes	1	8.15	0	no	no	no
651	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	152	6.9	Stable	No	Yes or Unknown	Signature.4	PALB2	No	1	15.97	0	no	no	no
652	Non-ICI treated	Never received ICI	61 - 65	Male	SCLC	2015	IV	136	12.8	Stable	No	Yes or Unknown	Signature.4		No	1	15.34	0	no	no	no
653	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	III	1	6.9	Stable	No	No			No	0	7.66	0	no	no	no
654	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	0	4.9	Stable	No	No		BLM	No	1	51.88	0	no	no	no
655	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	34	4.9	Stable	No	Yes or Unknown			No	0	54.14	0	no	no	no
656	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	IV	250	3	Stable	No	Yes or Unknown		ARID1A	No	1	19.65	0	no	no	yes
657	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	I	0	3	Stable	No	No			No	0	50.07	0	no	no	no
658	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	III	29	0	Stable	No	No			No	0	53.75	0	no	no	no
659	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	2	Stable	No	No			No	0	53.62	0	no	no	no
660	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	15	3.5	Stable	No	Yes or Unknown		BLM	No	1	39.46	0	no	no	no
661	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	0	5.3		No	No			No	1	30.98	0	no	no	no
662	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	33	0	Stable	No	No			No	0	53.52	0	no	no	no
663	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	53	2	Stable	No	No			No	0	13.93	0	no	no	no
664	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	218	3	Stable	No	Yes or Unknown	Signature.9		No	1	11.27	0	no	no	no
665	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	1540	4.4	Stable	No	No	Signature.4		No	0	54.24	0	no	no	no
666	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	921	0		No	Yes or Unknown			No	1	40.74	0	no	no	no
667	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	673	4.4		No	Yes or Unknown			No	0	54.11	0	no	no	no
668	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	34	6.9	Stable	No	No			No	0	54.37	0	no	no	no
669	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	1	21.9	Indeterminate	No	Yes or Unknown	Signature.2	ERCC4 | MLH1 | MUTYH	No	1	36.76	0	no	no	no
670	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	51	3	Stable	No	No			No	0	23.39	0	no	no	no
671	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	23	19.7	Stable	No	Yes or Unknown	Signature.2	ARID1A | RAD51C	No	1	14.78	0	no	no	yes
672	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		6	2	Stable	Yes or Unknown	Yes or Unknown			No	1	12.71	0	no	no	no
673	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2015	IV	0	17.7	Stable	No	No	Signature.7		No	0	45.7	0	no	no	no
674	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	3	4.9	Stable	No	No		ARID1A	Yes	1	25.59	0	no	no	yes
675	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	16	9.8	Stable	No	No	Signature.4		No	0	53.32	0	no	no	no
676	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	III	36	3.9	Stable	No	Yes or Unknown	Signature.16		No	1	34.43	0	no	no	no
677	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	41	4.9	Stable	No	Yes or Unknown			No	0	53.72	0	no	no	no
678	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	336	0	Stable	No	Yes or Unknown			Yes	0	51.81	0	no	no	no
679	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	388	3	Stable	No	Yes or Unknown			No	0	25.3	0	no	no	no
680	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	21.75	0	no	no	yes
681	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	22	6.1	Stable	No	No	Signature.3	ARID1A	No	1	44.65	0	no	no	yes
682	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	II	0	2	Stable	No	Yes or Unknown			Yes	0	51.84	0	no	no	no
683	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	49.94	0	no	no	no
684	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	30	9.8	Stable	No	No	Signature.4	MUTYH	No	1	1.38	0	no	no	no
685	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	I	29	0.9		No	No			No	0	45.08	0	no	no	no
686	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	294	13.8	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	17.81	0	no	no	yes
687	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	21	3.9	Stable	No	No			No	1	32.69	0	no	no	no
688	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2015	IV	0	0	Stable	No	No			No	1	19.58	0	no	no	no
689	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	0	3.5		No	Yes or Unknown		ATM	No	1	22.64	0	no	no	no
690	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	25	9.8	Stable	No	No	Signature.1		No	0	46.72	0	no	no	no
691	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	931	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	53.65	0	no	no	no
692	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	71	1	Stable	No	No			No	0	50.43	0	no	no	no
693	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	363	10.8	Stable	No	Yes or Unknown	Signature.1		No	0	53.75	0	no	no	no
694	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2015	II	45	1	Stable	No	No			No	0	48.69	0	no	no	no
695	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	53	1.8	Stable	No	No			Yes	0	53.98	0	no	no	no
696	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	II	0	59	Unstable	No	No	Signature.6	ARID1A | ATM	Yes	0	50.56	0	other-MMRd	mut-MMRd	yes
697	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	357	1	Stable	No	Yes or Unknown			Yes	1	13.54	0	no	no	no
698	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	18	3	Stable	No	Yes or Unknown			Yes	0	51.88	0	no	no	no
699	Non-ICI treated	Never received ICI	86 - 90	Female	Head & Neck	2015	IV	36	10.8	Stable	No	No	Signature.2		Yes	1	18.63	0	no	no	no
700	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	193	5.3	Stable	No	Yes or Unknown			No	0	53.95	0	no	no	no
701	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	I	721	0.9	Stable	No	No			Yes	0	52.76	0	no	no	no
702	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	35	3	Stable	No	Yes or Unknown			No	0	53.62	0	no	no	no
703	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	0	4.9	Stable	No	Yes or Unknown			No	0	54.64	0	no	no	no
704	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	6	1	Stable	No	No			No	1	11.73	0	no	no	no
705	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	85	5.9	Stable	No	Yes or Unknown			No	1	42.18	0	no	no	no
706	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	I	0	0	Stable	No	No			Yes	0	2.76	0	no	no	no
707	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	II	29	3.9	Stable	No	No			No	0	47.97	0	no	no	no
708	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	0	1	Stable	No	No		ARID1A	No	0	47.34	0	no	no	yes
709	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	III	152	3	Stable	No	Yes or Unknown			No	0	52.17	0	no	no	no
710	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	22	4.9	Stable	No	No			No	1	16.3	0	no	no	no
711	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown		FANCA	No	1	25.49	0	no	no	no
712	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	1419	3.5	Stable	No	Yes or Unknown			No	0	54.14	0	no	no	no
713	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	III	40	2.6		No	Yes or Unknown		ATR	No	0	53.16	0	no	no	no
714	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	II	31	0	Stable	No	Yes or Unknown			Yes	0	47.05	0	no	no	no
715	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	1394	0	Stable	No	Yes or Unknown			No	0	52.7	0	no	no	no
716	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	99	3.5	Stable	No	No			No	0	53.98	0	no	no	no
717	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	26	4.4	Stable	No	No			No	0	52.86	0	no	no	no
718	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2015	III	1205	5.3	Stable	No	No	Signature.7		No	0	52.01	0	no	no	no
719	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	20	4.9	Stable	No	No			No	1	29.63	0	no	no	no
720	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	375	3.9	Stable	No	Yes or Unknown			No	1	31.05	0	no	no	no
721	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	8	4.9	Stable	No	No			No	1	47.77	0	no	no	no
722	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	378	3.9	Stable	No	Yes or Unknown			No	1	28.42	0	no	no	no
723	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	0	3.5	Stable	No	No		BRCA1	No	0	52.37	0	no	no	no
724	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	26.25	0	no	no	no
725	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	84	4.9	Indeterminate	No	Yes or Unknown			Yes	1	10.41	0	no	no	no
726	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	100	3	Indeterminate	No	Yes or Unknown		MDC1	No	1	9.76	0	no	no	no
727	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	IV	0	5.9	Stable	No	No	Signature.1	ARID1A	No	1	10.12	0	no	no	yes
728	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	174	0.9	Stable	No	Yes or Unknown			No	1	37.19	0	no	no	no
729	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	II	12	5.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	53.26	0	no	no	yes
730	Non-ICI treated	Never received ICI	46 - 50	Male	Renal	2015	III	0	0	Stable	No	No			No	0	49.94	0	no	no	no
731	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	52.99	0	no	no	no
732	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	14	5.9	Stable	No	No			No	1	2.07	0	no	no	no
733	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	4.9	Stable	No	No			Yes	1	27.14	0	no	no	no
734	Non-ICI treated	Never received ICI	15-Nov	Male	CNS	2015		9	1	Stable	No	No			No	0	13.63	0	no	no	no
735	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	166	2.6		No	No	Signature.5	XRCC2	No	0	53.09	0	no	no	no
736	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	34	2	Stable	No	Yes or Unknown			No	1	26.41	0	no	no	no
737	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	3	3.9	Stable	No	No			Yes	1	8.28	0	no	no	no
738	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	IV	1170	7	Stable	No	Yes or Unknown	Signature.1		No	0	52.21	0	no	no	no
739	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	1088	1.8	Stable	No	Yes or Unknown			No	0	52.07	0	no	no	no
740	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	56	5.9	Stable	No	No			No	1	3.38	0	no	no	no
741	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			Yes	0	53.36	0	no	no	no
742	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	15	6.9	Stable	No	No	Signature.2		No	1	12.35	0	no	no	no
743	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	971	2.6	Stable	No	Yes or Unknown		BRCA2	Yes	0	36.17	0	no	no	no
744	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	172	7.9	Stable	No	Yes or Unknown	Signature.6		No	1	12.06	0	no	no	no
745	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	7	5.9	Stable	No	No	Signature.10		No	1	7.06	0	no	no	no
746	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	92	5.3	Stable	No	Yes or Unknown			No	0	53.52	0	no	no	no
747	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	571	7.9		No	Yes or Unknown	Signature.26	TP53BP1	No	0	52.6	0	no	no	no
748	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2015	II	0	4.9	Stable	No	No		RAD50	No	1	29.24	0	no	no	no
749	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	36	3	Stable	No	No			No	1	46.88	0	no	no	no
750	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	22	4.9	Stable	No	No			No	1	11.3	0	no	no	no
751	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	0	5.9	Stable	No	No		FANCA	No	0	50.43	0	no	no	no
752	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	40	7.9	Stable	No	No		ERCC5	Yes	0	32.62	0	no	no	no
753	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	67	3.5	Stable	No	No		BRCA2	No	0	50.92	0	no	no	no
754	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	I	521	6.9	Stable	No	Yes or Unknown			Yes	0	50.63	0	no	no	no
755	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	0	3	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	1	47.34	0	no	no	no
756	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		RAD50	No	0	52.9	0	no	no	no
757	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2015	I	0	5.3	Stable	No	No			Yes	0	50.33	0	no	no	no
758	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	35	21.6	Stable	No	No	Signature.4	ERCC2	No	1	6.83	0	no	no	no
759	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		7	3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	15.7	0	no	no	no
760	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	11	2	Stable	No	No			Yes	0	51.88	0	no	no	no
761	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	III	0	0	Stable	No	No			Yes	1	10.84	0	no	no	no
762	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	6	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	52.76	0	no	no	no
763	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	0	1	Stable	No	No			No	1	18.07	0	no	no	no
764	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.30		No	1	12.16	0	no	no	no
765	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	104	5.9	Stable	No	Yes or Unknown			Yes	0	51.29	0	no	no	no
766	Non-ICI treated	Never received ICI	36 - 40	Male	NSCLC	2015	IV	412	2	Stable	No	Yes or Unknown			No	1	24.38	0	no	no	no
767	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	14.8	Stable	No	No	Signature.4		Yes	1	1.87	0	no	no	no
768	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	I	10	2	Stable	No	Yes or Unknown			No	0	53.06	0	no	no	no
769	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	17	8.9	Stable	No	No	Signature.24		Yes	1	7	0	no	no	no
770	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	220	10.8	Stable	No	Yes or Unknown	Signature.29		No	1	11.73	0	no	no	no
771	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	28	11.8	Stable	No	No	Signature.4		No	0	51.52	0	no	no	no
772	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	18	0.9	Stable	No	No			No	0	53.13	0	no	no	no
773	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	19.98	0	no	no	no
774	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	41.3	Unstable	No	No	Signature.6		Yes	1	13.27	0	other-MMRd	other-MMRd	no
775	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	164	2.6	Stable	No	No			No	0	41.59	0	no	no	no
776	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2015	III	53	317.7	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | MDC1 | MLH1 | MSH3 | MSH6 | NBN | PALB2 | PMS2 | RAD50 | RAD51C | RAD54L | TP53BP1	No	0	53.32	0	no	no	yes
777	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	7	3	Stable	No	No	Signature.12		No	0	48.89	0	no	no	no
778	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2015	IV	24	10.8	Stable	No	No	Signature.24		No	1	15.51	0	no	no	no
779	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	574	1.8		No	Yes or Unknown	Signature.3	BRCA1	No	1	36.44	0	no	no	no
780	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	25	3.9	Stable	No	No			No	0	49.35	0	no	no	no
781	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	48	21.6		No	Yes or Unknown	Signature.4		No	0	51.98	0	no	no	no
782	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	46	5.3		No	No			No	1	21.16	0	no	no	no
783	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	961	0.9	Stable	No	Yes or Unknown			No	1	33.77	0	no	no	no
784	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	164	1	Stable	No	Yes or Unknown			No	1	45.47	0	no	no	no
785	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	IV	32	5.9	Stable	No	Yes or Unknown		ARID1A	Yes	1	6.31	0	no	no	yes
786	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	IV	18	0	Stable	No	No			Yes	0	48.26	0	no	no	no
787	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	126	3	Stable	No	Yes or Unknown			No	1	10.45	0	no	no	no
788	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	10	1	Stable	No	No			Yes	0	54.05	0	no	no	no
789	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	145	2	Stable	No	Yes or Unknown			Yes	0	24.8	0	no	no	no
790	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	II	718	4.4	Stable	No	Yes or Unknown	Signature.13		No	1	42.05	0	no	no	no
791	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	IV	10	4.9	Stable	No	No		ARID1A	No	1	2.99	0	no	no	yes
792	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	11	7.9	Stable	No	Yes or Unknown	Signature.2		No	1	5.45	0	no	no	no
793	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	22	14.8	Stable	No	No	Signature.4	ATM	Yes	1	1.77	0	no	no	no
794	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	69	7	Stable	No	Yes or Unknown			No	0	45.08	0	no	no	no
795	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2015	III	62	6.9	Stable	No	No		ARID1A	No	1	7.33	0	no	no	yes
796	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	1	15.7	Stable	No	Yes or Unknown	Signature.4	ERCC4	No	1	12.29	0	no	no	no
797	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	0	39.4	Stable	No	No	Signature.4		Yes	0	52.47	0	no	no	no
798	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	243	7.9	Stable	No	Yes or Unknown			Yes	0	51.42	0	no	no	no
799	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2015	III	27	0	Stable	No	No			No	1	8.9	0	no	no	no
800	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	IV	49	0	Stable	No	No			No	1	25.69	0	no	no	no
801	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2015	IV	0	6.9	Stable	No	No	Signature.4		No	1	15.64	0	no	no	no
802	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	II	31	143.6	Stable	No	Yes or Unknown	Signature.10	ATM | ATR | FANCC | MLH1 | MRE11A | MSH2 | RAD54L | XRCC2	Yes	0	51.55	0	no	no	no
803	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	267	4.4	Stable	No	Yes or Unknown			No	1	34.66	0	no	no	no
804	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	IV	61	1	Stable	No	No			Yes	1	5.75	0	no	no	no
805	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	28	3.9	Stable	No	No	Signature.1		No	0	52.9	0	no	no	no
806	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	41	6.9	Stable	No	No	Signature.1		No	1	15.41	0	no	no	no
807	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2015	I	0	1	Stable	No	No			No	0	48.72	0	no	no	no
808	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		1223	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	51.52	0	no	no	no
809	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	823	4.4	Stable	No	Yes or Unknown	Signature.5	BRCA2 | RAD52	No	1	30	0	no	no	no
810	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	29	7.9	Stable	No	No	Signature.1		No	1	14.16	0	no	no	no
811	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2015	IV	0	29.5	Stable	No	No	Signature.5	BRCA2 | ERCC2 | ERCC4	Yes	0	48.2	0	no	no	no
812	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	IV	0	3.9	Stable	No	No		RAD50	Yes	1	16.59	0	no	no	no
813	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2015	II	19	3.9	Stable	No	No			No	0	49.35	0	no	no	no
814	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		5	4.9		No	No	Signature.1		No	1	10.09	0	no	no	no
815	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2015	IV	21	2	Stable	No	No			No	0	52.27	0	no	no	no
816	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	1422	8.8	Stable	No	Yes or Unknown	Signature.4	RAD50	Yes	0	47.24	0	no	no	no
817	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	0	3	Stable	No	No		ATM	No	1	51.52	0	no	no	no
818	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	13	3.9	Stable	No	No		XRCC2	No	1	33.18	0	no	no	no
819	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	I	636	4.4		No	Yes or Unknown		MUTYH	No	0	52.99	0	no	no	no
820	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	22	3.9	Stable	No	Yes or Unknown			No	0	53.49	0	no	no	no
821	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	II	118	0	Stable	Yes or Unknown	Yes or Unknown			Yes	0	40.28	0	no	no	no
822	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	26	4.9	Stable	No	Yes or Unknown			No	0	27.1	0	no	no	no
823	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	II	52	12.8	Stable	No	No	Signature.24	PARP1 | PMS2	Yes	0	40.44	0	no	no	no
824	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	29	5.9	Stable	No	No			Yes	0	6.74	0	no	no	no
825	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	II	30	4.9	Stable	No	No			No	1	21.55	0	no	no	no
826	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	1149	4.4	Stable	No	Yes or Unknown			No	0	49.51	0	no	no	no
827	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	IV	35	16.7	Stable	No	Yes or Unknown	Signature.13	ARID1A | MSH3 | PALB2	No	0	53.13	0	no	no	yes
828	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015		0	0	Stable	No	No			No	0	28.48	0	no	no	no
829	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	0	5.3	Stable	No	No	Signature.3		No	0	52.47	0	no	no	no
830	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	655	0.9		No	Yes or Unknown			No	1	28.85	0	no	no	no
831	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown	Signature.20		No	0	51.06	0	no	no	no
832	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	44	0	Stable	No	No			No	0	50.2	0	no	no	no
833	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	39	3.9	Stable	No	No			Yes	0	52.34	0	no	no	no
834	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	980	3.5	Stable	No	Yes or Unknown		MSH6	No	1	47.28	0	no	no	no
835	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	45	5.9	Stable	No	Yes or Unknown		MDC1	No	1	12.16	0	no	no	no
836	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	III	0	1	Stable	No	Yes or Unknown			Yes	1	10.38	0	no	no	no
837	Non-ICI treated	Never received ICI	41 - 45	Female	Bladder	2015	I	6	409.3	Stable	No	No	Signature.14	ARID1A | ATM | BLM | BRCA1 | BRCA2 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | FANCC | MDC1 | MLH1 | MSH2 | MSH6 | NBN | PALB2 | RAD51C | RAD54L | XRCC2	Yes	0	17.94	0	no	no	yes
838	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	III	20	2.6	Stable	No	No	Signature.24		No	0	52.57	0	no	no	no
839	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	II	0	5.9	Stable	No	No		CHEK1	No	1	17.22	0	no	no	no
840	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	38	13.8	Stable	No	No	Signature.4		Yes	1	21.72	0	no	no	no
841	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	1	16.07	0	no	no	no
842	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.11	0	no	no	no
843	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2015	IV	150	0	Stable	No	No			Yes	1	33.87	0	no	no	no
844	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	56	0	Stable	No	No			No	0	49.51	0	no	no	no
845	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	24.8	0	no	no	no
846	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	51.75	0	no	no	no
847	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	43	58	Unstable	No	No	Signature.1	BLM | ERCC3 | MRE11A | MSH2 | RAD50	Yes	0	42.09	0	mut-MMRd	mut-MMRd	no
848	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2015	IV	0	3.9	Stable	No	No	Signature.1		Yes	0	52.57	0	no	no	no
849	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	72	3.9	Stable	No	No			Yes	1	36.6	0	no	no	no
850	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	93	3.9	Stable	No	No			No	0	26.05	0	no	no	no
851	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	I	24	8.9	Stable	No	No			Yes	0	37.52	0	no	no	no
852	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	1	9.8	Stable	No	No			No	1	12.48	0	no	no	no
853	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2015	III	133	4.9	Stable	No	Yes or Unknown	Signature.1		No	1	5.52	0	no	no	no
854	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	387	3	Stable	No	Yes or Unknown			No	1	18.63	0	no	no	no
855	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.13	BRCA2	No	0	52.11	0	no	no	no
856	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2015	I	27	5.9	Stable	No	No		ARID1A	No	0	49.64	0	no	no	yes
857	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	IV	0	7.9	Stable	No	No	Signature.2		No	1	23.26	0	no	no	no
858	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	II	0	6.9	Stable	No	No	Signature.3		No	0	51.38	0	no	no	no
859	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	IV	1068	2.6	Stable	No	Yes or Unknown			No	0	52.21	0	no	no	no
860	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2015	IV	527	6.1	Stable	No	Yes or Unknown			No	0	51.15	0	no	no	no
861	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	37	4.9	Stable	No	Yes or Unknown			No	1	10.09	0	no	no	no
862	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	III	129	13.8	Stable	No	Yes or Unknown	Signature.4		No	1	15.64	0	no	no	no
863	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	17	5.9	Stable	No	No			Yes	0	46.75	0	no	no	no
864	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	35	10.8	Stable	No	No	Signature.16	ATM	No	0	49.45	0	no	no	no
865	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	5	8.9	Stable	No	No	Signature.24	ARID1A	Yes	0	39.66	0	no	no	yes
866	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	II	14	23.6	Stable	No	No	Signature.13	ARID1A | BRCA2 | ERCC3	Yes	0	52.63	0	no	no	yes
867	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	679	2.6	Stable	No	Yes or Unknown			No	0	52.24	0	no	no	no
868	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	IV	128	2	Stable	No	No			No	1	12.42	0	no	no	no
869	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	12	10.8	Stable	No	No	Signature.29		No	1	28.85	0	no	no	no
870	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	I	0	0.9		No	No			No	0	48.85	0	no	no	no
871	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	84	4.9	Stable	No	Yes or Unknown		PMS2	No	0	48.62	0	no	no	no
872	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	0	4.9	Stable	No	No	Signature.3	NBN	No	0	51.84	0	no	no	no
873	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	855	2.6	Stable	No	Yes or Unknown			No	0	54.31	0	no	no	no
874	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	995	27.2	Stable	No	No	Signature.4	PMS1	No	0	45.6	0	no	no	no
875	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	II	92	2	Stable	No	Yes or Unknown			No	0	51.55	0	no	no	no
876	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	584	5.3		No	Yes or Unknown	Signature.6	ATR	No	1	22.37	0	no	no	no
877	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	0	1	Stable	No	No			No	0	48.36	0	no	no	no
878	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	378	8.9	Indeterminate	No	No	Signature.13	BRCA2	No	1	19.12	0	no	no	no
879	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2015	III	9	4.9	Stable	No	No			No	0	52.04	0	no	no	no
880	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	65	1	Stable	No	Yes or Unknown			No	0	52.63	0	no	no	no
881	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	III	40	2	Stable	No	Yes or Unknown			Yes	0	51.65	0	no	no	no
882	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	38	7.9	Stable	No	No	Signature.5	PARP1	Yes	1	8.21	0	no	no	no
883	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	41	7.9	Stable	No	No	Signature.4	PARP1	No	0	41.13	0	no	no	no
884	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	304	2	Stable	No	Yes or Unknown		ARID1A	No	0	49.68	0	no	no	yes
885	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	20	5.9	Stable	No	No			No	0	37.95	0	no	no	no
886	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		69	11.8	Stable	No	No	Signature.13	CHEK2	No	0	52.01	0	no	no	no
887	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	40.97	0	no	no	no
888	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2015	I	0	62.3	Unstable	No	No	Signature.1	ARID1A | MSH2 | PALB2 | SLX4	Yes	0	42.41	0	mut-MMRd	mut-MMRd	yes
889	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	1	31.77	0	no	no	no
890	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	47	0		No	No	Signature.1		Yes	1	12.12	0	no	no	no
891	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1024	1.8	Stable	No	Yes or Unknown		BRCA2	No	1	45.9	0	no	no	no
892	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			No	0	13.8	0	no	no	no
893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	28	3	Stable	No	Yes or Unknown		ARID1A	No	1	30.42	0	no	no	yes
894	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	15	7.9	Stable	No	No	Signature.24		No	1	3.19	0	no	no	no
895	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	III	31	0	Stable	No	Yes or Unknown			No	1	33.54	0	no	no	no
896	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	273	4.9	Stable	No	No			No	1	25.1	0	no	no	no
897	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	IV	0	4.9	Stable	No	Yes or Unknown			Yes	1	8.67	0	no	no	no
898	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	7	Stable	No	No		MRE11A	No	1	29.37	0	no	no	no
899	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	32	4.9	Stable	No	No			No	1	1.54	0	no	no	no
900	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	15	10.8	Stable	No	No	Signature.18		No	1	2.56	0	no	no	no
901	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2015	II	0	5.9	Stable	No	No			Yes	0	41	0	no	no	no
902	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	19.09	0	no	no	no
903	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	653	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	23.06	0	no	no	yes
904	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	160	2	Stable	No	Yes or Unknown			No	0	44.78	0	no	no	no
905	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	1209	0	Stable	No	Yes or Unknown			No	0	51.52	0	no	no	no
906	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	0	5.9	Stable	No	No			Yes	0	13.31	0	no	no	no
907	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	9	2	Stable	No	No	Signature.5		No	1	23.2	0	no	no	no
908	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	562	10.5	Stable	No	No	Signature.4		Yes	0	45.5	0	no	no	no
909	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	0	4.4	Stable	No	No	Signature.3		No	1	40.8	0	no	no	no
910	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			No	1	12.09	0	no	no	no
911	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	IV	575	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	41.1	0	no	no	no
912	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1188	1.8	Stable	No	Yes or Unknown			No	0	51.15	0	no	no	no
913	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	133	0	Stable	No	Yes or Unknown			Yes	0	48.85	0	no	no	no
914	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	II	0	3.9	Stable	No	No			No	1	25.13	0	no	no	no
915	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	0	0	Stable	No	No			No	0	50.69	0	no	no	no
916	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	45	0	Stable	No	No			Yes	0	51.02	0	no	no	no
917	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2015	IV	0	1	Stable	No	No			No	1	5.03	0	no	no	no
918	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2015		0	4.9	Stable	No	No			No	0	2.76	0	no	no	no
919	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2015	IV	0	3.9	Stable	No	No			Yes	1	8.87	0	no	no	no
920	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	16	3	Stable	No	No		ARID1A	No	0	8.74	0	no	no	yes
921	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015		68	8.9	Stable	No	No		MSH2	No	1	7.62	0	no	no	no
922	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	2	3	Stable	No	Yes or Unknown	Signature.4		No	0	53.19	0	no	no	no
923	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	5.9	Stable	No	Yes or Unknown		FANCA	No	1	7.98	0	no	no	no
924	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	I	30	7	Stable	No	No	Signature.4	ERCC5	No	0	22.57	0	no	no	no
925	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	IV	339	5.9	Stable	No	Yes or Unknown		ARID1A | ATM	No	1	19.32	0	no	no	yes
926	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	14	3	Stable	No	No			No	0	50.73	0	no	no	no
927	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	18	2	Stable	No	No			No	1	17.77	0	no	no	no
928	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	IV	0	38.4	Unstable	No	No	Signature.6	BRCA1 | BRCA2 | MDC1 | MLH1 | NBN | PARP1 | RAD54L	No	1	7.69	0	mut-MMRd	mut-MMRd	no
929	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	14	3.5	Stable	No	No			No	0	47.47	0	no	no	no
930	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	29	4.9	Stable	No	No	Signature.4		No	0	47.9	0	no	no	no
931	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	3	Stable	No	No			Yes	0	1.94	0	no	no	no
932	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2015	IV	28	3	Stable	No	No			Yes	1	1.94	0	no	no	no
933	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2015		1	0.9	Stable	No	Yes or Unknown			No	0	51.35	0	no	no	no
934	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	II	623	0.9	Stable	No	Yes or Unknown			No	0	50.6	0	no	no	no
935	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	9.8	Stable	No	No	Signature.5	MLH1	Yes	1	3.15	0	no	no	no
936	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	IV	122	16.7	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA2 | MDC1	No	0	52.7	0	no	no	no
937	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2015	IV	749	1.8	Stable	No	Yes or Unknown		FANCC	No	1	42.25	0	no	no	no
938	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	II	111	4.9	Stable	No	No			No	0	49.38	0	no	no	no
939	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	5	3.9	Stable	No	No		BRCA2	No	1	25.2	0	no	no	no
940	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	0	5.9	Stable	No	Yes or Unknown		ERCC5	No	1	12.16	0	no	no	no
941	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	190	0	Stable	No	Yes or Unknown			No	0	49.08	0	no	no	no
942	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	27	5.9	Stable	No	No	Signature.1		No	1	14.26	0	no	no	no
943	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	I	15	15.7	Stable	No	No	Signature.29	RAD50	No	0	48.82	0	no	no	no
944	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	2	Stable	No	Yes or Unknown		CHEK2	No	0	51.02	0	no	no	no
945	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	0	4.4	Stable	No	No			No	0	49.87	0	no	no	no
946	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	52	2	Stable	No	No			No	0	47.61	0	no	no	no
947	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2015	III	0	11.4	Stable	No	No	Signature.28	ARID1A | ATM | ERCC2	No	0	50.83	0	no	no	yes
948	Non-ICI treated	Never received ICI	56 - 60	Female	Renal	2015	IV	9	4.9	Stable	No	Yes or Unknown			No	1	8.9	0	no	no	no
949	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2015	IV	0	7.9	Stable	No	No		ARID1A	Yes	0	50.53	0	no	no	yes
950	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	14	0.9	Stable	No	No			Yes	0	51.42	0	no	no	no
951	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	41	3	Stable	No	No		ATM | MDC1	No	0	50.79	0	no	no	no
952	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	0	1	Stable	No	Yes or Unknown			No	0	44.06	0	no	no	no
953	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	5.9	Stable	No	No	Signature.4	ARID1A	No	0	37.78	0	no	no	yes
954	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	21	3	Stable	No	No			No	1	17.58	0	no	no	no
955	Non-ICI treated	Never received ICI	10-Jun	Male	Cutaneous Melanoma 	2015	III	0	2	Stable	No	No			No	0	52.17	0	no	no	no
956	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	7.9	Stable	No	No	Signature.1		Yes	1	2.86	0	no	no	no
957	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	715	5.3	Stable	No	Yes or Unknown	Signature.8		No	0	51.81	0	no	no	no
958	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	91	0.9	Stable	No	Yes or Unknown		BRCA2	No	1	39.85	0	no	no	no
959	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	17	7.9	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	0	52.9	0	no	no	yes
960	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	1200	3.5	Stable	No	Yes or Unknown		CHEK2	No	1	46.98	0	no	no	no
961	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	232	5.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	47.28	0	no	no	no
962	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	9	5.9	Stable	No	No	Signature.30		No	1	15.24	0	no	no	no
963	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	II	8	3	Stable	No	Yes or Unknown	Signature.3		No	0	48.59	0	no	no	no
964	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	I	25	6.9	Stable	No	No		ARID1A	No	0	27.6	0	no	no	yes
965	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	14	2	Stable	No	Yes or Unknown			No	0	48.72	0	no	no	no
966	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	11	1	Stable	No	Yes or Unknown			No	0	45.44	0	no	no	no
967	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		15	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	6.47	0	no	no	no
968	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	9	2	Stable	No	No			Yes	1	4.44	0	no	no	no
969	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	II	445	7.9		No	Yes or Unknown	Signature.4	ATM	No	1	26.51	0	no	no	no
970	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	III	21	1	Stable	No	Yes or Unknown			Yes	0	47.05	0	no	no	no
971	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2015	IV	42	13.8	Stable	No	Yes or Unknown	Signature.7	ATM	No	1	6.97	0	no	no	no
972	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	58	0.9	Stable	No	No			No	0	45.8	0	no	no	no
973	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	I	37	3.9	Stable	No	No		MUTYH	No	0	42.41	0	no	no	no
974	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.12	BRIP1	No	1	2.83	0	no	no	no
975	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	18	3.5		No	No			No	0	50.92	0	no	no	no
976	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	IV	15	5.9	Stable	No	No	Signature.24	BRCA2	No	1	23.95	0	no	no	no
977	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		22	8.9	Stable	No	No	Signature.11		No	0	36.34	0	no	no	no
978	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	33	0	Stable	No	No			Yes	0	51.32	0	no	no	no
979	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	155	2.6	Stable	No	Yes or Unknown			Yes	0	49.28	0	no	no	no
980	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	II	169	3.5	Indeterminate	No	Yes or Unknown	Signature.3		No	1	35.06	0	no	no	no
981	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2015	I	0	2	Stable	No	Yes or Unknown			Yes	0	42.09	0	no	no	no
982	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	185	11.8	Stable	No	No	Signature.6		No	0	33.25	0	no	no	no
983	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown			Yes	0	48.66	0	no	no	no
984	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	14	10.8	Stable	No	No	Signature.4		No	0	49.51	0	no	no	no
985	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	I	1441	7.9	Stable	No	Yes or Unknown	Signature.2		No	0	51.94	0	no	no	no
986	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	63	4.9	Stable	No	No			Yes	0	51.52	0	no	no	no
987	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	IV	19	3.9	Stable	No	Yes or Unknown	Signature.1		No	1	17.45	0	no	no	no
988	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	56	2	Stable	No	No			Yes	0	50.89	0	no	no	no
989	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	76	3	Stable	No	No			No	1	24.18	0	no	no	no
990	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	27	7.9		No	No	Signature.17	ATM	No	1	25.13	0	no	no	no
991	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	19.15	0	no	no	no
992	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	160	0	Stable	No	No			No	0	23.75	0	no	no	no
993	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	1260	0.9	Stable	No	Yes or Unknown		ATM	No	1	47.97	0	no	no	no
994	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		28	1	Stable	Yes or Unknown	Yes or Unknown			Yes	1	16.3	0	no	no	no
995	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	48	0	Stable	No	No			No	0	36.24	0	no	no	no
996	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	434	7.9	Stable	No	Yes or Unknown	Signature.17	RAD50	No	1	16.3	0	no	no	no
997	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	21.62	0	no	no	yes
998	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	19	3.9	Stable	No	No		ARID1A	No	1	10.74	0	no	no	yes
999	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2015	II	34	6.9	Stable	No	No	Signature.13	ATR	Yes	0	46.46	0	no	no	no
1000	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	50.79	0	no	no	no
1001	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	I	31	71.8	Unstable	No	No	Signature.6	ARID1A | BRCA2 | ERCC3 | MSH6 | NBN	No	0	39.23	0	mut-MMRd	mut-MMRd	yes
1002	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	507	3.5	Stable	No	Yes or Unknown	Signature.8	BRIP1	No	0	51.35	0	no	no	no
1003	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	10	12.8	Stable	No	No	Signature.4	MUTYH	Yes	0	51.12	0	no	no	no
1004	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	I	16	33.4	Unstable	No	No	Signature.6	ARID1A | ATM | MDC1 | XRCC2	No	0	45.21	0	other-MMRd	mut-MMRd	yes
1005	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	III	602	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	51.45	0	no	no	no
1006	Non-ICI treated	Never received ICI	81 - 85	Male	Head & Neck	2015	IV	200	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	7.16	0	no	no	no
1007	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	40	20.2		No	No	Signature.1	MSH2 | XRCC2	Yes	0	46.46	0	no	no	no
1008	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	7		No	Yes or Unknown			No	0	50.14	0	no	no	no
1009	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015		1080	0.9	Stable	No	Yes or Unknown			No	0	50.14	0	no	no	no
1010	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	5	6.9	Stable	No	No	Signature.1	MDC1 | RAD54L	No	1	17.22	0	no	no	no
1011	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	III	0	1	Stable	No	No			Yes	0	47.24	0	no	no	no
1012	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	0	2	Stable	No	No		MLH1	No	0	49.15	0	no	no	no
1013	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	0	6.9	Stable	No	No	Signature.4	RAD50	No	0	42.74	0	no	no	no
1014	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	15	3	Stable	No	No			Yes	1	4.37	0	no	no	no
1015	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		21	3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	20.11	0	no	no	no
1016	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	1155	3.5	Stable	No	Yes or Unknown			No	0	54.54	0	no	no	no
1017	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	1	Stable	No	No			Yes	0	49.05	0	no	no	no
1018	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	99	3.9	Stable	No	Yes or Unknown		ARID1A	Yes	1	4.47	0	no	no	yes
1019	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	65	0	Stable	No	No			No	0	47.77	0	no	no	no
1020	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	II	700	8.8	Stable	No	Yes or Unknown	Signature.6	BRCA1	No	1	50.56	0	no	no	no
1021	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	21	2	Stable	No	Yes or Unknown			No	0	14.46	0	no	no	no
1022	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	266	3.9	Stable	No	Yes or Unknown			No	0	51.55	0	no	no	no
1023	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	181	4.9	Stable	No	Yes or Unknown			No	1	12.71	0	no	no	no
1024	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	II	142	0	Stable	No	Yes or Unknown			No	0	51.12	0	no	no	no
1025	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	34	10.8	Stable	No	No	Signature.13	BRCA2 | FANCC	Yes	1	22.64	0	no	no	no
1026	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	75	2	Stable	No	No			No	0	21.98	0	no	no	no
1027	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	III	28	7.9		No	No	Signature.1		No	1	27.53	0	no	no	no
1028	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	1.8		No	Yes or Unknown			No	1	39.16	0	no	no	no
1029	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	5	8.9	Stable	No	No	Signature.2	RAD50	Yes	1	4.6	0	no	no	no
1030	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	485	2.6		No	Yes or Unknown			No	1	28.39	0	no	no	no
1031	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	III	56	3.5		No	Yes or Unknown			No	1	27.79	0	no	no	no
1032	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	369	5.3		No	Yes or Unknown		BRCA2	No	1	30.26	0	no	no	no
1033	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	II	265	57.1	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | MLH1 | MSH6 | PALB2	No	0	44.62	0	mut-MMRd	mut-MMRd	yes
1034	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	I	26	67.9	Unstable	No	No	Signature.6	ARID1A | ERCC3 | FANCA | MRE11A | MSH6 | PALB2	No	0	45.14	0	mut-MMRd	mut-MMRd	yes
1035	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	81	3	Stable	No	Yes or Unknown			No	1	42.02	0	no	no	no
1036	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	21	2	Stable	No	No			No	0	48.56	0	no	no	no
1037	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.4	ATM	No	0	51.48	0	no	no	no
1038	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	II	15	4.9	Stable	No	No			Yes	0	49.31	0	no	no	no
1039	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	1101	2.6	Stable	No	Yes or Unknown		ARID1A | CHEK2	No	0	47.93	0	no	no	yes
1040	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	78	11.8	Stable	No	No	Signature.29	ATR	No	0	46.92	0	no	no	no
1041	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No			No	1	16.92	0	no	no	no
1042	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	0	3.9	Stable	No	No			No	1	14.62	0	no	no	no
1043	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	107	3.5	Stable	No	Yes or Unknown			No	0	51.15	0	no	no	no
1044	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2015	IV	881	0	Stable	No	Yes or Unknown			No	1	34.56	0	no	no	no
1045	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		0	1	Stable	No	No			No	0	46.95	0	no	no	no
1046	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	25	0.9	Stable	No	No		BLM	No	1	36.47	0	no	no	no
1047	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	37	1.8	Stable	No	Yes or Unknown			No	0	51.98	0	no	no	no
1048	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	7	1.8		No	No			No	1	34.2	0	no	no	no
1049	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	1161	7	Stable	No	Yes or Unknown	Signature.4		No	0	50.5	0	no	no	no
1050	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	14.8	Stable	No	No	Signature.24	ATR | BRCA1	Yes	1	20.73	0	no	no	no
1051	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2015	IV	34	0	Stable	No	No			No	1	12.88	0	no	no	no
1052	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.2		No	1	11.3	0	no	no	no
1053	Non-ICI treated	Never received ICI	36 - 40	Male	Renal	2015	I	31	3	Stable	No	No		NBN	No	0	47.47	0	no	no	no
1054	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2015		0	1	Stable	No	No			No	0	38.44	0	no	no	no
1055	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	III	0	3	Stable	No	No			No	1	25.33	0	no	no	no
1056	Non-ICI treated	Never received ICI	26 - 30	Female	Pancreatic	2015	IV	56	1	Stable	Yes or Unknown	Yes or Unknown			No	1	11.43	0	no	no	no
1057	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	III	0	5.3		No	No			No	1	25.86	0	no	no	no
1058	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	4	4.9	Stable	No	No			No	1	44.25	0	no	no	no
1059	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	33	5.9	Stable	No	No			Yes	0	49.08	0	no	no	no
1060	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	174	2	Stable	No	Yes or Unknown			No	0	52.86	0	no	no	no
1061	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	14	9.8	Stable	No	No	Signature.4		No	1	9.2	0	no	no	no
1062	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	24	1	Stable	No	No			No	0	42.58	0	no	no	no
1063	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	61	3.9	Stable	No	Yes or Unknown			No	0	49.71	0	no	no	no
1064	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	28	7.9	Stable	No	No	Signature.13		No	1	19.02	0	no	no	no
1065	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	28	3.9	Stable	No	Yes or Unknown			No	1	31.61	0	no	no	no
1066	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	IV	7	1.8		No	No			Yes	0	50.27	0	no	no	no
1067	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	626	0.9	Stable	No	No			No	0	46.42	0	no	no	no
1068	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2015		0	0	Stable	No	No			No	0	44.62	0	no	no	no
1069	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	26	3.9	Stable	No	No			No	1	5.19	0	no	no	no
1070	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015		0	3.9	Stable	No	No			Yes	0	35.06	0	no	no	no
1071	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	1	3.9	Stable	No	No			No	1	26.41	0	no	no	no
1072	Non-ICI treated	Never received ICI	51 - 55	Female	SCLC	2015	II	0	6.9	Indeterminate	No	No	Signature.3		Yes	0	49.15	0	no	no	no
1073	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	15	3	Stable	No	Yes or Unknown			No	1	16.62	0	no	no	no
1074	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	1177	22.8	Stable	No	Yes or Unknown	Signature.1	MSH2 | TP53BP1	No	1	40.84	0	no	no	no
1075	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	7.9		No	Yes or Unknown	Signature.30	ARID1A	No	1	28.32	0	no	no	yes
1076	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	396	3	Stable	No	Yes or Unknown	Signature.5	ATM	No	0	24.02	0	no	no	no
1077	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	1127	1.8	Stable	No	Yes or Unknown			No	0	49.54	0	no	no	no
1078	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	I	1218	3.5	Stable	No	No	Signature.5		No	0	50.6	0	no	no	no
1079	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	0	1.8	Stable	No	Yes or Unknown			No	0	50.23	0	no	no	no
1080	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	13	7.9	Stable	No	No	Signature.3		No	0	50.2	0	no	no	no
1081	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	15	3	Stable	No	No			No	1	44.02	0	no	no	no
1082	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	26	19.7	Stable	No	Yes or Unknown	Signature.4		Yes	1	3.35	0	no	no	no
1083	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2015	IV	22	7.9		No	No	Signature.13		Yes	0	37.65	0	no	no	no
1084	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	IV	55	3.5	Stable	No	No	Signature.6	ATM | NBN	No	0	51.02	0	no	no	no
1085	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	245	3.9	Stable	No	Yes or Unknown			No	0	26.41	0	no	no	no
1086	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2015	IV	14	10.8	Stable	No	No	Signature.17		Yes	1	7.85	0	no	no	no
1087	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		7	4.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	18.96	0	no	no	no
1088	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	IV	0	0	Stable	No	No			No	0	51.32	0	no	no	no
1089	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	1102	9.7	Stable	No	Yes or Unknown	Signature.1	BRCA2 | TP53BP1	No	0	50.43	0	no	no	no
1090	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	12	4.9	Stable	No	No			No	1	13.54	0	no	no	no
1091	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2015	II	35	342.4	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC3 | FANCA | MDC1 | MRE11A | MSH2 | MUTYH | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD51C | RAD52	Yes	0	46.82	0	no	no	yes
1092	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	189	6.9	Stable	No	Yes or Unknown			Yes	0	49.94	0	no	no	no
1093	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	II	1375	0.9	Stable	No	Yes or Unknown			No	0	50.2	0	no	no	no
1094	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		10	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	14.78	0	no	no	no
1095	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	198	3.9	Stable	No	Yes or Unknown			No	1	13.47	0	no	no	no
1096	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	IV	57	1	Stable	No	No			No	0	51.06	0	no	no	no
1097	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2015	III	33	5.9	Stable	No	Yes or Unknown			Yes	1	7.62	0	no	no	no
1098	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	0	9.8	Stable	No	Yes or Unknown			No	0	51.09	0	no	no	no
1099	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	142	0	Stable	No	Yes or Unknown			Yes	1	10.25	0	no	no	no
1100	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	15.31	0	no	no	no
1101	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	18	6.9	Stable	No	No	Signature.13		Yes	0	48.03	0	no	no	no
1102	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	17	7	Stable	No	No	Signature.3		Yes	0	48.53	0	no	no	no
1103	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	24	1.8		No	No			Yes	0	49.81	0	no	no	no
1104	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		1	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	RAD50	Yes	1	13.04	0	no	no	no
1105	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2015		41	5.9	Stable	No	Yes or Unknown			No	1	13.6	0	no	no	no
1106	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2015	IV	103	17.7	Stable	No	Yes or Unknown	Signature.2	ATR	Yes	1	21.78	0	no	no	no
1107	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	II	300	6.1		No	Yes or Unknown	Signature.13		No	1	33.45	0	no	no	no
1108	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	14	3.5	Stable	No	Yes or Unknown			No	0	49.15	0	no	no	no
1109	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	0	4.9	Stable	No	No	Signature.9	ARID1A	No	1	25.43	0	no	no	yes
1110	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4		Yes	1	7.85	0	no	no	no
1111	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	773	0	Stable	No	Yes or Unknown			Yes	0	34.96	0	no	no	no
1112	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	0	50.83	0	no	no	no
1113	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	IV	0	5.3	Indeterminate	No	No	Signature.1		No	0	48.53	0	no	no	no
1114	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	3.5		Yes or Unknown	Yes or Unknown			Yes	0	51.09	0	no	no	no
1115	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	27	25.6	Stable	No	No	Signature.4		No	0	47.93	0	no	no	no
1116	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	III	1356	3.5	Stable	No	Yes or Unknown			No	0	50.07	0	no	no	no
1117	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	II	19	2	Stable	No	No			Yes	0	47.87	0	no	no	no
1118	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	17	4.4	Stable	No	No		ARID1A	No	0	49.74	0	no	no	yes
1119	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	III	122	2.6		No	Yes or Unknown			No	1	21.88	0	no	no	no
1120	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2015	IV	0	6.9	Stable	No	No			No	1	17.97	0	no	no	no
1121	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	25	1.8		No	No			No	0	31.44	0	no	no	no
1122	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	840	6.1	Stable	No	Yes or Unknown			No	0	49.05	0	no	no	no
1123	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	III	21	2	Stable	No	No		BRCA1	No	0	15.54	0	no	no	no
1124	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	6.9	Indeterminate	No	No	Signature.1	RAD52	No	1	7.43	0	no	no	no
1125	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No			No	1	16.49	0	no	no	no
1126	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	65	1.8		No	Yes or Unknown			Yes	0	50.43	0	no	no	no
1127	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2015	IV	0	3	Stable	No	No			Yes	0	11.4	0	no	no	no
1128	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	I	32	2	Stable	No	Yes or Unknown			No	1	49.18	0	no	no	no
1129	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	10.8		No	No		ATM	No	1	21.98	0	no	no	no
1130	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	0	2	Stable	No	Yes or Unknown			Yes	0	50.33	0	no	no	no
1131	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	III	802	4.4	Stable	No	No			No	0	45.96	0	no	no	no
1132	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3.5		No	No		BRCA1 | MUTYH	No	1	23.23	0	no	no	no
1133	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	II	28	50.2	Unstable	No	No	Signature.1	ARID1A | MDC1 | MSH2	No	0	47.8	0	mut-MMRd	mut-MMRd	yes
1134	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	II	29	7.9	Stable	No	No			No	0	45.08	0	no	no	no
1135	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	2	5.9	Indeterminate	No	No	Signature.1		Yes	1	8.31	0	no	no	no
1136	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.44	0	no	no	no
1137	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	1051	1.8	Stable	No	Yes or Unknown			No	0	51.98	0	no	no	no
1138	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	III	164	0.9		No	Yes or Unknown		ATM	No	1	29.93	0	no	no	no
1139	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1197	2.6	Stable	No	Yes or Unknown			No	0	49.87	0	no	no	no
1140	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	III	46	19.3	Unstable	No	No	Signature.6	ARID1A	No	0	51.71	0	other-MMRd	mut-MMRd	yes
1141	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2015	II	155	3	Stable	No	Yes or Unknown			No	1	12.29	0	no	no	no
1142	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	67	3.9	Stable	No	No			Yes	0	47.28	0	no	no	no
1143	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	52	3.9	Stable	No	No			No	0	31.8	0	no	no	no
1144	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	28	1	Stable	No	Yes or Unknown			No	1	21.32	0	no	no	no
1145	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	12	2	Stable	No	No			Yes	1	12.19	0	no	no	no
1146	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	18.17	0	no	no	no
1147	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	217	6.9	Stable	No	Yes or Unknown	Signature.1		No	0	50.14	0	no	no	no
1148	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	48	3.5	Stable	No	No			No	0	39.26	0	no	no	no
1149	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			No	0	28.12	0	no	no	no
1150	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	0	17.6	Stable	No	No	Signature.13	BRCA1	No	1	19.06	0	no	no	no
1151	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	3	14.8	Stable	No	Yes or Unknown	Signature.2	ARID1A | ERCC3	Yes	1	5.13	0	no	no	yes
1152	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	IV	0	8.9	Stable	No	No	Signature.6	ARID1A	No	1	25.13	0	no	no	yes
1153	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.29	ARID1A	Yes	0	32.85	0	no	no	yes
1154	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	211	2.6	Stable	No	Yes or Unknown			No	0	49.74	0	no	no	no
1155	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	10.09	0	no	no	no
1156	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2015	IV	14	6.9	Indeterminate	No	No	Signature.1		No	0	47.54	0	no	no	no
1157	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	10	5.3	Stable	No	No		ERCC2	Yes	0	13.8	0	no	no	no
1158	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	III	0	1	Stable	No	Yes or Unknown			No	1	13.6	0	no	no	no
1159	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	5	13.8	Indeterminate	No	No	Signature.1		Yes	1	7.36	0	no	no	no
1160	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	15	3	Stable	No	Yes or Unknown			No	0	43.76	0	no	no	no
1161	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	107	2.6	Stable	No	Yes or Unknown			No	0	49.74	0	no	no	no
1162	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	IV	0	1	Stable	No	No			No	0	48.56	0	no	no	no
1163	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	34	13.2		No	No	Signature.13	ARID1A | ATM	No	0	36.96	0	no	no	yes
1164	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2015		455	1.8		No	Yes or Unknown			No	0	48.72	0	no	no	no
1165	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	252	3.9	Stable	No	Yes or Unknown		ARID1A	No	1	11.33	0	no	no	yes
1166	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	0	2	Stable	No	No			No	0	49.81	0	no	no	no
1167	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	20	6.9	Stable	No	No	Signature.24	PALB2 | PMS2	No	0	44.45	0	no	no	no
1168	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	131	1	Stable	No	Yes or Unknown			Yes	0	47.57	0	no	no	no
1169	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	47	2	Stable	No	Yes or Unknown			No	0	24.77	0	no	no	no
1170	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	95	1	Stable	No	No			No	0	47.77	0	no	no	no
1171	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	2	Stable	No	No	Signature.16		No	1	7.23	0	no	no	no
1172	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	0	2	Stable	No	No			No	0	37.29	0	no	no	no
1173	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	28	3.9	Stable	No	Yes or Unknown		ATM | RAD54L	Yes	0	46.36	0	no	no	no
1174	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	25	2	Stable	No	No	Signature.29		No	1	19.94	0	no	no	no
1175	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	II	26	3	Stable	No	No			No	1	47.05	0	no	no	no
1176	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	III	639	4.4	Stable	No	Yes or Unknown			No	1	48.3	0	no	no	no
1177	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	95	2	Stable	No	Yes or Unknown		BRCA2	No	0	49.68	0	no	no	no
1178	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	II	1312	3.5	Stable	No	Yes or Unknown			No	0	50.79	0	no	no	no
1179	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	10.8	Stable	No	No			No	1	12.94	0	no	no	no
1180	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	IV	0	4.9	Stable	No	Yes or Unknown		RAD51	Yes	0	47.28	0	no	no	no
1181	Non-ICI treated	Never received ICI	56 - 60	Female	SCLC	2015	IV	0	16.7	Stable	No	No	Signature.4	ATM | BLM | CHEK2 | PMS1	No	1	41.07	0	no	no	no
1182	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	1	Stable	No	No			No	1	10.22	0	no	no	no
1183	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	83	1	Stable	No	Yes or Unknown			Yes	0	45.08	0	no	no	no
1184	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	34	3	Stable	No	No		FANCA	No	1	2	0	no	no	no
1185	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	65	3.9	Stable	No	No		ATM | PMS1	Yes	1	27.37	0	no	no	no
1186	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	154	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	47.93	0	no	no	no
1187	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	39	3.9	Stable	No	No			No	1	20.11	0	no	no	no
1188	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	22	4.9	Indeterminate	No	No	Signature.16	ATM	No	1	21.65	0	no	no	no
1189	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	0	1	Stable	No	No		ARID1A	No	0	49.64	0	no	no	yes
1190	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	0	Stable	No	No			Yes	1	7.69	0	no	no	no
1191	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2015	I	154	0	Stable	No	Yes or Unknown			No	0	49.74	0	no	no	no
1192	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	42	29.5	Stable	No	Yes or Unknown	Signature.4		Yes	0	38.64	0	no	no	no
1193	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	III	0	4.9	Stable	No	No		ARID1A | ERCC3	Yes	1	3.29	0	no	no	yes
1194	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	21	2	Stable	No	No			No	0	50.33	0	no	no	no
1195	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	IV	41	2	Stable	No	No			No	1	16.95	0	no	no	no
1196	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	62	0.9	Stable	No	Yes or Unknown			No	0	50.4	0	no	no	no
1197	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	II	19	7	Stable	No	No		BRCA2	No	0	47.64	0	no	no	no
1198	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	IV	79	1	Stable	No	Yes or Unknown			No	1	4.37	0	no	no	no
1199	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016		0	0		No	No			No	0	34.3	0	no	no	no
1200	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	27	3.9	Stable	No	No		RAD50	No	1	25.07	0	no	no	no
1201	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	1234	4.4	Stable	No	Yes or Unknown			No	0	53.88	0	no	no	no
1202	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	III	169	1	Stable	No	Yes or Unknown			No	1	21.68	0	no	no	no
1203	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	26	3	Stable	No	No			No	1	5.65	0	no	no	no
1204	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	1518	1.8	Stable	No	Yes or Unknown			No	0	50.99	0	no	no	no
1205	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	473	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	31.01	0	no	no	no
1206	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	11	4.9	Stable	No	No			No	1	18.99	0	no	no	no
1207	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	155	1	Stable	No	Yes or Unknown			No	1	10.58	0	no	no	no
1208	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	0	4.9	Stable	No	No		ARID1A	Yes	1	11.27	0	no	no	yes
1209	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	II	38	62	Unstable	No	No	Signature.1	ARID1A | MSH2 | PALB2 | PMS2	No	0	39.23	0	mut-MMRd	mut-MMRd	yes
1210	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	IV	36	1	Stable	No	Yes or Unknown			No	1	16.85	0	no	no	no
1211	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	0	1.8	Stable	No	No			No	1	31.64	0	no	no	no
1212	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	14	7.9	Stable	No	No			No	1	15.74	0	no	no	no
1213	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	12	7.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	5.95	0	no	no	no
1214	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	980	15.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	Yes	0	48.3	0	no	no	yes
1215	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	III	0	46.2	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | BRCA2	Yes	0	38.05	0	other-MMRd	mut-MMRd	yes
1216	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		3	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	5.91	0	no	no	no
1217	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	153	0	Stable	No	Yes or Unknown			No	1	35.38	0	no	no	no
1218	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	10	0	Stable	No	No			Yes	1	12.16	0	no	no	no
1219	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	1	Stable	No	No			Yes	1	4.8	0	no	no	no
1220	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	0	2	Stable	No	No			No	0	45.44	0	no	no	no
1221	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.25	MSH6	No	1	12.91	0	no	no	no
1222	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	II	103	0	Stable	No	No			No	0	46.42	0	no	no	no
1223	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2015	IV	33	2	Stable	No	No			No	1	10.35	0	no	no	no
1224	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	216	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	33.08	0	no	no	yes
1225	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	607	2.6	Stable	No	Yes or Unknown			No	1	46.52	0	no	no	no
1226	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	46	2	Stable	No	No			No	0	14.23	0	no	no	no
1227	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	848	1.8	Stable	No	Yes or Unknown		ATM | BRCA2	No	1	41.26	0	no	no	no
1228	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	1237	0	Stable	No	Yes or Unknown			No	0	47.41	0	no	no	no
1229	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	61	3.9	Stable	No	Yes or Unknown		ATM | PMS1	No	0	49.51	0	no	no	no
1230	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	III	582	3.5		No	Yes or Unknown			No	1	28.29	0	no	no	no
1231	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		12	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	49.22	0	no	no	no
1232	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	I	16	42.3	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | MSH2 | MUTYH	No	0	48.13	0	mut-MMRd	mut-MMRd	yes
1233	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	4.9	Indeterminate	Yes or Unknown	Yes or Unknown		ARID1A	No	1	20.44	0	no	no	yes
1234	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	41	1.8		No	No			No	1	23.92	0	no	no	no
1235	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	21	3	Stable	No	Yes or Unknown		ARID1A	No	1	14.82	0	no	no	yes
1236	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2015	IV	21	11.8	Stable	No	No	Signature.24		Yes	1	3.45	0	no	no	no
1237	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	33	58	Unstable	No	No	Signature.6	ATM | BRIP1 | MDC1 | MSH6 | PMS2	Yes	0	49.58	0	mut-MMRd	mut-MMRd	no
1238	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	650	1.8	Stable	No	Yes or Unknown			No	0	47.08	0	no	no	no
1239	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	2	4.9	Stable	No	Yes or Unknown			No	1	15.84	0	no	no	no
1240	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	248	3.9	Stable	No	Yes or Unknown			No	0	26.51	0	no	no	no
1241	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	IV	71	5.9	Stable	No	No	Signature.14		No	1	12.29	0	no	no	no
1242	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	12	3	Stable	No	No			Yes	1	25.79	0	no	no	no
1243	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	165	1.8	Stable	No	No			No	0	47.41	0	no	no	no
1244	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	3	Stable	No	No			Yes	0	48.85	0	no	no	no
1245	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	16	4.9	Stable	No	No			Yes	1	29.6	0	no	no	no
1246	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	370	6.9	Stable	No	No		ARID1A	No	1	26.15	0	no	no	yes
1247	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	0	2	Stable	No	No			No	0	49.87	0	no	no	no
1248	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	III	169	5.3	Stable	No	No			Yes	0	46.26	0	no	no	no
1249	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	34	3.9	Stable	No	No			No	0	41.69	0	no	no	no
1250	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	I	554	0	Stable	No	No			No	0	47.74	0	no	no	no
1251	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	92	3.9	Stable	No	No			No	0	11.47	0	no	no	no
1252	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	169	8.9	Stable	No	Yes or Unknown	Signature.8		No	1	13.63	0	no	no	no
1253	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		0	1	Stable	No	No			No	1	38.97	0	no	no	no
1254	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	III	1261	1.8	Stable	No	Yes or Unknown		ARID1A	No	1	47.77	0	no	no	yes
1255	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2015	III	8	5.9	Stable	No	No	Signature.4		Yes	1	9.79	0	no	no	no
1256	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2015		9	1.8		Yes or Unknown	Yes or Unknown			No	0	42.87	0	no	no	no
1257	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	9	4.9	Stable	No	No			Yes	0	48.36	0	no	no	no
1258	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	48	3	Stable	No	No			No	0	45.01	0	no	no	no
1259	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	2	7.9	Stable	No	No	Signature.16		No	1	15.54	0	no	no	no
1260	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	III	1226	3.5	Stable	No	Yes or Unknown		BRIP1	No	0	48.99	0	no	no	no
1261	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	120	5.9	Stable	No	Yes or Unknown	Signature.9	ERCC2 | MSH6	No	0	49.28	0	no	no	no
1262	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	25	3.9	Stable	No	No			No	1	26.51	0	no	no	no
1263	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	231	3	Indeterminate	Yes or Unknown	Yes or Unknown			No	0	48.16	0	no	no	no
1264	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	II	62	0	Stable	No	No			No	0	48.76	0	no	no	no
1265	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	III	17	6.9	Stable	No	No			No	1	22.34	0	no	no	no
1266	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	III	250	0		No	No			No	1	52.04	0	no	no	no
1267	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	II	1293	5.3	Stable	No	Yes or Unknown			No	0	48.49	0	no	no	no
1268	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown	Signature.2		No	1	25.63	0	no	no	no
1269	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	32	3	Stable	No	No			Yes	0	51.02	0	no	no	no
1270	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	147	2	Stable	No	No			No	0	47.18	0	no	no	no
1271	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	1252	1.8	Stable	No	Yes or Unknown			No	0	46.23	0	no	no	no
1272	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	III	13	15.7	Stable	No	No	Signature.13	ARID1A | ATM | BRCA2 | RAD50	No	1	2.27	0	no	no	yes
1273	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	II	22	4.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	33.28	0	no	no	no
1274	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	1	Stable	No	No			No	1	44.09	0	no	no	no
1275	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	III	879	1.8	Stable	No	Yes or Unknown			No	0	48.33	0	no	no	no
1276	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	II	30	52.1	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MSH6 | NBN | PALB2 | PARP1	No	1	17.77	0	mut-MMRd	mut-MMRd	yes
1277	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	317	4.4		No	Yes or Unknown	Signature.22	FANCA	No	1	23.46	0	no	no	no
1278	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	30	4.4	Stable	No	Yes or Unknown			No	1	44.45	0	no	no	no
1279	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		5	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	8.21	0	no	no	no
1280	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	848	3.5	Stable	No	Yes or Unknown		ERCC4	No	0	48.95	0	no	no	no
1281	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2015	II	23	2	Stable	No	No			No	0	48.69	0	no	no	no
1282	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	IV	143	1	Stable	Yes or Unknown	Yes or Unknown			No	1	29.4	0	no	no	no
1283	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	15	8.9	Stable	No	No	Signature.4		Yes	1	6.01	0	no	no	no
1284	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	6	16.7	Stable	No	Yes or Unknown	Signature.2		No	1	17.45	0	no	no	no
1285	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	IV	46	4.9	Stable	No	No			No	1	5.85	0	no	no	no
1286	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.19	0	no	no	no
1287	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	59	5.3	Stable	No	No		ATR	Yes	0	28.81	0	no	no	no
1288	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	21	3	Stable	No	No			No	0	48.39	0	no	no	no
1289	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	II	75	4.9	Stable	No	No			No	0	50.17	0	no	no	no
1290	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	0	3.5	Stable	No	No			No	0	49.41	0	no	no	no
1291	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	0	0	Stable	No	No			Yes	0	48.69	0	no	no	no
1292	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	6.9	Stable	No	No		BRIP1	No	0	28.58	0	no	no	no
1293	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015		77	5.9	Stable	No	No	Signature.19	ARID1A	No	1	11.96	0	no	no	yes
1294	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015		70	6.1		No	No	Signature.1		No	1	21.42	0	no	no	no
1295	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2016	I	26	2.6		No	No			No	0	31.21	0	no	no	no
1296	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	119	3.9	Stable	No	No			No	0	38.83	0	no	no	no
1297	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	1615	1.8	Stable	No	Yes or Unknown			No	0	47.93	0	no	no	no
1298	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	85	3.9	Stable	No	No			No	0	48.76	0	no	no	no
1299	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	47	3.9	Stable	No	No			No	0	46.55	0	no	no	no
1300	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	153	2	Stable	No	Yes or Unknown			No	0	18.4	0	no	no	no
1301	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2015	IV	26	8.9	Stable	No	No	Signature.29		Yes	1	15.21	0	no	no	no
1302	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	II	15	2	Stable	No	Yes or Unknown			No	1	37.75	0	no	no	no
1303	Non-ICI treated	Never received ICI	46 - 50	Female	SCLC	2015	IV	1	10.8	Indeterminate	No	No	Signature.4	ARID1A | ATR	No	1	12.88	0	no	no	yes
1304	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		18	1	Stable	Yes or Unknown	Yes or Unknown			No	1	12.42	0	no	no	no
1305	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	I	366	6.1	Stable	No	No		ARID1A	Yes	0	46.52	0	no	no	yes
1306	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	21	3	Stable	No	Yes or Unknown		ARID1A	No	1	11.4	0	no	no	yes
1307	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	42	7.9	Stable	No	No	Signature.4		No	0	46.88	0	no	no	no
1308	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	623	1.8	Stable	No	Yes or Unknown			No	1	38.31	0	no	no	no
1309	Non-ICI treated	Never received ICI	61 - 65	Male	SCLC	2015	IV	0	2	Stable	No	No	Signature.4		Yes	1	4.76	0	no	no	no
1310	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	III	960	3.5	Stable	No	Yes or Unknown	Signature.2		Yes	1	39.75	0	no	no	no
1311	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	6	5.9	Stable	No	No		BRCA1 | MDC1	No	1	28.52	0	no	no	no
1312	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	359	12.8	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	44.94	0	no	no	yes
1313	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2015	IV	30	6.9	Stable	No	No	Signature.4		No	1	11.96	0	no	no	no
1314	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	I	28	3.9	Stable	No	No		RAD50	Yes	0	42.91	0	no	no	no
1315	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	11	3	Stable	No	No			Yes	0	48.82	0	no	no	no
1316	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	19	4.9	Stable	No	Yes or Unknown			No	1	17.08	0	no	no	no
1317	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	37	1.8		No	Yes or Unknown	Signature.1		Yes	1	28.68	0	no	no	no
1318	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	21	2	Stable	No	Yes or Unknown			No	0	48.2	0	no	no	no
1319	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	8	3	Stable	No	No			No	1	24.44	0	no	no	no
1320	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	1	11.4	Stable	No	No	Signature.1		No	0	49.02	0	no	no	no
1321	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	5.9	Stable	No	No			No	0	21.85	0	no	no	no
1322	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2015	III	0	1	Stable	No	No			No	1	12.12	0	no	no	no
1323	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	III	0	7.9	Stable	No	No	Signature.4	MRE11A	No	1	10.25	0	no	no	no
1324	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	0	6.9	Stable	No	No			No	1	21.65	0	no	no	no
1325	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2015	II	0	0	Stable	No	No			No	0	41.2	0	no	no	no
1326	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	4.9	Stable	No	No			No	0	46.78	0	no	no	no
1327	Non-ICI treated	Never received ICI	21 - 25	Male	Gastric	2015	III	154	1	Stable	No	Yes or Unknown			No	1	20.11	0	no	no	no
1328	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	26	3	Stable	No	No			No	1	32.26	0	no	no	no
1329	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	26	4.9	Stable	No	Yes or Unknown			No	0	49.35	0	no	no	no
1330	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	3	Stable	No	No			No	0	50.63	0	no	no	no
1331	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	0	0	Stable	No	No			No	0	47.84	0	no	no	no
1332	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	247	2	Stable	No	Yes or Unknown			Yes	0	46.52	0	no	no	no
1333	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	4	5.9	Stable	No	No	Signature.1		No	1	31.47	0	no	no	no
1334	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	640	4.4	Stable	No	Yes or Unknown			No	0	49.05	0	no	no	no
1335	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	84	1	Stable	No	Yes or Unknown			No	1	44.55	0	no	no	no
1336	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	0	2	Stable	No	No			Yes	0	43.7	0	no	no	no
1337	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	0	4.9	Stable	No	No			Yes	0	48.23	0	no	no	no
1338	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	IV	0	2.6		No	No			Yes	1	34.96	0	no	no	no
1339	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	I	473	0		No	No			No	0	46.95	0	no	no	no
1340	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	295	22.6	Stable	No	Yes or Unknown	Signature.13	BLM | BRCA2 | BRIP1 | RAD54L	No	1	26.55	0	no	no	no
1341	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2015	III	71	6.1	Indeterminate	No	No			No	1	44.62	0	no	no	no
1342	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	21	8.9	Stable	No	No	Signature.1	ARID1A	No	1	9.86	0	no	no	yes
1343	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	48	2	Stable	No	Yes or Unknown			No	0	39.79	0	no	no	no
1344	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	30	4.9	Stable	No	Yes or Unknown		BRCA1	No	0	48.36	0	no	no	no
1345	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	0	3.9	Stable	No	No			No	1	24.41	0	no	no	no
1346	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	3	1	Stable	No	Yes or Unknown			No	0	48	0	no	no	no
1347	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	34	3	Stable	No	No			No	1	14.46	0	no	no	no
1348	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	323	6.1		No	Yes or Unknown			Yes	0	46.49	0	no	no	no
1349	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	2.6	Stable	No	Yes or Unknown			No	0	45.67	0	no	no	no
1350	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2015	IV	136	6.9	Stable	No	Yes or Unknown	Signature.1	ARID1A | PMS1	No	1	41.46	0	no	no	yes
1351	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	III	19	58	Unstable	No	No	Signature.6	BLM | CHEK2 | MSH2 | NBN	No	0	46.19	0	mut-MMRd	mut-MMRd	no
1352	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	13	5.9	Stable	No	No	Signature.4		Yes	0	49.61	0	no	no	no
1353	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	I	0	5.9	Stable	No	No	Signature.1	BRCA1	No	0	49.74	0	no	no	no
1354	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	21	3	Stable	No	No			No	1	18.83	0	no	no	no
1355	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	0	3	Stable	No	No			No	0	44.22	0	no	no	no
1356	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	1	2	Stable	No	Yes or Unknown			No	0	48.39	0	no	no	no
1357	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2015	IV	99	3.9	Stable	No	Yes or Unknown			No	1	6.41	0	no	no	no
1358	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	I	0	1	Stable	No	No			No	0	42.74	0	no	no	no
1359	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	I	0	4.9	Stable	No	Yes or Unknown			Yes	0	45.5	0	no	no	no
1360	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	155	3	Stable	No	Yes or Unknown			No	1	28.71	0	no	no	no
1361	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	II	1372	6.1	Stable	No	No		ARID1A	No	0	46.69	0	no	no	yes
1362	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	6	3.9	Stable	No	Yes or Unknown			No	1	10.09	0	no	no	no
1363	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	32	7.9	Stable	No	No		ATR | MSH6	No	1	23.75	0	no	no	no
1364	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	186	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	31.9	0	no	no	no
1365	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	78	3.9	Stable	No	No		MUTYH	No	1	17.91	0	no	no	no
1366	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	9	4.9	Stable	No	No			Yes	0	8.21	0	no	no	no
1367	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	II	0	3.9	Stable	No	No			No	0	49.45	0	no	no	no
1368	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	21.82	0	no	no	no
1369	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	1	2	Stable	No	No			No	1	6.41	0	no	no	no
1370	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2015	IV	0	10.8	Stable	No	No	Signature.1		No	1	17.54	0	no	no	no
1371	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	1377	7	Stable	No	No	Signature.13	ARID1A	Yes	0	48.69	0	no	no	yes
1372	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	9	54.1	Unstable	No	No	Signature.6	ARID1A | BRCA2 | ERCC5 | MSH6 | RAD50	No	0	42.32	0	mut-MMRd	mut-MMRd	yes
1373	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	794	2.6	Stable	No	Yes or Unknown		ARID1A	No	0	47.51	0	no	no	yes
1374	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	71	3	Stable	No	No			No	0	42.64	0	no	no	no
1375	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	0	3.9	Stable	No	No			No	0	17.97	0	no	no	no
1376	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	23	356.1	Stable	No	No	Signature.10	ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | ERCC2 | ERCC4 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | MSH6 | MUTYH | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD51 | RAD51C | RAD52 | RAD54L | XRCC2	No	0	33.35	0	no	no	no
1377	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2015	I	1437	3.5	Stable	No	No	Signature.24	BRCA1	Yes	0	48.2	0	no	no	no
1378	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2015		0	0	Stable	No	No			No	0	47.05	0	no	no	no
1379	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	III	30	2	Stable	No	No			Yes	0	46.72	0	no	no	no
1380	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	27	11.8	Stable	No	No	Signature.4	ARID1A	No	0	45.31	0	no	no	yes
1381	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	III	39	5.3	Stable	No	No			No	0	47.24	0	no	no	no
1382	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	III	501	4.4	Stable	No	Yes or Unknown	Signature.1	ERCC5	Yes	0	26.15	0	no	no	no
1383	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	7	4.9	Stable	No	No		MSH6	No	0	48.56	0	no	no	no
1384	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	II	807	5.3	Stable	No	No			Yes	0	45.34	0	no	no	no
1385	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	262	5.9	Stable	No	Yes or Unknown	Signature.30	ERCC2	No	1	21.72	0	no	no	no
1386	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	III	20	3	Stable	No	No		ARID1A	No	1	20.73	0	no	no	yes
1387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3.9		No	No			No	1	49.77	0	no	no	no
1388	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	75	1	Stable	No	No			No	1	42.68	0	no	no	no
1389	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	132	2.6	Stable	No	No			Yes	0	48.99	0	no	no	no
1390	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	III	867	4.4	Stable	No	Yes or Unknown			No	1	33.05	0	no	no	no
1391	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	III	195	2	Stable	No	Yes or Unknown			No	1	33.25	0	no	no	no
1392	Non-ICI treated	Never received ICI	61 - 65	Male	Cutaneous Melanoma 	2015	I	23	29.5	Stable	No	No	Signature.7	ARID1A | MUTYH	No	0	41.86	0	no	no	yes
1393	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	215	5.9	Stable	No	Yes or Unknown			No	1	12.75	0	no	no	no
1394	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	I	94	0.9	Stable	No	Yes or Unknown			No	0	48.76	0	no	no	no
1395	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2015	IV	3	2	Stable	No	No			No	1	9.63	0	no	no	no
1396	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	27	6.9	Stable	No	No	Signature.4		No	0	40.64	0	no	no	no
1397	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	11	5.9	Stable	No	No	Signature.15		No	1	9.03	0	no	no	no
1398	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2015	IV	7	1	Stable	No	No		PALB2	No	1	11.1	0	no	no	no
1399	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	56	2	Stable	No	Yes or Unknown			No	0	49.08	0	no	no	no
1400	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.5	MRE11A	No	1	35.55	0	no	no	no
1401	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	1366	5.3	Stable	No	Yes or Unknown			No	0	48.53	0	no	no	no
1402	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	12	7.9	Stable	No	No		BRCA2 | FANCA	No	1	26.68	0	no	no	no
1403	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	28	6.1	Indeterminate	No	No		ATM	No	1	46.42	0	no	no	no
1404	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	56	4.9	Stable	No	Yes or Unknown			Yes	1	4.44	0	no	no	no
1405	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2015	III	169	8.9	Stable	No	Yes or Unknown	Signature.6	MSH2 | RAD54L	No	0	44.94	0	no	no	no
1406	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	4	6.9	Stable	No	No			No	0	48.2	0	no	no	no
1407	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	20.76	0	no	no	no
1408	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	959	1.8	Stable	No	Yes or Unknown			No	0	49.68	0	no	no	no
1409	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		0	2	Stable	No	No			Yes	0	31.41	0	no	no	no
1410	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	402	4.4		No	Yes or Unknown	Signature.3		No	1	16.49	0	no	no	no
1411	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	4.4		No	No			Yes	1	21.98	0	no	no	no
1412	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	0	2.6		No	Yes or Unknown			No	1	16.53	0	no	no	no
1413	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	346	1	Stable	No	Yes or Unknown			No	1	21.68	0	no	no	no
1414	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	16	5.3	Stable	No	No		ATM	Yes	0	16.56	0	no	no	no
1415	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	IV	13	1	Stable	No	Yes or Unknown			No	1	35.55	0	no	no	no
1416	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	77	3	Stable	No	No			Yes	0	46.85	0	no	no	no
1417	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	6.9	Stable	No	No	Signature.6		Yes	0	13.24	0	no	no	no
1418	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	161	22.6	Stable	No	Yes or Unknown	Signature.4	MUTYH	No	0	48.23	0	no	no	no
1419	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	152	3	Stable	No	Yes or Unknown			No	0	41.23	0	no	no	no
1420	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	126	14	Stable	No	Yes or Unknown	Signature.13	ARID1A | BRCA2 | MDC1	No	0	17.35	0	no	no	yes
1421	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	54	1	Stable	No	No			Yes	0	45.7	0	no	no	no
1422	Non-ICI treated	Never received ICI	31 - 35	Male	NSCLC	2015	IV	45	2	Stable	No	Yes or Unknown		MLH1	No	0	46.59	0	no	no	no
1423	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2015	II	1168	2.6	Stable	No	Yes or Unknown	Signature.5		No	0	48.79	0	no	no	no
1424	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	152	0		No	Yes or Unknown			No	0	43.86	0	no	no	no
1425	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	30	4.9	Stable	No	No			No	1	17.64	0	no	no	no
1426	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	0	64.9	Unstable	No	No	Signature.1	ARID1A | ATM | MRE11A | MSH2	Yes	0	47.31	0	mut-MMRd	mut-MMRd	yes
1427	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	4.9	Stable	No	No	Signature.13	ATR	Yes	1	4.7	0	no	no	no
1428	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	38	5.9	Stable	No	No	Signature.3		Yes	1	3.52	0	no	no	no
1429	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	0	9.8	Stable	No	No	Signature.4		No	0	36.83	0	no	no	no
1430	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		5	5.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	32	0	no	no	no
1431	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	1	16.76	0	no	no	no
1432	Non-ICI treated	Never received ICI	66 - 70	Female	Esophageal	2015	III	0	5.9	Stable	No	No		ARID1A	Yes	0	37.22	0	no	no	yes
1433	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	85	3.9	Stable	No	No			No	0	48.49	0	no	no	no
1434	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	1022	7.9	Stable	No	Yes or Unknown		MRE11A	No	0	48.33	0	no	no	no
1435	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	1421	10.5	Stable	No	Yes or Unknown	Signature.30		No	0	48.26	0	no	no	no
1436	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	2	4.9	Stable	No	Yes or Unknown	Signature.9		No	1	10.55	0	no	no	no
1437	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	4	2	Stable	No	No			No	1	25.99	0	no	no	no
1438	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	0	2.6		No	No			No	0	47.05	0	no	no	no
1439	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	43	5.9	Stable	No	No	Signature.24	BRCA2	No	0	47.44	0	no	no	no
1440	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.4		Yes	1	5.72	0	no	no	no
1441	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	7	25.5		No	No	Signature.6	ARID1A | ATR | MSH6 | TP53BP1	Yes	0	29.01	0	no	no	yes
1442	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	23	2.6	Stable	No	No			Yes	0	52.01	0	no	no	no
1443	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	49.48	0	no	no	no
1444	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	III	51	7.9	Stable	No	No	Signature.24	BRIP1 | MRE11A | PMS1	Yes	0	44.12	0	no	no	no
1445	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	38	7.9	Stable	No	No			No	0	39.82	0	no	no	no
1446	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	7	2	Stable	No	No			No	1	8.71	0	no	no	no
1447	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	4.9	Stable	No	Yes or Unknown		RAD54L	No	0	48.36	0	no	no	no
1448	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	II	699	2.6	Stable	No	Yes or Unknown			No	0	48.26	0	no	no	no
1449	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	239	8.9	Stable	No	Yes or Unknown	Signature.10		No	0	49.28	0	no	no	no
1450	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	407	7		No	Yes or Unknown	Signature.3		No	1	18.73	0	no	no	no
1451	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	0	77.7	Unstable	No	No	Signature.6	ATM | BLM | BRCA2 | ERCC5 | MDC1 | NBN | RAD50	No	0	45.8	0	other-MMRd	mut-MMRd	no
1452	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2015	IV	0	4.9	Stable	No	No	Signature.29	PARP1	Yes	1	5.42	0	no	no	no
1453	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	III	1006	2.6	Stable	No	Yes or Unknown		ERCC2	No	0	47.15	0	no	no	no
1454	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	3	Stable	No	No		ATM	No	1	6.34	0	no	no	no
1455	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	13.9	0	no	no	no
1456	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	0	8.9	Stable	No	No	Signature.1		Yes	0	46	0	no	no	no
1457	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	II	45	3	Stable	No	Yes or Unknown			No	0	44.12	0	no	no	no
1458	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	III	13	1.8	Stable	No	No			No	1	41.63	0	no	no	no
1459	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	II	23	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	26.02	0	no	no	no
1460	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	6	1	Stable	No	Yes or Unknown			Yes	0	18.86	0	no	no	no
1461	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	13	5.9	Stable	No	No			No	0	11.7	0	no	no	no
1462	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	IV	22	2	Stable	No	No			No	0	47.61	0	no	no	no
1463	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.1		No	0	25.49	0	no	no	no
1464	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	1165	0.9	Stable	No	Yes or Unknown			Yes	0	47.11	0	no	no	no
1465	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	69	3	Stable	No	Yes or Unknown			No	0	47.08	0	no	no	no
1466	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		1	2	Stable	Yes or Unknown	Yes or Unknown			No	1	21.49	0	no	no	no
1467	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		3	0	Stable	Yes or Unknown	Yes or Unknown			Yes	0	47.15	0	no	no	no
1468	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		33	5.9	Stable	No	No			Yes	0	46.59	0	no	no	no
1469	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	56	2	Stable	No	No			No	0	42.81	0	no	no	no
1470	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2015	IV	48	6.9	Stable	No	No	Signature.29	BRCA1 | RAD50	No	1	4.37	0	no	no	no
1471	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	44.16	0	no	no	no
1472	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	112	9.8	Stable	No	No	Signature.1	ATM	No	0	19.22	0	no	no	no
1473	Non-ICI treated	Never received ICI	41 - 45	Female	Renal	2015	I	0	1	Stable	No	No			No	0	6.28	0	no	no	no
1474	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	1.8		No	Yes or Unknown			No	1	23.69	0	no	no	no
1475	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	404	5.3		No	Yes or Unknown	Signature.3		No	1	27.01	0	no	no	no
1476	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	409	7.9		No	Yes or Unknown	Signature.1		No	1	22.05	0	no	no	no
1477	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	I	0	4.9	Stable	No	No			No	0	43.66	0	no	no	no
1478	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	4	7.9	Stable	No	No		ERCC4	Yes	1	8.08	0	no	no	no
1479	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	24	1	Stable	No	No			No	1	16.59	0	no	no	no
1480	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	230	0	Stable	No	No			Yes	0	48.23	0	no	no	no
1481	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015		17	6.9	Stable	No	No			Yes	0	43.37	0	no	no	no
1482	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2015	III	34	6.1	Stable	No	No		ARID1A	No	1	23.43	0	no	no	yes
1483	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	148	30.5	Stable	No	No	Signature.4	ARID1A | ATM	No	0	16.43	0	no	no	yes
1484	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	31	4.4	Stable	No	No		MDC1	No	0	22.93	0	no	no	no
1485	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	91	6.9	Stable	No	Yes or Unknown	Signature.4		No	1	9.46	0	no	no	no
1486	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	47	3	Stable	No	No			No	0	45.08	0	no	no	no
1487	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	116	5.3	Stable	No	Yes or Unknown			No	0	46.65	0	no	no	no
1488	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	II	25	2	Stable	No	Yes or Unknown		RAD54L	No	1	15.51	0	no	no	no
1489	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	46	3	Stable	No	Yes or Unknown			No	0	47.47	0	no	no	no
1490	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	III	0	4.9	Indeterminate	No	No	Signature.4		Yes	0	47.28	0	no	no	no
1491	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	IV	291	3	Stable	No	Yes or Unknown		BRCA2	No	1	17.74	0	no	no	no
1492	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	0	8.9	Stable	No	No	Signature.1		No	0	48.33	0	no	no	no
1493	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	0	4.9	Stable	No	No	Signature.4		Yes	0	44.85	0	no	no	no
1494	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	0	3.9	Stable	No	No			No	1	10.35	0	no	no	no
1495	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	99	3.9	Stable	No	Yes or Unknown		BLM | BRCA2	No	0	48.03	0	no	no	no
1496	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2015	III	41	12.8	Stable	No	Yes or Unknown	Signature.1		Yes	0	46.39	0	no	no	no
1497	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2015	III	14	4.9	Stable	No	No	Signature.1		Yes	1	17.25	0	no	no	no
1498	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	III	337	6.1		No	Yes or Unknown	Signature.18		No	1	16.95	0	no	no	no
1499	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2015	III	0	1	Stable	No	No			No	0	47.11	0	no	no	no
1500	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	118	3.9	Stable	No	Yes or Unknown			Yes	1	12.09	0	no	no	no
1501	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	136	4.9	Stable	No	Yes or Unknown			No	1	4.83	0	no	no	no
1502	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	60	6.9	Stable	No	No	Signature.8		No	0	47.7	0	no	no	no
1503	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	32	3	Stable	No	No			No	1	17.22	0	no	no	no
1504	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	659	4.4	Stable	No	Yes or Unknown	Signature.2		No	1	27.93	0	no	no	no
1505	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	I	104	0	Stable	No	No			No	0	38.44	0	no	no	no
1506	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	27	3.5	Stable	No	No		BRCA1	No	1	37.75	0	no	no	no
1507	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	IV	70	4.9	Stable	No	Yes or Unknown		ATM	No	1	8.21	0	no	no	no
1508	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	0	2.6		No	Yes or Unknown			Yes	0	46.92	0	no	no	no
1509	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	17	2.6	Stable	No	Yes or Unknown			No	1	41.72	0	no	no	no
1510	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	III	250	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.6		No	1	18.23	0	no	no	no
1511	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2015		48	1	Stable	No	No			No	0	35.15	0	no	no	no
1512	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	28	2	Stable	No	Yes or Unknown			No	0	33.15	0	no	no	no
1513	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2015	II	0	3.5	Stable	No	No	Signature.9	ARID1A | RAD50	No	1	37.26	0	no	no	yes
1514	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	77	1	Stable	No	No			No	0	46.85	0	no	no	no
1515	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	1104	1.8	Stable	No	Yes or Unknown		BLM	No	0	46.36	0	no	no	no
1516	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	30	4.9	Stable	No	No			No	1	12.19	0	no	no	no
1517	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	III	131	2	Stable	No	Yes or Unknown			No	0	42.05	0	no	no	no
1518	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	71	12.8	Stable	No	No	Signature.4	PALB2	No	0	38.24	0	no	no	no
1519	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	46.65	0	no	no	no
1520	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	24	5.3	Stable	No	No		BRCA2	Yes	0	45.5	0	no	no	no
1521	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	I	22	8.9	Stable	No	No	Signature.1		No	0	30.16	0	no	no	no
1522	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	IV	6	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	16.72	0	no	no	yes
1523	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	21	7.9	Stable	No	Yes or Unknown			No	0	47.41	0	no	no	no
1524	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			Yes	1	9.1	0	no	no	no
1525	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	35	2.6	Stable	No	Yes or Unknown		ARID1A	No	1	3.25	0	no	no	yes
1526	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	6	0.9	Stable	No	Yes or Unknown			No	1	29.21	0	no	no	no
1527	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATM | NBN	Yes	1	36.5	0	no	no	no
1528	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	22	2.6		No	No			No	0	24.97	0	no	no	no
1529	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	28	3.5		No	Yes or Unknown			No	0	33.68	0	no	no	no
1530	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	1024	2.6	Stable	No	Yes or Unknown			Yes	0	42.78	0	no	no	no
1531	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	158	1	Stable	No	No			No	0	44.58	0	no	no	no
1532	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	0	0	Stable	No	No			No	0	42.18	0	no	no	no
1533	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	18	2	Stable	No	No			Yes	1	1.25	0	no	no	no
1534	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1092	0.9	Stable	No	Yes or Unknown			No	0	47.64	0	no	no	no
1535	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	15	5.9	Stable	No	No	Signature.4		Yes	1	4.34	0	no	no	no
1536	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	IV	192	2	Stable	No	Yes or Unknown			No	1	25.13	0	no	no	no
1537	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2015		0	4.9	Stable	No	No			Yes	1	20.5	0	no	no	no
1538	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2015	II	145	0	Stable	No	No			No	0	43.07	0	no	no	no
1539	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	44	1	Stable	No	No			Yes	0	10.51	0	no	no	no
1540	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	32	5.9	Stable	No	No		ATM | ERCC3	No	0	46.69	0	no	no	no
1541	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	150	0.9		No	Yes or Unknown			Yes	0	46.88	0	no	no	no
1542	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2015	IV	278	3	Stable	No	Yes or Unknown			No	1	13.08	0	no	no	no
1543	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	21.19	0	no	no	no
1544	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	35	2	Stable	No	Yes or Unknown		RAD54L	No	1	24.57	0	no	no	no
1545	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	36	3.9	Stable	No	No			No	0	45.04	0	no	no	no
1546	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	II	237	5.3	Stable	No	Yes or Unknown		CHEK2	No	0	45.9	0	no	no	no
1547	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	30	1	Stable	No	No			No	1	30.82	0	no	no	no
1548	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		73	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	27.53	0	no	no	no
1549	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	45.83	0	no	no	no
1550	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	182	12.8	Stable	No	Yes or Unknown	Signature.4	BLM	No	0	41.59	0	no	no	no
1551	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	133	8.9	Stable	No	Yes or Unknown	Signature.5		No	1	9.23	0	no	no	no
1552	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	12	1	Stable	No	No			No	0	46.65	0	no	no	no
1553	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	I	22	1	Stable	No	No			No	0	44.32	0	no	no	no
1554	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		5	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	46.98	0	no	no	no
1555	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	II	29	7.9	Stable	No	No	Signature.1		No	0	42.05	0	no	no	no
1556	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	193	0	Stable	No	No			No	0	48.79	0	no	no	no
1557	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	27	8.9		No	No			No	1	20.96	0	no	no	no
1558	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	27	5.9	Stable	No	Yes or Unknown			No	1	28.16	0	no	no	no
1559	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	96	3.5	Stable	No	Yes or Unknown			No	1	32.03	0	no	no	no
1560	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	16.13	0	no	no	no
1561	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	I	915	2.6	Stable	No	No			No	1	43.83	0	no	no	no
1562	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	2	5.9	Stable	No	No			No	1	23.26	0	no	no	no
1563	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	I	0	2	Stable	No	No			No	0	41.72	0	no	no	no
1564	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	II	25	2.6	Indeterminate	No	Yes or Unknown			No	0	48.46	0	no	no	no
1565	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	14	2	Stable	No	No			No	0	17.28	0	no	no	no
1566	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	26	4.4	Stable	No	No			No	0	12.35	0	no	no	no
1567	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	0	5.9	Stable	No	No			No	0	36.57	0	no	no	no
1568	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	16	4.4	Stable	No	No			Yes	0	43.89	0	no	no	no
1569	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	No			No	1	22.64	0	no	no	no
1570	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	89	3.5	Stable	No	No			Yes	0	27.89	0	no	no	no
1571	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	IV	37	1	Stable	No	No			No	1	20.14	0	no	no	no
1572	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	34	0	Stable	No	No			No	1	20.76	0	no	no	no
1573	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	22	16.7	Stable	No	No	Signature.1	FANCA | MLH1 | RAD52	No	1	8.71	0	no	no	no
1574	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	II	24	74.8	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | BRCA2 | ERCC4 | FANCA | MLH1 | MRE11A | RAD51	No	0	45.9	0	mut-MMRd	mut-MMRd	yes
1575	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	28	2	Stable	No	No			No	0	28.32	0	no	no	no
1576	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	I	951	0	Stable	No	No			Yes	0	46.65	0	no	no	no
1577	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2015		67	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	38.05	0	no	no	no
1578	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	1098	16.7	Stable	No	Yes or Unknown	Signature.30	BLM | MSH3	Yes	0	45.77	0	no	no	no
1579	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	44	4.9	Stable	No	No			No	0	42.51	0	no	no	no
1580	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	0	1.8	Indeterminate	No	No	Signature.1		No	1	42.91	0	no	no	no
1581	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	54	3	Stable	No	No			No	1	29.17	0	no	no	no
1582	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	25	5.9	Stable	No	No	Signature.20	MRE11A	No	1	39.98	0	no	no	no
1583	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	3	Stable	No	No			No	0	46.75	0	no	no	no
1584	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	III	22	0	Stable	No	No			Yes	1	16.39	0	no	no	no
1585	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	161	3	Stable	No	Yes or Unknown		ARID1A	No	0	12.88	0	no	no	yes
1586	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2015	IV	2	0	Stable	No	No			No	0	25.69	0	no	no	no
1587	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	II	29	1.8		No	No			Yes	0	44.52	0	no	no	no
1588	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	863	4.4	Stable	No	Yes or Unknown			No	0	47.9	0	no	no	no
1589	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	24	3	Stable	No	No			Yes	1	6.41	0	no	no	no
1590	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	2	0.9		No	No			No	1	13.77	0	no	no	no
1591	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	61	3	Stable	No	No			No	0	48.36	0	no	no	no
1592	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015	I	0	0	Stable	No	No			No	0	34.17	0	no	no	no
1593	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	3	18.7	Indeterminate	No	No	Signature.4	BRCA1 | CHEK2	No	1	1.54	0	no	no	no
1594	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2015	III	77	5.3	Stable	No	No		CHEK2	Yes	0	48.03	0	no	no	no
1595	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	58	9.8	Stable	No	Yes or Unknown	Signature.26		No	1	13.96	0	no	no	no
1596	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	II	21	1.8		No	No		BRCA1	No	0	30.59	0	no	no	no
1597	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	59	3	Stable	No	No			Yes	0	43.83	0	no	no	no
1598	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2015		0	9.8	Stable	No	No			No	0	42.12	0	no	no	no
1599	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	42	2.6		No	Yes or Unknown			No	0	36.86	0	no	no	no
1600	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2015		41	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	42.87	0	no	no	no
1601	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	42	3.9	Stable	No	No			No	0	42.81	0	no	no	no
1602	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	35	3	Stable	No	No			No	0	47.21	0	no	no	no
1603	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	53	4.4		No	Yes or Unknown			Yes	0	37.62	0	no	no	no
1604	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	0	5.3	Indeterminate	No	No	Signature.6		No	1	28.22	0	no	no	no
1605	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	51	2	Stable	No	Yes or Unknown			No	0	4.4	0	no	no	no
1606	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	III	12	36.4	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1	Yes	0	42.12	0	mut-MMRd	mut-MMRd	yes
1607	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	22	1.8		No	No		MSH3	Yes	0	41.92	0	no	no	no
1608	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	45.31	0	no	no	no
1609	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	10	5.9	Stable	No	No		ERCC2	No	1	16.23	0	no	no	no
1610	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	23	2.6	Stable	No	No			No	0	31.44	0	no	no	no
1611	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	23	15.8		No	No	Signature.26		Yes	0	41.33	0	no	no	no
1612	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	III	0	29	Unstable	No	No	Signature.6	ARID1A | ATR	Yes	0	46.75	0	other-MMRd	mut-MMRd	yes
1613	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	III	81	2	Stable	No	No			No	0	46.69	0	no	no	no
1614	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	27	3.9	Stable	No	No			No	1	24.71	0	no	no	no
1615	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	32	2	Stable	No	No			No	0	37.78	0	no	no	no
1616	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	0	0	Stable	No	No			No	0	13.04	0	no	no	no
1617	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	1272	3.5	Stable	No	Yes or Unknown	Signature.29	ARID1A | ATM	No	0	46.13	0	no	no	yes
1618	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	118	1.8	Stable	No	Yes or Unknown			No	0	45.86	0	no	no	no
1619	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	55	2.6		No	No			No	0	26.18	0	no	no	no
1620	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	3.5	Stable	No	Yes or Unknown			No	0	28.94	0	no	no	no
1621	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	599	2.6	Stable	No	Yes or Unknown			No	0	42.87	0	no	no	no
1622	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	37	5.9	Stable	No	Yes or Unknown			No	0	45.27	0	no	no	no
1623	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	47.38	0	no	no	no
1624	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	31	6.9	Stable	No	No	Signature.30		Yes	1	14.42	0	no	no	no
1625	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	III	151	3.9	Stable	No	Yes or Unknown		ATM	Yes	1	12.58	0	no	no	no
1626	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	428	2.6		No	No			No	0	46.88	0	no	no	no
1627	Non-ICI treated	Never received ICI	26 - 30	Female	Head & Neck	2015	II	14	2	Stable	No	No			No	0	6.83	0	no	no	no
1628	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2015	III	19	5.9	Stable	No	No			No	0	45.27	0	no	no	no
1629	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	255	2	Stable	No	Yes or Unknown			No	1	24.44	0	no	no	no
1630	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	0	3.9	Stable	No	No			No	1	8.97	0	no	no	no
1631	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	11	1	Stable	No	No			Yes	1	8.94	0	no	no	no
1632	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	282	1	Stable	No	Yes or Unknown		ARID1A	Yes	1	19.84	0	no	no	yes
1633	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	0	14.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	13.67	0	no	no	yes
1634	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	441	0.9		No	Yes or Unknown			No	1	18.4	0	no	no	no
1635	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	16	3	Stable	No	No		ARID1A | CHEK2	No	1	14.78	0	no	no	yes
1636	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	36	1	Stable	No	No			No	0	46.09	0	no	no	no
1637	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	I	21	0	Stable	No	No			No	0	45.83	0	no	no	no
1638	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2015	III	41	6.9	Stable	No	No	Signature.7		No	0	18.89	0	no	no	no
1639	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	0	0		No	No		MUTYH	No	1	36.47	0	no	no	no
1640	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	II	0	1	Stable	No	Yes or Unknown			No	0	45.54	0	no	no	no
1641	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	II	622	1.8	Stable	No	No			No	0	27.24	0	no	no	no
1642	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		41	2	Indeterminate	No	No			No	1	28.88	0	no	no	no
1643	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	34	2	Stable	No	No			No	1	19.12	0	no	no	no
1644	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	44	2.6		No	No			Yes	0	42.81	0	no	no	no
1645	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	II	69	1	Stable	No	No			No	0	3.25	0	no	no	no
1646	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	216	6.9	Stable	No	Yes or Unknown	Signature.1		No	1	17.58	0	no	no	no
1647	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	0	7.9	Stable	No	Yes or Unknown			No	0	23.89	0	no	no	no
1648	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	48	9.8	Stable	No	No	Signature.1		No	1	15.61	0	no	no	no
1649	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2015	I	32	3.5		No	No			Yes	1	44.62	0	no	no	no
1650	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			No	1	40.67	0	no	no	no
1651	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	24	8.9	Stable	No	No	Signature.1		No	1	20.47	0	no	no	no
1652	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2015	IV	271	1	Stable	No	Yes or Unknown			No	1	33.25	0	no	no	no
1653	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	4.9	Stable	No	No			No	1	16.59	0	no	no	no
1654	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	21	3.9	Stable	No	No			Yes	0	9.26	0	no	no	no
1655	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	II	46	21.6	Stable	No	No	Signature.4	BRCA2	Yes	0	43.33	0	no	no	no
1656	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	224	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	46.16	0	no	no	no
1657	Non-ICI treated	Never received ICI	46 - 50	Female	Head & Neck	2015	II	112	8.9	Stable	No	No	Signature.16		No	1	13.5	0	no	no	no
1658	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	IV	116	3.9	Stable	No	No			Yes	0	26.51	0	no	no	no
1659	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	32	3	Stable	No	No		BLM	No	0	46.06	0	no	no	no
1660	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	52	2	Stable	No	Yes or Unknown			No	1	17.71	0	no	no	no
1661	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	42.45	0	no	no	no
1662	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	II	241	0	Stable	No	Yes or Unknown			No	0	37.98	0	no	no	no
1663	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	40	5.3	Stable	No	No			No	0	44.48	0	no	no	no
1664	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	III	21	6.9	Stable	No	No		BLM	Yes	0	42.81	0	no	no	no
1665	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2015		0	3	Stable	No	No			No	1	7.82	0	no	no	no
1666	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015	I	0	3	Stable	No	No			No	1	2.63	0	no	no	no
1667	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	29	3.9	Stable	No	No			Yes	1	38.67	0	no	no	no
1668	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	462	4.4		No	Yes or Unknown		BRCA2	No	0	46.72	0	no	no	no
1669	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	46	8.9	Stable	No	No	Signature.1		Yes	0	46.49	0	no	no	no
1670	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	29	20.7	Stable	No	No	Signature.13	CHEK2	Yes	1	5.85	0	no	no	no
1671	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	6	4.9	Stable	No	No			No	1	24.21	0	no	no	no
1672	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	25.59	0	no	no	no
1673	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	1	2	Stable	No	No		ARID1A	Yes	1	5.29	0	no	no	yes
1674	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	9.8	Stable	No	No	Signature.1		No	1	11.96	0	no	no	no
1675	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	109	5.9	Stable	No	Yes or Unknown			No	0	46.32	0	no	no	no
1676	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	26	3	Stable	No	Yes or Unknown			No	1	18.83	0	no	no	no
1677	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	29	3.5		No	Yes or Unknown			Yes	0	44.12	0	no	no	no
1678	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATR	Yes	1	2.86	0	no	no	no
1679	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	18	3	Stable	No	No			No	0	5.91	0	no	no	no
1680	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	6.9	Stable	No	No		BRCA2 | ERCC3	No	1	19.22	0	no	no	no
1681	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2015	I	1039	1.8	Stable	No	No			No	0	41.72	0	no	no	no
1682	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015		0	0	Stable	No	No			No	0	43.96	0	no	no	no
1683	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2015	III	140	2	Stable	No	Yes or Unknown			No	0	46	0	no	no	no
1684	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	13	1.8		No	Yes or Unknown			No	0	45.24	0	no	no	no
1685	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	7.9	Stable	No	No	Signature.1		Yes	0	44.68	0	no	no	no
1686	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	57	1	Stable	No	No		BRCA2	No	0	45.8	0	no	no	no
1687	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	0	1	Stable	No	No			No	1	8.9	0	no	no	no
1688	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	559	0.9	Indeterminate	No	Yes or Unknown			Yes	1	25.49	0	no	no	no
1689	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	17	0.9	Indeterminate	No	No			No	1	28.19	0	no	no	no
1690	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	I	42	1	Stable	No	Yes or Unknown			No	0	45.54	0	no	no	no
1691	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	113	3.9	Stable	No	No			No	1	26.74	0	no	no	no
1692	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	58	1.8		No	No			No	0	42.09	0	no	no	no
1693	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	16	6.9	Stable	No	No			No	1	9.59	0	no	no	no
1694	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	28	2	Stable	No	Yes or Unknown			No	0	45.73	0	no	no	no
1695	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	572	1.8	Stable	No	Yes or Unknown			Yes	0	36.99	0	no	no	no
1696	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	281	7	Stable	No	Yes or Unknown			No	0	45.86	0	no	no	no
1697	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	8	4.9	Stable	No	No			No	1	10.05	0	no	no	no
1698	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	55	3	Stable	No	Yes or Unknown			No	1	27.14	0	no	no	no
1699	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2015	III	32	3.5	Stable	No	Yes or Unknown			No	0	46.09	0	no	no	no
1700	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	0	3	Stable	No	No			Yes	0	3.29	0	no	no	no
1701	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	1	3.9	Stable	No	No			Yes	1	6.21	0	no	no	no
1702	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	12	3.9	Stable	No	No			Yes	1	13.57	0	no	no	no
1703	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	39	1.8		No	No			No	0	39.1	0	no	no	no
1704	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	36	2.6		No	No			No	0	42.87	0	no	no	no
1705	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	II	33	7.9	Stable	No	No			No	1	18.99	0	no	no	no
1706	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	3	3	Indeterminate	No	No			No	1	35.52	0	no	no	no
1707	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	86	0		No	Yes or Unknown			No	1	21.75	0	no	no	no
1708	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	IV	974	3.5	Stable	No	Yes or Unknown			No	1	43.79	0	no	no	no
1709	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	34	6.9	Stable	No	No		BRIP1	No	1	7.56	0	no	no	no
1710	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	2	4.9	Stable	No	No		ARID1A	No	1	9.13	0	no	no	yes
1711	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	1	Stable	No	No	Signature.15		Yes	1	4.4	0	no	no	no
1712	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	47	4.9	Stable	No	No	Signature.1		Yes	0	45.54	0	no	no	no
1713	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	66	1	Stable	No	Yes or Unknown			Yes	0	43.83	0	no	no	no
1714	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		17	6.9	Stable	No	No			No	0	3.52	0	no	no	no
1715	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	23.39	0	no	no	no
1716	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	10.8	Stable	No	No	Signature.1		Yes	1	1.94	0	no	no	no
1717	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	20	3	Stable	No	No			No	1	14.39	0	no	no	no
1718	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	148	0	Stable	No	No			No	0	19.78	0	no	no	no
1719	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	155	5.9	Stable	No	Yes or Unknown			Yes	0	40.21	0	no	no	no
1720	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	50	6.9	Stable	No	No	Signature.4	MDC1	No	0	43.93	0	no	no	no
1721	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	606	3.5	Stable	No	Yes or Unknown			No	1	39.56	0	no	no	no
1722	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2015		5	0	Stable	Yes or Unknown	Yes or Unknown			No	1	12.85	0	no	no	no
1723	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	4	6.1	Stable	No	No	Signature.5		No	1	25.17	0	no	no	no
1724	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		MDC1	No	1	15.21	0	no	no	no
1725	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	36	4.4	Stable	No	Yes or Unknown		SLX4	No	0	47.38	0	no	no	no
1726	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	19	6.9	Stable	No	No	Signature.4	NBN	Yes	1	4.5	0	no	no	no
1727	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	24.9	0	no	no	no
1728	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2015	III	14	3	Stable	No	No			Yes	1	8.28	0	no	no	no
1729	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	127	4.9	Stable	No	No		ATM	No	0	30.39	0	no	no	no
1730	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	34	0.9		No	No			No	0	42.94	0	no	no	no
1731	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	IV	23	4.4	Stable	No	No	Signature.2		Yes	0	5.09	0	no	no	no
1732	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	0	5.3	Stable	No	No	Signature.1		No	1	18.89	0	no	no	no
1733	Non-ICI treated	Never received ICI	21 - 25	Male	Hepatobiliary	2015	IV	0	12.8	Stable	No	Yes or Unknown	Signature.6	ARID1A	Yes	0	23.06	0	no	no	yes
1734	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	173	12.8	Stable	No	No	Signature.4		No	1	14.09	0	no	no	no
1735	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	I	29	0	Stable	No	No			No	0	44.58	0	no	no	no
1736	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	22	12.8	Stable	No	No	Signature.1	ARID1A	No	1	4.57	0	no	no	yes
1737	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	146	0	Stable	No	Yes or Unknown			No	0	46.16	0	no	no	no
1738	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	0	10.8	Stable	No	No	Signature.3	BRCA2	No	1	29.37	0	no	no	no
1739	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	28	17.7	Stable	No	No	Signature.4	ARID1A | BRCA2 | BRIP1 | XRCC2	No	1	8.41	0	no	no	yes
1740	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	52	21.6	Stable	No	No	Signature.4		Yes	1	3.22	0	no	no	no
1741	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	1145	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	40.94	0	no	no	no
1742	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	1	Stable	No	No			No	1	43.4	0	no	no	no
1743	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	269	4.9	Stable	No	Yes or Unknown			Yes	1	10.32	0	no	no	no
1744	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	18	3.9	Stable	No	No	Signature.2		No	1	10.41	0	no	no	no
1745	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	5.9	Stable	No	No	Signature.4	FANCA	No	1	9.1	0	no	no	no
1746	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	0.9	Stable	No	No			No	0	40.84	0	no	no	no
1747	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	I	0	4.9	Stable	No	No	Signature.1	ERCC2	No	0	46.42	0	no	no	no
1748	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	0	12.8	Stable	No	No	Signature.4	ERCC3 | MDC1	Yes	1	33.35	0	no	no	no
1749	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	II	25	6.1	Stable	No	No		ATM	No	1	34.56	0	no	no	no
1750	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	0	4.9	Stable	No	No		FANCA	No	0	45.27	0	no	no	no
1751	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2015	IV	4	24.6	Unstable	No	No	Signature.4	BRCA1 | MLH1 | PALB2 | RAD50	Yes	0	41.4	0	mut-MMRd	mut-MMRd	no
1752	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	31	7.9	Stable	No	No	Signature.1		No	0	45.63	0	no	no	no
1753	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			Yes	1	29.27	0	no	no	no
1754	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	18	0	Stable	No	No			Yes	0	45.5	0	no	no	no
1755	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	2	6.9	Stable	No	Yes or Unknown	Signature.26		No	1	22.41	0	no	no	no
1756	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2015	IV	627	0.9	Stable	No	Yes or Unknown			No	0	47.74	0	no	no	no
1757	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.2		No	0	45.77	0	no	no	no
1758	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	I	62	1.8	Stable	No	No			No	1	15.7	0	no	no	no
1759	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	42	2	Stable	No	Yes or Unknown			No	0	45.37	0	no	no	no
1760	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	14	4.9	Stable	No	Yes or Unknown		ATM	No	1	36.11	0	no	no	no
1761	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	41	1	Stable	No	Yes or Unknown		MUTYH	No	0	45.77	0	no	no	no
1762	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	30	3	Stable	No	Yes or Unknown			No	1	27.89	0	no	no	no
1763	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015		138	1.8	Stable	No	Yes or Unknown			Yes	1	36.11	0	no	no	no
1764	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	0	3	Stable	No	No			No	1	8.15	0	no	no	no
1765	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	15	3	Stable	No	Yes or Unknown		MUTYH	No	0	45.8	0	no	no	no
1766	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	II	0	2	Stable	No	No			No	0	30.52	0	no	no	no
1767	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		94	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	8.84	0	no	no	no
1768	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		8	2	Stable	No	No			No	1	20.83	0	no	no	no
1769	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	156	4.4	Stable	No	Yes or Unknown			No	0	45.54	0	no	no	no
1770	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	No			No	1	28.88	0	no	no	no
1771	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2015	IV	70	6.1	Stable	No	No	Signature.26		No	0	47.7	0	no	no	no
1772	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	15	4.9	Stable	No	No	Signature.13		No	1	13.24	0	no	no	no
1773	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	IV	0	4.9	Stable	No	No	Signature.14	ARID1A	Yes	1	2.2	0	no	no	yes
1774	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	7	2.6		No	No		ATM	No	1	11.99	0	no	no	no
1775	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	125	2	Stable	No	Yes or Unknown			No	1	37.91	0	no	no	no
1776	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	IV	15	3.9	Stable	No	No		ARID1A	No	1	12.65	0	no	no	yes
1777	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	63	4.9	Stable	No	No	Signature.4		No	1	17.25	0	no	no	no
1778	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	117	6.1	Indeterminate	No	Yes or Unknown	Signature.26		No	1	26.41	0	no	no	no
1779	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	125	0	Stable	No	Yes or Unknown			No	1	12.85	0	no	no	no
1780	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	5.9	Stable	Yes or Unknown	Yes or Unknown		ERCC2	Yes	1	13.21	0	no	no	no
1781	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	49	3.9	Stable	No	Yes or Unknown			No	0	17.61	0	no	no	no
1782	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2015	IV	15	5.9	Stable	No	No			No	1	27.24	0	no	no	no
1783	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		8	5.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	3.88	0	no	no	no
1784	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	35	0.9	Stable	No	Yes or Unknown			No	1	33.31	0	no	no	no
1785	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2015	IV	56	5.9	Stable	No	No	Signature.7	MRE11A	No	1	24.48	0	no	no	no
1786	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	30	6.1	Stable	No	No		CHEK1	No	1	38.08	0	no	no	no
1787	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	848	2.6	Stable	No	Yes or Unknown		MDC1	No	0	34.63	0	no	no	no
1788	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2015	III	40	7.9		No	Yes or Unknown	Signature.7		Yes	0	45.31	0	no	no	no
1789	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	28	1	Stable	No	No			No	0	30.55	0	no	no	no
1790	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	9	1	Stable	No	Yes or Unknown			Yes	0	41	0	no	no	no
1791	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	19	6.9	Stable	No	No			No	0	45.24	0	no	no	no
1792	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	247	5.9	Stable	No	No			Yes	1	46.82	0	no	no	no
1793	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	476	3.5	Stable	No	Yes or Unknown			No	0	45.34	0	no	no	no
1794	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	0	0.9	Stable	No	No			No	0	48.62	0	no	no	no
1795	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	29	9.8	Stable	No	No	Signature.4	BLM	No	0	44.85	0	no	no	no
1796	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	0	1	Stable	No	Yes or Unknown			No	0	43.79	0	no	no	no
1797	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	55	8.9	Stable	No	No	Signature.8		No	0	38.8	0	no	no	no
1798	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	0	3	Stable	No	No			No	0	44.85	0	no	no	no
1799	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	202	3	Stable	No	Yes or Unknown			No	0	44.48	0	no	no	no
1800	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	III	943	4.4	Stable	No	Yes or Unknown	Signature.1		Yes	0	39.1	0	no	no	no
1801	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	10.8	Stable	No	No	Signature.24	BRCA2 | ERCC5	No	0	45.24	0	no	no	no
1802	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	0	4.9	Stable	No	No			No	1	40.21	0	no	no	no
1803	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	0	3.5		No	Yes or Unknown			No	0	44.35	0	no	no	no
1804	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	8	1	Stable	No	No		ARID1A	No	1	39.82	0	no	no	yes
1805	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	11.8		No	No	Signature.1		Yes	0	45.08	0	no	no	no
1806	Non-ICI treated	Never received ICI	26 - 30	Female	Gastric	2015	IV	19	1	Stable	No	No		ATM	No	1	10.28	0	no	no	no
1807	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	17	14	Stable	No	No	Signature.4	ATM | BRCA1	No	0	25.49	0	no	no	no
1808	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	30	4.9	Stable	No	Yes or Unknown			No	0	44.55	0	no	no	no
1809	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2015	III	0	1	Stable	No	No			Yes	0	6.74	0	no	no	no
1810	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	98	9.7	Stable	No	Yes or Unknown	Signature.6	MDC1	No	1	18.6	0	no	no	no
1811	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	7	3	Stable	No	No			No	1	13.04	0	no	no	no
1812	Non-ICI treated	Never received ICI	61 - 65	Male	Cutaneous Melanoma 	2015	I	861	31.6	Stable	No	No	Signature.7	ATR	No	0	28.55	0	no	no	no
1813	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	III	0	3		No	No	Signature.3	ARID1A	No	1	25.43	0	no	no	yes
1814	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	7	0	Stable	No	No		CHEK2	No	1	24.61	0	no	no	no
1815	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	1	4.9	Stable	No	No			No	1	15.84	0	no	no	no
1816	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	1	5.3	Stable	No	No			No	1	34.14	0	no	no	no
1817	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	96	0	Stable	No	No			No	0	45.01	0	no	no	no
1818	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	2	3	Stable	No	No		MLH1	No	1	10.97	0	no	no	no
1819	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2015	I	1198	3.5	Stable	No	No			Yes	0	44.91	0	no	no	no
1820	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	30	37.4	Unstable	No	No	Signature.15	ARID1A | RAD52	No	0	44.78	0	other-MMRd	mut-MMRd	yes
1821	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	35	5.9	Stable	No	Yes or Unknown		RAD51C	No	0	45.54	0	no	no	no
1822	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			Yes	0	45.04	0	no	no	no
1823	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	0	1	Stable	No	No			No	0	41.86	0	no	no	no
1824	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	73	1.8		No	No			No	0	43.6	0	no	no	no
1825	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	442	7	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	45.17	0	no	no	yes
1826	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	6.9	Stable	No	No	Signature.4		Yes	1	23.29	0	no	no	no
1827	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	IV	0	9.7		Yes or Unknown	Yes or Unknown	Signature.1	MDC1 | MUTYH	No	0	44.91	0	no	no	no
1828	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	58	2.6		No	Yes or Unknown			Yes	0	36.53	0	no	no	no
1829	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	II	565	2.6	Stable	No	Yes or Unknown			No	1	20.83	0	no	no	no
1830	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	3.9	Stable	No	No			No	0	45.11	0	no	no	no
1831	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	18.96	0	no	no	no
1832	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	0	37.4	Stable	No	No	Signature.4	BRCA1 | ERCC5	No	0	43.43	0	no	no	no
1833	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	35	1.8		No	No			No	0	10.87	0	no	no	no
1834	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	605	6.1	Stable	No	Yes or Unknown			No	1	35.71	0	no	no	no
1835	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		75	1	Stable	No	Yes or Unknown			No	1	27.4	0	no	no	no
1836	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	33	3	Stable	No	No		PARP1	No	0	37.03	0	no	no	no
1837	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	IV	0	7.9	Stable	No	Yes or Unknown	Signature.17	ARID1A	No	1	9.82	0	no	no	yes
1838	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	351	1.8	Stable	No	Yes or Unknown			No	1	41.03	0	no	no	no
1839	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	IV	0	8.9	Stable	No	No	Signature.19	ARID1A | BRCA2	Yes	1	3.22	0	no	no	yes
1840	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	II	903	12.3	Stable	No	No	Signature.2	ARID1A | ATM	No	0	43.96	0	no	no	yes
1841	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	39	6.9	Stable	No	No	Signature.4		No	0	30.03	0	no	no	no
1842	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2017	III	12	2.6	Stable	No	Yes or Unknown			No	0	26.48	0	no	no	no
1843	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	No			No	0	25.92	0	no	no	no
1844	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2015	III	119	0.9	Stable	No	Yes or Unknown			No	0	45.54	0	no	no	no
1845	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	48	2	Stable	No	No			No	1	8.05	0	no	no	no
1846	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015		10	0	Stable	No	No			No	0	48.66	0	no	no	no
1847	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2015	IV	15	1.8		No	No			No	0	44.58	0	no	no	no
1848	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No	Signature.1		No	1	7.75	0	no	no	no
1849	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	23	0	Stable	No	Yes or Unknown			No	1	2.63	0	no	no	no
1850	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	II	209	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	13.01	0	no	no	no
1851	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	8.97	0	no	no	no
1852	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	0	6.9	Stable	No	No	Signature.9		No	1	9.86	0	no	no	no
1853	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	1	7.9	Stable	No	Yes or Unknown			No	0	39.69	0	no	no	no
1854	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	1047	4.4	Stable	No	Yes or Unknown	Signature.2		No	0	46.32	0	no	no	no
1855	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	14	6.9	Stable	No	Yes or Unknown	Signature.3	ARID1A	Yes	0	20.04	0	no	no	yes
1856	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	0	5.3	Stable	No	No	Signature.1		No	1	21.29	0	no	no	no
1857	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	II	15	3.9	Indeterminate	No	No		PALB2	No	1	13.31	0	no	no	no
1858	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	154	0.9	Stable	No	Yes or Unknown		BRCA1	No	0	45.96	0	no	no	no
1859	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	50	3	Stable	No	Yes or Unknown			No	0	46.23	0	no	no	no
1860	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	9	3		No	No			No	0	24.21	0	no	no	no
1861	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	46	0.9	Stable	No	Yes or Unknown			No	0	43.63	0	no	no	no
1862	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015		272	3.5		No	Yes or Unknown			No	0	44.39	0	no	no	no
1863	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	49	3	Stable	No	No			No	1	13.14	0	no	no	no
1864	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	33	5.9	Stable	No	No			No	0	42.78	0	no	no	no
1865	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	560	2.6	Stable	No	No			No	0	29.67	0	no	no	no
1866	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	85	3.9	Stable	No	No			No	1	43.63	0	no	no	no
1867	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		7	3.5		Yes or Unknown	Yes or Unknown			Yes	0	43.66	0	no	no	no
1868	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	103	0.9	Stable	No	Yes or Unknown			No	1	39.59	0	no	no	no
1869	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	3	Stable	No	No		MLH1	No	0	43.56	0	no	no	no
1870	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	154	2	Stable	No	Yes or Unknown			No	1	9.2	0	no	no	no
1871	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		5	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	44.94	0	no	no	no
1872	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	38	2	Stable	No	No			No	0	36.21	0	no	no	no
1873	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	172	3.5		No	Yes or Unknown			No	0	42.45	0	no	no	no
1874	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	399	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	45.73	0	no	no	no
1875	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	128	3.5	Stable	No	Yes or Unknown			No	0	47.84	0	no	no	no
1876	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	I	38	0	Stable	No	No			No	0	27.43	0	no	no	no
1877	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		16	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.8		No	0	44.55	0	no	no	no
1878	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	267	0.9		No	Yes or Unknown			No	1	16.23	0	no	no	no
1879	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	871	6.1	Stable	No	Yes or Unknown		ERCC4	No	0	43.83	0	no	no	no
1880	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2015		20	2	Stable	No	No		FANCA	No	0	42.38	0	no	no	no
1881	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	II	47	9.8	Stable	No	No		ARID1A	Yes	1	9.33	0	no	no	yes
1882	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	III	9	3.5		No	No			Yes	1	21.03	0	no	no	no
1883	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	I	16	27.5	Unstable	No	No	Signature.1	ERCC5 | MDC1 | NBN	No	0	25.72	0	other-MMRd	mut-MMRd	no
1884	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2015	I	41	0.9		No	No			Yes	0	41.03	0	no	no	no
1885	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.9	Stable	No	No			Yes	0	44.06	0	no	no	no
1886	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	31	4.9	Stable	No	No			Yes	0	28.81	0	no	no	no
1887	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	13	3.5	Stable	No	No	Signature.1		No	0	45.27	0	no	no	no
1888	Non-ICI treated	Never received ICI	0 - 5	Female	Pancreatic	2015	II	8	1	Stable	No	No			No	0	44.16	0	no	no	no
1889	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	9	3.9	Stable	No	Yes or Unknown			No	1	23.66	0	no	no	no
1890	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	106	1.8		No	No			No	0	18.3	0	no	no	no
1891	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.1	ATM	No	1	4.9	0	no	no	no
1892	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	36	4.4	Stable	No	No			No	0	25.99	0	no	no	no
1893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	36	3.5	Stable	No	No			No	0	40.84	0	no	no	no
1894	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	37	4.9	Stable	No	No			Yes	1	12.62	0	no	no	no
1895	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	74	2.6		No	No			No	0	45.73	0	no	no	no
1896	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	11.8		No	No	Signature.1		No	0	29.57	0	no	no	no
1897	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		8	3.9	Stable	No	No			Yes	1	5.75	0	no	no	no
1898	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	19	3	Stable	No	No			No	1	9.26	0	no	no	no
1899	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			No	0	45.08	0	no	no	no
1900	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	97	8.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	41.13	0	no	no	no
1901	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	II	165	23.6	Stable	No	No	Signature.4	ARID1A	No	0	6.64	0	no	no	yes
1902	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	21	2	Stable	No	No			No	0	6.08	0	no	no	no
1903	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	20	6.1		No	No		ARID1A | BRCA1	No	0	30.62	0	no	no	yes
1904	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	677	3.5	Stable	No	Yes or Unknown			No	1	33.94	0	no	no	no
1905	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	305	8.8		No	Yes or Unknown	Signature.8	ERCC2	No	1	14.55	0	no	no	no
1906	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	0	6.9	Stable	No	No	Signature.1	ERCC3	No	1	7.85	0	no	no	no
1907	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	0	2.6		No	Yes or Unknown			No	1	20.01	0	no	no	no
1908	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	II	0	3.9	Stable	No	No			Yes	0	41.53	0	no	no	no
1909	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	8	4.9	Stable	No	No			No	1	21.95	0	no	no	no
1910	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	957	2.6	Stable	No	Yes or Unknown			No	0	44.09	0	no	no	no
1911	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	53	5.9	Stable	No	No	Signature.29		No	0	39.95	0	no	no	no
1912	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	IV	21	1.8		No	No			No	0	44.62	0	no	no	no
1913	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	47	0.9	Stable	No	Yes or Unknown			No	1	38.7	0	no	no	no
1914	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	63	4.9	Stable	No	No		ATM	Yes	0	36.86	0	no	no	no
1915	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	1	Stable	No	No			Yes	1	4.24	0	no	no	no
1916	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2015	II	921	10.5	Stable	No	No	Signature.13		Yes	1	41.63	0	no	no	no
1917	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	13	9.8	Stable	No	No	Signature.4		No	0	42.32	0	no	no	no
1918	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	III	198	3	Stable	No	Yes or Unknown			No	1	16.13	0	no	no	no
1919	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	45	3.9	Stable	No	No		MSH6	No	1	11.96	0	no	no	no
1920	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	201	3.5	Stable	No	Yes or Unknown		XRCC2	No	0	44.12	0	no	no	no
1921	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	1295	6.1	Stable	No	Yes or Unknown	Signature.9	BRCA1	Yes	0	43.43	0	no	no	no
1922	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	III	0	0	Stable	No	No			No	0	41.26	0	no	no	no
1923	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	108	3.9	Stable	No	Yes or Unknown			No	1	25.07	0	no	no	no
1924	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	51	7	Stable	No	No			Yes	0	41.72	0	no	no	no
1925	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	600	7	Stable	No	No		TP53BP1	No	0	44.06	0	no	no	no
1926	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	7	1	Stable	No	Yes or Unknown			No	0	43.76	0	no	no	no
1927	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	I	20	3		No	No	Signature.5		No	0	42.78	0	no	no	no
1928	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	4.6	0	no	no	no
1929	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	III	0	4.9	Stable	No	No	Signature.14	MDC1	No	1	7.69	0	no	no	no
1930	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	I	42	3	Stable	No	No			No	1	11.63	0	no	no	no
1931	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	29	36.4	Stable	No	No	Signature.4	MSH2 | PARP1	No	1	12.29	0	no	no	no
1932	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	34	3.5	Stable	No	No			No	0	44.35	0	no	no	no
1933	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	2	4.9	Stable	No	No			No	0	24.8	0	no	no	no
1934	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	II	42	78.7	Unstable	No	No	Signature.6	BRCA1 | ERCC5 | MSH2 | NBN | RAD52	No	0	46.98	0	mut-MMRd	mut-MMRd	no
1935	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	1320	1.8	Stable	No	Yes or Unknown			No	0	48.53	0	no	no	no
1936	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	553	6.1	Stable	No	Yes or Unknown		ATM	No	0	43.93	0	no	no	no
1937	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	92	6.9	Stable	No	Yes or Unknown			No	1	17.64	0	no	no	no
1938	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	15	0	Stable	No	No			No	1	7.2	0	no	no	no
1939	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	38	1	Indeterminate	No	No			Yes	1	10.94	0	no	no	no
1940	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	IV	64	7		No	Yes or Unknown	Signature.5	MUTYH	No	1	19.38	0	no	no	no
1941	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	22	4.9	Stable	No	No		ARID1A	No	1	4.8	0	no	no	yes
1942	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	69	3.5		No	No			Yes	0	40.64	0	no	no	no
1943	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	127	2.6		No	Yes or Unknown			No	0	43.4	0	no	no	no
1944	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		RAD54L	No	1	28.19	0	no	no	no
1945	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	4	11.8	Stable	No	No	Signature.4	FANCA	Yes	1	1.68	0	no	no	no
1946	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	0	0	Stable	No	Yes or Unknown			No	0	43.99	0	no	no	no
1947	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATM | BRCA1	Yes	1	3.48	0	no	no	no
1948	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	1126	0.9	Stable	No	Yes or Unknown	Signature.1		No	0	44.32	0	no	no	no
1949	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	91	2	Stable	No	Yes or Unknown			No	1	12.52	0	no	no	no
1950	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2016	I	0	2	Stable	No	No			No	0	15.64	0	no	no	no
1951	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	460	6.1	Stable	No	Yes or Unknown	Signature.1	RAD50	No	1	33.54	0	no	no	no
1952	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.24	ATM	Yes	1	22.9	0	no	no	no
1953	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	60	2	Stable	No	Yes or Unknown			No	1	15.64	0	no	no	no
1954	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	3.5		No	No	Signature.18		No	0	35.29	0	no	no	no
1955	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	0	3.9	Stable	No	No			No	1	34.46	0	no	no	no
1956	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	56	57.1	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BLM | BRCA2 | CHEK1	No	1	5.62	0	other-MMRd	mut-MMRd	yes
1957	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2015	IV	392	2.6	Stable	No	Yes or Unknown		BRCA1 | CHEK2 | RAD50	No	1	43.17	0	no	no	no
1958	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	1078	2.6	Stable	No	Yes or Unknown		BRCA1 | FANCA	No	1	41.13	0	no	no	no
1959	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2015	III	439	7.9	Stable	No	Yes or Unknown	Signature.7		No	0	44.12	0	no	no	no
1960	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	226	0	Stable	No	Yes or Unknown			No	1	12.75	0	no	no	no
1961	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	34	2	Stable	No	Yes or Unknown			No	0	20.04	0	no	no	no
1962	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	35	6.9	Stable	No	No			No	0	35.91	0	no	no	no
1963	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	24	4.9	Stable	No	No			No	0	35.84	0	no	no	no
1964	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	58	19.3		No	No	Signature.13		No	0	39.36	0	no	no	no
1965	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	0.9		No	No	Signature.5		No	0	35.32	0	no	no	no
1966	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	II	557	0.9	Stable	No	No			No	0	37.03	0	no	no	no
1967	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	50	5.3		No	Yes or Unknown			No	0	38.01	0	no	no	no
1968	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	29	3.5		No	No			No	0	42.35	0	no	no	no
1969	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2015	IV	10	7.9	Stable	No	No	Signature.16	ATM	No	1	9.66	0	no	no	no
1970	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	11	3	Stable	No	No			No	1	19.81	0	no	no	no
1971	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2015	IV	62	1.8	Stable	No	No			Yes	0	39.95	0	no	no	no
1972	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	I	0	0	Stable	No	No			No	0	30.62	0	no	no	no
1973	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	4	3.9	Stable	No	Yes or Unknown		BRCA1	No	0	6.34	0	no	no	no
1974	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	229	3	Stable	No	Yes or Unknown			No	1	33.18	0	no	no	no
1975	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	40	1	Stable	No	No			Yes	0	7.16	0	no	no	no
1976	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	II	26	4.9	Stable	No	No	Signature.1	BRIP1	No	0	44.48	0	no	no	no
1977	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	0	1	Stable	No	No			No	0	41.99	0	no	no	no
1978	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	52	5.3		No	No		BRIP1	No	0	28.16	0	no	no	no
1979	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	III	21	5.9	Stable	No	No			No	0	9.33	0	no	no	no
1980	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	5	8.9	Stable	No	No	Signature.3	ATM	Yes	1	18.4	0	no	no	no
1981	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	92	10.8	Stable	No	No	Signature.24		No	1	25.56	0	no	no	no
1982	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	III	14	3	Stable	No	No			Yes	0	43.27	0	no	no	no
1983	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.1		Yes	1	1.87	0	no	no	no
1984	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	0	6.1		No	No	Signature.11	ARID1A | NTHL1	No	1	23	0	no	no	yes
1985	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	IV	14	0	Stable	No	No			Yes	1	1.64	0	no	no	no
1986	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	7	0	Stable	No	Yes or Unknown			Yes	0	43.76	0	no	no	no
1987	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	14	2	Stable	No	Yes or Unknown		CHEK2	No	1	7.29	0	no	no	no
1988	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	19	4.9	Stable	No	No			Yes	0	44.12	0	no	no	no
1989	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	26	4.4	Stable	No	Yes or Unknown	Signature.19		No	0	46.69	0	no	no	no
1990	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	4	5.9	Stable	No	No			No	1	5.82	0	no	no	no
1991	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	III	35	2	Stable	No	No			No	0	42.58	0	no	no	no
1992	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2015	III	0	6.9		No	No	Signature.30	BRCA1	No	0	39.49	0	no	no	no
1993	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	20	10.8	Stable	No	No	Signature.2		No	1	8.8	0	no	no	no
1994	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	IV	48	3	Stable	No	No			No	0	9.26	0	no	no	no
1995	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	IV	32	4.9	Stable	No	No			No	0	44.94	0	no	no	no
1996	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	III	0	0.9	Stable	No	No			Yes	0	43.4	0	no	no	no
1997	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	III	0	2.6	Stable	No	No			No	0	44.06	0	no	no	no
1998	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2015	IV	43	10.8	Indeterminate	No	No	Signature.3		No	1	2.4	0	no	no	no
1999	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	45	3	Stable	No	No			No	0	43.17	0	no	no	no
2000	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	230	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	28.55	0	no	no	no
2001	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	0	2.6	Stable	No	No			No	0	44.45	0	no	no	no
2002	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	67	9.8	Stable	No	No	Signature.4	ARID1A	No	0	36.37	0	no	no	yes
2003	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	33	2.6		No	No			No	0	31.54	0	no	no	no
2004	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	2	6.1	Stable	No	Yes or Unknown		BRCA2	No	0	12.25	0	no	no	no
2005	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	120	10.8	Stable	No	Yes or Unknown	Signature.3		No	1	6.64	0	no	no	no
2006	Non-ICI treated	Never received ICI	81 - 85	Female	Gastric	2015	III	47	3.5	Stable	No	No			Yes	0	42.78	0	no	no	no
2007	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	144	3.9	Stable	No	Yes or Unknown	Signature.24	PMS1	No	1	15.11	0	no	no	no
2008	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	0	10.8	Stable	No	No	Signature.4		No	1	1.51	0	no	no	no
2009	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	100	1	Stable	No	No			No	1	9.4	0	no	no	no
2010	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	40	4.9	Stable	No	Yes or Unknown		ATM	No	0	44.42	0	no	no	no
2011	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	42	0.9		No	Yes or Unknown			No	0	43.7	0	no	no	no
2012	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		8	4.9	Stable	No	No		ATM	No	0	38.8	0	no	no	no
2013	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	24	2	Stable	No	No			Yes	0	43.04	0	no	no	no
2014	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	918	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	42.68	0	no	no	no
2015	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	58	22.6	Stable	No	Yes or Unknown	Signature.4		No	1	10.78	0	no	no	no
2016	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	0	19.7	Indeterminate	No	No	Signature.4	ARID1A | ATR	No	1	7.92	0	no	no	yes
2017	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	58	1.8		No	Yes or Unknown			No	0	41.72	0	no	no	no
2018	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	29	3	Stable	No	Yes or Unknown			No	0	36.11	0	no	no	no
2019	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	34	4.9	Stable	No	No			No	0	41.23	0	no	no	no
2020	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	47	7.9	Stable	No	No	Signature.4	BRCA1 | BRIP1	No	1	2.37	0	no	no	no
2021	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	29	2	Stable	No	No			No	0	43.07	0	no	no	no
2022	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	21	3	Stable	No	No			No	1	28.39	0	no	no	no
2023	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	857	1.8	Stable	No	Yes or Unknown		BRCA1	No	0	46.19	0	no	no	no
2024	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	5	3.9	Stable	No	No			No	1	9.76	0	no	no	no
2025	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	I	70	3.9	Stable	No	No			No	1	9.07	0	no	no	no
2026	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	III	325	3.5		No	Yes or Unknown			No	1	11.73	0	no	no	no
2027	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		9	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	37.72	0	no	no	no
2028	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	II	715	4.4	Stable	No	Yes or Unknown			Yes	0	50.46	0	no	no	no
2029	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	III	6	4.9	Stable	No	No			No	1	19.61	0	no	no	no
2030	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	3	3.9	Stable	No	No	Signature.1		No	1	18.07	0	no	no	no
2031	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	9	1	Stable	No	Yes or Unknown			No	0	43.5	0	no	no	no
2032	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	I	68	3.5	Stable	No	No			No	0	39.92	0	no	no	no
2033	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	424	29	Stable	No	Yes or Unknown	Signature.6	MSH3 | RAD50	No	0	27.89	0	no	no	no
2034	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	II	0	2	Stable	No	No			Yes	0	40.74	0	no	no	no
2035	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	710	1.8	Stable	No	No	Signature.1		Yes	0	42.09	0	no	no	no
2036	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	II	90	6.9	Stable	No	No	Signature.5		No	1	3.42	0	no	no	no
2037	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	4.9	Stable	No	No			No	1	12.09	0	no	no	no
2038	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	8	3	Stable	No	No			No	1	8.84	0	no	no	no
2039	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	36	1	Stable	No	Yes or Unknown			No	0	42.64	0	no	no	no
2040	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	13	3	Stable	No	No			No	1	11.33	0	no	no	no
2041	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	20.17	0	no	no	no
2042	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	7	1.8		No	No			No	1	16.13	0	no	no	no
2043	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	23	3	Stable	No	No			No	1	29.04	0	no	no	no
2044	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2016	IV	0	10.8	Stable	No	No	Signature.5		Yes	1	24.15	0	no	no	no
2045	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	56	0	Stable	No	No			No	0	29.8	0	no	no	no
2046	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	II	0	0		No	No			No	0	43.01	0	no	no	no
2047	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	III	31	3.5	Stable	No	No		SLX4	Yes	0	42.97	0	no	no	no
2048	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	726	1.8	Stable	No	Yes or Unknown			Yes	1	34.37	0	no	no	no
2049	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	III	0	14.8	Stable	No	No	Signature.2	BRCA1 | MDC1	Yes	1	2.73	0	no	no	no
2050	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.2		No	0	42.78	0	no	no	no
2051	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	435	2.6	Stable	No	Yes or Unknown			No	1	35.29	0	no	no	no
2052	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	161	4.9	Stable	No	No			No	1	18.56	0	no	no	no
2053	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	10.8	Stable	No	No	Signature.4	MDC1	No	1	2.63	0	no	no	no
2054	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	134	0.9	Stable	No	No			Yes	0	43.04	0	no	no	no
2055	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	0	1	Stable	No	No			No	0	40.54	0	no	no	no
2056	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	175	3	Stable	No	Yes or Unknown			No	0	42.97	0	no	no	no
2057	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	50	1.8	Stable	No	Yes or Unknown		ATM | MUTYH	No	0	44.39	0	no	no	no
2058	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	186	0	Stable	No	Yes or Unknown		PMS2	Yes	0	41.99	0	no	no	no
2059	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	260	2.6		No	Yes or Unknown			No	0	43.04	0	no	no	no
2060	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	III	0	8.9	Stable	No	No	Signature.1		Yes	1	6.9	0	no	no	no
2061	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	5.9	Indeterminate	No	No		MDC1	No	0	39.56	0	no	no	no
2062	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	57	0		No	No			No	0	39.79	0	no	no	no
2063	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	0	5.9	Stable	No	Yes or Unknown			No	0	43.24	0	no	no	no
2064	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	0	Stable	No	No			No	0	38.87	0	no	no	no
2065	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2015	IV	66	6.9	Stable	No	Yes or Unknown	Signature.25	BRCA1	No	1	17.18	0	no	no	no
2066	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	232	8.8	Stable	No	Yes or Unknown	Signature.6	PALB2	No	1	37.68	0	no	no	no
2067	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		9	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	37.55	0	no	no	no
2068	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016		0	0	Stable	No	No			No	0	37.62	0	no	no	no
2069	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	5.9	Stable	No	No		ARID1A	Yes	0	40.71	0	no	no	yes
2070	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	24	4.9	Stable	No	No			No	1	12.78	0	no	no	no
2071	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	I	50	2.6	Stable	No	No			No	0	40.8	0	no	no	no
2072	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	19	2	Stable	No	No			No	0	41.4	0	no	no	no
2073	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	9	3	Stable	No	No		BRCA1	Yes	0	2.17	0	no	no	no
2074	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	3.9	Stable	No	No		ARID1A	Yes	1	1.51	0	no	no	yes
2075	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	12	3.5		No	Yes or Unknown	Signature.19		No	0	43.04	0	no	no	no
2076	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	II	50	15.7	Stable	No	No	Signature.4	BRCA2 | FANCA	No	0	39.52	0	no	no	no
2077	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	860	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	29.47	0	no	no	no
2078	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	IV	0	0	Stable	No	No			No	1	28.91	0	no	no	no
2079	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	3.9	Stable	No	No			No	1	4.37	0	no	no	no
2080	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	2	6.9	Stable	No	No	Signature.6		Yes	0	41.49	0	no	no	no
2081	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	380	3.5	Stable	No	Yes or Unknown			No	0	43.5	0	no	no	no
2082	Non-ICI treated	Never received ICI	21 - 25	Male	Hepatobiliary	2016	III	28	0.9		No	No			Yes	1	26.91	0	no	no	no
2083	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	26	0.9		No	Yes or Unknown			No	0	42.78	0	no	no	no
2084	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	482	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	37.13	0	no	no	no
2085	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	1	3.9	Stable	No	No			No	1	18.17	0	no	no	no
2086	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	514	7.9	Stable	No	No	Signature.1		No	0	46.65	0	no	no	no
2087	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	61	1	Stable	No	No			Yes	0	43.63	0	no	no	no
2088	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	44	5.3		No	No		ARID1A	No	1	14.29	0	no	no	yes
2089	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	III	36	7	Stable	No	No	Signature.6		No	1	32.43	0	no	no	no
2090	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	29	2	Stable	No	No		ARID1A	Yes	0	42.51	0	no	no	yes
2091	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	II	36	6.9	Stable	No	No	Signature.2	ARID1A	No	0	37.65	0	no	no	yes
2092	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	671	2.6	Stable	No	No		MUTYH	No	0	43.17	0	no	no	no
2093	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	II	0	6.1	Stable	No	No	Signature.1		Yes	0	44.85	0	no	no	no
2094	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	5.9	Stable	No	No			No	1	6.31	0	no	no	no
2095	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2016	IV	145	0	Stable	No	Yes or Unknown			Yes	0	41.82	0	no	no	no
2096	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	4.9	Stable	No	No	Signature.4		No	1	8.9	0	no	no	no
2097	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	IV	54	1	Stable	No	No		ARID1A	No	0	43.3	0	no	no	yes
2098	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	II	29	6.9	Stable	No	No	Signature.1		Yes	0	39.52	0	no	no	no
2099	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	35	3	Stable	No	Yes or Unknown			No	0	44.29	0	no	no	no
2100	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	29	7.9		No	No			No	0	42.55	0	no	no	no
2101	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	II	52	3	Stable	No	No			No	0	44.45	0	no	no	no
2102	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	161	3	Stable	No	No			No	0	35.71	0	no	no	no
2103	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2016		0	0.9	Stable	No	No			No	0	42.02	0	no	no	no
2104	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	21	2	Stable	No	No			No	1	19.65	0	no	no	no
2105	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	88	2.6	Stable	No	Yes or Unknown			No	1	31.01	0	no	no	no
2106	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	0.9		No	Yes or Unknown			Yes	0	42.41	0	no	no	no
2107	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	0	4.9	Stable	No	No			No	1	12.94	0	no	no	no
2108	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	23	1	Stable	No	No			No	1	25.26	0	no	no	no
2109	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	50	3.9	Stable	No	No			No	0	38.7	0	no	no	no
2110	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	40	1.8		No	No			No	0	37.45	0	no	no	no
2111	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	22	3.9	Stable	No	Yes or Unknown	Signature.9		Yes	0	27.04	0	no	no	no
2112	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	255	1.8	Stable	No	Yes or Unknown			Yes	1	24.25	0	no	no	no
2113	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	I	239	0.9		No	Yes or Unknown			No	1	28.58	0	no	no	no
2114	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	7	12.8	Stable	No	No	Signature.1		No	0	42.78	0	no	no	no
2115	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	0	5.3	Stable	No	Yes or Unknown	Signature.5		No	0	23.59	0	no	no	no
2116	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	I	225	5.3		No	Yes or Unknown	Signature.3		No	0	38.47	0	no	no	no
2117	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2016	I	864	5.3	Stable	No	Yes or Unknown		ARID1A | PALB2	Yes	0	41.4	0	no	no	yes
2118	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	45	1	Stable	No	Yes or Unknown			No	0	41.92	0	no	no	no
2119	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3.5		No	Yes or Unknown			No	0	42.91	0	no	no	no
2120	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	34	5.9	Stable	No	No	Signature.4	BRCA2	No	0	38.87	0	no	no	no
2121	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	2	Stable	No	No			No	1	23.56	0	no	no	no
2122	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	919	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	41.59	0	no	no	no
2123	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	1	3	Stable	No	Yes or Unknown			No	0	40.51	0	no	no	no
2124	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	0	2	Stable	No	No			No	1	3.78	0	no	no	no
2125	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	III	94	0		No	Yes or Unknown			No	1	37.13	0	no	no	no
2126	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	34	5.9	Stable	No	No		ARID1A | BRCA2	No	0	42.68	0	no	no	yes
2127	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		0	3	Stable	No	No			No	0	7.89	0	no	no	no
2128	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	3.9	Stable	No	No			No	1	13.6	0	no	no	no
2129	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	1	Stable	No	No			No	0	40.44	0	no	no	no
2130	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	57	1.8	Stable	No	No			No	0	42.41	0	no	no	no
2131	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	66	8.9	Stable	No	No	Signature.1	ATM	No	1	12.12	0	no	no	no
2132	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	45	0		No	Yes or Unknown			Yes	0	36.7	0	no	no	no
2133	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	892	1.8	Stable	No	Yes or Unknown			No	0	42.78	0	no	no	no
2134	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2016	IV	22	3	Stable	No	No			No	1	5.36	0	no	no	no
2135	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	IV	10	2	Stable	No	No			No	0	43.7	0	no	no	no
2136	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	40	3.9	Stable	No	No			Yes	0	41.03	0	no	no	no
2137	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	119	6.9	Stable	No	No			No	0	29.04	0	no	no	no
2138	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	3.9	Indeterminate	No	No	Signature.1		No	1	9.79	0	no	no	no
2139	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	42	38.4	Unstable	No	No	Signature.6	MLH1 | PALB2	No	0	41.1	0	mut-MMRd	mut-MMRd	no
2140	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	87	3	Stable	No	No			Yes	0	38.31	0	no	no	no
2141	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	43	0.9	Stable	No	No			No	0	43.33	0	no	no	no
2142	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	7	3.5		No	Yes or Unknown	Signature.1		No	1	19.94	0	no	no	no
2143	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	16	7.9		No	No	Signature.13	ATR	No	0	38.24	0	no	no	no
2144	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		14	0	Stable	No	No			Yes	0	42.28	0	no	no	no
2145	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	97	1	Indeterminate	No	Yes or Unknown			No	1	5.59	0	no	no	no
2146	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	15.7	Stable	No	Yes or Unknown	Signature.4		No	1	1.94	0	no	no	no
2147	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	28	3.5		No	No			No	0	24.34	0	no	no	no
2148	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	46	3	Stable	No	No		ERCC4	No	0	36.3	0	no	no	no
2149	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	35	1.8		No	No			No	0	39.89	0	no	no	no
2150	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	27	22.6	Stable	No	Yes or Unknown	Signature.2	CHEK2	No	0	42.48	0	no	no	no
2151	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	II	37	25.6	Unstable	No	No	Signature.6	ARID1A	No	0	23.29	0	other-MMRd	mut-MMRd	yes
2152	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	18	10.8	Stable	No	No	Signature.1		No	1	16.95	0	no	no	no
2153	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	II	12	2	Stable	No	No			No	0	12.42	0	no	no	no
2154	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	II	28	7.9	Stable	No	No		BLM	Yes	0	24.44	0	no	no	no
2155	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	0	3.9	Stable	No	Yes or Unknown		BRCA2	No	0	40.57	0	no	no	no
2156	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	58	3.9	Stable	No	No			Yes	1	8.8	0	no	no	no
2157	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	16	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	32.03	0	no	no	yes
2158	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	IV	0	0	Stable	No	Yes or Unknown			No	0	42.22	0	no	no	no
2159	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	2	Stable	No	No			Yes	0	22.57	0	no	no	no
2160	Non-ICI treated	Never received ICI	86 - 90	Male	Bladder	2016	IV	17	84.6	Unstable	No	No	Signature.6	ARID1A | BRCA1 | CHEK2 | MDC1 | MSH2 | NBN	No	0	30.82	0	mut-MMRd	mut-MMRd	yes
2161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	7	3.9	Stable	No	Yes or Unknown	Signature.5	BRCA2	No	1	11.79	0	no	no	no
2162	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	166	3.9		No	Yes or Unknown	Signature.26		No	0	42.51	0	no	no	no
2163	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	1	Stable	No	No			Yes	0	38.57	0	no	no	no
2164	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	386	5.3	Stable	No	Yes or Unknown	Signature.9		No	1	28.25	0	no	no	no
2165	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	177	0	Stable	No	Yes or Unknown			No	1	6.97	0	no	no	no
2166	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	22	3	Stable	No	No			No	0	27.83	0	no	no	no
2167	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	46	4.9	Stable	No	No	Signature.5		Yes	1	7.89	0	no	no	no
2168	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	0	3.9	Stable	No	No	Signature.18	ATM	No	0	42.38	0	no	no	no
2169	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	III	0	4.4	Stable	No	No			No	1	27.5	0	no	no	no
2170	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	14	3.9	Stable	No	No			No	0	16.89	0	no	no	no
2171	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	186	0		No	No			Yes	0	41.79	0	no	no	no
2172	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	2	2	Stable	No	Yes or Unknown			No	1	14.92	0	no	no	no
2173	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	III	671	7.9	Indeterminate	No	Yes or Unknown	Signature.17		No	1	24.31	0	no	no	no
2174	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	14	5.9	Stable	No	No	Signature.1		No	0	17.68	0	no	no	no
2175	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	IV	199	3.5		No	Yes or Unknown			No	1	13.96	0	no	no	no
2176	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	2.6		No	Yes or Unknown			No	0	24.21	0	no	no	no
2177	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	6	2	Stable	No	No			No	1	9.53	0	no	no	no
2178	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	37.75	0	no	no	no
2179	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	II	99	25.6	Indeterminate	No	Yes or Unknown	Signature.6	ARID1A | ATR | RAD54L	Yes	0	43.83	0	no	no	yes
2180	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	16	5.9	Stable	No	No	Signature.1	BRCA1	Yes	0	43.56	0	no	no	no
2181	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	57	0	Stable	No	Yes or Unknown			Yes	0	32.46	0	no	no	no
2182	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	44	1.8		No	Yes or Unknown			No	0	41.53	0	no	no	no
2183	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	21	14.8	Stable	No	Yes or Unknown	Signature.1		Yes	1	8.34	0	no	no	no
2184	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	26	2	Stable	No	Yes or Unknown			No	1	28.02	0	no	no	no
2185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	0	4.4		No	No			Yes	0	39.92	0	no	no	no
2186	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	68	6.9	Stable	No	No	Signature.13		Yes	1	39.75	0	no	no	no
2187	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	19	4.9	Stable	No	No	Signature.4		Yes	0	42.55	0	no	no	no
2188	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	307	5.9	Stable	No	No			No	0	50.79	0	no	no	no
2189	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	0	1	Stable	No	Yes or Unknown		BRCA2	Yes	0	38.44	0	no	no	no
2190	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.4		Yes	1	20.3	0	no	no	no
2191	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	46	7		No	No			Yes	0	37.85	0	no	no	no
2192	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	28	23.6	Stable	No	No	Signature.4	ARID1A | BLM | MSH2	Yes	0	42.32	0	no	no	yes
2193	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	II	24	4.9	Stable	No	No	Signature.1		No	0	40.21	0	no	no	no
2194	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	I	121	3	Stable	No	No			Yes	1	30.06	0	no	no	no
2195	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	15	4.9	Stable	No	No			No	1	10.38	0	no	no	no
2196	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	0	3.9	Stable	No	No		ATM	No	0	32.59	0	no	no	no
2197	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	787	1.8	Stable	No	Yes or Unknown			No	0	41.89	0	no	no	no
2198	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	15	68.5	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC2 | MRE11A | MSH2 | MUTYH	Yes	0	41.66	0	mut-MMRd	mut-MMRd	yes
2199	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	17	1	Stable	No	No			No	0	40.67	0	no	no	no
2200	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	85	1	Stable	No	No			No	0	8.57	0	no	no	no
2201	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	49	3	Stable	No	Yes or Unknown			Yes	0	27.5	0	no	no	no
2202	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015		450	1.8	Stable	No	No			No	0	36.63	0	no	no	no
2203	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	I	26	8.9	Stable	No	No	Signature.1		No	0	25.49	0	no	no	no
2204	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	28	11.8	Stable	No	No	Signature.13	ERCC5 | PARP1	No	1	3.91	0	no	no	no
2205	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		9	3	Stable	Yes or Unknown	Yes or Unknown			No	1	9.79	0	no	no	no
2206	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	III	4	17.7		No	No	Signature.13	ARID1A | FANCA	No	1	8.87	0	no	no	yes
2207	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	22	1	Stable	No	No			Yes	0	40.71	0	no	no	no
2208	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	31	37.4	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BRIP1 | MSH6	Yes	0	37.78	0	mut-MMRd	mut-MMRd	yes
2209	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	104	2.6	Stable	No	Yes or Unknown			No	0	42.32	0	no	no	no
2210	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	40	6.1		No	No			No	0	40.21	0	no	no	no
2211	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2016		551	1.8	Stable	No	Yes or Unknown			No	1	37.68	0	no	no	no
2212	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	115	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	19.75	0	no	no	no
2213	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	678	1.8	Stable	No	Yes or Unknown			No	0	42.48	0	no	no	no
2214	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	0	6.9	Stable	No	Yes or Unknown			No	1	32.2	0	no	no	no
2215	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	I	0	0		No	No			No	0	40.05	0	no	no	no
2216	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	1163	9.7	Stable	No	Yes or Unknown	Signature.1	ATM	No	0	44.55	0	no	no	no
2217	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	2		No	No			No	0	42.55	0	no	no	no
2218	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	12	3.5		No	Yes or Unknown			Yes	0	37.65	0	no	no	no
2219	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	8	4.9	Stable	No	No			No	1	19.65	0	no	no	no
2220	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	679	6.1	Stable	No	Yes or Unknown	Signature.8		No	1	29.57	0	no	no	no
2221	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	20.47	0	no	no	no
2222	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	36	2	Indeterminate	No	Yes or Unknown			No	0	7.16	0	no	no	no
2223	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	23	3	Stable	No	Yes or Unknown			Yes	1	13.9	0	no	no	no
2224	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2017	I	54	0.9	Stable	No	No			No	0	27.24	0	no	no	no
2225	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	37.72	0	no	no	no
2226	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	24	3.5		No	No	Signature.13		No	0	35.22	0	no	no	no
2227	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	202	0		No	Yes or Unknown			No	0	41.36	0	no	no	no
2228	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	0	0.9	Stable	No	No			No	1	18.89	0	no	no	no
2229	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	24	3	Stable	No	No			No	0	41.07	0	no	no	no
2230	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	0	Stable	No	Yes or Unknown		BRCA2	No	0	41.4	0	no	no	no
2231	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	99	1.8	Stable	No	No			Yes	0	29.54	0	no	no	no
2232	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	3	5.9	Stable	No	No	Signature.8		Yes	0	39.72	0	no	no	no
2233	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	0	6.9	Stable	No	No			No	0	41.56	0	no	no	no
2234	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	204	8.9	Stable	No	No		ATR | NBN	No	1	38.11	0	no	no	no
2235	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016	IV	63	2	Stable	No	Yes or Unknown			No	1	6.67	0	no	no	no
2236	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	III	49	0	Stable	No	No		CHEK2	No	0	40.9	0	no	no	no
2237	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	29	7.9	Stable	No	No	Signature.22	BRCA2	No	0	37.03	0	no	no	no
2238	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	I	433	9.7	Stable	No	No	Signature.1	MUTYH	No	0	42.94	0	no	no	no
2239	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	651	1.8	Stable	No	Yes or Unknown			No	0	41.92	0	no	no	no
2240	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	54	1.8		No	No			Yes	0	40.57	0	no	no	no
2241	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	3	2	Stable	No	No			No	0	41.56	0	no	no	no
2242	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	560	11.4	Stable	No	Yes or Unknown	Signature.17	ATR	Yes	0	40.21	0	no	no	no
2243	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	93	6.9	Stable	No	No			No	0	7.59	0	no	no	no
2244	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	55	2	Stable	No	No			No	0	13.8	0	no	no	no
2245	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	515	3.5	Stable	No	Yes or Unknown		ARID1A	No	1	21.22	0	no	no	yes
2246	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	35	5.9	Stable	No	Yes or Unknown			No	1	10.84	0	no	no	no
2247	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	26	5.9	Stable	No	No	Signature.4		Yes	1	8.11	0	no	no	no
2248	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	15	1.8		No	Yes or Unknown			No	0	36.34	0	no	no	no
2249	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	82	3	Stable	No	No			No	0	40.74	0	no	no	no
2250	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	13	3	Stable	No	No			No	1	7.46	0	no	no	no
2251	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	250	6.1	Stable	No	Yes or Unknown			No	1	35.09	0	no	no	no
2252	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	IV	17	5.9		No	No	Signature.5		No	1	6.51	0	no	no	no
2253	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	13	1	Stable	No	No			Yes	1	4.27	0	no	no	no
2254	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	III	29	4.9	Stable	No	No			Yes	1	17.64	0	no	no	no
2255	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	22	3	Stable	No	Yes or Unknown			No	0	42.09	0	no	no	no
2256	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	II	9	1.8	Stable	No	No		MUTYH	No	0	41.23	0	no	no	no
2257	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	26	4.4		No	No			Yes	0	41.79	0	no	no	no
2258	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	1	Stable	No	No			No	0	41.53	0	no	no	no
2259	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	160	3.9	Stable	No	Yes or Unknown	Signature.4		Yes	0	41.56	0	no	no	no
2260	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	18	2	Stable	No	No			No	0	39.92	0	no	no	no
2261	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2016	I	245	2.6	Stable	No	No			No	0	32.49	0	no	no	no
2262	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	5.9	Stable	No	No	Signature.18	ATM	No	0	37.52	0	no	no	no
2263	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	43	3	Stable	No	Yes or Unknown			No	1	9.36	0	no	no	no
2264	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	13	8.9	Stable	No	No		ARID1A	Yes	1	6.34	0	no	no	yes
2265	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	6.9	Stable	No	No			No	1	8.94	0	no	no	no
2266	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	42.15	0	no	no	no
2267	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	II	0	10.8	Indeterminate	No	No	Signature.1		No	0	37.68	0	no	no	no
2268	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2016		36	0		No	No			No	0	39.03	0	no	no	no
2269	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	14	2	Stable	No	No			Yes	0	28.58	0	no	no	no
2270	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	III	27	4.9	Stable	No	No	Signature.3	FANCA	Yes	1	12.02	0	no	no	no
2271	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016		90	0	Stable	No	Yes or Unknown		MUTYH	No	1	34.92	0	no	no	no
2272	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	846	3.5	Stable	No	Yes or Unknown			No	1	32.62	0	no	no	no
2273	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	33	5.3	Stable	No	No	Signature.3		No	1	36.34	0	no	no	no
2274	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	26	3.9	Stable	No	No			No	1	5.22	0	no	no	no
2275	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	8.9	Stable	No	No	Signature.4	ATM | CHEK1 | ERCC5	No	0	21.42	0	no	no	no
2276	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	I	55	2	Stable	No	No		CHEK2	No	0	42.28	0	no	no	no
2277	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	85	1	Stable	No	No			No	0	40.44	0	no	no	no
2278	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	31	4.9	Stable	No	Yes or Unknown			No	0	38.41	0	no	no	no
2279	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	49	10.8	Stable	No	No	Signature.2		No	1	16.62	0	no	no	no
2280	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2016	I	29	2	Stable	No	No			No	0	7.52	0	no	no	no
2281	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	125	3	Stable	No	Yes or Unknown			No	0	41.33	0	no	no	no
2282	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	37	5.3		No	No	Signature.16		Yes	0	35.65	0	no	no	no
2283	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	46	3	Stable	No	No		CHEK2	No	0	41.33	0	no	no	no
2284	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	4	3.9	Stable	No	No			Yes	0	32.56	0	no	no	no
2285	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	38	3.5	Stable	No	No			Yes	0	42.45	0	no	no	no
2286	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	39	17.7	Stable	No	No	Signature.13	ARID1A | BRCA1	No	1	2.04	0	no	no	yes
2287	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		24	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATR	No	1	14.26	0	no	no	no
2288	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	20	3.5		No	No			No	0	38.18	0	no	no	no
2289	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2016		168	7.9		Yes or Unknown	Yes or Unknown			No	0	41.86	0	no	no	no
2290	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	21	4.9	Stable	No	No	Signature.5		No	1	24.21	0	no	no	no
2291	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	32	1	Stable	No	No			No	1	8.11	0	no	no	no
2292	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	2	Stable	No	No			No	0	36.5	0	no	no	no
2293	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	III	56	5.9	Stable	No	No			Yes	1	8.54	0	no	no	no
2294	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	27	3.5		No	Yes or Unknown			No	0	40.44	0	no	no	no
2295	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	I	251	0		No	Yes or Unknown			Yes	0	41.17	0	no	no	no
2296	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	13	1	Stable	No	No			No	0	41.92	0	no	no	no
2297	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	8	3	Stable	No	No			No	0	41.86	0	no	no	no
2298	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	4.4	Stable	No	No			No	0	37.68	0	no	no	no
2299	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	12	2.6	Stable	No	No			No	0	41.79	0	no	no	no
2300	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	134	1.8		No	Yes or Unknown			No	1	34.37	0	no	no	no
2301	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	3	Stable	No	Yes or Unknown	Signature.8		No	0	24.9	0	no	no	no
2302	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	92	1	Stable	No	No			No	0	40.8	0	no	no	no
2303	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	387	4.4	Stable	No	Yes or Unknown		MLH1	No	0	42.74	0	no	no	no
2304	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	0	57.1	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | MSH2	Yes	0	39.16	0	mut-MMRd	mut-MMRd	yes
2305	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	I	72	2	Stable	No	No			No	0	28.58	0	no	no	no
2306	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	1077	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	41.66	0	no	no	no
2307	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	8.9	Stable	No	No			No	0	40.57	0	no	no	no
2308	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		54	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	5.91	0	no	no	no
2309	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	IV	178	0.9		No	No			Yes	0	45.4	0	no	no	no
2310	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	386	1.8	Stable	No	Yes or Unknown			No	1	32.82	0	no	no	no
2311	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	6	1	Stable	No	No			No	1	9.07	0	no	no	no
2312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	1130	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	41.79	0	no	no	no
2313	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	7	1	Stable	No	Yes or Unknown	Signature.16		No	0	43.27	0	no	no	no
2314	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	12.8	Indeterminate	No	Yes or Unknown	Signature.24	ATM	No	1	5.88	0	no	no	no
2315	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2016		0	3	Stable	Yes or Unknown	Yes or Unknown			No	0	40.67	0	no	no	no
2316	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	9.8	Stable	No	No	Signature.4	PMS1	No	0	36.83	0	no	no	no
2317	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	I	21	4.4	Stable	No	No		ARID1A	No	0	41.89	0	no	no	yes
2318	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	IV	13	8.9	Stable	No	No	Signature.18	ARID1A	No	1	11.7	0	no	no	yes
2319	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	0	1.8	Stable	No	No			No	1	14.09	0	no	no	no
2320	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	III	29	3	Stable	No	No			Yes	0	36.73	0	no	no	no
2321	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		9	1	Stable	No	No			No	0	39.66	0	no	no	no
2322	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	28	7.9		No	No	Signature.2	ARID1A	No	0	41.36	0	no	no	yes
2323	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	25.6	Indeterminate	No	No	Signature.4	ATM | RAD50	No	0	5.19	0	no	no	no
2324	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	III	29	5.9	Indeterminate	No	No	Signature.30		No	0	42.12	0	no	no	no
2325	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	34	1.8		No	No			Yes	0	40.21	0	no	no	no
2326	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	57	3.9	Stable	No	No			No	1	7.59	0	no	no	no
2327	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	0	5.9	Indeterminate	No	No		BRCA1	No	0	12.39	0	no	no	no
2328	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	III	203	2.6		No	Yes or Unknown		ATM	Yes	0	41.23	0	no	no	no
2329	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	456	3.5	Stable	No	No			Yes	0	50	0	no	no	no
2330	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	16	1.8	Stable	No	Yes or Unknown		BRCA2	No	0	39.92	0	no	no	no
2331	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	2	3	Stable	No	No			No	1	8.87	0	no	no	no
2332	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2016	IV	435	5.3	Stable	No	Yes or Unknown	Signature.30	ATM	Yes	0	40.97	0	no	no	no
2333	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	0	1	Stable	No	No			No	1	19.91	0	no	no	no
2334	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2016	IV	15	0.9	Stable	No	No			Yes	1	15.08	0	no	no	no
2335	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	184	3.5	Stable	No	No			No	0	45.5	0	no	no	no
2336	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	II	0	0	Stable	No	No			No	0	40.87	0	no	no	no
2337	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	5	2	Stable	No	No			No	0	39.13	0	no	no	no
2338	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	21	7		No	No	Signature.3		No	0	40.21	0	no	no	no
2339	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	58	3	Stable	No	Yes or Unknown			No	0	41.72	0	no	no	no
2340	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	21	3	Stable	No	No			No	0	41.03	0	no	no	no
2341	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		3	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	41.07	0	no	no	no
2342	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016		0	3	Stable	No	No			No	0	34.63	0	no	no	no
2343	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	42	3	Stable	No	Yes or Unknown			No	0	39.62	0	no	no	no
2344	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	519	1.8	Stable	No	Yes or Unknown	Signature.3		No	0	40.71	0	no	no	no
2345	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	9.46	0	no	no	no
2346	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	48	4.9	Stable	No	Yes or Unknown			No	1	10.32	0	no	no	no
2347	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	4.9	Stable	No	No			No	1	15.15	0	no	no	no
2348	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	III	48	5.3	Stable	No	No	Signature.11		No	1	34.43	0	no	no	no
2349	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	IV	0	3	Stable	No	No			Yes	0	11.99	0	no	no	no
2350	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	82	0	Stable	No	No			No	0	41.36	0	no	no	no
2351	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	64	1	Stable	No	Yes or Unknown			No	0	39.33	0	no	no	no
2352	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	1037	7.9	Stable	No	Yes or Unknown	Signature.3	MDC1 | PALB2	No	1	36.44	0	no	no	no
2353	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	47	0	Stable	No	Yes or Unknown			Yes	0	11.66	0	no	no	no
2354	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		42	2	Stable	No	No			No	0	24.84	0	no	no	no
2355	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	III	30	9.8	Stable	No	No			Yes	0	38.18	0	no	no	no
2356	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		71	0	Stable	No	No			No	0	38.21	0	no	no	no
2357	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	I	15	1.8	Indeterminate	No	No		ATM	No	0	39.1	0	no	no	no
2358	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	540	6.1	Stable	No	Yes or Unknown	Signature.4	BRCA2 | SLX4	No	0	41.49	0	no	no	no
2359	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	48	3.5		No	Yes or Unknown			No	0	41.3	0	no	no	no
2360	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	86	2	Stable	No	Yes or Unknown			No	1	12.94	0	no	no	no
2361	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	778	4.4	Stable	No	Yes or Unknown			No	0	39.75	0	no	no	no
2362	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	12.8	Stable	No	No	Signature.24		No	0	40.67	0	no	no	no
2363	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2016	IV	924	2.6	Stable	No	Yes or Unknown	Signature.1	ATM	No	1	40.31	0	no	no	no
2364	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	0	3.9	Stable	No	No			No	0	40.94	0	no	no	no
2365	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	6.1		No	No	Signature.13		No	0	38.93	0	no	no	no
2366	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	23	2	Stable	No	No			No	0	40.8	0	no	no	no
2367	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	28	3.9	Stable	No	No			No	1	24.9	0	no	no	no
2368	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	0	169.2	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC3 | MLH1 | MSH6 | PALB2 | RAD52 | RAD54L | XRCC2	No	0	9.3	0	no	no	yes
2369	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	22	4.9	Stable	No	No			No	0	35.81	0	no	no	no
2370	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	29	63	Unstable	No	No	Signature.1	ARID1A | BRCA2 | FANCA | FANCC | MSH2 | NBN | RAD54L	Yes	0	42.18	0	mut-MMRd	mut-MMRd	yes
2371	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		8	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.68	0	no	no	no
2372	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	12	1	Stable	No	Yes or Unknown			Yes	0	27.3	0	no	no	no
2373	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	352	5.3	Stable	No	Yes or Unknown	Signature.3		No	0	16.62	0	no	no	no
2374	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.2		Yes	1	3.52	0	no	no	no
2375	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	0	3.9	Stable	No	No			No	1	18.4	0	no	no	no
2376	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	14	3	Stable	No	Yes or Unknown			No	1	14.92	0	no	no	no
2377	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	47	3.9	Stable	No	No			No	1	12.39	0	no	no	no
2378	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		56	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	40.74	0	no	no	no
2379	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	0	2	Stable	No	No			No	1	28.02	0	no	no	no
2380	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	41	3.9	Stable	No	No			Yes	1	31.74	0	no	no	no
2381	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.29		No	1	13.14	0	no	no	no
2382	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	14	0	Stable	No	No			No	0	40.61	0	no	no	no
2383	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	18	8.9	Stable	No	No	Signature.16	ATM	No	1	3.12	0	no	no	no
2384	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	III	17	6.9	Stable	No	No			No	0	35.78	0	no	no	no
2385	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	34	3	Stable	No	Yes or Unknown			Yes	0	40.87	0	no	no	no
2386	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	5	2		No	No			No	1	7.75	0	no	no	no
2387	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	III	120	2	Stable	No	No			No	0	10.18	0	no	no	no
2388	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	II	0	2.6		No	No			No	0	36.99	0	no	no	no
2389	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	8	3.5	Stable	No	Yes or Unknown			No	1	34.27	0	no	no	no
2390	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	4	5.9	Stable	No	No			No	0	15.05	0	no	no	no
2391	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		16	1	Stable	Yes or Unknown	Yes or Unknown			No	1	12.52	0	no	no	no
2392	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	0	40.71	0	no	no	no
2393	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	23	0	Stable	No	No			No	0	41.13	0	no	no	no
2394	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	87	2.6	Stable	No	No		NBN	No	0	40.67	0	no	no	no
2395	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	21	6.1		No	No			No	0	41.2	0	no	no	no
2396	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	33	2.6	Stable	No	No		ARID1A | ATM	No	1	25.89	0	no	no	yes
2397	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		0	3.9	Stable	No	No			Yes	0	40.61	0	no	no	no
2398	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	3	Stable	No	No			No	0	27.04	0	no	no	no
2399	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2016	II	8	1	Stable	No	No		ARID1A	Yes	0	37.95	0	no	no	yes
2400	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	308	1.8	Stable	No	Yes or Unknown			No	0	41.03	0	no	no	no
2401	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	35	74.8	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC5 | MSH2 | RAD52	No	0	41.1	0	mut-MMRd	mut-MMRd	yes
2402	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	I	49	5.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	39.36	0	no	no	no
2403	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	1114	2.6	Stable	No	Yes or Unknown	Signature.19	ATM	No	0	40.31	0	no	no	no
2404	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	31	3.5	Stable	No	No			Yes	0	41.13	0	no	no	no
2405	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	0	4.9	Stable	No	No	Signature.4	ATM	Yes	0	39.59	0	no	no	no
2406	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	2	Stable	No	No			Yes	0	40.08	0	no	no	no
2407	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	78	1.8		No	No		BRCA2 | MUTYH	No	0	41.79	0	no	no	no
2408	Non-ICI treated	Never received ICI	31 - 35	Female	Gastric	2016	II	0	3	Stable	No	No			No	0	7.06	0	no	no	no
2409	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	830	5.3	Stable	No	Yes or Unknown	Signature.13	NBN	No	0	41.07	0	no	no	no
2410	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	328	15.8		No	Yes or Unknown	Signature.4	ERCC4	No	1	37.95	0	no	no	no
2411	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	4.9	Stable	No	Yes or Unknown			Yes	0	38.67	0	no	no	no
2412	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	55	24.6	Indeterminate	No	Yes or Unknown	Signature.13	ATM | BRCA2 | MLH1 | PMS1	No	0	41.07	0	no	no	no
2413	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	96	0.9	Stable	No	Yes or Unknown			No	1	32.1	0	no	no	no
2414	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	21.09	0	no	no	no
2415	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	17	0.9	Stable	No	No			No	1	36.44	0	no	no	no
2416	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	I	0	0	Stable	No	No			No	0	36.83	0	no	no	no
2417	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	801	4.4	Stable	No	Yes or Unknown		ERCC2	No	0	41.49	0	no	no	no
2418	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	6	6.9	Stable	No	No	Signature.1		No	1	10.84	0	no	no	no
2419	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		83	3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	34	0	no	no	no
2420	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	II	0	4.9	Stable	No	No			Yes	0	36.73	0	no	no	no
2421	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	22	1.8		No	Yes or Unknown			Yes	0	37.42	0	no	no	no
2422	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	18	0		No	No			No	0	38.93	0	no	no	no
2423	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2016		27	7.9	Stable	No	No	Signature.13	ARID1A | BLM | ERCC5	No	0	38.64	0	no	no	yes
2424	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	8	14.8	Stable	No	No	Signature.4	ATM | PMS2	No	0	37.09	0	no	no	no
2425	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	III	0	3	Stable	No	No			No	1	20.4	0	no	no	no
2426	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	15	2	Stable	No	Yes or Unknown			No	1	20.76	0	no	no	no
2427	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	84	3.9	Stable	No	No			No	0	21.22	0	no	no	no
2428	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	I	43	15.7		No	No	Signature.5		No	0	41.2	0	no	no	no
2429	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		40	3	Stable	No	No			No	0	6.37	0	no	no	no
2430	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	IV	90	0	Stable	No	No			Yes	0	30.09	0	no	no	no
2431	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	4.4		No	No		MLH1 | RAD52	No	0	40.84	0	no	no	no
2432	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	14.8	Stable	No	No	Signature.29		Yes	0	1.02	0	no	no	no
2433	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	III	682	3.5	Stable	No	Yes or Unknown			No	0	33.81	0	no	no	no
2434	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	35	3	Stable	No	No			No	0	15.64	0	no	no	no
2435	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	0	Stable	No	No			Yes	1	4.37	0	no	no	no
2436	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	III	0	5.3	Stable	No	No		BRCA2	No	0	41	0	no	no	no
2437	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	3.9	Stable	No	Yes or Unknown			No	1	20.53	0	no	no	no
2438	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	10.8	Stable	No	No	Signature.13	BRIP1	Yes	0	37.91	0	no	no	no
2439	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	98	3	Stable	No	No			No	0	40.9	0	no	no	no
2440	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	44	1.8		No	No			Yes	0	39.39	0	no	no	no
2441	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	975	0.9	Stable	No	Yes or Unknown			No	0	40.97	0	no	no	no
2442	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	5.9	Indeterminate	No	No	Signature.16	BRCA2	No	0	15.51	0	no	no	no
2443	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		0	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	40.51	0	no	no	no
2444	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	0	1	Stable	No	No			Yes	0	37.29	0	no	no	no
2445	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	222	0.9		No	Yes or Unknown		ERCC5	No	0	41.1	0	no	no	no
2446	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	35	5.3	Stable	No	No		MLH1	No	0	41.59	0	no	no	no
2447	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	28	6.9	Stable	No	Yes or Unknown	Signature.7		No	0	38.6	0	no	no	no
2448	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	731	0	Stable	No	Yes or Unknown			No	0	41.36	0	no	no	no
2449	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	40	4.9	Stable	No	No			No	0	38.64	0	no	no	no
2450	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	0	78.7	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | PALB2 | RAD54L	Yes	0	35.61	0	other-MMRd	mut-MMRd	yes
2451	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	8	9.8	Stable	No	No	Signature.4	ATM	Yes	1	1.74	0	no	no	no
2452	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	798	7.9	Stable	No	Yes or Unknown	Signature.4		No	0	41.2	0	no	no	no
2453	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	27	2.6		No	No			No	0	38.8	0	no	no	no
2454	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	9	5.9	Stable	No	No	Signature.4		No	1	19.55	0	no	no	no
2455	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	18	4.9	Stable	No	No			No	0	40.51	0	no	no	no
2456	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	7	0	Stable	No	No			No	1	33.22	0	no	no	no
2457	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	0	4.9	Stable	No	No			Yes	1	2.23	0	no	no	no
2458	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2016	I	0	0		No	No			No	0	35.29	0	no	no	no
2459	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		2	15.7	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.12	ATM | NBN	No	1	21.95	0	no	no	no
2460	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	1	12.8	Indeterminate	No	No	Signature.29	ATM | BRIP1 | ERCC2	No	1	1.77	0	no	no	no
2461	Non-ICI treated	Never received ICI	15-Nov	Male	CNS	2016		0	1	Stable	No	No			No	0	39.95	0	no	no	no
2462	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2016	IV	0	4.9	Stable	No	Yes or Unknown			Yes	1	4.83	0	no	no	no
2463	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	5.9	Stable	No	No	Signature.3		No	1	16.43	0	no	no	no
2464	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	174	3.5		No	Yes or Unknown			No	0	41.3	0	no	no	no
2465	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	45.3	Stable	No	No	Signature.4	ARID1A | BLM | CHEK2 | PALB2	No	1	3.61	0	no	no	yes
2466	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2016		5	0	Stable	Yes or Unknown	Yes or Unknown			No	1	18.66	0	no	no	no
2467	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	II	59	49.2	Unstable	No	No	Signature.6	FANCA | PALB2 | PARP1 | RAD52	No	0	38.9	0	other-MMRd	mut-MMRd	no
2468	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	277	2.6		No	Yes or Unknown			No	0	40.84	0	no	no	no
2469	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	42	6.1	Stable	No	No			No	0	24.8	0	no	no	no
2470	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	22	2	Stable	No	No		ARID1A	No	0	36.24	0	no	no	yes
2471	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	56	20.7	Stable	No	No	Signature.13	BLM	No	0	40.54	0	no	no	no
2472	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	23	5.9	Stable	No	No	Signature.1		Yes	0	39.36	0	no	no	no
2473	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	6.1		No	No			No	0	29.7	0	no	no	no
2474	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	3.9	Stable	No	No		ARID1A | ATM	No	1	4.17	0	no	no	yes
2475	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	36	7.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	38.18	0	no	no	no
2476	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	29	2.6		No	No		BRCA2	No	0	40.8	0	no	no	no
2477	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	3.5	Stable	No	No			No	0	35.88	0	no	no	no
2478	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	751	26.3	Stable	No	Yes or Unknown	Signature.26	ARID1A | ATM | RAD52	No	0	40.71	0	no	no	yes
2479	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	282	10.5	Stable	No	Yes or Unknown	Signature.13	BRCA2	No	0	41.89	0	no	no	no
2480	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2016	IV	61	0	Stable	No	No			No	0	40.84	0	no	no	no
2481	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	42	3	Stable	No	Yes or Unknown			No	0	40.84	0	no	no	no
2482	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	8	3	Stable	No	Yes or Unknown			No	1	22.41	0	no	no	no
2483	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2016	IV	119	15.8	Stable	No	Yes or Unknown	Signature.2	ATR | BLM | MLH1 | MRE11A | MSH2 | RAD50	Yes	0	41.13	0	no	no	no
2484	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2016	I	53	1.8		No	No			No	0	22.14	0	no	no	no
2485	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	16	9.8	Indeterminate	No	No	Signature.29	PMS1	Yes	1	1.68	0	no	no	no
2486	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	42	10.8	Stable	No	No	Signature.4	BRCA1	No	0	34.96	0	no	no	no
2487	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	0	2	Stable	No	Yes or Unknown			No	0	37.13	0	no	no	no
2488	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3	Stable	No	Yes or Unknown			No	0	40.41	0	no	no	no
2489	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	IV	15	1	Stable	No	No			Yes	0	39.33	0	no	no	no
2490	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	21	0		No	No			Yes	0	36.63	0	no	no	no
2491	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	5.9	Stable	No	Yes or Unknown		ATM	No	1	28.94	0	no	no	no
2492	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	685	1.8	Stable	No	Yes or Unknown	Signature.5		No	0	40.05	0	no	no	no
2493	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	0	2		No	No			No	0	40.71	0	no	no	no
2494	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	10.8		No	No	Signature.5	BRCA1 | MUTYH | PMS1	Yes	1	26.84	0	no	no	no
2495	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	68	3.9	Stable	No	Yes or Unknown			No	0	38.14	0	no	no	no
2496	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	24	6.9	Stable	No	Yes or Unknown		ARID1A	No	0	27.37	0	no	no	yes
2497	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	IV	0	2	Stable	No	No			No	1	26.78	0	no	no	no
2498	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	I	224	4.4	Stable	No	Yes or Unknown			Yes	0	37.32	0	no	no	no
2499	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2016	IV	17	7.9	Stable	No	No	Signature.5	BLM	No	1	31.15	0	no	no	no
2500	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	IV	100	0	Stable	No	No			Yes	0	29.08	0	no	no	no
2501	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	29.93	0	no	no	no
2502	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	32	7		No	No			Yes	0	39.75	0	no	no	no
2503	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3	Stable	No	No			Yes	0	39.06	0	no	no	no
2504	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	0	12.8	Stable	No	No		ARID1A	No	1	4.57	0	no	no	yes
2505	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		1	8.9	Stable	No	No			Yes	0	39.66	0	no	no	no
2506	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2016	III	269	57.1		No	No	Signature.7	ATR | BRCA2 | MRE11A | SLX4 | TP53BP1	No	0	39.95	0	no	no	no
2507	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	103	3.5		No	No	Signature.1	ATR	No	1	40.51	0	no	no	no
2508	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	4.9	Stable	No	No			No	0	34.07	0	no	no	no
2509	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	31	2	Stable	No	Yes or Unknown	Signature.2		Yes	0	38.74	0	no	no	no
2510	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	14	4.9	Stable	No	No			Yes	0	35.25	0	no	no	no
2511	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	957	7.9	Stable	No	Yes or Unknown	Signature.6	BRCA1	No	0	40.94	0	no	no	no
2512	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	I	442	0.9	Stable	No	Yes or Unknown			No	0	40.9	0	no	no	no
2513	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	35	7	Stable	No	No			Yes	0	36.44	0	no	no	no
2514	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	59	3.5		No	Yes or Unknown		FANCA	Yes	0	37.95	0	no	no	no
2515	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		39	1	Stable	No	No			No	1	22.08	0	no	no	no
2516	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2016		14	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.5	FANCA	No	1	33.41	0	no	no	no
2517	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	55	2	Stable	No	No			No	1	19.75	0	no	no	no
2518	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	26	11.8	Stable	No	No		ARID1A	No	0	35.98	0	no	no	yes
2519	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	57	4.9	Stable	No	No		ATR	No	0	37.36	0	no	no	no
2520	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	14	3	Stable	No	Yes or Unknown			Yes	0	26.64	0	no	no	no
2521	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	III	247	3.5	Stable	No	Yes or Unknown			No	0	27.04	0	no	no	no
2522	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2016	II	0	2	Stable	No	No			Yes	0	2.33	0	no	no	no
2523	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	31	4.9	Stable	No	No		ATM | PMS2	No	1	10.71	0	no	no	no
2524	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		5	5.9	Stable	Yes or Unknown	Yes or Unknown		ARID1A	Yes	0	39.43	0	no	no	yes
2525	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	19	6.9	Stable	No	No		FANCA	No	1	1.54	0	no	no	no
2526	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	17	1		No	No			No	0	38.54	0	no	no	no
2527	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	28	3.9	Stable	No	Yes or Unknown			No	1	12.75	0	no	no	no
2528	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	21	0	Stable	No	No			Yes	1	4.47	0	no	no	no
2529	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	1.8		No	Yes or Unknown			No	1	21.52	0	no	no	no
2530	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	IV	34	2	Stable	No	No			No	0	1.54	0	no	no	no
2531	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	0	40.71	0	no	no	no
2532	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	9	236.1	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK2 | MDC1 | MSH2 | MSH6 | PALB2 | PMS1 | PMS2 | RAD50	Yes	0	36.5	0	no	no	yes
2533	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	III	0	15.7	Indeterminate	No	No	Signature.24		Yes	0	29.47	0	no	no	no
2534	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2016		1	3	Stable	Yes or Unknown	Yes or Unknown			No	1	13.11	0	no	no	no
2535	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	21	6.9	Stable	No	No	Signature.1		Yes	1	28.45	0	no	no	no
2536	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	0	3	Stable	No	No		ATM	No	0	40.05	0	no	no	no
2537	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	0	2	Stable	No	No			Yes	0	39.1	0	no	no	no
2538	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	32.99	0	no	no	no
2539	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	II	40	59	Unstable	No	No	Signature.6	ATM | ERCC3 | MRE11A | PMS1	No	0	40.48	0	other-MMRd	mut-MMRd	no
2540	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	10.8	Stable	No	No	Signature.1	MSH6	Yes	1	3.02	0	no	no	no
2541	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	83	4.9	Stable	No	No		ARID1A	Yes	1	16.16	0	no	no	yes
2542	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	24	1	Stable	No	No			No	0	37.91	0	no	no	no
2543	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		15	1	Stable	No	No			No	1	10.61	0	no	no	no
2544	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	0	1.8	Stable	No	No			Yes	0	14.75	0	no	no	no
2545	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	1153	0.9	Stable	No	Yes or Unknown			No	0	40.38	0	no	no	no
2546	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	44	8.9	Indeterminate	No	No	Signature.4	ATM	Yes	1	5.26	0	no	no	no
2547	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	9.8	Stable	No	Yes or Unknown	Signature.18		Yes	1	2.76	0	no	no	no
2548	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	7	Stable	No	No	Signature.1		No	0	42.02	0	no	no	no
2549	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	I	425	7	Stable	No	Yes or Unknown			No	0	39.82	0	no	no	no
2550	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	35	0.9		No	No			No	0	36.96	0	no	no	no
2551	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	2	Stable	No	Yes or Unknown			Yes	0	19.84	0	no	no	no
2552	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	128	2.6		No	No	Signature.3		No	0	35.88	0	no	no	no
2553	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	3	8.9	Indeterminate	No	No	Signature.3	ATM	Yes	1	2.69	0	no	no	no
2554	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	II	20	2	Stable	No	No			No	1	10.58	0	no	no	no
2555	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		42	4.9	Stable	Yes or Unknown	Yes or Unknown		ERCC4	No	1	8.64	0	no	no	no
2556	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		1	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	20.01	0	no	no	no
2557	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		18	0		No	No			No	0	33.45	0	no	no	no
2558	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	9	26.6	Stable	No	No	Signature.18	ATM | FANCA | MRE11A | PALB2	No	0	39.62	0	no	no	no
2559	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	55	1	Stable	No	No			Yes	0	40.57	0	no	no	no
2560	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	28	4.4		No	No			No	0	38.47	0	no	no	no
2561	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	24	3	Stable	No	No			No	0	37.52	0	no	no	no
2562	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	69	8.9	Stable	No	No	Signature.29	ERCC2	No	0	3.52	0	no	no	no
2563	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	0	0	Stable	No	No			No	0	36.11	0	no	no	no
2564	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		0	2	Stable	No	No			No	1	20.83	0	no	no	no
2565	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2016	IV	126	6.1	Stable	No	No		ARID1A	Yes	1	20.67	0	no	no	yes
2566	Non-ICI treated	Never received ICI	16 - 20	Male	Cutaneous Melanoma 	2016	II	58	0	Stable	No	No			No	0	35.94	0	no	no	no
2567	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	8	6.9	Stable	No	No	Signature.4		No	0	38.18	0	no	no	no
2568	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	0	Stable	No	No			No	0	37.32	0	no	no	no
2569	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	47	12.8	Stable	No	No	Signature.24		Yes	1	20.63	0	no	no	no
2570	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	59	2.6		No	No			Yes	0	39.13	0	no	no	no
2571	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	42	2	Stable	No	No			No	0	21.85	0	no	no	no
2572	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2016	III	32	6.9	Stable	No	No	Signature.24		Yes	0	36.47	0	no	no	no
2573	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	59	46.2	Stable	No	No	Signature.6	ARID1A | ATM | ATR | MLH1 | MUTYH	No	0	35.09	0	no	no	yes
2574	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	37	5.3	Stable	No	No	Signature.3	ARID1A | MSH6	No	0	40.28	0	no	no	yes
2575	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	43	4.9	Stable	No	No		ARID1A	No	0	38.77	0	no	no	yes
2576	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	601	2.6	Stable	No	Yes or Unknown	Signature.1		No	0	39.98	0	no	no	no
2577	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2016	IV	7	3	Stable	No	Yes or Unknown			No	0	40.31	0	no	no	no
2578	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	175	0		No	No			No	0	39.79	0	no	no	no
2579	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	187	7	Stable	No	Yes or Unknown	Signature.25	ATM	No	1	20.57	0	no	no	no
2580	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	22	6.1		No	No			No	0	38.41	0	no	no	no
2581	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	17	4.9	Stable	No	No		BRCA1	No	0	37.03	0	no	no	no
2582	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	211	2.6	Stable	No	Yes or Unknown			No	0	40.25	0	no	no	no
2583	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	12	19.7	Stable	No	No	Signature.24	ATR | BRCA2 | CHEK2	No	1	11.53	0	no	no	no
2584	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	26	1	Stable	No	No			No	0	20.24	0	no	no	no
2585	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	0	6.9	Stable	No	No		ARID1A	No	1	5.98	0	no	no	yes
2586	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	20	57.9	Unstable	No	No	Signature.6	ARID1A | ATM | MSH3	No	0	8.41	0	other-MMRd	mut-MMRd	yes
2587	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016		503	0.9	Stable	No	Yes or Unknown			No	1	36.96	0	no	no	no
2588	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	0	4.4		No	No			No	1	13.17	0	no	no	no
2589	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	28	4.9	Stable	No	No	Signature.4		No	0	37.52	0	no	no	no
2590	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	114	1.8		No	No			No	0	15.28	0	no	no	no
2591	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	III	43	3.9	Stable	No	No			No	0	40.11	0	no	no	no
2592	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	IV	42	2.6	Stable	No	No			Yes	0	37.68	0	no	no	no
2593	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	I	13	1.8	Stable	No	No			No	0	40.21	0	no	no	no
2594	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	0	8.9	Stable	No	No		ARID1A	No	0	26.02	0	no	no	yes
2595	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	132	4.9		No	Yes or Unknown			No	0	38.41	0	no	no	no
2596	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	4	1	Stable	No	No			No	0	39.56	0	no	no	no
2597	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	20	1	Stable	No	No			No	0	39.75	0	no	no	no
2598	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	36	0	Stable	No	No			No	0	35.84	0	no	no	no
2599	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	I	23	1	Stable	No	No			No	0	38.14	0	no	no	no
2600	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	III	30	0	Stable	No	No			No	0	37.75	0	no	no	no
2601	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	568	1.8	Stable	No	Yes or Unknown			No	0	38.01	0	no	no	no
2602	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	26	10.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	0	39.79	0	no	no	yes
2603	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2016	I	37	3	Stable	No	No			No	0	15.61	0	no	no	no
2604	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	153	0	Stable	No	Yes or Unknown			No	0	34.4	0	no	no	no
2605	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	3	8.9	Indeterminate	No	No	Signature.4		No	0	12.65	0	no	no	no
2606	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	227	5.3		No	Yes or Unknown			No	1	26.87	0	no	no	no
2607	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	4.9	Stable	No	No			No	0	21.03	0	no	no	no
2608	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	III	749	2.6	Indeterminate	No	Yes or Unknown		ATR	No	0	40.25	0	no	no	no
2609	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	19	32.5	Stable	No	No	Signature.4		No	0	37.13	0	no	no	no
2610	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	19	6.9	Stable	No	No	Signature.13		No	0	37.91	0	no	no	no
2611	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	0	11.4		No	No	Signature.3		No	0	8.84	0	no	no	no
2612	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	29	4.4		No	No		BRCA2	Yes	0	37.75	0	no	no	no
2613	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	3	5.9	Stable	No	No	Signature.1		No	1	23.13	0	no	no	no
2614	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	781	3.5	Stable	No	Yes or Unknown	Signature.6		No	0	41.56	0	no	no	no
2615	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	76	2	Stable	No	No			No	0	39.49	0	no	no	no
2616	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	22	1.8		No	No			No	0	39.03	0	no	no	no
2617	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	493	0.9	Stable	No	Yes or Unknown			No	1	26.18	0	no	no	no
2618	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	IV	18	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	20.76	0	no	no	no
2619	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	580	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	25.95	0	no	no	no
2620	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	III	119	3.5	Stable	No	No			No	1	29.5	0	no	no	no
2621	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	4	10.8	Stable	No	No	Signature.1	ARID1A | ATM	Yes	0	10.35	0	no	no	yes
2622	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	III	1005	0	Stable	No	No			Yes	1	35.48	0	no	no	no
2623	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	0	3	Stable	No	No			No	0	37.98	0	no	no	no
2624	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	554	0.9	Stable	No	Yes or Unknown			No	1	31.24	0	no	no	no
2625	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	I	58	3.9	Stable	No	Yes or Unknown			Yes	1	16.82	0	no	no	no
2626	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3	Stable	No	No			No	1	32.66	0	no	no	no
2627	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	1	17.84	0	no	no	no
2628	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	26	3	Stable	No	Yes or Unknown			No	0	37.19	0	no	no	no
2629	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	III	0	3.9	Stable	No	No			Yes	0	40.18	0	no	no	no
2630	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	37	8.9	Stable	No	No	Signature.13	ATR	No	1	1.71	0	no	no	no
2631	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	1027	3.5	Stable	No	Yes or Unknown		BRCA2 | MDC1	No	0	39.75	0	no	no	no
2632	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	29	13.8	Stable	No	No	Signature.4	FANCA	Yes	1	12.16	0	no	no	no
2633	Non-ICI treated	Never received ICI	26 - 30	Female	Pancreatic	2016	IV	10	3.9	Stable	No	No		ARID1A	No	0	15.67	0	no	no	yes
2634	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	IV	18	0	Stable	No	No			No	1	9.4	0	no	no	no
2635	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	IV	29	7.9	Indeterminate	No	Yes or Unknown	Signature.3		No	1	7.52	0	no	no	no
2636	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	3.9	Stable	No	No		ARID1A	No	0	15.38	0	no	no	yes
2637	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	38.67	0	no	no	no
2638	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		6	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	30.88	0	no	no	no
2639	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	8.9		Yes or Unknown	Yes or Unknown		ARID1A	No	0	23.2	0	no	no	yes
2640	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	12	6.9	Stable	No	No			No	1	18.99	0	no	no	no
2641	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	14	5.9	Stable	No	No	Signature.1		No	1	25.59	0	no	no	no
2642	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2016		1015	1.8	Stable	No	No		ATR	No	0	37.62	0	no	no	no
2643	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	21	112.2	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | ERCC4 | MRE11A | RAD50	No	0	38.21	0	no	no	yes
2644	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	162	7.9		No	Yes or Unknown	Signature.3		No	1	7.03	0	no	no	no
2645	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	0	4.9	Stable	No	No	Signature.26	ATM	No	1	7.2	0	no	no	no
2646	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	42	3.5		No	No			No	0	38.34	0	no	no	no
2647	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	1	3	Stable	No	Yes or Unknown			No	0	37.13	0	no	no	no
2648	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2016	IV	0	1.8		No	No			No	1	14.52	0	no	no	no
2649	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	8	8.9	Stable	No	No	Signature.24		Yes	0	33.08	0	no	no	no
2650	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	22	3	Stable	No	Yes or Unknown			No	0	37.29	0	no	no	no
2651	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	IV	255	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	33.74	0	no	no	no
2652	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	56	4.9	Stable	No	No			No	0	25.56	0	no	no	no
2653	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	46	1	Stable	No	No			No	1	36.11	0	no	no	no
2654	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			No	0	40.74	0	no	no	no
2655	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	37	7.9	Stable	No	No	Signature.2		No	1	14.26	0	no	no	no
2656	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	266	0.9		No	Yes or Unknown			No	1	28.32	0	no	no	no
2657	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	21	7.9	Stable	No	No			Yes	1	4.9	0	no	no	no
2658	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	62	2.6		No	No			Yes	0	39.16	0	no	no	no
2659	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	0.9		No	Yes or Unknown			No	0	39.2	0	no	no	no
2660	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	2.6		No	No			Yes	0	18.73	0	no	no	no
2661	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	78	40.3	Unstable	No	No	Signature.6	ARID1A | BLM	No	0	5.36	0	other-MMRd	mut-MMRd	yes
2662	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2016	I	0	1		No	No			No	0	38.87	0	no	no	no
2663	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	35	3.5		No	No		RAD50	Yes	0	36.5	0	no	no	no
2664	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	69	0		No	No			Yes	0	39.13	0	no	no	no
2665	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	6	3	Stable	No	No			No	1	8.48	0	no	no	no
2666	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	89	3.5	Stable	No	Yes or Unknown		ERCC5 | PARP1	No	1	22.54	0	no	no	no
2667	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	6	3.9	Stable	No	Yes or Unknown			No	0	40.18	0	no	no	no
2668	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	267	1.8	Stable	No	No			No	0	40.67	0	no	no	no
2669	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	0	2	Stable	No	No			Yes	0	6.64	0	no	no	no
2670	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	63	12.8	Indeterminate	No	No	Signature.1	ARID1A | ATR	Yes	0	39.52	0	no	no	yes
2671	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	0	3.5		No	No			No	1	10.87	0	no	no	no
2672	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	I	56	0.9		No	No			Yes	0	31.64	0	no	no	no
2673	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		3	3.9	Stable	No	No			No	1	2.3	0	no	no	no
2674	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	30	3	Stable	No	No			No	0	38.9	0	no	no	no
2675	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	15	242	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | MDC1 | MRE11A | MSH6 | NBN | PMS2 | RAD50 | RAD51C	Yes	0	39.56	0	mut-MMRd	mut-MMRd	yes
2676	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	32	3.9	Stable	No	No			Yes	1	4.3	0	no	no	no
2677	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	70	0		No	No		PMS2	No	0	39.62	0	no	no	no
2678	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	4.9	Stable	No	No		ATM	No	0	26.48	0	no	no	no
2679	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	43	0	Stable	No	No			No	0	23.23	0	no	no	no
2680	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	5	3.9	Stable	No	Yes or Unknown			No	0	37.26	0	no	no	no
2681	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	II	50	4.9	Stable	No	Yes or Unknown			No	0	39.59	0	no	no	no
2682	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	IV	32	4.9	Stable	No	No		ATM	Yes	1	11.24	0	no	no	no
2683	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2016	II	0	42.1		No	Yes or Unknown	Signature.7	ATM | ATR	Yes	0	38.83	0	no	no	no
2684	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	III	0	3.9	Stable	No	No			Yes	0	37.26	0	no	no	no
2685	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	1	Stable	No	No			No	0	39.03	0	no	no	no
2686	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	28	0	Stable	No	No			No	0	38.44	0	no	no	no
2687	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	51	1	Stable	No	Yes or Unknown			Yes	0	8.34	0	no	no	no
2688	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	III	1	9.8	Stable	No	No	Signature.1	ERCC2	Yes	0	39.43	0	no	no	no
2689	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	39	1	Stable	No	No			No	0	30.52	0	no	no	no
2690	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	36	3.9	Stable	No	No			No	1	6.24	0	no	no	no
2691	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016		170	1.8		No	Yes or Unknown			No	0	37.49	0	no	no	no
2692	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	56	2.6		No	No			Yes	0	30.82	0	no	no	no
2693	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	0	4.9	Stable	No	No	Signature.1	ATM	Yes	1	3.61	0	no	no	no
2694	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	567	10.5	Stable	No	Yes or Unknown	Signature.13		No	1	38.01	0	no	no	no
2695	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	48	7.9	Stable	No	No		ARID1A	No	0	37.91	0	no	no	yes
2696	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	37	27.5	Stable	No	No	Signature.4	FANCC	No	0	22.51	0	no	no	no
2697	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	26	2	Stable	No	Yes or Unknown			Yes	0	37.42	0	no	no	no
2698	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	49	1.8		No	No			No	0	38.87	0	no	no	no
2699	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	59	0.9		No	No			Yes	0	39.62	0	no	no	no
2700	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	127	0.9	Stable	No	No			No	0	42.81	0	no	no	no
2701	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	56	2	Stable	No	No			No	0	37.09	0	no	no	no
2702	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	0	78.7	Stable	No	No	Signature.10	ARID1A | ATM | ERCC3 | MDC1 | MSH6 | PALB2 | PMS1 | RAD50 | XRCC2	Yes	0	38.57	0	no	no	yes
2703	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	36	220.4	Stable	No	No	Signature.1	ARID1A | ATM | BRCA2 | BRIP1 | CHEK1 | ERCC2 | ERCC3 | ERCC4 | MDC1 | MSH6 | MUTYH | PARP1 | RAD50	No	0	35.65	0	no	no	yes
2704	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3	Stable	No	No			No	1	16.85	0	no	no	no
2705	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	8.9	Indeterminate	No	No	Signature.3		No	0	11.89	0	no	no	no
2706	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	6.9	Stable	No	No	Signature.1		No	1	23.72	0	no	no	no
2707	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	15	0	Stable	No	No			Yes	0	37.39	0	no	no	no
2708	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	23	4.9	Stable	No	Yes or Unknown			No	1	35.19	0	no	no	no
2709	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	0	3.5	Stable	No	No			No	0	38.64	0	no	no	no
2710	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2016	IV	0	6.9	Stable	No	No			No	1	11.86	0	no	no	no
2711	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	0	3.9	Indeterminate	No	No			No	0	39.1	0	no	no	no
2712	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	48	30.5	Unstable	No	No	Signature.6	ARID1A | PARP1	No	0	39.2	0	other-MMRd	mut-MMRd	yes
2713	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		72	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	35.48	0	no	no	no
2714	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	0	4.4		No	No			No	1	10.45	0	no	no	no
2715	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	181	30.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATR | MUTYH	No	0	11.7	0	other-MMRd	mut-MMRd	yes
2716	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	13	7.9	Stable	No	No	Signature.1		No	1	21.65	0	no	no	no
2717	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2016	IV	1	1		No	No		ATM	No	1	32.66	0	no	no	no
2718	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	668	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	37.75	0	no	no	no
2719	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	30	2	Stable	No	No		MUTYH	No	0	34.73	0	no	no	no
2720	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	23	2	Stable	No	No			No	0	35.91	0	no	no	no
2721	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	0	5.9	Stable	No	No			No	0	39.26	0	no	no	no
2722	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	1	11.93	0	no	no	no
2723	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		18	3	Stable	Yes or Unknown	Yes or Unknown			No	1	28.42	0	no	no	no
2724	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	272	4.4		No	Yes or Unknown			No	1	29.04	0	no	no	no
2725	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	19	6.9	Stable	No	No			No	0	32.39	0	no	no	no
2726	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	16	3	Stable	No	No			No	1	16.03	0	no	no	no
2727	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	6.9	Stable	No	No	Signature.4		No	0	32.3	0	no	no	no
2728	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	9	8.8	Stable	No	No	Signature.15	ERCC2 | MSH3 | RAD54L	No	0	38.44	0	no	no	no
2729	Non-ICI treated	Never received ICI	46 - 50	Male	Bladder	2016	III	429	4.4	Stable	No	Yes or Unknown	Signature.13	SLX4	No	1	29.83	0	no	no	no
2730	Non-ICI treated	Never received ICI	26 - 30	Female	NSCLC	2016	IV	110	1.8		No	Yes or Unknown			No	0	39	0	no	no	no
2731	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	588	3.5	Stable	No	Yes or Unknown	Signature.3		No	1	36.24	0	no	no	no
2732	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	10	6.9	Indeterminate	No	No	Signature.3		No	1	14.13	0	no	no	no
2733	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	82	2	Stable	No	Yes or Unknown			No	0	33.05	0	no	no	no
2734	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	28	2	Stable	No	Yes or Unknown			Yes	0	38.77	0	no	no	no
2735	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	38	2		No	No		BRCA2	No	0	38.44	0	no	no	no
2736	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	0	4.4	Stable	No	No			Yes	0	40.54	0	no	no	no
2737	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	39.13	0	no	no	no
2738	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	16	3	Indeterminate	No	No			No	1	5.78	0	no	no	no
2739	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		20	3	Stable	No	No		BLM	No	1	28.09	0	no	no	no
2740	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	42	4.9	Stable	No	Yes or Unknown			Yes	0	33.51	0	no	no	no
2741	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		30	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	FANCA	Yes	1	17.25	0	no	no	no
2742	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016	IV	0	3.9	Stable	No	No			No	1	6.41	0	no	no	no
2743	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016	III	0	0.9		No	No			No	0	39.82	0	no	no	no
2744	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	16	7.9	Stable	No	No		ATM	Yes	0	38.34	0	no	no	no
2745	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	1063	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	36.3	0	no	no	no
2746	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	II	252	3.5	Stable	No	Yes or Unknown	Signature.9		No	1	32.82	0	no	no	no
2747	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	III	18	0.9	Stable	No	No			Yes	0	39	0	no	no	no
2748	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2016	III	48	6.1		No	No	Signature.1		No	0	39.29	0	no	no	no
2749	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	7	3.9	Stable	No	No	Signature.1		No	0	39.98	0	no	no	no
2750	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	27.1	0	no	no	no
2751	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	6	4.9	Stable	No	Yes or Unknown			No	0	38.6	0	no	no	no
2752	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	71	3	Stable	No	Yes or Unknown			No	0	39.1	0	no	no	no
2753	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2016	I	77	2	Stable	No	No			No	0	35.38	0	no	no	no
2754	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2016	IV	16	2.6		No	No			No	1	19.19	0	no	no	no
2755	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	63	1.8		No	No			No	0	39.89	0	no	no	no
2756	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	333	5.3	Stable	No	Yes or Unknown		ARID1A | BLM	No	1	18	0	no	no	yes
2757	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	58	3	Stable	No	No			Yes	0	39.16	0	no	no	no
2758	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	II	859	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	34.96	0	no	no	no
2759	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	24	9.8	Stable	No	Yes or Unknown	Signature.2		No	0	39.2	0	no	no	no
2760	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	2.6	Stable	No	No			Yes	0	17.84	0	no	no	no
2761	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	6.67	0	no	no	no
2762	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	III	766	1.8	Indeterminate	No	Yes or Unknown	Signature.3		No	0	38.11	0	no	no	no
2763	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	0	3.5		No	Yes or Unknown		ERCC5	No	0	38.8	0	no	no	no
2764	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	16	3.9	Stable	No	No			No	1	12.35	0	no	no	no
2765	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	20	2	Stable	No	No			No	0	38.54	0	no	no	no
2766	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	385	7.9	Stable	No	Yes or Unknown		ATM | BRCA1 | RAD54L	Yes	0	43.53	0	no	no	no
2767	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2016	II	4	18.7	Stable	No	No	Signature.13	ATM | BLM | ERCC4	Yes	0	37.95	0	no	no	no
2768	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	54	4.4		No	Yes or Unknown			Yes	0	39.1	0	no	no	no
2769	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	8.9	Stable	No	No	Signature.4		No	0	26.48	0	no	no	no
2770	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	1	Stable	No	No			No	1	9.89	0	no	no	no
2771	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	59	4.9	Stable	No	No	Signature.3		No	0	38.87	0	no	no	no
2772	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	18	394.1		No	No	Signature.8	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC4 | ERCC5 | FANCA | MDC1 | MRE11A | MSH2 | MSH3 | MSH6 | NBN | PALB2 | PARP1 | PMS1 | RAD51 | SLX4 | TP53BP1	Yes	0	36.93	0	no	no	yes
2773	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	37	2.6	Stable	No	No			No	0	38.7	0	no	no	no
2774	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	75	15.8		No	Yes or Unknown	Signature.2	ARID1A	No	0	39.03	0	no	no	yes
2775	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	108	1.8		No	No		NBN	Yes	0	39.52	0	no	no	no
2776	Non-ICI treated	Never received ICI	56 - 60	Male	Breast	2016	IV	34	3.5		No	No			No	0	39.29	0	no	no	no
2777	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		17	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	7.26	0	no	no	no
2778	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	275	6.1		No	Yes or Unknown			No	1	22.34	0	no	no	no
2779	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	17	12.8	Stable	No	No	Signature.13	ARID1A	No	0	11.79	0	no	no	yes
2780	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	14	5.9	Stable	No	No		ERCC4	No	0	39.1	0	no	no	no
2781	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	57	3.5		No	No		ARID1A	No	0	37.13	0	no	no	yes
2782	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	130	1.8		No	No			Yes	0	40.21	0	no	no	no
2783	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	II	0	8.9	Stable	No	Yes or Unknown	Signature.1		No	0	39.52	0	no	no	no
2784	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	28	2	Stable	No	Yes or Unknown			No	0	37.95	0	no	no	no
2785	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	44	10.8		No	No	Signature.26	ATM | RAD54L	No	1	5.65	0	no	no	no
2786	Non-ICI treated	Never received ICI	86 - 90	Female	SCLC	2016	III	0	16.7	Indeterminate	No	No	Signature.13		No	1	5.22	0	no	no	no
2787	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	34.4	Stable	No	No	Signature.4	ARID1A | ERCC3	No	1	7.16	0	no	no	yes
2788	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	7	4.4	Stable	No	No			No	0	10.18	0	no	no	no
2789	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	0	0		No	No			No	0	38.7	0	no	no	no
2790	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	7	1.8		No	Yes or Unknown			No	0	36.83	0	no	no	no
2791	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2016	IV	72	6.1	Stable	No	Yes or Unknown			No	0	39.85	0	no	no	no
2792	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	143	6.1	Stable	No	Yes or Unknown		MSH6	No	0	36.01	0	no	no	no
2793	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	7	13.8	Indeterminate	No	No	Signature.29		No	1	0.85	0	no	no	no
2794	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2016	IV	0	0	Stable	No	No			No	1	7	0	no	no	no
2795	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	10.8	Stable	No	No	Signature.1		No	0	38.18	0	no	no	no
2796	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		76	3	Stable	No	No			No	0	38.7	0	no	no	no
2797	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2016		15	0	Stable	No	No			No	0	22.54	0	no	no	no
2798	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		10	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	11.37	0	no	no	no
2799	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	32	6.9	Stable	No	No	Signature.3		No	0	36.76	0	no	no	no
2800	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	3	9.8	Stable	No	No	Signature.1	CHEK2	No	1	18.6	0	no	no	no
2801	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		0	1.8	Stable	No	No			No	0	21.85	0	no	no	no
2802	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	25	5.9	Stable	No	No			No	0	23.29	0	no	no	no
2803	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	33	3	Stable	No	No			Yes	0	36.47	0	no	no	no
2804	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	II	20	0	Stable	No	No			No	0	33.91	0	no	no	no
2805	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	34.69	0	no	no	no
2806	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2016	IV	0	5.9	Stable	No	No			Yes	0	38.67	0	no	no	no
2807	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		20	5.9		Yes or Unknown	Yes or Unknown			Yes	0	38.8	0	no	no	no
2808	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	876	0.9	Stable	No	Yes or Unknown			No	0	39.33	0	no	no	no
2809	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	38	6.9	Stable	No	Yes or Unknown	Signature.12	ATM	No	1	13.73	0	no	no	no
2810	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	4.9	Stable	No	No	Signature.1		No	1	24.77	0	no	no	no
2811	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	8.9	Stable	No	No			Yes	1	1.18	0	no	no	no
2812	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	785	10.5	Stable	No	Yes or Unknown	Signature.2	BRCA1	No	0	38.31	0	no	no	no
2813	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	III	303	5.3	Stable	No	Yes or Unknown		BRCA2	No	1	19.29	0	no	no	no
2814	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	8.77	0	no	no	no
2815	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	2	Stable	No	No			No	0	18.6	0	no	no	no
2816	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	0	1.8	Stable	No	No	Signature.5		No	0	38.44	0	no	no	no
2817	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	108	4.4	Stable	No	No			No	0	38.37	0	no	no	no
2818	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	14	1	Stable	No	Yes or Unknown			No	1	6.14	0	no	no	no
2819	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	1	Stable	No	No			No	0	36.44	0	no	no	no
2820	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	29	5.9	Stable	No	Yes or Unknown			Yes	0	36.93	0	no	no	no
2821	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	41	6.9	Stable	No	Yes or Unknown			No	0	38.93	0	no	no	no
2822	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		10	3.9	Stable	No	No		BRIP1	No	1	9	0	no	no	no
2823	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	34	5.3	Stable	No	No			No	0	24.08	0	no	no	no
2824	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	0		No	No			No	0	36.21	0	no	no	no
2825	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	28	1	Stable	No	Yes or Unknown			No	0	36.3	0	no	no	no
2826	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	13	3.9	Stable	No	Yes or Unknown			Yes	0	36.67	0	no	no	no
2827	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	24	4.9	Stable	No	No		BRCA2	Yes	1	6.11	0	no	no	no
2828	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	200	5.3	Stable	No	Yes or Unknown			No	1	34.73	0	no	no	no
2829	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	9	5.3	Stable	No	No		BRCA2	Yes	0	38.9	0	no	no	no
2830	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	25	0	Stable	No	No			Yes	0	37.19	0	no	no	no
2831	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	0	Stable	No	Yes or Unknown			Yes	1	16.43	0	no	no	no
2832	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		25	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	11.27	0	no	no	no
2833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	49	3.5		No	No	Signature.4		Yes	0	35.06	0	no	no	no
2834	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		21	2	Stable	Yes or Unknown	Yes or Unknown			No	1	15.97	0	no	no	no
2835	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	0	8.8		No	No	Signature.4		No	0	30.09	0	no	no	no
2836	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	0		Yes or Unknown	Yes or Unknown			No	1	18.37	0	no	no	no
2837	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	49	11.8	Stable	No	No	Signature.1	ATM	No	0	29.86	0	no	no	no
2838	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	0	1	Stable	No	No		ATM	No	1	24.41	0	no	no	no
2839	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	3.9	Stable	No	Yes or Unknown		ARID1A | PALB2	No	0	37.75	0	no	no	yes
2840	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	42	3	Stable	No	No			No	1	28.39	0	no	no	no
2841	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016		63	3.9	Stable	No	No			No	1	3.91	0	no	no	no
2842	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	182	5.3	Stable	No	Yes or Unknown			No	0	37.68	0	no	no	no
2843	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	95	7		No	No	Signature.4	ARID1A	Yes	1	13.96	0	no	no	yes
2844	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.15	MSH6	No	0	17.22	0	no	no	no
2845	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	0	37.22	0	no	no	no
2846	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	0	146.6	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC4 | FANCA | MRE11A | MSH6 | MUTYH | RAD50 | RAD54L	No	0	38.28	0	no	no	yes
2847	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	0		No	No			No	0	32.2	0	no	no	no
2848	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	48	2	Stable	No	No		MUTYH	Yes	0	38.47	0	no	no	no
2849	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	30	4.9	Stable	No	No		ATM	No	0	36.9	0	no	no	no
2850	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016		0	1	Stable	No	No			Yes	0	7.98	0	no	no	no
2851	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	25	5.9	Stable	No	No	Signature.8		No	1	10.25	0	no	no	no
2852	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2015	IV	302	1.8		No	Yes or Unknown			Yes	0	11.96	0	no	no	no
2853	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	148	0		No	Yes or Unknown			No	0	38.8	0	no	no	no
2854	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016	I	70	0	Stable	No	No			Yes	0	35.48	0	no	no	no
2855	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	28	6.9	Stable	No	No	Signature.1		No	0	38.41	0	no	no	no
2856	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	29	3.9	Stable	No	No			Yes	0	37.22	0	no	no	no
2857	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	II	51	6.1	Stable	No	No			No	0	35.48	0	no	no	no
2858	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	26	2	Stable	No	No		ATM	No	0	38.08	0	no	no	no
2859	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	24.87	0	no	no	no
2860	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	I	0	0	Stable	No	No			Yes	0	36.67	0	no	no	no
2861	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	21	2	Stable	No	No			No	0	38.41	0	no	no	no
2862	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	19	52.1	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC3 | NBN | RAD54L	No	0	36.27	0	other-MMRd	mut-MMRd	yes
2863	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	46	3	Stable	No	Yes or Unknown			No	0	38.31	0	no	no	no
2864	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	20	3.9	Stable	No	No			No	0	36.67	0	no	no	no
2865	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	63	4.9		No	Yes or Unknown	Signature.3		No	0	38.14	0	no	no	no
2866	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	170	0.9	Stable	No	Yes or Unknown			No	1	20.4	0	no	no	no
2867	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	25	7.9	Stable	No	No	Signature.13		Yes	0	37.78	0	no	no	no
2868	Non-ICI treated	Never received ICI	31 - 35	Female	Head & Neck	2016	IV	100	3		No	No			Yes	0	39.36	0	no	no	no
2869	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	111	0.9	Stable	No	No			No	0	24.31	0	no	no	no
2870	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	III	51	3	Stable	No	No			No	1	6.77	0	no	no	no
2871	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	37.72	0	no	no	no
2872	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	27	2	Stable	No	Yes or Unknown			No	0	38.08	0	no	no	no
2873	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	4.4		No	No	Signature.1		No	1	10.78	0	no	no	no
2874	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	3.9	Stable	No	Yes or Unknown			No	0	38.74	0	no	no	no
2875	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	0	2	Stable	No	No			Yes	0	37.59	0	no	no	no
2876	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	II	22	2	Stable	No	No			No	0	5.03	0	no	no	no
2877	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	65	3		No	No			No	0	9.76	0	no	no	no
2878	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	II	673	0.9	Stable	No	Yes or Unknown			No	1	36.73	0	no	no	no
2879	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	26	1.8	Stable	No	No			No	0	35.52	0	no	no	no
2880	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	3.9	Stable	No	No			No	0	26.91	0	no	no	no
2881	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016		0	0	Stable	No	No			No	0	37.29	0	no	no	no
2882	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	2.4	0	no	no	no
2883	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	II	27	21.6	Stable	No	No	Signature.4		No	1	1.12	0	no	no	no
2884	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	57	0.9		No	No			No	0	36.76	0	no	no	no
2885	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	0	9.8	Stable	No	No	Signature.29	ATM	No	0	36.99	0	no	no	no
2886	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	46	3		No	No			Yes	1	5.55	0	no	no	no
2887	Non-ICI treated	Never received ICI	36 - 40	Female	Head & Neck	2016	III	29	3	Stable	No	No		ERCC5	No	0	24.44	0	no	no	no
2888	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	89	2.6	Stable	No	No			No	0	37.59	0	no	no	no
2889	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	8.9	Stable	No	No	Signature.1		No	1	23.72	0	no	no	no
2890	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	521	7	Stable	No	Yes or Unknown	Signature.8		No	1	32.53	0	no	no	no
2891	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	14	7.9	Stable	No	No	Signature.5		No	0	9.79	0	no	no	no
2892	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	12	7.9	Stable	No	No			No	0	26.94	0	no	no	no
2893	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	0	4.9	Stable	No	No			No	0	37.95	0	no	no	no
2894	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	35	4.9	Stable	No	No			No	1	19.88	0	no	no	no
2895	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	18	61	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1 | PALB2	Yes	0	15.87	0	mut-MMRd	mut-MMRd	yes
2896	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	III	37	5.9	Stable	No	No	Signature.1		No	0	38.64	0	no	no	no
2897	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	167	7		No	Yes or Unknown	Signature.4		No	1	15.21	0	no	no	no
2898	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	70	58.8	Unstable	No	No	Signature.1	ARID1A | ERCC2 | MDC1 | MSH2 | SLX4	No	0	38.77	0	mut-MMRd	mut-MMRd	yes
2899	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	1	0	Stable	No	No			No	0	27.83	0	no	no	no
2900	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	37	7	Stable	No	No		BRCA2	No	1	22.47	0	no	no	no
2901	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	248	2.6	Stable	No	Yes or Unknown			No	1	31.41	0	no	no	no
2902	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	35	15.8	Stable	No	No	Signature.2	ATR	Yes	1	9.59	0	no	no	no
2903	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	64	3.9	Stable	No	Yes or Unknown			No	1	23.82	0	no	no	no
2904	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2016		4	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	3.29	0	no	no	no
2905	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	1		No	No			No	0	34.37	0	no	no	no
2906	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	36	0	Stable	No	Yes or Unknown			Yes	0	34.2	0	no	no	no
2907	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	24	3.9	Stable	No	No			No	1	17.91	0	no	no	no
2908	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016		603	1.8	Stable	No	No			No	0	37.98	0	no	no	no
2909	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	III	301	0		No	Yes or Unknown			No	0	29.57	0	no	no	no
2910	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	43	0.9	Stable	No	No			Yes	0	32.49	0	no	no	no
2911	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	IV	42	1.8	Stable	No	No		FANCA	No	1	29.24	0	no	no	no
2912	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	1109	1.8	Stable	No	Yes or Unknown			No	0	38.97	0	no	no	no
2913	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	28	0	Stable	No	No			No	0	26.87	0	no	no	no
2914	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		8	2.6		No	No			Yes	1	15.64	0	no	no	no
2915	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	II	49	3.5		No	No			Yes	0	32.23	0	no	no	no
2916	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	0	10.8	Indeterminate	No	No	Signature.1		Yes	1	6.31	0	no	no	no
2917	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	87	7		No	Yes or Unknown	Signature.1		No	1	9.1	0	no	no	no
2918	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		17	7.9	Stable	No	No		BLM	No	0	38.28	0	no	no	no
2919	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	26	9.8	Stable	No	No	Signature.1		No	0	38.14	0	no	no	no
2920	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	0	1.8	Stable	No	No			No	0	38.21	0	no	no	no
2921	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	19	1.8		No	Yes or Unknown			No	0	38.14	0	no	no	no
2922	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	40	3.9		No	No			No	0	37.26	0	no	no	no
2923	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	0.9		No	No			No	0	37.88	0	no	no	no
2924	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	205	4.4	Stable	No	Yes or Unknown			No	1	16	0	no	no	no
2925	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	183	0	Stable	No	Yes or Unknown			No	1	30.82	0	no	no	no
2926	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	36	1	Stable	No	No			No	0	37.62	0	no	no	no
2927	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2016		2	2.6		Yes or Unknown	Yes or Unknown			Yes	1	12.94	0	no	no	no
2928	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2016	II	409	0.9	Stable	No	Yes or Unknown		BRCA2	No	0	37.22	0	no	no	no
2929	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		271	5.3		Yes or Unknown	Yes or Unknown			No	1	14.78	0	no	no	no
2930	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	39	5.3	Stable	No	Yes or Unknown			Yes	0	37.49	0	no	no	no
2931	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	22	1	Stable	No	No			No	0	29.93	0	no	no	no
2932	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	3	Indeterminate	No	No		ATM	No	0	37.03	0	no	no	no
2933	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	15	3.9	Stable	No	Yes or Unknown			Yes	0	34.86	0	no	no	no
2934	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	IV	39	2.6		No	Yes or Unknown			No	0	38.51	0	no	no	no
2935	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	40	8.9	Stable	No	No		PARP1	No	0	39.98	0	no	no	no
2936	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	94	0.9		No	Yes or Unknown			No	1	18.4	0	no	no	no
2937	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	36	3.9	Stable	No	No		ARID1A	No	0	37.59	0	no	no	yes
2938	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	21	3	Stable	No	No			No	0	36.93	0	no	no	no
2939	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	43	3.9	Stable	No	No			No	0	38.08	0	no	no	no
2940	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	II	0	24.6		No	Yes or Unknown	Signature.4	ATM | MSH3	No	0	37.72	0	no	no	no
2941	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	24	6.1	Stable	No	No			No	1	20.83	0	no	no	no
2942	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2016	IV	20	8.9	Stable	No	Yes or Unknown	Signature.2	ATR	No	0	35.19	0	no	no	no
2943	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	66	3.9	Stable	No	No			No	1	17.41	0	no	no	no
2944	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	826	3.5	Stable	No	Yes or Unknown			No	0	37.95	0	no	no	no
2945	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	II	22	1		No	No		ARID1A	No	0	26.28	0	no	no	yes
2946	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	0	2.6	Stable	No	No		ARID1A	Yes	0	22.83	0	no	no	yes
2947	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2016	II	0	4.4		No	No	Signature.13	BRCA2	No	0	20.14	0	no	no	no
2948	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2016	IV	0	3	Stable	No	No			No	0	21.65	0	no	no	no
2949	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	III	0	3.5	Stable	No	Yes or Unknown			No	1	25.76	0	no	no	no
2950	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2016	I	0	5.3		No	No	Signature.10		Yes	0	36.21	0	no	no	no
2951	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	89	7.9		No	No	Signature.4	BRCA1	Yes	0	29.34	0	no	no	no
2952	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	64	4.9	Stable	No	Yes or Unknown			No	1	24.94	0	no	no	no
2953	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	III	57	11.4		No	No	Signature.6	TP53BP1	No	1	11.73	0	no	no	no
2954	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	III	41	18.7	Indeterminate	No	No	Signature.6	ARID1A | ATM | MDC1 | MLH1 | PALB2	No	0	33.94	0	no	no	yes
2955	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	II	47	2.6		No	No			No	0	37.72	0	no	no	no
2956	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	12	4.9	Stable	No	No			No	1	21.68	0	no	no	no
2957	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	238	7.9		No	Yes or Unknown			No	1	16.49	0	no	no	no
2958	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	34	4.9	Stable	No	No			No	1	12.35	0	no	no	no
2959	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	58	0.9		No	No			No	0	37.26	0	no	no	no
2960	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	54	3.9	Stable	No	No			No	0	37.03	0	no	no	no
2961	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		37	5.9	Stable	No	No			No	1	10.71	0	no	no	no
2962	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			Yes	1	18.83	0	no	no	no
2963	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	2	3	Stable	No	No		MUTYH	No	1	15.8	0	no	no	no
2964	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	I	20	3.9	Stable	No	No			No	0	8.74	0	no	no	no
2965	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	34	4.9	Stable	No	No	Signature.29		Yes	1	4.14	0	no	no	no
2966	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	57	4.9		No	No		ARID1A	Yes	0	33.81	0	no	no	yes
2967	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	11	6.1		No	Yes or Unknown			No	0	37.82	0	no	no	no
2968	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	3.5		No	No			No	0	32.99	0	no	no	no
2969	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	1033	3.5	Stable	No	Yes or Unknown			No	0	38.37	0	no	no	no
2970	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2016		0	5.9	Stable	No	No		BRCA2	No	1	10.05	0	no	no	no
2971	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	203	2.6		No	Yes or Unknown			No	0	38.24	0	no	no	no
2972	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	0	4.4	Stable	No	No			No	1	17.58	0	no	no	no
2973	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	42.3	Stable	No	No	Signature.4	ARID1A | BRIP1 | RAD51C	No	0	16.2	0	no	no	yes
2974	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016	II	76	0	Stable	No	No			No	0	39.33	0	no	no	no
2975	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	418	2.6	Stable	No	Yes or Unknown			No	0	37.52	0	no	no	no
2976	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	392	4.4	Stable	No	Yes or Unknown	Signature.6		No	1	39.69	0	no	no	no
2977	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	30	1	Stable	No	Yes or Unknown			Yes	0	30.69	0	no	no	no
2978	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	0	9.7	Stable	No	No	Signature.30		No	1	17.68	0	no	no	no
2979	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016		95	0	Stable	No	Yes or Unknown			No	0	39.23	0	no	no	no
2980	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	II	0	2		No	No	Signature.16		No	0	38.34	0	no	no	no
2981	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	240	3		No	No			Yes	1	11.56	0	no	no	no
2982	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	30	3	Stable	No	No			Yes	1	20.57	0	no	no	no
2983	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	77	9.7		No	No	Signature.29	ATM | BRCA2	Yes	0	33.12	0	no	no	no
2984	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	308	0.9	Stable	No	Yes or Unknown			No	0	36.07	0	no	no	no
2985	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	III	17	7.9		No	No			No	0	15.41	0	no	no	no
2986	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2016		106	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	28.98	0	no	no	no
2987	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	25	0	Stable	No	Yes or Unknown			No	0	37.98	0	no	no	no
2988	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	211	2.6	Stable	No	Yes or Unknown			No	1	25.46	0	no	no	no
2989	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	35	0		No	No			No	1	27.27	0	no	no	no
2990	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	18	2.6	Stable	No	No			No	1	14.78	0	no	no	no
2991	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	30	6.9	Stable	No	No	Signature.18		Yes	1	1.81	0	no	no	no
2992	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	299	1.8		No	No			No	0	22.8	0	no	no	no
2993	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	3.9	Stable	No	Yes or Unknown			No	0	34.96	0	no	no	no
2994	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	4.4		No	No	Signature.1	RAD52	No	0	28.02	0	no	no	no
2995	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	10	7.9		No	No		BLM	No	1	16.23	0	no	no	no
2996	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	6.9	Stable	No	No		MSH2	No	0	1.84	0	no	no	no
2997	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	395	2.6	Stable	No	Yes or Unknown			No	1	23.26	0	no	no	no
2998	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	IV	0	17.7	Stable	No	No	Signature.13	ARID1A | ATR	Yes	0	35.35	0	no	no	yes
2999	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	37	3.9		No	No	Signature.25	ATR	Yes	0	36.57	0	no	no	no
3000	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	118	0		No	Yes or Unknown			No	1	37.29	0	no	no	no
3001	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	5	3	Stable	No	Yes or Unknown			No	0	35.55	0	no	no	no
3002	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	27	9.7	Stable	No	No		ARID1A	No	0	29.11	0	no	no	yes
3003	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	6	7	Stable	No	No	Signature.1	ARID1A	No	1	36.37	0	no	no	yes
3004	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	III	71	3.5	Stable	No	No			No	0	38.74	0	no	no	no
3005	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	29	2.6		No	Yes or Unknown		MSH6	No	0	37.75	0	no	no	no
3006	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	0	6.9	Stable	No	No	Signature.1	ARID1A	Yes	0	35.19	0	no	no	yes
3007	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	18.7	Stable	No	No	Signature.13	BRCA1 | BRCA2 | ERCC4	Yes	1	6.21	0	no	no	no
3008	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	0	3.5	Stable	No	No			No	0	36.67	0	no	no	no
3009	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	8.9		No	No	Signature.4		No	0	7.03	0	no	no	no
3010	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	41	9.8		No	No	Signature.24		No	0	29.27	0	no	no	no
3011	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	68	3.5		No	No	Signature.13	ATM	No	0	37.16	0	no	no	no
3012	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	6.9	Stable	No	No			No	0	37.75	0	no	no	no
3013	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2016	III	170	4.4	Stable	No	Yes or Unknown	Signature.17		Yes	1	17.12	0	no	no	no
3014	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	7.26	0	no	no	no
3015	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	3		No	Yes or Unknown			No	0	36.07	0	no	no	no
3016	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	IV	12	2	Stable	No	No		MUTYH	Yes	1	7	0	no	no	no
3017	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	7	7.9	Stable	No	No	Signature.29		No	1	4.07	0	no	no	no
3018	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	218	9.7	Stable	No	Yes or Unknown	Signature.3		No	1	33.64	0	no	no	no
3019	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	3.9	Stable	No	No		RAD50	No	1	21.42	0	no	no	no
3020	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	44	11.8	Stable	No	No	Signature.6	PMS2	No	1	11.27	0	no	no	no
3021	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	193	1		No	No			No	0	39.98	0	no	no	no
3022	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	9.8	Stable	No	No	Signature.4	MSH6	No	1	1.84	0	no	no	no
3023	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	0	10.8	Stable	No	No	Signature.1		Yes	0	11.73	0	no	no	no
3024	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3	Stable	No	No			No	0	35.09	0	no	no	no
3025	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	152	11.4		No	Yes or Unknown	Signature.18	ARID1A | MLH1	Yes	0	30.16	0	no	no	yes
3026	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3.9	Stable	No	No		ATR	Yes	0	36.4	0	no	no	no
3027	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	44	2.6	Stable	No	No			No	1	33.41	0	no	no	no
3028	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	28	3		No	No		PMS1	Yes	0	12.58	0	no	no	no
3029	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		15	0	Stable	No	No			No	0	33.51	0	no	no	no
3030	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	IV	0	14.8	Stable	No	Yes or Unknown	Signature.29	ARID1A	Yes	1	4.27	0	no	no	yes
3031	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	160	1.8	Stable	No	Yes or Unknown			No	0	37.52	0	no	no	no
3032	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	30	2.6	Stable	No	No			No	1	22.74	0	no	no	no
3033	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	9	2		No	Yes or Unknown			Yes	1	1.68	0	no	no	no
3034	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	0	3.9		No	No		ARID1A | RAD50	Yes	1	34.1	0	no	no	yes
3035	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	26	2.6		No	No			No	1	8.38	0	no	no	no
3036	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	56	0.9	Stable	No	No			No	0	35.84	0	no	no	no
3037	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	33	5.3	Stable	No	No			No	0	35.88	0	no	no	no
3038	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2016	IV	2	7	Stable	No	No	Signature.1		No	1	19.25	0	no	no	no
3039	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	104	2.6		No	No			No	0	21.39	0	no	no	no
3040	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2016		0	2	Stable	No	No			Yes	0	37.59	0	no	no	no
3041	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	IV	69	2.6		No	No			No	1	13.67	0	no	no	no
3042	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	IV	227	5.3	Stable	No	Yes or Unknown			Yes	0	37.06	0	no	no	no
3043	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	19	4.9		No	No			No	1	11.47	0	no	no	no
3044	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	34	4.9	Stable	No	No			No	0	37.45	0	no	no	no
3045	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	7.9	Indeterminate	No	No			No	1	28.48	0	no	no	no
3046	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	112	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	37.42	0	no	no	no
3047	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	113	1.8		No	No			No	0	28.35	0	no	no	no
3048	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	35	4.4		No	No			No	0	36.96	0	no	no	no
3049	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	3.5		No	No	Signature.6		No	0	36.86	0	no	no	no
3050	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	1002	4.4	Stable	No	Yes or Unknown			No	0	37.26	0	no	no	no
3051	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	0	1.8		No	No			No	0	28.55	0	no	no	no
3052	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	665	4.4	Stable	No	Yes or Unknown			No	0	37.98	0	no	no	no
3053	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	I	47	5.3	Stable	No	No		MSH6	No	0	35.68	0	no	no	no
3054	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	44	4.4	Stable	No	No			Yes	0	34.92	0	no	no	no
3055	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	41	2.6	Stable	No	No			No	1	26.18	0	no	no	no
3056	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	27.24	0	no	no	no
3057	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	II	25	5.9		No	No	Signature.5		No	0	28.42	0	no	no	no
3058	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	3	3.9	Stable	No	No		RAD50	No	0	28.32	0	no	no	no
3059	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	41	0	Stable	No	Yes or Unknown			No	0	37.95	0	no	no	no
3060	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	18	7.9		No	No	Signature.4		No	0	34.73	0	no	no	no
3061	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	0	3.9		No	Yes or Unknown			No	1	18.73	0	no	no	no
3062	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	62	3.5		No	No			Yes	0	36.53	0	no	no	no
3063	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	I	0	0.9	Stable	No	No			No	0	28.91	0	no	no	no
3064	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	14	3.5		No	No		ARID1A	No	1	32.2	0	no	no	yes
3065	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	36	7		No	No	Signature.5	ERCC2	No	1	7.46	0	no	no	no
3066	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	544	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	36.11	0	no	no	no
3067	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	II	0	0.9	Stable	No	No			Yes	0	34.56	0	no	no	no
3068	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	38	1		No	No			No	0	36.53	0	no	no	no
3069	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2016	III	15	23.7		No	No	Signature.7	BRCA2	No	0	34.99	0	no	no	no
3070	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	52	1.8	Stable	No	No			No	0	33.28	0	no	no	no
3071	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	31	3.9	Stable	No	No			No	0	37.52	0	no	no	no
3072	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	5	5.3	Stable	No	No	Signature.1		No	1	12.52	0	no	no	no
3073	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	56	1.8		No	No			No	0	37.29	0	no	no	no
3074	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	I	36	1		No	No			No	0	33.35	0	no	no	no
3075	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	I	407	7.9	Stable	No	No	Signature.1		No	0	13.96	0	no	no	no
3076	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	42	2.6		No	No			No	1	32.13	0	no	no	no
3077	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	0.9		No	No			Yes	0	5.03	0	no	no	no
3078	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	47	2		No	No		BLM	No	0	37.49	0	no	no	no
3079	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	36	24.6	Unstable	No	No	Signature.6		Yes	0	30	0	other-MMRd	other-MMRd	no
3080	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	34	3		No	No			No	0	37.13	0	no	no	no
3081	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	162	2.6		No	No			No	1	25.86	0	no	no	no
3082	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	26	2.6	Stable	No	No			Yes	0	36.07	0	no	no	no
3083	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	271	3.5	Stable	No	Yes or Unknown			No	0	36.5	0	no	no	no
3084	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2016	I	0	0		No	Yes or Unknown			Yes	0	30.78	0	no	no	no
3085	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2016		15	2	Stable	Yes or Unknown	Yes or Unknown			Yes	1	9.92	0	no	no	no
3086	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	I	62	2.6	Stable	No	No			No	0	32.82	0	no	no	no
3087	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	II	142	0		No	No			No	0	34.23	0	no	no	no
3088	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	32	1		No	Yes or Unknown			No	1	6.05	0	no	no	no
3089	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	8	5.9	Stable	No	No		ARID1A	No	0	36.96	0	no	no	yes
3090	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	III	43	57.1	Unstable	No	No	Signature.1	ARID1A | ATR | ERCC2 | MDC1 | MSH2 | NBN	No	1	7.49	0	mut-MMRd	mut-MMRd	yes
3091	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	0	2		No	No			No	0	27.6	0	no	no	no
3092	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	118	1.8		No	Yes or Unknown			No	1	9.99	0	no	no	no
3093	Non-ICI treated	Never received ICI	51 - 55	Female	SCLC	2016	IV	126	7.9		No	Yes or Unknown	Signature.4	ARID1A | NBN	No	1	7.85	0	no	no	yes
3094	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	III	14	5.3	Stable	No	No			No	1	23.66	0	no	no	no
3095	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	1.8		No	No			No	0	33.81	0	no	no	no
3096	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	0.9		No	No	Signature.1		Yes	1	9.82	0	no	no	no
3097	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	34	0		No	Yes or Unknown			Yes	1	29.9	0	no	no	no
3098	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	II	80	4.4		No	Yes or Unknown		ARID1A | ATM	No	0	36.8	0	no	no	yes
3099	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	6.1		No	No	Signature.16		Yes	0	36.5	0	no	no	no
3100	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	21	0	Stable	No	No			No	0	16.62	0	no	no	no
3101	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	I	163	0.9		No	No			No	0	39.59	0	no	no	no
3102	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	21	6.1		No	No			Yes	0	37.22	0	no	no	no
3103	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	177	7		No	No	Signature.4		No	0	20.99	0	no	no	no
3104	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	59	1		No	No			No	0	28.68	0	no	no	no
3105	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	35	4.4		No	No			No	0	36.34	0	no	no	no
3106	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	0	3.9		No	No		RAD50	No	1	4.11	0	no	no	no
3107	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	41	2.6		No	No			No	0	36.9	0	no	no	no
3108	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2016	III	0	17.7	Stable	No	No	Signature.7	ATM | ATR	No	0	34.43	0	no	no	no
3109	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	2.6		No	No			Yes	0	33.31	0	no	no	no
3110	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	20	0		No	No			No	1	18.33	0	no	no	no
3111	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	34	3	Stable	No	No			No	0	22.47	0	no	no	no
3112	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	I	25	0.9	Stable	No	No			No	1	33.81	0	no	no	no
3113	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	294	0	Stable	No	Yes or Unknown			No	0	37.72	0	no	no	no
3114	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	II	376	0.9	Stable	No	Yes or Unknown			No	0	35.19	0	no	no	no
3115	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	II	7	4.4	Stable	No	No			Yes	0	36.6	0	no	no	no
3116	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	104	3.5	Stable	No	Yes or Unknown			No	0	37.22	0	no	no	no
3117	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	76	2.6		No	No			No	0	27.73	0	no	no	no
3118	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	25	1.8		No	No			No	0	36.6	0	no	no	no
3119	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3		No	No			No	1	8.44	0	no	no	no
3120	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	4	3.9	Stable	No	No			No	1	6.83	0	no	no	no
3121	Non-ICI treated	Never received ICI	26 - 30	Female	Endometrial	2016	I	55	3.9	Stable	No	No			Yes	0	36.44	0	no	no	no
3122	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	14	2.6	Stable	No	Yes or Unknown			Yes	0	33.91	0	no	no	no
3123	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	0	3.9	Stable	No	No			No	1	1.35	0	no	no	no
3124	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	32	4.9	Stable	No	No			No	0	32.36	0	no	no	no
3125	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			Yes	0	37.06	0	no	no	no
3126	Non-ICI treated	Never received ICI	81 - 85	Female	Cutaneous Melanoma 	2016	I	42	0.9		No	No			No	0	26.41	0	no	no	no
3127	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	68	5.9		No	No			No	0	37.19	0	no	no	no
3128	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	62	8.9	Stable	No	No	Signature.5		No	0	8.9	0	no	no	no
3129	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	22	0		No	No			No	0	34.37	0	no	no	no
3130	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	II	28	39.5		No	No	Signature.7	ARID1A | ERCC5	No	0	6.18	0	no	no	yes
3131	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	33	0	Stable	No	No			No	0	19.52	0	no	no	no
3132	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	79	27.2	Unstable	No	No	Signature.1	ARID1A | BLM | MRE11A | MSH3 | PMS2	Yes	0	37.98	0	mut-MMRd	mut-MMRd	yes
3133	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	14	6.9		No	No	Signature.29	ARID1A	Yes	1	6.51	0	no	no	yes
3134	Non-ICI treated	Never received ICI	36 - 40	Female	Bladder	2016	III	7	4.4		No	No			Yes	0	35.02	0	no	no	no
3135	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	IV	243	4.4	Stable	No	Yes or Unknown			No	0	36.7	0	no	no	no
3136	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	3		No	No	Signature.29		Yes	1	3.84	0	no	no	no
3137	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	0	1	Stable	No	No			No	1	7.16	0	no	no	no
3138	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	5.49	0	no	no	no
3139	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	13	1		No	No			No	1	17.35	0	no	no	no
3140	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	428	6.1	Stable	No	Yes or Unknown		ATM	No	0	37.75	0	no	no	no
3141	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	6.37	0	no	no	no
3142	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	16	2		No	No			No	1	11.3	0	no	no	no
3143	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	0	4.4	Stable	No	No		ARID1A	No	0	34.3	0	no	no	yes
3144	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	143	1.8	Stable	No	No			No	0	35.48	0	no	no	no
3145	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	32	9.7		No	No	Signature.5	ARID1A | ATR	No	1	19.38	0	no	no	yes
3146	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	188	6.1	Stable	No	Yes or Unknown	Signature.1		No	1	19.84	0	no	no	no
3147	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	0		No	Yes or Unknown			No	0	37.85	0	no	no	no
3148	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016		165	0		No	Yes or Unknown			No	0	38.01	0	no	no	no
3149	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	66	2.6		No	Yes or Unknown	Signature.6	ARID1A	Yes	0	36.5	0	no	no	yes
3150	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	173	0.9		No	No	Signature.1		Yes	1	14.85	0	no	no	no
3151	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	9	3.9	Stable	No	No	Signature.1		No	0	36.76	0	no	no	no
3152	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	752	2.6	Stable	No	No			No	1	34.43	0	no	no	no
3153	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	21	2.6		No	Yes or Unknown			No	1	13.44	0	no	no	no
3154	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	58	4.4		No	Yes or Unknown		RAD50	No	0	38.05	0	no	no	no
3155	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	41	0.9		No	No			No	0	33.58	0	no	no	no
3156	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	28	5.3		No	No			No	0	34.89	0	no	no	no
3157	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	7.9		No	No	Signature.5	ARID1A	No	0	36.17	0	no	no	yes
3158	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	11	0.9	Stable	No	No			No	0	38.08	0	no	no	no
3159	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	421	0		No	No			Yes	0	33.71	0	no	no	no
3160	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	337	3.5	Stable	No	Yes or Unknown			No	1	30.95	0	no	no	no
3161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	61	5.3	Stable	No	Yes or Unknown		ERCC5	No	0	14.85	0	no	no	no
3162	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.9		No	No			No	1	22.18	0	no	no	no
3163	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	3	7	Stable	No	No	Signature.6	BRCA2	No	1	15.97	0	no	no	no
3164	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	39	10.5	Stable	No	No	Signature.3		No	1	25.89	0	no	no	no
3165	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	19	3.5		No	No			No	0	37.55	0	no	no	no
3166	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	I	880	0.9	Stable	No	No			No	0	36.04	0	no	no	no
3167	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	III	87	34.2	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | MSH3 | MSH6 | NBN	Yes	0	34.2	0	mut-MMRd	mut-MMRd	yes
3168	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	34	4.4	Stable	No	No		BRCA1	No	1	24.54	0	no	no	no
3169	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	30	9.7		No	Yes or Unknown	Signature.21	BRCA2 | MLH1 | MSH3	No	0	37.26	0	no	no	no
3170	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	36	9.8		No	No	Signature.18	RAD50	No	0	12.42	0	no	no	no
3171	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	362	7	Stable	No	Yes or Unknown	Signature.1	ATM | MUTYH	No	0	22.9	0	no	no	no
3172	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	128	2.6	Stable	No	Yes or Unknown			No	0	37.72	0	no	no	no
3173	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	5	2.6		No	No			No	0	36.99	0	no	no	no
3174	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	84	3		No	No		ATM	No	1	19.22	0	no	no	no
3175	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	IV	10	19.3		No	No	Signature.16	ARID1A | CHEK2 | ERCC2 | FANCC	No	0	28.48	0	no	no	yes
3176	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	15	5.3		No	Yes or Unknown			No	0	33.12	0	no	no	no
3177	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	II	0	0		No	No			No	1	17.48	0	no	no	no
3178	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	47	8.8		No	No	Signature.13		No	0	36.67	0	no	no	no
3179	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	3		No	No			No	1	18.33	0	no	no	no
3180	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	III	542	0	Stable	No	No			No	0	35.32	0	no	no	no
3181	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	22	3.9		No	No		PMS2	No	0	35.58	0	no	no	no
3182	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	128	0		No	No			No	0	36.21	0	no	no	no
3183	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		14	3.5		Yes or Unknown	Yes or Unknown			No	1	3.61	0	no	no	no
3184	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	3	3	Stable	No	No			No	0	35.98	0	no	no	no
3185	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	363	5.3	Stable	No	Yes or Unknown			No	0	16.62	0	no	no	no
3186	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	2.6	Stable	No	Yes or Unknown			No	0	36.76	0	no	no	no
3187	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	10.5	Stable	No	No		ARID1A	No	0	15.47	0	no	no	yes
3188	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	27	16.7		No	Yes or Unknown	Signature.4	ATR | MDC1	Yes	1	1.64	0	no	no	no
3189	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	III	0	1		No	No			No	0	36.11	0	no	no	no
3190	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	36	3.5		No	Yes or Unknown			Yes	0	14.49	0	no	no	no
3191	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	3.5	Stable	No	No			No	1	10.12	0	no	no	no
3192	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	III	0	0.9		No	Yes or Unknown			No	0	36.76	0	no	no	no
3193	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	23	4.4		No	No			No	1	22.57	0	no	no	no
3194	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	254	4.4	Stable	No	Yes or Unknown			No	0	37.06	0	no	no	no
3195	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	0	12.55	0	no	no	no
3196	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	4.67	0	no	no	no
3197	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	III	4	2		No	No			No	1	11.24	0	no	no	no
3198	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	II	325	9.7	Stable	No	Yes or Unknown	Signature.9	PMS2	No	1	15.7	0	no	no	no
3199	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	71	3.5		No	No			No	0	37.45	0	no	no	no
3200	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	6.1		No	No	Signature.24	BLM	No	0	35.58	0	no	no	no
3201	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	I	0	8.8		No	No	Signature.1		No	1	30.42	0	no	no	no
3202	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	28	3	Indeterminate	No	No	Signature.9		No	0	37.68	0	no	no	no
3203	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	35	8.8		No	No		ARID1A	No	0	34.33	0	no	no	yes
3204	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	5.3		No	No			No	0	25.69	0	no	no	no
3205	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	26	8.8	Stable	No	No	Signature.1		Yes	0	33.05	0	no	no	no
3206	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	40	6.1	Stable	No	No	Signature.1	MLH1	Yes	0	31.61	0	no	no	no
3207	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	14	4.9		No	No			No	0	37.49	0	no	no	no
3208	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	111	5.3	Stable	No	Yes or Unknown			No	1	25.49	0	no	no	no
3209	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	56	2.6		No	No			No	0	28.42	0	no	no	no
3210	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	25	1.8		No	No			No	1	9.3	0	no	no	no
3211	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	146	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	9.63	0	no	no	no
3212	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		0	3.9		Yes or Unknown	Yes or Unknown			No	1	7.49	0	no	no	no
3213	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	28	3.5	Stable	No	No			No	0	21.13	0	no	no	no
3214	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		11	2.6		Yes or Unknown	Yes or Unknown	Signature.5		No	1	14.06	0	no	no	no
3215	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	743	2.6	Stable	No	Yes or Unknown			No	0	36.67	0	no	no	no
3216	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	22	4.4	Stable	No	No			No	0	38.44	0	no	no	no
3217	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	II	0	5.3	Stable	No	No		MLH1	No	0	36.67	0	no	no	no
3218	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	30	65		No	Yes or Unknown	Signature.4	ATM | BRCA1 | BRCA2 | RAD54L	No	0	8.71	0	no	no	no
3219	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	20	3.5		No	No	Signature.7		Yes	0	27.14	0	no	no	no
3220	Non-ICI treated	Never received ICI	71 - 75	Female	Esophageal	2016	IV	10	7		No	No	Signature.1		No	0	36.7	0	no	no	no
3221	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016	I	0	7		No	No	Signature.5	ERCC4 | MSH6	No	0	36.86	0	no	no	no
3222	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	83	4.4		No	Yes or Unknown			No	0	32.3	0	no	no	no
3223	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	II	37	7		No	No			No	0	32.03	0	no	no	no
3224	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	30	4.4	Stable	No	No	Signature.1		No	0	9.86	0	no	no	no
3225	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2016		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	22.93	0	no	no	no
3226	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	6.1	Stable	No	No			No	0	17.02	0	no	no	no
3227	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	36	0.9		No	No			Yes	0	30.69	0	no	no	no
3228	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	71	3.5		No	No			No	0	35.65	0	no	no	no
3229	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	62	0.9		No	No			No	0	36.27	0	no	no	no
3230	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2016	III	54	6.1	Stable	No	No	Signature.1		No	0	21.03	0	no	no	no
3231	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	0	1.8		No	No			No	1	17.71	0	no	no	no
3232	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	20	7.9		No	Yes or Unknown			No	0	36.27	0	no	no	no
3233	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2016		14	5.3		Yes or Unknown	Yes or Unknown			Yes	1	8.8	0	no	no	no
3234	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	0	0.9		No	No			No	0	20.5	0	no	no	no
3235	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	30	1.8		No	No			No	0	36.6	0	no	no	no
3236	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	1.38	0	no	no	no
3237	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	5.3		No	No	Signature.1		Yes	1	7.39	0	no	no	no
3238	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	104	3.5	Stable	No	Yes or Unknown			No	1	23.62	0	no	no	no
3239	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	No			No	0	21.13	0	no	no	no
3240	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	21	5.3		No	No	Signature.24	ARID1A	No	1	23.85	0	no	no	yes
3241	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	17	1.8	Stable	No	No			No	1	18.6	0	no	no	no
3242	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	0	8.8		No	Yes or Unknown	Signature.30		No	0	34.3	0	no	no	no
3243	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	2.6		No	Yes or Unknown			No	0	34.89	0	no	no	no
3244	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	0	2.6	Stable	No	No			No	1	31.74	0	no	no	no
3245	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	II	379	3.5	Stable	No	Yes or Unknown			No	1	18.92	0	no	no	no
3246	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	II	18	2.6	Stable	No	No			Yes	0	34.04	0	no	no	no
3247	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	III	0	1.8		No	No			Yes	0	36.34	0	no	no	no
3248	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	57	4.4		No	No			No	0	34.96	0	no	no	no
3249	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	523	7.9	Indeterminate	No	Yes or Unknown	Signature.19		No	1	32.23	0	no	no	no
3250	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	392	0.9	Stable	No	Yes or Unknown			No	0	29.83	0	no	no	no
3251	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.9		No	No		BRCA2	No	0	36.4	0	no	no	no
3252	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	16	4.4		No	Yes or Unknown			No	0	22.51	0	no	no	no
3253	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	35	4.4		No	No			No	0	35.91	0	no	no	no
3254	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	33	2.6		No	No			No	0	33.02	0	no	no	no
3255	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	164	7	Stable	No	Yes or Unknown		ARID1A	No	0	36.24	0	no	no	yes
3256	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	6.1	Stable	No	No	Signature.19	ARID1A	No	0	37.06	0	no	no	yes
3257	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	5.3	Stable	No	No	Signature.10	ATR	No	0	34.92	0	no	no	no
3258	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	49	4.4		No	Yes or Unknown		MSH3	No	0	36.14	0	no	no	no
3259	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	0	3.5		No	No			Yes	1	4.6	0	no	no	no
3260	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	8	1.8	Stable	No	No			Yes	0	9.72	0	no	no	no
3261	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	31	23.7	Unstable	No	No	Signature.6	ARID1A | ATM	Yes	0	20.24	0	other-MMRd	mut-MMRd	yes
3262	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	2.6		No	No			Yes	0	35.71	0	no	no	no
3263	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	32	5.3		No	No	Signature.29	ATM | ERCC5	No	1	2.63	0	no	no	no
3264	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	0	0.9		No	No			No	0	32.16	0	no	no	no
3265	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	16	8.8	Stable	No	No		ARID1A	No	0	21.42	0	no	no	yes
3266	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	21	56.2	Unstable	No	No	Signature.6	ERCC5 | MSH3 | MSH6 | NBN | PARP1 | RAD50	Yes	0	34.46	0	mut-MMRd	mut-MMRd	no
3267	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	4.4		No	Yes or Unknown			No	1	11.17	0	no	no	no
3268	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016		0	0.9		No	No			No	0	26.51	0	no	no	no
3269	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	5.3	Stable	No	No	Signature.1	ATM | TP53BP1	No	1	25.69	0	no	no	no
3270	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	72	7	Stable	No	No	Signature.1		No	0	37.39	0	no	no	no
3271	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	169	1.8		No	Yes or Unknown			No	0	36.14	0	no	no	no
3272	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	29	3.5		No	No			No	1	7.92	0	no	no	no
3273	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	7		No	No	Signature.4	ARID1A | MLH1	No	0	33.68	0	no	no	yes
3274	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	0	1.8		No	No			No	0	31.51	0	no	no	no
3275	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	52	1.8	Stable	No	No			No	0	35.25	0	no	no	no
3276	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	28	3.5		No	Yes or Unknown			No	0	33.38	0	no	no	no
3277	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	92	0.9	Stable	No	No			Yes	0	35.81	0	no	no	no
3278	Non-ICI treated	Never received ICI	16 - 20	Female	Renal	2016	IV	13	0.9		No	Yes or Unknown			No	0	30.85	0	no	no	no
3279	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	7	2		No	No			Yes	0	36.17	0	no	no	no
3280	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	43	1.8		No	No			No	0	26.09	0	no	no	no
3281	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	III	0	3.5		No	No			No	1	22.31	0	no	no	no
3282	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	213	0.9		No	No			Yes	0	13.08	0	no	no	no
3283	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	121	3.5	Stable	No	Yes or Unknown			No	0	36.21	0	no	no	no
3284	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	31	2.6		No	No			No	0	34.79	0	no	no	no
3285	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	4.4	Stable	No	No			No	0	34.56	0	no	no	no
3286	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2016	IV	0	1.8		No	No			Yes	0	36.53	0	no	no	no
3287	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2016		25	4.4		Yes or Unknown	Yes or Unknown		ERCC4	Yes	0	9.13	0	no	no	no
3288	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	22	1.8		No	No		ARID1A	No	0	36.07	0	no	no	yes
3289	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	38	13.2	Unstable	No	No	Signature.1	ARID1A | MRE11A	No	0	33.22	0	other-MMRd	mut-MMRd	yes
3290	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	5	1.8		No	No	Signature.5		Yes	0	34.92	0	no	no	no
3291	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	44	1.8		No	No			No	0	35.61	0	no	no	no
3292	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	14	7	Stable	No	Yes or Unknown		MRE11A	No	0	35.35	0	no	no	no
3293	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	58	0.9		No	No			No	0	37.09	0	no	no	no
3294	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	II	779	1.8	Stable	No	No			No	0	29.9	0	no	no	no
3295	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	III	0	4.4		No	No	Signature.13		No	0	33.38	0	no	no	no
3296	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	0	0.9		No	No			No	1	21.36	0	no	no	no
3297	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	II	51	7	Stable	No	No			No	0	30.82	0	no	no	no
3298	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	40	1.8		No	No			No	1	11.99	0	no	no	no
3299	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	3.5		No	No		ARID1A	No	0	36.07	0	no	no	yes
3300	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	3	7	Stable	No	No		TP53BP1	No	0	8.38	0	no	no	no
3301	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	59	3.5		No	No			No	1	4.07	0	no	no	no
3302	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	61	1.8		No	No			Yes	0	34.99	0	no	no	no
3303	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	0	1.8		No	No			No	0	35.58	0	no	no	no
3304	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	81	0.9		No	No			No	0	34.73	0	no	no	no
3305	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	43	5.3	Stable	No	No			Yes	0	20.83	0	no	no	no
3306	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	617	7	Stable	No	Yes or Unknown	Signature.15		No	0	36.27	0	no	no	no
3307	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	8	5.3		No	No	Signature.7		No	0	35.48	0	no	no	no
3308	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	6	3.5		No	No		ATM	No	1	17.81	0	no	no	no
3309	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2016	II	54	3.5		No	No		ARID1A	No	0	36.37	0	no	no	yes
3310	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	I	0	0.9		No	No			No	0	34.1	0	no	no	no
3311	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	28	0		No	Yes or Unknown			No	0	35.98	0	no	no	no
3312	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	33	4.4		No	Yes or Unknown			Yes	0	35.81	0	no	no	no
3313	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	30	12.3		No	No	Signature.4		Yes	1	3.78	0	no	no	no
3314	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	45	1.8		No	No		ATM	No	0	35.98	0	no	no	no
3315	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	I	0	0.9		No	No			Yes	0	35.32	0	no	no	no
3316	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	0.9		No	No			No	0	30.32	0	no	no	no
3317	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	10.5		No	No	Signature.3	MDC1	No	0	14.65	0	no	no	no
3318	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	74	6.1		No	Yes or Unknown	Signature.4	NBN	No	1	4.21	0	no	no	no
3319	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	1	0		No	No			No	0	35.65	0	no	no	no
3320	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	40	4.4	Stable	No	No	Signature.13	BRCA2	No	0	29.8	0	no	no	no
3321	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	18	7	Stable	No	No			No	1	13.47	0	no	no	no
3322	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	28	44.8	Stable	No	No	Signature.6	ARID1A | ATM | ERCC2 | MSH6	No	0	6.24	0	no	no	yes
3323	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	44	6.1		No	No	Signature.4	BRIP1	Yes	0	26.78	0	no	no	no
3324	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	16	3.5	Stable	No	No			Yes	0	34.76	0	no	no	no
3325	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	21	3.5	Stable	No	No		BRIP1 | SLX4	Yes	0	2.83	0	no	no	no
3326	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	35	7.9	Stable	No	No		ARID1A	No	0	30.03	0	no	no	yes
3327	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	38	0		No	No			No	0	3.25	0	no	no	no
3328	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	35	12.3		No	No	Signature.13	MSH6	Yes	0	35.84	0	no	no	no
3329	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	III	343	6.1	Stable	No	No			Yes	0	35.84	0	no	no	no
3330	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		40	2.6		No	No			No	1	26.87	0	no	no	no
3331	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	35	0	Stable	No	No			Yes	0	36.11	0	no	no	no
3332	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	16	3.5	Stable	No	Yes or Unknown			No	0	35.75	0	no	no	no
3333	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	IV	39	3.5	Stable	No	Yes or Unknown			Yes	0	35.45	0	no	no	no
3334	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	0	8.8		No	No	Signature.4		No	0	24.97	0	no	no	no
3335	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	212	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	11.43	0	no	no	no
3336	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	116	3.5	Stable	No	Yes or Unknown			No	0	36.07	0	no	no	no
3337	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3.5		No	No		ATM	No	0	35.22	0	no	no	no
3338	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	168	1.8	Stable	No	Yes or Unknown			No	0	33.77	0	no	no	no
3339	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2016		11	2.6		No	No			No	0	20.73	0	no	no	no
3340	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	1.8		No	No			No	1	22.37	0	no	no	no
3341	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	III	16	2.6	Stable	No	No			No	0	35.45	0	no	no	no
3342	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2016		2	1.8		No	No			No	0	31.97	0	no	no	no
3343	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2016	IV	61	0	Stable	No	Yes or Unknown			No	0	33.64	0	no	no	no
3344	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	35	15.8	Indeterminate	No	No	Signature.1	ARID1A	No	0	23.33	0	no	no	yes
3345	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	4	4.4		No	No		BRCA2	No	0	35.81	0	no	no	no
3346	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	27	5.3		No	Yes or Unknown	Signature.3		No	0	32.95	0	no	no	no
3347	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	166	1.8	Stable	No	Yes or Unknown	Signature.13		No	0	33.35	0	no	no	no
3348	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	29	3.5		No	No			Yes	1	4.04	0	no	no	no
3349	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	48	3.5		No	Yes or Unknown			No	0	7.39	0	no	no	no
3350	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	26	51.8	Unstable	No	No	Signature.26	ARID1A | ATM | MSH3 | MSH6 | PMS2	No	0	32.43	0	mut-MMRd	mut-MMRd	yes
3351	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	24	5.3		No	No		RAD51C	Yes	1	2.96	0	no	no	no
3352	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	67	3.5		No	No	Signature.3	BRCA2	No	0	31.08	0	no	no	no
3353	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	0	0.9		No	No			No	0	30.85	0	no	no	no
3354	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	20	2.6	Stable	No	No			No	0	35.09	0	no	no	no
3355	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	46	4.4		No	No	Signature.19		No	0	32.43	0	no	no	no
3356	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2016	IV	0	1.8		No	No		RAD50	Yes	0	3.25	0	no	no	no
3357	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	84	2.6		No	No		PMS1	Yes	0	8.25	0	no	no	no
3358	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	0	1.8	Stable	No	No			No	1	28.32	0	no	no	no
3359	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	30	0	Stable	No	No			No	0	35.22	0	no	no	no
3360	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	26	1.8		No	No			No	0	34.3	0	no	no	no
3361	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	6	2.6		No	No		NBN	No	1	12.85	0	no	no	no
3362	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	14	20.2		No	No	Signature.13	BRCA1 | FANCA | MSH3 | RAD54L	Yes	1	3.55	0	no	no	no
3363	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	37	3.5		No	No			No	0	24.18	0	no	no	no
3364	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	232	4.4	Stable	No	No		BRCA1	No	0	40.74	0	no	no	no
3365	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	149	7.9	Stable	No	No		ATM	No	1	24.48	0	no	no	no
3366	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	309	6.1	Stable	No	Yes or Unknown	Signature.24		Yes	1	24.15	0	no	no	no
3367	Non-ICI treated	Never received ICI	41 - 45	Male	Cutaneous Melanoma 	2016	III	23	11.4		No	No	Signature.7		No	0	31.28	0	no	no	no
3368	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	160	4.4	Stable	No	Yes or Unknown		BRCA2 | MSH6	No	1	34.86	0	no	no	no
3369	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	51	7	Stable	No	No	Signature.1		No	0	35.42	0	no	no	no
3370	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	888	2.6	Stable	No	Yes or Unknown			No	0	34.92	0	no	no	no
3371	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	24	4.4		No	No			Yes	0	32.3	0	no	no	no
3372	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	IV	229	0	Stable	No	Yes or Unknown			No	1	12.55	0	no	no	no
3373	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	II	914	4.4	Stable	No	Yes or Unknown			No	0	35.58	0	no	no	no
3374	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	29	0.9		No	No			Yes	0	29.7	0	no	no	no
3375	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	II	383	5.3	Stable	No	Yes or Unknown			No	1	18.89	0	no	no	no
3376	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	12	12.3		No	No	Signature.2		No	0	24.97	0	no	no	no
3377	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	5.3		No	No			No	0	12.75	0	no	no	no
3378	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	15	4.4	Stable	No	No	Signature.1		No	0	21.16	0	no	no	no
3379	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	8	2.6		No	No			Yes	1	4.17	0	no	no	no
3380	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	21	9.7		No	No	Signature.18	ERCC5	Yes	0	4.8	0	no	no	no
3381	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	202	0	Stable	No	Yes or Unknown			No	0	33.91	0	no	no	no
3382	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	522	7	Indeterminate	No	Yes or Unknown	Signature.1	SLX4	No	0	35.52	0	no	no	no
3383	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	181	0.9	Stable	No	Yes or Unknown			No	0	34.76	0	no	no	no
3384	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	0	4.4		No	No		BRIP1	Yes	1	4.83	0	no	no	no
3385	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	32	4.4	Stable	No	No			No	0	8.67	0	no	no	no
3386	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	567	2.6	Stable	No	Yes or Unknown		BRCA2 | XRCC2	No	0	35.45	0	no	no	no
3387	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	13	36.9		No	No	Signature.4	MDC1 | MLH1 | PARP1 | TP53BP1	No	1	7.1	0	no	no	no
3388	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	36	3.5		No	Yes or Unknown		PARP1	No	0	35.61	0	no	no	no
3389	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	8.8		No	No	Signature.2		No	0	28.94	0	no	no	no
3390	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	7		No	No	Signature.18	ARID1A	Yes	1	4.07	0	no	no	yes
3391	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	56	15.8		No	No	Signature.2		No	0	33.51	0	no	no	no
3392	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	39	0		No	No			No	1	22.54	0	no	no	no
3393	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	41	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	35.42	0	no	no	no
3394	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	42	8.8	Stable	No	No		SLX4	No	1	25.99	0	no	no	no
3395	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	2	3.5	Stable	No	No			No	1	10.09	0	no	no	no
3396	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	50	5.3		No	No			Yes	0	36.01	0	no	no	no
3397	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	1.8	Stable	No	No			No	0	33.51	0	no	no	no
3398	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	29	2.6		No	No			No	0	33.02	0	no	no	no
3399	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	IV	0	0.9		No	No			Yes	0	35.75	0	no	no	no
3400	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	38	1.8		No	Yes or Unknown			No	0	35.68	0	no	no	no
3401	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	520	6.1	Stable	No	Yes or Unknown			No	0	33.87	0	no	no	no
3402	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	3	3.5		No	No			Yes	1	8.97	0	no	no	no
3403	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	39	1.8		No	No			No	0	32.89	0	no	no	no
3404	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	43	0.9		No	Yes or Unknown			No	0	32	0	no	no	no
3405	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	0	4.4	Stable	No	No			Yes	0	34	0	no	no	no
3406	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	38	1.8		No	No			No	0	35.61	0	no	no	no
3407	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.15		No	1	3.22	0	no	no	no
3408	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	0	120.2	Stable	No	No	Signature.10	ARID1A | ATR | BRCA2 | ERCC2 | ERCC3 | MSH2 | PARP1 | RAD51	No	0	32.82	0	no	no	yes
3409	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	38	6.1		No	Yes or Unknown		BRCA1	No	0	36.14	0	no	no	no
3410	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	II	32	81.6	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | CHEK2 | ERCC2 | MSH3 | MSH6 | PALB2 | RAD50 | TP53BP1	No	1	18.17	0	mut-MMRd	mut-MMRd	yes
3411	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	270	3.5	Stable	No	Yes or Unknown		ATM	No	0	34.23	0	no	no	no
3412	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	33	6.1		No	No	Signature.13		No	0	27.96	0	no	no	no
3413	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	22	3.5	Stable	No	No		SLX4	No	0	34.99	0	no	no	no
3414	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	0	11.4		No	No	Signature.1	ARID1A	No	1	2.27	0	no	no	yes
3415	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	IV	0	11.4		No	Yes or Unknown	Signature.13	BRCA1	No	1	5.32	0	no	no	no
3416	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	46	0	Stable	No	Yes or Unknown			No	0	35.15	0	no	no	no
3417	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	I	47	0.9		No	No			No	0	20.67	0	no	no	no
3418	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	35	1.8		No	No			No	0	31.54	0	no	no	no
3419	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	41	9.7		No	No	Signature.6	FANCA | NBN	Yes	0	35.61	0	no	no	no
3420	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	87	2.6	Stable	No	Yes or Unknown		BRCA1	No	1	30.65	0	no	no	no
3421	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No	Signature.5		No	0	11.63	0	no	no	no
3422	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	11	2.6	Stable	No	No			No	1	28.12	0	no	no	no
3423	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	50	4.4	Stable	No	Yes or Unknown			No	0	33.91	0	no	no	no
3424	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	3.12	0	no	no	no
3425	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	II	55	4.4		No	No			No	1	25.99	0	no	no	no
3426	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	44	0	Stable	No	No			No	0	29.86	0	no	no	no
3427	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	2.6	Stable	No	No	Signature.1		No	1	9.99	0	no	no	no
3428	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	377	3.5	Stable	No	Yes or Unknown			No	0	35.88	0	no	no	no
3429	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	2.6	Stable	No	No			No	0	35.15	0	no	no	no
3430	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	0	30.7		No	No	Signature.1	PMS1 | RAD50	No	0	30.36	0	no	no	no
3431	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	4	10.5	Stable	No	No	Signature.1	ARID1A	No	0	36.27	0	no	no	yes
3432	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		99	0		No	No			No	0	21.39	0	no	no	no
3433	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	22	10.5	Stable	No	No	Signature.1		Yes	0	34	0	no	no	no
3434	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	59	1.8		No	No		MLH1	No	0	33.35	0	no	no	no
3435	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	55	3.5		No	No		ARID1A	No	0	29.44	0	no	no	yes
3436	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	20	2.6		No	No			No	0	24.54	0	no	no	no
3437	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	0	4.4	Stable	No	Yes or Unknown			No	1	34.46	0	no	no	no
3438	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	31	3.5		No	Yes or Unknown			No	0	33.81	0	no	no	no
3439	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	0	7	Stable	No	No	Signature.1		No	0	34.17	0	no	no	no
3440	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	0	3.5		No	Yes or Unknown		BRCA2	No	0	34.46	0	no	no	no
3441	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	I	0	0		No	No			No	0	22.31	0	no	no	no
3442	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	IV	28	3.5		No	No			Yes	0	17.51	0	no	no	no
3443	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	5	4.4		No	No	Signature.1		No	1	29.5	0	no	no	no
3444	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	20	2.6		No	No		ARID1A	No	1	7.43	0	no	no	yes
3445	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	3	8.8	Stable	No	No	Signature.1		Yes	0	34.76	0	no	no	no
3446	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	47	7.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	21.88	0	no	no	yes
3447	Non-ICI treated	Never received ICI	46 - 50	Female	Head & Neck	2016	I	27	0		No	Yes or Unknown			Yes	0	32.59	0	no	no	no
3448	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	58	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	34.99	0	no	no	no
3449	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	13	82.5	Indeterminate	No	No	Signature.4	ATM | ATR | BRCA1 | ERCC5 | MDC1 | MSH6 | PARP1 | SLX4	No	0	22.08	0	no	no	no
3450	Non-ICI treated	Never received ICI	56 - 60	Female	Renal	2016	IV	130	2.6	Stable	No	Yes or Unknown			No	1	11.56	0	no	no	no
3451	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	0.9		No	No			Yes	0	9.72	0	no	no	no
3452	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	2.6		No	Yes or Unknown			No	1	15.31	0	no	no	no
3453	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2016	II	162	93.9	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | CHEK1 | ERCC3 | MSH2 | MSH3 | MSH6	Yes	0	30.52	0	mut-MMRd	mut-MMRd	yes
3454	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	168	0.9		No	Yes or Unknown			Yes	0	16.13	0	no	no	no
3455	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	31	1.8		No	Yes or Unknown			Yes	0	24.61	0	no	no	no
3456	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	30	3.5		No	No			No	1	31.84	0	no	no	no
3457	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	3.5		No	No			No	1	7.2	0	no	no	no
3458	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	21	1.8	Stable	No	Yes or Unknown			No	0	34.56	0	no	no	no
3459	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	1.8		No	Yes or Unknown		ATM	No	0	31.61	0	no	no	no
3460	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	0	3.5	Stable	No	No		RAD54L	No	1	8.11	0	no	no	no
3461	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	1.8		No	Yes or Unknown			Yes	0	30.29	0	no	no	no
3462	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	198	1.8	Stable	No	Yes or Unknown			No	1	20.47	0	no	no	no
3463	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2016	III	0	8.8		No	No	Signature.29		Yes	0	32.62	0	no	no	no
3464	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	52	1.8		No	No			Yes	0	34.96	0	no	no	no
3465	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	209	7	Stable	No	Yes or Unknown			No	0	17.02	0	no	no	no
3466	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2017	I	7	50	Indeterminate	No	No	Signature.1	ARID1A | ERCC4 | FANCA | MSH2 | MSH3 | MSH6	No	0	30.52	0	no	no	yes
3467	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	638	17.6	Stable	No	Yes or Unknown	Signature.4	ERCC3	No	1	26.55	0	no	no	no
3468	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2016	I	0	11.4		No	No	Signature.2	ERCC3	No	0	32.2	0	no	no	no
3469	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	III	673	1.8	Stable	No	Yes or Unknown			No	0	28.25	0	no	no	no
3470	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	42	2.6		No	Yes or Unknown			No	0	25.17	0	no	no	no
3471	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	III	0	13.2		No	No	Signature.13	ERCC2	Yes	0	10.28	0	no	no	no
3472	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	2	3.5	Stable	No	No	Signature.19	BRCA1	Yes	0	33.12	0	no	no	no
3473	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	21	7		No	Yes or Unknown	Signature.5		Yes	0	33.51	0	no	no	no
3474	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			Yes	0	35.45	0	no	no	no
3475	Non-ICI treated	Never received ICI	15-Nov	Female	Renal	2016	II	4	0		No	No			No	0	33.94	0	no	no	no
3476	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	0	4.4		No	Yes or Unknown	Signature.1		No	0	34.96	0	no	no	no
3477	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	19	0		No	Yes or Unknown			No	0	34.99	0	no	no	no
3478	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	1	20.96	0	no	no	no
3479	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	224	13.2		No	No	Signature.2	ERCC2	No	0	30.16	0	no	no	no
3480	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	11	2.6	Stable	No	Yes or Unknown			No	1	22.21	0	no	no	no
3481	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	19	6.1	Stable	No	No	Signature.6		Yes	1	12.85	0	no	no	no
3482	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	1	2.6		No	Yes or Unknown	Signature.1		No	0	34.4	0	no	no	no
3483	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	29	12.3		No	No	Signature.29	PMS1	Yes	1	15.18	0	no	no	no
3484	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	10	6.1		No	No	Signature.2		No	1	12.35	0	no	no	no
3485	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2016	IV	2	5.3		No	Yes or Unknown		BRCA2	Yes	0	34.14	0	no	no	no
3486	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2016	III	868	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	36.07	0	no	no	no
3487	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	167	4.4	Stable	No	No		ERCC4	No	0	32.16	0	no	no	no
3488	Non-ICI treated	Never received ICI	26 - 30	Male	Hepatobiliary	2016	II	737	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	36.6	0	no	no	no
3489	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	IV	19	0		No	No			Yes	1	4.3	0	no	no	no
3490	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	0	1.8	Stable	No	No			No	0	33.12	0	no	no	no
3491	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	429	2.6	Stable	No	Yes or Unknown			No	0	40.02	0	no	no	no
3492	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	10	7.9	Stable	No	No	Signature.1		No	1	18.07	0	no	no	no
3493	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		1	0.9		No	Yes or Unknown	Signature.1		No	0	34.73	0	no	no	no
3494	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	0	4.4	Stable	No	No	Signature.13		No	1	21.03	0	no	no	no
3495	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	2.6		No	No			No	1	15.05	0	no	no	no
3496	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	0.9		No	Yes or Unknown			No	0	33.94	0	no	no	no
3497	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	0	5.3	Stable	No	No	Signature.3		No	0	35.12	0	no	no	no
3498	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	II	92	4.4		No	Yes or Unknown			No	0	34.66	0	no	no	no
3499	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	54	5.3		No	Yes or Unknown	Signature.5		No	0	35.48	0	no	no	no
3500	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	99	2.6	Stable	No	No			Yes	0	35.78	0	no	no	no
3501	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	30	4.4		No	No	Signature.3		No	0	29.5	0	no	no	no
3502	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	19	0.9		No	No			Yes	0	32.33	0	no	no	no
3503	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	22	10.5		No	No	Signature.13	BRCA2 | RAD51C	No	1	28.48	0	no	no	no
3504	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	IV	1	2.6		No	Yes or Unknown		ATM	No	0	35.15	0	no	no	no
3505	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	34	16.7		No	No	Signature.13	MSH2 | SLX4	No	0	34.53	0	no	no	no
3506	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2016	IV	62	9.7		No	Yes or Unknown	Signature.24		Yes	1	6.24	0	no	no	no
3507	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	2.6		No	No			Yes	0	17.28	0	no	no	no
3508	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	IV	22	2.6	Stable	No	Yes or Unknown			No	1	23.43	0	no	no	no
3509	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	30	0.9		No	No			No	0	32.03	0	no	no	no
3510	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	0	2.6		No	No			No	0	32.49	0	no	no	no
3511	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	51	4.4		No	Yes or Unknown		ARID1A	No	0	34.69	0	no	no	yes
3512	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	III	841	5.3	Stable	No	No	Signature.30		No	0	34.27	0	no	no	no
3513	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	6.1		No	No			No	0	34.79	0	no	no	no
3514	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	IV	62	6.1	Stable	No	No			No	0	34.17	0	no	no	no
3515	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	19	4.4		No	No			No	1	18.1	0	no	no	no
3516	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			No	0	37.55	0	no	no	no
3517	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	33	1.8		No	Yes or Unknown			No	0	32.2	0	no	no	no
3518	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	585	2.6	Stable	No	Yes or Unknown			No	0	35.09	0	no	no	no
3519	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	25	98.3	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | CHEK2 | ERCC5 | MLH1 | MSH6 | NBN	No	0	34.73	0	no	no	yes
3520	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	902	3.5	Stable	No	Yes or Unknown			No	0	32.56	0	no	no	no
3521	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	9	10.5		No	No	Signature.1	BRCA2	No	0	19.12	0	no	no	no
3522	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	49	3.5		No	No			Yes	0	34.99	0	no	no	no
3523	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2016	III	36	4.4	Stable	No	No			Yes	0	34.83	0	no	no	no
3524	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	35	6.1		No	No			No	1	10.71	0	no	no	no
3525	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2.6		No	No			No	0	23	0	no	no	no
3526	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	41	73.7	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC4 | ERCC5 | MDC1 | MRE11A | MSH6	No	0	33.41	0	mut-MMRd	mut-MMRd	yes
3527	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	209	6.1	Stable	No	No			Yes	0	13.86	0	no	no	no
3528	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	25	3.5		No	No			No	0	27.37	0	no	no	no
3529	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	24	2.6	Stable	No	Yes or Unknown			No	0	34.86	0	no	no	no
3530	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	33	9.7		No	No	Signature.4		Yes	0	31.21	0	no	no	no
3531	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	64	6.1		No	No	Signature.24	CHEK2	No	1	3.19	0	no	no	no
3532	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	II	16	4.4		No	No		BRIP1	No	0	34.43	0	no	no	no
3533	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	630	3.5	Stable	No	Yes or Unknown	Signature.3	FANCA	Yes	0	24.94	0	no	no	no
3534	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	III	11	1.8		No	No			No	0	33.12	0	no	no	no
3535	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	40	1.8		No	No			No	0	7.79	0	no	no	no
3536	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	37	265.9	Indeterminate	No	No	Signature.10	ARID1A | ATM | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC2 | ERCC4 | ERCC5 | MDC1 | MRE11A | MSH2 | MSH6 | PARP1 | PMS2 | RAD54L | SLX4 | TP53BP1	Yes	0	31.05	0	no	no	yes
3537	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	II	63	7.9	Stable	No	No	Signature.1		No	0	16.79	0	no	no	no
3538	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	71	7		No	No	Signature.13		No	0	35.71	0	no	no	no
3539	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	I	0	0.9		No	No			No	0	31.97	0	no	no	no
3540	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.3		Yes	0	34.43	0	no	no	no
3541	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2016	IV	0	5.3		No	No		ARID1A | BRCA2	No	0	34.53	0	no	no	yes
3542	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	0	2.6		No	No			No	0	32.43	0	no	no	no
3543	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	0	6.1	Stable	No	No			No	1	12.85	0	no	no	no
3544	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	12	5.3	Stable	No	No			No	0	33.71	0	no	no	no
3545	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	1.8		No	Yes or Unknown			No	1	25.72	0	no	no	no
3546	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	0	0.9		No	No			No	1	5.42	0	no	no	no
3547	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	21	0.9		No	No		NTHL1	No	0	34.53	0	no	no	no
3548	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	IV	0	7		No	Yes or Unknown	Signature.18	ARID1A	No	1	14.29	0	no	no	yes
3549	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	11.4		No	No	Signature.3		Yes	1	2.66	0	no	no	no
3550	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	31	2.6	Stable	No	No			No	0	23.79	0	no	no	no
3551	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			No	1	11.96	0	no	no	no
3552	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	7		No	No			No	0	24.57	0	no	no	no
3553	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	33	1.8		No	No			No	0	29.34	0	no	no	no
3554	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	15	8.8	Stable	No	No	Signature.6		No	0	10.48	0	no	no	no
3555	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	10	10.5	Stable	No	No	Signature.1		No	1	12.75	0	no	no	no
3556	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	19	3.5		No	No			Yes	0	20.11	0	no	no	no
3557	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	15	7		No	No	Signature.4	ATR	No	1	2.99	0	no	no	no
3558	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	22	9.7	Stable	No	No			No	0	31.51	0	no	no	no
3559	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	7	2.6	Stable	No	Yes or Unknown			No	0	33.48	0	no	no	no
3560	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	488	0.9	Stable	No	Yes or Unknown			No	0	34.17	0	no	no	no
3561	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	34	7.9		No	No	Signature.4		Yes	0	28.78	0	no	no	no
3562	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	14	7		No	No	Signature.2	NBN	No	0	34.76	0	no	no	no
3563	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	77	1.8		No	No			No	0	20.4	0	no	no	no
3564	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	27	1.8		No	No			No	0	34.1	0	no	no	no
3565	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	32	4.4	Stable	No	No			Yes	0	34.79	0	no	no	no
3566	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	0	2.6		No	No	Signature.5		No	0	10.71	0	no	no	no
3567	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	2.6		No	No			No	0	28.22	0	no	no	no
3568	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	0.9	Stable	No	No			No	1	26.05	0	no	no	no
3569	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	1.8		No	No			Yes	0	34.23	0	no	no	no
3570	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	1.8		No	No			No	0	34.04	0	no	no	no
3571	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			Yes	1	28.81	0	no	no	no
3572	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	33	5.3	Stable	No	No			Yes	0	31.74	0	no	no	no
3573	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	III	45	2.6	Stable	No	No			No	1	30	0	no	no	no
3574	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		0	4.4	Stable	No	No			No	0	12.68	0	no	no	no
3575	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	0	7		No	No	Signature.4	ATM	Yes	0	34.07	0	no	no	no
3576	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	30	4.4		No	No		ATM	No	0	31.74	0	no	no	no
3577	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	0	10.5	Stable	No	No	Signature.17	PMS1	Yes	0	24.64	0	no	no	no
3578	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	12.06	0	no	no	no
3579	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	I	289	6.1	Stable	No	Yes or Unknown			Yes	0	35.02	0	no	no	no
3580	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	32.5		No	No	Signature.4	MRE11A	No	0	34.1	0	no	no	no
3581	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		16	3.5		Yes or Unknown	Yes or Unknown			Yes	1	3.52	0	no	no	no
3582	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	721	0		No	Yes or Unknown			No	1	30.69	0	no	no	no
3583	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	20	6.1		No	No	Signature.8	BRIP1	Yes	0	33.08	0	no	no	no
3584	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	26	1.8		No	No			No	0	33.22	0	no	no	no
3585	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	0	4.4	Stable	No	No	Signature.1	PARP1	No	0	34.63	0	no	no	no
3586	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	0		No	No	Signature.1		No	0	29.11	0	no	no	no
3587	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	52	1.8		No	No			No	0	30.16	0	no	no	no
3588	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	0.9		No	No			Yes	0	29.4	0	no	no	no
3589	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	834	7	Stable	No	Yes or Unknown	Signature.1		No	0	33.51	0	no	no	no
3590	Non-ICI treated	Never received ICI	31 - 35	Male	NSCLC	2016	IV	0	9.7		No	No	Signature.13		No	1	17.74	0	no	no	no
3591	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	5.3		No	No			No	1	23.52	0	no	no	no
3592	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	254	1.8	Stable	No	Yes or Unknown			No	1	16.85	0	no	no	no
3593	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2016	IV	0	3.5		No	Yes or Unknown		ATM	No	0	34.3	0	no	no	no
3594	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016	IV	14	4.4		No	No			No	1	7.66	0	no	no	no
3595	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	165	0	Stable	No	No			No	0	32.23	0	no	no	no
3596	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	II	113	7		No	Yes or Unknown	Signature.18		Yes	0	32.1	0	no	no	no
3597	Non-ICI treated	Never received ICI	66 - 70	Female	Esophageal	2016	II	362	4.4	Stable	No	No	Signature.5		No	0	23.69	0	no	no	no
3598	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	13	2.6		No	No			Yes	0	30.32	0	no	no	no
3599	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	430	1.8	Stable	No	Yes or Unknown			No	1	29.37	0	no	no	no
3600	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	I	32	2.6		No	No			No	0	33.97	0	no	no	no
3601	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	III	0	1.8	Stable	No	No			No	1	9.1	0	no	no	no
3602	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	28	5.3		No	No			No	0	7.2	0	no	no	no
3603	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	122	0		No	Yes or Unknown			Yes	0	18.69	0	no	no	no
3604	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	824	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	34.89	0	no	no	no
3605	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	31	2.6		No	No			No	0	33.74	0	no	no	no
3606	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	51	6.1	Stable	No	No		SLX4	No	0	31.9	0	no	no	no
3607	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	0	0.9		No	Yes or Unknown			No	0	24.64	0	no	no	no
3608	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	42	0		No	No			Yes	0	23.23	0	no	no	no
3609	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	70	1.8		No	No			No	0	34.46	0	no	no	no
3610	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	206	7	Stable	No	Yes or Unknown			No	0	34.66	0	no	no	no
3611	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2016	IV	0	12.3		No	No	Signature.21	NBN	No	1	2.83	0	no	no	no
3612	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.6		No	1	25.13	0	no	no	no
3613	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown			No	1	11.07	0	no	no	no
3614	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	654	6.1	Stable	No	Yes or Unknown	Signature.1	MDC1	No	0	34.89	0	no	no	no
3615	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	34	7		No	No		FANCA	No	0	29.5	0	no	no	no
3616	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	3.5	Stable	No	No		ERCC5	No	1	27.99	0	no	no	no
3617	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	91	8.8	Stable	No	No	Signature.1	ATM	No	0	34.6	0	no	no	no
3618	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	2.6	Stable	No	No		BRCA2	No	1	28.62	0	no	no	no
3619	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	2.6	Stable	No	No	Signature.3		No	0	33.94	0	no	no	no
3620	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	137	29.8		No	Yes or Unknown	Signature.4		Yes	0	5.82	0	no	no	no
3621	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	IV	40	49.2	Unstable	No	No	Signature.6	ARID1A | ATR | ERCC5 | FANCA | PALB2 | RAD54L	No	1	6.01	0	other-MMRd	mut-MMRd	yes
3622	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	2.6		No	No			No	0	28.68	0	no	no	no
3623	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	582	0.9	Stable	No	Yes or Unknown			No	0	24.97	0	no	no	no
3624	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	188	2		No	No			No	0	32.92	0	no	no	no
3625	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	0		No	No			No	0	25.36	0	no	no	no
3626	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	0.9		No	No			No	0	28.75	0	no	no	no
3627	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	30	0.9		No	No			No	0	34	0	no	no	no
3628	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	2.6		No	No			No	0	29.21	0	no	no	no
3629	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	IV	0	0.9		No	No			No	0	34.4	0	no	no	no
3630	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	40	1.8		No	No			Yes	0	30.36	0	no	no	no
3631	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	18	54.4	Unstable	No	No	Signature.6	ARID1A | BRCA1 | MSH3 | MUTYH | RAD50 | TP53BP1	No	0	2.07	0	other-MMRd	mut-MMRd	yes
3632	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	23	0.9		No	No			Yes	0	31.7	0	no	no	no
3633	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2016	IV	224	0	Stable	No	Yes or Unknown			No	0	8.48	0	no	no	no
3634	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016		0	2.6		No	No			No	1	9.49	0	no	no	no
3635	Non-ICI treated	Never received ICI	46 - 50	Male	Bladder	2016	II	0	3.5		No	No	Signature.19	BRCA2	Yes	0	29.47	0	no	no	no
3636	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	39	1.8		No	No			No	0	34.96	0	no	no	no
3637	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	15	0		No	No			No	0	26.87	0	no	no	no
3638	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	33	12.3		No	No	Signature.8		No	0	32.59	0	no	no	no
3639	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	15	3.5	Stable	No	No			No	0	34.07	0	no	no	no
3640	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	33	3.5		No	No			Yes	0	34.43	0	no	no	no
3641	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	III	17	5.3	Stable	No	No		MUTYH	Yes	0	33.15	0	no	no	no
3642	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	966	3.5	Stable	No	No	Signature.13		No	0	32.85	0	no	no	no
3643	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	70	0	Stable	No	No			No	0	34.33	0	no	no	no
3644	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	14	3.5	Stable	No	No		ERCC4	No	1	12.81	0	no	no	no
3645	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	191	5.3	Stable	No	Yes or Unknown	Signature.1		Yes	1	7.98	0	no	no	no
3646	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	0	5.3	Stable	No	No	Signature.3	MUTYH	No	0	33.22	0	no	no	no
3647	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	IV	74	1.8		No	No			No	1	34.3	0	no	no	no
3648	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	III	5	105.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC4 | MSH2 | MSH6 | PALB2 | SLX4	No	0	34.2	0	mut-MMRd	mut-MMRd	yes
3649	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	II	42	5.3		No	No			No	0	25.89	0	no	no	no
3650	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	I	0	7.9	Stable	No	No	Signature.4		No	0	32.69	0	no	no	no
3651	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2016	III	938	9.7	Stable	No	Yes or Unknown	Signature.1	ATR	No	0	34.6	0	no	no	no
3652	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	1	2.6		No	No			Yes	0	16	0	no	no	no
3653	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	0	0.9		No	No			No	0	7.43	0	no	no	no
3654	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	IV	18	12.3		No	No	Signature.4	MSH2	Yes	1	7.89	0	no	no	no
3655	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	I	323	0.9	Stable	No	Yes or Unknown			Yes	0	19.09	0	no	no	no
3656	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	109	2.6	Stable	No	Yes or Unknown			No	1	5.29	0	no	no	no
3657	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	53	0.9		No	No			No	0	30.46	0	no	no	no
3658	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2016	III	136	1.8		No	Yes or Unknown		BRCA1	No	0	34.69	0	no	no	no
3659	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	0	4.4	Stable	No	No		CHEK2	No	0	23.39	0	no	no	no
3660	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	296	18.4	Stable	No	Yes or Unknown	Signature.29	ATM | ERCC2	Yes	0	17.08	0	no	no	no
3661	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	15	1.8	Stable	No	No			Yes	0	33.51	0	no	no	no
3662	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	216	21.1	Stable	No	No	Signature.6	ARID1A | ATM | MLH1	No	0	32.89	0	no	no	yes
3663	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		13	3.5		Yes or Unknown	Yes or Unknown			No	1	4.8	0	no	no	no
3664	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	977	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	34.07	0	no	no	no
3665	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	40	0.9		No	No			Yes	0	16.59	0	no	no	no
3666	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	7	3.5		No	No	Signature.1	ATM	No	1	9.99	0	no	no	no
3667	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	88	1.8	Stable	No	No			No	0	30.82	0	no	no	no
3668	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	375	6.1	Stable	No	Yes or Unknown	Signature.30		Yes	1	18.27	0	no	no	no
3669	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	48	1.8	Stable	No	No			Yes	0	31.87	0	no	no	no
3670	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	28	2.6		No	No			Yes	0	32.3	0	no	no	no
3671	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	203	0.9		No	No			No	0	39.66	0	no	no	no
3672	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	3.5		No	No			Yes	1	18.76	0	no	no	no
3673	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	6	3.5		No	No			Yes	0	32	0	no	no	no
3674	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	41	0.9		No	No			No	0	33.97	0	no	no	no
3675	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3.5		No	No			No	1	11.63	0	no	no	no
3676	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	59	1.8	Stable	No	No			No	0	34.14	0	no	no	no
3677	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	0	33.51	0	no	no	no
3678	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	3.5		No	No		TP53BP1	Yes	0	29.73	0	no	no	no
3679	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	53	0.9		No	No			Yes	0	30.62	0	no	no	no
3680	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	49	2.6	Stable	No	No			No	1	24.51	0	no	no	no
3681	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	27	4.4		No	Yes or Unknown			No	0	33.31	0	no	no	no
3682	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	23	3.5		No	No		ARID1A	Yes	0	29.77	0	no	no	yes
3683	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		12	6.1		Yes or Unknown	Yes or Unknown			Yes	0	34.63	0	no	no	no
3684	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	20	6.1	Stable	No	No	Signature.3		Yes	0	34.17	0	no	no	no
3685	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	20	0.9		No	No			No	0	29.54	0	no	no	no
3686	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	54	2.6		No	Yes or Unknown			No	0	32.85	0	no	no	no
3687	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	7	Stable	No	No	Signature.1	ARID1A	Yes	0	19.88	0	no	no	yes
3688	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	37	4.4	Stable	No	No			No	0	35.42	0	no	no	no
3689	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	194	3.5	Stable	No	Yes or Unknown			No	0	34	0	no	no	no
3690	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	40	4.4	Stable	No	No			No	0	33.84	0	no	no	no
3691	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2016	IV	0	4.4	Stable	No	No	Signature.1	ATR	Yes	1	2.79	0	no	no	no
3692	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2016	IV	0	0		No	No		CHEK2	No	1	10.68	0	no	no	no
3693	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	I	0	0		No	No		CHEK2	No	0	31.05	0	no	no	no
3694	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2016		41	1.8		Yes or Unknown	Yes or Unknown			Yes	0	34.04	0	no	no	no
3695	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	3	1.8		No	No			Yes	1	3.22	0	no	no	no
3696	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No	Signature.15		No	1	32.56	0	no	no	no
3697	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	57	1.8		No	No			No	0	33.15	0	no	no	no
3698	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	27	2.6		No	Yes or Unknown			No	1	6.01	0	no	no	no
3699	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	140	1.8		No	Yes or Unknown			No	0	37.55	0	no	no	no
3700	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	61	4.4		No	Yes or Unknown			No	0	13.7	0	no	no	no
3701	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	55	37.7	Unstable	No	No	Signature.6	ARID1A | ATR | BLM | ERCC5 | MSH3 | MSH6	No	0	34.17	0	mut-MMRd	mut-MMRd	yes
3702	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	707	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	33.28	0	no	no	no
3703	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	29	2.6		No	No			No	0	30.85	0	no	no	no
3704	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	16	51.8	Unstable	No	No	Signature.6	ATM | ATR | RAD50 | RAD51	Yes	0	31.61	0	other-MMRd	mut-MMRd	no
3705	Non-ICI treated	Never received ICI	10-Jun	Male	Renal	2016	IV	0	0		No	No			No	1	10.68	0	no	no	no
3706	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	1.8		No	No			No	0	23.79	0	no	no	no
3707	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	130	1.8	Stable	No	No			No	0	33.77	0	no	no	no
3708	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	5.3		No	Yes or Unknown			No	0	33.97	0	no	no	no
3709	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	34	7.9	Stable	No	No	Signature.13		Yes	0	33.74	0	no	no	no
3710	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2016	I	47	37.7	Unstable	No	No	Signature.6	BLM | BRCA1 | BRIP1 | MRE11A | SLX4	No	0	28.45	0	other-MMRd	mut-MMRd	no
3711	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown	Signature.3		No	1	30.78	0	no	no	no
3712	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	40	3.5		No	Yes or Unknown			No	0	31.47	0	no	no	no
3713	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	0	3.5	Stable	No	No		BRCA2	No	0	33.38	0	no	no	no
3714	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		137	2.6		Yes or Unknown	Yes or Unknown			No	1	10.68	0	no	no	no
3715	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	718	7.9	Stable	No	Yes or Unknown	Signature.13		No	1	27.99	0	no	no	no
3716	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	I	0	0.9		No	No			No	0	30.78	0	no	no	no
3717	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	14	0.9		No	Yes or Unknown			Yes	0	33.38	0	no	no	no
3718	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	764	9.7	Stable	No	Yes or Unknown	Signature.3	CHEK1 | FANCA	No	0	31.7	0	no	no	no
3719	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	6	6.1		No	No			No	0	34.1	0	no	no	no
3720	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	52	3.5		No	No		ARID1A	Yes	0	33.41	0	no	no	yes
3721	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	6.1		No	No			No	1	6.8	0	no	no	no
3722	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		736	2.6	Stable	No	No		RAD50	No	0	32.16	0	no	no	no
3723	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	195	9.7	Stable	No	Yes or Unknown		ARID1A	No	0	11.24	0	no	no	yes
3724	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	II	0	1.8	Stable	No	No			No	0	32.2	0	no	no	no
3725	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	31	5.3		No	No		PALB2	No	0	10.91	0	no	no	no
3726	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	288	3.5	Stable	No	Yes or Unknown	Signature.3		No	1	11.27	0	no	no	no
3727	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	494	4.4	Stable	No	Yes or Unknown			No	0	33.48	0	no	no	no
3728	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	14	5.3	Stable	No	No	Signature.1	BRIP1 | MDC1	No	0	33.91	0	no	no	no
3729	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	40	4.4		No	Yes or Unknown			No	0	33.58	0	no	no	no
3730	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	7		No	No			No	0	23.06	0	no	no	no
3731	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	31	3.5		No	No			Yes	0	33.58	0	no	no	no
3732	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	II	29	1.8	Stable	No	Yes or Unknown			No	0	28.25	0	no	no	no
3733	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	24	4.4	Stable	No	Yes or Unknown		BLM	No	0	33.54	0	no	no	no
3734	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	II	21	5.3	Stable	No	No			Yes	0	21.39	0	no	no	no
3735	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	1014	15.8	Stable	No	Yes or Unknown	Signature.4	CHEK2	No	0	35.91	0	no	no	no
3736	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	0	0	Stable	No	Yes or Unknown			No	1	7.49	0	no	no	no
3737	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	29	7		No	No			No	0	32.43	0	no	no	no
3738	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	59	49.2	Stable	No	No	Signature.10	ATM | BLM | BRCA2 | CHEK2 | MSH6 | PALB2	No	0	24.94	0	no	no	no
3739	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		55	0		No	No			No	0	12.58	0	no	no	no
3740	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	0	7.9		No	No	Signature.4		No	0	24.54	0	no	no	no
3741	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	0	4.4	Stable	No	No			No	0	12.16	0	no	no	no
3742	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	III	0	3.5		No	No	Signature.5		No	1	17.28	0	no	no	no
3743	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2016	I	0	5.3	Stable	No	No			No	1	24.54	0	no	no	no
3744	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	21	2.6		No	Yes or Unknown			No	0	24.18	0	no	no	no
3745	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	18.07	0	no	no	no
3746	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	30	3.5		No	Yes or Unknown			No	0	33.84	0	no	no	no
3747	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	233	2.6	Stable	No	No			Yes	0	34.2	0	no	no	no
3748	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		11	4.4		No	No			Yes	0	30.88	0	no	no	no
3749	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016		692	1.8	Stable	No	No			No	0	32.92	0	no	no	no
3750	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	I	84	7.9	Stable	No	No	Signature.21	ERCC5 | FANCA | MSH3	No	0	31.93	0	no	no	no
3751	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	0	1.8	Stable	No	No			No	1	19.19	0	no	no	no
3752	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	0	2.6	Stable	No	Yes or Unknown			No	0	33.25	0	no	no	no
3753	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	92	0.9	Stable	No	No			No	0	32.13	0	no	no	no
3754	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	119	9.7	Stable	No	Yes or Unknown	Signature.4	ATR	No	0	33.87	0	no	no	no
3755	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2016	IV	20	0		No	No			Yes	0	33.08	0	no	no	no
3756	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	24	0.9		No	No		PMS2	No	0	33.25	0	no	no	no
3757	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	8	0.9		No	Yes or Unknown			No	0	33.87	0	no	no	no
3758	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	11	5.3		No	Yes or Unknown		BRCA2	No	0	27.27	0	no	no	no
3759	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016		0	0		No	No			No	0	30	0	no	no	no
3760	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	15	0		No	No			No	0	32.79	0	no	no	no
3761	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	25	3.5		No	No			No	0	29.67	0	no	no	no
3762	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	24	6.1	Stable	No	No	Signature.1		No	0	33.68	0	no	no	no
3763	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	29	6.1		No	No	Signature.1		No	1	10.74	0	no	no	no
3764	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	IV	66	7.9		No	Yes or Unknown	Signature.4		Yes	0	8.21	0	no	no	no
3765	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	22	6.1		No	No	Signature.24		No	0	26.78	0	no	no	no
3766	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	191	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	24.25	0	no	no	no
3767	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	136	43.9		No	No	Signature.4	BRCA1 | ERCC3	No	0	32.69	0	no	no	no
3768	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	II	91	2.6		No	No			No	1	29.24	0	no	no	no
3769	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	8	11.4		No	Yes or Unknown	Signature.26	FANCA	No	0	33.22	0	no	no	no
3770	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	44	1.8	Stable	No	No			No	0	32.39	0	no	no	no
3771	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	55	3.5		No	No			Yes	0	32.95	0	no	no	no
3772	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	11.4	Stable	No	No	Signature.18	ARID1A | PALB2	No	0	20.99	0	no	no	yes
3773	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	28	4.4	Stable	No	No			No	0	31.31	0	no	no	no
3774	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2016	IV	32	7.9		No	No	Signature.4	FANCA	Yes	0	17.91	0	no	no	no
3775	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	18.4		No	No	Signature.4		No	0	2.73	0	no	no	no
3776	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	5	10.5		No	No	Signature.4	BLM	Yes	0	34.17	0	no	no	no
3777	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		2	3.5		Yes or Unknown	Yes or Unknown		BRCA2	No	1	24.44	0	no	no	no
3778	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	327	21.9	Stable	No	Yes or Unknown	Signature.2	ATM | BLM | PMS1	No	0	33.54	0	no	no	no
3779	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	0	6.1	Stable	No	No		BRCA1	No	1	15.51	0	no	no	no
3780	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	0	2.6	Stable	No	No			No	1	33.61	0	no	no	no
3781	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	0.9		No	No			No	1	8.34	0	no	no	no
3782	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	II	105	0		No	Yes or Unknown			No	0	33.25	0	no	no	no
3783	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	III	0	0.9		No	No		MUTYH	No	1	19.12	0	no	no	no
3784	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	5.3		No	No	Signature.3		Yes	1	3.25	0	no	no	no
3785	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016	III	0	1.8	Stable	No	No			No	0	31.21	0	no	no	no
3786	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	13	4.4	Stable	No	No			No	1	21.65	0	no	no	no
3787	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	IV	31	1.8		No	Yes or Unknown			No	0	33.68	0	no	no	no
3788	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	63	2.6		No	No			Yes	0	31.47	0	no	no	no
3789	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	0.9	Stable	No	No			No	0	33.15	0	no	no	no
3790	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3.5	Stable	No	No			No	1	18.76	0	no	no	no
3791	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	17	2.6		No	No			No	0	30.55	0	no	no	no
3792	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	26	12.3		No	No	Signature.4		No	1	2.37	0	no	no	no
3793	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	17	7.9	Stable	No	No		ARID1A	Yes	0	30.29	0	no	no	yes
3794	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	26	0.9		No	Yes or Unknown			Yes	0	33.51	0	no	no	no
3795	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	43	5.9		No	Yes or Unknown		ARID1A | BRCA2	No	0	33.51	0	no	no	yes
3796	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	III	0	2.6	Stable	No	No			Yes	0	29.93	0	no	no	no
3797	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	28	0.9		No	No			Yes	1	7.69	0	no	no	no
3798	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		176	0	Stable	No	No			No	0	16.92	0	no	no	no
3799	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	III	30	4.4		No	No			No	0	32.99	0	no	no	no
3800	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	236	0	Stable	No	Yes or Unknown			No	0	33.12	0	no	no	no
3801	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	37	2.6		No	No	Signature.13		Yes	1	3.48	0	no	no	no
3802	Non-ICI treated	Never received ICI	91 - 95	Female	Cutaneous Melanoma 	2016	II	308	2.6	Stable	No	No	Signature.5		No	0	33.77	0	no	no	no
3803	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	35	0.9		No	No			No	0	25.43	0	no	no	no
3804	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	II	9	3.5		No	Yes or Unknown			Yes	0	34.04	0	no	no	no
3805	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	41	1.8		No	Yes or Unknown			No	0	34.3	0	no	no	no
3806	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	2.6		No	No			Yes	0	32.07	0	no	no	no
3807	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	65	0	Stable	No	No			No	0	30.23	0	no	no	no
3808	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	2.6		No	No	Signature.5		No	0	33.64	0	no	no	no
3809	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	27	4.4	Stable	No	No			Yes	0	33.61	0	no	no	no
3810	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	8	7		No	No		ARID1A	No	0	32.95	0	no	no	yes
3811	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	III	0	5.3	Stable	No	No			No	0	31.84	0	no	no	no
3812	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016		0	1.8		No	Yes or Unknown			No	0	17.38	0	no	no	no
3813	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	IV	55	1.8	Stable	No	No			Yes	0	6.44	0	no	no	no
3814	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	0	1.8		No	No			Yes	0	29.11	0	no	no	no
3815	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	39	23.7	Unstable	No	No	Signature.6	MRE11A | SLX4	No	1	30.92	0	other-MMRd	mut-MMRd	no
3816	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	30	7	Stable	No	No	Signature.1	MDC1	No	0	33.94	0	no	no	no
3817	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	28	0.9		No	No			No	1	7.72	0	no	no	no
3818	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	14	7		No	No		ATM	No	1	9.53	0	no	no	no
3819	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	48	2.6		No	No		BRCA1	Yes	0	32.43	0	no	no	no
3820	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	II	0	1.8		No	No			No	0	12.16	0	no	no	no
3821	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	41	4.4		No	No		ARID1A	Yes	0	32.69	0	no	no	yes
3822	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	15	7.9		No	No	Signature.1	ARID1A	No	1	6.18	0	no	no	yes
3823	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	0.9		No	No			No	0	33.08	0	no	no	no
3824	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	56	9.7	Stable	No	Yes or Unknown		BRCA2 | FANCA | MSH2	No	0	31.67	0	no	no	no
3825	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	II	470	1.8		No	No		PMS2	No	0	27.4	0	no	no	no
3826	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	117	5.3	Stable	No	No			Yes	0	34.53	0	no	no	no
3827	Non-ICI treated	Never received ICI	61 - 65	Male	Breast	2016	III	42	1.8		No	No			No	0	32.85	0	no	no	no
3828	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	III	99	10.5	Stable	No	No	Signature.2		Yes	1	22.64	0	no	no	no
3829	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	95	1.8		No	Yes or Unknown			No	0	28.71	0	no	no	no
3830	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	5.3	Indeterminate	No	No			Yes	1	9.69	0	no	no	no
3831	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		5	2.6		Yes or Unknown	Yes or Unknown			Yes	0	32.23	0	no	no	no
3832	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	30	1.8		No	No			No	0	24.64	0	no	no	no
3833	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	II	176	2.6	Stable	No	Yes or Unknown			No	1	27.3	0	no	no	no
3834	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	25	1.8		No	No		MUTYH	No	0	14.26	0	no	no	no
3835	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	2	4.4	Stable	No	No			No	0	26.28	0	no	no	no
3836	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	I	42	3.5		No	No			No	0	14.55	0	no	no	no
3837	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	21	1.8		No	No			No	0	32.79	0	no	no	no
3838	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	II	56	0		No	No			No	0	33.45	0	no	no	no
3839	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	183	0.9	Stable	No	No			No	1	21.75	0	no	no	no
3840	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	22	3.5		No	No			Yes	0	33.38	0	no	no	no
3841	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	78	13.2		No	Yes or Unknown	Signature.4	ARID1A	Yes	0	29.96	0	no	no	yes
3842	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		2	0		No	No			No	1	28.06	0	no	no	no
3843	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	30	1.8		No	No			No	1	10.22	0	no	no	no
3844	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	3.5	Stable	No	No	Signature.5	BRCA1	No	0	33.51	0	no	no	no
3845	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	76	0.9	Stable	No	Yes or Unknown			No	1	20.83	0	no	no	no
3846	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	II	108	0	Stable	No	Yes or Unknown			No	0	32.07	0	no	no	no
3847	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	22	7	Stable	No	No		ATM	No	0	33.22	0	no	no	no
3848	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	17	0		No	No			No	0	29.5	0	no	no	no
3849	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	IV	20	14.9		No	No	Signature.13	ATR | ERCC2	No	0	31.01	0	no	no	no
3850	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	39	1.8		No	No			Yes	0	28.52	0	no	no	no
3851	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	77	6.1		No	No			No	0	32.82	0	no	no	no
3852	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	0	3.5		No	No			Yes	0	32.92	0	no	no	no
3853	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	18	0		No	Yes or Unknown			Yes	0	29.96	0	no	no	no
3854	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	0.9		No	No			No	0	29.9	0	no	no	no
3855	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	0	2.6		No	No			No	0	34	0	no	no	no
3856	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	99	0		No	Yes or Unknown			Yes	0	28.81	0	no	no	no
3857	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	0	0.9		No	No			No	0	32.69	0	no	no	no
3858	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	25	2.6	Stable	No	No			Yes	0	21.65	0	no	no	no
3859	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	32	2.6		No	Yes or Unknown			No	0	25.4	0	no	no	no
3860	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	42	0.9		No	No			Yes	0	30.65	0	no	no	no
3861	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	0	0.9	Stable	No	Yes or Unknown			No	0	23.59	0	no	no	no
3862	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2016		28	1.8		No	No			Yes	0	29.77	0	no	no	no
3863	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	0	2.6		No	No			No	0	33.31	0	no	no	no
3864	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	43	14		No	No	Signature.4	ERCC5 | XRCC2	No	1	4.86	0	no	no	no
3865	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2016		43	0.9		No	No			No	0	6.97	0	no	no	no
3866	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	65	3.9		No	No			Yes	0	33.28	0	no	no	no
3867	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	I	413	0.9	Stable	No	Yes or Unknown			No	1	14.69	0	no	no	no
3868	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2016		187	2.6	Stable	No	Yes or Unknown			No	1	11.4	0	no	no	no
3869	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	75	0.9		No	No			Yes	0	32.39	0	no	no	no
3870	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	2.6	Stable	No	No			No	0	34.76	0	no	no	no
3871	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	8.8		No	No	Signature.2	MSH6	No	1	5.55	0	no	no	no
3872	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	26	2.6		No	No			Yes	0	28.25	0	no	no	no
3873	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	4.4		No	No	Signature.1		Yes	0	31.74	0	no	no	no
3874	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	0	2.6		No	No			Yes	1	7.98	0	no	no	no
3875	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	33.77	0	no	no	no
3876	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	0	0	Stable	No	No			No	0	32.13	0	no	no	no
3877	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	29	4.4		No	Yes or Unknown	Signature.3	BRCA2 | ERCC2	No	0	33.35	0	no	no	no
3878	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	33.35	0	no	no	no
3879	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	36	1.8	Stable	No	No			No	0	33.05	0	no	no	no
3880	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	21	5.3	Stable	No	No		ARID1A	No	0	25.36	0	no	no	yes
3881	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	100	2.6	Stable	No	No			No	0	22.54	0	no	no	no
3882	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	32	7.9		No	No	Signature.3		No	0	31.74	0	no	no	no
3883	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	42	5.3		No	No		BRIP1	No	0	26.18	0	no	no	no
3884	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	125	0.9	Stable	No	Yes or Unknown			No	1	23.16	0	no	no	no
3885	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	III	0	0.9	Stable	No	No			No	1	14.19	0	no	no	no
3886	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		8	3.5		No	No			No	1	4.27	0	no	no	no
3887	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	161	9.7	Stable	No	Yes or Unknown	Signature.1	ATR	No	0	35.38	0	no	no	no
3888	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	III	25	2.6	Stable	No	No			Yes	0	32.2	0	no	no	no
3889	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	III	142	3.5	Stable	No	No			No	0	32.49	0	no	no	no
3890	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	II	110	7.9	Stable	No	No	Signature.2		No	0	16.92	0	no	no	no
3891	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	48	5.3	Stable	No	No	Signature.1	ERCC3	Yes	0	33.28	0	no	no	no
3892	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	59	5.3		No	No		MSH6	No	0	31.44	0	no	no	no
3893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	40	3.5		No	Yes or Unknown			No	0	33.12	0	no	no	no
3894	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	25	3.5		No	No			No	0	33.15	0	no	no	no
3895	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	0	6.1		No	No		MLH1 | NBN	No	1	28.94	0	no	no	no
3896	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	II	126	4.4		No	No			No	1	24.9	0	no	no	no
3897	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	I	0	0		No	No			Yes	0	29.57	0	no	no	no
3898	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	64	0.9		No	Yes or Unknown			No	0	33.15	0	no	no	no
3899	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	2.6		No	Yes or Unknown		ARID1A	No	0	32.85	0	no	no	yes
3900	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2016		18	6.1		Yes or Unknown	Yes or Unknown	Signature.3	MRE11A	Yes	1	2.6	0	no	no	no
3901	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	28	6.9		No	Yes or Unknown	Signature.4	ATM	Yes	0	26.55	0	no	no	no
3902	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	22	5.3	Stable	No	No		BRCA1	Yes	0	28.02	0	no	no	no
3903	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	II	0	4.4		No	No			No	0	31.15	0	no	no	no
3904	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	IV	219	4.4	Indeterminate	No	Yes or Unknown	Signature.1		No	1	22.67	0	no	no	no
3905	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	832	7	Stable	No	Yes or Unknown	Signature.16	MLH1	No	0	33.54	0	no	no	no
3906	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	1.8		No	No			Yes	0	33.68	0	no	no	no
3907	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	868	0.9	Stable	No	Yes or Unknown			No	0	32.16	0	no	no	no
3908	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	32	3.5	Stable	No	No			No	0	32.72	0	no	no	no
3909	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	23	2.6		No	No			No	0	28.58	0	no	no	no
3910	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	0	4.4		No	Yes or Unknown	Signature.13		No	0	32.95	0	no	no	no
3911	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	2.6		No	Yes or Unknown			No	0	32.43	0	no	no	no
3912	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	34	4.4	Stable	No	Yes or Unknown			No	0	34.76	0	no	no	no
3913	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	III	42	0.9		No	No			No	0	17.38	0	no	no	no
3914	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	IV	20	4.4		No	No			Yes	1	2.46	0	no	no	no
3915	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	1	19.91	0	no	no	no
3916	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	154	4.4	Stable	No	Yes or Unknown	Signature.24		No	0	32.07	0	no	no	no
3917	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	33	12.3		No	No	Signature.29	MDC1	Yes	1	9.23	0	no	no	no
3918	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	20	2.6	Stable	No	No			No	1	8.25	0	no	no	no
3919	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	21	2.6		No	No		ATM	No	0	32.62	0	no	no	no
3920	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	1	1.8		No	No	Signature.19		No	1	12.45	0	no	no	no
3921	Non-ICI treated	Never received ICI	26 - 30	Male	Cutaneous Melanoma 	2016	III	15	20.2		No	No	Signature.7	ATR	No	0	33.51	0	no	no	no
3922	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	24	3.5	Stable	No	No			No	0	19.06	0	no	no	no
3923	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	67	1.8	Stable	No	No		BRCA2	No	0	35.88	0	no	no	no
3924	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	223	0		No	Yes or Unknown			No	0	33.12	0	no	no	no
3925	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	6.1	Stable	No	No			No	1	31.11	0	no	no	no
3926	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	169	22.8	Stable	No	Yes or Unknown	Signature.13	MSH2 | RAD51C	Yes	0	31.74	0	no	no	no
3927	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	32	2.6		No	No			No	0	29.63	0	no	no	no
3928	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	IV	71	3.5		No	No		ATM	No	1	4.7	0	no	no	no
3929	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	II	52	5.3	Stable	No	No			Yes	0	31.8	0	no	no	no
3930	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	IV	33	2.6		No	No		ARID1A	No	0	15.21	0	no	no	yes
3931	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	47	0		No	No			Yes	0	22.37	0	no	no	no
3932	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	1.8		No	Yes or Unknown			No	0	32.62	0	no	no	no
3933	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	0	5.3	Stable	No	No	Signature.6		No	1	19.78	0	no	no	no
3934	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	1	4.9		No	Yes or Unknown			No	0	33.28	0	no	no	no
3935	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		2	3.5	Stable	No	No	Signature.1		Yes	0	9.66	0	no	no	no
3936	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2016	II	26	1.8		No	No			No	0	31.84	0	no	no	no
3937	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	57	7.9	Stable	No	No		ARID1A	No	0	24.38	0	no	no	yes
3938	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	560	0.9	Stable	No	Yes or Unknown			No	0	32.89	0	no	no	no
3939	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	45	7.9	Stable	No	No	Signature.1		No	0	5.13	0	no	no	no
3940	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	378	2.6		No	Yes or Unknown			Yes	0	1.71	0	no	no	no
3941	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	15	7		No	No	Signature.7	ARID1A	No	1	2.76	0	no	no	yes
3942	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	5.3		No	No			No	1	8.25	0	no	no	no
3943	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	120	2.6	Stable	No	Yes or Unknown			No	0	33.12	0	no	no	no
3944	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	37	0.9		No	No			No	0	22.64	0	no	no	no
3945	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	4.4		No	Yes or Unknown		ATM	No	1	15.31	0	no	no	no
3946	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	1	2.6		No	Yes or Unknown			No	1	23.06	0	no	no	no
3947	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	0	2.6		No	No			No	1	15.77	0	no	no	no
3948	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	35	1.8		No	No			Yes	0	32.72	0	no	no	no
3949	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	21	2.6	Stable	No	No			No	0	32.56	0	no	no	no
3950	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	79	1.8		No	Yes or Unknown			No	0	27.86	0	no	no	no
3951	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	31	3.5		No	No			No	0	27.83	0	no	no	no
3952	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	I	123	0	Stable	No	No			No	0	33.18	0	no	no	no
3953	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2016	IV	3	6.1		No	No	Signature.1		Yes	1	11.37	0	no	no	no
3954	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	657	5.3	Stable	No	Yes or Unknown	Signature.24	BRCA1	No	0	31.77	0	no	no	no
3955	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	0	0.9		No	No			No	0	29.9	0	no	no	no
3956	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	0	0.9	Stable	No	No			No	0	33.18	0	no	no	no
3957	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	361	4.4	Stable	No	Yes or Unknown	Signature.5		No	0	33.61	0	no	no	no
3958	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	12.3		No	No	Signature.3	BRCA1	No	1	14.95	0	no	no	no
3959	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	14	2.6	Stable	No	No		NBN	No	0	32.99	0	no	no	no
3960	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	2.6	Stable	No	Yes or Unknown		PMS1	No	0	32.66	0	no	no	no
3961	Non-ICI treated	Never received ICI	96 - 100	Female	Endometrial	2016	IV	48	2.6	Stable	No	No			Yes	0	32.39	0	no	no	no
3962	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2016	IV	0	3.5		No	No			No	1	20.53	0	no	no	no
3963	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	103	1.8		No	Yes or Unknown			No	1	15.57	0	no	no	no
3964	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	III	34	0.9	Indeterminate	No	No			Yes	1	13.93	0	no	no	no
3965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	0	7	Stable	No	No		PARP1	No	0	24.15	0	no	no	no
3966	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	17.6		No	No	Signature.4	BRCA2 | MSH2 | PARP1	No	1	1.25	0	no	no	no
3967	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	12	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	33.97	0	no	no	no
3968	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	0	6.1	Stable	No	Yes or Unknown	Signature.2		No	0	31.74	0	no	no	no
3969	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	7.9	Stable	No	No	Signature.25		Yes	1	9.23	0	no	no	no
3970	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016	I	16	0		No	No			No	0	30.42	0	no	no	no
3971	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	339	1.8	Stable	No	Yes or Unknown			No	0	35.19	0	no	no	no
3972	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	0.9		No	No			Yes	0	24.48	0	no	no	no
3973	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2016	IV	5	2.6	Stable	No	No		ATM	No	1	8.71	0	no	no	no
3974	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	3.5		No	No			No	0	26.25	0	no	no	no
3975	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.30		No	1	24.71	0	no	no	no
3976	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2016	III	0	14		No	No	Signature.4	BLM | BRIP1	Yes	1	10.25	0	no	no	no
3977	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		14	4.4		Yes or Unknown	Yes or Unknown			Yes	0	32.23	0	no	no	no
3978	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	54	7.9		No	No	Signature.24	BRCA1	No	1	19.19	0	no	no	no
3979	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	25	1.8		No	No			Yes	0	31.01	0	no	no	no
3980	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	3	7	Stable	No	No	Signature.1	ATM	No	1	14.39	0	no	no	no
3981	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	38	40.4	Unstable	No	No	Signature.1	ARID1A	No	0	33.31	0	other-MMRd	mut-MMRd	yes
3982	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	44	3.5		No	No			Yes	0	30.13	0	no	no	no
3983	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	1.8		No	No			No	0	31.31	0	no	no	no
3984	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	26	0		No	Yes or Unknown			No	0	32.89	0	no	no	no
3985	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	58	4.4	Stable	No	No			No	0	32.16	0	no	no	no
3986	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.4		No	Yes or Unknown		PALB2	No	0	32.82	0	no	no	no
3987	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	134	27.2	Indeterminate	No	Yes or Unknown	Signature.1	ARID1A | SLX4	No	0	31.28	0	no	no	yes
3988	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	639	7	Stable	No	Yes or Unknown	Signature.3		No	0	31.9	0	no	no	no
3989	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	244	0.9	Stable	No	No			No	1	20.57	0	no	no	no
3990	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	39	4.4		No	No			No	0	30.39	0	no	no	no
3991	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	130	0.9	Stable	No	Yes or Unknown			No	0	32.92	0	no	no	no
3992	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	6.1	Stable	No	No			Yes	1	5.55	0	no	no	no
3993	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		14	4.4		No	No			Yes	1	1.64	0	no	no	no
3994	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	41	2.6		No	No		MRE11A	Yes	0	27.6	0	no	no	no
3995	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	25	0		No	No			No	0	8.31	0	no	no	no
3996	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	I	20	0.9		No	No			No	0	26.55	0	no	no	no
3997	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	IV	0	7		No	No	Signature.7		No	1	5.32	0	no	no	no
3998	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	0	32.66	0	no	no	no
3999	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	0	7	Stable	No	No	Signature.3	BRCA1	No	0	31.51	0	no	no	no
4000	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		305	0	Stable	No	No			No	0	25.69	0	no	no	no
4001	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	26	6.1	Stable	No	No	Signature.4		No	1	27.01	0	no	no	no
4002	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	1.8		No	No			No	0	26.32	0	no	no	no
4003	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	I	40	0.9		No	No			No	0	31.41	0	no	no	no
4004	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	109	2.6	Stable	No	Yes or Unknown		BLM	No	0	31.21	0	no	no	no
4005	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	148	2.6	Stable	No	Yes or Unknown			No	0	32.76	0	no	no	no
4006	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		4	3.5		Yes or Unknown	Yes or Unknown			Yes	0	8.08	0	no	no	no
4007	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	2.6	Stable	No	No			No	0	32.49	0	no	no	no
4008	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	15	7.9	Stable	No	No	Signature.4		Yes	0	32	0	no	no	no
4009	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2016	IV	0	2.6		No	No		BRCA1	Yes	0	28.98	0	no	no	no
4010	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	IV	0	3.5		No	No			No	1	24.21	0	no	no	no
4011	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2016	IV	0	8.8	Stable	No	No	Signature.13	MDC1 | MUTYH	No	0	23.89	0	no	no	no
4012	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		21	6.1	Stable	Yes or Unknown	Yes or Unknown		ARID1A	Yes	0	36.4	0	no	no	yes
4013	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	7	7	Stable	No	No			No	0	32.82	0	no	no	no
4014	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	30	0.9		No	No			Yes	0	30.19	0	no	no	no
4015	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		226	0	Stable	No	No			No	0	34.43	0	no	no	no
4016	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	38	3.5	Stable	No	No			No	0	31.9	0	no	no	no
4017	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	III	0	4.4		No	No		ARID1A	No	0	32.1	0	no	no	yes
4018	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2016		272	0		No	No			No	0	19.88	0	no	no	no
4019	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	III	0	2.6		No	Yes or Unknown			No	0	31.51	0	no	no	no
4020	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	20	5.3		No	Yes or Unknown			No	0	20.9	0	no	no	no
4021	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	22.8		No	No	Signature.4	BLM | NBN | RAD51C	Yes	1	4.76	0	no	no	no
4022	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	15	0.9		No	Yes or Unknown			No	0	32.53	0	no	no	no
4023	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	162	0.9	Stable	No	Yes or Unknown			No	0	32.49	0	no	no	no
4024	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	29.17	0	no	no	no
4025	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	153	4.4	Stable	No	Yes or Unknown		ERCC2	No	1	23.39	0	no	no	no
4026	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	III	21	0.9	Stable	No	Yes or Unknown			No	0	30.59	0	no	no	no
4027	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	35	5.3	Stable	No	Yes or Unknown			No	0	32.62	0	no	no	no
4028	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	58	2.6		No	No			No	0	32.89	0	no	no	no
4029	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016		2	1.8		No	No			No	1	11.6	0	no	no	no
4030	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	7	6.1	Stable	No	No			No	0	32.49	0	no	no	no
4031	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	III	23	15.8		No	No	Signature.6	ATR	No	1	4.63	0	no	no	no
4032	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	168	2.6	Stable	No	No			Yes	0	32.72	0	no	no	no
4033	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	184	0.9	Stable	No	Yes or Unknown		BLM	No	0	32.46	0	no	no	no
4034	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	28	4.4	Stable	No	No			No	0	32.66	0	no	no	no
4035	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	40	11.4		No	No	Signature.4	ATM | CHEK2 | ERCC4	No	0	17.41	0	no	no	no
4036	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	20	7		No	No	Signature.4		No	0	27.76	0	no	no	no
4037	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	18	4.4		No	No		BRCA1	Yes	0	2.76	0	no	no	no
4038	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	12	10.5		No	No	Signature.3	BRCA1	No	1	23.2	0	no	no	no
4039	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	0	5.3		No	Yes or Unknown			No	0	34.6	0	no	no	no
4040	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	0	9.7		No	No	Signature.4		No	0	25.26	0	no	no	no
4041	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	47	3.5	Stable	No	No	Signature.17	ARID1A	No	0	24.34	0	no	no	yes
4042	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	317	2.6	Stable	No	Yes or Unknown			No	1	32.13	0	no	no	no
4043	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	36	7		No	No	Signature.13		Yes	0	31.93	0	no	no	no
4044	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	35	4.4		No	No			Yes	0	31.93	0	no	no	no
4045	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	21	48.3	Unstable	No	No	Signature.1	ATM | BLM | MSH3 | NBN | PARP1	Yes	0	26.25	0	other-MMRd	mut-MMRd	no
4046	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	22	3.5		No	No			Yes	1	3.78	0	no	no	no
4047	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	III	7	17.6		No	No	Signature.2	ARID1A	No	0	32.39	0	no	no	yes
4048	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	17	1.8		No	No			No	0	31.8	0	no	no	no
4049	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	15	40.4	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MSH3 | MSH6	No	0	26.51	0	mut-MMRd	mut-MMRd	yes
4050	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	II	152	4.4	Stable	No	No		ATM	Yes	0	31.31	0	no	no	no
4051	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2016	IV	5	45.6		No	No	Signature.7	ARID1A | MDC1 | RAD50 | RAD51C	No	0	0.89	0	no	no	yes
4052	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	99	0.9		No	No			No	0	28.35	0	no	no	no
4053	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	71	10.5	Stable	No	No	Signature.1	ATR	No	0	32.72	0	no	no	no
4054	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	19	3.5		No	No			No	1	22.54	0	no	no	no
4055	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	65	7.9	Stable	No	No			No	0	32.95	0	no	no	no
4056	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	9	3.5		No	No			No	0	32.33	0	no	no	no
4057	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	3.5		No	No	Signature.30		No	0	30.13	0	no	no	no
4058	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	51	3.5		No	No			No	0	29.31	0	no	no	no
4059	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	24	3.5	Stable	No	No			Yes	0	22.87	0	no	no	no
4060	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	III	0	4.4	Stable	No	No		ARID1A	No	0	29.57	0	no	no	yes
4061	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	2.6	Stable	No	No			Yes	1	15.21	0	no	no	no
4062	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	1.8		No	No			No	0	31.51	0	no	no	no
4063	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	16	5.3	Stable	No	Yes or Unknown		SLX4	Yes	0	28.48	0	no	no	no
4064	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	55	1.8		No	Yes or Unknown			No	0	29.57	0	no	no	no
4065	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	2	4.4	Stable	No	No			No	1	7.33	0	no	no	no
4066	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	0	5.3		No	No			Yes	1	2.63	0	no	no	no
4067	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	No		ARID1A	No	1	8.51	0	no	no	yes
4068	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		13	2.6		No	Yes or Unknown			Yes	1	4.73	0	no	no	no
4069	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	III	9	3.5		No	No			No	1	13.86	0	no	no	no
4070	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	710	7.9	Stable	No	Yes or Unknown	Signature.1	NTHL1	No	1	28.32	0	no	no	no
4071	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	44	2.6		No	No			No	0	31.61	0	no	no	no
4072	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	49	2.6		No	Yes or Unknown			Yes	0	32.89	0	no	no	no
4073	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	0.9	Stable	No	No			No	0	31.87	0	no	no	no
4074	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	5.3	Stable	No	No	Signature.3		No	0	32.46	0	no	no	no
4075	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	III	196	8.8	Stable	No	No	Signature.13		No	0	32.72	0	no	no	no
4076	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2016	IV	24	10.5		No	No	Signature.4	ERCC4	Yes	1	9.3	0	no	no	no
4077	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016	III	29	1.8		No	No			No	0	27.63	0	no	no	no
4078	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	2	5.3	Stable	No	No		RAD50	No	1	7.95	0	no	no	no
4079	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	41	1.8		No	Yes or Unknown			Yes	0	32.2	0	no	no	no
4080	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	46	0	Stable	No	No			No	0	32.46	0	no	no	no
4081	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	III	812	6.1	Stable	No	Yes or Unknown	Signature.9	ARID1A	Yes	0	28.42	0	no	no	yes
4082	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	0	9.7		No	No	Signature.29	ARID1A | BRCA2	No	0	2.27	0	no	no	yes
4083	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	IV	66	0	Stable	No	No			No	1	25.03	0	no	no	no
4084	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2016	IV	7	5.3	Stable	No	No	Signature.19	SLX4	No	0	30.88	0	no	no	no
4085	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	0		No	No			No	0	32.13	0	no	no	no
4086	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	IV	51	21.1	Stable	No	No	Signature.2	MDC1 | PARP1 | RAD54L	Yes	0	17.51	0	no	no	no
4087	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	330	5.3	Stable	No	Yes or Unknown		BRCA1	No	1	22.08	0	no	no	no
4088	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	70	3.5	Stable	No	No		MUTYH	No	0	30.95	0	no	no	no
4089	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	17	0	Stable	No	No			No	0	24.48	0	no	no	no
4090	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	15	3.5	Stable	No	No			No	1	6.11	0	no	no	no
4091	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	26	2.6		No	No		SLX4	No	0	19.68	0	no	no	no
4092	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	35.1	Stable	No	No	Signature.4		No	1	4.9	0	no	no	no
4093	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	69	2.6	Stable	No	No			No	0	32	0	no	no	no
4094	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	III	103	0		No	Yes or Unknown			No	0	31.97	0	no	no	no
4095	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016		0	1.8		No	No			No	0	31.84	0	no	no	no
4096	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	9	2.6		No	Yes or Unknown		MUTYH	Yes	0	30.13	0	no	no	no
4097	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	764	11.4	Indeterminate	No	Yes or Unknown	Signature.13	ATM | ATR | BLM	No	1	28.19	0	no	no	no
4098	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	5.3		No	No		ATM | CHEK1	Yes	1	8.21	0	no	no	no
4099	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	21	5.3	Stable	No	No			No	0	8.9	0	no	no	no
4100	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	0	424.8	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | MUTYH | NTHL1 | PALB2 | PARP1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1	No	0	8.05	0	no	no	yes
4101	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	5.3	Stable	No	No			No	0	32.59	0	no	no	no
4102	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	III	193	1.8	Stable	No	No			Yes	0	29.44	0	no	no	no
4103	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	I	7	2		No	No			No	0	1.02	0	no	no	no
4104	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	156	2.6	Stable	No	Yes or Unknown		ERCC4	No	0	29.4	0	no	no	no
4105	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2.6		No	No		ATM	No	0	25.76	0	no	no	no
4106	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	434	2.6	Stable	No	Yes or Unknown			No	1	24.77	0	no	no	no
4107	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	33	3.5		No	Yes or Unknown			No	0	31.7	0	no	no	no
4108	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	IV	0	0.9		No	No			No	0	29.96	0	no	no	no
4109	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		1	5.9		No	No			Yes	1	7.66	0	no	no	no
4110	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	IV	60	0.9		No	Yes or Unknown		XRCC2	Yes	0	32.33	0	no	no	no
4111	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	0	2.6	Stable	No	No			No	0	29.7	0	no	no	no
4112	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	111	0		No	Yes or Unknown			No	0	30.85	0	no	no	no
4113	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	0	6.9	Stable	No	No		ATM	No	0	32.3	0	no	no	no
4114	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	II	21	8.8		No	No	Signature.4		Yes	0	30.42	0	no	no	no
4115	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	23	9.8	Stable	No	No	Signature.1	ARID1A	No	0	32.07	0	no	no	yes
4116	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		66	0		No	No			No	0	4.44	0	no	no	no
4117	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	II	0	4.4	Stable	No	No			No	0	26.64	0	no	no	no
4118	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	229	1.8	Stable	No	Yes or Unknown			Yes	0	23.03	0	no	no	no
4119	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	21	2.6		No	No			No	0	32.07	0	no	no	no
4120	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	14	3.5	Stable	No	No			No	0	31.57	0	no	no	no
4121	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	2.6	Stable	No	No			No	0	30.88	0	no	no	no
4122	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	153	7.9	Stable	No	Yes or Unknown	Signature.18	ATM	No	0	30.62	0	no	no	no
4123	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	3.9		Yes or Unknown	Yes or Unknown			No	1	10.05	0	no	no	no
4124	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	IV	8	2.6	Stable	No	No			No	0	25.56	0	no	no	no
4125	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	0	2.6		No	No			No	1	18.33	0	no	no	no
4126	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	31	3.5		No	Yes or Unknown			No	0	31.93	0	no	no	no
4127	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	15	3.5		No	No			Yes	0	31.8	0	no	no	no
4128	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	I	146	2.6	Stable	No	Yes or Unknown			Yes	0	7.26	0	no	no	no
4129	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	47	4.4		No	Yes or Unknown		MUTYH	No	0	31.93	0	no	no	no
4130	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		4	4.4		Yes or Unknown	Yes or Unknown	Signature.1		No	0	9.59	0	no	no	no
4131	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	26	4.4		No	No			No	0	31.31	0	no	no	no
4132	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	35	3.5	Stable	No	No			No	0	30.62	0	no	no	no
4133	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	195	4.4	Stable	No	Yes or Unknown			No	1	9.66	0	no	no	no
4134	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	II	49	3.5	Stable	No	No			No	0	31.47	0	no	no	no
4135	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	0	43	Unstable	No	No	Signature.6	ARID1A | BLM | MSH3 | NBN	Yes	0	31.93	0	other-MMRd	mut-MMRd	yes
4136	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	1.8		No	No			No	0	32.13	0	no	no	no
4137	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		45	1.8		No	No			No	0	24.94	0	no	no	no
4138	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	19	0.9		No	No			No	1	7.98	0	no	no	no
4139	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	III	53	5.3		No	No	Signature.13	TP53BP1	Yes	0	30.29	0	no	no	no
4140	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	401	3.5	Stable	No	No			No	0	26.55	0	no	no	no
4141	Non-ICI treated	Never received ICI	36 - 40	Female	Cutaneous Melanoma 	2016	III	20	2.6		No	No			No	0	2.66	0	no	no	no
4142	Non-ICI treated	Never received ICI	41 - 45	Female	Bladder	2016	II	0	12.3	Stable	No	No	Signature.13	ARID1A | ATR | MLH1	Yes	0	30.13	0	no	no	yes
4143	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	14	8.9	Stable	No	No	Signature.1		No	0	32.16	0	no	no	no
4144	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	9	8.8		No	No	Signature.5	ARID1A | PALB2 | RAD50 | SLX4	No	0	27.37	0	no	no	yes
4145	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	88	0	Stable	No	Yes or Unknown			No	0	31.74	0	no	no	no
4146	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2016	III	16	3.5		No	No			No	1	2.43	0	no	no	no
4147	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	31	2		No	Yes or Unknown			Yes	0	15.41	0	no	no	no
4148	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	129	1.8		No	No			No	1	12.52	0	no	no	no
4149	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	36	13.2		No	Yes or Unknown	Signature.2	ARID1A | BRCA2 | SLX4	No	0	30.16	0	no	no	yes
4150	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	20	1.8		No	No			No	0	31.84	0	no	no	no
4151	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	319	7.9	Stable	No	No	Signature.1	BRCA2	No	0	30.78	0	no	no	no
4152	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	1	0.9	Stable	No	No		CHEK2 | MRE11A	No	0	31.7	0	no	no	no
4153	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	22	3.5	Stable	No	No			No	1	28.25	0	no	no	no
4154	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	0	1.8		No	No			No	1	11.79	0	no	no	no
4155	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	180	3.5	Stable	No	No			No	0	32.16	0	no	no	no
4156	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	8	2.6	Stable	No	Yes or Unknown			No	0	6.47	0	no	no	no
4157	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	15	5.9	Stable	No	No			Yes	0	31.67	0	no	no	no
4158	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	0	Stable	No	No			No	0	31.47	0	no	no	no
4159	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	922	2.6	Stable	No	No			No	0	31.15	0	no	no	no
4160	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	III	30	1.8	Stable	No	No			Yes	0	30.13	0	no	no	no
4161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	3	1.8		No	No		ARID1A	No	0	31.44	0	no	no	yes
4162	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	6	8.8		No	No	Signature.3		No	1	2.92	0	no	no	no
4163	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	43	7		No	No			Yes	1	3.12	0	no	no	no
4164	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	2.6		No	Yes or Unknown			No	0	31.24	0	no	no	no
4165	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	II	24	7.9		No	Yes or Unknown		ATM	No	0	30.59	0	no	no	no
4166	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016		0	1.8		No	No	Signature.1	ARID1A | MSH6	Yes	0	29.9	0	no	no	yes
4167	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	0	3		No	No			No	1	22.67	0	no	no	no
4168	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	51	2.6	Stable	No	Yes or Unknown			No	0	18.37	0	no	no	no
4169	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	10	2.6		No	No			No	1	26.05	0	no	no	no
4170	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	II	125	59.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BRIP1 | ERCC3 | MSH2 | SLX4	No	0	29.9	0	mut-MMRd	mut-MMRd	yes
4171	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	36	2.6		No	No			No	0	30.55	0	no	no	no
4172	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	37	6.1	Stable	No	No		ARID1A	No	0	28.16	0	no	no	yes
4173	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	115	1.8	Stable	No	No			No	0	31.31	0	no	no	no
4174	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	III	0	3.5	Stable	No	No			No	1	17.74	0	no	no	no
4175	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	709	5.3	Stable	No	Yes or Unknown			No	1	25.53	0	no	no	no
4176	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	133	5.3	Stable	No	Yes or Unknown			No	1	27.27	0	no	no	no
4177	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	41	3.5	Stable	No	Yes or Unknown		ATM	No	0	32.59	0	no	no	no
4178	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	47	0.9	Stable	No	No			No	0	31.97	0	no	no	no
4179	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	0	12.8		No	No	Signature.4	BRCA2 | RAD50	No	0	26.81	0	no	no	no
4180	Non-ICI treated	Never received ICI	91 - 95	Male	NSCLC	2016	II	0	14		No	No	Signature.4		No	1	12.12	0	no	no	no
4181	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	4.4	Stable	No	Yes or Unknown			No	0	31.61	0	no	no	no
4182	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	144	1.8	Stable	No	Yes or Unknown			No	1	27.63	0	no	no	no
4183	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		7	4.4		Yes or Unknown	Yes or Unknown			No	1	29.4	0	no	no	no
4184	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2016	IV	0	0.9		No	No			Yes	0	31.41	0	no	no	no
4185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	3.5	Stable	No	No			No	0	31.31	0	no	no	no
4186	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	58	14	Stable	No	Yes or Unknown	Signature.4	RAD50	No	1	14.29	0	no	no	no
4187	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	23	12.3		No	No	Signature.4		No	0	26.78	0	no	no	no
4188	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	1.8		No	No			No	0	26.05	0	no	no	no
4189	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	36	2.6		No	No			Yes	0	9.66	0	no	no	no
4190	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	14	0.9		No	No			No	0	30.85	0	no	no	no
4191	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	3		No	No			No	0	31.01	0	no	no	no
4192	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	I	17	3.5		No	No			No	0	27.83	0	no	no	no
4193	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	2	0.9		No	No			No	1	28.88	0	no	no	no
4194	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	6.1		No	No			Yes	1	2.53	0	no	no	no
4195	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2017	II	44	0	Indeterminate	No	No			No	0	2.83	0	no	no	no
4196	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	31	2.6		No	Yes or Unknown			No	0	31.34	0	no	no	no
4197	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	66	303.7	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC3 | ERCC5 | FANCA | MDC1 | MSH2 | MSH3 | MSH6 | MUTYH | NBN | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	28.02	0	mut-MMRd	mut-MMRd	yes
4198	Non-ICI treated	Never received ICI	76 - 80	Male	Breast	2016	I	230	0.9	Stable	No	Yes or Unknown			No	0	26.81	0	no	no	no
4199	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	0	314.2	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BRCA1 | BRCA2 | ERCC3 | MSH2 | MSH3 | MSH6 | NTHL1 | PARP1 | PMS1 | RAD50 | RAD51 | RAD51C | RAD54L | SLX4 | TP53BP1	No	0	26.09	0	no	no	yes
4200	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	10	1.8		No	No			No	0	22.64	0	no	no	no
4201	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	0	2.6		No	No			Yes	0	31.87	0	no	no	no
4202	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2016	II	127	1.8	Stable	No	No			No	0	30.52	0	no	no	no
4203	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	III	288	7	Stable	No	Yes or Unknown	Signature.2		No	1	12.85	0	no	no	no
4204	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	24	2.6		No	No			No	0	31.31	0	no	no	no
4205	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	52	0.9		No	Yes or Unknown			No	0	31.87	0	no	no	no
4206	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	0	5.3		No	Yes or Unknown		ATM	No	1	23.13	0	no	no	no
4207	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2016		31	8.8		No	No	Signature.1		Yes	0	13.6	0	no	no	no
4208	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	0	2.6		No	No			No	0	29.4	0	no	no	no
4209	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	0	1.8	Stable	No	No			No	1	6.01	0	no	no	no
4210	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	77	4.4		No	No			No	0	27.79	0	no	no	no
4211	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	33	6.1	Stable	No	No	Signature.13	BRCA2	Yes	0	27.83	0	no	no	no
4212	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	IV	19	7	Stable	No	No		ARID1A	Yes	0	28.09	0	no	no	yes
4213	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	4.4	Stable	No	No			No	1	23.59	0	no	no	no
4214	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	0	1.8	Stable	No	No			Yes	0	12.75	0	no	no	no
4215	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	9	6.1		No	No	Signature.1		No	0	14.23	0	no	no	no
4216	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	41	37.7	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1	No	0	26.84	0	other-MMRd	mut-MMRd	yes
4217	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	15	2		No	No		ATM	No	1	26.35	0	no	no	no
4218	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	I	0	4.4	Stable	No	No			Yes	0	30.75	0	no	no	no
4219	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	31.74	0	no	no	no
4220	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	3	52.7	Unstable	No	No	Signature.6	ATM | BRCA2 | FANCA | MDC1 | MLH1 | MSH3	Yes	0	30.16	0	mut-MMRd	mut-MMRd	no
4221	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	127	1.8	Stable	No	Yes or Unknown			Yes	0	20.14	0	no	no	no
4222	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	23	5.3		No	Yes or Unknown			Yes	1	12.45	0	no	no	no
4223	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown		MUTYH	No	0	30.95	0	no	no	no
4224	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	0.9		No	No			Yes	0	5.03	0	no	no	no
4225	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	40	21.1	Unstable	No	No	Signature.6	ARID1A | TP53BP1	No	0	26.18	0	other-MMRd	mut-MMRd	yes
4226	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	0	3.5	Stable	No	No			No	0	30.78	0	no	no	no
4227	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		2	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	31.77	0	no	no	no
4228	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	28	1.8	Stable	No	No		ARID1A	No	0	30.65	0	no	no	yes
4229	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	26	3.5	Stable	No	No			No	1	19.68	0	no	no	no
4230	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	II	142	58.8	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | BRIP1 | MLH1 | MUTYH	No	0	27.66	0	mut-MMRd	mut-MMRd	yes
4231	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	32	6.1		No	Yes or Unknown	Signature.3		No	0	31.21	0	no	no	no
4232	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	452	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	31.44	0	no	no	no
4233	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	8	3		No	No			Yes	1	0.72	0	no	no	no
4234	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	35	2.6		No	No			Yes	0	29.93	0	no	no	no
4235	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	5.3	Stable	No	No			Yes	0	31.24	0	no	no	no
4236	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	IV	0	0.9		No	Yes or Unknown			No	1	14.19	0	no	no	no
4237	Non-ICI treated	Never received ICI	81 - 85	Male	Head & Neck	2016		85	0	Indeterminate	No	No			No	0	29.5	0	no	no	no
4238	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	1	12.78	0	no	no	no
4239	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		34	5.3		Yes or Unknown	Yes or Unknown			Yes	1	6.9	0	no	no	no
4240	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	35	3.9		No	No			Yes	0	28.81	0	no	no	no
4241	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	17	11.4		No	No	Signature.1	ATM | MSH3	Yes	1	7.1	0	no	no	no
4242	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	20	3.5	Stable	No	No			No	0	31.47	0	no	no	no
4243	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	II	0	9.7	Stable	No	No	Signature.7	FANCA	No	0	30.88	0	no	no	no
4244	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	33	4.4		No	No			Yes	0	27.63	0	no	no	no
4245	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	0	6.1	Stable	No	No		ARID1A	No	0	7.89	0	no	no	yes
4246	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	2		Yes or Unknown	Yes or Unknown			Yes	0	5.49	0	no	no	no
4247	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	0	0	Stable	No	No			No	0	25.23	0	no	no	no
4248	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	40	14.9		No	No	Signature.4		No	0	28.98	0	no	no	no
4249	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	27	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	30.32	0	no	no	no
4250	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	45	4.4		No	No		MUTYH	Yes	0	27.14	0	no	no	no
4251	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	917	2.6	Stable	No	No			Yes	0	33.77	0	no	no	no
4252	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2016	I	49	0.9	Stable	No	No			No	0	27.17	0	no	no	no
4253	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	0	6.1	Stable	No	No	Signature.1		No	1	3.38	0	no	no	no
4254	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2016	IV	42	2.6		No	Yes or Unknown			No	1	9.69	0	no	no	no
4255	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		0	3.5		Yes or Unknown	Yes or Unknown			No	1	16.23	0	no	no	no
4256	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	0	0.9	Stable	No	No			No	0	22.41	0	no	no	no
4257	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	31	9.7	Stable	No	No		ARID1A	No	0	30.59	0	no	no	yes
4258	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	I	25	8.8	Stable	No	No		ATM	No	0	21.49	0	no	no	no
4259	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	5.3	Stable	No	No			No	1	23.39	0	no	no	no
4260	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	168	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	31.9	0	no	no	no
4261	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	6.1	Stable	No	No		ARID1A	No	1	14.26	0	no	no	yes
4262	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	29.47	0	no	no	no
4263	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	15	3.9	Stable	No	No			Yes	0	28.71	0	no	no	no
4264	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	1	2.6		No	No	Signature.26	BRCA1	No	0	31.18	0	no	no	no
4265	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	39	63.2	Unstable	No	No	Signature.20	ARID1A | ATM | BRIP1 | MSH2 | MSH6 | RAD51C	Yes	0	29.93	0	mut-MMRd	mut-MMRd	yes
4266	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	16	2.6		No	No		ATM | PARP1	Yes	1	18.3	0	no	no	no
4267	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	8.8	Stable	No	No	Signature.1		No	0	30.92	0	no	no	no
4268	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	0	1.8	Stable	No	No			Yes	0	31.31	0	no	no	no
4269	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	55	1.8		No	No			No	0	22.9	0	no	no	no
4270	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	55	4.4	Stable	No	No		ARID1A	Yes	0	5.36	0	no	no	yes
4271	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	29.08	0	no	no	no
4272	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	8	1.8	Stable	No	Yes or Unknown			No	0	16.89	0	no	no	no
4273	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	0	4.4	Stable	No	No			No	1	8.94	0	no	no	no
4274	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	24	2.6	Stable	No	No			No	0	10.41	0	no	no	no
4275	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	0	2.6	Stable	No	No			No	0	32.53	0	no	no	no
4276	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	155	2.6	Stable	No	No			No	0	27.14	0	no	no	no
4277	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	20	2.6	Stable	No	No			No	0	25.92	0	no	no	no
4278	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2016		384	0.9	Stable	No	Yes or Unknown			No	0	30.26	0	no	no	no
4279	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	187	4.4	Stable	No	Yes or Unknown			No	0	30.32	0	no	no	no
4280	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	197	1.8	Stable	No	Yes or Unknown			No	0	31.08	0	no	no	no
4281	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017		642	3.5	Stable	No	No	Signature.19	CHEK2	No	1	24.57	0	no	no	no
4282	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	7	7	Stable	No	No	Signature.3		No	0	30.39	0	no	no	no
4283	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	I	32	15.8		No	No	Signature.3	BRCA2	No	0	25.95	0	no	no	no
4284	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	III	0	3.5	Stable	No	No			No	1	16.76	0	no	no	no
4285	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	0	3.5		No	No		CHEK2	No	0	24.02	0	no	no	no
4286	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	13	2.6		No	No			Yes	0	29.27	0	no	no	no
4287	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	II	431	7	Stable	No	Yes or Unknown	Signature.8		No	1	20.44	0	no	no	no
4288	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	120	0		No	Yes or Unknown			No	0	15.31	0	no	no	no
4289	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	41	6.1	Stable	No	No		BRCA2	No	1	24.8	0	no	no	no
4290	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0		No	No			No	0	30.62	0	no	no	no
4291	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		MSH6	No	0	29.93	0	no	no	no
4292	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	12	0.9		No	No			Yes	0	4.04	0	no	no	no
4293	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	41	4.4		No	No			No	0	32.07	0	no	no	no
4294	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	17	0.9		No	No			No	0	30.23	0	no	no	no
4295	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	II	17	6.1	Stable	No	No			No	0	31.01	0	no	no	no
4296	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	0	5.3		No	No		ARID1A	No	1	20.86	0	no	no	yes
4297	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2017	I	23	7	Stable	No	No	Signature.16	ARID1A | PMS1	Yes	1	28.58	0	no	no	yes
4298	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	26	0.9	Stable	No	No			No	0	26.09	0	no	no	no
4299	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		47	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	37.22	0	no	no	no
4300	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	53	20.2	Stable	No	No	Signature.4	BRCA2	Yes	0	30.65	0	no	no	no
4301	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	497	2.6	Stable	No	Yes or Unknown			No	1	20.9	0	no	no	no
4302	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		73	7		Yes or Unknown	Yes or Unknown	Signature.2		No	1	10.25	0	no	no	no
4303	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	674	2.6	Stable	No	Yes or Unknown		ARID1A	No	0	31.21	0	no	no	yes
4304	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	23	2.6		No	No			No	0	27.4	0	no	no	no
4305	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	561	7	Stable	No	Yes or Unknown	Signature.1	BRCA1	No	0	31.74	0	no	no	no
4306	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	64	13.2	Stable	No	Yes or Unknown	Signature.2		No	1	16.03	0	no	no	no
4307	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	119	2.6	Stable	No	Yes or Unknown		MUTYH	Yes	0	29.24	0	no	no	no
4308	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	78	0.9	Stable	No	No			No	0	29.21	0	no	no	no
4309	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	46	3.5	Stable	No	No	Signature.1		Yes	1	9.66	0	no	no	no
4310	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	III	10	4.4	Stable	No	No		BLM	Yes	0	30.72	0	no	no	no
4311	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	455	7	Stable	No	Yes or Unknown	Signature.1		No	0	30.69	0	no	no	no
4312	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	33	1.8	Stable	No	No			Yes	0	29.17	0	no	no	no
4313	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	0	4.4	Stable	No	No		CHEK2	No	1	11.43	0	no	no	no
4314	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	23	5.3	Stable	No	Yes or Unknown	Signature.24	MDC1	No	0	29.93	0	no	no	no
4315	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	505	7	Stable	No	Yes or Unknown	Signature.3	BLM	No	0	31.77	0	no	no	no
4316	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	4.4		No	No		BRCA2	No	0	31.11	0	no	no	no
4317	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	0	2.6		No	No			Yes	1	27.53	0	no	no	no
4318	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	0	30.75	0	no	no	no
4319	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	27	13.2		No	No	Signature.5	ATR | MSH6 | RAD54L	No	0	12.48	0	no	no	no
4320	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	133	2.6	Stable	No	Yes or Unknown			Yes	1	15.38	0	no	no	no
4321	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	11.4	Stable	No	No	Signature.15		No	0	31.24	0	no	no	no
4322	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	53	42.1	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | CHEK2 | MSH3 | MSH6	No	0	17.74	0	mut-MMRd	mut-MMRd	yes
4323	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	7	Stable	No	No	Signature.1		No	0	31.44	0	no	no	no
4324	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	3.5	Stable	No	No			No	0	25.89	0	no	no	no
4325	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	I	27	39.5	Unstable	No	No	Signature.6	ARID1A | CHEK1 | MSH2 | PARP1	Yes	0	30.85	0	mut-MMRd	mut-MMRd	yes
4326	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	14	6.1		No	No	Signature.4		No	1	1.94	0	no	no	no
4327	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	0	6.1	Stable	No	No			No	1	18.27	0	no	no	no
4328	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	0	4.4		No	No			Yes	1	0.92	0	no	no	no
4329	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	III	29	12.3		No	No	Signature.4	MUTYH	Yes	0	31.97	0	no	no	no
4330	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2017	IV	252	2.6	Stable	No	Yes or Unknown	Signature.1		No	1	19.61	0	no	no	no
4331	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	IV	41	14	Stable	No	No	Signature.4	MSH2	No	1	2.92	0	no	no	no
4332	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	267	5.3	Stable	No	Yes or Unknown			No	0	10.68	0	no	no	no
4333	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	34	3.5		No	No			No	0	25.49	0	no	no	no
4334	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	6.1	Stable	No	No		ARID1A	No	0	27.93	0	no	no	yes
4335	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	21	7	Stable	No	No	Signature.1	ARID1A | BRIP1	No	0	30.95	0	no	no	yes
4336	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	0	3.5	Stable	No	No			No	1	15.34	0	no	no	no
4337	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	1	0.9	Stable	No	No			No	0	23.13	0	no	no	no
4338	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	11	3.5		No	No		RAD51C	Yes	1	4.37	0	no	no	no
4339	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	IV	0	5.3		No	No	Signature.27		No	1	13.17	0	no	no	no
4340	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	III	246	0	Stable	No	No			No	0	17.02	0	no	no	no
4341	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	364	5.3	Stable	No	Yes or Unknown			No	0	25.56	0	no	no	no
4342	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	51	5.3		No	No		CHEK2	No	0	30.36	0	no	no	no
4343	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	57	1.8	Stable	No	No			Yes	0	29.01	0	no	no	no
4344	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	30	4.4	Stable	No	No			No	0	24.44	0	no	no	no
4345	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	257	5.3	Stable	No	Yes or Unknown			No	0	29.86	0	no	no	no
4346	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	II	0	3.5	Stable	No	Yes or Unknown			No	0	30.85	0	no	no	no
4347	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017		0	1.8		No	No			No	0	30.65	0	no	no	no
4348	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	3	2.6		No	Yes or Unknown			No	0	30	0	no	no	no
4349	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	I	28	33.4	Unstable	No	No	Signature.6	ARID1A | BRCA2 | CHEK2 | FANCC | MSH3	No	0	6.41	0	other-MMRd	mut-MMRd	yes
4350	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	30.98	0	no	no	no
4351	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2017		0	2.6		Yes or Unknown	Yes or Unknown			Yes	0	3.61	0	no	no	no
4352	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	245	3.5	Stable	No	Yes or Unknown			No	0	30.75	0	no	no	no
4353	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	54	2.6		No	No			Yes	0	27.2	0	no	no	no
4354	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	33	2.6	Stable	No	No			No	0	25.2	0	no	no	no
4355	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	III	699	1.8	Stable	No	No		FANCA	No	0	32.16	0	no	no	no
4356	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2017	III	111	20.2	Stable	No	No	Signature.7	MUTYH | PALB2	Yes	0	28.78	0	no	no	no
4357	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	19	3.5		No	Yes or Unknown			Yes	0	29.83	0	no	no	no
4358	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	2	0.9	Stable	No	No			No	0	12.65	0	no	no	no
4359	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	IV	586	4.4	Stable	No	Yes or Unknown			No	0	20.93	0	no	no	no
4360	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	182	2.6	Stable	No	Yes or Unknown			Yes	0	31.74	0	no	no	no
4361	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	6	6.1		No	No			No	1	18.07	0	no	no	no
4362	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		12	3.5		Yes or Unknown	Yes or Unknown			No	0	8.11	0	no	no	no
4363	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	104	1.8		No	No			No	0	31.97	0	no	no	no
4364	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	IV	20	2.6	Stable	No	No	Signature.29	MDC1	No	1	27.86	0	no	no	no
4365	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	2.6		No	Yes or Unknown			No	0	29.93	0	no	no	no
4366	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2016	II	42	25.5	Stable	No	No	Signature.13	ARID1A | ATR | BLM	Yes	0	30.26	0	no	no	yes
4367	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	7.69	0	no	no	no
4368	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	26	7.9		No	No	Signature.4		No	0	4.83	0	no	no	no
4369	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	5.3	Stable	No	No	Signature.1	SLX4	No	0	29.47	0	no	no	no
4370	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	9	1.8	Stable	No	No		MUTYH	No	1	26.87	0	no	no	no
4371	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	59	1.8	Stable	No	No			No	0	30.62	0	no	no	no
4372	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	3.5		No	No			No	1	7.06	0	no	no	no
4373	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	31	6.1	Stable	No	No		ERCC4	Yes	0	28.32	0	no	no	no
4374	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	0	0		No	No			No	1	22.83	0	no	no	no
4375	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	28	7.9	Stable	No	No		ARID1A	No	0	25.26	0	no	no	yes
4376	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		0	0.9		No	No			No	0	27.6	0	no	no	no
4377	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	20	1.8	Stable	No	No			No	0	31.74	0	no	no	no
4378	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	26	4.4		No	No			Yes	0	16.07	0	no	no	no
4379	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	22	3.5	Stable	No	No			Yes	0	30.13	0	no	no	no
4380	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	29	2.6		No	No			Yes	0	30	0	no	no	no
4381	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	31.08	0	no	no	no
4382	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	540	3.5	Stable	No	Yes or Unknown	Signature.13		No	1	21.36	0	no	no	no
4383	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	IV	33	4.4	Stable	No	No			No	1	17.51	0	no	no	no
4384	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	49	0.9	Stable	No	No			No	0	27.17	0	no	no	no
4385	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	30	1.8		No	No			No	0	30.59	0	no	no	no
4386	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	26	4.4	Stable	No	No			No	0	30.16	0	no	no	no
4387	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	14	1.8		No	Yes or Unknown			No	0	29.37	0	no	no	no
4388	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	41	9.7		No	No	Signature.2		No	0	26.87	0	no	no	no
4389	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	16	4.4	Stable	No	No			Yes	0	29.24	0	no	no	no
4390	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	2.6		No	No		BRCA1	No	0	27.07	0	no	no	no
4391	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	239	3.5	Stable	No	Yes or Unknown			No	0	29.9	0	no	no	no
4392	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	40	0.9	Stable	No	Yes or Unknown			No	0	27.3	0	no	no	no
4393	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	138	1.8	Stable	No	Yes or Unknown			No	0	8.94	0	no	no	no
4394	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	40	4.4		No	No		ATR	No	0	26.61	0	no	no	no
4395	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2017	II	321	7.9	Stable	No	Yes or Unknown	Signature.13	ARID1A | MSH6	No	0	30.82	0	no	no	yes
4396	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	52	7.9	Stable	No	No	Signature.1		Yes	0	30.49	0	no	no	no
4397	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2017	I	49	4.4	Stable	No	No			No	0	27.17	0	no	no	no
4398	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	0	3.5	Stable	No	No		ARID1A | ATM	Yes	1	8.21	0	no	no	yes
4399	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	50	8.8	Stable	No	No	Signature.2	PMS1	Yes	1	30.59	0	no	no	no
4400	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	23	1.8		No	No			No	0	30.88	0	no	no	no
4401	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	III	0	5.3	Stable	No	No			Yes	0	30.62	0	no	no	no
4402	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	27.76	0	no	no	no
4403	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	26	5.3	Stable	No	No		ARID1A	No	0	32.82	0	no	no	yes
4404	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	91	3.5	Stable	No	No			No	0	29.83	0	no	no	no
4405	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	0	2.6	Stable	No	No		BRCA2	No	0	30.62	0	no	no	no
4406	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	0	30.09	0	no	no	no
4407	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	13	3.5		No	No		PALB2	Yes	1	8.94	0	no	no	no
4408	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	IV	5	2.6	Stable	No	No			No	1	11.01	0	no	no	no
4409	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	29	7.9	Stable	No	No		ATM	No	0	30.85	0	no	no	no
4410	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	31.93	0	no	no	no
4411	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	79	0	Stable	No	Yes or Unknown			No	0	32.23	0	no	no	no
4412	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	36	0.9	Stable	No	No			Yes	0	23.2	0	no	no	no
4413	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	10	3.5		No	Yes or Unknown			No	0	30.32	0	no	no	no
4414	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	III	22	8.8	Stable	No	No	Signature.25	ATR | CHEK2	No	1	2.5	0	no	no	no
4415	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	I	692	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	29.73	0	no	no	no
4416	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	762	4.4	Stable	No	Yes or Unknown			No	0	27.56	0	no	no	no
4417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.3	MSH2	No	1	5.82	0	no	no	no
4418	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	I	107	32.5	Unstable	No	No	Signature.1	NBN | SLX4	No	0	31.74	0	other-MMRd	mut-MMRd	no
4419	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	8	12.3	Stable	No	No	Signature.1	ATR	No	0	27.1	0	no	no	no
4420	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	4.4	Stable	No	No		ARID1A	Yes	0	25.17	0	no	no	yes
4421	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	68	1.8	Stable	No	No			No	0	26.41	0	no	no	no
4422	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	130	7	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	7.66	0	no	no	yes
4423	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	48	3.5	Stable	No	No	Signature.3		No	0	25.99	0	no	no	no
4424	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	20	6.1		No	No		ARID1A	Yes	1	3.02	0	no	no	yes
4425	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0	Stable	No	No			No	0	28.29	0	no	no	no
4426	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	45	7.9	Stable	No	No	Signature.1	ARID1A	Yes	1	2.56	0	no	no	yes
4427	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	15	0.9		No	No			No	0	30.62	0	no	no	no
4428	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	378	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	24.71	0	no	no	no
4429	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			No	1	9.26	0	no	no	no
4430	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0	Stable	No	No			No	0	26.94	0	no	no	no
4431	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	III	38	41.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC4 | MDC1 | MSH3	Yes	1	3.58	0	other-MMRd	mut-MMRd	yes
4432	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	23	0.9		No	No			No	0	29.7	0	no	no	no
4433	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	I	26	0.9	Stable	No	No			No	0	30.26	0	no	no	no
4434	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.5		No	1	28.25	0	no	no	no
4435	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	194	3.5	Stable	No	Yes or Unknown			No	0	30.39	0	no	no	no
4436	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	55	1.8	Stable	No	No	Signature.12		No	0	30.69	0	no	no	no
4437	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	729	5.3	Stable	No	Yes or Unknown			No	0	31.74	0	no	no	no
4438	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	2.6	Stable	No	No			No	0	9.53	0	no	no	no
4439	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	1.8	Stable	No	No			No	0	24.87	0	no	no	no
4440	Non-ICI treated	Never received ICI	21 - 25	Female	NSCLC	2017	IV	191	8.8	Stable	No	Yes or Unknown	Signature.13	CHEK2 | TP53BP1	No	0	29.27	0	no	no	no
4441	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.87	0	no	no	no
4442	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	14.9	Stable	No	No	Signature.4	XRCC2	Yes	1	9.92	0	no	no	no
4443	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	34	14.9		No	No	Signature.26		Yes	0	30.42	0	no	no	no
4444	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	36	2.6	Stable	No	No		MRE11A	No	0	29.47	0	no	no	no
4445	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	II	0	8.8	Stable	No	No	Signature.29	RAD50	No	0	7.16	0	no	no	no
4446	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	7	1.8	Stable	No	Yes or Unknown			No	0	29.86	0	no	no	no
4447	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	20	0.9		No	No			No	0	27.27	0	no	no	no
4448	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	27	4.4	Stable	No	No			Yes	0	27.3	0	no	no	no
4449	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	14.9	Stable	No	Yes or Unknown	Signature.6	ARID1A | MLH1	Yes	0	24.54	0	no	no	yes
4450	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	I	64	0.9	Stable	No	No			No	0	3.02	0	no	no	no
4451	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	25	8.8	Stable	No	No		ARID1A	No	0	29.08	0	no	no	yes
4452	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	20	4.4	Stable	No	No		MUTYH	No	0	30.52	0	no	no	no
4453	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	25	8.8	Stable	No	No	Signature.1		No	0	30.75	0	no	no	no
4454	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		0	1.8		Yes or Unknown	Yes or Unknown			Yes	0	18.07	0	no	no	no
4455	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	48	7	Stable	No	Yes or Unknown			No	0	30.13	0	no	no	no
4456	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	13	4.4	Stable	No	No		CHEK1	No	1	9.2	0	no	no	no
4457	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	0		No	No			No	0	29.67	0	no	no	no
4458	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	29	1.8	Stable	No	No			No	0	28.65	0	no	no	no
4459	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	IV	24	1.8	Stable	No	No			No	0	29.27	0	no	no	no
4460	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		4	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	10.18	0	no	no	no
4461	Non-ICI treated	Never received ICI	86 - 90	Female	Ovarian	2017	IV	125	4.4	Stable	No	Yes or Unknown			No	0	30.59	0	no	no	no
4462	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	39	3.5	Stable	No	No			No	0	28.39	0	no	no	no
4463	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	44	15.8	Unstable	No	No	Signature.6	ATM | MSH2	Yes	0	25.53	0	mut-MMRd	mut-MMRd	no
4464	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	0	0	Stable	No	No			No	0	30.98	0	no	no	no
4465	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		2	4.4	Stable	No	No			No	1	15.18	0	no	no	no
4466	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	9	4.4	Indeterminate	No	No			Yes	0	28.09	0	no	no	no
4467	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	22	2.6	Stable	No	Yes or Unknown			Yes	0	29.7	0	no	no	no
4468	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	0	0	Stable	No	No			No	0	28.42	0	no	no	no
4469	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	16	3.5	Stable	No	No			Yes	0	26.64	0	no	no	no
4470	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016		319	2.6	Stable	No	Yes or Unknown			Yes	0	12.09	0	no	no	no
4471	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	IV	29	2.6	Stable	No	No		RAD50	No	1	10.25	0	no	no	no
4472	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	7.9	Stable	No	No			No	0	28.62	0	no	no	no
4473	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	5.3	Stable	No	No			No	1	25.89	0	no	no	no
4474	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	71	7	Stable	No	Yes or Unknown			No	1	12.81	0	no	no	no
4475	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	31	2.6	Stable	No	Yes or Unknown			No	0	29.5	0	no	no	no
4476	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	45	0	Stable	No	No			Yes	0	27.47	0	no	no	no
4477	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	4.4	Stable	No	No			Yes	0	6.47	0	no	no	no
4478	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	749	0.9	Stable	No	Yes or Unknown			Yes	0	28.42	0	no	no	no
4479	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		23	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	26.41	0	no	no	no
4480	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017		0	0		No	No			No	0	30.19	0	no	no	no
4481	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	5.3	Stable	No	Yes or Unknown		MSH6	No	0	25.99	0	no	no	no
4482	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	IV	98	0		No	Yes or Unknown			No	0	30.32	0	no	no	no
4483	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	0	30.13	0	no	no	no
4484	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	128	3.5	Stable	No	Yes or Unknown			No	0	30.19	0	no	no	no
4485	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	261	2.6	Stable	No	Yes or Unknown			No	0	28.75	0	no	no	no
4486	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	98	4.4	Stable	No	Yes or Unknown	Signature.3		No	1	17.97	0	no	no	no
4487	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	26	2.6	Stable	No	Yes or Unknown			No	0	24.97	0	no	no	no
4488	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	868	2.6	Stable	No	Yes or Unknown			No	0	31.05	0	no	no	no
4489	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	0	0	Stable	No	Yes or Unknown			No	0	31.64	0	no	no	no
4490	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	IV	51	14.9	Stable	No	Yes or Unknown	Signature.2		No	1	20.3	0	no	no	no
4491	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	165	4.4	Stable	No	Yes or Unknown	Signature.10	NBN	No	1	11.4	0	no	no	no
4492	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	45	4.4	Stable	No	No	Signature.24	BRIP1	Yes	0	28.58	0	no	no	no
4493	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			Yes	0	24.71	0	no	no	no
4494	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	30.32	0	no	no	no
4495	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	IV	44	12.3	Stable	No	No	Signature.13	ARID1A | ATM | MSH2	No	0	4.9	0	no	no	yes
4496	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	III	12	1.8	Stable	No	No			No	0	5.72	0	no	no	no
4497	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	64	7		No	No	Signature.6		Yes	1	8.31	0	no	no	no
4498	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	90	3.5	Stable	No	Yes or Unknown		BRCA2	No	0	28.88	0	no	no	no
4499	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	283	0	Stable	No	Yes or Unknown			Yes	0	29.73	0	no	no	no
4500	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	0.9	Stable	No	No			Yes	0	24.64	0	no	no	no
4501	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown		PARP1	No	0	24.05	0	no	no	no
4502	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	3	8.8	Stable	No	No	Signature.13		Yes	0	29.21	0	no	no	no
4503	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	175	0	Stable	No	No			No	0	30.06	0	no	no	no
4504	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	26.48	0	no	no	no
4505	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	0	5.3	Stable	No	No	Signature.6		No	0	26.35	0	no	no	no
4506	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	15	4.4		No	No	Signature.26	BRCA2	Yes	0	29.73	0	no	no	no
4507	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	14	2.6	Stable	No	No		ATM	No	1	2.99	0	no	no	no
4508	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	24	6.1	Stable	No	No	Signature.2		No	0	25.59	0	no	no	no
4509	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	4.4		No	No		RAD50	No	1	20.6	0	no	no	no
4510	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	52	65.8	Stable	No	Yes or Unknown	Signature.2	ARID1A | ATM | ERCC2 | ERCC3 | ERCC4 | ERCC5 | FANCA | PMS2 | RAD50 | TP53BP1	No	0	29.24	0	no	no	yes
4511	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	218	4.4	Stable	No	Yes or Unknown			No	1	27.6	0	no	no	no
4512	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	0	28.58	0	no	no	no
4513	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	0.9	Stable	No	Yes or Unknown			No	0	30.92	0	no	no	no
4514	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	7	Stable	No	No			No	0	17.91	0	no	no	no
4515	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	9	2.6	Stable	No	Yes or Unknown			No	0	30.09	0	no	no	no
4516	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	27	4.4	Stable	No	Yes or Unknown		MSH6	No	0	5.82	0	no	no	no
4517	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	29	0		No	No			No	0	29.93	0	no	no	no
4518	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	20	1.8	Stable	No	No			No	0	13.34	0	no	no	no
4519	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	33	0.9	Stable	No	Yes or Unknown			No	0	29.8	0	no	no	no
4520	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	19	0.9		No	No			Yes	0	26.18	0	no	no	no
4521	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		3	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	29.44	0	no	no	no
4522	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4		No	No	Signature.5	CHEK2	No	0	24.74	0	no	no	no
4523	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	4	7		No	No	Signature.4	BRIP1	Yes	0	1.77	0	no	no	no
4524	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	I	24	8.8	Stable	No	No	Signature.4	ATM | BRCA2	No	0	26.15	0	no	no	no
4525	Non-ICI treated	Never received ICI	81 - 85	Male	Sarcoma	2018	III	47	0	Stable	No	No			No	0	13.57	0	no	no	no
4526	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	65	4.4	Stable	No	Yes or Unknown			Yes	0	29.54	0	no	no	no
4527	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2017		0	0	Stable	No	No			No	0	27.79	0	no	no	no
4528	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	53	14	Stable	No	No	Signature.18		No	0	29.34	0	no	no	no
4529	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	12	5.3	Stable	No	No		ARID1A	No	0	28.55	0	no	no	yes
4530	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		1	3.5	Stable	No	No		BRCA1	No	0	11.01	0	no	no	no
4531	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	100	0.9	Stable	No	No			No	0	27.63	0	no	no	no
4532	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	15.38	0	no	no	no
4533	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	0	0.9	Stable	No	No			No	0	28.25	0	no	no	no
4534	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	7.9	Stable	No	No	Signature.18	ARID1A	No	0	29.86	0	no	no	yes
4535	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	28.58	0	no	no	no
4536	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	27.33	0	no	no	no
4537	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	11.4	Stable	No	No	Signature.4		No	0	25.03	0	no	no	no
4538	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	92	2.6	Stable	No	No			No	0	30.98	0	no	no	no
4539	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	440	2.6	Stable	No	Yes or Unknown			No	1	29.04	0	no	no	no
4540	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	0	13.2	Stable	No	No	Signature.1	ARID1A	Yes	0	29.57	0	no	no	yes
4541	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	29	2.6	Stable	No	Yes or Unknown			Yes	0	7.66	0	no	no	no
4542	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			No	0	2.79	0	no	no	no
4543	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	186	2.6	Stable	No	No	Signature.1		No	1	11.86	0	no	no	no
4544	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	21	3.5	Stable	No	No			No	0	21.98	0	no	no	no
4545	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	24	2.6	Stable	No	No			Yes	0	28.16	0	no	no	no
4546	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2017	III	0	0	Stable	No	No			No	0	29.47	0	no	no	no
4547	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	82	3.5	Stable	No	No			Yes	0	27.6	0	no	no	no
4548	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	50	0.9	Stable	No	Yes or Unknown			No	0	30.16	0	no	no	no
4549	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	24	13.2	Stable	No	No	Signature.4	ARID1A | ERCC5	No	0	30.23	0	no	no	yes
4550	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	36	4.4	Stable	No	Yes or Unknown			No	1	22.31	0	no	no	no
4551	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	22	1.8	Stable	No	Yes or Unknown			Yes	0	28.98	0	no	no	no
4552	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	14	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	29.21	0	no	no	no
4553	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	33	5.3	Stable	No	No			No	0	17.84	0	no	no	no
4554	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	35	6.1	Stable	No	No			No	1	20.96	0	no	no	no
4555	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	2.6	Stable	No	No			No	0	25.99	0	no	no	no
4556	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	0	6.1	Stable	No	No		ARID1A	No	0	25.56	0	no	no	yes
4557	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	22	35.1	Stable	No	No	Signature.6	ARID1A	No	0	20.34	0	no	no	yes
4558	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	10	13.2		No	No	Signature.4		Yes	1	5.72	0	no	no	no
4559	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2017	IV	21	7	Stable	No	No	Signature.29	BRCA2	Yes	1	20.9	0	no	no	no
4560	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	6	3.5	Stable	No	No			No	1	1.68	0	no	no	no
4561	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	8	4.4	Stable	No	No			No	1	7.62	0	no	no	no
4562	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	177	0.9	Stable	No	Yes or Unknown			No	0	19.84	0	no	no	no
4563	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	21	3.5	Stable	No	No			No	0	27.99	0	no	no	no
4564	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	27	5.3	Stable	No	No			No	0	26.05	0	no	no	no
4565	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	809	10.5	Stable	No	Yes or Unknown	Signature.1		No	0	30.16	0	no	no	no
4566	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	17	4.4	Stable	No	No			No	1	26.55	0	no	no	no
4567	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	577	1.8	Stable	No	Yes or Unknown	Signature.5		No	0	30.09	0	no	no	no
4568	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	360	5.3	Stable	No	No			No	0	30.03	0	no	no	no
4569	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	9.7	Stable	No	No	Signature.3	ATR	Yes	0	27.56	0	no	no	no
4570	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	14	7	Stable	No	No	Signature.19	TP53BP1	Yes	0	28.39	0	no	no	no
4571	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	0	29.9	0	no	no	no
4572	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	30.32	0	no	no	no
4573	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	III	27	0.9	Stable	No	Yes or Unknown			No	0	28.98	0	no	no	no
4574	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	23	0.9	Stable	No	No			No	0	23.89	0	no	no	no
4575	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	7	5.3	Stable	No	No		ARID1A | FANCC	Yes	1	3.71	0	no	no	yes
4576	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	15	0.9	Stable	No	No			No	0	29.31	0	no	no	no
4577	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	0	3.5	Stable	No	No		BRCA1	No	0	29.8	0	no	no	no
4578	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	0	1.8	Stable	No	No			No	1	27.47	0	no	no	no
4579	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	28	0.9	Stable	No	Yes or Unknown			No	0	26.18	0	no	no	no
4580	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	21	2.6	Stable	No	No			No	0	27.66	0	no	no	no
4581	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		41	1.8	Stable	No	No			No	0	3.12	0	no	no	no
4582	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	1	6.1		No	No			No	1	18.96	0	no	no	no
4583	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	1	7.9	Stable	No	No	Signature.1		No	1	28.88	0	no	no	no
4584	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	IV	0	8.8	Stable	No	No	Signature.1		No	1	11.07	0	no	no	no
4585	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		6	0.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	3.55	0	no	no	no
4586	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	29.21	0	no	no	no
4587	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	2.6	Stable	No	No		MSH3	No	0	29.77	0	no	no	no
4588	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	23.46	0	no	no	no
4589	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	1	10.84	0	no	no	no
4590	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	26.61	0	no	no	no
4591	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	7	Stable	No	No		PMS2	No	1	1.18	0	no	no	no
4592	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	26	0.9	Stable	No	No			No	0	14.92	0	no	no	no
4593	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	9	6.1	Stable	No	No			No	1	20.34	0	no	no	no
4594	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	220	2.6	Stable	No	Yes or Unknown			No	0	29.37	0	no	no	no
4595	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	64	5.3	Stable	No	No			No	0	20.73	0	no	no	no
4596	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	27	6.1	Stable	No	No	Signature.1	ATM | ERCC2	Yes	1	2.17	0	no	no	no
4597	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	I	0	0	Stable	No	No			No	0	18.14	0	no	no	no
4598	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	286	3.5	Stable	No	Yes or Unknown			No	0	32.13	0	no	no	no
4599	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	28	4.4	Stable	No	No		ATM	Yes	0	28.48	0	no	no	no
4600	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	17	4.4	Stable	No	No		CHEK2	No	0	27.17	0	no	no	no
4601	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	0	5.3	Stable	No	Yes or Unknown			Yes	0	24.11	0	no	no	no
4602	Non-ICI treated	Never received ICI	26 - 30	Male	Head & Neck	2017	IV	0	8.8	Stable	No	No		ARID1A	Yes	0	30.03	0	no	no	yes
4603	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	39	6.1	Stable	No	Yes or Unknown	Signature.2		Yes	0	27.14	0	no	no	no
4604	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	39	4.4	Stable	No	No			No	0	20.5	0	no	no	no
4605	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	II	7	9.7	Stable	No	No	Signature.1	FANCA	No	0	3.52	0	no	no	no
4606	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	18.53	0	no	no	no
4607	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	369	3.5	Stable	No	Yes or Unknown			No	1	23.16	0	no	no	no
4608	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	22	4.4	Stable	No	No			No	1	7.89	0	no	no	no
4609	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	409	10.5	Stable	No	Yes or Unknown	Signature.2	CHEK2	No	0	29.9	0	no	no	no
4610	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	24	9.7		No	No	Signature.24		Yes	1	2.27	0	no	no	no
4611	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	III	673	2.6	Stable	No	Yes or Unknown			No	0	29.24	0	no	no	no
4612	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	50	3.5	Stable	No	No			No	0	28.42	0	no	no	no
4613	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	26	7	Stable	No	No	Signature.29		No	0	4.34	0	no	no	no
4614	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	10.02	0	no	no	no
4615	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	37	2.6	Stable	No	Yes or Unknown		PALB2	No	0	23.85	0	no	no	no
4616	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	48	40.4	Stable	No	No	Signature.4	ATR | BRCA1	No	0	12.65	0	no	no	no
4617	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	26.51	0	no	no	no
4618	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	IV	0	1.8		No	Yes or Unknown			No	0	29.73	0	no	no	no
4619	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	17	1.8	Stable	No	No			No	0	28.68	0	no	no	no
4620	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	257	3.5	Stable	No	Yes or Unknown			No	1	19.71	0	no	no	no
4621	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	26.15	0	no	no	no
4622	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	29.34	0	no	no	no
4623	Non-ICI treated	Never received ICI	86 - 90	Female	Sarcoma	2017	III	42	0.9	Stable	No	Yes or Unknown			Yes	0	8.71	0	no	no	no
4624	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	16	2.6	Stable	No	No			No	0	29.47	0	no	no	no
4625	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		71	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	29.21	0	no	no	no
4626	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	28.29	0	no	no	no
4627	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	28	3.5	Stable	No	No		PALB2	No	0	26.12	0	no	no	no
4628	Non-ICI treated	Never received ICI	61 - 65	Female	Esophageal	2017	IV	0	6.1	Stable	No	No			No	1	14.95	0	no	no	no
4629	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	12.75	0	no	no	no
4630	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			Yes	0	29.37	0	no	no	no
4631	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	33	2.6	Stable	No	No			No	0	30.06	0	no	no	no
4632	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	0	4.4	Stable	No	No		ERCC5	Yes	0	28.22	0	no	no	no
4633	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		22	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	3.52	0	no	no	no
4634	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	27	4.4	Stable	No	No	Signature.1		No	1	14.62	0	no	no	no
4635	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	I	35	4.4	Stable	No	No	Signature.4		No	0	16.49	0	no	no	no
4636	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	1.8	Stable	No	Yes or Unknown			Yes	0	28.88	0	no	no	no
4637	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	7	8.8	Stable	No	No	Signature.6		Yes	1	10.05	0	no	no	no
4638	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	28	1.8	Stable	No	No			Yes	0	2.89	0	no	no	no
4639	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	21	5.3	Stable	No	No			Yes	0	29.27	0	no	no	no
4640	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2017		42	0.9	Stable	No	No			No	0	23.46	0	no	no	no
4641	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		2	4.4	Stable	No	No			Yes	1	6.11	0	no	no	no
4642	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	I	0	2.6	Stable	No	No		NBN	Yes	0	26.55	0	no	no	no
4643	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	33	2.6	Stable	No	No			Yes	0	29.17	0	no	no	no
4644	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	442	9.7	Stable	No	Yes or Unknown	Signature.3		No	1	21.16	0	no	no	no
4645	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			No	0	29.4	0	no	no	no
4646	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	174	1.8	Stable	No	Yes or Unknown			No	0	29.83	0	no	no	no
4647	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	33	37.7	Unstable	No	No	Signature.1	ARID1A | ATM | MSH2 | MSH6	No	0	25.63	0	mut-MMRd	mut-MMRd	yes
4648	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	II	14	57.9	Unstable	No	No	Signature.6	ARID1A | FANCA | MSH3 | XRCC2	Yes	0	27.6	0	other-MMRd	mut-MMRd	yes
4649	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	237	6.1	Stable	No	Yes or Unknown			No	1	9.26	0	no	no	no
4650	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	30.16	0	no	no	no
4651	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.18		No	0	29.63	0	no	no	no
4652	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	49	2.6	Stable	No	Yes or Unknown			Yes	0	25.4	0	no	no	no
4653	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	102	1.8	Stable	No	No			Yes	0	30.72	0	no	no	no
4654	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	13.47	0	no	no	no
4655	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	III	16	36	Unstable	No	No	Signature.6	ATM | BLM | CHEK2 | MDC1	No	0	24.57	0	other-MMRd	mut-MMRd	no
4656	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	II	0	3.5	Stable	No	No		ATM	No	0	21.36	0	no	no	no
4657	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	62	1.8	Stable	No	No			No	1	15.44	0	no	no	no
4658	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	49	2.6	Stable	No	Yes or Unknown			No	0	30.09	0	no	no	no
4659	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	26	2.6	Stable	No	No			No	0	28.55	0	no	no	no
4660	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	36	115	Unstable	No	No	Signature.6	ATM | BRCA2 | BRIP1 | MDC1 | MLH1 | MSH2 | MSH3 | PALB2 | PMS1 | TP53BP1	No	0	26.22	0	mut-MMRd	mut-MMRd	no
4661	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	2	10.5	Stable	No	No	Signature.4	BRCA2 | MDC1	No	0	29.04	0	no	no	no
4662	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	III	0	15.8	Stable	No	No	Signature.4		No	1	24.84	0	no	no	no
4663	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	3.5	Stable	No	No		ATR	Yes	0	29.08	0	no	no	no
4664	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	35	13.2	Stable	No	No	Signature.2	RAD51	No	0	25.89	0	no	no	no
4665	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	0	3.5	Stable	No	No			No	0	15.18	0	no	no	no
4666	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	35	3.5	Stable	No	No			Yes	0	24.08	0	no	no	no
4667	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		5	7	Stable	No	No			No	1	26.25	0	no	no	no
4668	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	12	2.6	Stable	No	No			Yes	1	20.83	0	no	no	no
4669	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	42	7	Stable	No	No			Yes	0	28.55	0	no	no	no
4670	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	146	1.8	Stable	No	No	Signature.5		No	0	27.47	0	no	no	no
4671	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	21	4.4	Stable	No	No		MSH2	No	0	29.24	0	no	no	no
4672	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	IV	28	33.4	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | PALB2	No	1	5.82	0	other-MMRd	mut-MMRd	yes
4673	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	54	2.6	Stable	No	Yes or Unknown			Yes	0	26.41	0	no	no	no
4674	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	29	0.9	Stable	No	No			No	0	24.08	0	no	no	no
4675	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	III	0	0.9	Stable	No	No			Yes	0	14.82	0	no	no	no
4676	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	29	6.1	Stable	No	No			No	0	27.4	0	no	no	no
4677	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	15.8	Indeterminate	No	No	Signature.13	ARID1A	No	1	5.68	0	no	no	yes
4678	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	11	2.6	Stable	No	No			Yes	1	8.21	0	no	no	no
4679	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		9	0	Stable	No	No			No	0	21.45	0	no	no	no
4680	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	20	0.9	Stable	No	No			No	0	28.45	0	no	no	no
4681	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	1	20.76	0	no	no	no
4682	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	25.03	0	no	no	no
4683	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	19	3.5	Stable	No	No			No	0	28.81	0	no	no	no
4684	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2017	IV	196	18.4	Stable	No	Yes or Unknown	Signature.13	ATM | MDC1	No	0	29.54	0	no	no	no
4685	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	20	5.3	Stable	No	No		ATM | MSH6	No	0	29.17	0	no	no	no
4686	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	19	6.1	Stable	No	No			No	0	23.2	0	no	no	no
4687	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2017	I	7	2.6	Stable	No	No			Yes	1	7.69	0	no	no	no
4688	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	35	0.9	Stable	No	No			Yes	0	28.09	0	no	no	no
4689	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2017		14	0.9	Stable	No	No			Yes	0	28.35	0	no	no	no
4690	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	141	2.6	Stable	No	No			No	0	32	0	no	no	no
4691	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	6.1	Stable	No	No			Yes	0	29.01	0	no	no	no
4692	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2017	II	13	3.5	Stable	No	No			No	0	24.61	0	no	no	no
4693	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	14	4.4	Stable	No	No			No	0	21.32	0	no	no	no
4694	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	0.9	Stable	No	Yes or Unknown			No	0	28.88	0	no	no	no
4695	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	28.29	0	no	no	no
4696	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	9.7	Stable	No	Yes or Unknown	Signature.13	MDC1	No	0	27.14	0	no	no	no
4697	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	19	4.4	Stable	No	No			Yes	1	5.68	0	no	no	no
4698	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	29.47	0	no	no	no
4699	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017	IV	0	2.6	Stable	No	No			Yes	0	27.04	0	no	no	no
4700	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	143	0	Stable	No	Yes or Unknown	Signature.5		No	0	29.17	0	no	no	no
4701	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	4.4	Indeterminate	No	No	Signature.4		No	0	28.32	0	no	no	no
4702	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	154	0.9	Stable	No	Yes or Unknown			No	0	27.66	0	no	no	no
4703	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0	Stable	No	No		MLH1	No	0	29.04	0	no	no	no
4704	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	21.39	0	no	no	no
4705	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	2.6	Stable	No	No		MSH2	No	0	23.85	0	no	no	no
4706	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	18	36.9	Unstable	No	No	Signature.6	ARID1A | NTHL1	Yes	0	20.9	0	other-MMRd	mut-MMRd	yes
4707	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	455	16.7	Stable	No	Yes or Unknown	Signature.13	ATR | BRCA2 | MRE11A | RAD50 | SLX4	Yes	0	20.47	0	no	no	no
4708	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	18	5.3	Stable	No	No			No	1	3.58	0	no	no	no
4709	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	31	1.8	Stable	No	Yes or Unknown			Yes	0	29.11	0	no	no	no
4710	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	632	3.5	Stable	No	Yes or Unknown			Yes	0	29.31	0	no	no	no
4711	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	29	3.5	Stable	No	No		BRCA1	No	0	25.82	0	no	no	no
4712	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	15	7	Stable	No	No	Signature.1		Yes	0	28.58	0	no	no	no
4713	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	518	4.4	Stable	No	Yes or Unknown	Signature.3	PARP1	No	0	29.17	0	no	no	no
4714	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	176	6.1	Stable	No	No			No	0	33.12	0	no	no	no
4715	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2017	IV	0	4.4	Stable	No	No		ARID1A	No	0	10.35	0	no	no	yes
4716	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	II	0	28.1	Stable	No	No	Signature.13	BRCA2 | CHEK2 | ERCC5 | RAD54L | SLX4	Yes	0	28.75	0	no	no	no
4717	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	54	3.5	Stable	No	No			Yes	0	28.52	0	no	no	no
4718	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	5	5.3	Stable	No	No			Yes	0	9.03	0	no	no	no
4719	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	8.77	0	no	no	no
4720	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	10	1.8	Stable	No	No			No	0	28.85	0	no	no	no
4721	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	23.33	0	no	no	no
4722	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	20	0.9	Stable	No	No			No	0	25.63	0	no	no	no
4723	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	0	29.67	0	no	no	no
4724	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	726	0.9	Stable	No	Yes or Unknown			No	0	29.21	0	no	no	no
4725	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	43	228.2	Stable	No	No	Signature.10	ARID1A | ATM | BRCA1 | BRCA2 | ERCC4 | ERCC5 | FANCC | MRE11A | MSH3 | MSH6 | PMS1 | PMS2 | RAD50 | SLX4 | TP53BP1	No	0	26.91	0	no	no	yes
4726	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	0.9	Stable	No	No			Yes	0	25.07	0	no	no	no
4727	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	21	4.4	Stable	No	No			No	0	27.37	0	no	no	no
4728	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	20	7	Stable	No	No	Signature.13	BRCA2	No	0	29.14	0	no	no	no
4729	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	29	40.4	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA2 | ERCC3 | MLH1	No	0	20.53	0	mut-MMRd	mut-MMRd	yes
4730	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	II	0	3.5	Stable	No	No	Signature.3	ATR	Yes	1	15.15	0	no	no	no
4731	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	9.7	Stable	No	No	Signature.17	ARID1A	No	1	13.11	0	no	no	yes
4732	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	28	7	Stable	No	No			No	0	25.1	0	no	no	no
4733	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	365	4.4	Stable	No	Yes or Unknown	Signature.3		No	0	31.34	0	no	no	no
4734	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	21	3.5	Stable	No	No			No	0	29.96	0	no	no	no
4735	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	28.39	0	no	no	no
4736	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	76	3.5	Stable	No	No			No	0	24.84	0	no	no	no
4737	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	28	2.6	Stable	No	No			Yes	0	27.4	0	no	no	no
4738	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2017	III	0	3.5	Stable	No	No			Yes	0	24.77	0	no	no	no
4739	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	175	0		No	Yes or Unknown			No	0	30.09	0	no	no	no
4740	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	56	4.4	Stable	No	No			No	0	30.09	0	no	no	no
4741	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No			No	1	15.8	0	no	no	no
4742	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	I	0	0	Stable	No	No	Signature.1		No	0	18.99	0	no	no	no
4743	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	128	3.5	Stable	No	Yes or Unknown		ARID1A	No	1	10.18	0	no	no	yes
4744	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	30	1.8	Stable	No	No			No	0	26.02	0	no	no	no
4745	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	5.3	Stable	No	No			No	1	17.12	0	no	no	no
4746	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	33	5.3	Stable	No	No	Signature.2	MSH6	Yes	0	28.09	0	no	no	no
4747	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	II	0	4.4	Stable	No	No			No	0	7.82	0	no	no	no
4748	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		6	6.1	Stable	Yes or Unknown	Yes or Unknown			No	0	10.61	0	no	no	no
4749	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	35	1.8	Stable	No	No		ATM	Yes	0	29.24	0	no	no	no
4750	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	429	4.4	Stable	No	No			No	0	14.72	0	no	no	no
4751	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	496	1.8	Stable	No	Yes or Unknown			No	1	20.04	0	no	no	no
4752	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	3.5	Stable	No	No			No	0	25.17	0	no	no	no
4753	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	1	25.13	0	no	no	no
4754	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	16	3.5	Stable	No	Yes or Unknown			No	0	29.7	0	no	no	no
4755	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	19	5.3	Stable	No	No	Signature.19	ARID1A	No	1	5.32	0	no	no	yes
4756	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	23	1.8	Stable	No	No			No	0	25.63	0	no	no	no
4757	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	7.9	Stable	No	Yes or Unknown			No	0	28.55	0	no	no	no
4758	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	4.4	Indeterminate	No	No	Signature.3	RAD54L	No	1	11.93	0	no	no	no
4759	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	41	3.5	Stable	No	No		ARID1A	Yes	1	16.49	0	no	no	yes
4760	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	I	48	0.9	Stable	No	No			No	0	30.09	0	no	no	no
4761	Non-ICI treated	Never received ICI	36 - 40	Male	Bladder	2017	I	0	4.4	Stable	No	No		BRCA2	No	0	28.98	0	no	no	no
4762	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	18	5.3	Stable	No	No			No	0	26.71	0	no	no	no
4763	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	28.85	0	no	no	no
4764	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	392	2.6	Stable	No	Yes or Unknown			No	1	26.09	0	no	no	no
4765	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	33	1.8	Stable	No	No			Yes	0	25.56	0	no	no	no
4766	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	31	3.5	Stable	No	No			No	0	27.2	0	no	no	no
4767	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.5		Yes	1	7.2	0	no	no	no
4768	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	286	8.8	Stable	No	No	Signature.1	BRCA2 | MSH3	Yes	0	29.17	0	no	no	no
4769	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	180	0	Stable	No	Yes or Unknown			No	0	29.86	0	no	no	no
4770	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	IV	12	0	Stable	No	No			Yes	0	3.22	0	no	no	no
4771	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		0	3.5	Stable	No	No			No	0	21.65	0	no	no	no
4772	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	16	7	Stable	No	No	Signature.24		No	1	14.19	0	no	no	no
4773	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2017	II	586	1.8	Stable	No	No			No	0	26.81	0	no	no	no
4774	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	II	8	2.6	Stable	No	No		PALB2	No	1	25.17	0	no	no	no
4775	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	145	0	Stable	No	No			No	1	24.11	0	no	no	no
4776	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	III	6	1.8	Stable	No	No			No	1	20.17	0	no	no	no
4777	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	0	7	Stable	No	Yes or Unknown	Signature.13		No	0	27.99	0	no	no	no
4778	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	8.25	0	no	no	no
4779	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	26.35	0	no	no	no
4780	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	0	6.1	Stable	No	No	Signature.5	RAD50	Yes	0	28.98	0	no	no	no
4781	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	7	2.6	Stable	No	No			No	0	29.17	0	no	no	no
4782	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	3.5	Stable	No	Yes or Unknown		BRCA2	No	0	28.55	0	no	no	no
4783	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	183	0		No	Yes or Unknown			No	0	28.45	0	no	no	no
4784	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	22	1.8	Stable	No	No			No	0	24.84	0	no	no	no
4785	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	1	5.3	Stable	No	No	Signature.6		No	0	29.27	0	no	no	no
4786	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	184	3.5	Stable	No	Yes or Unknown			No	0	26.15	0	no	no	no
4787	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	27.99	0	no	no	no
4788	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	0	6.93	0	no	no	no
4789	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	60	3.5	Stable	No	No		NBN	No	0	27.63	0	no	no	no
4790	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	19	7	Stable	No	No			Yes	0	24.97	0	no	no	no
4791	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	14	11.4	Stable	No	No	Signature.1	ARID1A | FANCC	No	1	17.41	0	no	no	yes
4792	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	13	10.5	Stable	No	No	Signature.1		No	0	29.4	0	no	no	no
4793	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	18	32.5	Unstable	No	No	Signature.6	ARID1A | ATM | FANCA | MSH6 | MUTYH	No	0	26.68	0	mut-MMRd	mut-MMRd	yes
4794	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	1	27.27	0	no	no	no
4795	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown		ATR	No	0	18.86	0	no	no	no
4796	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	46	1.8	Stable	No	No			No	0	23.85	0	no	no	no
4797	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	34	5.3	Stable	No	No			No	0	29.17	0	no	no	no
4798	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	106	7	Stable	No	Yes or Unknown	Signature.15		No	0	29.5	0	no	no	no
4799	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	0.9	Stable	No	No			No	0	26.25	0	no	no	no
4800	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	37	6.1	Stable	No	No	Signature.1		Yes	0	26.64	0	no	no	no
4801	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	22	7	Stable	No	No	Signature.1		Yes	0	26.02	0	no	no	no
4802	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	74	3.5	Stable	No	Yes or Unknown			No	1	6.11	0	no	no	no
4803	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	260	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	30.39	0	no	no	no
4804	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	6.7	0	no	no	no
4805	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	9	1.8	Stable	No	Yes or Unknown			No	0	29.67	0	no	no	no
4806	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	5.29	0	no	no	no
4807	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	3.5	Stable	No	No	Signature.2		No	0	27.96	0	no	no	no
4808	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	IV	42	36.9	Unstable	No	No	Signature.6	ARID1A | MSH6	No	0	28.71	0	mut-MMRd	mut-MMRd	yes
4809	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2017	I	16	4.4	Stable	No	No			No	0	24.11	0	no	no	no
4810	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	24	8.8	Stable	No	No			Yes	0	8.28	0	no	no	no
4811	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		25	3.5	Stable	No	No			No	1	12.25	0	no	no	no
4812	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	224	10.5	Stable	No	No	Signature.2	ERCC4	Yes	0	30.16	0	no	no	no
4813	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No		BRCA1	No	1	25.63	0	no	no	no
4814	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	III	31	1.8	Stable	No	No			Yes	0	27.6	0	no	no	no
4815	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	27	1.8	Stable	No	No			No	0	25.76	0	no	no	no
4816	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	6	8.8	Stable	No	No	Signature.3	BRCA2	No	0	28.29	0	no	no	no
4817	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	27	0.9	Stable	No	No			No	0	25.2	0	no	no	no
4818	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	1.8	Stable	No	No			Yes	0	25.69	0	no	no	no
4819	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2017	I	25	0.9	Stable	No	No			No	0	23.1	0	no	no	no
4820	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	419	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	26.97	0	no	no	no
4821	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	5.3	Stable	No	No		ATM	No	0	14.46	0	no	no	no
4822	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	27	4.4	Stable	No	No		ARID1A	Yes	0	28.71	0	no	no	yes
4823	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	40	2.6	Stable	No	No		MSH3	Yes	0	22.51	0	no	no	no
4824	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	18	5.3	Stable	No	No			No	0	27.17	0	no	no	no
4825	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	26	3.5	Stable	No	No	Signature.20		No	0	28.65	0	no	no	no
4826	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	30	0.9	Stable	No	Yes or Unknown			No	0	28.85	0	no	no	no
4827	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2016	IV	0	4.4	Stable	No	No		ATR	No	0	31.93	0	no	no	no
4828	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	3.5	Stable	No	No		ARID1A	Yes	0	25.76	0	no	no	yes
4829	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017		0	0.9	Stable	No	Yes or Unknown			No	0	28.65	0	no	no	no
4830	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	II	17	1.8	Stable	No	No			No	0	17.84	0	no	no	no
4831	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	82	0.9	Stable	No	No			No	0	31.57	0	no	no	no
4832	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	26	7	Stable	No	Yes or Unknown	Signature.3	ERCC2	No	0	28.78	0	no	no	no
4833	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		5	2.6	Stable	No	No			No	1	27.4	0	no	no	no
4834	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	0	2.6	Stable	No	No		MSH2	No	0	33.97	0	no	no	no
4835	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	0	Stable	No	Yes or Unknown			No	0	29.11	0	no	no	no
4836	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2017	IV	19	0	Stable	No	No			No	1	10.48	0	no	no	no
4837	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	0.9	Stable	No	No		ATM | FANCA	No	0	29.08	0	no	no	no
4838	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	4.11	0	no	no	no
4839	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	III	179	3.5	Stable	No	Yes or Unknown			No	1	22.9	0	no	no	no
4840	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	3.5	Stable	No	No			No	0	28.16	0	no	no	no
4841	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	12	5.3	Stable	No	No		ATM	Yes	0	24.11	0	no	no	no
4842	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	264	5.3	Stable	No	Yes or Unknown			No	0	28.35	0	no	no	no
4843	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	IV	28	2.6	Stable	No	No			No	1	24.34	0	no	no	no
4844	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	44	5.3	Stable	No	No		ARID1A | CHEK2	No	1	17.64	0	no	no	yes
4845	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		BRCA2	No	1	14.88	0	no	no	no
4846	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.6		No	0	30.39	0	no	no	no
4847	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	1	18.83	0	no	no	no
4848	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	III	109	3.5	Stable	No	No	Signature.1		No	0	29.8	0	no	no	no
4849	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	4.4	Stable	No	No	Signature.1		No	0	6.11	0	no	no	no
4850	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	34	0	Stable	No	Yes or Unknown			No	0	28.88	0	no	no	no
4851	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	0	0.9	Stable	No	No			No	0	26.22	0	no	no	no
4852	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	0	0		No	No			No	1	9.63	0	no	no	no
4853	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	44	23.7	Stable	No	No	Signature.6	SLX4	No	0	26.71	0	no	no	no
4854	Non-ICI treated	Never received ICI	31 - 35	Female	Gastric	2016	IV	112	2.6	Stable	No	No	Signature.1		No	0	9.03	0	no	no	no
4855	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		2	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	22.08	0	no	no	no
4856	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	0	3.5	Stable	No	No		ARID1A	No	0	25.92	0	no	no	yes
4857	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	23.1	0	no	no	no
4858	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	154	0	Stable	No	Yes or Unknown			Yes	0	29.9	0	no	no	no
4859	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	1.8	Stable	No	No			Yes	0	26.91	0	no	no	no
4860	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	24	3.5	Stable	No	No	Signature.1		No	1	20.07	0	no	no	no
4861	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	27	4.4	Stable	No	No	Signature.1		Yes	0	26.48	0	no	no	no
4862	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	I	66	10.5		No	No	Signature.5	ATR	No	0	3.35	0	no	no	no
4863	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	27	4.4	Stable	No	No		ARID1A	Yes	0	28.65	0	no	no	yes
4864	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	21.72	0	no	no	no
4865	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	29.11	0	no	no	no
4866	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	28	2.6	Stable	No	No			No	0	28.09	0	no	no	no
4867	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	64	7	Stable	No	No		PALB2	Yes	1	9.3	0	no	no	no
4868	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		2	4.4	Stable	No	No			No	1	7.89	0	no	no	no
4869	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	0	1.8	Stable	No	No			No	1	12.32	0	no	no	no
4870	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	25.99	0	no	no	no
4871	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		166	0	Stable	No	No			No	0	26.41	0	no	no	no
4872	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	III	0	14.9	Stable	No	No	Signature.3	ATM	Yes	0	26.15	0	no	no	no
4873	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	I	29	0	Stable	No	No			No	0	28.78	0	no	no	no
4874	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	6	9.7	Stable	No	No	Signature.22	ARID1A | BRIP1	No	1	6.47	0	no	no	yes
4875	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	4.4	Stable	No	No			No	1	8.61	0	no	no	no
4876	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	12	1.8	Stable	No	No			No	0	25.1	0	no	no	no
4877	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	III	0	7.9	Stable	No	No	Signature.2	MRE11A	Yes	1	11.14	0	no	no	no
4878	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		95	2.6	Stable	No	No			Yes	0	27.1	0	no	no	no
4879	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	17	12.3	Stable	No	No	Signature.4	MDC1	Yes	1	1.74	0	no	no	no
4880	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	25	32.5	Unstable	No	No	Signature.6	ARID1A | PARP1	No	0	19.48	0	other-MMRd	mut-MMRd	yes
4881	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	III	0	2.6	Stable	No	No			Yes	0	2.14	0	no	no	no
4882	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	2.6	Stable	No	No		ARID1A	No	0	28.55	0	no	no	yes
4883	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	IV	126	0	Stable	No	No			No	1	24.94	0	no	no	no
4884	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	III	143	1.8	Indeterminate	No	Yes or Unknown			No	0	28.85	0	no	no	no
4885	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	14.16	0	no	no	no
4886	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	22	4.4	Stable	No	Yes or Unknown			No	1	19.84	0	no	no	no
4887	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	3	2.6	Stable	No	No	Signature.26		Yes	1	6.28	0	no	no	no
4888	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	2.6	Stable	No	No		ERCC5	No	1	7.23	0	no	no	no
4889	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2017	I	0	29.8	Stable	No	No	Signature.2	ATM | ERCC2 | RAD50	Yes	0	26.18	0	no	no	no
4890	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	0.9	Stable	No	No			No	0	21.39	0	no	no	no
4891	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	0	4.4	Stable	No	No		BRCA1	No	0	27.76	0	no	no	no
4892	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	688	0.9	Stable	No	No			No	0	28.45	0	no	no	no
4893	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2017	IV	3	0	Stable	No	No			No	0	28.29	0	no	no	no
4894	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	0	0	Stable	No	No			No	0	23.59	0	no	no	no
4895	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	1	21.82	0	no	no	no
4896	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	II	337	2.6	Stable	No	No			No	0	28.35	0	no	no	no
4897	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	17	5.3	Stable	No	No	Signature.8	BRCA2 | NTHL1	Yes	0	28.45	0	no	no	no
4898	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	20	7	Stable	No	Yes or Unknown	Signature.1	RAD50	No	0	22.37	0	no	no	no
4899	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	715	8.8	Stable	No	No		MSH6	Yes	0	28.25	0	no	no	no
4900	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	III	168	19.3	Stable	No	No	Signature.4	ATM	No	0	23.1	0	no	no	no
4901	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2017	IV	0	7.9	Stable	No	No	Signature.13	ARID1A	No	0	27.83	0	no	no	yes
4902	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	27.33	0	no	no	no
4903	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	5.3	Stable	No	Yes or Unknown			No	0	30.52	0	no	no	no
4904	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	20	5.3	Stable	No	No			No	1	16.72	0	no	no	no
4905	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	17	4.4	Stable	No	Yes or Unknown			No	0	28.02	0	no	no	no
4906	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	70	4.4	Stable	No	No		PALB2	Yes	0	25.2	0	no	no	no
4907	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2017	IV	0	11.4	Stable	No	No	Signature.29	ARID1A | FANCA	Yes	1	12.02	0	no	no	yes
4908	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	II	720	0		No	Yes or Unknown			No	0	28.25	0	no	no	no
4909	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	86	0.9	Stable	No	No			Yes	0	28.62	0	no	no	no
4910	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	28	6.1	Stable	No	No			No	0	27.6	0	no	no	no
4911	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	21	0.9	Stable	No	No			Yes	0	28.48	0	no	no	no
4912	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	48	4.4	Stable	No	No			Yes	0	26.58	0	no	no	no
4913	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	29.7	0	no	no	no
4914	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	3	0.9	Stable	No	No			Yes	0	27.53	0	no	no	no
4915	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017		495	1.8	Stable	No	Yes or Unknown			No	0	30.03	0	no	no	no
4916	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	II	0	6.1	Stable	No	No		BRCA2	No	0	27.24	0	no	no	no
4917	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	2.6	Stable	No	Yes or Unknown			No	0	24.15	0	no	no	no
4918	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	38	0.9	Stable	No	Yes or Unknown			No	0	27.76	0	no	no	no
4919	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	4.4	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.18	ATR	No	0	14.16	0	no	no	no
4920	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	37	2.6	Stable	No	No		PMS2	No	0	34.04	0	no	no	no
4921	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	25	0.9	Stable	No	Yes or Unknown			No	0	26.91	0	no	no	no
4922	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	20	0.9	Stable	No	No			No	0	23.06	0	no	no	no
4923	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	0	20.6	0	no	no	no
4924	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	71	5.3	Stable	No	Yes or Unknown	Signature.3	BRIP1	No	0	29.86	0	no	no	no
4925	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	626	2.6	Stable	No	Yes or Unknown			No	0	29.11	0	no	no	no
4926	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2017	II	60	4.4	Stable	No	No			No	0	28.85	0	no	no	no
4927	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	478	6.1	Stable	No	Yes or Unknown	Signature.24		No	1	26.78	0	no	no	no
4928	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	708	12.3	Stable	No	Yes or Unknown	Signature.3	MDC1 | PARP1	No	1	23.69	0	no	no	no
4929	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	197	1.8	Stable	No	Yes or Unknown			No	1	15.61	0	no	no	no
4930	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	21.75	0	no	no	no
4931	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No	Signature.1		No	0	20.53	0	no	no	no
4932	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2017	III	17	3.5	Stable	No	No		FANCC	Yes	0	28.62	0	no	no	no
4933	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	20	0.9	Stable	No	No			No	0	28.25	0	no	no	no
4934	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	4.4	Stable	No	No			Yes	0	23.43	0	no	no	no
4935	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	202	0	Stable	No	Yes or Unknown			No	0	27.89	0	no	no	no
4936	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	18	0.9	Stable	No	No			No	0	27.43	0	no	no	no
4937	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	12.3	Stable	No	No	Signature.4		No	1	2.46	0	no	no	no
4938	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	28.09	0	no	no	no
4939	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	28	17.6	Indeterminate	No	No	Signature.5	ARID1A | BLM | PMS2 | SLX4	Yes	0	23.23	0	no	no	yes
4940	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	263	1.8	Stable	No	No			No	0	11.7	0	no	no	no
4941	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	28	0.9	Stable	No	No			Yes	0	25.95	0	no	no	no
4942	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	7	12.3	Stable	No	Yes or Unknown	Signature.4		No	0	27.1	0	no	no	no
4943	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	11	4.4	Stable	No	No		ATM	No	0	23	0	no	no	no
4944	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	III	0	2.6	Stable	No	No	Signature.5		No	0	28.68	0	no	no	no
4945	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	40	1.8	Stable	No	No		MUTYH	Yes	0	28.32	0	no	no	no
4946	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	8	5.3	Stable	No	Yes or Unknown			No	1	15.15	0	no	no	no
4947	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		Yes	0	26.91	0	no	no	no
4948	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	25	0		No	No		MUTYH	No	0	26.02	0	no	no	no
4949	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	4.4	Stable	No	No	Signature.24		Yes	0	2.27	0	no	no	no
4950	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	26.45	0	no	no	no
4951	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	25	36.9	Unstable	No	Yes or Unknown	Signature.1	ARID1A | SLX4	No	0	28.39	0	other-MMRd	mut-MMRd	yes
4952	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	163	0	Stable	No	Yes or Unknown			Yes	0	26.81	0	no	no	no
4953	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	28.32	0	no	no	no
4954	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	267	0.9	Stable	No	No	Signature.1		No	0	18.96	0	no	no	no
4955	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	6.1	Stable	No	No	Signature.8		No	0	12.91	0	no	no	no
4956	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	274	4.4	Stable	No	No			No	0	13.11	0	no	no	no
4957	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	93	0	Stable	No	No			No	0	27.4	0	no	no	no
4958	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	39	0		No	No			No	0	27.14	0	no	no	no
4959	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	22.24	0	no	no	no
4960	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	51	0.9	Stable	No	No			No	0	28.85	0	no	no	no
4961	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	31	7	Stable	No	No			No	0	2.99	0	no	no	no
4962	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		15	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	17.58	0	no	no	no
4963	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			Yes	0	28.06	0	no	no	no
4964	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	24	0.9	Stable	No	Yes or Unknown			No	1	21.65	0	no	no	no
4965	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	69	4.4	Stable	No	No			No	0	28.42	0	no	no	no
4966	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	62	1.8	Stable	No	Yes or Unknown			No	0	27.63	0	no	no	no
4967	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	1	7.89	0	no	no	no
4968	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.29		No	1	15.74	0	no	no	no
4969	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	33	9.7	Stable	No	No	Signature.4	PMS1	No	0	25.3	0	no	no	no
4970	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4	Stable	No	No			No	0	23.69	0	no	no	no
4971	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	20.2	Stable	No	No	Signature.4	BRCA1 | BRCA2 | MDC1	Yes	1	6.8	0	no	no	no
4972	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	31	0.9	Stable	No	No			No	0	27.83	0	no	no	no
4973	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	33	0	Stable	No	No			No	0	27.37	0	no	no	no
4974	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2017	IV	5	1.8	Stable	No	No		ARID1A	No	1	6.41	0	no	no	yes
4975	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	34	0.9	Stable	No	No			No	0	28.39	0	no	no	no
4976	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	49	5.3	Indeterminate	No	Yes or Unknown			No	0	28.29	0	no	no	no
4977	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	13	1.8	Stable	No	No			No	0	27.6	0	no	no	no
4978	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	20	4.4	Stable	No	No			Yes	0	27.76	0	no	no	no
4979	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	317	6.1	Stable	No	No		ATM	No	0	25.4	0	no	no	no
4980	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	III	23	7.9	Stable	No	No	Signature.3		No	0	27.43	0	no	no	no
4981	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		0	5.3	Stable	No	No			Yes	0	26.48	0	no	no	no
4982	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	I	0	6.1	Stable	No	No			Yes	0	26.91	0	no	no	no
4983	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	32	7	Stable	No	No		ARID1A	No	0	25.56	0	no	no	yes
4984	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	0	5.3	Stable	No	No			Yes	0	25.59	0	no	no	no
4985	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	4	6.1	Stable	No	No	Signature.2	ATM	No	0	27.99	0	no	no	no
4986	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	48	0	Stable	Yes or Unknown	Yes or Unknown			No	0	28.09	0	no	no	no
4987	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	1	21.52	0	no	no	no
4988	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	49	1.8	Stable	No	Yes or Unknown			No	0	28.19	0	no	no	no
4989	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	No	Signature.7		No	0	27.37	0	no	no	no
4990	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	0	0.9	Indeterminate	No	No			No	0	26.71	0	no	no	no
4991	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	II	4	7	Stable	No	No	Signature.13		No	0	25.63	0	no	no	no
4992	Non-ICI treated	Never received ICI	81 - 85	Male	Gastric	2017	IV	14	3.5	Stable	No	No	Signature.19		No	1	8.05	0	no	no	no
4993	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	37	2.6	Stable	No	No		FANCC	Yes	0	28.19	0	no	no	no
4994	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	4.4	Stable	No	No	Signature.24		No	0	0.92	0	no	no	no
4995	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		0	3.5	Stable	No	Yes or Unknown			No	0	27.53	0	no	no	no
4996	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	32	4.4	Stable	No	Yes or Unknown			No	0	27.7	0	no	no	no
4997	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	IV	8	1.8	Stable	No	No		ARID1A	No	1	7.16	0	no	no	yes
4998	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	16	1.8	Stable	No	Yes or Unknown			No	0	26.87	0	no	no	no
4999	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	151	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	Yes	1	5.39	0	no	no	no
5000	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	21	0.9	Stable	No	No	Signature.3		No	0	26.38	0	no	no	no
5001	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	16	12.3	Stable	No	No	Signature.4		Yes	0	25.17	0	no	no	no
5002	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	110	2.6	Indeterminate	No	Yes or Unknown	Signature.5	BRCA2	Yes	1	4.7	0	no	no	no
5003	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	28.16	0	no	no	no
5004	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	35	3.5	Stable	No	Yes or Unknown			No	0	19.78	0	no	no	no
5005	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	54	0.9	Stable	No	No			No	0	26.68	0	no	no	no
5006	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	II	85	4.4	Stable	No	No			No	0	29.73	0	no	no	no
5007	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	38	54.4	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC2 | FANCA | MSH3 | RAD50	No	0	25.82	0	other-MMRd	mut-MMRd	yes
5008	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	IV	303	0	Stable	No	No			Yes	0	28.58	0	no	no	no
5009	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	36	1.8	Stable	No	No			No	0	23.62	0	no	no	no
5010	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	224	2.6	Stable	No	No			No	1	10.05	0	no	no	no
5011	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	III	57	21.1	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2	Yes	0	26.55	0	other-MMRd	mut-MMRd	yes
5012	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	91	1.8	Stable	No	No			No	0	28.68	0	no	no	no
5013	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	37	2.6	Stable	No	No			Yes	0	23.1	0	no	no	no
5014	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	5	1.8	Stable	No	No			No	0	28.52	0	no	no	no
5015	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	29	2.6	Stable	No	No			No	1	9.36	0	no	no	no
5016	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	86	374.8	Unstable	No	No	Signature.14	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | CHEK1 | CHEK2 | ERCC2 | ERCC3 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | PALB2 | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	25.95	0	mut-MMRd	mut-MMRd	yes
5017	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	11.4	Stable	No	No	Signature.4	ARID1A | ATR	No	0	23.43	0	no	no	yes
5018	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	9	6.1	Stable	No	No			No	1	21.65	0	no	no	no
5019	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	5	2.6	Stable	No	No			No	1	27.17	0	no	no	no
5020	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	0	5.3	Stable	No	No			No	0	24.87	0	no	no	no
5021	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	0	3.5	Stable	No	No			No	0	28.62	0	no	no	no
5022	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	35	4.4	Stable	No	No		ATM	No	0	27.17	0	no	no	no
5023	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	15	0.9	Stable	No	No	Signature.8		No	0	2.27	0	no	no	no
5024	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	109	4.4	Stable	No	No			No	0	12.62	0	no	no	no
5025	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2017	III	0	0.9	Stable	No	No		MUTYH	Yes	0	27.1	0	no	no	no
5026	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	25	0	Stable	No	No			Yes	0	26.28	0	no	no	no
5027	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	35	4.4	Stable	No	No	Signature.25	ERCC5	Yes	0	28.45	0	no	no	no
5028	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	1	10.22	0	no	no	no
5029	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	III	36	9.7	Stable	No	No		ARID1A | MUTYH	No	0	27.66	0	no	no	yes
5030	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	29	5.3	Stable	No	No		ARID1A	No	0	5.95	0	no	no	yes
5031	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	25.82	0	no	no	no
5032	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	22	1.8	Stable	No	Yes or Unknown			No	0	27.76	0	no	no	no
5033	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	36	10.5	Stable	No	No	Signature.13	ATR | RAD51	No	0	24.64	0	no	no	no
5034	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	38	6.1	Stable	No	No	Signature.1		Yes	0	26.55	0	no	no	no
5035	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	10	2.6	Stable	No	No	Signature.3	BRCA2	No	0	25.63	0	no	no	no
5036	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	64	2.6	Stable	No	No			No	0	28.62	0	no	no	no
5037	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	369	7.9	Stable	No	Yes or Unknown			No	0	26.84	0	no	no	no
5038	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	18	1.8	Stable	No	No			No	0	27.04	0	no	no	no
5039	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	39	1.8	Stable	No	No			No	0	27.99	0	no	no	no
5040	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	I	30	158	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | ERCC3 | ERCC5 | MSH2 | MSH3 | PMS2 | RAD50 | RAD51 | SLX4 | TP53BP1	No	0	21.75	0	no	no	yes
5041	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	27.4	0	no	no	no
5042	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	0	0.9	Stable	No	No			No	0	26.45	0	no	no	no
5043	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	54	0	Stable	No	No			No	1	19.78	0	no	no	no
5044	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	125	2.6	Stable	No	Yes or Unknown			No	0	29.17	0	no	no	no
5045	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	I	367	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	28.02	0	no	no	no
5046	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	III	533	9.7	Stable	No	Yes or Unknown	Signature.30		No	0	23.46	0	no	no	no
5047	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	IV	65	12.3	Stable	No	No	Signature.2	ARID1A	No	0	28.78	0	no	no	yes
5048	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	II	0	10.5	Stable	No	No	Signature.13		Yes	1	4.27	0	no	no	no
5049	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	26	2.6	Stable	No	No			Yes	1	10.74	0	no	no	no
5050	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	56	2.6	Stable	No	Yes or Unknown			No	0	28.02	0	no	no	no
5051	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	No			No	1	6.34	0	no	no	no
5052	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	0	4.4	Stable	No	No	Signature.13	ATR	No	0	26.09	0	no	no	no
5053	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	3	5.3	Stable	No	No		MUTYH	No	0	27.3	0	no	no	no
5054	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2017		0	1.8	Stable	No	No			No	0	3.91	0	no	no	no
5055	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	24.02	0	no	no	no
5056	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	25	2.6	Stable	No	No			No	1	14.82	0	no	no	no
5057	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	22	14.9	Stable	No	No	Signature.24		Yes	0	23.85	0	no	no	no
5058	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	40	0.9	Stable	No	Yes or Unknown			Yes	0	27.1	0	no	no	no
5059	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2017	IV	16	3.5	Stable	No	No			No	1	7.62	0	no	no	no
5060	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	18	0.9	Stable	No	No		BLM	No	0	27.33	0	no	no	no
5061	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	21	130.8	Stable	No	No	Signature.10	ARID1A | ATM | ATR | CHEK1 | ERCC3 | ERCC5 | MSH2 | MSH3 | MUTYH | PALB2 | RAD54L | SLX4	No	0	26.87	0	no	no	yes
5062	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	22	5.3	Stable	No	No			No	0	23	0	no	no	no
5063	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	12	8.8	Stable	No	No	Signature.4		Yes	1	2.1	0	no	no	no
5064	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	27	3.5	Stable	No	No			No	0	26.97	0	no	no	no
5065	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	1	13.24	0	no	no	no
5066	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	1	3.5	Stable	No	No			No	0	27.6	0	no	no	no
5067	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	12.42	0	no	no	no
5068	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	3.5	Stable	No	No			No	0	28.09	0	no	no	no
5069	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	IV	236	0	Stable	No	Yes or Unknown			No	1	14.52	0	no	no	no
5070	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	41	3.5	Stable	No	No	Signature.3		No	0	30.69	0	no	no	no
5071	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	13	1.8	Stable	No	No			Yes	0	4.86	0	no	no	no
5072	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	198	1.8	Stable	No	No		BRCA1	No	0	25.56	0	no	no	no
5073	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	4	0	Stable	No	No			No	1	11.1	0	no	no	no
5074	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	37	0.9	Stable	No	No			No	0	20.3	0	no	no	no
5075	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	III	10	8.8	Stable	No	No			Yes	0	25.49	0	no	no	no
5076	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	30	2.6	Stable	No	No			Yes	1	8.54	0	no	no	no
5077	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No			No	1	4.86	0	no	no	no
5078	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	34	1.8	Stable	No	No			Yes	0	27.86	0	no	no	no
5079	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	II	22	45.6	Unstable	No	No	Signature.6	BLM | BRCA2 | PMS1	No	0	26.58	0	other-MMRd	mut-MMRd	no
5080	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	9.53	0	no	no	no
5081	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	43	2.6	Stable	No	Yes or Unknown			No	0	27.2	0	no	no	no
5082	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	III	10	4.4	Stable	No	No		BRIP1	No	0	25.99	0	no	no	no
5083	Non-ICI treated	Never received ICI	51 - 55	Male	Breast	2017	II	665	2.6	Stable	No	Yes or Unknown	Signature.2	PARP1	No	0	27.66	0	no	no	no
5084	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	5.3	Stable	No	No		ARID1A	No	0	25.4	0	no	no	yes
5085	Non-ICI treated	Never received ICI	91 - 95	Female	Endometrial	2017	III	0	1.8	Stable	No	No			No	1	18.96	0	no	no	no
5086	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	21	2.6	Stable	No	No			No	0	27.79	0	no	no	no
5087	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	14	3.5	Stable	No	No			No	1	4.67	0	no	no	no
5088	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	7	2.6	Stable	No	Yes or Unknown			No	1	17.38	0	no	no	no
5089	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	39	1.8	Stable	No	No			No	0	24.48	0	no	no	no
5090	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	20	1.8	Stable	No	No			Yes	0	27.37	0	no	no	no
5091	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	28	2.6	Stable	No	No		CHEK2	Yes	0	26.41	0	no	no	no
5092	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	9	40.4	Stable	No	No	Signature.13	BRCA1 | BRCA2 | ERCC3 | MSH2	Yes	0	24.08	0	no	no	no
5093	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.19		No	1	15.05	0	no	no	no
5094	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		3	4.4	Stable	No	No			Yes	0	6.51	0	no	no	no
5095	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	82	2.6	Stable	No	No			Yes	0	28.52	0	no	no	no
5096	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	24	4.4	Stable	No	No	Signature.3		No	0	13.44	0	no	no	no
5097	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	330	6.1	Stable	No	No	Signature.1		No	0	31.51	0	no	no	no
5098	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	13	20.2	Stable	No	No	Signature.4		No	0	24.77	0	no	no	no
5099	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	29	4.4	Stable	No	No			Yes	0	25.3	0	no	no	no
5100	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	14	6.1	Stable	No	No	Signature.1		No	0	27.2	0	no	no	no
5101	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	21.42	0	no	no	no
5102	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	III	12	14.9	Stable	No	No	Signature.5	MSH2	Yes	0	28.29	0	no	no	no
5103	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	507	1.8	Stable	No	Yes or Unknown			No	0	29.17	0	no	no	no
5104	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	36	5.3	Stable	No	No	Signature.24	RAD54L	Yes	0	26.12	0	no	no	no
5105	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	34	7.9	Stable	No	No	Signature.13	ATM	No	0	23.98	0	no	no	no
5106	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	47	3.5	Stable	No	No	Signature.6	ARID1A	No	0	27.89	0	no	no	yes
5107	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	109	5.3	Stable	No	No		ATR	Yes	0	30.52	0	no	no	no
5108	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	579	3.5	Stable	No	Yes or Unknown			No	0	42.84	0	no	no	no
5109	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	13	1.8	Stable	No	No			No	0	28.48	0	no	no	no
5110	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2017	IV	131	6.1	Stable	No	Yes or Unknown		ATM	No	0	26.15	0	no	no	no
5111	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		35	4.4	Stable	No	No			No	0	25.66	0	no	no	no
5112	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1	MSH3	No	1	9.66	0	no	no	no
5113	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	115	1.8	Stable	No	No		SLX4	No	0	21.42	0	no	no	no
5114	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	2.6	Stable	No	No	Signature.8		No	1	18.76	0	no	no	no
5115	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	14	6.1	Stable	No	Yes or Unknown	Signature.2	XRCC2	No	0	26.38	0	no	no	no
5116	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	I	0	6.1	Stable	No	No		ARID1A	Yes	0	25.99	0	no	no	yes
5117	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	10	13.2	Stable	No	No	Signature.3	ARID1A | FANCA	No	1	6.44	0	no	no	yes
5118	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	III	62	7.9	Stable	No	No	Signature.6		No	0	5.42	0	no	no	no
5119	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No		MSH6	No	0	24.8	0	no	no	no
5120	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	29	1.8	Stable	No	Yes or Unknown			No	0	26.64	0	no	no	no
5121	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	646	1.8	Stable	No	No			Yes	0	27.27	0	no	no	no
5122	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	224	1.8	Stable	No	Yes or Unknown			No	0	26.28	0	no	no	no
5123	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	26	2.6	Stable	No	No			No	0	24.05	0	no	no	no
5124	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	22	7	Stable	No	No			No	1	13.9	0	no	no	no
5125	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	41	2.6	Stable	No	No			Yes	0	24.38	0	no	no	no
5126	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	4	2.6	Stable	No	Yes or Unknown		ERCC5	No	0	7.95	0	no	no	no
5127	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2017	III	25	7.9	Stable	No	No	Signature.4	MRE11A | NBN	No	1	12.32	0	no	no	no
5128	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	IV	2	7	Stable	No	No	Signature.3	PARP1	No	1	17.41	0	no	no	no
5129	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	I	0	24.6	Indeterminate	No	No	Signature.1	BLM | MDC1 | SLX4	No	0	27.7	0	no	no	no
5130	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	III	0	9.7	Stable	No	No	Signature.13		No	1	8.9	0	no	no	no
5131	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		12	5.3	Stable	No	No		FANCC	Yes	0	4.63	0	no	no	no
5132	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	1	20.53	0	no	no	no
5133	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	III	0	72	Unstable	No	No	Signature.6	ARID1A | MDC1 | MRE11A | MSH3 | MSH6 | PMS1 | TP53BP1	Yes	0	26.84	0	mut-MMRd	mut-MMRd	yes
5134	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	16	3.5	Stable	No	No		BRCA1	No	0	26.51	0	no	no	no
5135	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2017	IV	16	2.6	Stable	No	No			No	0	9.79	0	no	no	no
5136	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No		ARID1A	No	1	13.01	0	no	no	yes
5137	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	22.8	0	no	no	no
5138	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	10.5	Stable	No	No	Signature.1		No	0	27.2	0	no	no	no
5139	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	2	4.4	Stable	No	No	Signature.12		No	0	26.05	0	no	no	no
5140	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	20	7.9	Stable	No	No		ARID1A | ERCC5	No	0	8.15	0	no	no	yes
5141	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	39	7	Stable	No	No		ARID1A	No	0	27.3	0	no	no	yes
5142	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	28.75	0	no	no	no
5143	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	306	7.9	Stable	No	Yes or Unknown	Signature.8	BRCA2	No	0	24.31	0	no	no	no
5144	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	0	4.4	Stable	No	No	Signature.1		Yes	1	16.59	0	no	no	no
5145	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	671	7	Stable	No	Yes or Unknown	Signature.3		No	0	27.79	0	no	no	no
5146	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	8.8	Stable	No	No	Signature.1		Yes	0	12.65	0	no	no	no
5147	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	II	0	2.6	Stable	No	No			No	0	33.54	0	no	no	no
5148	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	II	0	2.6	Stable	No	No			Yes	0	28.32	0	no	no	no
5149	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	34	9.7	Stable	No	No	Signature.1		Yes	0	22.9	0	no	no	no
5150	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No		TP53BP1	No	1	2.33	0	no	no	no
5151	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	II	446	5.3	Stable	No	Yes or Unknown			No	0	29.67	0	no	no	no
5152	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	53	7	Stable	No	No		ARID1A	No	1	16.1	0	no	no	yes
5153	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	331	4.4	Stable	No	Yes or Unknown			No	1	23.13	0	no	no	no
5154	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017		59	0	Stable	No	No			No	0	15.47	0	no	no	no
5155	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	25.99	0	no	no	no
5156	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	0	26.15	0	no	no	no
5157	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	6	9.7	Stable	No	Yes or Unknown	Signature.1	PALB2 | SLX4	No	0	27.27	0	no	no	no
5158	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	1	17.18	0	no	no	no
5159	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	325	7	Stable	No	Yes or Unknown	Signature.3	FANCA | RAD51C	No	0	30.03	0	no	no	no
5160	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	0	12.3	Stable	No	No	Signature.29		No	0	3.65	0	no	no	no
5161	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	III	108	0.9	Stable	No	Yes or Unknown			No	0	27.27	0	no	no	no
5162	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	17	4.4	Stable	No	No			Yes	0	27.04	0	no	no	no
5163	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	19	1.8	Stable	No	No			No	0	25.89	0	no	no	no
5164	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	23	8.8	Stable	No	No	Signature.29	ATR	No	0	22.67	0	no	no	no
5165	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	35	2.6	Stable	No	No			No	0	27.17	0	no	no	no
5166	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	4.4	Stable	No	No	Signature.19		No	0	4.8	0	no	no	no
5167	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	III	15	6.1	Stable	No	No			Yes	0	24.8	0	no	no	no
5168	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	109	0.9	Stable	No	Yes or Unknown			No	0	27.07	0	no	no	no
5169	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	III	29	0	Stable	No	No			Yes	0	26.87	0	no	no	no
5170	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	29	34.2	Unstable	No	No	Signature.15	ARID1A | PARP1 | PMS1	No	0	23.52	0	other-MMRd	mut-MMRd	yes
5171	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			Yes	0	26.45	0	no	no	no
5172	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	38	0.9	Stable	No	No			Yes	0	26.94	0	no	no	no
5173	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	39	2.6	Stable	No	No		CHEK2	No	0	27.07	0	no	no	no
5174	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	III	286	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	26.51	0	no	no	no
5175	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	224	0	Stable	No	No			No	0	23.23	0	no	no	no
5176	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	30	7	Stable	No	No		ARID1A	Yes	0	27.1	0	no	no	yes
5177	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	25	4.4	Stable	No	No		ARID1A	No	0	24.77	0	no	no	yes
5178	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	9	0	Stable	No	Yes or Unknown			No	0	27.3	0	no	no	no
5179	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	15	0	Stable	No	No			No	0	1.84	0	no	no	no
5180	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	33	0	Stable	No	No			No	0	26.18	0	no	no	no
5181	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	133	0.9	Stable	No	No			No	1	14.39	0	no	no	no
5182	Non-ICI treated	Never received ICI	10-Jun	Female	Cutaneous Melanoma 	2017	II	0	0	Stable	No	No			No	0	5.52	0	no	no	no
5183	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	41	4.4	Stable	No	No			No	1	23.2	0	no	no	no
5184	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	8	5.3	Stable	No	No	Signature.3		No	0	26.97	0	no	no	no
5185	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	2.56	0	no	no	no
5186	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	15	9.7	Indeterminate	No	No	Signature.13		No	1	7.29	0	no	no	no
5187	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	17	9.7	Stable	No	No	Signature.13	BLM | SLX4	No	0	26.12	0	no	no	no
5188	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	126	1.8	Stable	No	Yes or Unknown			Yes	0	28.78	0	no	no	no
5189	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	38	7	Stable	No	No	Signature.30	NTHL1	No	0	26.22	0	no	no	no
5190	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	3.5	Stable	No	No			No	0	28.19	0	no	no	no
5191	Non-ICI treated	Never received ICI	51 - 55	Male	Breast	2017	II	39	2.6	Stable	No	Yes or Unknown			No	0	27.1	0	no	no	no
5192	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		111	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.5		Yes	1	12.78	0	no	no	no
5193	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	7.9	Stable	No	Yes or Unknown			No	0	27.33	0	no	no	no
5194	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	379	2.6	Stable	No	No			Yes	0	27.14	0	no	no	no
5195	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	I	0	0.9	Stable	No	No			No	0	18.27	0	no	no	no
5196	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	III	52	2.6	Stable	No	No			Yes	0	5.59	0	no	no	no
5197	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	0	3.5	Stable	No	No			No	0	27.56	0	no	no	no
5198	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	27	86.9	Unstable	No	No	Signature.6	ATM | BLM | BRIP1 | CHEK2 | MSH3 | MSH6 | NBN | PALB2 | PMS2 | SLX4	No	0	26.12	0	mut-MMRd	mut-MMRd	no
5199	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	3	6.1	Stable	No	No		ATR	No	0	26.87	0	no	no	no
5200	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	14	Stable	No	No	Signature.4		No	1	5.16	0	no	no	no
5201	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	34	0.9	Stable	No	No		ATM | NBN	No	0	27.14	0	no	no	no
5202	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	15	0	Stable	No	No			No	0	3.12	0	no	no	no
5203	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			No	1	15.77	0	no	no	no
5204	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	6	5.3	Stable	No	No			Yes	1	2.92	0	no	no	no
5205	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	1	10.64	0	no	no	no
5206	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			Yes	0	5.36	0	no	no	no
5207	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	652	2.6	Stable	No	Yes or Unknown			No	0	29.44	0	no	no	no
5208	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	15	7.9	Stable	No	No	Signature.4	BRIP1	No	1	10.38	0	no	no	no
5209	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	21	0.9	Stable	No	No			Yes	0	26.64	0	no	no	no
5210	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	136	0.9	Stable	No	No			Yes	0	29.44	0	no	no	no
5211	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	35	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	0	25	0	no	no	no
5212	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	35	7	Stable	No	No		ARID1A	No	0	21.75	0	no	no	yes
5213	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	IV	2	7	Stable	No	No	Signature.19		Yes	1	4.37	0	no	no	no
5214	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	37	2.6	Stable	No	No		RAD51C	Yes	0	26.22	0	no	no	no
5215	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	19	0.9	Stable	No	No			No	0	27.1	0	no	no	no
5216	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	77	0	Stable	No	Yes or Unknown			No	0	27.2	0	no	no	no
5217	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	16	3.5	Stable	No	No			No	0	4.9	0	no	no	no
5218	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	61	1.8	Stable	No	No			No	0	26.87	0	no	no	no
5219	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	48	2.6	Stable	No	No			No	0	26.58	0	no	no	no
5220	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	51	2.6	Stable	No	No			No	0	27.01	0	no	no	no
5221	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	33	7	Stable	No	No	Signature.1		No	0	25.53	0	no	no	no
5222	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	761	4.4	Stable	No	Yes or Unknown		ARID1A	Yes	0	26.91	0	no	no	yes
5223	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	3.5	Indeterminate	No	No			No	0	26.32	0	no	no	no
5224	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	21	0	Stable	No	No			No	0	26.87	0	no	no	no
5225	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	III	30	8.8	Stable	No	No	Signature.1	ARID1A	Yes	0	27.01	0	no	no	yes
5226	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	III	0	12.3	Indeterminate	No	No	Signature.24		Yes	0	27.01	0	no	no	no
5227	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	4.4	Stable	No	No			No	0	19.78	0	no	no	no
5228	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	23.98	0	no	no	no
5229	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	13	4.4	Stable	No	No			No	1	9.82	0	no	no	no
5230	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	58	7.9	Stable	No	No	Signature.4	ATM	No	0	27.83	0	no	no	no
5231	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	143	10.5	Stable	No	Yes or Unknown	Signature.24		No	0	26.12	0	no	no	no
5232	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	136	0.9	Stable	No	Yes or Unknown			No	1	22.37	0	no	no	no
5233	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	691	10.5	Stable	No	Yes or Unknown	Signature.1	MRE11A	Yes	0	30.39	0	no	no	no
5234	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	40	4.4	Stable	No	No			Yes	0	26.71	0	no	no	no
5235	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	45	3.5	Stable	No	No			Yes	0	15.93	0	no	no	no
5236	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	131	0	Stable	No	No			No	0	24.05	0	no	no	no
5237	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	26	3.5	Stable	No	No			Yes	0	26.68	0	no	no	no
5238	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	365	8.8	Stable	No	No	Signature.1	BLM | MSH2	No	0	14.13	0	no	no	no
5239	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	34	2.6	Stable	No	No			No	0	28.62	0	no	no	no
5240	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2018		0	0	Stable	No	No			No	0	13.54	0	no	no	no
5241	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	447	3.5	Stable	No	Yes or Unknown	Signature.3	CHEK1	No	1	18.3	0	no	no	no
5242	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	III	523	5.3	Stable	No	No			No	0	25.95	0	no	no	no
5243	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	7	0	Stable	No	Yes or Unknown			No	0	27.37	0	no	no	no
5244	Non-ICI treated	Never received ICI	86 - 90	Male	Cutaneous Melanoma 	2017	IV	20	38.6	Stable	No	No	Signature.7	ATR | BLM | ERCC4 | MRE11A | PARP1	No	1	1.18	0	no	no	no
5245	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	18	4.4	Stable	No	No			No	0	27.4	0	no	no	no
5246	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	13	0.9	Stable	No	No			No	1	14.06	0	no	no	no
5247	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	504	9.7	Stable	No	Yes or Unknown	Signature.1		No	0	26.58	0	no	no	no
5248	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	17	0.9	Stable	No	No			No	0	26.55	0	no	no	no
5249	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	11.73	0	no	no	no
5250	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	23	6.1	Stable	No	No			No	0	23.49	0	no	no	no
5251	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No			No	1	4.11	0	no	no	no
5252	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2017	IV	29	5.3	Stable	No	No			No	0	27.5	0	no	no	no
5253	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	29	1.8	Stable	No	Yes or Unknown		ATM	Yes	0	26.87	0	no	no	no
5254	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	27.07	0	no	no	no
5255	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		36	5.3	Stable	Yes or Unknown	Yes or Unknown			No	0	29.7	0	no	no	no
5256	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	13	2.6	Stable	No	No		ERCC4	Yes	0	23.95	0	no	no	no
5257	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	27.6	0	no	no	no
5258	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	18	1.8	Stable	No	No			Yes	0	25.3	0	no	no	no
5259	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2017	IV	0	0	Stable	No	No			No	1	25.92	0	no	no	no
5260	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	II	0	2.6	Stable	No	No			Yes	0	26.64	0	no	no	no
5261	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	37.7	Stable	No	No	Signature.4	BRCA2 | ERCC2 | PARP1	No	0	21.78	0	no	no	no
5262	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2017	III	20	39.5	Stable	No	No	Signature.7	ERCC2 | MDC1	No	0	26.94	0	no	no	no
5263	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No	Signature.1		No	0	26.81	0	no	no	no
5264	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	45	4.4	Stable	No	Yes or Unknown			No	0	26.35	0	no	no	no
5265	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	47	2.6	Stable	No	No			Yes	0	27.63	0	no	no	no
5266	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	II	34	0	Stable	No	No			No	1	23.13	0	no	no	no
5267	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	0	2.6	Stable	No	No		BRCA1	No	0	27.1	0	no	no	no
5268	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	57	9.7	Stable	No	No	Signature.1		Yes	0	26.51	0	no	no	no
5269	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	27	13.2	Stable	No	No	Signature.1		No	0	26.68	0	no	no	no
5270	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	3.5	Stable	No	No			No	0	26.71	0	no	no	no
5271	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2017	I	26	0		No	No			No	0	21.26	0	no	no	no
5272	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	303	7	Stable	No	Yes or Unknown	Signature.1		No	0	26.22	0	no	no	no
5273	Non-ICI treated	Never received ICI	91 - 95	Female	CNS	2017		16	2.6	Stable	No	No			No	1	1.64	0	no	no	no
5274	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2017		0	0.9	Stable	No	No	Signature.5		No	0	24.25	0	no	no	no
5275	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	II	0	9.7	Stable	No	No	Signature.3		No	0	27.53	0	no	no	no
5276	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.4		Yes	1	7.13	0	no	no	no
5277	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	158	5.3	Stable	No	Yes or Unknown		ARID1A	No	1	9.95	0	no	no	yes
5278	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	1	7.23	0	no	no	no
5279	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	34	0.9	Stable	No	No			No	0	16.99	0	no	no	no
5280	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2017	IV	19	3.5	Stable	No	No			Yes	0	24.18	0	no	no	no
5281	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	294	5.3	Stable	No	Yes or Unknown			No	1	14.98	0	no	no	no
5282	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	28	5.3	Stable	No	No			No	0	26.74	0	no	no	no
5283	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	9	0.9	Stable	No	Yes or Unknown			No	0	22.08	0	no	no	no
5284	Non-ICI treated	Never received ICI	61 - 65	Male	Breast	2017	I	32	2.6	Stable	No	No			Yes	0	12.98	0	no	no	no
5285	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	0	14.9	Stable	No	No	Signature.4		No	0	24.15	0	no	no	no
5286	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017		0	0	Stable	No	No			No	0	21.82	0	no	no	no
5287	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	1	6.97	0	no	no	no
5288	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	54	0.9	Stable	No	Yes or Unknown			No	0	26.91	0	no	no	no
5289	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	III	18	8.8	Stable	No	No	Signature.10	NTHL1	No	0	22.47	0	no	no	no
5290	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	254	7	Stable	No	Yes or Unknown	Signature.1		No	1	23.26	0	no	no	no
5291	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	ATR | MDC1 | PMS2 | XRCC2	Yes	0	25.2	0	no	no	no
5292	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	6	6.1	Stable	No	No		BLM	No	0	26.45	0	no	no	no
5293	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	1	14.36	0	no	no	no
5294	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	20	2.6	Stable	No	No			No	0	24.38	0	no	no	no
5295	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	334	4.4	Stable	No	No			No	1	26.74	0	no	no	no
5296	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	26	3.5	Stable	No	No			No	0	24.97	0	no	no	no
5297	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	20	1.8	Stable	No	Yes or Unknown			Yes	0	23.16	0	no	no	no
5298	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	1	1.48	0	no	no	no
5299	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	21	1.8	Stable	No	No			Yes	0	25.82	0	no	no	no
5300	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	36	6.1	Stable	No	No		ARID1A	No	0	4.37	0	no	no	yes
5301	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	8.8	Stable	No	No	Signature.3		No	0	25.49	0	no	no	no
5302	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	I	274	4.4	Stable	No	No		MSH3 | MUTYH	No	0	12.25	0	no	no	no
5303	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	0	1.8	Stable	No	No	Signature.1		No	0	26.74	0	no	no	no
5304	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			No	0	26.71	0	no	no	no
5305	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	25.53	0	no	no	no
5306	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	743	2.6	Stable	No	Yes or Unknown			Yes	0	25.1	0	no	no	no
5307	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	47	7	Stable	No	No	Signature.4		No	0	22.31	0	no	no	no
5308	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	82	1.8	Stable	No	No			No	0	28.98	0	no	no	no
5309	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	204	0.9	Stable	No	No			No	0	8.38	0	no	no	no
5310	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	10	2.6	Stable	No	No			No	1	15.08	0	no	no	no
5311	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	1	0.9	Stable	No	Yes or Unknown		MUTYH	No	1	20.7	0	no	no	no
5312	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	624	7	Stable	No	Yes or Unknown	Signature.6		No	0	26.97	0	no	no	no
5313	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	0	4.4	Stable	No	Yes or Unknown			No	1	19.65	0	no	no	no
5314	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		18	3.5	Stable	No	No		BLM	Yes	1	16.33	0	no	no	no
5315	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	23	1.8	Stable	No	No			No	0	14.78	0	no	no	no
5316	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	18	7	Indeterminate	No	No	Signature.7		No	1	4.27	0	no	no	no
5317	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	No	Signature.1		No	1	4.63	0	no	no	no
5318	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	783	2.6	Stable	No	Yes or Unknown			No	0	27.7	0	no	no	no
5319	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	31	3.5	Stable	No	No			No	0	26.09	0	no	no	no
5320	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	25	1.8	Stable	No	No			No	0	26.55	0	no	no	no
5321	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2017		46	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	25.76	0	no	no	no
5322	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	0	29	Unstable	No	Yes or Unknown	Signature.6	ATM | MSH2 | MSH6 | SLX4 | TP53BP1	No	0	27.01	0	mut-MMRd	mut-MMRd	no
5323	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	15	5.3	Stable	No	No	Signature.1	ARID1A	Yes	0	23.39	0	no	no	yes
5324	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	31	7	Stable	No	No		FANCA	No	0	25.72	0	no	no	no
5325	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	32	2.6	Stable	No	No			No	0	24.21	0	no	no	no
5326	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	43	0	Stable	No	No			No	0	20.21	0	no	no	no
5327	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	241	7	Stable	No	Yes or Unknown			No	0	25.59	0	no	no	no
5328	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	15	4.4	Stable	No	No			Yes	0	5.68	0	no	no	no
5329	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2017	III	32	8.8	Stable	No	No	Signature.4	FANCA | PMS1	No	1	17.02	0	no	no	no
5330	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	28	2.6	Stable	No	No			No	0	26.48	0	no	no	no
5331	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	12	7	Indeterminate	No	No	Signature.15		No	0	17.12	0	no	no	no
5332	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017		259	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	27.07	0	no	no	yes
5333	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	35	0	Stable	No	No			Yes	1	3.42	0	no	no	no
5334	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	67	0	Stable	No	Yes or Unknown		BRCA2	No	0	24.11	0	no	no	no
5335	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	III	0	2.6	Stable	No	No		BRCA2	No	0	25.53	0	no	no	no
5336	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	10	49.2	Unstable	No	No	Signature.1	ARID1A | ATR | BRCA2 | MSH6 | RAD54L | TP53BP1	No	0	4.27	0	mut-MMRd	mut-MMRd	yes
5337	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		0	4.4	Stable	No	No			Yes	1	6.6	0	no	no	no
5338	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	7	5.3	Stable	No	No	Signature.1	ARID1A	No	1	5.65	0	no	no	yes
5339	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	266	0		No	Yes or Unknown			No	0	24.8	0	no	no	no
5340	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	III	19	26.3	Unstable	No	No	Signature.1	ARID1A | BLM	No	0	26.35	0	other-MMRd	mut-MMRd	yes
5341	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			No	1	18.5	0	no	no	no
5342	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	10	14	Stable	No	No	Signature.4	ERCC4	No	1	4.57	0	no	no	no
5343	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	33	0.9	Stable	No	No			No	0	24.54	0	no	no	no
5344	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	0.9	Stable	No	No			No	0	21.88	0	no	no	no
5345	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2017		169	1.8	Stable	No	No			No	0	28.81	0	no	no	no
5346	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2017	IV	218	0	Stable	No	Yes or Unknown			Yes	0	24.44	0	no	no	no
5347	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	68	0		No	No		BRCA1	No	0	25.3	0	no	no	no
5348	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	50	3.5	Stable	No	No			No	0	25.89	0	no	no	no
5349	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	38	7	Stable	No	Yes or Unknown		ARID1A	No	0	26.12	0	no	no	yes
5350	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	145	1.8	Stable	No	No		ARID1A	No	1	14.03	0	no	no	yes
5351	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	32	0.9	Stable	No	No			No	0	23	0	no	no	no
5352	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		ATM	No	1	16.89	0	no	no	no
5353	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	13	8.8	Stable	No	Yes or Unknown		BRCA2	No	0	22.08	0	no	no	no
5354	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	1	19.45	0	no	no	no
5355	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	0	5.3	Stable	No	No			No	0	26.15	0	no	no	no
5356	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	24	0.9	Stable	No	No			No	0	26.45	0	no	no	no
5357	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	289	1.8	Stable	No	Yes or Unknown			Yes	0	27.2	0	no	no	no
5358	Non-ICI treated	Never received ICI	46 - 50	Male	Renal	2017	I	0	0	Stable	No	No			No	0	19.94	0	no	no	no
5359	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	509	4.4	Stable	No	No		ARID1A | FANCA	No	1	23.82	0	no	no	yes
5360	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2017	IV	308	12.3	Stable	No	No	Signature.7		No	0	10.12	0	no	no	no
5361	Non-ICI treated	Never received ICI	46 - 50	Female	Cutaneous Melanoma 	2017	I	0	0.9	Stable	No	No			No	0	26.41	0	no	no	no
5362	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	12	0.9	Stable	No	No			No	1	17.08	0	no	no	no
5363	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	504	1.8	Stable	No	Yes or Unknown			Yes	1	24.51	0	no	no	no
5364	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	40	2.6	Stable	No	Yes or Unknown			No	0	25.66	0	no	no	no
5365	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	16	0	Stable	No	No			No	0	18.73	0	no	no	no
5366	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	IV	6	4.4	Stable	No	No	Signature.4		Yes	1	11.04	0	no	no	no
5367	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	39	1.8	Stable	No	No			No	0	23.16	0	no	no	no
5368	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	0	0.9	Stable	No	No			No	1	22.21	0	no	no	no
5369	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2017		14	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	15.05	0	no	no	no
5370	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	373	8.8	Stable	No	Yes or Unknown	Signature.10		No	0	26.35	0	no	no	no
5371	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	739	1.8	Stable	No	Yes or Unknown			No	0	26.58	0	no	no	no
5372	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	9.26	0	no	no	no
5373	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	25.92	0	no	no	no
5374	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	9	3.5	Stable	No	No	Signature.3	ATM	No	1	18.33	0	no	no	no
5375	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	26.18	0	no	no	no
5376	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	73	3.5	Stable	No	No			No	0	10.45	0	no	no	no
5377	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	47	1.8	Stable	No	No			No	0	23.92	0	no	no	no
5378	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	0	9.7	Stable	No	No	Signature.5	ARID1A | FANCA	Yes	0	26.41	0	no	no	yes
5379	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	II	140	1.8	Stable	No	Yes or Unknown			No	0	23.23	0	no	no	no
5380	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	III	28	0.9	Stable	No	Yes or Unknown			Yes	0	25.66	0	no	no	no
5381	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	0	0.9	Stable	No	No			Yes	0	21.36	0	no	no	no
5382	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	86	1.8	Stable	No	No			No	0	7.13	0	no	no	no
5383	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	49	0.9	Stable	No	No			No	0	21.95	0	no	no	no
5384	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	20	0.9	Stable	No	Yes or Unknown			No	0	25.99	0	no	no	no
5385	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	142	6.1	Stable	No	No			No	0	25.07	0	no	no	no
5386	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		ARID1A	No	1	9.86	0	no	no	yes
5387	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	60	23.7	Stable	No	Yes or Unknown	Signature.4		No	1	10.58	0	no	no	no
5388	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	187	0	Stable	No	Yes or Unknown	Signature.16		Yes	0	24.97	0	no	no	no
5389	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	77	3.5	Stable	No	No			No	1	19.91	0	no	no	no
5390	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	28	4.4	Stable	No	No			No	0	26.02	0	no	no	no
5391	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	254	31.6	Stable	No	No	Signature.4	ARID1A | FANCA | NBN	No	0	32.82	0	no	no	yes
5392	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	43	2.6	Stable	No	Yes or Unknown		BLM	Yes	1	14	0	no	no	no
5393	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	24	3.5	Stable	No	No	Signature.1		No	0	25.86	0	no	no	no
5394	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	12	5.3	Stable	No	No			No	1	21.62	0	no	no	no
5395	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	46	0.9	Stable	No	No			Yes	0	23.98	0	no	no	no
5396	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	4.4	Stable	No	No	Signature.3	BRCA2	No	0	25.63	0	no	no	no
5397	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	3.5	Stable	No	No			No	0	25.86	0	no	no	no
5398	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	34	7.9	Stable	No	No	Signature.4	BRCA2	No	0	25.69	0	no	no	no
5399	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	28	2.6	Stable	No	No			Yes	0	25.79	0	no	no	no
5400	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		22	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	8.71	0	no	no	no
5401	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	9	7	Stable	No	No	Signature.1		No	0	25.13	0	no	no	no
5402	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2017	III	0	4.4	Stable	No	No	Signature.5		No	0	23.36	0	no	no	no
5403	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	I	656	2.6	Stable	No	No			No	0	25.3	0	no	no	no
5404	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	38	4.4	Stable	No	Yes or Unknown	Signature.13	NBN	No	0	24.15	0	no	no	no
5405	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	45	7	Stable	No	Yes or Unknown			Yes	0	24.11	0	no	no	no
5406	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	91	1.8	Stable	No	No			Yes	0	25.86	0	no	no	no
5407	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	III	139	0	Stable	No	No			No	0	22.54	0	no	no	no
5408	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	4.4	Stable	No	No			Yes	0	25.82	0	no	no	no
5409	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	24.08	0	no	no	no
5410	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	42	27.2	Unstable	No	No	Signature.6	ARID1A | MRE11A	No	0	25.59	0	other-MMRd	mut-MMRd	yes
5411	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	IV	0	0.9	Stable	No	No		ARID1A	No	0	25.36	0	no	no	yes
5412	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	10	5.3	Stable	No	No			No	1	13.14	0	no	no	no
5413	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	0	0.9	Stable	No	No			Yes	0	25.13	0	no	no	no
5414	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	167	1.8	Stable	No	Yes or Unknown			No	0	25.59	0	no	no	no
5415	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	203	4.4	Stable	No	Yes or Unknown	Signature.8	SLX4	No	0	25.99	0	no	no	no
5416	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	6	3.5	Stable	No	Yes or Unknown		MDC1	No	1	18.04	0	no	no	no
5417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	123	14	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	15.77	0	no	no	yes
5418	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	5.3	Stable	No	No		ATM	No	1	6.67	0	no	no	no
5419	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	28	4.4	Stable	No	No		ATR	Yes	0	23.69	0	no	no	no
5420	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2017		72	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	24.67	0	no	no	no
5421	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1	ATM	No	0	24.9	0	no	no	no
5422	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	III	41	1.8	Stable	No	No			Yes	0	10.74	0	no	no	no
5423	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	35	10.5	Stable	No	Yes or Unknown		BRCA2	No	0	23.85	0	no	no	no
5424	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	0	4.4	Stable	No	No		MSH6	No	0	25.23	0	no	no	no
5425	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	200	0	Stable	No	Yes or Unknown		ATM	No	0	25.69	0	no	no	no
5426	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	25.79	0	no	no	no
5427	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	308	4.4	Stable	No	Yes or Unknown			No	0	25.2	0	no	no	no
5428	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	26	1.8	Stable	No	Yes or Unknown			Yes	0	4.11	0	no	no	no
5429	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	192	0.9	Stable	No	Yes or Unknown			No	0	26.09	0	no	no	no
5430	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	II	20	0.9	Stable	No	No			No	0	26.28	0	no	no	no
5431	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	52	2.6	Stable	No	No			No	0	25.26	0	no	no	no
5432	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	12	2.6	Stable	No	No			Yes	1	7.06	0	no	no	no
5433	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	16	7	Stable	No	No		BLM	Yes	0	24.38	0	no	no	no
5434	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	34	4.4	Stable	No	No			Yes	0	25.82	0	no	no	no
5435	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017		0	0	Stable	No	No			No	0	24.61	0	no	no	no
5436	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	5.3	Stable	No	No			No	0	25.1	0	no	no	no
5437	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	22	1.8	Stable	No	No			Yes	0	20.8	0	no	no	no
5438	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	III	0	0.9	Stable	No	No			Yes	0	20.11	0	no	no	no
5439	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	23	2.6	Stable	No	No			No	0	25.86	0	no	no	no
5440	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	514	0	Indeterminate	No	Yes or Unknown	Signature.5		No	0	24.94	0	no	no	no
5441	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	14	2.6	Stable	No	No			No	0	25.69	0	no	no	no
5442	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		4	4.4	Stable	No	No	Signature.1		No	1	16.99	0	no	no	no
5443	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	71	32.5	Stable	No	No	Signature.4	BRCA1 | ERCC5 | NTHL1	No	0	23.52	0	no	no	no
5444	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	310	3.5	Stable	No	Yes or Unknown			No	0	25.56	0	no	no	no
5445	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	2.6	Stable	No	Yes or Unknown			No	0	19.91	0	no	no	no
5446	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No		ARID1A	Yes	0	25.82	0	no	no	yes
5447	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	0	1.8	Stable	No	No			No	0	25.03	0	no	no	no
5448	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	64	0	Stable	No	No			Yes	0	24.84	0	no	no	no
5449	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	26.15	0	no	no	no
5450	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2017	III	0	7	Stable	No	No	Signature.13	TP53BP1	No	1	8.77	0	no	no	no
5451	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	21	0.9	Stable	No	No			Yes	0	24.64	0	no	no	no
5452	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	3.5	Stable	No	No		ERCC2	No	0	25.3	0	no	no	no
5453	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	5	4.4	Stable	No	Yes or Unknown			Yes	0	26.15	0	no	no	no
5454	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	29	4.4	Stable	No	No	Signature.6		Yes	0	22.51	0	no	no	no
5455	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	47	6.1	Stable	No	No		PALB2	No	1	10.97	0	no	no	no
5456	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	155	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	20.83	0	no	no	no
5457	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	21	2.6	Indeterminate	No	No			No	0	21.52	0	no	no	no
5458	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	0	2.6	Stable	No	No			Yes	1	12.45	0	no	no	no
5459	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	11	2.6	Stable	No	No			No	1	15.51	0	no	no	no
5460	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	565	5.3	Stable	No	Yes or Unknown	Signature.24		No	0	26.55	0	no	no	no
5461	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	118	13.2	Stable	No	No	Signature.1	RAD50	No	0	24.34	0	no	no	no
5462	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	0	16.7	Stable	No	No	Signature.1		No	0	25.53	0	no	no	no
5463	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	27	2.6	Stable	No	No			No	0	25.92	0	no	no	no
5464	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	22	3.5	Stable	No	Yes or Unknown			No	0	25.76	0	no	no	no
5465	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	28	2.6	Stable	No	No			No	0	25.53	0	no	no	no
5466	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	13.2	Stable	No	No	Signature.13	MSH6	No	0	25.76	0	no	no	no
5467	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	152	0		No	Yes or Unknown			Yes	0	25.3	0	no	no	no
5468	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	15	10.5	Stable	No	No		ERCC2	No	1	4.11	0	no	no	no
5469	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	45	1.8	Stable	No	No			No	1	6.97	0	no	no	no
5470	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017		53	1.8	Stable	No	Yes or Unknown			Yes	1	14.65	0	no	no	no
5471	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	11	6.1	Stable	No	No		ATM | BRCA2	Yes	0	26.12	0	no	no	no
5472	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	4.4	Stable	No	No			Yes	0	25.36	0	no	no	no
5473	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	75	4.4	Stable	No	Yes or Unknown	Signature.5		Yes	0	25.76	0	no	no	no
5474	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	79	2.6	Stable	No	No			No	0	15.74	0	no	no	no
5475	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	0	0	Stable	No	No			No	0	24.77	0	no	no	no
5476	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	23.29	0	no	no	no
5477	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	19	10.5	Stable	No	No	Signature.1	ERCC2 | SLX4 | TP53BP1	Yes	1	8.02	0	no	no	no
5478	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	I	0	9.7	Stable	No	No		ARID1A | ATM | ERCC3	No	1	10.12	0	no	no	yes
5479	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		5	3.5	Stable	Yes or Unknown	Yes or Unknown		MSH2	No	1	17.05	0	no	no	no
5480	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	14	3.5	Stable	No	No	Signature.2		Yes	0	25.03	0	no	no	no
5481	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	73	0.9	Stable	No	No			Yes	0	24.28	0	no	no	no
5482	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	II	0	32.5	Stable	No	No	Signature.2	ARID1A | ERCC2 | FANCA | RAD50	No	0	25.99	0	no	no	yes
5483	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	34	0	Stable	No	Yes or Unknown			No	0	22.05	0	no	no	no
5484	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	I	0	3.5	Stable	No	No			No	0	25	0	no	no	no
5485	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	100	3.5	Stable	No	Yes or Unknown		MUTYH	No	0	26.71	0	no	no	no
5486	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	III	0	3.5	Indeterminate	No	No			No	0	25.79	0	no	no	no
5487	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	38	5.3	Stable	No	No	Signature.1		Yes	0	25.76	0	no	no	no
5488	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2017	II	34	12.3	Stable	No	No	Signature.7	ERCC3 | MRE11A	No	0	25.76	0	no	no	no
5489	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	9	3.5	Stable	No	No			No	1	8.61	0	no	no	no
5490	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	IV	0	2.6	Stable	No	No			Yes	0	22.93	0	no	no	no
5491	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	24	6.1	Stable	No	No	Signature.6		Yes	0	21.75	0	no	no	no
5492	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	86	0.9	Stable	No	No			No	0	23.98	0	no	no	no
5493	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	54	2.6	Stable	No	No			No	0	23.79	0	no	no	no
5494	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	24.94	0	no	no	no
5495	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2017	III	9	0.9	Stable	No	No		ERCC3	No	0	19.02	0	no	no	no
5496	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	III	14	3.5	Stable	No	No			No	0	25.82	0	no	no	no
5497	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	69.3	Unstable	No	No	Signature.1	ERCC3 | MSH3 | SLX4 | TP53BP1	No	0	25.23	0	other-MMRd	mut-MMRd	no
5498	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	24	8.8	Stable	No	No	Signature.1	RAD51	No	0	23.13	0	no	no	no
5499	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	II	23	81.6	Unstable	No	No	Signature.6	ARID1A | BRCA1 | BRCA2 | ERCC5 | MSH3	Yes	0	24.38	0	other-MMRd	mut-MMRd	yes
5500	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	33	4.4	Stable	No	Yes or Unknown			No	0	25	0	no	no	no
5501	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	II	86	0		No	No			No	0	25.33	0	no	no	no
5502	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	54	12.3	Stable	No	Yes or Unknown	Signature.24	ARID1A | PALB2	No	0	25.26	0	no	no	yes
5503	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	7	6.1	Stable	No	Yes or Unknown	Signature.3	MDC1	No	0	25.63	0	no	no	no
5504	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	16	5.3	Stable	No	No	Signature.15	ATM	Yes	0	25.13	0	no	no	no
5505	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	41	13.2	Stable	No	No	Signature.4	ERCC2 | NBN	No	0	24.21	0	no	no	no
5506	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		80	5.3	Stable	No	No			No	0	19.42	0	no	no	no
5507	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	152	6.1	Stable	No	Yes or Unknown	Signature.20		No	1	12.75	0	no	no	no
5508	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		31	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	16.39	0	no	no	no
5509	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	4	7	Stable	No	No	Signature.1		Yes	1	0.79	0	no	no	no
5510	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	1	16.99	0	no	no	no
5511	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	6.34	0	no	no	no
5512	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	0	1.8	Stable	No	No			Yes	0	23.89	0	no	no	no
5513	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	48	1.8	Stable	No	Yes or Unknown			No	0	25.53	0	no	no	no
5514	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	III	2	4.4	Stable	No	No			No	0	25.76	0	no	no	no
5515	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	18	5.3	Stable	No	No			No	1	10.05	0	no	no	no
5516	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	214	6.1	Stable	No	Yes or Unknown	Signature.4		No	0	24.38	0	no	no	no
5517	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	24	3.5	Stable	No	No			Yes	0	25.3	0	no	no	no
5518	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	39	6.1	Stable	No	No			No	0	24.02	0	no	no	no
5519	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No			No	1	15.38	0	no	no	no
5520	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	4.4	Stable	No	No			Yes	0	26.71	0	no	no	no
5521	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			Yes	0	24.84	0	no	no	no
5522	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No	Signature.1		Yes	1	20.37	0	no	no	no
5523	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	II	311	5.3	Stable	No	No		ARID1A	No	1	26.15	0	no	no	yes
5524	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	146	2.6		No	Yes or Unknown	Signature.5		No	0	25.76	0	no	no	no
5525	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	16	3.5	Stable	No	No			Yes	0	23.92	0	no	no	no
5526	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	223	0		No	Yes or Unknown			Yes	0	24.44	0	no	no	no
5527	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	84	0	Stable	No	No			No	0	24.38	0	no	no	no
5528	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	13	0.9	Stable	No	No			No	0	25.33	0	no	no	no
5529	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	36	5.3	Stable	No	No	Signature.29	MRE11A	Yes	0	24.31	0	no	no	no
5530	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	I	45	38.6	Unstable	No	No	Signature.1	CHEK2 | FANCC | NBN	No	0	22.37	0	other-MMRd	mut-MMRd	no
5531	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	1.8	Stable	No	No			Yes	0	24.21	0	no	no	no
5532	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	174	1.8	Stable	No	Yes or Unknown			Yes	0	25.53	0	no	no	no
5533	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		17	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.91	0	no	no	no
5534	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	25.72	0	no	no	no
5535	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	0	2.6	Stable	No	No		BRCA1	Yes	0	22.97	0	no	no	no
5536	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		4	3.5	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	1	13.54	0	no	no	no
5537	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	3.5	Stable	No	No			Yes	0	23.46	0	no	no	no
5538	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	235	1.8	Stable	No	Yes or Unknown	Signature.13		No	1	14.62	0	no	no	no
5539	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	36	3.5	Stable	No	Yes or Unknown			No	0	23.69	0	no	no	no
5540	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	159	1.8	Stable	No	No			Yes	1	22.6	0	no	no	no
5541	Non-ICI treated	Never received ICI	21 - 25	Female	Ovarian	2017	III	4	0	Stable	No	No			Yes	0	23.59	0	no	no	no
5542	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	II	41	53.5	Unstable	No	No	Signature.6	BLM | BRCA1 | CHEK1 | ERCC5 | MSH3 | RAD50	No	0	24.08	0	other-MMRd	mut-MMRd	no
5543	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	69	2.6	Stable	No	Yes or Unknown			Yes	0	23.26	0	no	no	no
5544	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	18	1.8	Stable	No	No	Signature.16		No	0	23.2	0	no	no	no
5545	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	III	158	3.5	Stable	No	No			No	0	19.94	0	no	no	no
5546	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	I	0	0	Stable	No	No			No	0	19.06	0	no	no	no
5547	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	5	1.8	Stable	No	No			No	0	23.2	0	no	no	no
5548	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.2	FANCA	Yes	0	22.11	0	no	no	no
5549	Non-ICI treated	Never received ICI	76 - 80	Female	Cutaneous Melanoma 	2017	IV	0	3.5	Stable	No	No	Signature.7		No	0	12.25	0	no	no	no
5550	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	9	2.6	Stable	No	No			Yes	1	3.06	0	no	no	no
5551	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	10.5	Stable	No	No	Signature.24		No	1	1.71	0	no	no	no
5552	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	62	1.8	Stable	No	No			No	0	24.64	0	no	no	no
5553	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	20	1.8	Stable	No	No			No	0	19.32	0	no	no	no
5554	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	0	12.3	Stable	No	Yes or Unknown	Signature.4		No	1	4.57	0	no	no	no
5555	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	48	3.5	Stable	No	No			Yes	0	14.75	0	no	no	no
5556	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.2	ARID1A	No	0	24.77	0	no	no	yes
5557	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	11	0	Stable	No	No			No	0	24.74	0	no	no	no
5558	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	5.3	Stable	No	No			Yes	0	9.03	0	no	no	no
5559	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	IV	0	2.6	Stable	No	No			No	1	9.1	0	no	no	no
5560	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	76	3.5	Stable	No	No			No	0	5.75	0	no	no	no
5561	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	48	4.4	Stable	No	No			No	0	26.22	0	no	no	no
5562	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	337	0.9	Stable	No	Yes or Unknown			No	1	24.44	0	no	no	no
5563	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	3.5	Stable	No	No			No	0	15.41	0	no	no	no
5564	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	31	3.5	Stable	No	No			Yes	0	24.31	0	no	no	no
5565	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	2.6	Stable	No	Yes or Unknown			Yes	0	22.74	0	no	no	no
5566	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	IV	0	2.6	Stable	No	No			No	0	22.28	0	no	no	no
5567	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	26	2.6	Stable	No	Yes or Unknown			Yes	0	25.2	0	no	no	no
5568	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	0	4.4	Stable	No	No			Yes	1	0.85	0	no	no	no
5569	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	6.1	Stable	No	No	Signature.13	ATR | BRCA1 | CHEK1	No	0	24.38	0	no	no	no
5570	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	43	0		No	No			No	1	7.98	0	no	no	no
5571	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	III	87	2.6	Stable	No	Yes or Unknown			No	0	22.47	0	no	no	no
5572	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	5.3	Stable	No	No		ARID1A	No	0	6.97	0	no	no	yes
5573	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	0	5.3	Stable	No	No		ARID1A	Yes	0	22.34	0	no	no	yes
5574	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	7.9	Stable	No	No	Signature.4	CHEK2	No	0	9.72	0	no	no	no
5575	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	25	7	Stable	No	Yes or Unknown	Signature.1		No	0	25.13	0	no	no	no
5576	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	30	3.5	Stable	No	No			No	1	23.75	0	no	no	no
5577	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	37	8.8	Stable	No	No	Signature.1		No	0	25.13	0	no	no	no
5578	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	3.5	Stable	No	Yes or Unknown		NBN	No	0	24.74	0	no	no	no
5579	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	8	0	Stable	No	No			No	0	25.76	0	no	no	no
5580	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		5	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	24.77	0	no	no	no
5581	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	103	3.5	Stable	No	No			No	0	24.21	0	no	no	no
5582	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	4.4	Stable	No	Yes or Unknown			Yes	0	23.98	0	no	no	no
5583	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	18.66	0	no	no	no
5584	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	50	5.3	Stable	No	Yes or Unknown	Signature.30		No	1	13.5	0	no	no	no
5585	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	37	5.3	Stable	No	No	Signature.13		No	1	18.63	0	no	no	no
5586	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	56	0.9	Stable	No	No			No	0	22.57	0	no	no	no
5587	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	7	7	Stable	No	No	Signature.3		No	0	23.13	0	no	no	no
5588	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	37	5.3	Stable	No	No			Yes	0	22.97	0	no	no	no
5589	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	III	32	2.6	Stable	No	No			Yes	0	5.22	0	no	no	no
5590	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	5	6.1	Stable	No	No	Signature.12		Yes	1	4.86	0	no	no	no
5591	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	42	0.9	Stable	No	No			Yes	0	24.15	0	no	no	no
5592	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	30	9.7	Stable	No	No	Signature.1		No	0	26.74	0	no	no	no
5593	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	23.98	0	no	no	no
5594	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	II	22	2.6	Indeterminate	No	No	Signature.1		No	0	24.84	0	no	no	no
5595	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	74	4.4	Stable	No	No		ATM	No	0	20.73	0	no	no	no
5596	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		BRCA2	No	1	6.57	0	no	no	no
5597	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	II	126	0.9	Stable	No	No			No	0	25.79	0	no	no	no
5598	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	15	3.5	Stable	No	No	Signature.3		No	0	22.54	0	no	no	no
5599	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	23.23	0	no	no	no
5600	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown			Yes	0	1.61	0	no	no	no
5601	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	III	25	2.6	Stable	No	No			No	0	19.58	0	no	no	no
5602	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	3.5	Stable	No	No	Signature.11		No	0	25.13	0	no	no	no
5603	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	7	Stable	No	No	Signature.18		No	0	21.95	0	no	no	no
5604	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		92	0.9	Stable	No	No			Yes	0	16.46	0	no	no	no
5605	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	27	6.1	Stable	No	No	Signature.4		No	0	13.67	0	no	no	no
5606	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	24.25	0	no	no	no
5607	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		187	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	23.72	0	no	no	no
5608	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	IV	0	0.9	Indeterminate	No	No	Signature.5		No	0	23.69	0	no	no	no
5609	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	16	4.4	Stable	No	Yes or Unknown			No	0	22.8	0	no	no	no
5610	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	III	207	27.2	Stable	No	Yes or Unknown	Signature.4	BRCA1	Yes	0	23.1	0	no	no	no
5611	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	0	0	Stable	No	No			No	0	24.15	0	no	no	no
5612	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	IV	0	6.1	Stable	No	No	Signature.13		Yes	0	15.21	0	no	no	no
5613	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	II	0	2.6	Stable	No	No			No	1	6.18	0	no	no	no
5614	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	7	1.8	Stable	No	No		RAD50	No	0	25.26	0	no	no	no
5615	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	IV	27	5.3	Stable	No	No	Signature.1		Yes	1	5.72	0	no	no	no
5616	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	IV	0	7	Stable	No	No	Signature.1		Yes	1	5.42	0	no	no	no
5617	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	3	4.4	Stable	No	Yes or Unknown			No	0	24.57	0	no	no	no
5618	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	3	0		No	Yes or Unknown			No	1	11.79	0	no	no	no
5619	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	106	1.8	Stable	No	Yes or Unknown			No	0	25.72	0	no	no	no
5620	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	22	74.6	Stable	No	No	Signature.10	ATM | BRCA2 | MSH3 | MSH6	Yes	0	23.36	0	no	no	no
5621	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	0	5.3	Stable	No	Yes or Unknown			Yes	0	28.25	0	no	no	no
5622	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0	Stable	No	Yes or Unknown			No	0	23.26	0	no	no	no
5623	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	34	4.4	Stable	No	No			No	0	24.44	0	no	no	no
5624	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	5.3	Stable	No	No			No	0	23.72	0	no	no	no
5625	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	231	7.9	Stable	No	Yes or Unknown			No	1	8.18	0	no	no	no
5626	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	35	2.6	Stable	No	No			No	0	23.62	0	no	no	no
5627	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	5	10.5	Stable	No	No	Signature.13	MSH6	No	1	19.06	0	no	no	no
5628	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2017		46	0.9	Stable	No	Yes or Unknown			No	0	23.85	0	no	no	no
5629	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	35	0.9	Stable	No	No		ERCC5	No	0	12.45	0	no	no	no
5630	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	0	4.4	Stable	No	No			Yes	0	19.52	0	no	no	no
5631	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	39	4.4	Stable	No	Yes or Unknown			No	0	24.28	0	no	no	no
5632	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2017	III	13	31.6	Stable	No	No	Signature.7	BRIP1 | RAD50	No	0	22.97	0	no	no	no
5633	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	III	562	29	Stable	No	Yes or Unknown	Signature.7	BLM | MLH1 | MSH6 | SLX4	No	0	25.07	0	no	no	no
5634	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	442	6.1	Stable	No	Yes or Unknown		ATM	No	0	23.98	0	no	no	no
5635	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	8	7.9	Stable	No	No	Signature.1	ARID1A	No	0	24.84	0	no	no	yes
5636	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	14	2.6	Stable	No	No			Yes	0	24.11	0	no	no	no
5637	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	12	2.6	Stable	No	No			No	0	13.31	0	no	no	no
5638	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	III	28	10.5	Stable	No	No	Signature.2	PALB2	No	0	24.71	0	no	no	no
5639	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	148	4.4	Stable	No	Yes or Unknown	Signature.9		Yes	0	23.43	0	no	no	no
5640	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	III	18	5.3	Stable	No	No			No	1	18.4	0	no	no	no
5641	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	0	0.9	Stable	No	No		BRCA2	Yes	0	7.39	0	no	no	no
5642	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	55	4.4	Stable	No	No			Yes	0	24.38	0	no	no	no
5643	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	211	0	Stable	No	No			No	1	24.21	0	no	no	no
5644	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		2	8.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	23.2	0	no	no	no
5645	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	15	3.5	Stable	No	No			No	0	24.38	0	no	no	no
5646	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	60	0.9	Stable	No	No			No	0	14.26	0	no	no	no
5647	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	32	3.5	Stable	No	No		BRCA2	No	0	25.56	0	no	no	no
5648	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	7	1.8	Stable	No	No			No	0	22.97	0	no	no	no
5649	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	23	4.4	Stable	No	Yes or Unknown			No	0	26.94	0	no	no	no
5650	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	19	111.5	Unstable	No	No	Signature.6	ARID1A | BRCA1 | BRCA2 | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | RAD50 | SLX4	No	0	21.85	0	mut-MMRd	mut-MMRd	yes
5651	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No		PMS2	No	0	24.38	0	no	no	no
5652	Non-ICI treated	Never received ICI	21 - 25	Male	Pancreatic	2017	II	0	1.8	Stable	No	No		ATM | RAD51C	Yes	0	24.28	0	no	no	no
5653	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2017	II	151	17.6	Stable	No	Yes or Unknown	Signature.13	ARID1A	Yes	0	24.38	0	no	no	yes
5654	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017	IV	0	0	Stable	No	Yes or Unknown			No	1	10.18	0	no	no	no
5655	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	14	6.1	Stable	No	No		ATM	No	0	23.98	0	no	no	no
5656	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	0.9		No	No	Signature.1		No	1	2.92	0	no	no	no
5657	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2017	II	217	6.1	Stable	No	Yes or Unknown	Signature.30	FANCC | SLX4	No	0	24.77	0	no	no	no
5658	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	32	3.5	Stable	No	No			No	0	24.8	0	no	no	no
5659	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	17	0	Stable	No	No			No	0	20.6	0	no	no	no
5660	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	213	0.9	Stable	No	Yes or Unknown			No	1	11.76	0	no	no	no
5661	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	33	3.5	Stable	No	No		ERCC4	No	0	20.14	0	no	no	no
5662	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	41	5.3	Stable	No	No			No	0	11.3	0	no	no	no
5663	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	54	3.5	Stable	No	No			Yes	0	23.85	0	no	no	no
5664	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	6	12.3	Stable	No	No	Signature.1		No	0	24.8	0	no	no	no
5665	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	21	5.3	Stable	No	No			No	0	2.56	0	no	no	no
5666	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	35	4.4	Stable	No	No			No	0	19.35	0	no	no	no
5667	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	7	0	Stable	No	No			No	0	11.14	0	no	no	no
5668	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	19	9.7	Stable	No	No	Signature.6		No	1	6.24	0	no	no	no
5669	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	13	3.5	Stable	No	Yes or Unknown		ATM	No	1	7.36	0	no	no	no
5670	Non-ICI treated	Never received ICI	81 - 85	Male	Cutaneous Melanoma 	2017	III	0	21.1	Stable	No	No	Signature.7		No	0	22.57	0	no	no	no
5671	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	178	1.8	Stable	No	No			No	1	11.56	0	no	no	no
5672	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	49	1.8	Stable	No	No		BRCA2	No	0	21.32	0	no	no	no
5673	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	3.5	Stable	No	No	Signature.20		No	0	18.76	0	no	no	no
5674	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	163	1.8	Stable	No	Yes or Unknown			No	0	24.57	0	no	no	no
5675	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	3.5	Stable	No	No		CHEK2	Yes	0	21.85	0	no	no	no
5676	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	56	1.8	Stable	No	No			Yes	0	21.36	0	no	no	no
5677	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	104	0.9	Stable	No	No			No	0	27.3	0	no	no	no
5678	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	16	0.9	Stable	No	No			Yes	0	22.77	0	no	no	no
5679	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	8	4.4	Stable	No	No	Signature.5	ARID1A	No	1	16.76	0	no	no	yes
5680	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	18	7.9	Stable	No	No	Signature.4		No	0	3.32	0	no	no	no
5681	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	21	1.8	Stable	No	No			Yes	0	19.58	0	no	no	no
5682	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	1	11.3	0	no	no	no
5683	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	33	2.6	Stable	No	No			Yes	0	23.13	0	no	no	no
5684	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	0	13.2	Stable	No	No	Signature.4	ARID1A	Yes	1	4.11	0	no	no	yes
5685	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	160	5.3	Stable	No	No			No	0	7.89	0	no	no	no
5686	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	87	3.5	Stable	No	No			Yes	0	26.55	0	no	no	no
5687	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	18	2.6	Stable	No	No			Yes	1	5.32	0	no	no	no
5688	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	16	2.6	Stable	No	No			No	1	20.44	0	no	no	no
5689	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	II	123	19.3	Stable	No	Yes or Unknown	Signature.4	ERCC5	Yes	0	22.47	0	no	no	no
5690	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	31	1.8	Stable	No	No			No	1	15.28	0	no	no	no
5691	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	44	7	Stable	No	No	Signature.4	MDC1	No	1	10.68	0	no	no	no
5692	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	10	7.9	Stable	No	No	Signature.26	BLM | CHEK2	Yes	1	4.37	0	no	no	no
5693	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	46	1.8	Stable	No	No			No	0	24.02	0	no	no	no
5694	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	30	2.6	Stable	No	Yes or Unknown			No	0	23.03	0	no	no	no
5695	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	0	6.1	Stable	No	No	Signature.13	BRCA2	No	0	24.18	0	no	no	no
5696	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	III	2	4.4	Stable	No	No			No	0	24.87	0	no	no	no
5697	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	29	7	Stable	No	No	Signature.2	MUTYH	No	0	22.97	0	no	no	no
5698	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	48	0.9	Stable	No	No			No	0	24.11	0	no	no	no
5699	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	3.5	Stable	No	No			No	0	22.05	0	no	no	no
5700	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			No	0	23.59	0	no	no	no
5701	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No			Yes	1	7.06	0	no	no	no
5702	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	IV	25	4.4	Stable	No	No	Signature.10	ARID1A | ATM	No	1	13.17	0	no	no	yes
5703	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	57	3.5	Stable	No	No			No	0	23.75	0	no	no	no
5704	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	0.9	Stable	No	No			No	0	23.29	0	no	no	no
5705	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	32	5.3	Stable	No	No			No	0	24.08	0	no	no	no
5706	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	23.52	0	no	no	no
5707	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	23.98	0	no	no	no
5708	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	29	7.9	Stable	No	No	Signature.1		No	1	17.35	0	no	no	no
5709	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		16	2.6	Stable	No	No			No	0	23.39	0	no	no	no
5710	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	148	0.9	Stable	No	Yes or Unknown			Yes	0	24.08	0	no	no	no
5711	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	0.9	Stable	No	No		TP53BP1	No	0	24.54	0	no	no	no
5712	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	51	4.4	Stable	No	No			Yes	0	21.88	0	no	no	no
5713	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	218	2.6	Stable	No	Yes or Unknown		ATM	No	1	23.26	0	no	no	no
5714	Non-ICI treated	Never received ICI	36 - 40	Female	Cutaneous Melanoma 	2017	III	0	6.1	Stable	No	No	Signature.7		No	0	18.63	0	no	no	no
5715	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	II	10	1.8	Stable	No	No			No	0	23.26	0	no	no	no
5716	Non-ICI treated	Never received ICI	26 - 30	Male	Head & Neck	2017	II	400	0.9	Stable	No	Yes or Unknown			Yes	0	24.41	0	no	no	no
5717	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	201	1.8	Stable	No	No			No	0	24.87	0	no	no	no
5718	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	IV	16	1.8	Stable	No	No	Signature.5		No	1	7.2	0	no	no	no
5719	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	1	13.83	0	no	no	no
5720	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	19	2.6	Stable	No	No			No	0	24.34	0	no	no	no
5721	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	22	0	Stable	No	No			No	0	21.22	0	no	no	no
5722	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	36	2.6	Stable	No	No			No	1	21.29	0	no	no	no
5723	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	125	0		No	No			No	0	4.76	0	no	no	no
5724	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	24	3.5	Stable	No	No	Signature.19		No	0	6.74	0	no	no	no
5725	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	132	4.4	Stable	No	Yes or Unknown		SLX4	No	1	22.28	0	no	no	no
5726	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	122	8.8	Stable	No	No	Signature.4	ATR | SLX4	No	0	6.24	0	no	no	no
5727	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	22	1.8	Stable	No	No			No	0	22.14	0	no	no	no
5728	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	II	13	4.4	Stable	No	No			Yes	0	24.38	0	no	no	no
5729	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	34	7	Stable	No	No	Signature.9		No	0	25	0	no	no	no
5730	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2017	IV	6	2.6	Stable	No	Yes or Unknown	Signature.9		No	1	6.34	0	no	no	no
5731	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	0	2.6	Stable	No	No			No	0	21.98	0	no	no	no
5732	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	8	3.5	Stable	No	No			Yes	0	24.38	0	no	no	no
5733	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	264	7	Stable	No	Yes or Unknown	Signature.1		No	1	17.31	0	no	no	no
5734	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	28	0.9	Stable	No	No			Yes	0	23.56	0	no	no	no
5735	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	III	16	3.5	Stable	No	No		BRCA2	No	1	9.92	0	no	no	no
5736	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	III	44	8.8	Stable	No	No	Signature.4		Yes	0	21.68	0	no	no	no
5737	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	III	0	12.3	Stable	No	No	Signature.7	BRCA2 | MDC1	No	0	24.08	0	no	no	no
5738	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	29	36.9	Stable	No	No	Signature.4	ATR | MDC1 | MSH6	No	0	19.98	0	no	no	no
5739	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	III	98	1.8	Stable	No	No			No	0	18.86	0	no	no	no
5740	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	142	2.6	Stable	No	Yes or Unknown			No	0	24.84	0	no	no	no
5741	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	30	4.4	Stable	No	No		MRE11A	No	0	23.16	0	no	no	no
5742	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	14	Stable	No	No	Signature.1	ARID1A | RAD54L	No	1	11.6	0	no	no	yes
5743	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	23	0.9	Stable	No	No			No	0	23.39	0	no	no	no
5744	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	0	7	Stable	No	No	Signature.26		No	1	11.17	0	no	no	no
5745	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	II	0	2.6	Stable	No	No			Yes	0	23.59	0	no	no	no
5746	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.62	0	no	no	no
5747	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	14	Stable	No	No	Signature.20	ARID1A	No	0	18.1	0	no	no	yes
5748	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	19.12	0	no	no	no
5749	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	1.8	Stable	No	No			Yes	0	23.92	0	no	no	no
5750	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	7.9	Stable	No	No			No	0	24.9	0	no	no	no
5751	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	16	3.5	Stable	No	No		ARID1A	Yes	0	20.14	0	no	no	yes
5752	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2017	I	8	1.8	Stable	No	No			No	0	23.52	0	no	no	no
5753	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	58	3.5	Stable	No	No		BRCA1	Yes	0	23	0	no	no	no
5754	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	8	10.5	Stable	No	No	Signature.3		Yes	0	7	0	no	no	no
5755	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	III	0	22.8	Stable	No	No	Signature.7	BRIP1 | MLH1	No	0	20.83	0	no	no	no
5756	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	15	1.8	Stable	No	Yes or Unknown			No	0	18.5	0	no	no	no
5757	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	40	8.8	Stable	No	No	Signature.1		No	0	24.08	0	no	no	no
5758	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	0	18.27	0	no	no	no
5759	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	0	Stable	No	No		BRCA2	Yes	1	8.71	0	no	no	no
5760	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	12.3	Stable	No	No	Signature.1	PARP1	No	1	20.99	0	no	no	no
5761	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2017	IV	7	4.4	Stable	No	No	Signature.1		No	0	20.01	0	no	no	no
5762	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	26.3	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1 | PMS1	No	1	2.92	0	mut-MMRd	mut-MMRd	yes
5763	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	27	0.9	Stable	No	No			No	1	12.02	0	no	no	no
5764	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		MUTYH	Yes	0	17.81	0	no	no	no
5765	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	13	2.6	Stable	No	No			No	1	13.47	0	no	no	no
5766	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	147	5.3	Stable	No	Yes or Unknown		BRCA1 | ERCC2	No	0	23.95	0	no	no	no
5767	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		14	2.6	Stable	No	No		BRCA1	No	1	7.06	0	no	no	no
5768	Non-ICI treated	Never received ICI	26 - 30	Male	Renal	2017	III	0	3.5	Stable	No	No			No	0	2.73	0	no	no	no
5769	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	55	0.9	Stable	No	No			Yes	0	21.65	0	no	no	no
5770	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	23	0.9	Stable	No	Yes or Unknown			Yes	0	23.52	0	no	no	no
5771	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	III	52	3.5	Stable	No	No		MRE11A	No	0	23.49	0	no	no	no
5772	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.13	0	no	no	no
5773	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	PMS2	No	0	23.39	0	no	no	no
5774	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	91	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	5.19	0	no	no	no
5775	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	III	33	4.4	Stable	No	No		ATM	No	1	15.34	0	no	no	no
5776	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	30	0		No	No			Yes	0	18.6	0	no	no	no
5777	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	33	4.4	Stable	No	No			No	0	24.08	0	no	no	no
5778	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	40	6.1	Stable	No	Yes or Unknown			Yes	0	23.75	0	no	no	no
5779	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	25.76	0	no	no	no
5780	Non-ICI treated	Never received ICI	21 - 25	Female	Ovarian	2017	I	0	3.5	Stable	No	No			No	0	22.24	0	no	no	no
5781	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	35	1.8	Stable	No	No		TP53BP1	Yes	0	21.62	0	no	no	no
5782	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2017	III	0	7.9	Stable	No	No	Signature.19		Yes	0	23.66	0	no	no	no
5783	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	78	1.8	Stable	No	No			No	0	24.34	0	no	no	no
5784	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	1	4.96	0	no	no	no
5785	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	617	5.3	Stable	No	Yes or Unknown	Signature.30		Yes	0	23.56	0	no	no	no
5786	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	78	14.9	Stable	No	No	Signature.1	RAD54L	No	0	3.94	0	no	no	no
5787	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	393	3.5	Stable	No	Yes or Unknown			No	0	24.64	0	no	no	no
5788	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	427	3.5	Stable	No	Yes or Unknown		SLX4	No	0	24.15	0	no	no	no
5789	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	6	1.8	Stable	No	No			No	0	24.11	0	no	no	no
5790	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	III	13	5.3	Stable	No	No			No	0	24.71	0	no	no	no
5791	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	19	4.4	Stable	No	No			Yes	1	8.15	0	no	no	no
5792	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	0	7	Stable	No	No	Signature.13		Yes	0	22.83	0	no	no	no
5793	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2017	IV	26	56.2	Stable	No	No	Signature.4	ARID1A | ATR | BRCA2 | FANCA | MSH3	Yes	0	5.52	0	no	no	yes
5794	Non-ICI treated	Never received ICI	46 - 50	Male	Breast	2017	II	32	0	Stable	No	No			No	0	27.3	0	no	no	no
5795	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	I	117	5.3	Stable	No	No			No	0	24.64	0	no	no	no
5796	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2017	IV	6	2.6	Stable	No	No		ARID1A	No	1	12.39	0	no	no	yes
5797	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	7	Stable	No	No	Signature.24		Yes	0	26.64	0	no	no	no
5798	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	189	0.9	Stable	No	Yes or Unknown			No	1	15.28	0	no	no	no
5799	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	35	2.6	Stable	No	No			Yes	0	23.39	0	no	no	no
5800	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	II	146	0.9	Stable	No	Yes or Unknown			No	0	23.92	0	no	no	no
5801	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	18	7.9	Stable	No	No	Signature.1	MUTYH	No	0	25	0	no	no	no
5802	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	2.6	Stable	No	No		ATM	No	0	13.24	0	no	no	no
5803	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.30		Yes	0	3.09	0	no	no	no
5804	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	8	3.5	Stable	No	No			Yes	0	23.75	0	no	no	no
5805	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	0	Stable	No	No			Yes	0	24.15	0	no	no	no
5806	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			Yes	0	23.59	0	no	no	no
5807	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	38	3.5	Stable	No	No			No	0	21.03	0	no	no	no
5808	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	6	6.1	Stable	No	No	Signature.3		Yes	1	15.11	0	no	no	no
5809	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	0	5.3	Stable	No	Yes or Unknown			Yes	0	18.83	0	no	no	no
5810	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	9	0.9	Stable	No	No			Yes	0	24.02	0	no	no	no
5811	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	19.02	0	no	no	no
5812	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	I	0	1.8	Stable	No	Yes or Unknown			Yes	0	6.74	0	no	no	no
5813	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	15	7	Stable	No	Yes or Unknown	Signature.3	ATM | BRCA2 | MDC1	Yes	0	23.92	0	no	no	no
5814	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	III	0	15.8	Stable	No	No	Signature.4		Yes	0	19.52	0	no	no	no
5815	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	6	7	Stable	No	No	Signature.29		No	0	17.48	0	no	no	no
5816	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	30	2.6	Stable	No	No		FANCA	No	1	7.23	0	no	no	no
5817	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	6	7	Stable	No	No			Yes	0	22.47	0	no	no	no
5818	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	32	3.5	Stable	No	No			Yes	0	20.76	0	no	no	no
5819	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	II	0	2.6	Stable	No	No			Yes	1	13.54	0	no	no	no
5820	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	16	0.9	Stable	No	No			No	0	26.64	0	no	no	no
5821	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	30	140.4	Stable	No	No	Signature.10	ARID1A | ATM | BRCA1 | BRCA2 | ERCC3 | ERCC5 | MRE11A | RAD51C | SLX4	No	0	24.18	0	no	no	yes
5822	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	23	1.8	Stable	No	Yes or Unknown			No	0	23.43	0	no	no	no
5823	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	11	3.5	Stable	No	No			No	1	16.82	0	no	no	no
5824	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	8	1.8	Stable	No	No			No	0	21.98	0	no	no	no
5825	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	147	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	23.33	0	no	no	yes
5826	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	29	3.5	Stable	No	No			No	0	23.49	0	no	no	no
5827	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	28	4.4	Stable	No	Yes or Unknown		ARID1A | RAD52	No	1	16.56	0	no	no	yes
5828	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	35	7.9	Stable	No	No	Signature.16		No	1	4.14	0	no	no	no
5829	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	0.9	Stable	No	No			Yes	0	19.75	0	no	no	no
5830	Non-ICI treated	Never received ICI	36 - 40	Male	Prostatic	2017	IV	64	1.8	Stable	No	Yes or Unknown			No	1	16	0	no	no	no
5831	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	7	5.3	Stable	No	No			No	1	9.33	0	no	no	no
5832	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	214	5.3	Stable	No	Yes or Unknown			No	0	21.55	0	no	no	no
5833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	0		No	No			No	0	19.38	0	no	no	no
5834	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	147	4.4	Stable	No	Yes or Unknown			No	0	24.15	0	no	no	no
5835	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	25	0	Stable	No	No			No	0	21.95	0	no	no	no
5836	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	7	Stable	No	No	Signature.1		No	1	21.26	0	no	no	no
5837	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	III	32	7.9	Stable	No	No	Signature.4	ATM | PALB2	Yes	0	20.27	0	no	no	no
5838	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2017	I	0	3.5	Stable	No	No		ATM	No	0	19.32	0	no	no	no
5839	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		9	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.29	0	no	no	no
5840	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	0	3.5	Stable	No	No			No	1	23.13	0	no	no	no
5841	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.62	0	no	no	no
5842	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	25	27.2	Stable	No	Yes or Unknown	Signature.4	ARID1A	Yes	0	24.02	0	no	no	yes
5843	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	0		No	No			Yes	0	3.32	0	no	no	no
5844	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	55	4.4	Stable	No	No			Yes	0	23.92	0	no	no	no
5845	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	39	1.8	Stable	No	No		BLM	No	0	18.99	0	no	no	no
5846	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	23.92	0	no	no	no
5847	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	0		No	No			No	1	6.47	0	no	no	no
5848	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	23	4.4	Stable	No	No			Yes	1	4.17	0	no	no	no
5849	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	4	2.6	Stable	No	No		ATM	Yes	0	23.89	0	no	no	no
5850	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	III	27	0		No	No			Yes	0	23.62	0	no	no	no
5851	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		112	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	11.56	0	no	no	no
5852	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	23	6.1	Stable	No	No			No	0	19.55	0	no	no	no
5853	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	9.7	Stable	No	No	Signature.3	BRCA2 | MSH6	No	0	23.66	0	no	no	no
5854	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	0	1.8	Stable	No	Yes or Unknown	Signature.1		No	0	25.95	0	no	no	no
5855	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	12	4.4	Stable	No	No	Signature.3		Yes	0	22.24	0	no	no	no
5856	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	17.97	0	no	no	no
5857	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	34	3.5	Stable	No	No	Signature.1		No	0	23.92	0	no	no	no
5858	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	0	0.62	0	no	no	no
5859	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	10	4.4	Stable	No	No		ERCC3	No	0	23.85	0	no	no	no
5860	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	10.5	Stable	No	No	Signature.5		No	0	16.79	0	no	no	no
5861	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	24.21	0	no	no	no
5862	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	IV	194	3.5	Stable	No	Yes or Unknown		MSH3	Yes	0	14.88	0	no	no	no
5863	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	0	9.7	Stable	No	No		ATR	No	0	24.15	0	no	no	no
5864	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	III	19	6.1	Stable	No	No	Signature.1		Yes	0	22.9	0	no	no	no
5865	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	3.5	Stable	No	No		ATR	No	0	22.41	0	no	no	no
5866	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	166	6.1	Stable	No	Yes or Unknown			No	0	23.23	0	no	no	no
5867	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	2	7.9	Stable	No	No			No	1	19.45	0	no	no	no
5868	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	II	32	3.5	Stable	No	No			Yes	1	20.57	0	no	no	no
5869	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	24.15	0	no	no	no
5870	Non-ICI treated	Never received ICI	81 - 85	Male	Cutaneous Melanoma 	2017	II	34	5.3	Stable	No	No	Signature.19		No	0	20.63	0	no	no	no
5871	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	7	Stable	No	Yes or Unknown			No	1	7.29	0	no	no	no
5872	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	IV	16	43.9	Unstable	No	No	Signature.6	ARID1A | ATM | CHEK1 | MSH3	Yes	1	6.18	0	other-MMRd	mut-MMRd	yes
5873	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2017	IV	20	2.6	Stable	No	No			No	0	6.57	0	no	no	no
5874	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	0	6.1	Stable	No	No	Signature.1		No	0	23.79	0	no	no	no
5875	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	28	2.6	Stable	No	No		ARID1A	No	0	12.12	0	no	no	yes
5876	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	29	2.6	Stable	No	No			Yes	0	21.59	0	no	no	no
5877	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	30	87.8	Unstable	No	No	Signature.6	BRCA1 | BRCA2 | MDC1 | MSH3 | RAD51	No	0	17.05	0	other-MMRd	mut-MMRd	no
5878	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	II	385	14	Stable	No	Yes or Unknown	Signature.24	ATM	No	0	14.49	0	no	no	no
5879	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	0	3.5	Stable	No	No			Yes	0	21.82	0	no	no	no
5880	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	III	0	8.8	Stable	No	No	Signature.5	ERCC2	Yes	0	20.93	0	no	no	no
5881	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	163	2.6	Stable	No	Yes or Unknown			No	1	10.87	0	no	no	no
5882	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	9	5.3	Stable	No	No		ATM	No	1	19.12	0	no	no	no
5883	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	56	2.6	Stable	No	Yes or Unknown			No	0	23.26	0	no	no	no
5884	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	22	0.9	Stable	No	No			No	0	22.37	0	no	no	no
5885	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	22.97	0	no	no	no
5886	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	15	4.4	Stable	No	Yes or Unknown			Yes	0	17.31	0	no	no	no
5887	Non-ICI treated	Never received ICI	86 - 90	Male	Pancreatic	2017	II	2	0.9	Stable	No	No			No	1	13.83	0	no	no	no
5888	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	5.3	Stable	No	Yes or Unknown		MSH6	Yes	1	4.21	0	no	no	no
5889	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2017		0	15.8	Stable	No	No	Signature.2	ERCC4	No	0	17.05	0	no	no	no
5890	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	10	8.8	Stable	No	No	Signature.1	ARID1A | ATM	No	1	18.3	0	no	no	yes
5891	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	0	8.8	Stable	No	No		ARID1A	Yes	1	3.75	0	no	no	yes
5892	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	0	5.3	Stable	No	No			Yes	0	5.26	0	no	no	no
5893	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	39	2.6	Stable	No	No			No	0	20.47	0	no	no	no
5894	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	44	1.8	Stable	No	No			No	0	23.03	0	no	no	no
5895	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	21	0.9	Stable	No	No			No	0	22.14	0	no	no	no
5896	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		41	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.16	0	no	no	no
5897	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	22.08	0	no	no	no
5898	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	36	14.9	Stable	No	No	Signature.13	NTHL1	Yes	0	23.66	0	no	no	no
5899	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	III	0	3.5	Stable	No	No			Yes	0	24.11	0	no	no	no
5900	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	27	4.4	Stable	No	No			Yes	0	22.74	0	no	no	no
5901	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	I	88	0.9	Stable	No	No			No	0	9.63	0	no	no	no
5902	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	I	0	1.8	Stable	No	No			No	0	16.13	0	no	no	no
5903	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2017		16	0	Stable	No	No			No	0	20.47	0	no	no	no
5904	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0	Stable	No	Yes or Unknown			No	0	19.91	0	no	no	no
5905	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	13.2	Stable	No	No	Signature.1		No	0	23.92	0	no	no	no
5906	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	85	3.5	Stable	No	No			Yes	0	19.61	0	no	no	no
5907	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	89	1.8	Stable	No	No			No	1	17.97	0	no	no	no
5908	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	15.8	Stable	No	No	Signature.4		No	0	16.62	0	no	no	no
5909	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	43	3.5	Stable	No	No			Yes	0	23.59	0	no	no	no
5910	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	III	1	1.8	Stable	No	No			Yes	0	24.18	0	no	no	no
5911	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No	Signature.26		No	1	19.81	0	no	no	no
5912	Non-ICI treated	Never received ICI	26 - 30	Male	Gastric	2017	IV	0	2.6	Stable	No	No			No	1	10.94	0	no	no	no
5913	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	0	26.78	0	no	no	no
5914	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2017	IV	0	16.7	Stable	No	No	Signature.17		No	0	9.07	0	no	no	no
5915	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	0	6.1	Stable	No	No			No	0	23.52	0	no	no	no
5916	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	21	3.5	Stable	No	No		ATM	No	1	12.45	0	no	no	no
5917	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	24.02	0	no	no	no
5918	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	752	3.5	Stable	No	Yes or Unknown		RAD51C	No	0	23.49	0	no	no	no
5919	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	28	2.6	Stable	No	No			No	0	23.52	0	no	no	no
5920	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	47	4.4	Stable	No	No		ATM	No	1	21.13	0	no	no	no
5921	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	5	7.9	Stable	No	No			Yes	0	11.01	0	no	no	no
5922	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2017	III	0	7	Stable	No	No	Signature.7		No	0	17.41	0	no	no	no
5923	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	III	21	0	Stable	No	Yes or Unknown			No	1	10.68	0	no	no	no
5924	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	44	2.6	Stable	No	No			Yes	0	17.94	0	no	no	no
5925	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	0	1.8	Stable	No	No	Signature.1		Yes	1	7	0	no	no	no
5926	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017		253	1.8	Stable	No	No			Yes	0	16.07	0	no	no	no
5927	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2017	I	16	1.8	Stable	No	No			No	0	20.63	0	no	no	no
5928	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		13	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.25	TP53BP1	Yes	0	15.67	0	no	no	no
5929	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	11.4	Stable	No	No	Signature.1	ATM	Yes	1	4.01	0	no	no	no
5930	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	5	5.3	Stable	No	No		FANCA	No	0	25.3	0	no	no	no
5931	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	21	1.8	Stable	No	No			Yes	0	22.77	0	no	no	no
5932	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	40	4.4	Stable	No	No			No	0	13.11	0	no	no	no
5933	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	20.96	0	no	no	no
5934	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	No			No	0	17.61	0	no	no	no
5935	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		25	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	RAD51C	No	1	2.53	0	no	no	no
5936	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	34	2.6	Stable	No	No			No	0	22.28	0	no	no	no
5937	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	0	24.44	0	no	no	no
5938	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	2.6	Stable	No	Yes or Unknown			No	0	23.49	0	no	no	no
5939	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	28	3.5	Stable	No	No		FANCA	Yes	0	23.43	0	no	no	no
5940	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	18.4	Stable	No	No	Signature.4	ARID1A	No	0	20.67	0	no	no	yes
5941	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	76	0.9	Stable	No	Yes or Unknown			Yes	0	24.05	0	no	no	no
5942	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	30	1.8	Stable	No	No			Yes	0	21.13	0	no	no	no
5943	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2017	I	0	3.5	Stable	No	No			No	0	13.04	0	no	no	no
5944	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			Yes	0	20.67	0	no	no	no
5945	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	67	4.4	Stable	No	No		MSH2	No	0	24.57	0	no	no	no
5946	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	9	1.8	Stable	No	No			No	0	21.68	0	no	no	no
5947	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	1	10.5	Stable	No	No	Signature.1		No	0	13.14	0	no	no	no
5948	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	II	6	74.6	Unstable	No	No	Signature.6	ARID1A | ATM | BRCA2 | ERCC3 | ERCC5 | MRE11A | MSH3 | MSH6 | RAD52 | TP53BP1 | XRCC2	No	0	21.09	0	mut-MMRd	mut-MMRd	yes
5949	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	7	0.9	Stable	No	No			No	1	5.03	0	no	no	no
5950	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	0	7	Stable	No	No		ARID1A | BRCA2	Yes	1	2.96	0	no	no	yes
5951	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	III	59	12.3	Stable	No	No	Signature.4	NBN	No	0	9.03	0	no	no	no
5952	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		0	1.8	Stable	No	No			No	0	1.15	0	no	no	no
5953	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	156	2.6	Stable	No	No			No	0	8.48	0	no	no	no
5954	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	4.4	Stable	No	No			No	1	15.77	0	no	no	no
5955	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.1	BLM	No	0	23.13	0	no	no	no
5956	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	49	1.8	Stable	No	No			No	0	23.62	0	no	no	no
5957	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2017	III	10	0.9	Stable	No	No			Yes	0	21.62	0	no	no	no
5958	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	33	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	23.03	0	no	no	no
5959	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	8	8.8	Stable	No	No	Signature.1	ARID1A	Yes	1	13.17	0	no	no	yes
5960	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	15	9.7	Stable	No	No	Signature.3	BRCA1	Yes	0	5.95	0	no	no	no
5961	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	22.51	0	no	no	no
5962	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	45	1.8	Stable	No	No			No	0	19.61	0	no	no	no
5963	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	IV	68	4.4	Stable	No	Yes or Unknown			Yes	0	14.88	0	no	no	no
5964	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		18	6.1	Stable	No	No	Signature.1		No	0	1.35	0	no	no	no
5965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	175	2.6	Stable	No	Yes or Unknown			No	0	8.8	0	no	no	no
5966	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	IV	0	5.3	Stable	No	Yes or Unknown	Signature.18	MUTYH | PALB2	No	0	23.69	0	no	no	no
5967	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	6.1	Stable	No	No		BRIP1	No	0	16.36	0	no	no	no
5968	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	17	0.9	Stable	No	No			Yes	0	19.42	0	no	no	no
5969	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	15	14.9	Stable	No	No	Signature.13		No	0	20.47	0	no	no	no
5970	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	0	16.39	0	no	no	no
5971	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	3.5	Stable	No	No	Signature.4		Yes	1	12.06	0	no	no	no
5972	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	0	11.4	Indeterminate	No	No	Signature.3		No	0	22.74	0	no	no	no
5973	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	III	622	0.9	Stable	No	Yes or Unknown			No	0	23.29	0	no	no	no
5974	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2017	IV	14	4.4	Stable	No	No			No	1	12.02	0	no	no	no
5975	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	0	5.3	Stable	No	No			No	0	21.19	0	no	no	no
5976	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	II	0	0.9	Stable	No	Yes or Unknown			Yes	0	20.9	0	no	no	no
5977	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	26	2.6	Stable	No	Yes or Unknown			Yes	0	23.26	0	no	no	no
5978	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	3	4.4	Stable	No	No			Yes	1	3.45	0	no	no	no
5979	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	22.64	0	no	no	no
5980	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	26	2.6	Stable	No	Yes or Unknown			Yes	0	20.9	0	no	no	no
5981	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	55	64.1	Unstable	No	No	Signature.6	ARID1A | MSH3 | MSH6 | PMS2	Yes	0	20.53	0	mut-MMRd	mut-MMRd	yes
5982	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		232	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	8.31	0	no	no	no
5983	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	47	0	Stable	No	No			No	0	21.19	0	no	no	no
5984	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	21	2.6	Stable	No	No			No	0	22.18	0	no	no	no
5985	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	21	2.6	Stable	No	No		BLM	No	0	23.52	0	no	no	no
5986	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	256	4.4		No	Yes or Unknown		BRCA1	No	0	23.43	0	no	no	no
5987	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	173	1.8	Stable	No	Yes or Unknown		BRCA1	No	0	19.88	0	no	no	no
5988	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	1.8	Stable	No	No	Signature.1		Yes	0	20.37	0	no	no	no
5989	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017		1	0	Stable	Yes or Unknown	Yes or Unknown			No	0	22.93	0	no	no	no
5990	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	III	502	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	23.1	0	no	no	no
5991	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	42	2.6	Stable	No	Yes or Unknown			No	0	21.13	0	no	no	no
5992	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	34	0	Stable	No	No			Yes	0	22.28	0	no	no	no
5993	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	II	69	2.6	Stable	No	No		ARID1A	Yes	0	23.26	0	no	no	yes
5994	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		BLM | BRCA2	Yes	0	21.78	0	no	no	no
5995	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	43	3.5	Stable	No	Yes or Unknown			No	0	23.43	0	no	no	no
5996	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	No		ATM	Yes	0	22.57	0	no	no	no
5997	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2017	IV	44	0		No	No			No	0	22.41	0	no	no	no
5998	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	4.4	Indeterminate	No	No	Signature.30		No	1	6.97	0	no	no	no
5999	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	25	3.5	Stable	No	No		ARID1A	Yes	1	6.18	0	no	no	yes
6000	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	1	7.36	0	no	no	no
6001	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	0	3.5	Stable	No	No			No	0	7.36	0	no	no	no
6002	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	17	0.9	Stable	No	No			No	0	22.83	0	no	no	no
6003	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	1.8	Stable	No	No	Signature.1	NBN	No	1	11.24	0	no	no	no
6004	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	43	3.5	Stable	No	Yes or Unknown			No	0	15.21	0	no	no	no
6005	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	2	8.8	Stable	No	No			Yes	0	24.25	0	no	no	no
6006	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	192	0	Stable	No	Yes or Unknown			No	1	22.01	0	no	no	no
6007	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	13	6.1	Stable	No	No	Signature.1		No	1	15.77	0	no	no	no
6008	Non-ICI treated	Never received ICI	81 - 85	Female	Esophageal	2017	IV	0	6.1	Stable	No	Yes or Unknown		ATR	No	1	20.76	0	no	no	no
6009	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	24	5.3	Stable	No	No	Signature.4	ATM | MRE11A	No	0	22.11	0	no	no	no
6010	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	202	5.3	Stable	No	Yes or Unknown			No	1	14.36	0	no	no	no
6011	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	148	7	Stable	No	No	Signature.1		No	0	14.78	0	no	no	no
6012	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	III	28	38.6	Stable	No	No	Signature.22	ARID1A | ATM | MDC1 | MSH3	No	0	20.47	0	no	no	yes
6013	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No		MDC1	Yes	1	4.07	0	no	no	no
6014	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2017	IV	21	4.4	Stable	No	No	Signature.1		No	0	22.9	0	no	no	no
6015	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	625	15.8	Stable	No	Yes or Unknown	Signature.1	BRIP1	No	0	25.1	0	no	no	no
6016	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	0	3.5	Stable	No	No	Signature.1		No	0	22.74	0	no	no	no
6017	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No		PALB2	No	1	11.79	0	no	no	no
6018	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	51	2.6	Stable	No	No		ARID1A	Yes	0	19.35	0	no	no	yes
6019	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	I	242	4.4	Stable	No	Yes or Unknown			No	0	25.66	0	no	no	no
6020	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	1.8	Indeterminate	No	No			No	1	15.47	0	no	no	no
6021	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2017	I	55	2.6	Stable	No	No			No	0	21.03	0	no	no	no
6022	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	14	4.4	Stable	No	No		CHEK2	Yes	1	5.62	0	no	no	no
6023	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	564	1.8	Stable	No	Yes or Unknown			No	0	22.77	0	no	no	no
6024	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	29	2.6	Stable	No	No			No	0	22.7	0	no	no	no
6025	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	433	27.2	Unstable	No	Yes or Unknown	Signature.12	ARID1A | ERCC5	Yes	0	21.72	0	other-MMRd	mut-MMRd	yes
6026	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No			Yes	1	12.45	0	no	no	no
6027	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	III	24	1.8	Stable	No	No			Yes	0	20.57	0	no	no	no
6028	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	4	7.9	Stable	No	No		BRCA2	No	0	22.87	0	no	no	no
6029	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	12	0	Stable	No	No		ATM	No	1	11.96	0	no	no	no
6030	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	20	4.4	Stable	No	No			No	1	3.52	0	no	no	no
6031	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	104	5.3	Stable	No	No	Signature.4		No	0	14.19	0	no	no	no
6032	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	119	2.6	Stable	No	Yes or Unknown			No	0	23	0	no	no	no
6033	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	52	3.5	Stable	No	No		MDC1	No	0	22.57	0	no	no	no
6034	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	70	6.1	Stable	No	No			Yes	0	22.34	0	no	no	no
6035	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	50	18.4	Stable	No	No	Signature.4	MDC1	No	0	21.26	0	no	no	no
6036	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	6	3.5	Stable	No	No			No	0	22.64	0	no	no	no
6037	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	22	6.1	Stable	No	No			No	0	22.83	0	no	no	no
6038	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	0	7.9	Stable	No	No	Signature.1	MLH1	Yes	0	7.52	0	no	no	no
6039	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	42	5.3	Stable	No	No			No	0	17.18	0	no	no	no
6040	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	21	4.4	Stable	No	No	Signature.6		No	0	22.77	0	no	no	no
6041	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	II	7	7.9	Stable	No	No	Signature.1		No	0	20.44	0	no	no	no
6042	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	171	0.9	Stable	No	Yes or Unknown			No	0	23.13	0	no	no	no
6043	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1	ARID1A	No	0	23.89	0	no	no	yes
6044	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	9.7	Stable	No	No		BRCA2	No	0	22.97	0	no	no	no
6045	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	119	2.6	Stable	No	No		ARID1A	No	0	25.46	0	no	no	yes
6046	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	22	2.6	Stable	No	No	Signature.5		No	0	17.94	0	no	no	no
6047	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	20	7	Stable	No	No			Yes	1	14.23	0	no	no	no
6048	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	22.44	0	no	no	no
6049	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2017	IV	0	2.6	Stable	No	No			No	1	13.86	0	no	no	no
6050	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	0	3.5	Stable	No	No		ARID1A	No	1	14.55	0	no	no	yes
6051	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	3	5.3	Stable	No	No			No	1	4.5	0	no	no	no
6052	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	112	0	Stable	No	No			No	0	3.68	0	no	no	no
6053	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1	ATR	Yes	0	10.48	0	no	no	no
6054	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	16	0.9	Stable	No	No			No	0	14.03	0	no	no	no
6055	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	197	0.9	Stable	No	Yes or Unknown			No	0	19.55	0	no	no	no
6056	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	0	2.6	Stable	No	No		ATM	No	0	3.81	0	no	no	no
6057	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	III	126	7	Stable	No	No	Signature.24		No	1	7.62	0	no	no	no
6058	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2017	III	0	2.6	Stable	No	Yes or Unknown			Yes	0	20.01	0	no	no	no
6059	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	2.6	Stable	No	No			No	0	19.55	0	no	no	no
6060	Non-ICI treated	Never received ICI	16 - 20	Male	Colorectal	2017	III	0	58.8	Unstable	No	No	Signature.6	ARID1A | ERCC4 | MLH1 | MSH3	Yes	0	19.91	0	mut-MMRd	mut-MMRd	yes
6061	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	16.72	0	no	no	no
6062	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	34	8.8	Stable	No	No	Signature.1	ATR	No	1	20.6	0	no	no	no
6063	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	11	7	Stable	No	No			No	0	23.1	0	no	no	no
6064	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	215	0	Stable	No	Yes or Unknown			No	0	22.57	0	no	no	no
6065	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	1	3.5	Stable	No	No			Yes	0	23.06	0	no	no	no
6066	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	III	26	25.5	Stable	No	No	Signature.6	BRCA1 | MDC1	No	0	22.47	0	no	no	no
6067	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	III	37	0.9	Stable	No	No			Yes	0	23.2	0	no	no	no
6068	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	20	0	Stable	No	No			No	0	17.94	0	no	no	no
6069	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	I	52	5.3	Stable	No	No	Signature.9	ERCC5	No	0	23.39	0	no	no	no
6070	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2017	II	24	2.6	Stable	No	No			No	0	18.83	0	no	no	no
6071	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No	Signature.1		Yes	1	5.13	0	no	no	no
6072	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	22.8	0	no	no	no
6073	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	0	22.97	0	no	no	no
6074	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	22	0.9	Stable	No	No			No	0	21.16	0	no	no	no
6075	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	III	186	9.7	Stable	No	Yes or Unknown	Signature.4	ERCC5	No	0	23.69	0	no	no	no
6076	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	III	142	0	Stable	No	No			No	0	4.96	0	no	no	no
6077	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	33	62.3	Unstable	No	No	Signature.6	ARID1A | ERCC2 | MSH3 | MSH6	No	0	23.26	0	mut-MMRd	mut-MMRd	yes
6078	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	35	4.4	Stable	No	No		ATM	Yes	0	6.37	0	no	no	no
6079	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	30	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	22.9	0	no	no	no
6080	Non-ICI treated	Never received ICI	26 - 30	Female	Hepatobiliary	2017		14	0	Stable	No	No			No	0	20.01	0	no	no	no
6081	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	0	0		No	No			No	0	20.99	0	no	no	no
6082	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		68	0	Stable	No	No			No	0	17.94	0	no	no	no
6083	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	28.1	Stable	No	No	Signature.4	ATR	No	1	6.64	0	no	no	no
6084	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	20	6.1	Stable	No	No		NBN	No	1	10.87	0	no	no	no
6085	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	5.3	Stable	No	No		MSH3	No	0	22.9	0	no	no	no
6086	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	22	40.4	Unstable	No	No	Signature.6	ATM | ERCC3 | MSH2 | PARP1 | PMS1	No	0	22.44	0	mut-MMRd	mut-MMRd	no
6087	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	III	0	0.9	Stable	No	No			Yes	0	22.28	0	no	no	no
6088	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	8	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	17.02	0	no	no	yes
6089	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	0	4.4	Stable	No	No			No	0	23.39	0	no	no	no
6090	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	40	5.3	Stable	No	No	Signature.5		No	0	5.26	0	no	no	no
6091	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	19	1.8	Stable	No	No			No	0	18.63	0	no	no	no
6092	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	4	4.4	Stable	No	No	Signature.6		No	0	22.05	0	no	no	no
6093	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	44	9.7	Stable	No	No	Signature.13		Yes	0	20.93	0	no	no	no
6094	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	23	5.3	Stable	No	No		BRCA2	No	0	22.51	0	no	no	no
6095	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	232	1.8	Stable	No	Yes or Unknown			No	1	9.59	0	no	no	no
6096	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	2.6	Stable	No	Yes or Unknown	Signature.7		No	0	23	0	no	no	no
6097	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	0	23.26	0	no	no	no
6098	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	IV	35	2.6	Stable	No	No			Yes	0	21.85	0	no	no	no
6099	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	2.6	Stable	No	No		BRCA2	Yes	1	3.48	0	no	no	no
6100	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	0	4.4	Stable	No	No	Signature.3		No	0	22.67	0	no	no	no
6101	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	6.1	Stable	No	No			Yes	1	6.47	0	no	no	no
6102	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	42	3.5	Stable	No	Yes or Unknown			No	0	18.89	0	no	no	no
6103	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	0	5.3	Stable	No	No			No	0	17.68	0	no	no	no
6104	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	30	4.4	Stable	No	Yes or Unknown			Yes	0	2.56	0	no	no	no
6105	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	144	6.1	Stable	No	Yes or Unknown			Yes	0	17.22	0	no	no	no
6106	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.4	BRCA2	No	0	20.07	0	no	no	no
6107	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	128	3.5	Stable	No	Yes or Unknown		PMS2	No	0	22.77	0	no	no	no
6108	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	280	14	Stable	No	Yes or Unknown	Signature.2	BRCA1	No	0	10.41	0	no	no	no
6109	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	237	0.9	Stable	No	Yes or Unknown			No	0	22.97	0	no	no	no
6110	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	46	3.5	Stable	No	No	Signature.29		No	0	20.44	0	no	no	no
6111	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	11	2.6	Stable	No	No		ATM | MSH3	No	1	18.1	0	no	no	no
6112	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2017	IV	1	4.4	Stable	No	No		PMS1	No	0	22.83	0	no	no	no
6113	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	1	4.4	Stable	No	No			No	0	23.1	0	no	no	no
6114	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	10	0.9	Stable	No	No			No	1	17.31	0	no	no	no
6115	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	63	2.6	Stable	No	No			No	0	23.16	0	no	no	no
6116	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	6	6.1	Stable	No	No	Signature.1		No	1	7.98	0	no	no	no
6117	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	50	10.5	Stable	No	No	Signature.13	ATR	No	0	20.86	0	no	no	no
6118	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	21	1.8	Stable	No	No		ATM	No	1	8.97	0	no	no	no
6119	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	I	62	0	Stable	No	No			No	0	4.93	0	no	no	no
6120	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	0	23.03	0	no	no	no
6121	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	102	1.8	Stable	No	Yes or Unknown			No	1	13.67	0	no	no	no
6122	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			No	0	22.54	0	no	no	no
6123	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	9	24.6	Unstable	No	No	Signature.6	ARID1A | MLH1	No	0	22.83	0	mut-MMRd	mut-MMRd	yes
6124	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	3	3.5	Stable	No	No			No	0	13.37	0	no	no	no
6125	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	22.51	0	no	no	no
6126	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	0	21.65	0	no	no	no
6127	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	17	1.8	Stable	No	Yes or Unknown			Yes	0	22.41	0	no	no	no
6128	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	28	1.8	Stable	No	No		RAD52	No	0	21.32	0	no	no	no
6129	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	5.3	Stable	No	No		ARID1A | BRIP1 | MSH2	No	0	17.12	0	no	no	yes
6130	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	8	3.5	Stable	No	No			No	0	20.53	0	no	no	no
6131	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	13	8.8	Stable	No	No		CHEK2	No	0	22.77	0	no	no	no
6132	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	266	1.8	Stable	No	Yes or Unknown			Yes	0	22.37	0	no	no	no
6133	Non-ICI treated	Never received ICI	21 - 25	Male	Pancreatic	2017	I	52	1.8	Stable	No	No		BRCA2	No	0	22.64	0	no	no	no
6134	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	134	3.5	Stable	No	Yes or Unknown		NBN	No	1	10.84	0	no	no	no
6135	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	34	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	2.92	0	no	no	no
6136	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	268	6.1	Stable	No	No		PALB2 | PMS2	No	0	22.18	0	no	no	no
6137	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	22.08	0	no	no	no
6138	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	I	34	2.6	Stable	No	No			No	0	21.85	0	no	no	no
6139	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	85	0.9	Stable	No	No			Yes	0	20.3	0	no	no	no
6140	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	21	37.7	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC3 | MSH2 | NTHL1 | TP53BP1	No	0	20.73	0	mut-MMRd	mut-MMRd	yes
6141	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	0	9.7	Stable	No	No	Signature.4		Yes	1	6.41	0	no	no	no
6142	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	IV	21	4.4	Stable	No	No	Signature.1	MSH6	Yes	0	4.17	0	no	no	no
6143	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		RAD50	Yes	0	22.37	0	no	no	no
6144	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	21.42	0	no	no	no
6145	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	1	4.4	Stable	No	No			No	1	16.46	0	no	no	no
6146	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	181	1.8	Stable	No	Yes or Unknown			Yes	0	18.23	0	no	no	no
6147	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	12.3	Stable	No	No	Signature.3	RAD50	No	1	16.76	0	no	no	no
6148	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	IV	14	7	Stable	No	No	Signature.8	ARID1A | ATM | CHEK2	No	1	8.61	0	no	no	yes
6149	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		19	0.9	Stable	No	No	Signature.5		Yes	1	2.17	0	no	no	no
6150	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	0	4.4	Stable	No	No	Signature.3		No	0	24.02	0	no	no	no
6151	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	3.5	Stable	No	No			No	0	20.99	0	no	no	no
6152	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	II	0	5.3	Stable	No	No			No	0	25.2	0	no	no	no
6153	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	100	0	Stable	No	No			No	0	20.57	0	no	no	no
6154	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	19	0.9	Stable	No	Yes or Unknown			Yes	0	19.29	0	no	no	no
6155	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	III	0	0	Stable	No	No			No	0	21.03	0	no	no	no
6156	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	38	0	Stable	No	No			No	0	21.98	0	no	no	no
6157	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	6.1	Stable	No	No			Yes	0	4.24	0	no	no	no
6158	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	41	2.6	Stable	No	No			No	1	17.25	0	no	no	no
6159	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	6.41	0	no	no	no
6160	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	34	25.5	Unstable	No	No	Signature.6	FANCA	No	0	21.55	0	other-MMRd	mut-MMRd	no
6161	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2017	III	14	6.1	Stable	No	No	Signature.2		No	0	20.6	0	no	no	no
6162	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2017		48	0.9	Stable	No	Yes or Unknown			Yes	0	18.86	0	no	no	no
6163	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	I	12	9.7	Stable	No	No	Signature.1	ARID1A | BRCA2	Yes	0	21.39	0	no	no	yes
6164	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	244	4.4	Stable	No	Yes or Unknown	Signature.17		No	0	24.25	0	no	no	no
6165	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	154	7	Stable	No	Yes or Unknown	Signature.1		Yes	0	14.46	0	no	no	no
6166	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		0	2.6	Stable	No	No			No	0	8.87	0	no	no	no
6167	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	21.16	0	no	no	no
6168	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	121	1.8	Stable	No	Yes or Unknown			No	1	18.04	0	no	no	no
6169	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	370	36	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA1 | ERCC4 | ERCC5 | MLH1 | MUTYH	No	1	18.69	0	mut-MMRd	mut-MMRd	yes
6170	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2017	II	391	1.8	Stable	No	Yes or Unknown			No	0	20.86	0	no	no	no
6171	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	1.8	Stable	No	No			Yes	0	12.45	0	no	no	no
6172	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	18	2.6	Stable	No	No			Yes	0	22.28	0	no	no	no
6173	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	21	0.9	Stable	No	Yes or Unknown		ATM	Yes	0	20.47	0	no	no	no
6174	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1		No	0	23.13	0	no	no	no
6175	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	12.39	0	no	no	no
6176	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	28	1.8	Stable	No	No			Yes	0	19.91	0	no	no	no
6177	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	0.9	Stable	No	No		BRCA2	No	0	20.04	0	no	no	no
6178	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	7	2.6	Stable	No	No		ARID1A	No	0	22.11	0	no	no	yes
6179	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	0	4.4	Indeterminate	No	No	Signature.5		No	0	22.34	0	no	no	no
6180	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	112	0		No	Yes or Unknown		NTHL1	No	0	22.54	0	no	no	no
6181	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	25	2.6	Stable	No	No			No	0	22.14	0	no	no	no
6182	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	48	1.8	Stable	No	No			Yes	0	22.44	0	no	no	no
6183	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	24	5.3	Stable	No	No			No	0	21.85	0	no	no	no
6184	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	III	0	3.5	Stable	No	No		ARID1A | TP53BP1	No	1	18.66	0	no	no	yes
6185	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	225	0.9	Stable	No	No			No	0	22.31	0	no	no	no
6186	Non-ICI treated	Never received ICI	51 - 55	Male	SCLC	2017	IV	0	13.2	Stable	No	No	Signature.4	BLM | NBN	Yes	0	18.14	0	no	no	no
6187	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	611	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	22.28	0	no	no	no
6188	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	5.3	Stable	No	No		BRCA2	No	0	23.23	0	no	no	no
6189	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2017		4	1.8	Stable	No	No			No	0	20.9	0	no	no	no
6190	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	III	28	7.9	Stable	No	No	Signature.3		No	0	22.14	0	no	no	no
6191	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	IV	11	7.9	Stable	No	No	Signature.13		Yes	1	1.77	0	no	no	no
6192	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	1	4.4	Stable	No	No			No	0	19.29	0	no	no	no
6193	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0	Stable	No	No			Yes	1	16.69	0	no	no	no
6194	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No			No	1	20.34	0	no	no	no
6195	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	45	25.5	Unstable	No	No	Signature.6	ARID1A	No	0	17.51	0	other-MMRd	mut-MMRd	yes
6196	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	2.6	Stable	No	No			No	0	19.12	0	no	no	no
6197	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	0	0	Stable	No	No			No	0	12.85	0	no	no	no
6198	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2017		7	8.8	Stable	No	No			No	0	21.49	0	no	no	no
6199	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	33	31.6	Unstable	No	No	Signature.6	ATR | FANCA | MSH6 | NTHL1	No	0	12.16	0	mut-MMRd	mut-MMRd	no
6200	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	13	6.1	Stable	No	No	Signature.2	FANCA	No	0	22.01	0	no	no	no
6201	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	36	1.8	Stable	No	No		BLM	No	0	20.21	0	no	no	no
6202	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	0	2.6	Stable	No	Yes or Unknown	Signature.5		No	1	17.51	0	no	no	no
6203	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	IV	153	3.5	Stable	No	No			No	1	24.31	0	no	no	no
6204	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2017	I	89	4.4	Stable	No	No	Signature.5		No	0	19.32	0	no	no	no
6205	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	18.23	0	no	no	no
6206	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	0	22.01	0	no	no	no
6207	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	29	3.5	Stable	No	No			No	0	19.35	0	no	no	no
6208	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			Yes	1	15.51	0	no	no	no
6209	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	22	2.6	Stable	No	No			No	1	11.17	0	no	no	no
6210	Non-ICI treated	Never received ICI	81 - 85	Male	SCLC	2017	IV	2	11.4	Stable	No	No	Signature.4		No	1	1.68	0	no	no	no
6211	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	18	2.6	Stable	No	No			No	0	21.68	0	no	no	no
6212	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	202	1.8	Stable	No	Yes or Unknown			No	0	21.95	0	no	no	no
6213	Non-ICI treated	Never received ICI	16 - 20	Male	Bladder	2017		0	0	Stable	No	No			No	0	22.24	0	no	no	no
6214	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	381	7	Stable	No	Yes or Unknown	Signature.1		No	0	20.07	0	no	no	no
6215	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017		0	1.8	Stable	No	No			No	0	18.99	0	no	no	no
6216	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	42	2.6	Stable	No	No			No	0	21.95	0	no	no	no
6217	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	645	8.8	Indeterminate	No	Yes or Unknown	Signature.1	MSH3	Yes	0	21.62	0	no	no	no
6218	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	2.6	Stable	No	No			Yes	0	20.17	0	no	no	no
6219	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	III	0	7	Stable	No	No		ATM | BRIP1	Yes	0	21.52	0	no	no	no
6220	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	13	2.6	Stable	No	No			No	0	20.01	0	no	no	no
6221	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	28	4.4	Stable	No	No			No	0	20.37	0	no	no	no
6222	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	IV	0	0	Stable	No	No			No	1	6.8	0	no	no	no
6223	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	575	1.8	Stable	No	Yes or Unknown			No	0	22.54	0	no	no	no
6224	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	I	0	4.4	Stable	No	No	Signature.1	BRCA2	No	0	17.94	0	no	no	no
6225	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	27	6.1	Stable	No	Yes or Unknown		BRCA2	No	0	20.7	0	no	no	no
6226	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	263	0.9	Stable	No	No			No	0	16.2	0	no	no	no
6227	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	0.9	Stable	No	No			No	0	6.37	0	no	no	no
6228	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	8	4.4	Stable	No	No	Signature.1		No	0	18.86	0	no	no	no
6229	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	3.5	Stable	No	No		ARID1A	Yes	0	13.93	0	no	no	yes
6230	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1		No	0	25.49	0	no	no	no
6231	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	IV	128	0	Stable	No	No			No	0	23.13	0	no	no	no
6232	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	43	41.3	Unstable	No	No	Signature.6	ATR | MDC1 | RAD54L | SLX4	No	0	5.88	0	other-MMRd	mut-MMRd	no
6233	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	6.1	Stable	No	No			No	0	22.05	0	no	no	no
6234	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	54	0.9	Stable	No	No			No	0	20.17	0	no	no	no
6235	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	29	2.6	Stable	No	Yes or Unknown		SLX4	No	0	21.98	0	no	no	no
6236	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	14	0.9	Stable	No	No			Yes	1	4.53	0	no	no	no
6237	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	23	3.5	Stable	No	No			No	0	21.72	0	no	no	no
6238	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	70	1.8	Stable	No	Yes or Unknown			No	0	24.67	0	no	no	no
6239	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		2	2.6	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	1	11.33	0	no	no	yes
6240	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	IV	27	0	Stable	Yes or Unknown	Yes or Unknown			No	0	21.85	0	no	no	no
6241	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	4	2.6	Stable	No	Yes or Unknown			Yes	0	22.08	0	no	no	no
6242	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	46	22.8	Indeterminate	No	No	Signature.6	ARID1A	No	0	17.81	0	no	no	yes
6243	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	7	6.1	Indeterminate	No	No		ARID1A	No	1	3.52	0	no	no	yes
6244	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	20	2.6	Stable	No	No			No	0	21.39	0	no	no	no
6245	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2017	III	0	34.2	Unstable	No	No	Signature.6	ARID1A | MLH1 | PALB2	Yes	0	19.42	0	mut-MMRd	mut-MMRd	yes
6246	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	0	5.3	Stable	No	No	Signature.4		Yes	0	1.74	0	no	no	no
6247	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	65	3.5	Stable	No	No			No	0	21.98	0	no	no	no
6248	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	13	6.1	Stable	No	No	Signature.15		No	0	5.62	0	no	no	no
6249	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017		30	6.1	Stable	No	No	Signature.24	ERCC2	Yes	0	22.08	0	no	no	no
6250	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No	Signature.3	BRCA2	No	1	1.51	0	no	no	no
6251	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	I	391	44.8	Unstable	No	No	Signature.6	ATM | CHEK1	No	0	20.04	0	other-MMRd	mut-MMRd	no
6252	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	28	69.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | RAD51	No	0	20.93	0	other-MMRd	mut-MMRd	yes
6253	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	II	58	2.6	Stable	No	No		ATM	Yes	0	20.93	0	no	no	no
6254	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	69	0.9	Stable	No	Yes or Unknown			No	0	22.31	0	no	no	no
6255	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	188	2.6	Stable	No	Yes or Unknown		ATR	No	1	13.27	0	no	no	no
6256	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	I	0	2.6	Stable	No	No			No	0	19.52	0	no	no	no
6257	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2017	IV	11	1.8	Stable	No	No			No	1	14.36	0	no	no	no
6258	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	II	186	7.9	Stable	No	Yes or Unknown	Signature.1	NTHL1	Yes	0	21.03	0	no	no	no
6259	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	II	690	5.3	Stable	No	No	Signature.8	SLX4	No	0	26.35	0	no	no	no
6260	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	59	10.5	Stable	No	No	Signature.4		No	0	20.47	0	no	no	no
6261	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	21.91	0	no	no	no
6262	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	47	0	Stable	No	No			No	1	9.53	0	no	no	no
6263	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	35	3.5	Stable	No	No	Signature.9		Yes	0	21.88	0	no	no	no
6264	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	32	7.9	Stable	No	No	Signature.1		Yes	0	22.01	0	no	no	no
6265	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	470	6.1	Stable	No	Yes or Unknown		NBN	No	0	21.72	0	no	no	no
6266	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	0	1.8	Stable	No	No			Yes	0	19.65	0	no	no	no
6267	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	33	4.4	Stable	No	Yes or Unknown	Signature.19		No	0	21.39	0	no	no	no
6268	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	43	0.9	Stable	No	No			Yes	0	22.8	0	no	no	no
6269	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	28	9.7	Stable	No	No	Signature.4		No	0	17.74	0	no	no	no
6270	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		1	3.5	Stable	No	No	Signature.2		Yes	0	21.22	0	no	no	no
6271	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		11	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	20.17	0	no	no	no
6272	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	22	2.6	Stable	No	No			No	0	21.59	0	no	no	no
6273	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	11	6.1	Stable	No	No		ARID1A | FANCC	No	1	11.47	0	no	no	yes
6274	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	II	63	15.8	Stable	No	No	Signature.26	ERCC2	No	0	22.14	0	no	no	no
6275	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2018	I	71	0	Stable	No	No			No	0	14.72	0	no	no	no
6276	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	I	42	3.5	Stable	No	No		ARID1A	No	0	19.32	0	no	no	yes
6277	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	7	Stable	No	No	Signature.5	ARID1A	No	0	18.73	0	no	no	yes
6278	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	I	20	44.8	Unstable	No	No	Signature.6	BRCA2 | MLH1 | NBN | PMS2	No	0	19.75	0	mut-MMRd	mut-MMRd	no
6279	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	I	106	4.4	Stable	No	No	Signature.5		No	0	12.19	0	no	no	no
6280	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	18.76	0	no	no	no
6281	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	2	2.6	Stable	No	Yes or Unknown	Signature.19	BRIP1	No	0	21.26	0	no	no	no
6282	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	21.22	0	no	no	no
6283	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	I	14	0.9	Stable	No	No			No	0	21.36	0	no	no	no
6284	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	20	2.6	Stable	No	No			No	0	21.82	0	no	no	no
6285	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2017	IV	15	5.3	Stable	No	No		ERCC5	No	1	9.03	0	no	no	no
6286	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			Yes	0	19.91	0	no	no	no
6287	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	37	6.1	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	20.76	0	no	no	no
6288	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	4	6.1	Stable	No	No			No	0	20.96	0	no	no	no
6289	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	25	5.3	Stable	No	No			No	0	16.99	0	no	no	no
6290	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	IV	34	9.7	Stable	No	No	Signature.1		Yes	1	2.56	0	no	no	no
6291	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	5.3	Stable	No	No	Signature.19		Yes	1	10.41	0	no	no	no
6292	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	IV	10	5.3	Stable	No	Yes or Unknown			No	1	13.54	0	no	no	no
6293	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	17	0.9	Stable	No	No			Yes	0	20.83	0	no	no	no
6294	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	III	75	0		No	No			No	0	21.49	0	no	no	no
6295	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	10	0.9	Stable	No	No			No	1	14.26	0	no	no	no
6296	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	IV	6	7.9	Stable	No	No		ERCC5 | MSH6	Yes	0	21.88	0	no	no	no
6297	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	2	0	Stable	No	No			Yes	0	21.29	0	no	no	no
6298	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			Yes	0	8.28	0	no	no	no
6299	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	II	374	3.5	Stable	No	Yes or Unknown			No	0	22.97	0	no	no	no
6300	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	26	2.6	Stable	No	No			No	0	19.29	0	no	no	no
6301	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	15	1.8	Stable	No	No			Yes	1	1.51	0	no	no	no
6302	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	33	3.5	Stable	No	Yes or Unknown			No	0	20.93	0	no	no	no
6303	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	17	2.6	Stable	No	Yes or Unknown			No	0	20.21	0	no	no	no
6304	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	III	106	0	Stable	No	Yes or Unknown			No	0	21.91	0	no	no	no
6305	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	159	7.9	Stable	No	Yes or Unknown		ATR	No	1	18.4	0	no	no	no
6306	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	0	Stable	No	No			No	0	22.57	0	no	no	no
6307	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	49	2.6	Stable	No	Yes or Unknown			No	0	21.82	0	no	no	no
6308	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	III	136	7.9	Stable	No	Yes or Unknown	Signature.3		No	1	14.39	0	no	no	no
6309	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			Yes	0	23.23	0	no	no	no
6310	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2017	II	0	104.4	Stable	No	No	Signature.7	ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC2 | MSH2 | MSH3 | PARP1 | SLX4 | TP53BP1	No	0	18.63	0	no	no	no
6311	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	14	0.9	Stable	No	No			Yes	0	21.19	0	no	no	no
6312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	167	1.8	Stable	No	Yes or Unknown		FANCC	No	0	20.83	0	no	no	no
6313	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	0	4.04	0	no	no	no
6314	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	89	0.9	Stable	No	No			Yes	0	21.65	0	no	no	no
6315	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2017		272	0	Stable	No	Yes or Unknown			No	1	21.55	0	no	no	no
6316	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	289	4.4	Stable	No	No	Signature.19		No	0	22.24	0	no	no	no
6317	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	113	0	Stable	No	Yes or Unknown		CHEK2	Yes	0	23.2	0	no	no	no
6318	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2017	I	245	10.5	Stable	No	No	Signature.2	MDC1 | RAD54L	No	1	13.31	0	no	no	no
6319	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	23	1.8	Stable	No	No		BLM	No	0	20.99	0	no	no	no
6320	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	29	0.9	Stable	No	No			No	0	13.31	0	no	no	no
6321	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017		23	1.8	Stable	No	No			No	0	11.37	0	no	no	no
6322	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	IV	7	3.5	Stable	No	No		ATM	No	1	14.13	0	no	no	no
6323	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	4	1.8	Stable	No	No			No	1	15.15	0	no	no	no
6324	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	35	3.5	Stable	No	No	Signature.5	MUTYH	No	1	19.88	0	no	no	no
6325	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	66	5.3	Stable	No	No			Yes	0	14.19	0	no	no	no
6326	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	387	5.3	Stable	No	Yes or Unknown	Signature.24	ARID1A	No	0	20.67	0	no	no	yes
6327	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	34	1.8	Stable	No	No			No	0	18.37	0	no	no	no
6328	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	No	No			Yes	1	8.38	0	no	no	no
6329	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	158	1.8	Stable	No	No			No	0	17.28	0	no	no	no
6330	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	26	0.9	Stable	No	No			No	0	21.09	0	no	no	no
6331	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	4.4	Stable	No	No			Yes	0	19.38	0	no	no	no
6332	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	66	5.3	Stable	No	No			No	0	22.11	0	no	no	no
6333	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	36	50	Unstable	No	No	Signature.6	ATM | BRCA2 | ERCC4 | MUTYH	No	0	13.54	0	other-MMRd	mut-MMRd	no
6334	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	11	4.4	Stable	No	No		BRIP1	Yes	0	20.63	0	no	no	no
6335	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	1	0	Stable	No	No			Yes	1	19.45	0	no	no	no
6336	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	28	1.8	Stable	No	No			No	0	19.58	0	no	no	no
6337	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	25	1.8	Stable	No	No			No	0	13.7	0	no	no	no
6338	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	20	7	Stable	No	No			No	0	10.25	0	no	no	no
6339	Non-ICI treated	Never received ICI	41 - 45	Female	Esophageal	2017	III	0	7.9	Stable	No	No			No	0	22.05	0	no	no	no
6340	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	7	7.9	Stable	No	Yes or Unknown		ARID1A | FANCC	Yes	1	2.43	0	no	no	yes
6341	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	20	2.6	Stable	No	No			No	0	18.33	0	no	no	no
6342	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	IV	0	0.9	Stable	No	No			No	1	5.82	0	no	no	no
6343	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	6	1.8	Stable	No	No		ATM	Yes	0	4.34	0	no	no	no
6344	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	131	7.9		No	No	Signature.1	MDC1	No	1	14.03	0	no	no	no
6345	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	11	7.9	Stable	No	No			No	1	16.16	0	no	no	no
6346	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	82	0.9	Stable	No	Yes or Unknown			Yes	0	20.6	0	no	no	no
6347	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	Yes	0	21.59	0	no	no	yes
6348	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		7	1.8	Stable	No	Yes or Unknown			No	0	20.8	0	no	no	no
6349	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	23	44.8	Unstable	No	No	Signature.1	ARID1A | ATM | BLM | BRIP1 | MRE11A | MSH6 | NTHL1	Yes	0	11.17	0	mut-MMRd	mut-MMRd	yes
6350	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	37	86.9	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | MLH1 | PMS2 | RAD51C | SLX4	Yes	0	16.59	0	mut-MMRd	mut-MMRd	yes
6351	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	0	0.9	Stable	No	Yes or Unknown		BRCA2	Yes	0	19.32	0	no	no	no
6352	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	52	6.1	Stable	No	No	Signature.5	ARID1A	No	0	3.45	0	no	no	yes
6353	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	44	17.6	Stable	No	No	Signature.4		No	0	20.53	0	no	no	no
6354	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	18.46	0	no	no	no
6355	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	14	6.1	Stable	No	No			No	0	20.7	0	no	no	no
6356	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	19	3.5	Stable	No	No			Yes	1	6.24	0	no	no	no
6357	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.14		No	0	20.53	0	no	no	no
6358	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	219	2.6	Stable	No	Yes or Unknown			No	0	22.11	0	no	no	no
6359	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	I	565	0.9	Stable	No	No	Signature.5		No	0	20.5	0	no	no	no
6360	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	4.4	Stable	No	No		ERCC5	No	0	20.93	0	no	no	no
6361	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	II	0	2.6	Stable	No	No			Yes	0	19.68	0	no	no	no
6362	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	127	3.5	Stable	No	No			No	0	24.15	0	no	no	no
6363	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	III	0	0		No	No			No	1	15.28	0	no	no	no
6364	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2017	III	0	9.7	Stable	No	No	Signature.4	MRE11A | MSH3	Yes	0	4.96	0	no	no	no
6365	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	3.5	Stable	No	No			No	0	17.28	0	no	no	no
6366	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	31	2.6	Stable	No	Yes or Unknown		CHEK2	Yes	0	18.73	0	no	no	no
6367	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2017		115	1.8	Stable	No	No		BRCA2	No	0	21.52	0	no	no	no
6368	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2017	II	390	6.1	Stable	No	Yes or Unknown	Signature.13	MSH2	No	0	22.97	0	no	no	no
6369	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	16	2.6	Stable	No	Yes or Unknown			No	0	15.9	0	no	no	no
6370	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017		83	0.9	Stable	No	No			No	0	20.11	0	no	no	no
6371	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	1	2.6	Stable	No	No			No	0	19.42	0	no	no	no
6372	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	3.5	Stable	No	No			No	0	20.9	0	no	no	no
6373	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	144	1.8	Stable	No	No			Yes	0	23	0	no	no	no
6374	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	0	4.4	Stable	No	No	Signature.1		No	0	21.52	0	no	no	no
6375	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	121	0.9	Stable	No	No	Signature.5		No	0	19.32	0	no	no	no
6376	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	81	9.7	Stable	No	No	Signature.4		No	0	15.77	0	no	no	no
6377	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	26	2.6	Stable	No	No			No	1	8.44	0	no	no	no
6378	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	34	2.6	Stable	No	No			No	0	14.29	0	no	no	no
6379	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	158	14.9	Stable	No	Yes or Unknown	Signature.4	BRCA2 | ERCC5 | MDC1	Yes	1	11.37	0	no	no	no
6380	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	66.7	Indeterminate	No	No	Signature.21	ARID1A | ATM | ATR | BRCA2 | CHEK2 | MSH2 | RAD54L | TP53BP1	No	0	20.21	0	no	no	yes
6381	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	166	8.8	Stable	No	Yes or Unknown	Signature.24	ARID1A | BRCA1	No	1	8.67	0	no	no	yes
6382	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	11	1.8	Stable	No	No	Signature.3		No	0	21.06	0	no	no	no
6383	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	25	1.8	Stable	No	No			Yes	0	20.24	0	no	no	no
6384	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	6.1	Stable	No	Yes or Unknown		BRCA1	No	0	21.36	0	no	no	no
6385	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	15	2.6	Stable	No	No			No	0	14.88	0	no	no	no
6386	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	0	2.6	Stable	No	No			No	0	12.45	0	no	no	no
6387	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	0	11.7	0	no	no	no
6388	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	10	7	Stable	No	No	Signature.13	ARID1A | ATM	Yes	1	6.74	0	no	no	yes
6389	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	42	3.5	Stable	No	No			Yes	0	18.89	0	no	no	no
6390	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	II	59	1.8	Stable	No	No			No	0	22.05	0	no	no	no
6391	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	26	47.4	Stable	No	Yes or Unknown	Signature.4	ATM | BLM | FANCC	Yes	0	6.01	0	no	no	no
6392	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	154	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	19.32	0	no	no	no
6393	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	33	1.8	Stable	No	No			No	0	19.98	0	no	no	no
6394	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	21	11.4	Stable	No	No	Signature.24		No	0	19.15	0	no	no	no
6395	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	271	7	Stable	No	Yes or Unknown			No	0	20.9	0	no	no	no
6396	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	27	3.5	Stable	No	No			No	0	21.39	0	no	no	no
6397	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	24	7.9	Stable	No	No	Signature.6		No	0	20.73	0	no	no	no
6398	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	31	0.9	Stable	No	No			No	0	19.78	0	no	no	no
6399	Non-ICI treated	Never received ICI	16 - 20	Female	Breast	2017	IV	11	0	Stable	No	Yes or Unknown			Yes	0	20.37	0	no	no	no
6400	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	4.4	Indeterminate	No	Yes or Unknown			No	0	19.15	0	no	no	no
6401	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	34	0		No	No			No	0	21.13	0	no	no	no
6402	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	286	9.7	Stable	No	Yes or Unknown	Signature.1		No	0	25.07	0	no	no	no
6403	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	0	1.8	Stable	No	No			No	0	20.86	0	no	no	no
6404	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	221	3.5	Stable	No	Yes or Unknown			No	0	21.98	0	no	no	no
6405	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	35	8.8	Stable	No	No		ARID1A	No	0	20.99	0	no	no	yes
6406	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	35	2.6	Stable	No	Yes or Unknown	Signature.19	TP53BP1	Yes	0	18.53	0	no	no	no
6407	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017		0	1.8	Stable	No	No		ATM	No	0	3.75	0	no	no	no
6408	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	63	1.8	Stable	No	No			No	0	20.67	0	no	no	no
6409	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	I	92	0.9	Stable	No	No			No	0	21.45	0	no	no	no
6410	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	19.48	0	no	no	no
6411	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2017		0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	20.76	0	no	no	no
6412	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	33	65	Unstable	No	No	Signature.6	ARID1A | BRCA2 | CHEK1 | CHEK2 | FANCC | MSH6 | MUTYH | NTHL1 | SLX4	No	0	2.07	0	mut-MMRd	mut-MMRd	yes
6413	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	0.9	Stable	No	No			No	0	19.29	0	no	no	no
6414	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	81	5.3	Stable	No	No	Signature.1		No	0	19.42	0	no	no	no
6415	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	24	6.1	Stable	No	No			No	1	18.53	0	no	no	no
6416	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	72	1.8	Stable	No	No			Yes	0	18.99	0	no	no	no
6417	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	16	53.5	Stable	No	No	Signature.4	ARID1A | ATR | BRCA1	Yes	0	20.24	0	no	no	yes
6418	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	0.9	Stable	No	No			No	0	20.99	0	no	no	no
6419	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	155	4.4	Stable	No	No			No	0	19.91	0	no	no	no
6420	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	0.9	Stable	No	No			Yes	0	20.93	0	no	no	no
6421	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	II	13	4.4	Stable	No	No			Yes	0	17.22	0	no	no	no
6422	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	0	10.5	Stable	No	No	Signature.18		No	0	4.14	0	no	no	no
6423	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	0	Stable	No	No			Yes	1	18.73	0	no	no	no
6424	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	24	1.8	Stable	No	No			Yes	0	20.86	0	no	no	no
6425	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	98	2.6	Stable	No	No			No	1	16.03	0	no	no	no
6426	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	95	2.6	Stable	No	No			No	0	24.31	0	no	no	no
6427	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	442	7.9		No	Yes or Unknown	Signature.5	ATM | ATR | MSH3	No	0	20.96	0	no	no	no
6428	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	III	36	6.1	Stable	No	No		MSH2	Yes	0	19.68	0	no	no	no
6429	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	III	0	7.9	Stable	No	No	Signature.4	PMS1	Yes	1	5.22	0	no	no	no
6430	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	177	7	Stable	No	No	Signature.5		No	0	18.4	0	no	no	no
6431	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No		FANCA	No	0	15.01	0	no	no	no
6432	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	0.9	Stable	No	No			Yes	0	19.94	0	no	no	no
6433	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	41	2.6	Stable	No	Yes or Unknown			No	0	18.07	0	no	no	no
6434	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	20.73	0	no	no	no
6435	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	33	7.9	Stable	No	No	Signature.1		No	0	21.13	0	no	no	no
6436	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2017	III	0	14	Stable	No	No	Signature.5		Yes	0	20.47	0	no	no	no
6437	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	42	4.4	Stable	No	No		MDC1	Yes	0	20.96	0	no	no	no
6438	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	10.5	Stable	No	No	Signature.13	BRCA1	Yes	0	15.7	0	no	no	no
6439	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		63	2.6	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	18.73	0	no	no	no
6440	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	17.77	0	no	no	no
6441	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	I	11	4.4	Stable	No	No			Yes	0	20.47	0	no	no	no
6442	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	35	60.6	Unstable	No	No	Signature.6	ARID1A | ATR | BLM | BRCA2 | XRCC2	No	0	21.09	0	other-MMRd	mut-MMRd	yes
6443	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	10	1.8	Stable	No	Yes or Unknown			No	0	18.69	0	no	no	no
6444	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	0	19.75	0	no	no	no
6445	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	27	0.9	Stable	No	No			No	0	19.48	0	no	no	no
6446	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	161	1.8	Stable	No	Yes or Unknown			No	0	20.44	0	no	no	no
6447	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	27	0	Stable	No	No			No	0	10.02	0	no	no	no
6448	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	I	0	4.4	Stable	No	No			No	0	20.73	0	no	no	no
6449	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	III	34	1.8	Stable	No	No			Yes	0	5.52	0	no	no	no
6450	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	136	4.4	Stable	No	Yes or Unknown			No	1	12.75	0	no	no	no
6451	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	I	61	1.8	Stable	No	No			No	0	20.67	0	no	no	no
6452	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.13		Yes	1	1.28	0	no	no	no
6453	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	75	4.4	Stable	No	No			No	0	19.42	0	no	no	no
6454	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	239	5.3	Stable	No	Yes or Unknown			No	0	20.44	0	no	no	no
6455	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	I	0	2.6	Stable	No	No			No	0	19.25	0	no	no	no
6456	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	0	8.8	Stable	No	No	Signature.8	PALB2	Yes	0	20.17	0	no	no	no
6457	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	55.3	Stable	No	No	Signature.4	ATM	Yes	0	16.56	0	no	no	no
6458	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	51	0	Stable	No	No			Yes	0	18.2	0	no	no	no
6459	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2017	II	361	10.5	Stable	No	No	Signature.2		No	0	25.82	0	no	no	no
6460	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	0	2.4	0	no	no	no
6461	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	37	39.5	Unstable	No	No	Signature.1	ARID1A | BRIP1 | CHEK1 | ERCC2 | MLH1	No	0	18.1	0	mut-MMRd	mut-MMRd	yes
6462	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	8	0.9	Stable	No	No			Yes	0	20.14	0	no	no	no
6463	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	1.8	Stable	No	No			No	0	20.01	0	no	no	no
6464	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	36	3.5	Stable	No	No			No	0	20.8	0	no	no	no
6465	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	15	8.8	Stable	No	No	Signature.1	ATM	No	0	20.7	0	no	no	no
6466	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	35	79.9	Unstable	No	No	Signature.1	ARID1A | CHEK2 | MSH2 | MUTYH	No	0	20.6	0	mut-MMRd	mut-MMRd	yes
6467	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	40	8.8	Stable	No	No	Signature.4		No	0	17.51	0	no	no	no
6468	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	7	4.4	Stable	No	Yes or Unknown			No	0	20.9	0	no	no	no
6469	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	0	0	Stable	No	Yes or Unknown			No	0	20.01	0	no	no	no
6470	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	II	28	6.1	Stable	No	No	Signature.1		No	0	20.6	0	no	no	no
6471	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	30	11.4	Stable	No	No	Signature.4	ATM	No	0	18.92	0	no	no	no
6472	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	II	42	2.6	Stable	No	Yes or Unknown			Yes	0	20.47	0	no	no	no
6473	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	34	0	Stable	No	Yes or Unknown			Yes	0	13.8	0	no	no	no
6474	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	2	3.5	Stable	No	Yes or Unknown			No	0	20.86	0	no	no	no
6475	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	20.96	0	no	no	no
6476	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	6	8.8	Stable	No	No	Signature.4	TP53BP1	Yes	0	19.98	0	no	no	no
6477	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	21	182.6	Stable	No	No	Signature.10	ARID1A | ATR | ERCC5 | MDC1 | MRE11A | MSH2 | PMS2 | RAD50 | RAD51C | RAD54L | SLX4	No	0	18.92	0	no	no	yes
6478	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2017	IV	39	1.8	Stable	No	Yes or Unknown			No	0	19.61	0	no	no	no
6479	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		10	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	29.24	0	no	no	no
6480	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	41	5.3	Stable	No	No			Yes	0	17.68	0	no	no	no
6481	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	I	162	21.9	Stable	No	No	Signature.4	ARID1A	No	0	17.81	0	no	no	yes
6482	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	III	0	1.8	Stable	No	Yes or Unknown			Yes	0	19.94	0	no	no	no
6483	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	182	0		No	Yes or Unknown			No	0	20.53	0	no	no	no
6484	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	IV	17	3.5	Stable	No	No			Yes	0	20.47	0	no	no	no
6485	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	280	7.9	Stable	No	Yes or Unknown	Signature.2	ARID1A	No	0	19.91	0	no	no	yes
6486	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No		MSH3	Yes	1	11.73	0	no	no	no
6487	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2017		0	5.3	Stable	No	No		ATR	Yes	0	19.29	0	no	no	no
6488	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	III	218	0	Stable	No	No			Yes	1	9.26	0	no	no	no
6489	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	II	482	0	Stable	No	Yes or Unknown			No	0	20.47	0	no	no	no
6490	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	24	10.5	Stable	No	Yes or Unknown	Signature.2	ATM | CHEK1	No	0	19.75	0	no	no	no
6491	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	4.4	Stable	No	No			No	0	17.58	0	no	no	no
6492	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	0.9	Stable	No	No			No	0	19.19	0	no	no	no
6493	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	17	5.3	Stable	No	No	Signature.5		No	0	16.2	0	no	no	no
6494	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	78	4.4	Stable	No	No			No	0	18.17	0	no	no	no
6495	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	19	5.3	Stable	No	No	Signature.1		Yes	0	12.22	0	no	no	no
6496	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	III	181	0	Stable	No	No			Yes	0	23.2	0	no	no	no
6497	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	7	2.6	Stable	No	No	Signature.5		No	0	20.01	0	no	no	no
6498	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	IV	0	4.4	Stable	No	No		BRCA1 | ERCC3 | FANCC	No	0	19.58	0	no	no	no
6499	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	11	2.6	Stable	No	Yes or Unknown			No	0	21.29	0	no	no	no
6500	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	111	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	8.51	0	no	no	no
6501	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	12	1.8	Stable	No	No		ARID1A	No	1	10.55	0	no	no	yes
6502	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		15	5.3	Stable	No	No		CHEK2	Yes	0	19.09	0	no	no	no
6503	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	64	2.6	Stable	No	Yes or Unknown			No	0	20.96	0	no	no	no
6504	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	2.6	Stable	No	No			Yes	0	18.86	0	no	no	no
6505	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2017	III	0	2.6	Stable	No	No			Yes	0	20.5	0	no	no	no
6506	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		192	0	Stable	No	No			No	0	16.1	0	no	no	no
6507	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		3	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	14.95	0	no	no	no
6508	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	7		No	No	Signature.5	BRCA1	No	0	19.75	0	no	no	no
6509	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	IV	333	0.9	Stable	No	Yes or Unknown			No	0	21.32	0	no	no	no
6510	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	8.8	Stable	No	Yes or Unknown	Signature.4	BRCA2	No	1	17.12	0	no	no	no
6511	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	21	2.6	Stable	No	No			No	0	18.46	0	no	no	no
6512	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	379	0	Stable	No	Yes or Unknown			No	0	20.53	0	no	no	no
6513	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	14	2.6	Stable	No	No	Signature.14		No	0	20.44	0	no	no	no
6514	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	66	0.9	Stable	No	No			No	0	8.54	0	no	no	no
6515	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	138	2.6	Stable	No	No			No	1	10.84	0	no	no	no
6516	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	38	3.5	Stable	No	No			No	0	14.85	0	no	no	no
6517	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	65	0.9	Stable	No	No			No	0	16.62	0	no	no	no
6518	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	II	127	4.4	Stable	No	Yes or Unknown		PMS1	Yes	0	18.23	0	no	no	no
6519	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	6	2.6	Stable	No	No			No	1	11.89	0	no	no	no
6520	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	116	1.8	Stable	No	Yes or Unknown			No	0	20.7	0	no	no	no
6521	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	49	0.9	Stable	No	No			Yes	0	19.75	0	no	no	no
6522	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	38	7.9	Stable	No	Yes or Unknown			Yes	0	18.63	0	no	no	no
6523	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	III	39	7	Stable	No	No	Signature.8		No	0	18.5	0	no	no	no
6524	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	9	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	11.24	0	no	no	no
6525	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	18	0	no	no	no
6526	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	93	1.8	Stable	No	Yes or Unknown			No	0	19.61	0	no	no	no
6527	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No		ARID1A | ATM	No	0	18.46	0	no	no	yes
6528	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2017	III	11	5.3	Stable	No	No			No	0	20.24	0	no	no	no
6529	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	6	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA1	No	0	20.01	0	no	no	no
6530	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	II	0	10.5	Stable	No	No	Signature.1		Yes	0	12.45	0	no	no	no
6531	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	II	20	7	Stable	No	No	Signature.1		No	0	19.75	0	no	no	no
6532	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	0	3.5	Stable	No	No	Signature.1		No	0	20.63	0	no	no	no
6533	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	1	0	Stable	No	No			No	0	17.71	0	no	no	no
6534	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2017		4	0.9	Stable	No	No			Yes	0	17.25	0	no	no	no
6535	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	0	0.9	Stable	No	Yes or Unknown			No	0	13.08	0	no	no	no
6536	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	21	4.4	Stable	No	No			No	0	19.75	0	no	no	no
6537	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	92	7	Stable	No	No		BRIP1 | PARP1	No	0	14.62	0	no	no	no
6538	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No		BRCA2	No	1	8.74	0	no	no	no
6539	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	16	2.6	Stable	No	No			No	0	19.12	0	no	no	no
6540	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	8.11	0	no	no	no
6541	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	22.8	Indeterminate	No	Yes or Unknown	Signature.6	ATM | ERCC3	No	0	18.37	0	no	no	no
6542	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	20	1.8	Stable	No	No			Yes	0	20.17	0	no	no	no
6543	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	III	0	31.6	Stable	No	No	Signature.4	BRCA1 | PARP1 | SLX4	No	0	19.42	0	no	no	no
6544	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		5	7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MSH6	No	1	13.24	0	no	no	no
6545	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	0		No	No			Yes	0	20.73	0	no	no	no
6546	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	66	9.7	Stable	No	No	Signature.3		No	0	18.53	0	no	no	no
6547	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	62	0	Stable	No	No			Yes	0	20.04	0	no	no	no
6548	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	III	14	0.9	Stable	No	No			Yes	0	8.87	0	no	no	no
6549	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017		63	1.8	Stable	No	No			No	0	16.85	0	no	no	no
6550	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	20	7	Stable	No	No			No	0	18.4	0	no	no	no
6551	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	53	1.8	Stable	No	No			Yes	0	20.4	0	no	no	no
6552	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	III	0	7.9	Stable	No	No	Signature.7	RAD50	No	0	20.63	0	no	no	no
6553	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	17	1.8	Stable	No	No			No	0	19.94	0	no	no	no
6554	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		6	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.8		Yes	1	13.37	0	no	no	no
6555	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	65	3.5	Stable	No	Yes or Unknown			No	0	20.07	0	no	no	no
6556	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	36	1.8	Stable	No	No			No	0	19.22	0	no	no	no
6557	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	0	0.9	Stable	No	No			No	0	14.46	0	no	no	no
6558	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	0	7.9	Stable	No	No	Signature.24		No	1	13.93	0	no	no	no
6559	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.15		No	0	21.65	0	no	no	no
6560	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	19.3	Stable	No	No	Signature.1	ERCC3	No	0	14.88	0	no	no	no
6561	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	3.5	Stable	No	No			Yes	0	1.38	0	no	no	no
6562	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	91	0.9	Stable	No	Yes or Unknown			No	0	19.91	0	no	no	no
6563	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	91	3.5	Stable	No	Yes or Unknown		PMS2	No	1	13.01	0	no	no	no
6564	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	20	0	Stable	No	No			No	0	19.68	0	no	no	no
6565	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No			No	1	11.99	0	no	no	no
6566	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	421	5.3	Stable	No	No			Yes	0	19.88	0	no	no	no
6567	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	35	7	Stable	No	No	Signature.3	BRCA1 | BRIP1	Yes	0	20.01	0	no	no	no
6568	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	9.53	0	no	no	no
6569	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	20.37	0	no	no	no
6570	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	25	13.2	Stable	No	Yes or Unknown	Signature.4		No	1	4.99	0	no	no	no
6571	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	141	0.9	Stable	No	Yes or Unknown			No	1	10.15	0	no	no	no
6572	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2017	III	170	26.3	Stable	No	Yes or Unknown	Signature.2	ATM | MSH6	Yes	0	21.55	0	no	no	no
6573	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	II	62	2.6	Indeterminate	No	Yes or Unknown			No	0	19.75	0	no	no	no
6574	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	25	0		No	No			No	0	20.04	0	no	no	no
6575	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	3.5	Stable	No	No		ARID1A	Yes	0	20.34	0	no	no	yes
6576	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017		0	4.4	Stable	No	No		ARID1A	Yes	1	7.13	0	no	no	yes
6577	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	18	5.3	Stable	No	No			No	0	19.78	0	no	no	no
6578	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		17	0.9	Stable	No	No			No	0	2.3	0	no	no	no
6579	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	5	5.3	Stable	No	No		RAD50	No	0	18.4	0	no	no	no
6580	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	2.6	Stable	No	No			No	0	20.24	0	no	no	no
6581	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	3.5	Stable	No	No			Yes	0	19.06	0	no	no	no
6582	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	III	27	11.4	Stable	No	No		ARID1A | ATM	Yes	0	17.68	0	no	no	yes
6583	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	71	15.8	Stable	No	No	Signature.4	FANCA	No	0	17.35	0	no	no	no
6584	Non-ICI treated	Never received ICI	91 - 95	Male	NSCLC	2017	IV	10	21.1	Stable	No	No	Signature.3	SLX4	No	1	12.81	0	no	no	no
6585	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2017	I	0	222.1	Stable	No	Yes or Unknown	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC5 | FANCC | MLH1 | MRE11A | MSH2 | MSH3 | MSH6 | PMS2 | RAD50 | TP53BP1	No	0	18.79	0	no	no	yes
6586	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	II	42	1.8	Stable	No	No			No	0	18.23	0	no	no	no
6587	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	IV	0	46.5	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA2 | ERCC4 | MSH2 | PMS1	No	1	4.27	0	mut-MMRd	mut-MMRd	yes
6588	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	22	2.6	Stable	No	Yes or Unknown			No	0	18.86	0	no	no	no
6589	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017	IV	33	6.1	Stable	No	No			No	0	18	0	no	no	no
6590	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	22	7.9	Stable	No	No	Signature.1		Yes	0	18.37	0	no	no	no
6591	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		61	0	Stable	No	No			No	0	18.37	0	no	no	no
6592	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	19	17.6	Indeterminate	No	No	Signature.4	NBN	Yes	0	17.45	0	no	no	no
6593	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	II	19	0		No	No			No	1	10.25	0	no	no	no
6594	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	314	7	Stable	No	Yes or Unknown	Signature.26	SLX4	No	1	13.6	0	no	no	no
6595	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	37	1.8	Stable	No	No			No	0	18.99	0	no	no	no
6596	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	26	3.5	Stable	No	No			No	0	17.97	0	no	no	no
6597	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	6	11.4	Stable	No	No	Signature.13		Yes	0	18.07	0	no	no	no
6598	Non-ICI treated	Never received ICI	21 - 25	Female	Gastric	2017	IV	10	1.8	Stable	No	No			No	0	15.74	0	no	no	no
6599	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	20.7	0	no	no	no
6600	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	294	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	19.29	0	no	no	no
6601	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	13	1.8	Stable	No	No			Yes	0	8.51	0	no	no	no
6602	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	7	7.9	Stable	No	No	Signature.4	ATM	Yes	0	16.26	0	no	no	no
6603	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	1	10.68	0	no	no	no
6604	Non-ICI treated	Never received ICI	36 - 40	Male	Cutaneous Melanoma 	2017	III	0	7.9	Stable	No	No	Signature.7		No	0	17.48	0	no	no	no
6605	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	7	5.3	Stable	No	No	Signature.29		No	0	19.25	0	no	no	no
6606	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			No	1	12.06	0	no	no	no
6607	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	19.58	0	no	no	no
6608	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	223	1.8	Stable	No	Yes or Unknown		ATM	No	0	20.44	0	no	no	no
6609	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	24	8.8	Stable	No	Yes or Unknown	Signature.3	RAD50	No	0	15.54	0	no	no	no
6610	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	24	4.4	Stable	No	No	Signature.24	CHEK2 | ERCC3	Yes	1	6.37	0	no	no	no
6611	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	19.42	0	no	no	no
6612	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	50	0	Stable	No	No			No	0	19.75	0	no	no	no
6613	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	0	4.4	Stable	No	No			No	0	19.65	0	no	no	no
6614	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	22	7	Stable	No	No	Signature.24		Yes	1	1.68	0	no	no	no
6615	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	15	3.5	Stable	No	No			No	1	12.29	0	no	no	no
6616	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	9.7	Stable	No	No	Signature.4	BLM | ERCC2	Yes	0	16.79	0	no	no	no
6617	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	6.1	Stable	No	No	Signature.13		No	0	19.45	0	no	no	no
6618	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	17	1.8	Stable	No	No			No	0	19.12	0	no	no	no
6619	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	0	0.9	Stable	No	Yes or Unknown		TP53BP1	No	1	12.88	0	no	no	no
6620	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	27	5.3	Stable	No	No			No	0	21.19	0	no	no	no
6621	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2017	IV	23	3.5	Stable	No	No			No	0	19.78	0	no	no	no
6622	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	27	2.6	Stable	No	No			No	0	19.81	0	no	no	no
6623	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	III	2	3.5	Stable	No	No		ARID1A	No	0	18.4	0	no	no	yes
6624	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	10	5.3	Stable	No	No	Signature.1		Yes	0	17.77	0	no	no	no
6625	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	3	6.1	Stable	No	No			No	0	19.32	0	no	no	no
6626	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	41	9.7	Stable	No	No	Signature.3	ARID1A | BRCA1 | BRCA2 | MUTYH	No	1	13.63	0	no	no	yes
6627	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2017	I	55	0		No	No			No	0	15.31	0	no	no	no
6628	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	II	75	7	Stable	No	No	Signature.5		Yes	0	13.77	0	no	no	no
6629	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	31	2.6	Stable	No	No			No	0	5.82	0	no	no	no
6630	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		0	0		No	No			Yes	0	15.7	0	no	no	no
6631	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	I	39	3.5	Stable	No	No	Signature.4	XRCC2	No	0	19.12	0	no	no	no
6632	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	III	0	1.8	Stable	No	No			No	0	21.42	0	no	no	no
6633	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017		0	7.9	Stable	No	No	Signature.1	ARID1A	No	0	14.98	0	no	no	yes
6634	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	II	27	5.3	Stable	No	No			No	0	13.96	0	no	no	no
6635	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	19	3.5	Stable	No	No			No	0	20.3	0	no	no	no
6636	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	6.1	Stable	No	No			No	1	5.65	0	no	no	no
6637	Non-ICI treated	Never received ICI	66 - 70	Male	Breast	2017	II	512	3.5	Stable	No	Yes or Unknown	Signature.1		No	0	19.75	0	no	no	no
6638	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	70	2.6		No	Yes or Unknown	Signature.1	BRCA2	Yes	0	18.6	0	no	no	no
6639	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		148	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	19.45	0	no	no	no
6640	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	37	3.5	Stable	No	Yes or Unknown		PALB2 | XRCC2	No	0	17.94	0	no	no	no
6641	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	0	2.6	Stable	No	No		FANCC	No	0	5.03	0	no	no	no
6642	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	34	0.9	Stable	No	No			Yes	0	14.95	0	no	no	no
6643	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	9	3.5	Stable	No	No			Yes	0	18.86	0	no	no	no
6644	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	126	1.8	Indeterminate	No	Yes or Unknown		PMS2	No	0	17.38	0	no	no	no
6645	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	6	6.1	Stable	No	No		SLX4	No	0	19.71	0	no	no	no
6646	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	70	0.9	Stable	No	No			No	0	20.4	0	no	no	no
6647	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	20	1.8	Stable	No	No			Yes	1	14.62	0	no	no	no
6648	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	1	15.8	Stable	No	No	Signature.1	MSH6	No	1	4.53	0	no	no	no
6649	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	35	7.9	Stable	No	No	Signature.1	BLM	No	0	20.3	0	no	no	no
6650	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	65	0		No	No			No	1	11.27	0	no	no	no
6651	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	161	7	Stable	No	Yes or Unknown	Signature.15		No	0	19.35	0	no	no	no
6652	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	23	8.8	Stable	No	No	Signature.4		Yes	0	19.71	0	no	no	no
6653	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	86	0	Stable	No	No			No	0	19.12	0	no	no	no
6654	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	IV	29	1.8	Stable	No	No			No	1	15.21	0	no	no	no
6655	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	35	8.8	Stable	No	Yes or Unknown	Signature.24	ARID1A | ATR | TP53BP1	Yes	1	4.4	0	no	no	yes
6656	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2017	IV	151	7.9	Stable	No	No		ARID1A	No	0	5.32	0	no	no	yes
6657	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2017	IV	0	7.9	Stable	No	No	Signature.13	ARID1A	Yes	1	5.22	0	no	no	yes
6658	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	III	29	2.6	Stable	No	No			No	0	16.82	0	no	no	no
6659	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018		3	3.5	Stable	No	No			Yes	0	17.77	0	no	no	no
6660	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	27	0	Stable	No	Yes or Unknown			Yes	0	19.81	0	no	no	no
6661	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	2.6	Stable	No	Yes or Unknown			No	1	16.79	0	no	no	no
6662	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	6.1	Stable	No	No			No	0	13.8	0	no	no	no
6663	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	51	3.5	Stable	No	No			No	0	20.86	0	no	no	no
6664	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	III	8	2.6	Stable	No	No			No	1	13.34	0	no	no	no
6665	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	0	5.3	Stable	No	No			Yes	0	19.38	0	no	no	no
6666	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	27	2.6	Stable	No	No			No	0	19.38	0	no	no	no
6667	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	II	25	4.4	Stable	No	No			No	0	13.73	0	no	no	no
6668	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.13		Yes	1	11.07	0	no	no	no
6669	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2017	I	510	18.4	Stable	No	No	Signature.7	ARID1A | PALB2	No	1	17.51	0	no	no	yes
6670	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	I	605	7	Stable	No	Yes or Unknown	Signature.17		Yes	0	20.76	0	no	no	no
6671	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.6		Yes	0	16.82	0	no	no	no
6672	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	0	9.7	Stable	No	No	Signature.5		Yes	0	18.92	0	no	no	no
6673	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		15	5.3	Stable	No	No	Signature.3		No	1	4.27	0	no	no	no
6674	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0.9	Stable	No	No		MUTYH	No	0	20.57	0	no	no	no
6675	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	0.9	Stable	No	No			No	0	19.09	0	no	no	no
6676	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	26	5.3	Stable	No	Yes or Unknown			No	0	19.94	0	no	no	no
6677	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	I	0	3.5	Stable	No	No	Signature.13	ARID1A | PARP1	No	0	19.55	0	no	no	yes
6678	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	19.06	0	no	no	no
6679	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	27	5.3	Stable	No	Yes or Unknown	Signature.1		Yes	0	15.67	0	no	no	no
6680	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	IV	41	1.8	Stable	No	No			No	0	19.55	0	no	no	no
6681	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	485	10.5	Stable	No	Yes or Unknown	Signature.2		No	0	17.74	0	no	no	no
6682	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	0.9	Stable	No	Yes or Unknown			No	0	18.4	0	no	no	no
6683	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	236	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	19.75	0	no	no	no
6684	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	27	3.5	Stable	No	No		ARID1A | FANCA	No	0	19.75	0	no	no	yes
6685	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	191	2.6	Stable	No	Yes or Unknown			No	0	20.73	0	no	no	no
6686	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	II	37	7	Stable	No	No			Yes	0	21.88	0	no	no	no
6687	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	18	3.5	Stable	No	No	Signature.5		Yes	0	17.81	0	no	no	no
6688	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	162	0	Stable	No	No			No	0	22.54	0	no	no	no
6689	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	III	8	13.2	Stable	No	No	Signature.24		No	0	18.69	0	no	no	no
6690	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	III	56	9.7	Stable	No	No	Signature.16	PARP1	Yes	0	17.25	0	no	no	no
6691	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	6	0.9	Stable	No	No			No	1	2.89	0	no	no	no
6692	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	459	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	19.09	0	no	no	no
6693	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	5	6.1	Stable	No	No	Signature.6		No	1	11.7	0	no	no	no
6694	Non-ICI treated	Never received ICI	91 - 95	Female	Colorectal	2018	II	24	45.6	Unstable	No	No	Signature.1	ATR | ERCC5 | MSH3 | MSH6 | NTHL1 | SLX4	No	0	17.68	0	mut-MMRd	mut-MMRd	no
6695	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	200	0	Stable	No	No			No	0	21.88	0	no	no	no
6696	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	I	29	0.9	Stable	No	No			No	0	14.09	0	no	no	no
6697	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	444	4.4	Stable	No	Yes or Unknown			No	0	19.68	0	no	no	no
6698	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	13.73	0	no	no	no
6699	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	IV	45	3.5	Stable	No	No			No	1	11.53	0	no	no	no
6700	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	3	3.5	Stable	No	No			No	0	20.04	0	no	no	no
6701	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	1	4.4	Stable	No	No			Yes	1	6.77	0	no	no	no
6702	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	0	2.6	Stable	No	No			No	1	8.25	0	no	no	no
6703	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	15	4.4	Stable	No	No	Signature.6		No	0	21.06	0	no	no	no
6704	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	III	11	3.5	Stable	No	No			Yes	0	18	0	no	no	no
6705	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	37	6.1	Stable	No	No		ATM	Yes	0	20.27	0	no	no	no
6706	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	452	0.9	Stable	No	Yes or Unknown			No	0	19.98	0	no	no	no
6707	Non-ICI treated	Never received ICI	31 - 35	Male	Head & Neck	2018	III	29	1.8	Stable	No	No			Yes	0	18.14	0	no	no	no
6708	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	17	2.6	Stable	No	No	Signature.1		No	0	12.78	0	no	no	no
6709	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	50	6.1	Stable	No	No	Signature.3	BRCA2	No	0	19.45	0	no	no	no
6710	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			Yes	0	19.12	0	no	no	no
6711	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	62	3.5	Stable	No	Yes or Unknown			Yes	0	19.94	0	no	no	no
6712	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	22	1.8	Stable	No	No	Signature.25		No	0	18.99	0	no	no	no
6713	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	III	80	0	Stable	No	Yes or Unknown			No	0	18.53	0	no	no	no
6714	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	I	147	1.8	Stable	No	Yes or Unknown		MUTYH	Yes	0	15.21	0	no	no	no
6715	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2017		103	9.7	Stable	No	No	Signature.12	BRCA1 | BRIP1 | CHEK2	Yes	0	20.86	0	no	no	no
6716	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		3	6.1	Stable	No	No			No	1	17.61	0	no	no	no
6717	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	14	6.1	Stable	No	No	Signature.4		No	0	16.23	0	no	no	no
6718	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		24	0	Stable	No	No			No	0	19.35	0	no	no	no
6719	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	III	53	1.8	Stable	No	No			No	0	18.33	0	no	no	no
6720	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	27	7.9	Stable	No	No		MSH6	No	0	19.09	0	no	no	no
6721	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	54	2.6	Stable	No	No			No	0	19.06	0	no	no	no
6722	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	IV	44	0.9	Stable	No	No			No	1	15.74	0	no	no	no
6723	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	7	0.9	Stable	No	No			Yes	0	16.79	0	no	no	no
6724	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	537	1.8	Stable	No	Yes or Unknown			No	0	19.81	0	no	no	no
6725	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	2	2.6	Stable	No	No			Yes	1	18.76	0	no	no	no
6726	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	III	10	3.5	Stable	No	No			No	1	17.05	0	no	no	no
6727	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	I	16	2.6	Stable	No	No			Yes	0	18.27	0	no	no	no
6728	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	91	4.4	Stable	No	No			Yes	0	16.79	0	no	no	no
6729	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	11	4.4	Stable	No	No			No	0	16.3	0	no	no	no
6730	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	26	8.8	Stable	No	No	Signature.4		No	0	14.88	0	no	no	no
6731	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	IV	0	3.5	Stable	No	No			Yes	1	3.02	0	no	no	no
6732	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	7	7	Stable	No	No	Signature.2		Yes	0	19.52	0	no	no	no
6733	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	23	2.6	Stable	No	Yes or Unknown			No	0	19.38	0	no	no	no
6734	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	0	19.29	0	no	no	no
6735	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2017	II	232	14.9	Stable	No	Yes or Unknown	Signature.13	MSH3	No	1	9.46	0	no	no	no
6736	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	51	1.8	Stable	No	No	Signature.1		Yes	0	20.04	0	no	no	no
6737	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2018		0	6.1	Stable	No	No	Signature.17	MSH3	Yes	0	17.51	0	no	no	no
6738	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	I	11	7	Stable	No	No		ARID1A	No	0	18.92	0	no	no	yes
6739	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	10	3.5	Stable	No	Yes or Unknown		BLM	No	1	18.33	0	no	no	no
6740	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	8.8	Stable	No	No	Signature.2	MLH1	No	0	17.84	0	no	no	no
6741	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	50	1.8	Stable	No	Yes or Unknown			No	0	19.19	0	no	no	no
6742	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	I	0	3.5	Stable	No	No	Signature.5		Yes	0	13.6	0	no	no	no
6743	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	0	Stable	No	No			Yes	0	18.14	0	no	no	no
6744	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	16.26	0	no	no	no
6745	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	6	3.5	Stable	No	No			No	0	18.1	0	no	no	no
6746	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	44	6.1	Stable	No	No	Signature.4	ARID1A	Yes	1	3.75	0	no	no	yes
6747	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	0	8.8	Stable	No	No	Signature.1		Yes	0	19.32	0	no	no	no
6748	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2018		14	3.5	Stable	No	No			Yes	0	18.17	0	no	no	no
6749	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017		36	0.9	Stable	No	No			No	0	19.55	0	no	no	no
6750	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		61	0.9	Stable	No	No			No	0	18.07	0	no	no	no
6751	Non-ICI treated	Never received ICI	81 - 85	Male	Esophageal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	1	9.2	0	no	no	no
6752	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	22	2.6	Stable	No	No		ARID1A	No	1	7.33	0	no	no	yes
6753	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	IV	6	3.5	Stable	No	No			No	0	3.98	0	no	no	no
6754	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018		0	1.8	Stable	No	No			No	0	17.94	0	no	no	no
6755	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	12.3	Stable	No	No	Signature.3	ATM	No	0	18.56	0	no	no	no
6756	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	11.4	Stable	No	No	Signature.4	ARID1A | ERCC5	No	0	17.94	0	no	no	yes
6757	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	63	2.6	Stable	No	No			No	0	16.23	0	no	no	no
6758	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	18.99	0	no	no	no
6759	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1	TP53BP1	No	0	19.02	0	no	no	no
6760	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	5.3		No	No	Signature.5	ATR | MLH1	No	1	11.17	0	no	no	no
6761	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	IV	31	0	Stable	No	Yes or Unknown			No	1	18.46	0	no	no	no
6762	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	364	8.8	Stable	No	Yes or Unknown	Signature.2		No	0	18.83	0	no	no	no
6763	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	I	158	12.3	Stable	No	No	Signature.4		Yes	0	13.24	0	no	no	no
6764	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2018	III	0	11.4	Stable	No	No	Signature.30	CHEK2 | ERCC2	Yes	0	17.31	0	no	no	no
6765	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	3	3.5	Stable	No	No			Yes	1	1.91	0	no	no	no
6766	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	13	7	Stable	No	No	Signature.1		Yes	0	18.6	0	no	no	no
6767	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	IV	16	2.6	Stable	No	No		ARID1A	No	1	9.1	0	no	no	yes
6768	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	81	2.6	Stable	No	No		ERCC2	Yes	0	13.9	0	no	no	no
6769	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	18	6.1	Stable	No	No	Signature.1	ARID1A	No	0	9.72	0	no	no	yes
6770	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	0	1.8	Stable	No	No	Signature.21		No	0	17.97	0	no	no	no
6771	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	IV	14	3.5	Stable	No	No			No	0	18.89	0	no	no	no
6772	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	5.3	Stable	No	Yes or Unknown		MSH2	No	0	21.06	0	no	no	no
6773	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	30	0	Stable	No	No			No	0	25.33	0	no	no	no
6774	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	IV	42	1.8	Stable	No	No			No	0	17.58	0	no	no	no
6775	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	III	38	5.3	Stable	No	No		ARID1A	No	0	19.38	0	no	no	yes
6776	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	0	6.1	Stable	No	No		BRCA1	No	0	14.65	0	no	no	no
6777	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018	II	120	0.9	Stable	No	Yes or Unknown			No	0	18.6	0	no	no	no
6778	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	127	1.8	Stable	No	No			No	0	12.68	0	no	no	no
6779	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	20	3.5		No	No	Signature.5		No	0	14.72	0	no	no	no
6780	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	8	1.8	Stable	No	No			No	0	19.19	0	no	no	no
6781	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	0	104.4	Unstable	No	No	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | ERCC4 | MLH1 | MSH3 | MUTYH | PMS1 | RAD54L | SLX4 | XRCC2	Yes	0	17.74	0	mut-MMRd	mut-MMRd	yes
6782	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	65	17.6	Stable	No	No	Signature.4	ERCC3 | FANCC	No	0	14.49	0	no	no	no
6783	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	39	10.5	Stable	No	No	Signature.4	ARID1A	No	0	18.73	0	no	no	yes
6784	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	36	3.5	Stable	No	No			Yes	0	16.85	0	no	no	no
6785	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2018	III	0	2.6	Stable	No	No	Signature.3	MUTYH	No	0	14.13	0	no	no	no
6786	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018		73	3.5	Stable	No	Yes or Unknown			No	0	19.25	0	no	no	no
6787	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		1	2.6	Stable	No	No			No	0	18.79	0	no	no	no
6788	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2018	IV	2	1.8	Stable	No	No			Yes	1	0.85	0	no	no	no
6789	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	9	4.4	Stable	No	No			Yes	1	2.79	0	no	no	no
6790	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2018	IV	379	3.5	Stable	No	Yes or Unknown			Yes	0	17.71	0	no	no	no
6791	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	IV	0	1.8	Stable	No	No			No	0	18.69	0	no	no	no
6792	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	I	74	3.5	Stable	No	No			No	0	18.04	0	no	no	no
6793	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2018	II	358	39.5	Stable	No	Yes or Unknown	Signature.2	ERCC4 | MSH6	Yes	0	17.87	0	no	no	no
6794	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	IV	0	1.8	Stable	No	No			No	0	17.97	0	no	no	no
6795	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	III	20	9.7	Stable	No	No	Signature.7		No	0	15.57	0	no	no	no
6796	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2018		0	0	Stable	No	No			No	0	12.45	0	no	no	no
6797	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	30	3.5	Stable	No	Yes or Unknown			No	1	13.44	0	no	no	no
6798	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	12	3.5	Stable	No	Yes or Unknown	Signature.30		Yes	1	13.86	0	no	no	no
6799	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	19.19	0	no	no	no
6800	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	IV	2	2.6	Indeterminate	No	No		FANCA	No	1	3.25	0	no	no	no
6801	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	3.5	Stable	No	No			Yes	0	18.27	0	no	no	no
6802	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	I	29	15.8	Unstable	No	No	Signature.1	ARID1A	No	0	18	0	other-MMRd	mut-MMRd	yes
6803	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2018	IV	34	7	Stable	No	No	Signature.4		Yes	1	2.83	0	no	no	no
6804	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018		0	1.8	Stable	No	No			Yes	0	16.62	0	no	no	no
6805	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	23	113.2	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC5 | FANCC | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | PARP1 | PMS1 | PMS2 | TP53BP1	No	0	9.1	0	no	no	yes
6806	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2018	IV	6	1.8	Stable	No	Yes or Unknown			No	1	9.46	0	no	no	no
6807	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	26	7	Stable	No	No	Signature.8		No	0	13.54	0	no	no	no
6808	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	18	2.6	Stable	No	No			No	0	14.69	0	no	no	no
6809	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	48	0.9	Stable	No	No			Yes	0	16.49	0	no	no	no
6810	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	6.1	Stable	No	No			No	1	17.58	0	no	no	no
6811	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	171	0.9	Stable	No	No			No	0	12.88	0	no	no	no
6812	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	43	1.8	Stable	No	No			Yes	0	17.97	0	no	no	no
6813	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	18	2.6	Stable	No	Yes or Unknown			No	1	13.01	0	no	no	no
6814	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	0	2.6	Stable	No	No		ATM	No	0	18.3	0	no	no	no
6815	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2018	III	496	1.8	Stable	No	Yes or Unknown			No	0	18.66	0	no	no	no
6816	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	5	7.9		No	No		ARID1A	No	1	10.68	0	no	no	yes
6817	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	66	0		No	No			Yes	1	6.9	0	no	no	no
6818	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	198	1.8	Stable	No	No			No	0	22.14	0	no	no	no
6819	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	115	0.9	Stable	No	No			No	0	17.94	0	no	no	no
6820	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	48	4.4	Stable	No	No		ARID1A	No	0	17.38	0	no	no	yes
6821	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	II	0	1.8	Stable	No	Yes or Unknown		MDC1	No	0	18.37	0	no	no	no
6822	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	314	1.8	Stable	No	Yes or Unknown			Yes	0	17.38	0	no	no	no
6823	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018		24	1.8	Stable	No	No			No	1	10.12	0	no	no	no
6824	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	70	4.4	Stable	No	No			No	0	15.74	0	no	no	no
6825	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	IV	40	1.8	Stable	No	No		ARID1A	No	0	18.69	0	no	no	yes
6826	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	394	7	Stable	No	No	Signature.1	BRCA2	No	0	17.35	0	no	no	no
6827	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	15	5.3	Stable	No	No	Signature.3	PMS1	No	1	11.33	0	no	no	no
6828	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	21	7	Stable	No	No	Signature.1		Yes	0	17.68	0	no	no	no
6829	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	0	18.27	0	no	no	no
6830	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	38	4.4	Stable	No	No			No	0	17.87	0	no	no	no
6831	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	39	4.4	Stable	No	No			Yes	0	8.77	0	no	no	no
6832	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	81	0.9	Stable	No	No			Yes	0	17.08	0	no	no	no
6833	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	6	8.8	Stable	No	No	Signature.1		No	0	18.56	0	no	no	no
6834	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	60	1.8	Stable	No	Yes or Unknown			Yes	0	17.94	0	no	no	no
6835	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	18.69	0	no	no	no
6836	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	266	2.6	Stable	No	Yes or Unknown			No	0	19.94	0	no	no	no
6837	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	17.94	0	no	no	no
6838	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	I	2	1.8	Stable	No	No			Yes	1	4.07	0	no	no	no
6839	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	4	5.3	Stable	No	No			No	1	3.19	0	no	no	no
6840	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	27	2.6	Stable	No	No			Yes	0	15.24	0	no	no	no
6841	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	16	2.6	Stable	No	Yes or Unknown			No	0	18.43	0	no	no	no
6842	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	III	156	4.4	Stable	No	No			No	0	17.31	0	no	no	no
6843	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2017	IV	83	0.9	Stable	No	Yes or Unknown			Yes	0	19.52	0	no	no	no
6844	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	2.6	Stable	No	No			No	0	18.3	0	no	no	no
6845	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018		0	4.4	Stable	No	No	Signature.4		No	0	12.78	0	no	no	no
6846	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2018	IV	31	6.1	Stable	No	No	Signature.2	BRCA2 | RAD51	No	1	7.52	0	no	no	no
6847	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	134	1.8	Stable	No	Yes or Unknown			No	0	17.94	0	no	no	no
6848	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	III	8	2.6	Stable	No	No			No	0	19.12	0	no	no	no
6849	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	78	7	Stable	No	No			No	0	18.76	0	no	no	no
6850	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	III	120	1.8	Stable	No	Yes or Unknown			Yes	0	18.14	0	no	no	no
6851	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	16	1.8	Stable	No	No			Yes	1	8.38	0	no	no	no
6852	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	45	3.5	Stable	No	Yes or Unknown			No	0	18.66	0	no	no	no
6853	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	18.23	0	no	no	no
6854	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1		No	0	18.6	0	no	no	no
6855	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	21	9.7	Stable	No	No	Signature.4		No	0	12.91	0	no	no	no
6856	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	27	2.6	Stable	No	Yes or Unknown			Yes	0	13.83	0	no	no	no
6857	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	54	1.8	Stable	No	No		FANCA	No	0	10.71	0	no	no	no
6858	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	456	1.8	Stable	No	Yes or Unknown			Yes	0	17.81	0	no	no	no
6859	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	52	10.5	Stable	No	No	Signature.29	ERCC5	No	0	14.29	0	no	no	no
6860	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	27	7.9	Stable	No	No	Signature.4	MUTYH	Yes	0	14.32	0	no	no	no
6861	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	28	2.6	Stable	No	No		ARID1A	No	0	18.17	0	no	no	yes
6862	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	451	2.6	Stable	No	Yes or Unknown			No	0	17.08	0	no	no	no
6863	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	27	5.3	Stable	No	No	Signature.2	NBN	No	0	18.07	0	no	no	no
6864	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	I	51	2.6	Stable	No	No			No	0	17.61	0	no	no	no
6865	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	5	7	Stable	No	No	Signature.1		Yes	0	18.53	0	no	no	no
6866	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	58	5.3	Stable	No	No	Signature.24		No	0	17.74	0	no	no	no
6867	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	7	6.1	Stable	No	No			Yes	1	12.48	0	no	no	no
6868	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	207	0		No	Yes or Unknown			No	0	19.32	0	no	no	no
6869	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	32	21.1	Stable	No	No	Signature.13		No	0	13.11	0	no	no	no
6870	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	45	3.5	Stable	No	No			Yes	0	13.77	0	no	no	no
6871	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	8.77	0	no	no	no
6872	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	19.25	0	no	no	no
6873	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	III	43	5.3	Stable	No	No			No	0	16.3	0	no	no	no
6874	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	46	3.5	Stable	No	No			No	0	17.25	0	no	no	no
6875	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	12	4.4	Stable	No	No			No	1	7.82	0	no	no	no
6876	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	12	34.2	Stable	No	No	Signature.1	MRE11A | RAD54L | SLX4	Yes	1	9.49	0	no	no	no
6877	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	44	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	18.73	0	no	no	no
6878	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	I	28	30.7	Unstable	No	No	Signature.1	ARID1A | RAD54L	No	0	17.25	0	other-MMRd	mut-MMRd	yes
6879	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	III	12	6.1	Stable	No	No		BRCA2	Yes	0	12.88	0	no	no	no
6880	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	42	1.8	Stable	No	No			No	0	17.38	0	no	no	no
6881	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	32	1.8	Stable	No	No			No	0	17.74	0	no	no	no
6882	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	16.79	0	no	no	no
6883	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	114	6.1	Stable	No	Yes or Unknown	Signature.30	BRCA2 | MLH1	No	0	17.05	0	no	no	no
6884	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	9	5.3	Stable	No	Yes or Unknown			No	1	12.48	0	no	no	no
6885	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	7	4.4	Stable	No	No	Signature.9		No	1	14.82	0	no	no	no
6886	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	4	7.9	Stable	No	No			No	0	17.28	0	no	no	no
6887	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	161	6.1	Stable	No	No			Yes	1	11.96	0	no	no	no
6888	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2018		30	33.4	Stable	No	No	Signature.1	MSH6	No	0	17.18	0	no	no	no
6889	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	76	19.3	Stable	No	No	Signature.2	ARID1A | BRCA1 | BRIP1	Yes	0	18.89	0	no	no	yes
6890	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	III	71	79.9	Unstable	No	No	Signature.6	ATM | ATR | CHEK1 | ERCC2 | MSH3 | PALB2 | PARP1 | PMS1 | RAD50	Yes	0	20.6	0	other-MMRd	mut-MMRd	no
6891	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	IV	2	6.1	Stable	No	Yes or Unknown			No	1	11.79	0	no	no	no
6892	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2018	IV	0	6.1	Stable	No	No	Signature.1		No	1	8.77	0	no	no	no
6893	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2018	II	9	7	Indeterminate	No	No	Signature.4	ERCC2 | FANCA | MSH6	Yes	0	15.61	0	no	no	no
6894	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	2	8.8	Stable	No	No	Signature.1	ATR | BRIP1	Yes	0	18.4	0	no	no	no
6895	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	27	361.6	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK1 | ERCC3 | ERCC5 | FANCA | MDC1 | MUTYH | NBN | RAD50 | RAD54L | SLX4 | TP53BP1	Yes	0	17.02	0	other-MMRd	mut-MMRd	yes
6896	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	III	27	1.8	Stable	No	No			No	0	16.36	0	no	no	no
6897	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	49	1.8	Stable	No	No			No	0	14.55	0	no	no	no
6898	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	0	0.9		No	No	Signature.5		No	0	13.04	0	no	no	no
6899	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	63	2.6	Stable	No	No			No	0	18	0	no	no	no
6900	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	III	21	7	Stable	No	No		TP53BP1	Yes	0	18.23	0	no	no	no
6901	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	21	0	Stable	No	No			Yes	0	17.51	0	no	no	no
6902	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	357	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	17.87	0	no	no	no
6903	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1	PMS2	Yes	1	1.77	0	no	no	no
6904	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	24	12.3	Stable	No	No	Signature.1	ATM	No	0	17.77	0	no	no	no
6905	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	0	0	Stable	No	No			No	0	10.61	0	no	no	no
6906	Non-ICI treated	Never received ICI	21 - 25	Female	Hepatobiliary	2018	IV	7	2.6	Stable	No	No			No	1	7.79	0	no	no	no
6907	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	5	4.4	Stable	No	No			Yes	0	2	0	no	no	no
6908	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	2	5.3	Stable	No	No	Signature.1	ATM	Yes	1	9.46	0	no	no	no
6909	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	11	5.3	Stable	No	No	Signature.6	ATM	Yes	0	17.64	0	no	no	no
6910	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	57	7	Stable	No	Yes or Unknown			No	0	19.06	0	no	no	no
6911	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	41	1.8	Stable	No	No			No	0	15.84	0	no	no	no
6912	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	94	272.1	Stable	No	Yes or Unknown	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC2 | ERCC4 | ERCC5 | FANCA | MDC1 | MLH1 | MSH3 | MSH6 | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1	No	0	19.25	0	no	no	yes
6913	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	215	7.9	Stable	No	No	Signature.1		No	0	21.06	0	no	no	no
6914	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	47	4.4	Stable	No	No	Signature.1		No	0	18.89	0	no	no	no
6915	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	9	10.5	Stable	No	No	Signature.1	BLM	No	1	11.1	0	no	no	no
6916	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	2.6	Stable	No	Yes or Unknown		FANCC	No	0	18.6	0	no	no	no
6917	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	126	5.3	Stable	No	No		ATM | CHEK2	Yes	0	17.45	0	no	no	no
6918	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	37	4.4	Stable	No	No	Signature.24		No	0	10.78	0	no	no	no
6919	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	11	1.8	Stable	No	No			No	0	3.81	0	no	no	no
6920	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	17.41	0	no	no	no
6921	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	37	31.6	Indeterminate	No	No	Signature.6	ARID1A | FANCC | MRE11A | MSH2	Yes	0	15.18	0	no	no	yes
6922	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	64	2.6	Stable	No	No			No	0	17.77	0	no	no	no
6923	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	316	0.9	Stable	No	Yes or Unknown			No	1	14.98	0	no	no	no
6924	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	59	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	17.51	0	no	no	no
6925	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	203	5.3	Stable	No	No			Yes	0	21.55	0	no	no	no
6926	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	II	15	0	Stable	No	No		BRCA2	Yes	0	17.84	0	no	no	no
6927	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	IV	156	3.5	Stable	No	Yes or Unknown			No	0	18.17	0	no	no	no
6928	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	47	9.7	Stable	No	No	Signature.4	MRE11A	No	0	17.02	0	no	no	no
6929	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	37	3.5	Stable	No	Yes or Unknown			No	0	17.74	0	no	no	no
6930	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	I	19	4.4	Stable	No	No		ARID1A	Yes	0	16.03	0	no	no	yes
6931	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	I	0	17.6	Stable	No	No	Signature.4	MUTYH	No	0	15.18	0	no	no	no
6932	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2018	IV	4	2.6	Stable	No	No			Yes	1	3.38	0	no	no	no
6933	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	2.6	Stable	No	No			Yes	1	6.14	0	no	no	no
6934	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	III	7	2.6	Stable	No	Yes or Unknown			No	1	16.76	0	no	no	no
6935	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	138	6.1	Stable	No	Yes or Unknown	Signature.4		Yes	0	13.11	0	no	no	no
6936	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2018		0	8.8	Stable	No	No	Signature.19	ERCC2	Yes	0	16.07	0	no	no	no
6937	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	43	4.4	Stable	No	No		ATM	No	0	17.61	0	no	no	no
6938	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	98	3.5	Stable	No	Yes or Unknown			No	0	17.91	0	no	no	no
6939	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	No			No	0	17.18	0	no	no	no
6940	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	75	1.8	Stable	No	No			No	0	17.31	0	no	no	no
6941	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	3.5	Stable	No	No			No	0	16.59	0	no	no	no
6942	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	74	1.8	Stable	No	No			No	0	18.07	0	no	no	no
6943	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	100	0.9	Stable	No	No			No	1	11.4	0	no	no	no
6944	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2018		11	0.9	Stable	No	No			No	1	17.18	0	no	no	no
6945	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		2	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MUTYH	Yes	1	5.88	0	no	no	no
6946	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	II	61	13.2	Stable	No	No	Signature.1		No	0	14.46	0	no	no	no
6947	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	26	6.1	Stable	No	No			Yes	0	14.88	0	no	no	no
6948	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	31	5.3	Stable	No	No	Signature.4		Yes	0	16.2	0	no	no	no
6949	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	31	1.8	Stable	No	No			Yes	0	8.61	0	no	no	no
6950	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2018	IV	0	6.1	Stable	No	No		ARID1A	No	1	4.01	0	no	no	yes
6951	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	II	15	3.5	Stable	No	No			No	0	17.02	0	no	no	no
6952	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	98	0	Stable	No	No			No	0	17.22	0	no	no	no
6953	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2018		10	19.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MRE11A | MSH6	No	0	17.28	0	no	no	no
6954	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	0	21.1	Stable	No	Yes or Unknown	Signature.4	ARID1A | ERCC5 | TP53BP1	Yes	0	16.99	0	no	no	yes
6955	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	210	7	Stable	No	No	Signature.8		No	0	19.61	0	no	no	no
6956	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	1.8	Stable	No	No			No	1	1.97	0	no	no	no
6957	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	16.79	0	no	no	no
6958	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		120	0	Stable	No	No			No	0	18.4	0	no	no	no
6959	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	14	0.9	Stable	No	Yes or Unknown			No	0	17.45	0	no	no	no
6960	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	7	36.9	Unstable	No	No	Signature.12	ARID1A | ATR | MSH6 | PMS2	Yes	0	11.1	0	mut-MMRd	mut-MMRd	yes
6961	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	III	19	0.9	Stable	No	No			No	1	11.76	0	no	no	no
6962	Non-ICI treated	Never received ICI	26 - 30	Female	Endometrial	2018	I	28	4.4	Stable	No	No		ARID1A	No	0	14	0	no	no	yes
6963	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	17	218.6	Unstable	No	No	Signature.15	ARID1A | ATM | BLM | BRCA1 | BRIP1 | ERCC2 | ERCC3 | ERCC4 | FANCC | MDC1 | MSH2 | MSH6 | MUTYH | NBN | PALB2 | PARP1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1 | XRCC2	No	0	12.58	0	mut-MMRd	mut-MMRd	yes
6964	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	4.4	Stable	No	No		PMS2	No	0	17.18	0	no	no	no
6965	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	III	162	0.9	Stable	No	No			Yes	0	17.71	0	no	no	no
6966	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	1	2.33	0	no	no	no
6967	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	7	Stable	No	No	Signature.17		No	1	16.92	0	no	no	no
6968	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	3.5	Stable	No	No			No	0	13.27	0	no	no	no
6969	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	II	0	5.3	Stable	No	No	Signature.3	MDC1	No	0	12.48	0	no	no	no
6970	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	22	2.6	Stable	No	No		MSH2	No	0	15.31	0	no	no	no
6971	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	II	24	59.7	Unstable	No	No	Signature.1	ARID1A | ERCC5 | MDC1 | MSH3 | MSH6 | NTHL1 | SLX4	No	0	14.32	0	mut-MMRd	mut-MMRd	yes
6972	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	4.4	Stable	No	No			No	0	18.14	0	no	no	no
6973	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	41	5.3	Stable	No	No		NBN	Yes	1	4.37	0	no	no	no
6974	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	127	0.9	Stable	No	No			No	0	13.31	0	no	no	no
6975	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	19	4.4	Stable	No	No			No	0	17.61	0	no	no	no
6976	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	46	0	Stable	No	No		BRIP1	No	0	16.95	0	no	no	no
6977	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2018	III	1	11.4	Stable	No	No	Signature.4	ARID1A | MSH3	Yes	0	17.31	0	no	no	yes
6978	Non-ICI treated	Never received ICI	16 - 20	Female	Colorectal	2018	III	7	0.9	Stable	No	No			No	0	17.45	0	no	no	no
6979	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1	RAD50	No	0	17.15	0	no	no	no
6980	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	II	12	2.6	Stable	No	No			No	0	17.18	0	no	no	no
6981	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	11	7.9	Stable	No	No	Signature.8	MRE11A	No	0	16.76	0	no	no	no
6982	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	77	2.6	Stable	No	No			No	0	14.78	0	no	no	no
6983	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		No	0	16.82	0	no	no	no
6984	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	98	2.6	Stable	No	Yes or Unknown			No	0	11.1	0	no	no	no
6985	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	49	1.8	Stable	No	No			No	0	17.74	0	no	no	no
6986	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2018	III	0	7	Stable	No	No	Signature.1		Yes	0	17.05	0	no	no	no
6987	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	II	9	2.6	Stable	No	No		ARID1A	No	1	7.52	0	no	no	yes
6988	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	3	7	Stable	No	No			No	0	17.22	0	no	no	no
6989	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	35	16.7	Stable	No	Yes or Unknown	Signature.13	CHEK2	No	0	17.35	0	no	no	no
6990	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	6	7.9	Stable	No	No	Signature.1		Yes	0	17.54	0	no	no	no
6991	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	0.9	Stable	No	No			Yes	0	17.74	0	no	no	no
6992	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	25	2.6	Stable	No	No			No	0	12.68	0	no	no	no
6993	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	175	0.9	Stable	No	No			No	0	18.83	0	no	no	no
6994	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	0	3.5	Stable	No	No	Signature.3		No	0	17.05	0	no	no	no
6995	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	75	8.8	Stable	No	Yes or Unknown	Signature.13		No	0	18.83	0	no	no	no
6996	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2018	III	192	0.9	Stable	No	Yes or Unknown		CHEK2	No	0	16	0	no	no	no
6997	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	II	16	4.4	Stable	No	No			Yes	0	6.97	0	no	no	no
6998	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2018	IV	16	6.1	Stable	No	No	Signature.7		Yes	0	17.94	0	no	no	no
6999	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	II	14	4.4	Stable	No	No			No	0	15.9	0	no	no	no
7000	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	22	1.8	Stable	No	Yes or Unknown			Yes	0	14.36	0	no	no	no
7001	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	79	0.9	Stable	No	No			Yes	0	17.77	0	no	no	no
7002	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2018		0	3.5	Stable	No	No			Yes	0	16.99	0	no	no	no
7003	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	0	0.9	Stable	No	No			No	0	20.44	0	no	no	no
7004	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	1.8	Stable	No	No			No	0	13.5	0	no	no	no
7005	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	5.3	Stable	No	No		ARID1A	No	1	11.47	0	no	no	yes
7006	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	38	1.8	Stable	No	No		ARID1A	Yes	0	14	0	no	no	yes
7007	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	17.35	0	no	no	no
7008	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	III	53	14.9	Indeterminate	No	No	Signature.1	ARID1A	Yes	0	17.97	0	no	no	yes
7009	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	9	2.6	Stable	No	No	Signature.1	BRIP1	Yes	0	17.25	0	no	no	no
7010	Non-ICI treated	Never received ICI	16 - 20	Female	Head & Neck	2018		0	0.9	Stable	No	No			No	0	17.12	0	no	no	no
7011	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	6	10.5	Stable	No	No	Signature.4		Yes	0	16.95	0	no	no	no
7012	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	67	6.1	Stable	No	No		ARID1A | ATM	No	0	20.57	0	no	no	yes
7013	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2018	III	0	0	Stable	No	No			Yes	0	12.25	0	no	no	no
7014	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	104	67.6	Stable	No	No	Signature.4	ATR | ERCC2 | FANCA | PMS1 | RAD51C	No	0	9.99	0	no	no	no
7015	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ERCC3 | PMS2	Yes	0	20.47	0	no	no	no
7016	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	0	17.41	0	no	no	no
7017	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	III	40	1.8	Stable	No	No			No	1	10.41	0	no	no	no
7018	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	20	1.8	Stable	No	Yes or Unknown			No	0	15.44	0	no	no	no
7019	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		19	10.5	Stable	No	No			No	0	17.48	0	no	no	no
7020	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	6.1	Stable	No	No		ARID1A	No	1	6.18	0	no	no	yes
7021	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	177	1.8	Stable	No	Yes or Unknown			No	1	15.08	0	no	no	no
7022	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	330	5.3	Stable	No	Yes or Unknown	Signature.3	BRCA1 | TP53BP1	No	0	16.92	0	no	no	no
7023	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	0	4.4	Stable	No	No			No	0	14.36	0	no	no	no
7024	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			Yes	0	14.95	0	no	no	no
7025	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	7.85	0	no	no	no
7026	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	I	50	1.8	Stable	No	No			No	0	14.55	0	no	no	no
7027	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	IV	25	14	Stable	No	No	Signature.4	BLM | BRIP1 | ERCC4	No	0	17.61	0	no	no	no
7028	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	I	146	1.8	Stable	No	No			No	1	11.93	0	no	no	no
7029	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	53	4.4	Stable	No	No			Yes	0	15.34	0	no	no	no
7030	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	15	4.4	Stable	No	No			Yes	0	16.69	0	no	no	no
7031	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	62	1.8	Stable	No	No			Yes	0	11.79	0	no	no	no
7032	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2018	IV	0	5.3	Stable	No	No		ARID1A	Yes	0	17.71	0	no	no	yes
7033	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	40	8.8	Stable	No	No	Signature.8	ARID1A	Yes	0	10.45	0	no	no	yes
7034	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	69	0	Stable	No	No			Yes	0	14.46	0	no	no	no
7035	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	IV	7	2.6	Stable	No	No			No	0	17.81	0	no	no	no
7036	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		147	0	Stable	No	No			No	0	11.86	0	no	no	no
7037	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	67	6.1	Stable	No	No	Signature.3	ERCC2	Yes	0	16.43	0	no	no	no
7038	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	174	3.5	Stable	No	Yes or Unknown			No	0	17.25	0	no	no	no
7039	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	56	2.6	Stable	No	No			Yes	0	16	0	no	no	no
7040	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	0.9	Stable	No	No			No	0	14.82	0	no	no	no
7041	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	224	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	16.62	0	no	no	yes
7042	Non-ICI treated	Never received ICI	46 - 50	Female	Renal	2018	I	0	4.4	Stable	No	No			No	0	11.63	0	no	no	no
7043	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	102	0	Stable	No	No			No	0	19.75	0	no	no	no
7044	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	44	1.8	Stable	No	No			No	0	17.25	0	no	no	no
7045	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2018	IV	0	4.4	Stable	No	No	Signature.5	ARID1A | ATM	Yes	0	17.15	0	no	no	yes
7046	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2018	II	34	1.8	Stable	No	No		NBN	No	0	13.77	0	no	no	no
7047	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	199	1.8	Stable	No	Yes or Unknown			No	0	17.18	0	no	no	no
7048	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	20	14.9	Stable	No	No	Signature.13	ARID1A | MSH2	No	0	17.12	0	no	no	yes
7049	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	II	15	6.1	Stable	No	No	Signature.3		Yes	0	16.33	0	no	no	no
7050	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2018	III	216	7.9	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	10.38	0	no	no	yes
7051	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	IV	458	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	17.08	0	no	no	yes
7052	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	27	3.5	Stable	No	No			No	0	16.95	0	no	no	no
7053	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	21	5.3	Stable	No	No			No	0	13.01	0	no	no	no
7054	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	96	6.1	Stable	No	No	Signature.30	BRCA2	Yes	0	11.04	0	no	no	no
7055	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	24	4.4	Indeterminate	No	No	Signature.13		No	0	17.02	0	no	no	no
7056	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	III	0	4.4	Stable	No	No			No	0	17.25	0	no	no	no
7057	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	II	58	9.7	Stable	No	No	Signature.1	ERCC2	Yes	0	17.81	0	no	no	no
7058	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2018	III	0	3.5	Stable	No	No	Signature.8		No	0	16.33	0	no	no	no
7059	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	133	2.6	Stable	No	No		MUTYH	No	0	20.9	0	no	no	no
7060	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	I	36	3.5	Stable	No	No			Yes	0	17.02	0	no	no	no
7061	Non-ICI treated	Never received ICI	91 - 95	Female	Hepatobiliary	2018	III	28	4.4	Stable	No	Yes or Unknown			Yes	0	15.61	0	no	no	no
7062	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	II	47	11.4	Stable	No	No	Signature.4	BRCA2	Yes	0	14.62	0	no	no	no
7063	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	34	0.9	Stable	No	No			No	0	13.93	0	no	no	no
7064	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	16.59	0	no	no	no
7065	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	III	298	4.4	Stable	No	Yes or Unknown	Signature.5	BRCA1 | BRIP1	Yes	0	17.68	0	no	no	no
7066	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018		27	2.6	Stable	No	No			No	0	8.9	0	no	no	no
7067	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	15.77	0	no	no	no
7068	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	0	6.1	Stable	No	No			Yes	0	16.2	0	no	no	no
7069	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	4.24	0	no	no	no
7070	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	13.27	0	no	no	no
7071	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	20	3.5	Stable	No	No		ERCC2 | ERCC4	No	0	16.53	0	no	no	no
7072	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	31	0.9	Stable	No	No			No	0	16.53	0	no	no	no
7073	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	7.9	Stable	No	No			No	0	17.08	0	no	no	no
7074	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	116	6.1	Stable	No	Yes or Unknown			No	0	17.64	0	no	no	no
7075	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2018	II	15	0	Stable	No	No			No	0	16.69	0	no	no	no
7076	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	III	34	9.7	Stable	No	Yes or Unknown			No	0	15.84	0	no	no	no
7077	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	49	0.9	Stable	No	No			No	0	13.77	0	no	no	no
7078	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	14	3.5	Stable	No	No			Yes	0	17.22	0	no	no	no
7079	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	3	58.8	Unstable	No	No	Signature.6	ARID1A | MLH1 | MSH3 | MUTYH	Yes	0	15.97	0	mut-MMRd	mut-MMRd	yes
7080	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	26	3.5	Stable	No	No			Yes	0	16.92	0	no	no	no
7081	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	312	0.9	Stable	No	Yes or Unknown			No	0	17.18	0	no	no	no
7082	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2018	III	27	0.9	Stable	No	Yes or Unknown			No	0	16.26	0	no	no	no
7083	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	1	7.9	Stable	No	No	Signature.30		No	0	4.63	0	no	no	no
7084	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2018	IV	43	1.8	Stable	No	No			No	0	14.65	0	no	no	no
7085	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	0	31.6		No	No	Signature.4	ATM | FANCC	Yes	0	15.74	0	no	no	no
7086	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	33	5.3	Stable	No	No			No	0	18.37	0	no	no	no
7087	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	IV	31	1.8	Stable	No	No			Yes	0	16.66	0	no	no	no
7088	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	39	1.8	Stable	No	No			No	0	15.31	0	no	no	no
7089	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	30	1.8	Stable	No	No			No	0	13.9	0	no	no	no
7090	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	13	6.1	Stable	No	No	Signature.3		Yes	0	16.53	0	no	no	no
7091	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2018	IV	28	0	Stable	No	No			No	0	16.26	0	no	no	no
7092	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	72	1.8	Stable	No	Yes or Unknown			No	0	17.05	0	no	no	no
7093	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	46	302.8	Indeterminate	No	No	Signature.12	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | NTHL1 | PARP1 | PMS1 | RAD54L | SLX4 | XRCC2	No	0	11.96	0	no	no	yes
7094	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	III	0	0.9	Stable	No	No			Yes	0	17.48	0	no	no	no
7095	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	68	1.8	Stable	No	No		ARID1A	No	0	14.52	0	no	no	yes
7096	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2018	III	68	2.6	Stable	No	No			Yes	0	14.16	0	no	no	no
7097	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	27	0.9	Stable	No	No			Yes	0	16.89	0	no	no	no
7098	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	I	13	3.5	Stable	No	No			No	0	14.26	0	no	no	no
7099	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	0	9.7	Stable	No	No	Signature.1		Yes	0	16.79	0	no	no	no
7100	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	IV	7	1.8	Stable	No	No			No	0	16.72	0	no	no	no
7101	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2018	III	12	3.5	Stable	No	No	Signature.13	ATM	Yes	0	17.12	0	no	no	no
7102	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	1.8	Stable	No	No		BRIP1	No	0	16.53	0	no	no	no
7103	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	27	2.6	Stable	No	Yes or Unknown			No	0	15.77	0	no	no	no
7104	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2018	IV	20	2.6	Stable	No	No			Yes	0	2.1	0	no	no	no
7105	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	22	6.1	Stable	No	No	Signature.1		No	1	9.1	0	no	no	no
7106	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2018		8	1.8	Stable	No	No	Signature.19		No	0	2.27	0	no	no	no
7107	Non-ICI treated	Never received ICI	81 - 85	Male	Esophageal	2018	I	16	2.6	Stable	No	No	Signature.17		No	0	15.64	0	no	no	no
7108	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	7	2.6	Stable	No	No			No	0	16.53	0	no	no	no
7109	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	16	5.3	Stable	No	Yes or Unknown		FANCA	No	1	16.2	0	no	no	no
7110	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	179	0.9	Stable	No	No			Yes	0	19.25	0	no	no	no
7111	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	9.7	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	16.66	0	no	no	no
7112	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	11	7	Stable	No	No	Signature.12	SLX4	No	0	16.79	0	no	no	no
7113	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	0	16.59	0	no	no	no
7114	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		21	0.9	Stable	No	No			No	0	15.44	0	no	no	no
7115	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	18	2.6	Stable	No	No			No	1	14.52	0	no	no	no
7116	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	II	64	4.4	Stable	No	No			Yes	0	16.99	0	no	no	no
7117	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	0	1.8	Stable	No	No			No	0	15.57	0	no	no	no
7118	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	57	1.8	Stable	No	No			No	0	15.47	0	no	no	no
7119	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	IV	20	4.4	Stable	No	No			No	0	16.82	0	no	no	no
7120	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	6.1	Stable	No	No			No	0	15.9	0	no	no	no
7121	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	37	6.1	Stable	No	No	Signature.1		No	1	16	0	no	no	no
7122	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	0	8.8	Stable	No	No	Signature.4		Yes	0	13.8	0	no	no	no
7123	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	7	3.5	Stable	No	No			No	0	16.62	0	no	no	no
7124	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	6	5.3	Stable	No	No	Signature.2		No	0	14.69	0	no	no	no
7125	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	0	5.3	Stable	No	No	Signature.2	FANCA	No	0	14.55	0	no	no	no
7126	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	0	0	Stable	No	Yes or Unknown			No	0	18.17	0	no	no	no
7127	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018	IV	45	0	Stable	No	No			No	0	16.3	0	no	no	no
7128	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	17	3.5	Stable	No	No			No	0	16.69	0	no	no	no
7129	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	14	0.9	Stable	No	No			No	1	14.42	0	no	no	no
7130	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2018	IV	127	1.8	Stable	No	Yes or Unknown			No	1	11.7	0	no	no	no
7131	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	22	6.1	Stable	No	No	Signature.1	ATM	No	1	14.75	0	no	no	no
7132	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.13		Yes	0	16.43	0	no	no	no
7133	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	II	209	4.4	Stable	No	Yes or Unknown			No	0	10.32	0	no	no	no
7134	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	I	0	7.9	Stable	No	No			No	0	16.16	0	no	no	no
7135	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	29	0	Stable	No	No			Yes	0	16.26	0	no	no	no
7136	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	29	1.8	Stable	No	No			No	0	16.89	0	no	no	no
7137	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018		0	0.9	Stable	No	No			No	1	4.67	0	no	no	no
7138	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		1	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	14.46	0	no	no	no
7139	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	9.7	Stable	No	Yes or Unknown	Signature.6		No	0	17.25	0	no	no	no
7140	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	II	0	93	Stable	No	No	Signature.7	ARID1A | ATR | MDC1 | MRE11A | SLX4	No	0	16.59	0	no	no	yes
7141	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		1	4.4	Stable	Yes or Unknown	Yes or Unknown		ATR	No	0	16.69	0	no	no	no
7142	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2018		0	0	Stable	No	No			No	0	9.49	0	no	no	no
7143	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	16	4.4	Stable	No	No		ERCC2	Yes	1	3.58	0	no	no	no
7144	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2018	I	77	1.8	Stable	No	No		BLM	No	0	12.65	0	no	no	no
7145	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018		0	1.8	Stable	No	No			No	1	0.26	0	no	no	no
7146	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	III	6	2.6	Stable	No	No		MUTYH	No	0	14.46	0	no	no	no
7147	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	0	7	Stable	No	No	Signature.1		No	0	16.07	0	no	no	no
7148	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	II	0	0.9	Stable	No	No			Yes	0	14.49	0	no	no	no
7149	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.5	ERCC5	No	1	1.71	0	no	no	no
7150	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	29	2.6	Stable	No	No			Yes	0	16.13	0	no	no	no
7151	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	6	1.8	Stable	No	Yes or Unknown		BRIP1	No	0	15.9	0	no	no	no
7152	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	III	23	1.8	Stable	No	No			No	1	10.09	0	no	no	no
7153	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	0	4.4	Stable	No	No			No	0	15.47	0	no	no	no
7154	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	39	1.8	Stable	No	No			No	0	15.44	0	no	no	no
7155	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	2	7.9	Stable	No	No	Signature.1	ARID1A | MDC1	Yes	1	6.41	0	no	no	yes
7156	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	I	4	5.3	Stable	No	No			No	0	15.21	0	no	no	no
7157	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	126	3.5	Stable	No	Yes or Unknown		BRCA2 | CHEK2	No	1	11.73	0	no	no	no
7158	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	11	4.4	Stable	No	No			No	1	10.94	0	no	no	no
7159	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	III	0	3.5	Stable	No	No			No	0	13.37	0	no	no	no
7160	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	21	2.6	Stable	No	No	Signature.5		No	0	16.89	0	no	no	no
7161	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	49	4.4	Stable	No	No	Signature.6		Yes	0	16.99	0	no	no	no
7162	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	IV	20	3.5	Stable	No	No	Signature.1		No	1	12.62	0	no	no	no
7163	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	II	0	1.8	Stable	No	No			Yes	0	13.7	0	no	no	no
7164	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		0	1.8	Stable	No	No			Yes	1	8.87	0	no	no	no
7165	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	77	3.5	Stable	No	No		NBN	Yes	0	17.38	0	no	no	no
7166	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	38	21.1	Stable	No	No	Signature.4	ATR	Yes	0	13.17	0	no	no	no
7167	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		39	0	Stable	No	No			No	0	16.33	0	no	no	no
7168	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	218	0		No	Yes or Unknown			No	0	16.23	0	no	no	no
7169	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	III	13	7.9	Stable	No	No	Signature.20	BRCA2 | MSH6	No	0	16	0	no	no	no
7170	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	21	0.9	Stable	No	No			No	0	16.03	0	no	no	no
7171	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	58	1.8	Stable	No	Yes or Unknown			No	0	15.61	0	no	no	no
7172	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	1	5.68	0	no	no	no
7173	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	27	1.8	Stable	No	No			No	0	12.68	0	no	no	no
7174	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	III	0	14	Stable	No	No	Signature.9	ATM	No	0	16.33	0	no	no	no
7175	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	22	0.9	Stable	No	No			Yes	0	15.64	0	no	no	no
7176	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	106	7.9	Stable	No	Yes or Unknown	Signature.13		No	1	9.99	0	no	no	no
7177	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	5.3	Stable	No	Yes or Unknown			Yes	0	14.26	0	no	no	no
7178	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2018	II	13	228.2	Stable	No	No	Signature.9	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | MDC1 | MLH1 | MSH2 | MSH6 | NBN | PALB2 | PMS1 | RAD50 | RAD54L | TP53BP1 | XRCC2	Yes	0	14.16	0	no	no	yes
7179	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2018	II	94	9.7	Stable	No	Yes or Unknown	Signature.17		Yes	0	16.03	0	no	no	no
7180	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	I	279	0.9	Stable	No	Yes or Unknown			Yes	0	12.81	0	no	no	no
7181	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	68	4.4	Stable	No	No			Yes	0	16.39	0	no	no	no
7182	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	28	2.6	Stable	No	No		MSH6	No	0	13.93	0	no	no	no
7183	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	16	0	no	no	no
7184	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	4.4	Stable	No	No	Signature.1	ATM	No	0	16.16	0	no	no	no
7185	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2018	IV	19	7	Stable	No	No			Yes	1	1.77	0	no	no	no
7186	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	27	20.2	Stable	No	No	Signature.4	SLX4	No	0	9.56	0	no	no	no
7187	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	Yes or Unknown	Signature.1		No	0	16.69	0	no	no	no
7188	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	27	1.8	Stable	No	No			No	0	17.41	0	no	no	no
7189	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	2.6	Stable	No	No		ATM	No	0	18.17	0	no	no	no
7190	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	24	5.3	Stable	No	No	Signature.1	FANCC | MUTYH | SLX4	Yes	0	12.42	0	no	no	no
7191	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	138	2.6	Stable	No	No			No	0	17.97	0	no	no	no
7192	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	27	3.5	Stable	No	No			No	0	14.13	0	no	no	no
7193	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	III	66	3.5	Stable	No	No		NBN	Yes	0	15.61	0	no	no	no
7194	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	11	10.5	Stable	No	No	Signature.1	TP53BP1	No	0	14.36	0	no	no	no
7195	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	309	4.4	Stable	No	No			No	0	23.95	0	no	no	no
7196	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	35	3.5	Stable	No	No			No	0	13.54	0	no	no	no
7197	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	34	2.6	Stable	No	Yes or Unknown			No	0	16.3	0	no	no	no
7198	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	IV	134	1.8	Stable	No	Yes or Unknown			No	0	16.16	0	no	no	no
7199	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	300	0	Stable	No	No			No	0	15.84	0	no	no	no
7200	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	52	6.1	Stable	No	No			No	0	14.95	0	no	no	no
7201	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	I	35	3.5	Stable	No	No			No	0	8.11	0	no	no	no
7202	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	225	8.8	Stable	No	No	Signature.1		No	0	14.13	0	no	no	no
7203	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	III	31	2.6	Stable	No	No			No	0	13.77	0	no	no	no
7204	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	15.41	0	no	no	no
7205	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	11	6.1	Stable	No	No			Yes	1	0.89	0	no	no	no
7206	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	I	362	7	Stable	No	No	Signature.1		No	0	21.39	0	no	no	no
7207	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	92	4.4	Stable	No	No		ATM	No	0	16.3	0	no	no	no
7208	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	II	15	0	Stable	No	No			Yes	0	15.51	0	no	no	no
7209	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	5.3	Stable	No	No			No	0	15.15	0	no	no	no
7210	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	211	2.6	Stable	No	Yes or Unknown		SLX4	No	0	16.2	0	no	no	no
7211	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	II	59	42.1	Unstable	No	No	Signature.26	ARID1A | ATR | BRIP1 | MDC1 | MRE11A | NTHL1 | PALB2 | PMS2 | TP53BP1	No	0	15.08	0	mut-MMRd	mut-MMRd	yes
7212	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	3	1.8	Stable	No	Yes or Unknown			No	0	17.94	0	no	no	no
7213	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	I	51	7	Stable	No	No			No	0	13.83	0	no	no	no
7214	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	60	3.5	Stable	No	No	Signature.4		No	0	10.58	0	no	no	no
7215	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	0	0.9	Stable	No	No			No	0	8.34	0	no	no	no
7216	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	25	0.9	Stable	No	No			Yes	0	13.83	0	no	no	no
7217	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	II	8	5.3	Stable	No	No	Signature.1		Yes	0	15.64	0	no	no	no
7218	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	4.4	Stable	No	No			No	0	15.01	0	no	no	no
7219	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2018	IV	13	2.6	Stable	No	No			No	1	9.89	0	no	no	no
7220	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	52	3.5	Stable	No	Yes or Unknown			Yes	0	15.47	0	no	no	no
7221	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	16.82	0	no	no	no
7222	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.1		No	0	16.3	0	no	no	no
7223	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1		Yes	0	16.76	0	no	no	no
7224	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	37	3.5	Stable	No	Yes or Unknown		ARID1A	No	0	15.18	0	no	no	yes
7225	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	186	2.6	Stable	No	No		ARID1A	No	0	20.53	0	no	no	yes
7226	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		7	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	23.79	0	no	no	no
7227	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	I	21	4.4	Stable	No	No			No	1	12.71	0	no	no	no
7228	Non-ICI treated	Never received ICI	31 - 35	Female	Cutaneous Melanoma 	2018	III	39	18.4	Stable	No	No	Signature.7	ARID1A	No	0	13.7	0	no	no	yes
7229	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	53	6.1	Stable	No	No			Yes	1	4.93	0	no	no	no
7230	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018	IV	0	0.9	Stable	No	No			No	0	15.87	0	no	no	no
7231	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	IV	6	7	Stable	No	No	Signature.4		Yes	1	10.25	0	no	no	no
7232	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	I	16	0.9	Stable	No	No			No	0	13.57	0	no	no	no
7233	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	21	5.3	Stable	No	No		ARID1A	Yes	0	13.14	0	no	no	yes
7234	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2018	IV	26	4.4	Stable	No	Yes or Unknown			No	1	13.04	0	no	no	no
7235	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	36	40.4	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MRE11A | SLX4	No	0	14.03	0	other-MMRd	mut-MMRd	yes
7236	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	7	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	15.67	0	no	no	no
7237	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	43	2.6	Stable	No	Yes or Unknown			No	0	16.43	0	no	no	no
7238	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	21	6.1	Stable	No	No			No	0	15.9	0	no	no	no
7239	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	0	1.8	Stable	No	No			No	0	12.94	0	no	no	no
7240	Non-ICI treated	Never received ICI	41 - 45	Male	Esophageal	2018	I	8	2.6	Stable	No	No			No	0	13.37	0	no	no	no
7241	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	III	0	4.4	Stable	No	No			No	0	16.49	0	no	no	no
7242	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	III	0	60.6	Unstable	No	Yes or Unknown	Signature.1	ERCC2 | MSH2 | SLX4 | XRCC2	Yes	0	13.14	0	mut-MMRd	mut-MMRd	no
7243	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	I	0	0.9	Stable	No	No			Yes	0	14.72	0	no	no	no
7244	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	19	32.5	Stable	No	No	Signature.2	MDC1	Yes	0	13.5	0	no	no	no
7245	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	422	2.6	Stable	No	Yes or Unknown			No	0	18.69	0	no	no	no
7246	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	3	8.8	Stable	No	No			Yes	0	15.74	0	no	no	no
7247	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	3	8.8	Stable	No	No		BRCA1	No	0	11.3	0	no	no	no
7248	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	47	34.2	Stable	No	Yes or Unknown	Signature.6	ARID1A | BRCA2 | ERCC2 | MLH1 | MSH6	Yes	0	18.07	0	no	no	yes
7249	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	III	22	94.8	Unstable	No	Yes or Unknown	Signature.6	ATM | ATR | BLM | BRCA1 | ERCC4 | FANCC | MRE11A | MSH3 | MSH6 | PALB2 | SLX4 | TP53BP1	Yes	0	13.37	0	mut-MMRd	mut-MMRd	no
7250	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.1	ATM	No	0	19.32	0	no	no	no
7251	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		0	0.9	Stable	No	No			Yes	0	13.7	0	no	no	no
7252	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2018	I	56	0	Stable	No	No			No	0	15.77	0	no	no	no
7253	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	22	0.9	Stable	No	Yes or Unknown			Yes	1	4.11	0	no	no	no
7254	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		No	0	16.2	0	no	no	no
7255	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	II	0	1.8	Stable	No	No			Yes	0	14.52	0	no	no	no
7256	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	41	5.3	Stable	No	Yes or Unknown		ATM | ATR	No	0	16.39	0	no	no	no
7257	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	30	19.3	Stable	No	No	Signature.2	ARID1A | ATR | FANCA | MSH6	Yes	0	15.38	0	no	no	yes
7258	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	11.4	Stable	No	No	Signature.4	BRCA2 | MRE11A | SLX4	Yes	0	7.43	0	no	no	no
7259	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	312	5.3	Stable	No	No			No	0	22.7	0	no	no	no
7260	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	0	15.84	0	no	no	no
7261	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	51	38.6	Unstable	No	No	Signature.6	ARID1A | MLH1 | PMS2 | SLX4	No	0	16.23	0	mut-MMRd	mut-MMRd	yes
7262	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		4	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.35	0	no	no	no
7263	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		6	0	Stable	No	No			No	0	14.88	0	no	no	no
7264	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2018	I	61	9.7	Stable	No	No	Signature.5	RAD51C | TP53BP1	No	0	15.51	0	no	no	no
7265	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	15.08	0	no	no	no
7266	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	77	5.3	Stable	No	No			No	0	16.33	0	no	no	no
7267	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	53	4.4	Stable	No	No			No	0	17.97	0	no	no	no
7268	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	46	9.7	Stable	No	No	Signature.1		No	0	15.9	0	no	no	no
7269	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	13	4.4	Stable	No	No	Signature.1	BRCA1	No	0	16.1	0	no	no	no
7270	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	5.3	Stable	No	No			Yes	0	15.47	0	no	no	no
7271	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2018	III	42	2.6	Stable	No	No			Yes	0	14.49	0	no	no	no
7272	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	0	42.1	Indeterminate	No	No	Signature.1	ARID1A | ERCC2 | ERCC5 | MSH6	No	0	11.53	0	no	no	yes
7273	Non-ICI treated	Never received ICI	41 - 45	Female	Esophageal	2018	III	0	1.8	Stable	No	No			No	0	15.11	0	no	no	no
7274	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	III	0	0.9	Stable	No	No			No	0	14.26	0	no	no	no
7275	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	0	1.8	Stable	No	No		MDC1	Yes	0	15.87	0	no	no	no
7276	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	20	0.9	Stable	No	No			No	0	13.31	0	no	no	no
7277	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	2	3.5	Stable	No	No		ARID1A	No	1	9.59	0	no	no	yes
7278	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	0	5.3	Stable	No	No		CHEK2	No	0	15.84	0	no	no	no
7279	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018		36	3.5	Stable	No	No	Signature.2		No	0	15.34	0	no	no	no
7280	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	IV	62	6.1	Stable	No	Yes or Unknown	Signature.16	RAD50	No	0	14.13	0	no	no	no
7281	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	14	0.9	Stable	No	No			Yes	0	11.79	0	no	no	no
7282	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	14	4.4	Stable	No	No	Signature.4	ATM | TP53BP1	No	1	1.58	0	no	no	no
7283	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	180	2.6	Stable	No	Yes or Unknown			Yes	0	12.29	0	no	no	no
7284	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	31	3.5	Stable	No	Yes or Unknown			Yes	0	11.83	0	no	no	no
7285	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	36	4.4	Stable	No	No			No	0	15.18	0	no	no	no
7286	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.29		No	0	15.51	0	no	no	no
7287	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	18	3.5	Stable	No	No	Signature.4		No	0	11.37	0	no	no	no
7288	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	0.9	Stable	No	No	Signature.13		No	0	14.59	0	no	no	no
7289	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	56	3.5	Stable	No	Yes or Unknown			Yes	0	15.64	0	no	no	no
7290	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	15.15	0	no	no	no
7291	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	138	4.4	Stable	No	Yes or Unknown			No	0	7.16	0	no	no	no
7292	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	20	6.1	Stable	No	No			No	0	15.61	0	no	no	no
7293	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	8	4.4	Stable	No	No			No	0	15.41	0	no	no	no
7294	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	II	22	5.3	Stable	No	No		BRCA1	Yes	0	15.11	0	no	no	no
7295	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	6.1	Stable	No	No			Yes	0	14.36	0	no	no	no
7296	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	IV	78	2.6	Stable	No	No			No	0	15.34	0	no	no	no
7297	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	0	14	Stable	No	No	Signature.3	ARID1A | ERCC5 | PMS1	No	0	12.68	0	no	no	yes
7298	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2018		54	2.6	Stable	No	No			No	0	13.83	0	no	no	no
7299	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	IV	25	6.1	Stable	No	No	Signature.1	ARID1A	No	0	15.87	0	no	no	yes
7300	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	7	Stable	No	No	Signature.13	ATM | BRCA1 | MLH1 | PALB2	No	0	15.18	0	no	no	no
7301	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	0	Stable	No	No			No	0	15.9	0	no	no	no
7302	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	77	7	Stable	No	Yes or Unknown	Signature.13		No	0	14.59	0	no	no	no
7303	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	21	4.4	Stable	No	No		BLM	Yes	0	13.31	0	no	no	no
7304	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	IV	1	11.4	Stable	No	No	Signature.2		Yes	0	6.44	0	no	no	no
7305	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	II	10	14.9	Stable	No	No	Signature.18	MUTYH	No	0	12.22	0	no	no	no
7306	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	33	4.4	Stable	No	No	Signature.4	BRCA2	No	0	4.7	0	no	no	no
7307	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	36	1.8	Stable	No	Yes or Unknown			No	1	8.38	0	no	no	no
7308	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	0	10.5	Stable	No	No	Signature.1	ARID1A	No	0	14.75	0	no	no	yes
7309	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	4	3.5	Stable	No	Yes or Unknown		FANCC	Yes	0	15.11	0	no	no	no
7310	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	III	17	12.3	Stable	No	No	Signature.1	ARID1A	No	0	15.28	0	no	no	yes
7311	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	32	2.6	Stable	No	No			Yes	0	13.67	0	no	no	no
7312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	271	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	17.84	0	no	no	no
7313	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	23	4.4	Stable	No	No	Signature.25	ATR	No	0	14.59	0	no	no	no
7314	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	II	11	3.5	Stable	No	No			Yes	0	15.38	0	no	no	no
7315	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2018	IV	156	0.9	Stable	No	No			No	0	6.47	0	no	no	no
7316	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	14.62	0	no	no	no
7317	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	12.22	0	no	no	no
7318	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	15.15	0	no	no	no
7319	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	III	111	0	Stable	No	Yes or Unknown			No	0	11.93	0	no	no	no
7320	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	15	3.5	Stable	No	No			Yes	0	14.92	0	no	no	no
7321	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	36	6.1	Stable	No	No	Signature.1		No	0	15.97	0	no	no	no
7322	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	18	1.8	Stable	No	No	Signature.13		No	0	12.19	0	no	no	no
7323	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	0	2.6	Stable	No	No			No	1	15.38	0	no	no	no
7324	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	13.57	0	no	no	no
7325	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	14	5.3	Stable	No	No	Signature.1		Yes	1	4.86	0	no	no	no
7326	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	4.24	0	no	no	no
7327	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	III	0	5.3	Stable	No	No			Yes	0	14.03	0	no	no	no
7328	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2018	I	17	6.1	Stable	No	No			No	0	13.11	0	no	no	no
7329	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	IV	90	3.5	Stable	No	Yes or Unknown			Yes	0	15.41	0	no	no	no
7330	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	151	2.6	Stable	No	No			No	0	14.95	0	no	no	no
7331	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018	IV	2	1.8	Stable	No	No			No	0	13.57	0	no	no	no
7332	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	147	0.9	Stable	No	Yes or Unknown			No	0	13.57	0	no	no	no
7333	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	53	0.9	Stable	No	No			Yes	0	14.29	0	no	no	no
7334	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	II	35	5.3	Stable	No	No			Yes	0	10.35	0	no	no	no
7335	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2018	IV	36	1.8	Stable	No	No		ERCC5	Yes	0	10.38	0	no	no	no
7336	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	31	7	Stable	No	No	Signature.5	BRCA2	Yes	0	7.29	0	no	no	no
7337	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	IV	0	1.8	Stable	No	No			Yes	1	2.53	0	no	no	no
7338	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	30	6.1	Stable	No	No			No	0	13.37	0	no	no	no
7339	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	20	0	Stable	No	No			No	0	13.63	0	no	no	no
7340	Non-ICI treated	Never received ICI	91 - 95	Female	Breast	2018	IV	0	4.4	Stable	No	No			No	0	14.29	0	no	no	no
7341	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	18	5.3	Stable	No	No			No	0	16.56	0	no	no	no
7342	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	14.03	0	no	no	no
7343	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2018	III	117	7	Stable	No	No	Signature.17	MDC1	No	0	10.55	0	no	no	no
7344	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	41	1.8	Stable	No	No		MSH3	No	0	12.29	0	no	no	no
7345	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	17	3.5	Stable	No	No	Signature.1		Yes	0	15.18	0	no	no	no
7346	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	16	7.9	Stable	No	No	Signature.24	ATM | MRE11A	No	0	13.8	0	no	no	no
7347	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	III	0	1.8	Stable	No	Yes or Unknown			No	0	14.62	0	no	no	no
7348	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018		0	4.4	Stable	No	No	Signature.2		No	0	15.74	0	no	no	no
7349	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	15.77	0	no	no	no
7350	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	15.87	0	no	no	no
7351	Non-ICI treated	Never received ICI	46 - 50	Female	Bladder	2017	II	0	4.4	Stable	No	No			No	0	14.52	0	no	no	no
7352	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2018	IV	0	6.1	Stable	No	No			Yes	0	16.53	0	no	no	no
7353	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	I	19	1.8	Stable	No	Yes or Unknown		ATM	Yes	0	13.63	0	no	no	no
7354	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	15.87	0	no	no	no
7355	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	III	2	1.8	Stable	No	No	Signature.1	MSH3	No	0	11.07	0	no	no	no
7356	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	0	8.8	Stable	No	No	Signature.1		Yes	0	12.85	0	no	no	no
7357	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	2	7	Stable	No	No			Yes	0	14.82	0	no	no	no
7358	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	III	34	66.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | CHEK2 | ERCC2 | MDC1 | MLH1 | MSH3	Yes	0	10.05	0	mut-MMRd	mut-MMRd	yes
7359	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	148	1.8	Stable	No	No			Yes	0	15.41	0	no	no	no
7360	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2018	I	315	8.8	Stable	No	Yes or Unknown	Signature.2		Yes	0	18.3	0	no	no	no
7361	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	28	3.5	Stable	No	No	Signature.1		No	0	15.21	0	no	no	no
7362	Non-ICI treated	Never received ICI	76 - 80	Female	Cutaneous Melanoma 	2018	III	27	5.3	Stable	No	No	Signature.7		No	0	14.19	0	no	no	no
7363	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	1	11.47	0	no	no	no
7364	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	27	4.4	Stable	No	No			Yes	0	14.69	0	no	no	no
7365	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	52	6.1	Stable	No	No		ARID1A	No	0	15.74	0	no	no	yes
7366	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	22	26.3	Unstable	No	No	Signature.6	ARID1A | ATR	No	0	11.56	0	other-MMRd	mut-MMRd	yes
7367	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	25	14	Stable	No	No	Signature.1		No	0	15.51	0	no	no	no
7368	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	52	12.3	Stable	No	No	Signature.1		No	0	14.06	0	no	no	no
7369	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		38	4.4	Stable	No	No	Signature.1		No	0	13.83	0	no	no	no
7370	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	No			Yes	0	15.7	0	no	no	no
7371	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1		No	0	15.87	0	no	no	no
7372	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	1.8	Stable	No	No			No	0	14.42	0	no	no	no
7373	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		10	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	15.15	0	no	no	no
7374	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	2.6	Stable	No	Yes or Unknown			No	0	14.06	0	no	no	no
7375	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	62	8.8	Stable	No	No	Signature.4		Yes	0	13.37	0	no	no	no
7376	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	82	2.6	Stable	No	No		ARID1A	No	0	15.38	0	no	no	yes
7377	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	35	2.6	Stable	No	No			No	0	14.49	0	no	no	no
7378	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	72	2.6	Stable	No	No			Yes	0	14.06	0	no	no	no
7379	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2018	III	139	16.7	Stable	No	Yes or Unknown	Signature.4	CHEK2 | PMS2 | TP53BP1	No	0	14.88	0	no	no	no
7380	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	153	7.9	Stable	No	Yes or Unknown	Signature.6		No	0	18.66	0	no	no	no
7381	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018		0	7	Stable	No	No	Signature.7	ATM | MDC1	No	0	9.63	0	no	no	no
7382	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	19	7.9	Stable	No	No	Signature.1	ATM	No	0	8.97	0	no	no	no
7383	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	48	2.6	Stable	No	No		ARID1A	No	0	14.98	0	no	no	yes
7384	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	85	1.8	Stable	No	No			No	0	16.53	0	no	no	no
7385	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	0	3.5	Stable	No	No		SLX4	Yes	0	14	0	no	no	no
7386	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	3	5.3	Stable	No	No		BRCA2	No	0	14.59	0	no	no	no
7387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	110	2.6	Stable	No	No		ATM	No	0	10.71	0	no	no	no
7388	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	42	0.9	Stable	No	No		FANCA	No	0	10.35	0	no	no	no
7389	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	33	1.8	Stable	No	No		BRCA2	No	0	15.31	0	no	no	no
7390	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	42	9.7	Stable	No	Yes or Unknown	Signature.13	ATR | BRCA2 | RAD51	No	0	14.06	0	no	no	no
7391	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	15.77	0	no	no	no
7392	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	27	7.9	Stable	No	No	Signature.6	ATM	Yes	0	14.42	0	no	no	no
7393	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	23	3.5	Stable	No	No			Yes	0	14.03	0	no	no	no
7394	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	0	Stable	No	No			No	0	15.28	0	no	no	no
7395	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	I	44	2.6	Stable	No	No			No	0	12.65	0	no	no	no
7396	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2018	IV	4	3.5	Stable	No	No			Yes	1	5.39	0	no	no	no
7397	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	2	5.3	Stable	No	No	Signature.1		Yes	0	8.11	0	no	no	no
7398	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	24	5.3	Stable	No	Yes or Unknown	Signature.13		Yes	0	13.37	0	no	no	no
7399	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	II	55	0.9	Stable	No	No			Yes	0	9.63	0	no	no	no
7400	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	0	15.8	Stable	No	No	Signature.13	ARID1A	Yes	0	13.8	0	no	no	yes
7401	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	61	7.9	Stable	No	No	Signature.1		No	0	13.11	0	no	no	no
7402	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	212	1.8	Stable	No	Yes or Unknown			No	0	14.39	0	no	no	no
7403	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	11	6.1	Stable	No	No	Signature.4	BLM	No	0	13.11	0	no	no	no
7404	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	1.8	Stable	No	Yes or Unknown			No	0	14.03	0	no	no	no
7405	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	2	2.6	Stable	No	No			Yes	0	14.72	0	no	no	no
7406	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	8	14	Stable	No	No	Signature.15	ATM	No	0	14.72	0	no	no	no
7407	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	II	0	11.4	Stable	No	No	Signature.4		Yes	0	10.74	0	no	no	no
7408	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	76.4	Unstable	No	No	Signature.6	BRIP1 | ERCC4 | FANCA | PMS2	No	0	15.7	0	mut-MMRd	mut-MMRd	no
7409	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	15.34	0	no	no	no
7410	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	22	0.9	Stable	No	No			No	0	14.52	0	no	no	no
7411	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	II	187	1.8	Stable	No	No			No	0	17.58	0	no	no	no
7412	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	12	3.5	Stable	No	Yes or Unknown			Yes	0	14	0	no	no	no
7413	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	3.5	Stable	No	No			No	0	14.72	0	no	no	no
7414	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	III	174	1.8	Stable	No	Yes or Unknown			No	0	14.69	0	no	no	no
7415	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	III	33	1.8	Stable	No	No			Yes	0	15.38	0	no	no	no
7416	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	149	3.5	Stable	No	Yes or Unknown			Yes	0	7	0	no	no	no
7417	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	47	3.5	Stable	No	No	Signature.8		No	0	2.3	0	no	no	no
7418	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2018	II	21	2.6	Stable	No	No		ARID1A	Yes	0	13.11	0	no	no	yes
7419	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	15.15	0	no	no	no
7420	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	16	3.5	Stable	No	No			Yes	0	15.67	0	no	no	no
7421	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	II	46	2.6	Stable	No	No			No	0	14.19	0	no	no	no
7422	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	2.6	Stable	No	No			No	0	15.51	0	no	no	no
7423	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	24	5.3	Stable	No	No			No	0	11.27	0	no	no	no
7424	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2018	II	32	42.1	Unstable	No	No	Signature.15	ARID1A | BRCA2 | BRIP1 | CHEK2 | FANCA | MRE11A | NTHL1 | SLX4	Yes	0	14.16	0	other-MMRd	mut-MMRd	yes
7425	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	0	Stable	No	No			Yes	0	11.93	0	no	no	no
7426	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	0	11.4	Stable	No	No	Signature.1	ATM	Yes	0	13.4	0	no	no	no
7427	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	I	245	0	Stable	No	Yes or Unknown			No	0	14.72	0	no	no	no
7428	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	0	3.5		No	No			No	0	11.3	0	no	no	no
7429	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	327	2.6	Stable	No	Yes or Unknown			No	0	14.49	0	no	no	no
7430	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	182	2.6	Stable	No	No			No	0	18.17	0	no	no	no
7431	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	15.8	Stable	No	No	Signature.4	BLM | ERCC3	No	0	13.01	0	no	no	no
7432	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	II	250	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	13.31	0	no	no	no
7433	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	6.1	Stable	No	No		PMS2	No	0	15.18	0	no	no	no
7434	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	57	6.1	Stable	No	No	Signature.4	NBN	Yes	0	13.9	0	no	no	no
7435	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	II	25	6.1	Stable	No	No			No	0	12.98	0	no	no	no
7436	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	74	7.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	11.99	0	no	no	yes
7437	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2018	IV	20	1.8	Stable	No	No		BLM	No	0	14.59	0	no	no	no
7438	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018	III	1	4.4	Stable	No	No			No	0	13.73	0	no	no	no
7439	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	II	170	5.3	Stable	No	Yes or Unknown		PMS2 | SLX4	No	0	14.42	0	no	no	no
7440	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	I	22	6.1	Stable	No	No	Signature.3	ERCC5	No	0	14.52	0	no	no	no
7441	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	27	5.3	Stable	No	No			Yes	0	14.88	0	no	no	no
7442	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	3	1.8	Stable	No	No			No	1	6.6	0	no	no	no
7443	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	43	10.5		No	No	Signature.3	BRCA1	No	0	14.26	0	no	no	no
7444	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	9	1.8	Stable	No	No		ARID1A	No	0	15.61	0	no	no	yes
7445	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	32	1.8	Stable	No	No			No	0	10.68	0	no	no	no
7446	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	IV	43	3.5	Stable	No	No			No	1	13.77	0	no	no	no
7447	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2018		20	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	14.75	0	no	no	no
7448	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		0	7	Stable	No	No			Yes	1	12.55	0	no	no	no
7449	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	0	28.1		No	No	Signature.5	BRCA1 | BRCA2 | FANCA | RAD54L | TP53BP1	No	0	4.47	0	no	no	no
7450	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	9	1.8	Stable	No	No			Yes	0	11.93	0	no	no	no
7451	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	2	3.5	Stable	No	No			No	0	15.21	0	no	no	no
7452	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	I	449	0	Stable	No	Yes or Unknown			No	0	18.14	0	no	no	no
7453	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	II	16	7	Stable	No	No	Signature.4		Yes	1	9.89	0	no	no	no
7454	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		0	0.9	Stable	No	No			No	0	14.69	0	no	no	no
7455	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	33	13.2	Stable	No	No	Signature.24	BRCA1 | MLH1	Yes	0	9.66	0	no	no	no
7456	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	55	8.8	Stable	No	No			No	0	13.11	0	no	no	no
7457	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	23	0.9	Stable	No	No			No	0	14.92	0	no	no	no
7458	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	I	5	8.8	Stable	No	No	Signature.1		Yes	0	12.42	0	no	no	no
7459	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2018	III	22	6.1	Stable	No	No			Yes	0	14.49	0	no	no	no
7460	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	1.8	Stable	No	No		ATM	No	0	14.03	0	no	no	no
7461	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	103	25.5	Stable	No	Yes or Unknown	Signature.4		Yes	0	13.14	0	no	no	no
7462	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018	III	4	0.9	Stable	No	No			Yes	0	13.8	0	no	no	no
7463	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	15	8.8	Stable	No	No	Signature.1		No	0	13.93	0	no	no	no
7464	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2018	II	0	1.8	Stable	No	No			Yes	0	13.83	0	no	no	no
7465	Non-ICI treated	Never received ICI	86 - 90	Female	Bladder	2018	IV	0	5.3	Stable	No	No	Signature.2	ATM | BRCA1	Yes	1	4.07	0	no	no	no
7466	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2018	II	26	8.8	Stable	No	No			No	0	14.03	0	no	no	no
7467	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	21	0	Stable	No	No			No	0	12.19	0	no	no	no
7468	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	I	292	2.6	Stable	No	Yes or Unknown			No	0	16.76	0	no	no	no
7469	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	II	0	0	Stable	No	No			No	0	15.67	0	no	no	no
7470	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	III	54	5.3	Stable	No	No			Yes	0	14.65	0	no	no	no
7471	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2018		3	10.5	Stable	No	No	Signature.13	RAD50	No	0	8.38	0	no	no	no
7472	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	0	3.5	Stable	No	No		ARID1A | ATM	Yes	0	12.42	0	no	no	yes
7473	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	21	7.9	Stable	No	No	Signature.4	RAD50	No	0	12.45	0	no	no	no
7474	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	6.14	0	no	no	no
7475	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		5	5.3	Stable	No	No	Signature.23	ATM | CHEK2	No	0	11.53	0	no	no	no
7476	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	23	0.9	Stable	No	No			Yes	0	14.32	0	no	no	no
7477	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2018	IV	3	5.3	Stable	No	No			Yes	0	5.16	0	no	no	no
7478	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	I	21	3.5	Stable	No	No			No	0	13.96	0	no	no	no
7479	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	II	17	2.6	Stable	No	No			Yes	0	13.8	0	no	no	no
7480	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	275	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	14.62	0	no	no	no
7481	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	IV	0	5.3	Stable	No	No	Signature.26		No	0	2.1	0	no	no	no
7482	Non-ICI treated	Never received ICI	21 - 25	Male	Head & Neck	2018	IV	36	6.1	Stable	No	No			Yes	0	13.57	0	no	no	no
7483	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	10	10.5	Stable	No	No	Signature.3	BRCA2 | CHEK2 | ERCC4	Yes	0	12.71	0	no	no	no
7484	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	10	22.8	Stable	No	No	Signature.4	ATM | BRIP1 | ERCC4	No	1	1.54	0	no	no	no
7485	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	13.14	0	no	no	no
7486	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	III	0	1.8	Stable	No	No			Yes	0	13.73	0	no	no	no
7487	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	5	6.1	Stable	No	No			No	0	17.51	0	no	no	no
7488	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	70	0.9	Stable	No	No			No	0	14.46	0	no	no	no
7489	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	31	3.5	Stable	No	No			Yes	0	12.62	0	no	no	no
7490	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	9.76	0	no	no	no
7491	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	0	1.8	Stable	No	Yes or Unknown			Yes	1	6.93	0	no	no	no
7492	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	IV	5	7.9	Stable	No	No		ARID1A	Yes	0	13.77	0	no	no	yes
7493	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	0	22.8	Stable	No	No	Signature.4	CHEK1 | MRE11A | PALB2 | TP53BP1	Yes	0	13.24	0	no	no	no
7494	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	32	10.5	Indeterminate	No	No	Signature.3	FANCC	No	0	14	0	no	no	no
7495	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	45	0.9	Stable	No	Yes or Unknown			No	0	13.37	0	no	no	no
7496	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2018	IV	200	3.5	Stable	No	No			Yes	1	13.44	0	no	no	no
7497	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	21	8.8	Stable	No	No	Signature.1	ARID1A	No	0	14.06	0	no	no	yes
7498	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2018	IV	19	2.6	Stable	No	No			No	0	15.31	0	no	no	no
7499	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	II	56	1.8	Stable	No	No			No	0	6.47	0	no	no	no
7500	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	9	3.5	Stable	No	No		ATM	Yes	0	14.55	0	no	no	no
7501	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	13.04	0	no	no	no
7502	Non-ICI treated	Never received ICI	36 - 40	Male	Bladder	2018	II	17	7.9	Stable	No	No	Signature.13	BRIP1	Yes	0	13.6	0	no	no	no
7503	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	42	10.5	Stable	No	No	Signature.1		Yes	0	12.91	0	no	no	no
7504	Non-ICI treated	Never received ICI	0 - 5	Male	Hepatobiliary	2018		1	1.8	Stable	No	No			Yes	0	13.27	0	no	no	no
7505	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	70	0		No	No			Yes	0	15.97	0	no	no	no
7506	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	8.8	Stable	No	No	Signature.13		No	1	6.74	0	no	no	no
7507	Non-ICI treated	Never received ICI	91 - 95	Male	Gastric	2018	III	0	0	Stable	No	Yes or Unknown			No	0	13.4	0	no	no	no
7508	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	1.8	Stable	No	No			Yes	0	12.78	0	no	no	no
7509	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	59	3.5	Stable	No	No		BRCA2	No	0	15.08	0	no	no	no
7510	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	IV	2	4.4	Stable	No	No			No	0	14.49	0	no	no	no
7511	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	37	0.9	Stable	No	Yes or Unknown			No	0	15.38	0	no	no	no
7512	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	0	0.9	Stable	No	No			No	0	14.09	0	no	no	no
7513	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2018	IV	27	3.5	Stable	No	No		ARID1A	No	0	4.5	0	no	no	yes
7514	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	31	5.3	Stable	No	No		ARID1A	Yes	0	14.42	0	no	no	yes
7515	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		2	2.6	Stable	Yes or Unknown	Yes or Unknown		FANCA	No	0	17.12	0	no	no	no
7516	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	I	0	4.4	Stable	No	No			No	0	9.23	0	no	no	no
7517	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	5	6.1	Stable	No	No	Signature.6	FANCA	No	1	12.32	0	no	no	no
7518	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	48	9.7	Stable	No	No	Signature.1	TP53BP1	No	0	14.23	0	no	no	no
7519	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2018		14	0	Stable	No	No			No	0	12.45	0	no	no	no
7520	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2018	IV	0	4.4	Stable	No	No			Yes	0	12.65	0	no	no	no
7521	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	III	161	0	Stable	No	No			No	0	6.08	0	no	no	no
7522	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	IV	0	4.4	Stable	No	No		MSH2	Yes	1	5.59	0	no	no	no
7523	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	130	3.5	Stable	No	No			No	0	16.95	0	no	no	no
7524	Non-ICI treated	Never received ICI	21 - 25	Female	Hepatobiliary	2018	IV	20	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	10.55	0	no	no	yes
7525	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	5.3	Stable	No	No		BRCA1	No	0	13.77	0	no	no	no
7526	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2018		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.38	0	no	no	no
7527	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	15	12.3	Stable	No	No	Signature.30	BRCA2	Yes	0	12.88	0	no	no	no
7528	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	9	3.5	Stable	No	Yes or Unknown			Yes	0	13.24	0	no	no	no
7529	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	III	2	5.3	Stable	No	No	Signature.1		No	0	12.94	0	no	no	no
7530	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	3.5	Stable	No	No			No	0	11.99	0	no	no	no
7531	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	III	0	2.6	Stable	No	No			No	0	13.21	0	no	no	no
7532	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	II	14	1.8	Stable	No	No			No	0	14.16	0	no	no	no
7533	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	0	9.7	Stable	No	No	Signature.1	ATR	No	0	15.15	0	no	no	no
7534	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	57	0.9	Stable	No	No			No	0	12.94	0	no	no	no
7535	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	12	78.1	Unstable	No	No	Signature.6	BLM | MLH1 | MSH3 | SLX4	Yes	0	4.4	0	mut-MMRd	mut-MMRd	no
7536	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018		0	0	Stable	No	No			Yes	0	13.37	0	no	no	no
7537	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	0	7	Stable	No	No		ATM	Yes	0	12.39	0	no	no	no
7538	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	22	7.9	Stable	No	No		ARID1A	No	0	14.49	0	no	no	yes
7539	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.52	0	no	no	no
7540	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	182.6	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA2 | BRIP1 | CHEK1 | ERCC5 | MDC1 | MSH6 | PMS1 | PMS2 | RAD50 | RAD51C | TP53BP1 | XRCC2	No	0	12.22	0	no	no	yes
7541	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			No	0	13.77	0	no	no	no
7542	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2018	IV	86	6.1	Stable	No	No			Yes	0	13.5	0	no	no	no
7543	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018	I	0	0	Stable	No	No			No	0	12.71	0	no	no	no
7544	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	2.6	Stable	No	No		PALB2	No	0	14.39	0	no	no	no
7545	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			Yes	0	13.14	0	no	no	no
7546	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	83	8.8	Stable	No	No	Signature.10		No	1	4.3	0	no	no	no
7547	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2018		141	8.8	Stable	No	No	Signature.15	ARID1A	No	0	12.65	0	no	no	yes
7548	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	I	182	11.4	Stable	No	Yes or Unknown	Signature.2		Yes	0	13.27	0	no	no	no
7549	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	91	1.8	Stable	No	Yes or Unknown			Yes	0	13.34	0	no	no	no
7550	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	I	0	5.3	Stable	No	No			No	0	13.17	0	no	no	no
7551	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2018		37	0	Stable	No	No			No	0	13.14	0	no	no	no
7552	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2018	IV	109	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	14.03	0	no	no	no
7553	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	13.14	0	no	no	no
7554	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	7	6.1	Stable	No	Yes or Unknown	Signature.1	BRCA2	No	0	14.23	0	no	no	no
7555	Non-ICI treated	Never received ICI	26 - 30	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			No	0	13.63	0	no	no	no
7556	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	38	8.8	Stable	No	No	Signature.2		Yes	0	13.21	0	no	no	no
7557	Non-ICI treated	Never received ICI	21 - 25	Male	Esophageal	2018	IV	29	0.9	Stable	No	No			No	0	13.14	0	no	no	no
7558	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	1	11.63	0	no	no	no
7559	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	153	1.8	Stable	No	Yes or Unknown			No	0	13.11	0	no	no	no
7560	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	0.9	Stable	No	Yes or Unknown			No	0	14.19	0	no	no	no
7561	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	59	1.8	Stable	No	No			No	0	8.84	0	no	no	no
7562	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018	III	149	0.9	Stable	No	Yes or Unknown			No	0	13.47	0	no	no	no
7563	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	71	2.6	Stable	No	No			No	0	15.01	0	no	no	no
7564	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	I	20	1.8	Stable	No	No			No	0	12.48	0	no	no	no
7565	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	204	0	Stable	No	Yes or Unknown			Yes	0	10.81	0	no	no	no
7566	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	II	36	10.5	Stable	No	No	Signature.4		Yes	0	13.96	0	no	no	no
7567	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	37	2.6	Stable	No	No			Yes	0	14.42	0	no	no	no
7568	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	0	2.6	Stable	No	No	Signature.26	ERCC3	No	0	11.89	0	no	no	no
7569	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	8	8.8	Stable	No	No	Signature.1		No	0	13.4	0	no	no	no
7570	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	28	7.9	Stable	No	No	Signature.1	ATM	No	0	13.08	0	no	no	no
7571	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		6	1.8	Stable	No	No			No	0	7.69	0	no	no	no
7572	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			Yes	0	11.99	0	no	no	no
7573	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	13.73	0	no	no	no
7574	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	40	0.9	Stable	No	No			Yes	0	13.6	0	no	no	no
7575	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	III	30	7	Stable	No	No	Signature.7	MDC1	Yes	0	14.23	0	no	no	no
7576	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	28	2.6	Stable	No	No		ERCC5	No	0	13.67	0	no	no	no
7577	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	IV	0	52.7	Stable	No	No	Signature.7	BRCA2 | BRIP1 | MSH6 | PALB2	No	0	11.43	0	no	no	no
7578	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	I	100	59.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | MRE11A | MSH2 | MSH3 | NBN | RAD50	Yes	0	13.8	0	mut-MMRd	mut-MMRd	yes
7579	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	58	4.4	Stable	No	No			Yes	0	12.02	0	no	no	no
7580	Non-ICI treated	Never received ICI	71 - 75	Female	Renal	2018	I	0	5.3	Stable	No	No		RAD50 | RAD51C	No	0	11.93	0	no	no	no
7581	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	I	103	0.9	Stable	No	No			No	0	6.93	0	no	no	no
7582	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	0	3.5	Stable	No	No			Yes	1	11.01	0	no	no	no
7583	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	24	7	Stable	No	No	Signature.1		Yes	0	13.9	0	no	no	no
7584	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	72	0.9	Stable	No	No			No	0	9.23	0	no	no	no
7585	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	177	16.7	Stable	No	No	Signature.4	ARID1A	No	0	8.02	0	no	no	yes
7586	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	97	6.1	Stable	No	No			No	0	13.34	0	no	no	no
7587	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	0	5.3	Stable	No	No	Signature.4		Yes	0	11.89	0	no	no	no
7588	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	48	6.1	Stable	No	No			No	0	14.03	0	no	no	no
7589	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	0	11.4	Stable	No	No	Signature.1	ARID1A	No	0	13.83	0	no	no	yes
7590	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	33	5.3	Stable	No	No			Yes	0	10.97	0	no	no	no
7591	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	0	2.6	Stable	No	No			No	1	13.01	0	no	no	no
7592	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1	SLX4	No	1	2.33	0	no	no	no
7593	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2018	III	0	2.6	Stable	No	No			No	1	10.91	0	no	no	no
7594	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	12	5.3	Stable	No	No	Signature.16		No	0	12.71	0	no	no	no
7595	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	III	27	31.6	Unstable	No	No	Signature.20	ARID1A | BLM | ERCC3 | ERCC5 | MRE11A | MSH3 | MSH6	No	0	13.8	0	mut-MMRd	mut-MMRd	yes
7596	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	12.29	0	no	no	no
7597	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2018	III	142	0	Stable	No	Yes or Unknown			No	0	13.14	0	no	no	no
7598	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	26	4.4	Stable	No	No	Signature.1	ERCC5	No	0	13.37	0	no	no	no
7599	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	28	3.5	Stable	No	No		ATM	No	0	14.06	0	no	no	no
7600	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	90	6.1	Stable	No	No			Yes	0	12.65	0	no	no	no
7601	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		0	3.5	Stable	No	No	Signature.26		Yes	0	13.54	0	no	no	no
7602	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	19	0.9	Stable	No	No			No	0	11.17	0	no	no	no
7603	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2018	I	0	4.4	Stable	No	No	Signature.6	BRCA2 | FANCA	Yes	0	14.85	0	no	no	no
7604	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	15	5.3	Stable	No	No	Signature.1		Yes	0	4.67	0	no	no	no
7605	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	14	3.5	Stable	No	No			No	1	6.64	0	no	no	no
7606	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2018	III	223	0	Stable	No	Yes or Unknown			No	0	12.12	0	no	no	no
7607	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	II	155	0	Stable	No	Yes or Unknown			No	0	13.86	0	no	no	no
7608	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		9	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	13.54	0	no	no	no
7609	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	125	1.8	Stable	No	No			Yes	0	15.05	0	no	no	no
7610	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	1	12.75	0	no	no	no
7611	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	14.65	0	no	no	no
7612	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	IV	0	6.1	Stable	No	No	Signature.3		No	1	11.76	0	no	no	no
7613	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	0.9	Stable	No	No			No	0	12.85	0	no	no	no
7614	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	92	0	Stable	No	Yes or Unknown		MRE11A	No	0	15.01	0	no	no	no
7615	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	0	2.6	Stable	No	No			No	0	12.94	0	no	no	no
7616	Non-ICI treated	Never received ICI	91 - 95	Female	Breast	2018	II	0	0.9	Stable	No	No			Yes	0	11.1	0	no	no	no
7617	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	III	0	5.3	Stable	No	No			No	1	7.16	0	no	no	no
7618	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	17	3.5	Stable	No	No			Yes	0	13.37	0	no	no	no
7619	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	1.8	Stable	No	No			Yes	0	14.03	0	no	no	no
7620	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	34	4.4	Stable	No	Yes or Unknown			Yes	0	14.13	0	no	no	no
7621	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2018	IV	196	3.5	Stable	No	Yes or Unknown			No	1	13.31	0	no	no	no
7622	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	32	11.4	Stable	No	No	Signature.24		Yes	0	9.63	0	no	no	no
7623	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	Yes or Unknown	Signature.2		No	0	14.42	0	no	no	no
7624	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	III	172	0		No	Yes or Unknown			Yes	0	12.29	0	no	no	no
7625	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	III	20	1.8	Stable	No	No		MSH3	No	0	12.91	0	no	no	no
7626	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2018		3	0.9	Indeterminate	No	No			No	0	13.73	0	no	no	no
7627	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	4.4	Stable	No	No	Signature.3		No	0	13.11	0	no	no	no
7628	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	19	4.4	Stable	No	No			Yes	0	14	0	no	no	no
7629	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	No			No	0	9.69	0	no	no	no
7630	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	273	1.8	Stable	No	No			Yes	0	14.03	0	no	no	no
7631	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	233	0	Stable	No	Yes or Unknown			Yes	0	14.03	0	no	no	no
7632	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	223	0	Stable	No	No			No	0	12.71	0	no	no	no
7633	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	20	5.3	Stable	No	No	Signature.24		No	0	13.57	0	no	no	no
7634	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	No			Yes	0	13.73	0	no	no	no
7635	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	56	1.8	Stable	No	No		NTHL1	No	0	13.93	0	no	no	no
7636	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	1	1.91	0	no	no	no
7637	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	32	1.8	Stable	No	No			No	0	13.14	0	no	no	no
7638	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	0.9	Stable	No	No		PMS1	No	0	9.69	0	no	no	no
7639	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	12.42	0	no	no	no
7640	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	3.5	Stable	No	No			Yes	1	4.11	0	no	no	no
7641	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	5.3	Stable	No	No			No	0	13.7	0	no	no	no
7642	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	III	18	2.6	Stable	No	No			Yes	0	8.31	0	no	no	no
7643	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	0	3.5	Stable	No	No			No	0	14.03	0	no	no	no
7644	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	112	1.8	Stable	No	Yes or Unknown			No	0	13.54	0	no	no	no
7645	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	0	4.4	Stable	No	No	Signature.5		Yes	0	5.22	0	no	no	no
7646	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	0	5.3	Stable	No	No			Yes	0	5.29	0	no	no	no
7647	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	13.14	0	no	no	no
7648	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	27	11.4	Stable	No	Yes or Unknown	Signature.4		No	1	5.55	0	no	no	no
7649	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.14		No	0	13.86	0	no	no	no
7650	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	111	20.2	Stable	No	No	Signature.2	PMS2	No	0	14.52	0	no	no	no
7651	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2018	III	0	8.8	Stable	No	No	Signature.16		Yes	0	11.07	0	no	no	no
7652	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	0	3.5	Stable	No	No			Yes	0	13.17	0	no	no	no
7653	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	3	3.5	Stable	No	No		SLX4	Yes	1	2.14	0	no	no	no
7654	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	3	8.8	Stable	No	No	Signature.17	MDC1	Yes	0	7.92	0	no	no	no
7655	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	35	1.8	Stable	No	Yes or Unknown		MUTYH	No	0	13.57	0	no	no	no
7656	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	48	5.3	Stable	No	No			No	0	11.73	0	no	no	no
7657	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2018		0	6.1	Stable	No	No			Yes	1	12.32	0	no	no	no
7658	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	6	3.5	Stable	No	No			Yes	0	13.54	0	no	no	no
7659	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		108	1.8	Stable	No	No			No	0	14.39	0	no	no	no
7660	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	3	0.9	Stable	No	Yes or Unknown		ERCC2	No	0	11.07	0	no	no	no
7661	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	2	2.6	Stable	No	No		ARID1A	No	1	5.42	0	no	no	yes
7662	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2018	IV	19	7	Stable	No	No	Signature.4		No	0	9.92	0	no	no	no
7663	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	II	58	8.8	Stable	No	No	Signature.4	MSH2	Yes	0	9.95	0	no	no	no
7664	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	2.33	0	no	no	no
7665	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	16	6.1	Stable	No	No	Signature.13		Yes	0	12.48	0	no	no	no
7666	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	1.8	Stable	No	Yes or Unknown			No	0	15.84	0	no	no	no
7667	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	17	2.6	Stable	No	No	Signature.1		Yes	0	12.19	0	no	no	no
7668	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	5.3	Stable	No	No	Signature.28		No	0	12.62	0	no	no	no
7669	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	12.75	0	no	no	no
7670	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	0	1.8	Stable	No	Yes or Unknown			No	0	13.4	0	no	no	no
7671	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	48	3.5	Indeterminate	No	No			No	0	14.26	0	no	no	no
7672	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2018	I	303	5.3	Stable	No	No			No	0	11.24	0	no	no	no
7673	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2018	I	49	0		No	No			No	1	4.37	0	no	no	no
7674	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	0	3.5	Stable	No	No			No	0	12.29	0	no	no	no
7675	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	0	7	Stable	No	No	Signature.1	FANCA	No	0	13.77	0	no	no	no
7676	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	85	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	7.85	0	no	no	yes
7677	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	0	Stable	No	No			No	0	12.22	0	no	no	no
7678	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	49	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA2 | CHEK2	No	0	11.76	0	no	no	no
7679	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	31	5.3	Stable	No	No			No	0	13.63	0	no	no	no
7680	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		1	3.5	Stable	No	No			No	0	11.1	0	no	no	no
7681	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	7	4.4	Stable	No	No			No	0	13.08	0	no	no	no
7682	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	III	27	6.1	Stable	No	No	Signature.2		No	0	15.7	0	no	no	no
7683	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018		0	0		No	No			No	0	12.71	0	no	no	no
7684	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	III	11	1.8	Stable	No	No			No	0	13.11	0	no	no	no
7685	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	16	2.6	Stable	No	No		BRCA2	Yes	0	13.21	0	no	no	no
7686	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	5.3	Stable	No	Yes or Unknown		SLX4	No	0	11.76	0	no	no	no
7687	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	IV	0	7.9	Stable	No	No	Signature.1		Yes	1	10.55	0	no	no	no
7688	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	I	47	4.4	Stable	No	No			No	0	2.66	0	no	no	no
7689	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	II	14	2.6	Stable	No	No			No	0	2.27	0	no	no	no
7690	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	95	1.8	Stable	No	No			No	0	12.65	0	no	no	no
7691	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	8	7	Stable	No	No		ATM	No	0	12.65	0	no	no	no
7692	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	15	0	Stable	No	No			No	0	12.25	0	no	no	no
7693	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	0	5.3	Stable	No	No			No	0	13.31	0	no	no	no
7694	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	0	3.5	Stable	No	No			No	0	1.97	0	no	no	no
7695	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	0	5.3	Stable	No	No			No	1	3.81	0	no	no	no
7696	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	0	7	Stable	No	Yes or Unknown		MSH6	Yes	0	14.03	0	no	no	no
7697	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	0.9	Stable	No	No			No	0	13.77	0	no	no	no
7698	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	337	1.8	Stable	No	Yes or Unknown			Yes	0	13.44	0	no	no	no
7699	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	20	3.5	Stable	No	No			Yes	1	12.88	0	no	no	no
7700	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	0	1.8	Stable	No	No			Yes	0	11.86	0	no	no	no
7701	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	20	9.7	Stable	No	No	Signature.4		Yes	0	11.99	0	no	no	no
7702	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	166	1.8	Stable	No	Yes or Unknown			No	0	13.08	0	no	no	no
7703	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	4	0	Stable	No	Yes or Unknown			No	0	14.26	0	no	no	no
7704	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	7.9	Stable	No	Yes or Unknown	Signature.13	BRCA2 | PMS2	No	1	13.8	0	no	no	no
7705	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2018	IV	2	7.9	Stable	No	No	Signature.4		Yes	0	11.89	0	no	no	no
7706	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	46	60.6	Stable	No	No	Signature.4	ARID1A | ATM | ATR | BRCA1 | MDC1 | MLH1 | PARP1	Yes	0	10.51	0	no	no	yes
7707	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	18	5.3	Stable	No	No			Yes	0	12.19	0	no	no	no
7708	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	0	7	Stable	No	No		MRE11A	No	0	13.14	0	no	no	no
7709	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		15	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	13.08	0	no	no	no
7710	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	I	28	0	Stable	No	No			No	0	7.79	0	no	no	no
7711	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2018	II	232	7	Stable	No	Yes or Unknown	Signature.10		Yes	0	13.54	0	no	no	no
7712	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	16	9.7	Stable	No	No	Signature.1	ARID1A	No	1	9.63	0	no	no	yes
7713	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	4.4	Stable	No	No			No	0	12.58	0	no	no	no
7714	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	II	17	20.2	Stable	No	No	Signature.4	ERCC5	Yes	0	9.03	0	no	no	no
7715	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	66	3.5	Stable	No	No			No	0	14.72	0	no	no	no
7716	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		47	0.9	Stable	No	No			No	0	2.04	0	no	no	no
7717	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	8	6.1	Stable	No	No			No	1	8.97	0	no	no	no
7718	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	I	11	0	Stable	No	No			No	0	6.41	0	no	no	no
7719	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	23	18.4	Stable	No	No	Signature.2		No	0	11.6	0	no	no	no
7720	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	0	12.91	0	no	no	no
7721	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	2.6	Stable	No	No		ATM	No	0	14.32	0	no	no	no
7722	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	23	5.3	Stable	No	No			No	0	12.94	0	no	no	no
7723	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	14	5.3	Stable	No	No	Signature.1	MSH3	Yes	0	12.09	0	no	no	no
7724	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	IV	13	4.4	Stable	No	No		RAD50	Yes	0	12.65	0	no	no	no
7725	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	60	0.9	Stable	No	No			No	0	13.5	0	no	no	no
7726	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	42	0.9	Stable	No	Yes or Unknown			No	0	12.48	0	no	no	no
7727	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	44	1.8	Stable	No	Yes or Unknown		ATM	No	0	13.8	0	no	no	no
7728	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	108	10.5	Stable	No	No	Signature.5		Yes	1	7.69	0	no	no	no
7729	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	43	3.5	Stable	No	No			Yes	0	13.34	0	no	no	no
7730	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	6	5.3	Stable	No	Yes or Unknown		ERCC3	Yes	0	4.73	0	no	no	no
7731	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	I	6	2.6	Stable	No	No			No	0	10.61	0	no	no	no
7732	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	IV	13	4.4	Stable	No	No	Signature.2	RAD52	Yes	1	2.6	0	no	no	no
7733	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	III	0	6.1	Stable	No	No		ARID1A	Yes	0	11.96	0	no	no	yes
7734	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	46	0.9	Stable	No	No			Yes	1	9.3	0	no	no	no
7735	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	39	3.5	Stable	No	No			Yes	0	11.47	0	no	no	no
7736	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	13.9	0	no	no	no
7737	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2018	IV	8	2.6	Stable	No	No			No	0	12.88	0	no	no	no
7738	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	III	16	6.1	Stable	No	No			Yes	0	12.98	0	no	no	no
7739	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	21	1.8	Indeterminate	No	Yes or Unknown			No	0	13.77	0	no	no	no
7740	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	0	10.5	Stable	No	No	Signature.1	MSH2 | MUTYH	No	1	11.1	0	no	no	no
7741	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	74	2.6	Stable	No	No			No	0	11.53	0	no	no	no
7742	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	0	2.6	Stable	No	No			No	0	13.44	0	no	no	no
7743	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	267	0.9	Stable	No	Yes or Unknown			No	0	13.77	0	no	no	no
7744	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	43	2.6	Stable	No	No			Yes	0	11.33	0	no	no	no
7745	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2018	I	38	20.2	Stable	No	No	Signature.2	ATM | ATR | BRCA1	No	0	9	0	no	no	no
7746	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	IV	140	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	12.55	0	no	no	yes
7747	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	0	6.1	Stable	No	No		CHEK2	No	0	13.5	0	no	no	no
7748	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	90	0	Stable	No	Yes or Unknown			Yes	0	9.92	0	no	no	no
7749	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	27	0	Stable	No	Yes or Unknown			No	0	12.81	0	no	no	no
7750	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	IV	0	9.7	Stable	No	No	Signature.1		No	0	13.01	0	no	no	no
7751	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	3	14	Stable	No	No	Signature.13	MLH1 | RAD50	No	1	2.89	0	no	no	no
7752	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	179	1.8	Stable	No	Yes or Unknown		ARID1A	No	0	11.86	0	no	no	yes
7753	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	2.6	Stable	No	No		ARID1A | ATM	No	0	10.97	0	no	no	yes
7754	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	27	1.8	Stable	No	No			No	0	12.45	0	no	no	no
7755	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		45	0		No	No			No	0	12.39	0	no	no	no
7756	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	28	2.6	Stable	No	No			Yes	0	12.78	0	no	no	no
7757	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	29	1.8	Stable	No	No			No	0	11.5	0	no	no	no
7758	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	12.45	0	no	no	no
7759	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2018	III	0	4.4	Stable	No	No		ARID1A	Yes	0	13.37	0	no	no	yes
7760	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	244	4.4	Stable	No	Yes or Unknown			No	0	21.36	0	no	no	no
7761	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		25	4.4		No	No	Signature.1		No	0	9.76	0	no	no	no
7762	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	I	0	25.5	Stable	No	No	Signature.4	BRIP1	No	0	11.99	0	no	no	no
7763	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018		5	0.9	Stable	No	No			No	0	12.39	0	no	no	no
7764	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	IV	0	3.5	Stable	No	No			Yes	0	10.84	0	no	no	no
7765	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	161	4.4	Stable	No	Yes or Unknown			No	0	14.23	0	no	no	no
7766	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2018	I	0	15.8	Stable	No	No	Signature.4	ARID1A | ATR | PALB2	Yes	0	13.63	0	no	no	yes
7767	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		3	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	11.63	0	no	no	no
7768	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	287	0.9	Stable	No	Yes or Unknown			No	0	12.68	0	no	no	no
7769	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	29	1.8	Stable	No	No			No	0	13.04	0	no	no	no
7770	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2018	I	0	3.5	Stable	No	No			No	1	7.03	0	no	no	no
7771	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	260	4.4	Stable	No	Yes or Unknown			No	0	13.9	0	no	no	no
7772	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	IV	17	5.3	Stable	No	No			Yes	1	2.99	0	no	no	no
7773	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	13	1.8	Stable	No	No		ATM	No	0	11.96	0	no	no	no
7774	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	103	4.4	Stable	No	Yes or Unknown			Yes	0	12.65	0	no	no	no
7775	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2018	III	187	3.5	Stable	No	No			No	0	10.78	0	no	no	no
7776	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2018	III	19	5.3	Stable	No	No	Signature.7		No	0	10.97	0	no	no	no
7777	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	I	42	1.8	Stable	No	No			No	0	13.21	0	no	no	no
7778	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	33	7	Stable	No	Yes or Unknown	Signature.1		No	0	13.21	0	no	no	no
7779	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	IV	0	11.4	Stable	No	No	Signature.1	ERCC2	Yes	0	12.42	0	no	no	no
7780	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	2.6	Stable	No	No			Yes	0	11.3	0	no	no	no
7781	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	0	3.5	Stable	No	No			No	0	12.42	0	no	no	no
7782	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	13	66.7	Stable	No	No	Signature.10	ATM | ATR | BRCA2 | ERCC5 | MSH2 | NBN | RAD54L	No	0	2.53	0	no	no	no
7783	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	177	14.9		No	Yes or Unknown	Signature.3	BRIP1	Yes	1	7.29	0	no	no	no
7784	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	13.17	0	no	no	no
7785	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	9	5.3	Stable	No	No			No	0	9.95	0	no	no	no
7786	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	I	141	0	Stable	No	Yes or Unknown			No	0	10.68	0	no	no	no
7787	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	50	2.6	Stable	No	No		CHEK1	No	0	8.84	0	no	no	no
7788	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	14	2.6	Stable	No	Yes or Unknown			No	0	9.59	0	no	no	no
7789	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	51	2.6	Stable	No	No			No	0	8.15	0	no	no	no
7790	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	II	26	1.8	Stable	No	No			No	0	5.88	0	no	no	no
7791	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		0	0	Stable	No	No			No	0	7.49	0	no	no	no
7792	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	I	31	8.8	Stable	No	No	Signature.1		No	0	11.07	0	no	no	no
7793	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	0	4.4	Stable	No	No			No	0	11.14	0	no	no	no
7794	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	0	10.5	Stable	No	No	Signature.2		No	0	12.32	0	no	no	no
7795	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	13	35.1	Unstable	No	No	Signature.6	ARID1A	Yes	0	9.89	0	other-MMRd	mut-MMRd	yes
7796	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	120	4.4	Stable	No	No			No	0	13.31	0	no	no	no
7797	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		2	2.6	Stable	No	No			No	0	12.29	0	no	no	no
7798	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	141	16.7	Stable	No	Yes or Unknown	Signature.29	MSH3	No	1	10.09	0	no	no	no
7799	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	III	24	2.6	Stable	No	No			No	0	12.42	0	no	no	no
7800	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	59	2.6	Stable	No	No			No	0	12.81	0	no	no	no
7801	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2018	II	35	1.8	Stable	No	No			Yes	0	10.68	0	no	no	no
7802	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	313	4.4	Stable	No	Yes or Unknown			No	0	12.42	0	no	no	no
7803	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	I	57	1.8	Stable	No	No			No	0	5.85	0	no	no	no
7804	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	6	9.7	Stable	No	No	Signature.1		No	0	12.42	0	no	no	no
7805	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	No			No	0	12.75	0	no	no	no
7806	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	33	7.9	Stable	No	No	Signature.1		No	1	12.12	0	no	no	no
7807	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			Yes	0	2.86	0	no	no	no
7808	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	III	161	0		No	Yes or Unknown			Yes	0	9.99	0	no	no	no
7809	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	II	36	6.1	Stable	No	No	Signature.1	ARID1A | ATM | MLH1	Yes	0	11.47	0	no	no	yes
7810	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	IV	7	5.3	Stable	No	No	Signature.13	MSH3 | MUTYH	No	1	8.74	0	no	no	no
7811	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	133	3.5	Stable	No	Yes or Unknown	Signature.3		Yes	0	12.35	0	no	no	no
7812	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	83	6.1	Stable	No	No			No	0	14.29	0	no	no	no
7813	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	5	0.9	Stable	No	No			No	0	6.18	0	no	no	no
7814	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		2	0	Stable	No	Yes or Unknown			No	0	12.58	0	no	no	no
7815	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	0	0		No	No			Yes	0	10.78	0	no	no	no
7816	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	65	1.8	Stable	No	No			No	0	12.35	0	no	no	no
7817	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2018	I	29	58.8	Unstable	No	No	Signature.6	ARID1A | ATR | MRE11A | MSH3 | RAD50 | SLX4	No	0	6.67	0	other-MMRd	mut-MMRd	yes
7818	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	28.1	Stable	No	No	Signature.4	MSH6	No	1	10.09	0	no	no	no
7819	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2018	IV	9	2.6	Stable	No	No			No	0	11.6	0	no	no	no
7820	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	I	0	0.9	Stable	No	No			Yes	0	14.72	0	no	no	no
7821	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	59	2.6	Stable	No	No			No	1	8.87	0	no	no	no
7822	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	2.6	Stable	No	No			No	1	9.56	0	no	no	no
7823	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	15	4.4	Stable	No	No	Signature.14		Yes	0	9.56	0	no	no	no
7824	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	III	0	11.4	Stable	No	No	Signature.24		Yes	1	4.37	0	no	no	no
7825	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2018	III	0	5.3	Stable	No	Yes or Unknown	Signature.3	PARP1	No	1	9.43	0	no	no	no
7826	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2018		0	0.9	Stable	No	No			Yes	0	16.33	0	no	no	no
7827	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	5.3	Stable	No	Yes or Unknown			Yes	1	13.4	0	no	no	no
7828	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	49	0	Stable	No	No			No	0	10.81	0	no	no	no
7829	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	0	0.9	Stable	No	Yes or Unknown			No	0	9.53	0	no	no	no
7830	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	10.64	0	no	no	no
7831	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2018	IV	0	3.5	Stable	No	No		ERCC3	Yes	0	12.45	0	no	no	no
7832	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	42	3.5	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	5.49	0	no	no	yes
7833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	65	1.8	Stable	No	No			No	0	10.12	0	no	no	no
7834	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	6	2.6	Stable	No	No			No	0	12.91	0	no	no	no
7835	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	249	0.9	Stable	No	Yes or Unknown			No	0	12.02	0	no	no	no
7836	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	0	18.83	0	no	no	no
7837	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	53	0.9	Stable	No	Yes or Unknown		MUTYH	No	0	12.32	0	no	no	no
7838	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	30	3.5	Stable	No	No			No	0	12.48	0	no	no	no
7839	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	14	3.5	Stable	No	No			Yes	1	1.45	0	no	no	no
7840	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	III	43	5.3	Stable	No	Yes or Unknown		PARP1	Yes	0	3.58	0	no	no	no
7841	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	I	27	4.4	Stable	No	Yes or Unknown			No	0	11.07	0	no	no	no
7842	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	25	256.3	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | MSH2 | MSH6 | MUTYH | RAD50 | RAD54L | TP53BP1 | XRCC2	No	0	10.45	0	no	no	yes
7843	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2018	I	38	7	Stable	No	No	Signature.1	MLH1	No	0	10.25	0	no	no	no
7844	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	27	1.8	Stable	No	No			No	0	12.52	0	no	no	no
7845	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	24	7.9	Stable	No	No	Signature.1	BRCA2	Yes	1	5.98	0	no	no	no
7846	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	IV	0	6.1	Stable	No	No			No	0	12.19	0	no	no	no
7847	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	0	1.8	Stable	No	No	Signature.20		Yes	0	11.53	0	no	no	no
7848	Non-ICI treated	Never received ICI	86 - 90	Female	Cutaneous Melanoma 	2018	IV	65	12.3	Stable	No	No	Signature.7	MSH3	Yes	0	12.42	0	no	no	no
7849	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	93	2.6	Stable	No	Yes or Unknown		FANCC	Yes	0	11.4	0	no	no	no
7850	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	223	0		No	Yes or Unknown			No	0	13.11	0	no	no	no
7851	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	III	49	7.9	Stable	No	No		ARID1A	No	0	10.05	0	no	no	yes
7852	Non-ICI treated	Never received ICI	51 - 55	Female	Esophageal	2018	III	0	8.8	Stable	No	No	Signature.17		No	1	8.08	0	no	no	no
7853	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	1	1.8	Stable	No	No			No	0	12.29	0	no	no	no
7854	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	14.72	0	no	no	no
7855	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	0	4.4	Stable	No	No			No	0	10.05	0	no	no	no
7856	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	0.9	Stable	No	No			No	0	11.63	0	no	no	no
7857	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	49	0	Stable	No	No			No	0	9.33	0	no	no	no
7858	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	12.19	0	no	no	no
7859	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2018	IV	11	7	Stable	No	No			No	0	12.29	0	no	no	no
7860	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2018	III	20	21.1	Stable	No	No	Signature.7	BLM	No	0	10.28	0	no	no	no
7861	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	74	0.9	Stable	No	No			No	0	11.93	0	no	no	no
7862	Non-ICI treated	Never received ICI	66 - 70	Female	Head & Neck	2018	IV	37	13.2	Stable	No	Yes or Unknown	Signature.4	MSH3	Yes	1	3.29	0	no	no	no
7863	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	4.4	Stable	No	No			Yes	0	11.04	0	no	no	no
7864	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	30	0.9	Stable	No	No			Yes	0	12.32	0	no	no	no
7865	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	13.44	0	no	no	no
7866	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	18	6.1	Stable	No	No			No	0	12.09	0	no	no	no
7867	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	7	5.3	Stable	No	No			Yes	1	9.43	0	no	no	no
7868	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	28	7	Stable	No	No			No	0	10.12	0	no	no	no
7869	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	97	0	Stable	No	No			No	0	11.89	0	no	no	no
7870	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	1.8	Stable	No	No			No	0	12.88	0	no	no	no
7871	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.3		Yes	0	12.35	0	no	no	no
7872	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2018	IV	51	4.4	Stable	No	No	Signature.13	BRCA1 | MSH6 | MUTYH	No	0	13.14	0	no	no	no
7873	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	IV	89	60.6	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | MLH1 | MRE11A | MSH2 | MSH3 | MSH6 | SLX4	Yes	1	3.94	0	mut-MMRd	mut-MMRd	yes
7874	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	8	0.9	Stable	No	Yes or Unknown			No	0	11.99	0	no	no	no
7875	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		0	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.25	0	no	no	no
7876	Non-ICI treated	Never received ICI	81 - 85	Male	Sarcoma	2018		70	7	Stable	No	No	Signature.11		No	0	13.37	0	no	no	no
7877	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	5.3	Stable	No	Yes or Unknown		SLX4	No	1	5.49	0	no	no	no
7878	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	57	14	Stable	No	No	Signature.13	PARP1	Yes	0	13.37	0	no	no	no
7879	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	IV	33	3.5	Stable	No	No			No	0	12.29	0	no	no	no
7880	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2018	III	26	0.9	Stable	No	No			Yes	0	11.89	0	no	no	no
7881	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	217	6.1	Stable	No	Yes or Unknown	Signature.3		Yes	0	12.29	0	no	no	no
7882	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	17	12.3	Stable	No	No	Signature.3	ARID1A | BRCA2	No	0	2.3	0	no	no	yes
7883	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	47	0	Stable	No	No			No	0	10.28	0	no	no	no
7884	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	57	10.5	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	11.76	0	no	no	yes
7885	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	29	6.1	Stable	No	No			Yes	0	11.66	0	no	no	no
7886	Non-ICI treated	Never received ICI	81 - 85	Male	Gastric	2018	II	13	4.4	Stable	No	No	Signature.15		Yes	0	11.47	0	no	no	no
7887	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	13	14	Stable	No	No	Signature.4	ARID1A	No	0	9.56	0	no	no	yes
7888	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	0	4.4	Stable	No	Yes or Unknown			No	0	8.77	0	no	no	no
7889	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	8	3.5	Stable	No	No			No	0	2.53	0	no	no	no
7890	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2018		83	0.9	Stable	No	No			Yes	0	5.98	0	no	no	no
7891	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	1.8	Stable	No	No			Yes	0	13.21	0	no	no	no
7892	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	18	10.5	Stable	No	No	Signature.1	CHEK2	No	0	11.93	0	no	no	no
7893	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	0	3.5	Stable	No	No		SLX4	No	0	11.96	0	no	no	no
7894	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	III	269	1.8	Stable	No	Yes or Unknown			No	0	9.2	0	no	no	no
7895	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	III	35	11.4	Stable	No	No	Signature.7		Yes	0	11.76	0	no	no	no
7896	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	0	8.8	Stable	No	No	Signature.1	BRIP1 | RAD51C	Yes	0	11.96	0	no	no	no
7897	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	0	4.4	Stable	No	Yes or Unknown			No	0	18.23	0	no	no	no
7898	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	18	7	Stable	No	Yes or Unknown			Yes	0	11.14	0	no	no	no
7899	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	II	24	5.3	Stable	No	No			Yes	0	11.53	0	no	no	no
7900	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	25	2.6	Stable	No	No			No	0	11.86	0	no	no	no
7901	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	44	7	Stable	No	No		ARID1A	No	0	7.82	0	no	no	yes
7902	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	III	12	3.5	Stable	No	Yes or Unknown			No	1	10.74	0	no	no	no
7903	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2018	II	33	47.4	Unstable	No	No	Signature.6	ARID1A | ERCC2 | MLH1 | MSH2	No	0	9.23	0	mut-MMRd	mut-MMRd	yes
7904	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2018	IV	0	2.6	Stable	No	No			No	0	10.58	0	no	no	no
7905	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	53	1.8	Stable	No	No			No	0	14.95	0	no	no	no
7906	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	III	0	13.2		No	No	Signature.5	BRCA1	Yes	0	7.33	0	no	no	no
7907	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	II	0	4.4	Stable	No	No			Yes	1	5.42	0	no	no	no
7908	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	19	3.5	Stable	No	No	Signature.1		No	0	12.85	0	no	no	no
7909	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	0	12.09	0	no	no	no
7910	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	13	3.5	Stable	No	No			No	0	11.27	0	no	no	no
7911	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		2	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	11.79	0	no	no	no
7912	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	0	0.9	Stable	No	No			Yes	0	8.15	0	no	no	no
7913	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	20	4.4	Stable	No	No		ERCC4	Yes	0	10.25	0	no	no	no
7914	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2018		1	3.5	Indeterminate	No	No			Yes	1	6.05	0	no	no	no
7915	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	II	7	5.3	Stable	No	No	Signature.15		No	0	11.73	0	no	no	no
7916	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	II	7	9.7	Stable	No	No			No	0	5.91	0	no	no	no
7917	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	19	5.3	Stable	No	No			No	1	9.86	0	no	no	no
7918	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	36	0.9	Stable	No	No			No	0	11.96	0	no	no	no
7919	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	1	2.6	Stable	No	No			No	1	11.43	0	no	no	no
7920	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2018	IV	120	20.2	Stable	No	No	Signature.4		Yes	0	9.46	0	no	no	no
7921	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	115	0.9	Stable	No	Yes or Unknown			Yes	0	10.87	0	no	no	no
7922	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	153	0.9	Stable	No	No			Yes	0	15.34	0	no	no	no
7923	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2018	IV	0	5.3	Stable	No	No	Signature.6		Yes	0	0.99	0	no	no	no
7924	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	18	1.8	Stable	No	No			Yes	0	5.19	0	no	no	no
7925	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	0.9	Stable	No	No			No	0	10.22	0	no	no	no
7926	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	6.37	0	no	no	no
7927	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	III	79	6.1	Stable	No	No		ATR	No	0	3.48	0	no	no	no
7928	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	28	6.1	Stable	No	No			No	1	2.2	0	no	no	no
7929	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	34	1.8	Stable	No	No		BRCA2	No	0	12.22	0	no	no	no
7930	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	16	68.5		No	No	Signature.15	ARID1A | BRCA2 | ERCC5 | MLH1 | MSH3	Yes	0	11.5	0	no	no	yes
7931	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	11.73	0	no	no	no
7932	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	II	0	15.8	Stable	No	No	Signature.2		Yes	0	8.51	0	no	no	no
7933	Non-ICI treated	Never received ICI	21 - 25	Female	Pancreatic	2018	IV	17	7.9	Stable	No	No	Signature.3	ARID1A	No	1	3.45	0	no	no	yes
7934	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2018	III	22	0	Stable	No	No			No	0	11.93	0	no	no	no
7935	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	0	10.5		No	No	Signature.1	PALB2 | RAD54L	No	0	9.53	0	no	no	no
7936	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2018	IV	23	0.9	Stable	No	Yes or Unknown			No	0	10.58	0	no	no	no
7937	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	0	5.3	Stable	No	No		BLM	Yes	0	9.69	0	no	no	no
7938	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	0	1.8	Stable	No	No			No	0	10.55	0	no	no	no
7939	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	Yes or Unknown	Signature.5		No	0	11.1	0	no	no	no
7940	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	III	25	1.8	Stable	No	No			Yes	0	11.63	0	no	no	no
7941	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	62	56.2	Unstable	No	Yes or Unknown	Signature.1	ARID1A | MSH2 | MSH6 | PARP1 | PMS1	Yes	0	3.68	0	mut-MMRd	mut-MMRd	yes
7942	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	0	7	Stable	No	No	Signature.4	PARP1	Yes	0	9.2	0	no	no	no
7943	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	IV	21	2.6	Stable	No	No			No	0	10.74	0	no	no	no
7944	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	158	4.4	Stable	No	No		ARID1A	Yes	0	13.57	0	no	no	yes
7945	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2018		47	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	14.13	0	no	no	no
7946	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.8		No	0	12.19	0	no	no	no
7947	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	III	0	6.1	Stable	No	Yes or Unknown			No	0	8.25	0	no	no	no
7948	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	No		ATM	No	0	10.84	0	no	no	no
7949	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	180	3.5	Stable	No	Yes or Unknown			Yes	0	11.86	0	no	no	no
7950	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	39	1.8	Stable	No	No			No	0	7.43	0	no	no	no
7951	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	24	0.9	Stable	No	No			Yes	0	8.97	0	no	no	no
7952	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	95	4.4	Stable	No	No		ATM	No	0	12.16	0	no	no	no
7953	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	III	134	3.5	Stable	No	No		ARID1A	No	0	11.53	0	no	no	yes
7954	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	IV	233	14	Stable	No	Yes or Unknown	Signature.2	ERCC3 | FANCC | TP53BP1	No	0	12.02	0	no	no	no
7955	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	II	159	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	11.37	0	no	no	no
7956	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	55	7	Stable	No	No	Signature.9	ATM | BRCA2	Yes	0	9.66	0	no	no	no
7957	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	11	2.6	Stable	No	No			No	0	11.17	0	no	no	no
7958	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	181	0		No	Yes or Unknown			No	0	11.86	0	no	no	no
7959	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	29	4.4	Stable	No	No			Yes	0	11.37	0	no	no	no
7960	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	29	20.2	Unstable	No	No	Signature.6	BRCA2 | MLH1	No	0	11.04	0	mut-MMRd	mut-MMRd	no
7961	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	46	0.9	Stable	No	Yes or Unknown		ATM	Yes	0	10.55	0	no	no	no
7962	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	III	0	3.5	Stable	No	No			No	0	11.47	0	no	no	no
7963	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	0	5.3	Stable	No	No	Signature.1		Yes	0	11.47	0	no	no	no
7964	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	7	Stable	No	No		ATM	No	0	11.4	0	no	no	no
7965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	119	0.9	Stable	No	Yes or Unknown			No	0	11.4	0	no	no	no
7966	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	5.3	Stable	No	No		BRCA2	No	0	11.7	0	no	no	no
7967	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	128	4.4	Stable	No	No	Signature.3		No	0	14.82	0	no	no	no
7968	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	9	6.1	Stable	No	No		MDC1	No	0	11.3	0	no	no	no
7969	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	44	1.8	Stable	No	Yes or Unknown			Yes	0	11.5	0	no	no	no
7970	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	4	3.5	Stable	No	No			No	0	10.51	0	no	no	no
7971	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2018	II	35	0.9	Stable	No	No			Yes	0	9.46	0	no	no	no
7972	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	I	24	6.1	Stable	No	No			No	0	6.64	0	no	no	no
7973	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	5.3	Stable	No	No			Yes	0	11.07	0	no	no	no
7974	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	31	0	Stable	No	No			Yes	0	8.74	0	no	no	no
7975	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	0	2.6	Stable	No	No			Yes	0	10.78	0	no	no	no
7976	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	11.4	0	no	no	no
7977	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	4.4	Stable	No	No		SLX4	No	0	11.5	0	no	no	no
7978	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	34	4.4	Stable	No	No			Yes	0	12.58	0	no	no	no
7979	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	41	41.3	Unstable	No	No	Signature.1	ATM | ERCC5 | MDC1 | MRE11A | MSH2 | MUTYH	No	0	8.97	0	mut-MMRd	mut-MMRd	no
7980	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		0	4.4	Stable	No	No			Yes	0	11.27	0	no	no	no
7981	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	0	Stable	No	No			No	0	11.3	0	no	no	no
7982	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	IV	231	3.5	Stable	No	Yes or Unknown			Yes	0	11.6	0	no	no	no
7983	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	2	5.3	Stable	No	No		MDC1	No	0	11.33	0	no	no	no
7984	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	54	5.3	Stable	No	No			Yes	0	10.61	0	no	no	no
7985	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	43	2.6	Stable	No	No			No	1	7.43	0	no	no	no
7986	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	2.6	Stable	No	No			Yes	0	12.48	0	no	no	no
7987	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	1	8.8	Stable	No	No	Signature.24	BRCA1 | MSH2	No	0	11.6	0	no	no	no
7988	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	19	6.1	Stable	No	No			No	0	10.74	0	no	no	no
7989	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	25	0.9	Stable	No	No			No	0	11.14	0	no	no	no
7990	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	2.6	Stable	No	No		SLX4	No	0	10.15	0	no	no	no
7991	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	27	4.4	Stable	No	No			No	0	2.53	0	no	no	no
7992	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	28	0.9	Stable	No	Yes or Unknown			No	0	13.21	0	no	no	no
7993	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	32	0.9	Stable	No	No			No	0	11.27	0	no	no	no
7994	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2018	III	56	1.8	Stable	No	No		ATM	Yes	0	11.76	0	no	no	no
7995	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	29	4.4	Stable	No	No			No	0	6.24	0	no	no	no
7996	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		Yes	0	11.27	0	no	no	no
7997	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	4.4	Stable	No	No	Signature.3		No	0	6.21	0	no	no	no
7998	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	7	4.4	Stable	No	No	Signature.3	BRCA1	No	0	11.47	0	no	no	no
7999	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	2.6	Stable	No	No		ARID1A	No	0	8.41	0	no	no	yes
8000	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	III	0	3.5	Stable	No	No			No	0	8.28	0	no	no	no
8001	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	II	1	7.9	Stable	No	No			No	0	9.46	0	no	no	no
8002	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	II	2	65	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | BRCA2 | MDC1 | MSH3 | MSH6 | NBN | SLX4 | TP53BP1	Yes	0	10.81	0	mut-MMRd	mut-MMRd	yes
8003	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	0.9	Stable	No	Yes or Unknown			Yes	0	10.97	0	no	no	no
8004	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	11.01	0	no	no	no
8005	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	3.5	Stable	No	No	Signature.3		No	0	11.14	0	no	no	no
8006	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	0	11.4	Stable	No	No	Signature.1	ATM | PMS2	Yes	0	10.15	0	no	no	no
8007	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		ERCC2 | ERCC5	Yes	0	11.86	0	no	no	no
8008	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	31	7.9	Stable	No	No	Signature.1	MSH2	No	0	10.64	0	no	no	no
8009	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	43	0.9	Stable	No	No			No	0	5.65	0	no	no	no
8010	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	3.5	Stable	No	No			No	0	10.55	0	no	no	no
8011	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	80	3.5	Stable	No	No	Signature.8		Yes	0	13.21	0	no	no	no
8012	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	11	6.1	Stable	No	Yes or Unknown			No	0	10.78	0	no	no	no
8013	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018	III	0	0	Stable	No	No			No	0	10.58	0	no	no	no
8014	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	232	7.9	Stable	No	Yes or Unknown			No	0	9.72	0	no	no	no
8015	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	16	5.3	Stable	No	No	Signature.1		Yes	0	9.86	0	no	no	no
8016	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	I	0	2.6	Stable	No	No			No	0	8.51	0	no	no	no
8017	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	1	8.97	0	no	no	no
8018	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	37	5.3	Stable	No	Yes or Unknown	Signature.20		No	0	9.69	0	no	no	no
8019	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	38	2.6	Stable	No	No			Yes	0	10.22	0	no	no	no
8020	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	23	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	10.58	0	no	no	no
8021	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	7.9	Stable	No	No		MSH3	No	0	13.9	0	no	no	no
8022	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	22	3.5	Stable	No	No			Yes	0	10.84	0	no	no	no
8023	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	26	0	Stable	No	No			No	0	9.23	0	no	no	no
8024	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	61	0.9	Stable	No	No			No	0	11.89	0	no	no	no
8025	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	III	9	123.8	Stable	No	No	Signature.10	ATM | ATR | BRCA1 | BRCA2 | MRE11A | MSH6 | RAD50 | SLX4	Yes	0	10.12	0	no	no	no
8026	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	33	2.6	Stable	No	No		MRE11A	No	0	10.78	0	no	no	no
8027	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	2	6.1	Stable	No	No			No	0	11.07	0	no	no	no
8028	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2018	IV	36	1.8	Stable	No	No			No	0	1.51	0	no	no	no
8029	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	175	1.8	Stable	No	Yes or Unknown			No	0	9.72	0	no	no	no
8030	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	1.8	Stable	No	Yes or Unknown		RAD51	No	0	10.71	0	no	no	no
8031	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	14	3.5	Stable	No	No			No	0	9.72	0	no	no	no
8032	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	35	5.3	Stable	No	No			No	0	10.68	0	no	no	no
8033	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	II	22	2.6	Stable	No	No			Yes	0	7.85	0	no	no	no
8034	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	25	9.7	Stable	No	No	Signature.6		Yes	0	10.45	0	no	no	no
8035	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		ATM	No	0	10.48	0	no	no	no
8036	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	10	70.2	Unstable	No	No	Signature.6	ATM | BLM | BRCA1 | FANCA | MSH6 | SLX4	No	0	5.16	0	mut-MMRd	mut-MMRd	no
8037	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	43	1.8	Stable	No	Yes or Unknown			No	0	11.53	0	no	no	no
8038	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	I	32	2.6	Stable	No	No			No	0	7.59	0	no	no	no
8039	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	170	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	9.72	0	no	no	no
8040	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	19	73.7	Unstable	No	No	Signature.6	ARID1A | CHEK1 | ERCC5 | MRE11A | MSH2 | MSH3 | MSH6 | RAD51C	No	0	10.41	0	mut-MMRd	mut-MMRd	yes
8041	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	18	6.1	Stable	No	No	Signature.10		Yes	1	3.06	0	no	no	no
8042	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.17	ATM | PALB2	No	1	4.7	0	no	no	no
8043	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	10.48	0	no	no	no
8044	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	14	6.1	Stable	No	No			Yes	0	10.61	0	no	no	no
8045	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	2.6	Stable	No	No			No	0	9.89	0	no	no	no
8046	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	91	3.5	Stable	No	No			Yes	0	10.81	0	no	no	no
8047	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	I	27	28.1	Unstable	No	No	Signature.6	BLM | BRCA2 | MLH1	No	0	7.72	0	mut-MMRd	mut-MMRd	no
8048	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	0	4.4	Stable	No	Yes or Unknown			No	0	10.45	0	no	no	no
8049	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	I	26	49.2	Unstable	No	No	Signature.6	ARID1A | ATM | CHEK2 | MSH3 | RAD50	No	0	6.37	0	other-MMRd	mut-MMRd	yes
8050	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	9.7	Stable	No	No			No	0	10.55	0	no	no	no
8051	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	10.41	0	no	no	no
8052	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	50	52.7	Unstable	No	No	Signature.6	ATM | BRCA2 | MRE11A | MSH3 | MSH6 | XRCC2	Yes	0	9.59	0	mut-MMRd	mut-MMRd	no
8053	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	18	4.4	Stable	No	No		ATM | CHEK2	Yes	0	7.16	0	no	no	no
8054	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	63	2.6	Stable	No	No			No	0	9.89	0	no	no	no
8055	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	28	10.5	Stable	No	No	Signature.1		Yes	0	9.17	0	no	no	no
8056	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	9.76	0	no	no	no
8057	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		PALB2	No	0	9.66	0	no	no	no
8058	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		11	0	Stable	No	No			No	0	10.35	0	no	no	no
8059	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	0	0.9	Stable	No	No			No	0	9.89	0	no	no	no
8060	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	0	2.6	Stable	No	No		FANCC	No	0	10.09	0	no	no	no
8061	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	10.61	0	no	no	no
8062	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	15	5.3	Stable	No	No			No	0	9.95	0	no	no	no
8063	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	37	2.6	Stable	No	No		MSH2	Yes	0	8.71	0	no	no	no
8064	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown		ATM | BRCA2	No	0	8.77	0	no	no	no
8065	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	10.12	0	no	no	no
8066	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	13	7	Stable	No	No	Signature.13	ATM	No	0	9.4	0	no	no	no
8067	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	37	6.1	Stable	No	No			Yes	0	11.76	0	no	no	no
8068	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	6	2.6	Stable	No	Yes or Unknown			No	0	9.69	0	no	no	no
8069	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	1	10.18	0	no	no	no
8070	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	2.6	Stable	No	No			Yes	0	7	0	no	no	no
8071	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	51	8.8	Stable	No	No		ARID1A	No	0	5.98	0	no	no	yes
8072	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	16.56	0	no	no	no
8073	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	21	4.4	Stable	No	No		NTHL1	No	0	8.94	0	no	no	no
8074	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	8.41	0	no	no	no
8075	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2018	IV	174	5.3	Stable	No	No	Signature.1		No	0	6.14	0	no	no	no
8076	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018	II	0	0	Stable	No	No			No	0	9.53	0	no	no	no
8077	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	68	0.9	Stable	No	Yes or Unknown			Yes	0	9.3	0	no	no	no
8078	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	85	0	Stable	No	No			No	0	5.06	0	no	no	no
8079	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	34	6.1	Stable	No	No			No	1	15.38	0	no	no	no
8080	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	3	6.1	Stable	No	No			No	0	10.68	0	no	no	no
8081	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018		44	1.8	Stable	No	Yes or Unknown			No	0	8.77	0	no	no	no
8082	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	3	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	9.63	0	no	no	yes
8083	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	21	0.9	Stable	No	Yes or Unknown	Signature.5		No	0	12.42	0	no	no	no
8084	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	34	4.4	Stable	No	No	Signature.5		Yes	0	8.77	0	no	no	no
8085	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	49	3.5	Stable	No	No			Yes	0	11.27	0	no	no	no
8086	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	41	7	Stable	No	No	Signature.8	ARID1A	No	0	9.07	0	no	no	yes
8087	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	9.23	0	no	no	no
8088	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	0.9	Stable	No	No			No	0	9.03	0	no	no	no
8089	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	20	7.9	Stable	No	No	Signature.29	ATM	No	0	7.36	0	no	no	no
8090	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	3.5	Stable	No	Yes or Unknown			No	0	10.41	0	no	no	no
8091	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	52	8.8	Stable	No	No	Signature.1	BRIP1	No	0	3.78	0	no	no	no
8092	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	I	7	2.6	Stable	No	No			Yes	0	9.36	0	no	no	no
8093	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		36	6.1	Stable	No	Yes or Unknown			No	0	8.84	0	no	no	no
8094	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	IV	63	7	Stable	No	Yes or Unknown	Signature.1		No	1	6.44	0	no	no	no
8095	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	112	2.6	Stable	No	No			No	0	10.32	0	no	no	no
8096	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	49	4.4	Stable	No	Yes or Unknown			No	0	9.82	0	no	no	no
8097	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	1.8	Stable	No	No			Yes	0	9.3	0	no	no	no
8098	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0		No	No			No	0	9.86	0	no	no	no
8099	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	3	2.6	Stable	No	Yes or Unknown			No	0	7.66	0	no	no	no
8100	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	0	3.5	Stable	No	No			No	0	10.38	0	no	no	no
8101	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	0	3.5	Stable	No	No			Yes	0	8.34	0	no	no	no
8102	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	49	0.9	Stable	No	No			Yes	0	8.34	0	no	no	no
8103	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	2.6	Stable	No	No			No	0	9.69	0	no	no	no
8104	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	0	1.8	Stable	No	No			No	0	8.97	0	no	no	no
8105	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	9	0	no	no	no
8106	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	I	35	24.6	Stable	No	No	Signature.4		No	0	8.34	0	no	no	no
8107	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	930	0	Stable	No	No			Yes	1	36.07	0	no	no	no
8108	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	36	0.9	Stable	No	Yes or Unknown			No	0	8.87	0	no	no	no
8109	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	III	0	3.5	Stable	No	No		ARID1A	No	0	9.49	0	no	no	yes
8110	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	10	14	Stable	No	No	Signature.10	MSH2	Yes	0	8.64	0	no	no	no
8111	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	22	7	Stable	No	No	Signature.13		Yes	0	8.8	0	no	no	no
8112	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	89	34.2	Unstable	No	Yes or Unknown	Signature.6	BRCA2 | ERCC3 | MSH2	Yes	0	8.9	0	mut-MMRd	mut-MMRd	no
8113	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	I	21	7.9	Stable	No	No	Signature.1	BRCA2	No	0	7.62	0	no	no	no
8114	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	40	7	Stable	No	No			Yes	0	9.17	0	no	no	no
8115	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	10.64	0	no	no	no
8116	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	10	3.5	Stable	No	No	Signature.1	ERCC3	Yes	0	8.11	0	no	no	no
8117	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	7	Stable	No	No			Yes	0	9.2	0	no	no	no
8118	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	8.67	0	no	no	no
8119	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	1	5.3	Stable	No	No			No	0	8.71	0	no	no	no
8120	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	4.4	Stable	No	No			No	0	7.75	0	no	no	no
8121	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	4	9.7	Stable	No	No	Signature.1		Yes	0	8.71	0	no	no	no
8122	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	IV	17	0	Stable	No	No			No	0	8.74	0	no	no	no
8123	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018		77	1.8	Stable	No	Yes or Unknown			No	0	8.8	0	no	no	no
8124	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	10.25	0	no	no	no
8125	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	17	3.5	Stable	No	No	Signature.1		No	0	7.39	0	no	no	no
8126	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		35	1.8	Stable	No	Yes or Unknown			Yes	0	8.97	0	no	no	no
8127	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	29	2.6	Stable	No	No		MRE11A	Yes	0	7.36	0	no	no	no
8128	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	3.5	Stable	No	No		MUTYH	Yes	0	9.36	0	no	no	no
8129	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0	Stable	No	No			Yes	0	6.54	0	no	no	no
8130	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	100	0	Stable	No	No			No	0	9.13	0	no	no	no
8131	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	47	4.4	Stable	No	No			Yes	0	3.84	0	no	no	no
8132	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	2.6	Stable	No	No	Signature.19		No	0	8.31	0	no	no	no
8133	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	219	3.5	Stable	No	Yes or Unknown		MSH3 | TP53BP1	No	0	9	0	no	no	no
8134	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	3.5	Stable	No	Yes or Unknown			No	0	8.28	0	no	no	no
8135	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	1.8	Stable	No	No			No	0	9.43	0	no	no	no
8136	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	1	6.1	Stable	No	No			Yes	0	8.84	0	no	no	no
8137	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	95	2.6	Stable	No	No			No	0	8.71	0	no	no	no
8138	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	40	4.4	Stable	No	No			No	0	9.2	0	no	no	no
8139	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	II	0	10.5	Stable	No	No	Signature.13	TP53BP1	No	0	8.64	0	no	no	no
8140	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	III	56	54.4	Unstable	No	No	Signature.6	ARID1A | ERCC5 | MRE11A | PARP1 | RAD50 | SLX4	No	0	8.11	0	other-MMRd	mut-MMRd	yes
8141	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	70	0		No	No			No	0	8.71	0	no	no	no
8142	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	191	0.9	Stable	No	No			No	0	10.28	0	no	no	no
8143	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	35	5.3	Stable	No	No		ATR	Yes	0	7.29	0	no	no	no
8144	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	51	4.4	Stable	No	No	Signature.1		No	0	9.63	0	no	no	no
8145	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	6	10.5	Stable	No	No	Signature.29		No	0	8.54	0	no	no	no
8146	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	0	7.16	0	no	no	no
8147	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1	ARID1A | SLX4	Yes	1	2.43	0	no	no	yes
8148	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.1	ATM | BRIP1	Yes	0	8.18	0	no	no	no
8149	Non-ICI treated	Never received ICI	15-Nov	Female	Renal	2018		36	1.8	Stable	No	Yes or Unknown			No	0	8.05	0	no	no	no
8150	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	2.6	Stable	No	No			No	0	12.42	0	no	no	no
8151	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	22	7	Stable	No	Yes or Unknown	Signature.8		No	0	8.54	0	no	no	no
8152	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	15	5.3	Stable	No	No	Signature.1		No	0	8.28	0	no	no	no
8153	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	11	1.8	Stable	No	No	Signature.13		No	0	10.35	0	no	no	no
8154	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.5	BRCA1	Yes	0	8.34	0	no	no	no
8155	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	4	4.4	Stable	No	No		ARID1A	No	0	8.25	0	no	no	yes
8156	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	I	49	67.6	Unstable	No	No	Signature.6	ARID1A | BLM | MSH3 | MUTYH | NBN | NTHL1 | TP53BP1	No	0	5.42	0	other-MMRd	mut-MMRd	yes
8157	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2018	IV	212	4.4	Stable	No	Yes or Unknown			Yes	0	8.9	0	no	no	no
8158	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	15	5.3	Stable	No	No	Signature.29		No	0	7.66	0	no	no	no
8159	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	45	53.5	Unstable	No	No	Signature.6	ATM | ATR | BRCA1 | BRCA2 | BRIP1 | PARP1 | TP53BP1	No	0	5.32	0	other-MMRd	mut-MMRd	no
8160	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	19	102.7	Unstable	No	No	Signature.6	ARID1A | BLM | FANCA | MSH3 | MSH6 | SLX4 | TP53BP1	No	0	7.06	0	mut-MMRd	mut-MMRd	yes
8161	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	2	5.3	Stable	No	No			No	0	7.89	0	no	no	no
8162	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	26	2.6	Stable	No	No	Signature.1		Yes	0	8.02	0	no	no	no
8163	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	0	0.9	Stable	No	No			No	0	7.85	0	no	no	no
8164	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018	IV	0	0.9	Stable	No	No			No	0	8.28	0	no	no	no
8165	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1		Yes	0	5.09	0	no	no	no
8166	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	10.5	Stable	No	No	Signature.1		No	0	8.11	0	no	no	no
8167	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	10	97.4	Stable	No	No	Signature.10	BRCA1 | BRCA2 | BRIP1 | FANCA | MSH6 | PMS1 | TP53BP1	Yes	0	7.16	0	no	no	no
8168	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	21	3.5	Stable	No	No		ATM	No	0	9.1	0	no	no	no
8169	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	34	0	Stable	No	No			Yes	0	8.21	0	no	no	no
8170	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	II	5	5.3	Stable	No	No			Yes	0	6.21	0	no	no	no
8171	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	21	36	Unstable	No	No	Signature.6	ARID1A | BLM | ERCC2 | PALB2	No	0	7.85	0	other-MMRd	mut-MMRd	yes
8172	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	28	11.4	Stable	No	No	Signature.1		Yes	0	7.62	0	no	no	no
8173	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	I	23	86	Unstable	No	No	Signature.6	ARID1A | BRIP1 | CHEK2 | ERCC2 | ERCC4 | MLH1 | MSH6 | RAD50 | TP53BP1	No	0	4.57	0	mut-MMRd	mut-MMRd	yes
8174	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2018	IV	6	1.8	Stable	No	No			No	0	7.79	0	no	no	no
8175	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	28	4.4	Stable	No	No		BRCA2	No	0	8.02	0	no	no	no
8176	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	20	4.4	Stable	No	No			Yes	0	7.52	0	no	no	no
8177	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	82	2.6	Stable	No	Yes or Unknown			No	0	9.23	0	no	no	no
8178	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	IV	6	0	Stable	No	Yes or Unknown			No	0	7.85	0	no	no	no
8179	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	42	3.5	Stable	No	Yes or Unknown			No	0	7.79	0	no	no	no
8180	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	154	0.9	Stable	No	Yes or Unknown			Yes	0	7.89	0	no	no	no
8181	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	26	61.4	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | ERCC4 | MSH3 | MSH6 | PARP1 | RAD51C | RAD54L	Yes	0	8.21	0	mut-MMRd	mut-MMRd	yes
8182	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		7	2.6	Stable	No	No			No	0	7.69	0	no	no	no
8183	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	70	49.2	Unstable	No	No	Signature.6	ARID1A | BLM | MDC1 | MRE11A | MSH3	No	0	7.92	0	other-MMRd	mut-MMRd	yes
8184	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	I	45	103.6	Unstable	No	No	Signature.1	ARID1A | ATM | ATR | ERCC3 | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | NBN | PALB2 | RAD50 | RAD54L	No	0	7	0	mut-MMRd	mut-MMRd	yes
8185	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	23	7	Stable	No	No			Yes	0	5.26	0	no	no	no
8186	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	35	3.5	Stable	No	No			No	0	5.06	0	no	no	no
8187	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2018	IV	0	13.2	Stable	No	No	Signature.2	ARID1A	No	0	8.97	0	no	no	yes
8188	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	41	13.2	Stable	No	Yes or Unknown	Signature.4		No	0	7.98	0	no	no	no
8189	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	6.1	Stable	No	No		RAD50	No	0	7.59	0	no	no	no
8190	Non-ICI treated	Never received ICI	16 - 20	Female	Cutaneous Melanoma 	2018	III	38	0.9	Stable	No	No			Yes	0	4.5	0	no	no	no
8191	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	22	6.1	Stable	No	No			No	0	8.08	0	no	no	no
8192	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	I	54	69.3	Unstable	No	No	Signature.6	ARID1A | BRCA2 | BRIP1 | MLH1 | MSH3 | MSH6 | PMS1 | RAD51 | TP53BP1	No	0	3.38	0	mut-MMRd	mut-MMRd	yes
8193	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	3.5	Stable	No	No			No	0	7.43	0	no	no	no
8194	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		3	4.4	Stable	No	No			No	0	5.22	0	no	no	no
8195	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	41	4.4	Stable	No	No			Yes	0	7.69	0	no	no	no
8196	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	59	8.8	Stable	No	No	Signature.1		Yes	0	7.89	0	no	no	no
8197	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			No	0	8.31	0	no	no	no
8198	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	0	6.1	Stable	No	No			No	1	7.13	0	no	no	no
8199	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	41	12.3	Stable	No	No	Signature.1		No	0	7.72	0	no	no	no
8200	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1	ERCC3 | RAD51C	No	0	7.82	0	no	no	no
8201	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	41	6.1	Stable	No	No	Signature.1		Yes	0	7.29	0	no	no	no
8202	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	54	1.8	Stable	No	No			Yes	0	7.56	0	no	no	no
8203	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	II	1	6.1	Stable	No	No	Signature.13	PMS1	Yes	0	7.59	0	no	no	no
8204	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	182	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	7.36	0	no	no	no
8205	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	11	0	Stable	No	No			No	1	9.36	0	no	no	no
8206	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	50.9	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA1 | ERCC4 | FANCA | MSH3 | RAD50	Yes	0	8.77	0	other-MMRd	mut-MMRd	yes
8207	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	III	78	4.4	Stable	No	No			Yes	0	7.89	0	no	no	no
8208	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	203	6.1	Stable	No	No	Signature.1		No	0	8.71	0	no	no	no
8209	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	III	34	3.5	Stable	No	No			No	0	26.87	0	no	no	no
8210	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	I	366	2.6		No	No			No	1	32.16	0	no	no	no
8211	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2018		0	0.9	Stable	No	No			No	0	15.41	0	no	no	no
8212	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2015		4	2	Stable	Yes or Unknown	Yes or Unknown			No	1	19.94	1	no	no	no
8213	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	0	4.9		No	No	Signature.1		No	1	5.62	1	no	no	no
8214	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	21	32.5	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH6 | PMS2	No	0	14.36	1	mut-MMRd	mut-MMRd	yes
8215	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2018	IV	9	19.3	Stable	No	No	Signature.4	ATM | NBN	No	0	8.41	1	no	no	no
8216	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	85	1	Stable	No	No			No	0	48.63	1	no	no	no
8217	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4		No	0	7.89	1	no	no	no
8218	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	447	6.1		No	Yes or Unknown			No	1	6.05	1	no	no	no
8219	ICI-treated	ICI as first line	51 - 55	Male	Gastric	2017	IV	0	0	Stable	No	Yes or Unknown			No	1	18.82	1	no	no	no
8220	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	1.65	1	no	no	no
8221	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2015	IV	0	2	Indeterminate	No	Yes or Unknown			No	1	2.33	1	no	no	no
8222	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2016	IV	264	4.4	Stable	Yes or Unknown	Yes or Unknown		TP53BP1	No	1	3.12	1	no	no	no
8223	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	III	34	41.3	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.6	MSH6 | SLX4 | TP53BP1	No	1	7.13	1	no	no	no
8224	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2016	IV	30	6.1		No	No			No	1	3.81	1	no	no	no
8225	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016	IV	73	8.8		No	No	Signature.13		Yes	1	2.36	1	no	no	no
8226	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	0	3.5	Stable	No	No	Signature.4		No	0	2	1	no	no	no
8227	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016	IV	237	5.3	Stable	No	Yes or Unknown			No	1	18.23	1	no	no	no
8228	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	431	7		No	Yes or Unknown	Signature.24		No	1	9.33	1	no	no	no
8229	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	64	19.7	Stable	No	Yes or Unknown	Signature.29	ARID1A | BRCA2	No	0	45.96	1	no	no	yes
8230	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	I	696	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BLM | BRIP1	No	1	6.77	1	no	no	no
8231	ICI-treated	ICI as first line	91 - 95	Female	Endometrial	2016	I	9	32.5	Unstable	No	No	Signature.1	ARID1A | ATM | NBN	No	0	13.44	1	other-MMRd	mut-MMRd	yes
8232	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	20	14	Stable	No	No	Signature.2	ATM | ERCC3 | ERCC4	No	1	5.52	1	no	no	no
8233	ICI-treated	ICI as subsequent line	76 - 80	Female	SCLC	2017	IV	11	15.8	Indeterminate	No	No	Signature.4	ATR | RAD52	No	0	15.18	1	no	no	no
8234	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2016		0	36.9	Unstable	No	No	Signature.1	ARID1A | ERCC2 | MSH3 | TP53BP1	No	0	9.23	1	other-MMRd	mut-MMRd	yes
8235	ICI-treated	ICI as subsequent line	46 - 50	Female	Bladder	2015	IV	0	1		No	No	Signature.30		No	1	2.92	1	no	no	no
8236	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	I	626	0.9	Stable	No	Yes or Unknown			No	0	19.09	1	no	no	no
8237	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	II	275	6.1		No	Yes or Unknown	Signature.24	XRCC2	No	1	1.94	1	no	no	no
8238	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	0	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.24	MRE11A	No	0	9.29	1	no	no	no
8239	ICI-treated	ICI as subsequent line	76 - 80	Female	Esophageal	2016	IV	62	24.6	Unstable	No	Yes or Unknown	Signature.1	ERCC2 | FANCA | PMS1	No	1	7.89	1	other-MMRd	mut-MMRd	no
8240	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2017	I	6	43	Stable	No	No	Signature.7	MSH3 | XRCC2	No	0	22.5	1	no	no	no
8241	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.3		No	1	6.01	1	no	no	no
8242	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2018	IV	17	3.5	Stable	No	Yes or Unknown			No	0	8.7	1	no	no	no
8243	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	19	3.5	Stable	No	No			No	1	4.5	1	no	no	no
8244	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	14	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.19	BRCA2	No	0	12.29	1	no	no	no
8245	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2018	IV	0	3.5	Stable	No	No	Signature.2		No	0	11.3	1	no	no	no
8246	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	0	9.7	Stable	No	No	Signature.4	ATR	No	0	25.1	1	no	no	no
8247	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	24	7		No	No			No	1	13.89	1	no	no	no
8248	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2015	IV	250	12.8	Stable	No	No	Signature.30	ATM	No	0	40.74	1	no	no	no
8249	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2015		24	3.9	Stable	Yes or Unknown	Yes or Unknown		NBN | RAD50	No	1	3.77	1	no	no	no
8250	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	13.84	1	no	no	no
8251	ICI-treated	ICI as first line	86 - 90	Female	NSCLC	2016	III	39	3.5		No	No			No	1	25.49	1	no	no	no
8252	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	2	50.9	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MDC1 | MRE11A | MSH6	No	0	18.43	1	mut-MMRd	mut-MMRd	yes
8253	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	32	0	Stable	No	No			No	1	13.83	1	no	no	no
8254	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	1	2.17	1	no	no	no
8255	ICI-treated	ICI as first line	81 - 85	Male	Sarcoma	2018	IV	45	8.8	Indeterminate	No	No	Signature.4	PARP1	Yes	1	0.33	1	no	no	no
8256	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	14	3.5	Stable	No	Yes or Unknown	Signature.19		No	1	18.6	1	no	no	no
8257	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016		34	7.9	Stable	No	No	Signature.7	ATM	No	0	33.64	1	no	no	no
8258	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	III	0	2	Stable	No	No	Signature.26		No	1	2.69	1	no	no	no
8259	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	III	16	3.9	Stable	No	Yes or Unknown			No	1	4.63	1	no	no	no
8260	ICI-treated	ICI as subsequent line	46 - 50	Male	Pancreatic	2017	II	515	3.5	Stable	No	Yes or Unknown			No	1	2.89	1	no	no	no
8261	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2015	IV	815	17.6	Stable	No	Yes or Unknown	Signature.1		No	0	10.55	1	no	no	no
8262	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	IV	0	5.3	Stable	No	No	Signature.6		No	1	0.13	1	no	no	no
8263	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	34	7.9	Stable	No	No	Signature.24		No	1	16.13	1	no	no	no
8264	ICI-treated	ICI as subsequent line	56 - 60	Female	Gastric	2017	II	242	5.3	Stable	Yes or Unknown	Yes or Unknown		BRCA2 | PALB2	No	1	0.950000000000001	1	no	no	no
8265	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	II	29	2	Stable	No	No			No	0	9.46	1	no	no	no
8266	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2016	IV	251	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	0	28.39	1	no	no	no
8267	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	0	12.8	Stable	No	No	Signature.24		Yes	1	0.85	1	no	no	no
8268	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2015	I	309	2		No	No		ATM	Yes	0	18.46	1	no	no	no
8269	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	36	2.6		No	No			No	0	20.92	1	no	no	no
8270	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2015	IV	4	1.8		No	No	Signature.24		No	1	7.06	1	no	no	no
8271	ICI-treated	ICI as subsequent line	71 - 75	Male	Cutaneous Melanoma 	2015	III	365	1.8		No	Yes or Unknown			No	0	32.19	1	no	no	no
8272	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	III	5	9.7	Stable	No	No	Signature.4	BRCA1 | PMS1	No	1	0.390000000000001	1	no	no	no
8273	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2017	I	30	29.8	Unstable	No	No	Signature.6	ARID1A | TP53BP1	No	1	11.27	1	other-MMRd	mut-MMRd	yes
8274	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2016	III	16	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ERCC2	Yes	0	26.39	1	no	no	yes
8275	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	1	8.25	1	no	no	no
8276	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2015	III	0	0	Stable	No	No			No	0	22.77	1	no	no	no
8277	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2017	III	238	4.4	Stable	No	Yes or Unknown			No	1	4.21	1	no	no	no
8278	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	0	36		No	Yes or Unknown	Signature.7	BRCA2 | FANCA | NBN	No	0	37.06	1	no	no	no
8279	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	II	56	6.1	Stable	No	No	Signature.25	ARID1A	No	0	4.34	1	no	no	yes
8280	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	8.9		No	No	Signature.4		No	0	9.1	1	no	no	no
8281	ICI-treated	ICI as first line	86 - 90	Male	Bladder	2017	IV	46	4.4	Indeterminate	No	No	Signature.25		No	1	12.12	1	no	no	no
8282	ICI-treated	ICI as first line	61 - 65	Female	CNS	2015		2	3	Stable	No	No			Yes	1	20.21	1	no	no	no
8283	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	IV	0	36		No	No	Signature.7	BRIP1 | ERCC2 | ERCC5 | FANCA | PARP1	No	0	3.41	1	no	no	no
8284	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2015	I	1052	11.4	Stable	No	No	Signature.4	ATM	Yes	1	6.6	1	no	no	no
8285	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2015	II	18	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	4.63	1	no	no	no
8286	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2017	IV	26	1.8	Stable	No	No			Yes	0	22.28	1	no	no	no
8287	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	1035	3.5	Stable	No	Yes or Unknown	Signature.17		No	0	19.55	1	no	no	no
8288	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	I	1270	4.4	Stable	No	No			No	0	8.28	1	no	no	no
8289	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	II	0	10.5	Stable	No	No	Signature.4	RAD50	No	1	7.79	1	no	no	no
8290	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2015	IV	18	3.9	Stable	No	Yes or Unknown			No	0	25.1	1	no	no	no
8291	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	III	0	8.9	Stable	No	No			Yes	0	45.54	1	no	no	no
8292	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2015	II	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	13.21	1	no	no	no
8293	ICI-treated	ICI as subsequent line	36 - 40	Male	Pancreatic	2015	III	379	3	Stable	No	Yes or Unknown			No	1	14.16	1	no	no	no
8294	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	I	518	9.7		No	No	Signature.13	ARID1A | CHEK2	No	1	12.06	1	no	no	yes
8295	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	41	30.5	Stable	No	Yes or Unknown	Signature.4	ATR | BRCA2	No	0	37.71	1	no	no	no
8296	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	325	7		No	Yes or Unknown	Signature.2		No	1	10.05	1	no	no	no
8297	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	499	39.4	Stable	No	Yes or Unknown	Signature.4	ATM | BRCA1 | FANCA | MUTYH	No	1	20.93	1	no	no	no
8298	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	0	49.2	Stable	No	No	Signature.7	ARID1A | BRIP1 | PMS1	Yes	0	52.43	1	no	no	yes
8299	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	II	22	5.9	Stable	No	Yes or Unknown	Signature.13		No	0	18.27	1	no	no	no
8300	ICI-treated	ICI as subsequent line	41 - 45	Male	Hepatobiliary	2015	II	89	4.9	Stable	No	Yes or Unknown			No	1	0.32	1	no	no	no
8301	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	I	409	2.6	Stable	No	Yes or Unknown			No	0	20.31	1	no	no	no
8302	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		43	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	4.17	1	no	no	no
8303	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	179	3	Stable	No	Yes or Unknown			No	1	0.0300000000000011	1	no	no	no
8304	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	1003	9.7	Stable	No	Yes or Unknown	Signature.4		No	1	12.13	1	no	no	no
8305	ICI-treated	ICI as subsequent line	16 - 20	Female	CNS	2015		3	7.9	Stable	No	No			No	1	1.54	1	no	no	no
8306	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	926	4.4	Stable	No	Yes or Unknown			No	1	35.74	1	no	no	no
8307	ICI-treated	ICI as first line	41 - 45	Female	Renal	2015	IV	0	6.9	Stable	No	No	Signature.18	ARID1A | MLH1 | MUTYH	Yes	0	50.36	1	no	no	yes
8308	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	29	3	Stable	No	Yes or Unknown			No	1	7.62	1	no	no	no
8309	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	31	1	Stable	No	No			No	1	3.35	1	no	no	no
8310	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	5.9	Stable	No	No			No	0	50.24	1	no	no	no
8311	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	IV	20	102.3	Indeterminate	No	Yes or Unknown	Signature.7	ARID1A | BRCA2 | MLH1 | MSH2	No	1	27.47	1	no	no	yes
8312	ICI-treated	ICI as subsequent line	76 - 80	Female	Head & Neck	2015	IV	242	3.9	Stable	No	Yes or Unknown	Signature.1		No	1	1.54	1	no	no	no
8313	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	277	4.9	Stable	No	Yes or Unknown			No	1	31.47	1	no	no	no
8314	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	III	27	4.9	Stable	No	Yes or Unknown			No	0	30.49	1	no	no	no
8315	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2015	II	48	3	Stable	No	No			No	0	7.13	1	no	no	no
8316	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	45	3	Stable	No	No			No	0	10.71	1	no	no	no
8317	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	IV	0	10.8	Stable	No	No	Signature.7		No	1	3.26	1	no	no	no
8318	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2015	IV	50	4.9	Stable	No	No	Signature.4	MUTYH	No	1	27.96	1	no	no	no
8319	ICI-treated	ICI as first line	21 - 25	Male	Cutaneous Melanoma 	2015	III	20	9.8	Stable	No	No	Signature.7	ERCC3 | MSH6	Yes	0	49.91	1	no	no	no
8320	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	0	13.8	Stable	No	No	Signature.4	BRCA1	No	1	3.68	1	no	no	no
8321	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	II	929	7	Stable	No	Yes or Unknown	Signature.1	FANCA	No	0	18.79	1	no	no	no
8322	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2015	IV	55	0	Stable	No	Yes or Unknown			No	1	11.34	1	no	no	no
8323	ICI-treated	ICI as subsequent line	10-Jun	Male	CNS	2015		12	0	Stable	Yes or Unknown	Yes or Unknown			No	1	3.25	1	no	no	no
8324	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2015	IV	26	4.9	Stable	No	No			No	1	24.9	1	no	no	no
8325	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2015	I	807	14.9	Stable	No	No	Signature.7	BRCA2	Yes	0	25	1	no	no	no
8326	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2015	I	1126	13.2	Stable	No	No	Signature.7	TP53BP1	No	1	12.81	1	no	no	no
8327	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	381	10.8	Stable	No	Yes or Unknown	Signature.4	BRCA2 | PMS1	No	1	9.53	1	no	no	no
8328	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	343	8.9	Stable	No	Yes or Unknown	Signature.29		No	1	1.02	1	no	no	no
8329	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	1.55	1	no	no	no
8330	ICI-treated	ICI as first line	81 - 85	Female	Cutaneous Melanoma 	2015	IV	25	39.4	Stable	No	No	Signature.7	ERCC4 | MLH1	Yes	1	10.55	1	no	no	no
8331	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2015	IV	653	0		No	Yes or Unknown	Signature.5		No	1	3.15	1	no	no	no
8332	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	346	8.9	Indeterminate	No	Yes or Unknown	Signature.3	NBN	No	1	1.64	1	no	no	no
8333	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	17	3	Stable	No	No		ATM	No	0	13.47	1	no	no	no
8334	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	IV	700	1.8	Stable	No	Yes or Unknown			No	1	9.69	1	no	no	no
8335	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	I	13	6.9	Stable	No	No	Signature.4	ATM	No	0	27.4	1	no	no	no
8336	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2015	IV	211	6.9	Stable	No	Yes or Unknown	Signature.1		No	1	3.88	1	no	no	no
8337	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	0	1	Stable	No	No			No	0	28.55	1	no	no	no
8338	ICI-treated	ICI - unknown sequence	51 - 55	Male	Prostatic	2015	IV	28	43.3	Unstable	No	Yes or Unknown	Signature.6	ARID1A | CHEK2 | MLH1 | PMS1 | PMS2 | RAD50	No	1	6.08	1	mut-MMRd	mut-MMRd	yes
8339	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	III	28	2	Stable	No	Yes or Unknown	Signature.9		No	1	5.12	1	no	no	no
8340	ICI-treated	ICI as subsequent line	56 - 60	Female	Esophageal	2015	IV	102	6.9	Stable	No	Yes or Unknown	Signature.2		No	1	2.76	1	no	no	no
8341	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	0	59	Stable	No	No	Signature.4	ATR | BRCA1 | ERCC3 | FANCA | RAD50	No	0	33.12	1	no	no	no
8342	ICI-treated	ICI as subsequent line	56 - 60	Female	Colorectal	2015	III	585	4.4	Stable	No	Yes or Unknown		ATM	No	1	20.2	1	no	no	no
8343	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	14	12.8	Stable	No	No	Signature.13	ATM	No	0	11.89	1	no	no	no
8344	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	194	3.9	Stable	No	Yes or Unknown			No	1	1.74	1	no	no	no
8345	ICI-treated	ICI as subsequent line	46 - 50	Female	Endometrial	2015	IV	63	3	Stable	No	No	Signature.26		No	1	12.32	1	no	no	no
8346	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	154	6.9	Stable	No	Yes or Unknown	Signature.4		No	1	13.66	1	no	no	no
8347	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	50	9.8	Stable	No	Yes or Unknown	Signature.29	ERCC5	No	1	1.74	1	no	no	no
8348	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	IV	162	14.8	Stable	No	Yes or Unknown	Signature.4		No	1	11.53	1	no	no	no
8349	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	III	0	1	Stable	Yes or Unknown	Yes or Unknown		ATM	No	1	11.3	1	no	no	no
8350	ICI-treated	ICI as subsequent line	41 - 45	Male	Esophageal	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.2		No	1	10.91	1	no	no	no
8351	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	III	104	8.8		No	Yes or Unknown	Signature.1	ARID1A	No	1	15.71	1	no	no	yes
8352	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	48	4.4		No	No	Signature.4		No	0	46.59	1	no	no	no
8353	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	18	5.9	Stable	No	No		ARID1A | ATM	No	1	23.79	1	no	no	yes
8354	ICI-treated	ICI as subsequent line	26 - 30	Male	Sarcoma	2015	I	980	0.9	Stable	No	Yes or Unknown			No	1	5.84	1	no	no	no
8355	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2015	IV	0	3.5		No	No		BRCA2 | RAD50	No	1	23.52	1	no	no	no
8356	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	I	6	4.4	Stable	No	No	Signature.4		No	0	9.98	1	no	no	no
8357	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	IV	43	3	Stable	Yes or Unknown	Yes or Unknown		BRIP1	No	0	18.47	1	no	no	no
8358	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	20	3	Stable	No	Yes or Unknown		ARID1A	No	1	39.39	1	no	no	yes
8359	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	0	51.2	Stable	No	No	Signature.7	MSH2	Yes	0	10.29	1	no	no	no
8360	ICI-treated	ICI as first line	51 - 55	Male	Sarcoma	2015		19	7		No	Yes or Unknown	Signature.1	BRCA2 | MSH2 | RAD54L	No	0	20.14	1	no	no	no
8361	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	32	11.8	Stable	No	Yes or Unknown	Signature.4	NBN	No	1	20.67	1	no	no	no
8362	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	34	3.9	Stable	No	No			No	1	10.55	1	no	no	no
8363	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	0	Stable	No	No			No	0	45.89	1	no	no	no
8364	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	IV	1	2	Indeterminate	No	No		BRCA1	No	0	17.51	1	no	no	no
8365	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	12	4.9	Stable	No	No			No	0	0	1	no	no	no
8366	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2015	IV	36	3.9	Stable	No	Yes or Unknown			No	0	0	1	no	no	no
8367	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2015	IV	0	8.9	Stable	No	Yes or Unknown	Signature.4	ATM | BRCA2 | ERCC2	No	1	7.95	1	no	no	no
8368	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	22	7.9		No	No	Signature.4	MSH2	No	0	36.11	1	no	no	no
8369	ICI-treated	ICI as first line	71 - 75	Male	Renal	2015	IV	51	9.8	Stable	No	No	Signature.3	ERCC5	Yes	0	48.59	1	no	no	no
8370	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	8.32	1	no	no	no
8371	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	21	36.4	Stable	No	No	Signature.7	PALB2	Yes	0	48.52	1	no	no	no
8372	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	IV	76	4.4	Stable	No	No		ARID1A	No	1	11.08	1	no	no	yes
8373	ICI-treated	ICI as subsequent line	31 - 35	Female	Gastric	2015	IV	1135	4.4	Stable	No	Yes or Unknown			No	1	2.43	1	no	no	no
8374	ICI-treated	ICI as subsequent line	76 - 80	Male	Cutaneous Melanoma 	2015	I	1126	12.3	Stable	No	No	Signature.7		No	0	35.94	1	no	no	no
8375	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	BRIP1	No	1	12.94	1	no	no	no
8376	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	378	9.8	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	4.2	1	no	no	no
8377	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	20	12.8	Stable	No	No	Signature.18	BRCA1 | MLH1 | MSH2	No	1	6.05	1	no	no	no
8378	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	966	1.8	Stable	No	No			No	0	17.02	1	no	no	no
8379	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	42	1	Stable	No	Yes or Unknown			No	1	8.81	1	no	no	no
8380	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2015		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	15.7	1	no	no	no
8381	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	146	2	Stable	No	Yes or Unknown			No	0	44.19	1	no	no	no
8382	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	IV	0	3.5		No	No			No	0	18.3	1	no	no	no
8383	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2015		31	2	Stable	Yes or Unknown	Yes or Unknown			No	1	5.06	1	no	no	no
8384	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	IV	0	27.5	Stable	No	No	Signature.7	BRCA2 | ERCC2 | FANCA | RAD51C	No	1	31.54	1	no	no	no
8385	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2015	IV	22	3.9	Stable	No	No			No	0	5.26000000000001	1	no	no	no
8386	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	IV	23	4.9	Stable	No	No	Signature.4		No	1	2.04	1	no	no	no
8387	ICI-treated	ICI as first line	71 - 75	Female	Sarcoma	2015	III	35	1.8	Stable	No	No		ERCC5 | TP53BP1	Yes	0	11.27	1	no	no	no
8388	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	IV	0	6.9	Stable	No	No	Signature.6		No	1	15.64	1	no	no	no
8389	ICI-treated	ICI as first line	61 - 65	Male	Esophageal	2015	II	456	8.8		No	No	Signature.17		Yes	1	6.08	1	no	no	no
8390	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	1319	9.7	Stable	No	Yes or Unknown	Signature.4	ATM	No	0	32.62	1	no	no	no
8391	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	IV	0	6.1	Stable	No	No		BRCA2 | SLX4	No	1	12.13	1	no	no	no
8392	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	286	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA1 | MSH6	No	1	4.93	1	no	no	no
8393	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2015	IV	1217	12.3	Stable	No	Yes or Unknown	Signature.13		No	0	10.25	1	no	no	no
8394	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	0	12.8	Stable	No	No	Signature.4		No	1	2.14	1	no	no	no
8395	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	II	42	2	Stable	No	No			Yes	0	19.78	1	no	no	no
8396	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	IV	1085	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.19		No	0	14.69	1	no	no	no
8397	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	III	25	7.9	Stable	No	No			No	1	18.53	1	no	no	no
8398	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	463	14.8	Indeterminate	No	Yes or Unknown	Signature.4		No	1	1.19	1	no	no	no
8399	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	III	252	7.9	Stable	No	Yes or Unknown	Signature.3		No	0	36.41	1	no	no	no
8400	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	III	182	4.9	Stable	No	No	Signature.7		Yes	0	45.54	1	no	no	no
8401	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	6	2	Stable	No	No			No	1	22.11	1	no	no	no
8402	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	72	17.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	0	18.13	1	no	no	no
8403	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	638	3.5		No	Yes or Unknown			No	1	5.56	1	no	no	no
8404	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	III	506	1.8		No	No			Yes	0	28.02	1	no	no	no
8405	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2015	IV	466	5.9		No	Yes or Unknown	Signature.11	PARP1	No	1	2.86	1	no	no	no
8406	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.51	1	no	no	no
8407	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	30	3.9	Stable	No	Yes or Unknown			No	1	20.11	1	no	no	no
8408	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	IV	159	27.5	Stable	No	Yes or Unknown	Signature.13	ATM | ATR | ERCC5 | MSH6 | PARP1	No	1	24.97	1	no	no	no
8409	ICI-treated	ICI as subsequent line	21 - 25	Male	Sarcoma	2015	IV	143	1	Stable	Yes or Unknown	Yes or Unknown			No	0	16.43	1	no	no	no
8410	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	89	6.9	Stable	No	Yes or Unknown			No	1	20.57	1	no	no	no
8411	ICI-treated	ICI as subsequent line	36 - 40	Male	Hepatobiliary	2015	IV	0	9.8	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	5.06	1	no	no	yes
8412	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	70	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	3.71	1	no	no	no
8413	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2015	IV	558	4.4		No	Yes or Unknown			No	1	1.52	1	no	no	no
8414	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	15	4.9	Stable	No	Yes or Unknown	Signature.1	PMS1	No	1	3.48	1	no	no	no
8415	ICI-treated	ICI as subsequent line	21 - 25	Male	Colorectal	2015	IV	7	3.9	Stable	No	No			No	1	4.14	1	no	no	no
8416	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	IV	0	6.9	Stable	No	Yes or Unknown	Signature.17		No	1	6.21	1	no	no	no
8417	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	0	40.78	1	no	no	no
8418	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	191	6.9	Stable	No	Yes or Unknown	Signature.24		No	1	3.21	1	no	no	no
8419	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	II	0	2	Stable	No	Yes or Unknown			No	1	36.96	1	no	no	no
8420	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	0	3.9	Stable	No	No		ARID1A	No	1	2.76	1	no	no	yes
8421	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	154	2	Stable	No	Yes or Unknown			No	1	1.61	1	no	no	no
8422	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	84	3	Stable	No	Yes or Unknown			No	1	7.1	1	no	no	no
8423	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2015	IV	268	3	Stable	No	Yes or Unknown			No	1	6.31	1	no	no	no
8424	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	IV	0	7.9	Stable	No	No			No	1	1.88	1	no	no	no
8425	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	0	7.9	Stable	No	No	Signature.4	FANCC	No	1	16.69	1	no	no	no
8426	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	28.81	1	no	no	no
8427	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2015	III	711	7		No	No	Signature.7		No	0	25.69	1	no	no	no
8428	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	II	349	1	Indeterminate	No	No			No	1	4.77	1	no	no	no
8429	ICI-treated	ICI as subsequent line	36 - 40	Male	Esophageal	2015	III	15	3	Stable	No	Yes or Unknown			No	1	0.59	1	no	no	no
8430	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2015	III	83	1	Stable	No	Yes or Unknown			No	1	9.99	1	no	no	no
8431	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	0	5.9	Stable	No	No		ATM	No	1	5.39	1	no	no	no
8432	ICI-treated	ICI as subsequent line	10-Jun	Female	Sarcoma	2015	III	0	0	Stable	No	No			No	1	0.490000000000002	1	no	no	no
8433	ICI-treated	ICI - unknown sequence	26 - 30	Male	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	35.94	1	no	no	no
8434	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2015	I	135	37.4	Stable	No	No	Signature.7	ATR | RAD54L	Yes	0	32.66	1	no	no	no
8435	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2015	III	299	51.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	MSH6	No	1	25.76	1	no	no	no
8436	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	301	12.3	Stable	No	Yes or Unknown	Signature.4		No	1	13.83	1	no	no	no
8437	ICI-treated	ICI as first line	61 - 65	Male	Colorectal	2015	IV	20	89.5	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC3 | MSH2 | RAD50	No	0	44.36	1	mut-MMRd	mut-MMRd	yes
8438	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	13	6.1		Yes or Unknown	Yes or Unknown			No	1	3.52	1	no	no	no
8439	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2015	IV	232	3	Stable	No	Yes or Unknown			No	1	2.72	1	no	no	no
8440	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	III	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	3.88	1	no	no	no
8441	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	379	34.4	Stable	No	Yes or Unknown	Signature.4		No	0	34.96	1	no	no	no
8442	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2015	IV	271	7.9	Indeterminate	No	Yes or Unknown	Signature.4		No	1	6.94	1	no	no	no
8443	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	350	1	Stable	No	Yes or Unknown			No	1	13.9	1	no	no	no
8444	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	1.38	1	no	no	no
8445	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	3	Stable	No	No			No	1	10.28	1	no	no	no
8446	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2015	IV	29	4.9	Stable	No	Yes or Unknown			No	1	1.74	1	no	no	no
8447	ICI-treated	ICI as subsequent line	36 - 40	Male	Head & Neck	2015	IV	125	1	Stable	No	Yes or Unknown			No	1	3.42	1	no	no	no
8448	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		17	3	Stable	Yes or Unknown	Yes or Unknown			No	1	4.54	1	no	no	no
8449	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2015	III	16	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	37.62	1	no	no	no
8450	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2015	IV	677	5.3	Stable	No	Yes or Unknown	Signature.8		No	1	26.12	1	no	no	no
8451	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	IV	27	5.9	Stable	No	No			No	1	3.09	1	no	no	no
8452	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	45	6.9	Stable	No	No	Signature.1		No	0	11.82	1	no	no	no
8453	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2015	IV	188	2.6	Stable	No	Yes or Unknown			No	0	28.87	1	no	no	no
8454	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	IV	271	4.9	Stable	No	Yes or Unknown		MSH6	No	0	28.06	1	no	no	no
8455	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		5	1	Stable	Yes or Unknown	Yes or Unknown			No	1	9.04	1	no	no	no
8456	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	623	5.3	Stable	No	Yes or Unknown		MDC1	No	1	12.1	1	no	no	no
8457	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2015	IV	0	26.6	Stable	No	No	Signature.7	ATR | MRE11A	No	0	34.76	1	no	no	no
8458	ICI-treated	ICI as subsequent line	36 - 40	Female	Renal	2015	IV	0	4.9	Stable	No	Yes or Unknown	Signature.3		No	0	12.75	1	no	no	no
8459	ICI-treated	ICI as subsequent line	56 - 60	Female	Hepatobiliary	2015	IV	0	1.8	Stable	No	Yes or Unknown			No	1	9.3	1	no	no	no
8460	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	69	17.7	Indeterminate	No	No	Signature.4		No	1	21.81	1	no	no	no
8461	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2015	IV	9	3.9	Stable	No	No	Signature.13	MDC1	No	1	9.07	1	no	no	no
8462	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	III	55	4.9	Stable	No	No	Signature.24		No	1	1.51	1	no	no	no
8463	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		1	3	Stable	Yes or Unknown	Yes or Unknown			No	1	21.75	1	no	no	no
8464	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	672	5.3	Stable	No	Yes or Unknown			No	1	14.13	1	no	no	no
8465	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	0	0.9		No	No			No	1	9.13	1	no	no	no
8466	ICI-treated	ICI - unknown sequence	66 - 70	Female	Hepatobiliary	2015	II	0	2	Stable	No	Yes or Unknown			No	0	2.03	1	no	no	no
8467	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	0	20.7	Stable	No	No	Signature.4	ARID1A	No	0	37.26	1	no	no	yes
8468	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	218	10.8	Stable	No	Yes or Unknown	Signature.4		No	1	1.9	1	no	no	no
8469	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	243	3.9	Stable	No	Yes or Unknown			No	1	31.84	1	no	no	no
8470	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	162	1	Stable	No	Yes or Unknown			Yes	0	43.7	1	no	no	no
8471	ICI-treated	ICI as subsequent line	31 - 35	Male	Sarcoma	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	23.26	1	no	no	no
8472	ICI-treated	ICI - unknown sequence	71 - 75	Female	CNS	2015		5	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.08	1	no	no	no
8473	ICI-treated	ICI as subsequent line	61 - 65	Male	Cutaneous Melanoma 	2015	IV	0	43.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | BRCA1 | FANCA	No	1	7.82	1	no	no	yes
8474	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	162	5.9	Indeterminate	No	Yes or Unknown	Signature.18	MRE11A	No	1	14.78	1	no	no	no
8475	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	1144	16.7	Stable	No	No	Signature.7		No	1	5.72	1	no	no	no
8476	ICI-treated	ICI as subsequent line	76 - 80	Female	Esophageal	2015	IV	24	4.9	Stable	No	No	Signature.3		No	1	1.38	1	no	no	no
8477	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	0	1	Indeterminate	No	No			No	1	17.71	1	no	no	no
8478	ICI-treated	ICI as first line	56 - 60	Male	CNS	2015		146	3.9	Stable	No	Yes or Unknown			No	1	21.82	1	no	no	no
8479	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		0	2	Stable	No	Yes or Unknown			No	1	1.71	1	no	no	no
8480	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	37	2	Stable	No	No			No	1	0.92	1	no	no	no
8481	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	574	14.8		No	Yes or Unknown	Signature.4	FANCA	No	1	3.75	1	no	no	no
8482	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	1	35.35	1	no	no	no
8483	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	437	12.3		No	Yes or Unknown	Signature.4	BRCA2	No	1	16.23	1	no	no	no
8484	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2015	III	0	6.9	Stable	No	No	Signature.20	BLM	No	0	35.94	1	no	no	no
8485	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	I	1031	1.8	Stable	No	Yes or Unknown			No	1	6.51000000000001	1	no	no	no
8486	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	40	13.8	Unstable	No	No	Signature.4		No	1	2.7	1	other-MMRd	other-MMRd	no
8487	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	20	0	Stable	No	No			No	1	6.34	1	no	no	no
8488	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2015	IV	207	4.9	Stable	No	Yes or Unknown			No	1	14.2	1	no	no	no
8489	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	53	18.7	Stable	No	Yes or Unknown	Signature.4	MDC1	No	0	29.44	1	no	no	no
8490	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2015	IV	706	0.9	Stable	No	Yes or Unknown			No	0	31.02	1	no	no	no
8491	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2015	III	44	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	13.31	1	no	no	no
8492	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	3.9	Stable	No	No	Signature.4		No	1	14.98	1	no	no	no
8493	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2015	IV	153	49.2	Unstable	No	Yes or Unknown	Signature.1	ARID1A | BRIP1 | MSH2 | MSH3 | SLX4	No	0	26.9	1	mut-MMRd	mut-MMRd	yes
8494	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	19	22.6	Stable	No	No	Signature.4	ARID1A | BRIP1 | MRE11A	No	0	38.41	1	no	no	yes
8495	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2015	IV	0	10.8	Stable	No	No			No	1	10.61	1	no	no	no
8496	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2015	II	330	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	3.85	1	no	no	yes
8497	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	39	2	Stable	No	No		ARID1A	No	1	3.64	1	no	no	yes
8498	ICI-treated	ICI as subsequent line	21 - 25	Female	Gastric	2015	IV	0	1	Stable	No	No			No	1	0.229999999999999	1	no	no	no
8499	ICI-treated	ICI as subsequent line	51 - 55	Male	Pancreatic	2015	II	31	3.9	Stable	No	No		ATM	No	1	8.47	1	no	no	no
8500	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2015	III	123	10.8	Stable	No	Yes or Unknown	Signature.29		No	1	10.64	1	no	no	no
8501	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	9	10.8	Stable	No	No	Signature.4	ARID1A | MUTYH | PALB2	No	1	6.08	1	no	no	yes
8502	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2015		6	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	9.69	1	no	no	no
8503	ICI-treated	ICI as subsequent line	15-Nov	Male	Hepatobiliary	2015	IV	9	0	Stable	No	Yes or Unknown			No	1	12.15	1	no	no	no
8504	ICI-treated	ICI as subsequent line	15-Nov	Female	Renal	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	7.23	1	no	no	no
8505	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		34	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	5.46	1	no	no	no
8506	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2015	I	43	7.9	Stable	No	Yes or Unknown	Signature.5		No	1	2.2	1	no	no	no
8507	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	143	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MRE11A	No	1	12.15	1	no	no	no
8508	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	17	0	Stable	No	No	Signature.26		No	0	26.91	1	no	no	no
8509	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	I	592	8.8		No	Yes or Unknown	Signature.8		No	1	1.61	1	no	no	no
8510	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	21	3	Stable	No	Yes or Unknown			No	0	44.81	1	no	no	no
8511	ICI-treated	ICI as first line	66 - 70	Female	Hepatobiliary	2015	III	35	2		No	No	Signature.25		Yes	0	36.11	1	no	no	no
8512	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	333	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	8.22	1	no	no	no
8513	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	0	40.21	1	no	no	no
8514	ICI-treated	ICI as subsequent line	61 - 65	Male	Colorectal	2015	III	8	153.5	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | ERCC5 | MLH1 | MSH6 | PMS1 | RAD50	No	1	1.68	1	no	no	yes
8515	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2015	III	358	8.8		Yes or Unknown	Yes or Unknown	Signature.25	BRCA1 | MRE11A	No	1	14.76	1	no	no	no
8516	ICI-treated	ICI as subsequent line	71 - 75	Male	Esophageal	2015	III	137	12.3	Stable	No	Yes or Unknown	Signature.19		No	1	0.460000000000001	1	no	no	no
8517	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2015	IV	0	15.7	Stable	No	No	Signature.7		Yes	0	46.36	1	no	no	no
8518	ICI-treated	ICI as subsequent line	31 - 35	Male	Pancreatic	2015	IV	0	3.9	Stable	No	No		BRCA1 | BRIP1	No	0	3.91	1	no	no	no
8519	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	5.9	Stable	No	No		ATM	No	1	8.57	1	no	no	no
8520	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2015		18	0	Stable	No	No			No	1	10.77	1	no	no	no
8521	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		4	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	2.79	1	no	no	no
8522	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2015	IV	407	10.5		No	Yes or Unknown	Signature.13	NBN	No	0	30.66	1	no	no	no
8523	ICI-treated	ICI as subsequent line	86 - 90	Male	Sarcoma	2015		35	35.4	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA1	No	1	2.66	1	no	no	no
8524	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2015	II	862	4.4	Stable	No	Yes or Unknown			No	1	0.98	1	no	no	no
8525	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2015	IV	19	6.9	Stable	No	No		ARID1A	No	1	36.76	1	no	no	yes
8526	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	2	23.6	Stable	No	No	Signature.4	ARID1A | MDC1	No	0	35.06	1	no	no	yes
8527	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		28	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	1.67	1	no	no	no
8528	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	IV	18	5.9	Stable	No	Yes or Unknown	Signature.24		No	0	36.5	1	no	no	no
8529	ICI-treated	ICI as subsequent line	46 - 50	Female	Head & Neck	2015	IV	337	3.5	Stable	No	Yes or Unknown			No	0	35.88	1	no	no	no
8530	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2015	IV	0	47.2	Unstable	No	No	Signature.6	ARID1A | ATM | MRE11A	No	1	4.93	1	other-MMRd	mut-MMRd	yes
8531	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	IV	45	3	Stable	No	Yes or Unknown			No	1	18.4	1	no	no	no
8532	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	III	379	7.9	Stable	No	Yes or Unknown	Signature.13	BLM	No	1	3.03	1	no	no	no
8533	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2015	II	971	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	14.29	1	no	no	no
8534	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	0	20.7	Stable	No	No	Signature.4	ATM | BRIP1	No	1	14.12	1	no	no	no
8535	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	65	7.9	Stable	No	No	Signature.24		No	0	36.54	1	no	no	no
8536	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2015		7	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	31.27	1	no	no	no
8537	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	III	242	3.5		No	Yes or Unknown			No	1	8.24	1	no	no	no
8538	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2015		3	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	2.14	1	no	no	no
8539	ICI-treated	ICI as first line	61 - 65	Female	Renal	2015	IV	0	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	18.79	1	no	no	no
8540	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	1.01	1	no	no	no
8541	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2015	III	1114	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	24.64	1	no	no	no
8542	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		6	4.4		Yes or Unknown	Yes or Unknown			No	1	14.13	1	no	no	no
8543	ICI-treated	ICI - unknown sequence	51 - 55	Female	Cutaneous Melanoma 	2015	III	649	4.4		Yes or Unknown	Yes or Unknown	Signature.3		No	1	14.19	1	no	no	no
8544	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	34	0	Stable	No	No			No	1	18.49	1	no	no	no
8545	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	III	277	2	Stable	No	No			No	1	6.2	1	no	no	no
8546	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2015		4	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	7.03	1	no	no	no
8547	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	0	3	Stable	No	No			No	1	13.18	1	no	no	no
8548	ICI-treated	ICI as subsequent line	31 - 35	Male	Head & Neck	2015	IV	38	4.9	Unstable	No	No	Signature.1		No	1	2.99	1	other-MMRd	other-MMRd	no
8549	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	IV	39	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	7.95	1	no	no	no
8550	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2015	III	463	6.1	Stable	No	Yes or Unknown	Signature.28		No	1	1.64	1	no	no	no
8551	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	9.8	Stable	No	No	Signature.13		No	1	13.44	1	no	no	no
8552	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	III	0	1	Stable	No	No			No	0	38.93	1	no	no	no
8553	ICI-treated	ICI as subsequent line	36 - 40	Male	Colorectal	2015	IV	0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.02	1	no	no	no
8554	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	II	0	8.9	Stable	No	No	Signature.4		No	1	5.89	1	no	no	no
8555	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2015	IV	7	1	Stable	No	Yes or Unknown			No	0	0.689999999999998	1	no	no	no
8556	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	II	48	49.2	Stable	No	No	Signature.4	BLM | CHEK2 | PMS2	No	0	12.62	1	no	no	no
8557	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	6.74	1	no	no	no
8558	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	161	8.8	Stable	No	Yes or Unknown		ARID1A	No	1	0.43	1	no	no	yes
8559	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	13	10.8	Stable	No	No	Signature.13		No	1	5.75	1	no	no	no
8560	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	IV	98	2	Stable	No	Yes or Unknown			No	0	12.88	1	no	no	no
8561	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2015	I	0	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	0	40.47	1	no	no	no
8562	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	18	4.9	Stable	No	No		ATR	No	1	21.48	1	no	no	no
8563	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.13		No	1	2.49	1	no	no	no
8564	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	34	4.9	Stable	No	No			No	1	11.34	1	no	no	no
8565	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		43	2	Stable	Yes or Unknown	Yes or Unknown			No	1	4.66	1	no	no	no
8566	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2015	IV	0	3.9	Stable	No	No			No	1	0.889999999999997	1	no	no	no
8567	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2015	I	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	7.09	1	no	no	no
8568	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	I	122	11.8	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	1	6.27	1	no	no	no
8569	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	306	7.9	Stable	No	No	Signature.3	MSH2	Yes	0	44.65	1	no	no	no
8570	ICI-treated	ICI as subsequent line	76 - 80	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	4.63	1	no	no	no
8571	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	III	89	18.7	Stable	No	Yes or Unknown	Signature.18		No	0	17.94	1	no	no	no
8572	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2015	III	0	7.9	Stable	No	Yes or Unknown			No	1	24.51	1	no	no	no
8573	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	44	8.9	Stable	No	No	Signature.4	BRCA2 | PALB2	No	1	0.69	1	no	no	no
8574	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	II	106	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | BRCA1	No	1	4.3	1	no	no	no
8575	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2015		24	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	9.4	1	no	no	no
8576	ICI-treated	ICI as subsequent line	41 - 45	Male	Hepatobiliary	2015	IV	0	3.9	Stable	No	No			No	1	0.949999999999999	1	no	no	no
8577	ICI-treated	ICI as subsequent line	41 - 45	Female	Pancreatic	2015	II	28	2	Stable	No	No			No	0	29.67	1	no	no	no
8578	ICI-treated	ICI as subsequent line	36 - 40	Female	NSCLC	2015	IV	319	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	23.98	1	no	no	no
8579	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	III	111	15.7	Stable	No	No	Signature.7		No	1	10.41	1	no	no	no
8580	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2015	IV	199	0	Stable	No	No			No	0	34.66	1	no	no	no
8581	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	0	3.9	Stable	No	No			No	1	4.93	1	no	no	no
8582	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	IV	43	5.3	Stable	No	No		PMS2	No	1	7.59	1	no	no	no
8583	ICI-treated	ICI as subsequent line	36 - 40	Female	Breast	2015	IV	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	0.720000000000006	1	no	no	no
8584	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	66	10.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	0.85	1	no	no	yes
8585	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	III	11	6.9	Stable	No	No	Signature.7		No	0	33.9	1	no	no	no
8586	ICI-treated	ICI as first line	66 - 70	Female	Renal	2015	III	0	5.3	Stable	Yes or Unknown	Yes or Unknown		ATM | CHEK2	Yes	0	21.65	1	no	no	no
8587	ICI-treated	ICI as subsequent line	61 - 65	Female	Cutaneous Melanoma 	2015		516	5.3	Stable	No	Yes or Unknown			No	1	13.57	1	no	no	no
8588	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	IV	0	6.9	Stable	No	No			No	1	7.2	1	no	no	no
8589	ICI-treated	ICI as subsequent line	51 - 55	Female	CNS	2015		6	5.9	Stable	No	No			No	1	11.34	1	no	no	no
8590	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2015	IV	8	0	Stable	No	Yes or Unknown			No	1	2.92	1	no	no	no
8591	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	801	0	Stable	No	Yes or Unknown			No	1	7.42	1	no	no	no
8592	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2015	IV	0	4.9	Stable	No	No	Signature.2	ARID1A	No	1	13.83	1	no	no	yes
8593	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		117	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	9.33	1	no	no	no
8594	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	19.7	Stable	No	No	Signature.4	MLH1 | MUTYH | PMS2	No	1	25.59	1	no	no	no
8595	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	IV	0	9.7		No	No	Signature.5		No	1	4.47	1	no	no	no
8596	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2015		687	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	32.23	1	no	no	no
8597	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	76	18.7	Stable	No	No	Signature.4	MDC1 | MSH2 | RAD50	No	0	23.85	1	no	no	no
8598	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2015	IV	27	4.9	Stable	No	Yes or Unknown	Signature.4		No	0	4.63	1	no	no	no
8599	ICI-treated	ICI as subsequent line	51 - 55	Female	Head & Neck	2015	I	389	3.5		Yes or Unknown	Yes or Unknown	Signature.1		No	0	26.91	1	no	no	no
8600	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	22	16.7	Stable	No	No	Signature.4		No	0	38.5	1	no	no	no
8601	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2015	IV	18	5.3		No	Yes or Unknown	Signature.29		No	0	1.08	1	no	no	no
8602	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	71	11.8	Stable	No	No	Signature.18	ATM | ERCC4	No	0	19.65	1	no	no	no
8603	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	27	5.9	Stable	No	No			No	1	6.05	1	no	no	no
8604	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	892	14	Stable	No	Yes or Unknown	Signature.7	ARID1A	No	0	22.73	1	no	no	yes
8605	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2015	III	33	3	Stable	No	No	Signature.13		No	0	43.23	1	no	no	no
8606	ICI-treated	ICI as subsequent line	71 - 75	Female	Head & Neck	2015	III	464	7		No	Yes or Unknown	Signature.1		No	0	26.51	1	no	no	no
8607	ICI-treated	ICI as subsequent line	51 - 55	Female	SCLC	2015	IV	211	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A	No	1	2.27	1	no	no	yes
8608	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	III	195	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	1	0.19	1	no	no	no
8609	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	III	40	5.9	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.18		No	1	24.58	1	no	no	no
8610	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2015	III	0	3.9	Stable	No	Yes or Unknown	Signature.16	ATM	No	1	12.91	1	no	no	no
8611	ICI-treated	ICI - unknown sequence	51 - 55	Male	Prostatic	2015	III	0	3	Stable	No	Yes or Unknown			No	1	0.560000000000002	1	no	no	no
8612	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	I	0	0.9		Yes or Unknown	Yes or Unknown			No	0	36.44	1	no	no	no
8613	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	II	23	48.2	Unstable	No	No	Signature.6	ARID1A | MRE11A | RAD51C	No	0	26.94	1	other-MMRd	mut-MMRd	yes
8614	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2015		13	3	Stable	Yes or Unknown	Yes or Unknown			No	1	16.09	1	no	no	no
8615	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	III	48	7	Stable	No	No			No	0	24.77	1	no	no	no
8616	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2015		14	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.98	1	no	no	no
8617	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	703	3.5	Stable	No	Yes or Unknown		ATM	No	1	10.12	1	no	no	no
8618	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2015	IV	0	9.8	Stable	No	No	Signature.26		No	0	41.66	1	no	no	no
8619	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2015	IV	65	4.4	Stable	No	Yes or Unknown			No	0	36.97	1	no	no	no
8620	ICI-treated	ICI as first line	61 - 65	Male	Sarcoma	2015	III	13	3.5	Stable	No	Yes or Unknown			No	0	14.52	1	no	no	no
8621	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	22	4.9	Stable	No	Yes or Unknown			No	0	16.52	1	no	no	no
8622	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	31	3.5	Stable	No	No		SLX4	No	0	17.97	1	no	no	no
8623	ICI-treated	ICI as subsequent line	56 - 60	Male	Sarcoma	2015	I	14	0	Stable	No	Yes or Unknown			No	0	8.8	1	no	no	no
8624	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	III	167	5.9	Stable	No	Yes or Unknown	Signature.13	CHEK2	No	1	0.759999999999998	1	no	no	no
8625	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	20	15.7	Stable	No	No	Signature.4		No	1	4.83	1	no	no	no
8626	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	III	377	10.8		No	Yes or Unknown	Signature.13		No	1	3.51	1	no	no	no
8627	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2015	IV	433	0		No	Yes or Unknown			No	1	28.98	1	no	no	no
8628	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	II	1064	7	Stable	No	No	Signature.19	ERCC2	Yes	1	2.4	1	no	no	no
8629	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	0	7.9	Stable	No	Yes or Unknown	Signature.15		No	1	23.49	1	no	no	no
8630	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2015	III	27	51.8	Unstable	No	Yes or Unknown	Signature.1	ARID1A | ATM | BRCA2 | MSH3 | PARP1 | RAD54L	No	0	14.71	1	other-MMRd	mut-MMRd	yes
8631	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	III	623	1.8	Stable	No	No			No	1	13.74	1	no	no	no
8632	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	284	0		No	Yes or Unknown			No	1	8.64	1	no	no	no
8633	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	II	491	4.4	Stable	No	Yes or Unknown			No	1	24.21	1	no	no	no
8634	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2015	I	30	3.5	Stable	No	No			No	0	9.76	1	no	no	no
8635	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	IV	32	43.3	Stable	No	No	Signature.7	ARID1A | MSH2 | PALB2	No	0	43.73	1	no	no	yes
8636	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	II	391	28.1		No	No	Signature.7	ATM | BLM | ERCC5 | MDC1 | NBN	Yes	1	3.16	1	no	no	no
8637	ICI-treated	ICI as subsequent line	36 - 40	Female	Breast	2015	II	512	4.4	Stable	No	Yes or Unknown	Signature.3		No	1	5.19	1	no	no	no
8638	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2015	IV	21	4.9	Stable	No	Yes or Unknown		ATM	No	1	20.63	1	no	no	no
8639	ICI-treated	ICI as subsequent line	36 - 40	Male	Bladder	2015	IV	229	23.6	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	12.49	1	no	no	no
8640	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	II	21	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ATM	No	0	40.31	1	no	no	no
8641	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2015	I	234	3.5		No	Yes or Unknown	Signature.13		Yes	1	1.08	1	no	no	no
8642	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	IV	385	1	Stable	No	Yes or Unknown			No	1	11.11	1	no	no	no
8643	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2015	IV	27	3	Stable	No	No			No	1	7.13	1	no	no	no
8644	ICI-treated	ICI - unknown sequence	0 - 5	Male	CNS	2015		471	0		Yes or Unknown	Yes or Unknown			No	0	19.78	1	no	no	no
8645	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2015	III	0	23.6	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	0	25.1	1	no	no	yes
8646	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	9.56	1	no	no	no
8647	ICI-treated	ICI as first line	51 - 55	Female	Endometrial	2015	IV	344	31.5	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ERCC5	No	0	38.15	1	other-MMRd	mut-MMRd	yes
8648	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		6	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.94	1	no	no	no
8649	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	58	6.9	Stable	No	Yes or Unknown	Signature.5	ERCC4	No	1	3.09	1	no	no	no
8650	ICI-treated	ICI as subsequent line	51 - 55	Male	Prostatic	2015	IV	47	1	Stable	No	No			No	1	0.66	1	no	no	no
8651	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2015	IV	182	1	Stable	No	Yes or Unknown			No	1	21.32	1	no	no	no
8652	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2015	IV	658	7	Stable	No	Yes or Unknown	Signature.7		No	1	6.7	1	no	no	no
8653	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	0	6.9	Stable	No	No	Signature.4	ARID1A	No	0	35.62	1	no	no	yes
8654	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	253	8.9	Stable	No	Yes or Unknown	Signature.4		No	0	35.25	1	no	no	no
8655	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		3	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	13.24	1	no	no	no
8656	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	0.26	1	no	no	no
8657	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2015	IV	0	7.9	Stable	No	No			No	1	11.17	1	no	no	no
8658	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2015	II	0	3.9	Stable	No	No	Signature.1		No	1	5.98	1	no	no	no
8659	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2015	IV	459	5.3		No	Yes or Unknown	Signature.1	MSH6	No	1	10.65	1	no	no	no
8660	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2015	III	35	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	15.87	1	no	no	no
8661	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2015	IV	0	4.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	28.13	1	no	no	no
8662	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2015	III	5	3	Stable	No	No		CHEK2	No	1	7.36	1	no	no	no
8663	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	25	32.5	Stable	No	No	Signature.4		No	1	35.58	1	no	no	no
8664	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	298	1.8		No	Yes or Unknown			No	1	9.23	1	no	no	no
8665	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2015	IV	53	3	Stable	No	No			No	0	3.55	1	no	no	no
8666	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	III	319	4.4		No	Yes or Unknown	Signature.5	CHEK2	No	1	12.81	1	no	no	no
8667	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2015	II	488	23.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ERCC2 | MDC1	No	0	12.88	1	no	no	no
8668	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		8	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	10.02	1	no	no	no
8669	ICI-treated	ICI as first line	66 - 70	Male	Renal	2015	IV	0	3.9	Stable	No	No			No	1	9.46	1	no	no	no
8670	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2015	II	168	16.7	Stable	No	Yes or Unknown	Signature.2	CHEK1 | MDC1	No	1	0.289999999999999	1	no	no	no
8671	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	III	509	6.1	Stable	No	Yes or Unknown			No	0	11.73	1	no	no	no
8672	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	654	10.5	Stable	No	Yes or Unknown	Signature.2	ARID1A	No	0	22.96	1	no	no	yes
8673	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	224	3.9	Stable	No	Yes or Unknown	Signature.2		No	1	4.34	1	no	no	no
8674	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	18	0	Stable	No	No		BRCA2	No	0	0.59	1	no	no	no
8675	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	138	0	Stable	No	Yes or Unknown			No	1	8.57	1	no	no	no
8676	ICI-treated	ICI as subsequent line	76 - 80	Male	Head & Neck	2015	IV	456	5.3		No	Yes or Unknown			No	1	15.74	1	no	no	no
8677	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	III	523	15.8	Stable	No	No	Signature.7	ARID1A | BLM | BRIP1 | ERCC5	No	0	29.86	1	no	no	yes
8678	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	38	6.9	Stable	No	No			No	0	3.19	1	no	no	no
8679	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2015	III	27	4.9	Stable	No	Yes or Unknown			No	1	2.13	1	no	no	no
8680	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	301	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | BRCA2 | ERCC4 | MSH6	No	1	18.07	1	no	no	yes
8681	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	4.4		No	No		BRCA2	No	1	32.98	1	no	no	no
8682	ICI-treated	ICI as subsequent line	21 - 25	Female	Colorectal	2015	IV	127	4.9	Stable	No	Yes or Unknown		ATR	No	1	4.47	1	no	no	no
8683	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	15	6.9	Stable	No	No	Signature.13	ATM	No	1	14.82	1	no	no	no
8684	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	0	10.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	21.75	1	no	no	no
8685	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	38	11.8	Stable	No	No	Signature.24	MDC1 | PARP1	No	1	1.48	1	no	no	no
8686	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2015	IV	0	3	Indeterminate	No	No			No	1	7.95	1	no	no	no
8687	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	102	26.3		No	No	Signature.7	ERCC5 | MSH2	Yes	0	34.95	1	no	no	no
8688	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	21	7.9	Stable	No	No	Signature.24		No	1	9.66	1	no	no	no
8689	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	22	2	Stable	No	Yes or Unknown			No	1	29.73	1	no	no	no
8690	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2015	II	71	0	Stable	No	No			No	0	39.78	1	no	no	no
8691	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.24		No	1	5.36	1	no	no	no
8692	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2015	IV	0	4.9	Stable	No	No			No	1	6.47	1	no	no	no
8693	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	21	11.8	Stable	No	No	Signature.4		No	0	31.51	1	no	no	no
8694	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	498	5.3	Stable	No	Yes or Unknown			No	1	4.63	1	no	no	no
8695	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2015	IV	293	1		No	No			No	1	22.7	1	no	no	no
8696	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	44	14.9		No	No	Signature.4	MDC1 | MSH3 | SLX4	No	1	18.01	1	no	no	no
8697	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	25	3	Stable	No	Yes or Unknown			No	1	4.24	1	no	no	no
8698	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	376	13.2		No	Yes or Unknown	Signature.4		No	1	14.94	1	no	no	no
8699	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	II	552	35.1	Stable	No	No	Signature.7	MSH2	Yes	0	23.95	1	no	no	no
8700	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	2	7.9	Stable	No	No	Signature.4		No	1	3.45	1	no	no	no
8701	ICI-treated	ICI as subsequent line	46 - 50	Female	Breast	2015	II	37	4.4		Yes or Unknown	Yes or Unknown	Signature.1		No	1	1.41	1	no	no	no
8702	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2015	III	14	22.6	Stable	No	No	Signature.7		Yes	1	36.6	1	no	no	no
8703	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2015	IV	22	3.9	Stable	No	No			No	1	4.9	1	no	no	no
8704	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2015	IV	12	3.9	Stable	No	No			No	1	0.85	1	no	no	no
8705	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	IV	53	7.9	Stable	No	No	Signature.3		No	1	4.73	1	no	no	no
8706	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	II	21	25.6		No	No	Signature.7		Yes	0	22.11	1	no	no	no
8707	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	8	11.8	Stable	No	No	Signature.4		No	1	7.36	1	no	no	no
8708	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2015	IV	3	2	Stable	No	No			No	0	3.45	1	no	no	no
8709	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	III	384	70.2		No	No	Signature.7	ATM | ATR | BRCA1 | MRE11A	Yes	0	26.16	1	no	no	no
8710	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2015	II	112	1	Stable	No	Yes or Unknown			No	1	29.07	1	no	no	no
8711	ICI-treated	ICI as subsequent line	41 - 45	Female	Hepatobiliary	2015	IV	2	13.8	Stable	No	No	Signature.6	ARID1A	No	0	22.73	1	no	no	yes
8712	ICI-treated	ICI - unknown sequence	76 - 80	Female	CNS	2015		8	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	14.88	1	no	no	no
8713	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	39	9.8	Stable	No	No	Signature.4	ATR	No	0	26.65	1	no	no	no
8714	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	III	74	6.9	Stable	No	No	Signature.3		No	1	3.32	1	no	no	no
8715	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	IV	15	40.3	Stable	No	No	Signature.7	MSH6 | XRCC2	Yes	0	37.95	1	no	no	no
8716	ICI-treated	ICI as subsequent line	71 - 75	Female	SCLC	2015	IV	3	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | ATR | MSH2	No	1	0.72	1	no	no	yes
8717	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	II	28	5.9	Stable	No	No			No	0	9.52	1	no	no	no
8718	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	0	6.9	Stable	No	No	Signature.1		No	1	9.92	1	no	no	no
8719	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	59	16.7	Stable	No	Yes or Unknown	Signature.4	BRCA1 | ERCC5	No	0	24.08	1	no	no	no
8720	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	33.31	1	no	no	no
8721	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	IV	11	5.9	Stable	No	No			No	1	1.54	1	no	no	no
8722	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2015		6	7.9	Stable	No	No	Signature.1		No	1	17.84	1	no	no	no
8723	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	I	36	8.8		No	No	Signature.13		No	1	13.34	1	no	no	no
8724	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2016	IV	0	3.5		No	No	Signature.8	BRIP1	No	1	1.67	1	no	no	no
8725	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	III	36	8.8	Stable	No	Yes or Unknown	Signature.2	ATM	No	1	7.76000000000001	1	no	no	no
8726	ICI-treated	ICI as first line	36 - 40	Male	Colorectal	2015	IV	162	8.8	Stable	No	No		RAD50	No	0	15.34	1	no	no	no
8727	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	III	181	17.6		No	Yes or Unknown	Signature.13	MSH3 | MSH6	No	1	1.41	1	no	no	no
8728	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	0	47.2	Stable	No	No	Signature.13	CHEK2 | ERCC5 | FANCA | RAD50	No	1	10.71	1	no	no	no
8729	ICI-treated	ICI as first line	26 - 30	Female	Cutaneous Melanoma 	2015	IV	11	15.7	Indeterminate	No	No	Signature.7		Yes	1	1.02	1	no	no	no
8730	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2015	I	731	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	2.69	1	no	no	no
8731	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2015	IV	32	29.5	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	16.42	1	no	no	yes
8732	ICI-treated	ICI as subsequent line	46 - 50	Female	Esophageal	2015	IV	0	3.9	Stable	No	No			No	1	3.91	1	no	no	no
8733	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2015	II	668	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	15.87	1	no	no	no
8734	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	193	2	Stable	No	Yes or Unknown			No	1	28.26	1	no	no	no
8735	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2015	IV	7	2	Stable	No	No			No	1	7.95	1	no	no	no
8736	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2015	III	0	1.8	Stable	No	No			No	0	12.68	1	no	no	no
8737	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	III	287	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	15.74	1	no	no	no
8738	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	IV	34	12.8	Stable	No	No	Signature.7	ARID1A	No	1	0.790000000000001	1	no	no	yes
8739	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	258	5.3		Yes or Unknown	Yes or Unknown	Signature.24		No	1	9	1	no	no	no
8740	ICI-treated	ICI as subsequent line	61 - 65	Female	Bladder	2015	II	0	5.9	Stable	No	No		ARID1A	No	0	37.72	1	no	no	yes
8741	ICI-treated	ICI as subsequent line	81 - 85	Female	Colorectal	2015	III	149	43.3	Unstable	No	Yes or Unknown	Signature.21	ARID1A	No	0	31.04	1	other-MMRd	mut-MMRd	yes
8742	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2016	III	0	5.3		No	No	Signature.19		No	1	1.31	1	no	no	no
8743	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	III	427	8.8		No	No	Signature.7	ATM | BRCA1	No	0	26.38	1	no	no	no
8744	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	15	3.9	Indeterminate	No	No	Signature.1	ERCC2	No	1	6.6	1	no	no	no
8745	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	II	500	64.1	Stable	No	Yes or Unknown	Signature.7	ARID1A | CHEK2 | ERCC2 | MDC1 | MLH1 | PMS2 | RAD50	No	0	25.42	1	no	no	yes
8746	ICI-treated	ICI as first line	66 - 70	Male	CNS	2015		38	3	Stable	No	No			No	1	16.33	1	no	no	no
8747	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	21	10.8	Stable	No	No	Signature.13		No	0	29.41	1	no	no	no
8748	ICI-treated	ICI as first line	36 - 40	Female	Cutaneous Melanoma 	2015	III	486	0.9	Stable	No	No			No	0	14.53	1	no	no	no
8749	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	I	0	3	Stable	No	Yes or Unknown			No	1	6.77	1	no	no	no
8750	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	4	2	Stable	No	No			No	1	3.87	1	no	no	no
8751	ICI-treated	ICI as first line	26 - 30	Female	Cutaneous Melanoma 	2015	III	28	0		No	No			No	1	20.92	1	no	no	no
8752	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	III	22	9.8	Stable	No	No	Signature.1	RAD54L	No	1	8.93	1	no	no	no
8753	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	17.6	Stable	No	No	Signature.4	ATM | ERCC4	No	0	34.82	1	no	no	no
8754	ICI-treated	ICI as first line	51 - 55	Male	CNS	2015		0	6.9	Stable	No	No			No	1	14.16	1	no	no	no
8755	ICI-treated	ICI as first line	66 - 70	Male	SCLC	2015	IV	106	8.9	Stable	No	No	Signature.16	BRCA2	No	1	10.38	1	no	no	no
8756	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	IV	376	5.3	Stable	No	Yes or Unknown		PARP1	No	0	22.77	1	no	no	no
8757	ICI-treated	ICI as subsequent line	10-Jun	Female	CNS	2015		710	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	4.79	1	no	no	no
8758	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	261	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	37.42	1	no	no	no
8759	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	II	30	1.8		No	No			No	0	22.02	1	no	no	no
8760	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2015	I	612	129	Stable	No	No	Signature.7	ARID1A | BRCA2 | FANCA | MDC1 | MSH2 | RAD52 | RAD54L | TP53BP1	No	0	1.38	1	no	no	yes
8761	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	8	5.9	Stable	No	No			No	1	0.99	1	no	no	no
8762	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	IV	36	4.9	Stable	No	No			No	1	5.39	1	no	no	no
8763	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	52	17.7	Stable	No	No	Signature.4	MSH2	No	0	30.55	1	no	no	no
8764	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	360	14.9		Yes or Unknown	Yes or Unknown	Signature.7		Yes	0	26.68	1	no	no	no
8765	ICI-treated	ICI as first line	71 - 75	Male	Hepatobiliary	2015	III	133	6.9	Stable	No	No		ARID1A	No	1	5.32	1	no	no	yes
8766	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2015		2	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.8		No	1	12.69	1	no	no	no
8767	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2015	III	0	0.9		No	No			No	0	5.52	1	no	no	no
8768	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	57	20.7	Stable	No	No	Signature.13		No	1	13.93	1	no	no	no
8769	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	4	2	Indeterminate	No	Yes or Unknown			No	1	23.26	1	no	no	no
8770	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2015	IV	25	8.9	Stable	No	No	Signature.4	ARID1A	No	1	27.79	1	no	no	yes
8771	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		11	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	7.2	1	no	no	no
8772	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	III	244	0.9		No	Yes or Unknown			No	1	2.86	1	no	no	no
8773	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	0	3.9	Stable	Yes or Unknown	Yes or Unknown	Signature.6		No	1	0.950000000000003	1	no	no	no
8774	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	22	22.6	Stable	No	No	Signature.4	ATR | MDC1	No	0	32.59	1	no	no	no
8775	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2016	IV	0	3	Stable	No	No		BRCA2	No	1	2.04	1	no	no	no
8776	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	460	12.3	Stable	No	Yes or Unknown	Signature.24		No	1	12.32	1	no	no	no
8777	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015		28	3.9	Stable	No	Yes or Unknown			No	0	16.76	1	no	no	no
8778	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	24	4.4		No	No	Signature.4	FANCC	No	1	21.25	1	no	no	no
8779	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2016	IV	183	8.8		No	Yes or Unknown	Signature.13		No	1	1.61	1	no	no	no
8780	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	IV	29	5.9	Stable	No	No	Signature.13		No	1	3.55	1	no	no	no
8781	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	7.9	Indeterminate	No	No	Signature.16	BRCA1 | CHEK2	No	1	1.41	1	no	no	no
8782	ICI-treated	ICI as first line	66 - 70	Male	SCLC	2015	IV	276	9.8	Stable	No	No	Signature.29	ATR	No	1	8.41	1	no	no	no
8783	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	910	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.11	ARID1A | ATM	No	0	11.5	1	no	no	yes
8784	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2015	II	981	28.1	Stable	No	No	Signature.7		Yes	0	9.46	1	no	no	no
8785	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2016	IV	88	2	Stable	Yes or Unknown	Yes or Unknown			No	0	9.2	1	no	no	no
8786	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2015	IV	456	93	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | BLM | BRCA1 | BRCA2 | MLH1 | MSH2 | MSH3 | MSH6 | PARP1 | TP53BP1	No	1	0.759999999999998	1	mut-MMRd	mut-MMRd	yes
8787	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	16.7	Stable	No	No	Signature.4	ARID1A | ATM	No	1	21.19	1	no	no	yes
8788	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	11	11.8	Stable	No	No	Signature.4		No	1	6.18	1	no	no	no
8789	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.1	FANCA | PALB2	No	1	0.92	1	no	no	no
8790	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2016	IV	10	5.9	Stable	No	No			No	1	3.32	1	no	no	no
8791	ICI-treated	ICI as first line	46 - 50	Male	Renal	2016	IV	0	5.3	Stable	No	Yes or Unknown			No	1	28.52	1	no	no	no
8792	ICI-treated	ICI - unknown sequence	56 - 60	Male	Prostatic	2015	IV	6	1	Stable	No	Yes or Unknown		ATM	No	1	2.11	1	no	no	no
8793	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2016	IV	51	7	Stable	No	No			No	1	10.38	1	no	no	no
8794	ICI-treated	ICI as subsequent line	16 - 20	Female	Sarcoma	2015	III	104	2	Stable	Yes or Unknown	Yes or Unknown			No	1	20.41	1	no	no	no
8795	ICI-treated	ICI as subsequent line	46 - 50	Male	Hepatobiliary	2016	II	36	1.8		No	No			No	1	10.67	1	no	no	no
8796	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		13	3	Stable	Yes or Unknown	Yes or Unknown			No	0	7.3	1	no	no	no
8797	ICI-treated	ICI as subsequent line	31 - 35	Male	Head & Neck	2015	II	429	8.8		Yes or Unknown	Yes or Unknown	Signature.24	ARID1A	No	0	6.96	1	no	no	yes
8798	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	IV	1	7	Stable	No	No	Signature.4		No	1	9.23	1	no	no	no
8799	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	II	17	4.9	Stable	No	No			No	1	19.38	1	no	no	no
8800	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	0	69.8	Stable	No	No	Signature.7	ERCC5 | MDC1 | MRE11A | NBN | RAD51C	No	0	38.21	1	no	no	no
8801	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	32	7.9	Stable	No	Yes or Unknown	Signature.24	ATM	No	1	16.06	1	no	no	no
8802	ICI-treated	ICI as subsequent line	31 - 35	Male	Hepatobiliary	2016	IV	0	10.8	Stable	No	No	Signature.3	ARID1A | BRCA2 | RAD51C	No	1	3.25	1	no	no	yes
8803	ICI-treated	ICI as subsequent line	41 - 45	Female	Sarcoma	2015	IV	242	0.9		No	Yes or Unknown			No	0	3.55	1	no	no	no
8804	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	21	3	Stable	No	No			No	1	12.85	1	no	no	no
8805	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	17	1	Stable	No	No			No	1	12.91	1	no	no	no
8806	ICI-treated	ICI as subsequent line	31 - 35	Female	Ovarian	2016	II	292	1.8		No	Yes or Unknown	Signature.1		No	1	0.59	1	no	no	no
8807	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2016	IV	234	5.3		No	Yes or Unknown	Signature.5		No	1	1.77	1	no	no	no
8808	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	7	5.9	Stable	No	No	Signature.4		No	1	16.49	1	no	no	no
8809	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	360	0		No	Yes or Unknown			No	0	28.06	1	no	no	no
8810	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2016	III	53	44.8	Unstable	No	Yes or Unknown	Signature.6	BRCA2 | MSH3	No	0	21.72	1	other-MMRd	mut-MMRd	no
8811	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2016	IV	0	1	Indeterminate	No	No			No	0	12.09	1	no	no	no
8812	ICI-treated	ICI as subsequent line	26 - 30	Male	Pancreatic	2016	IV	0	12.8	Stable	No	No		CHEK2	No	1	1.54	1	no	no	no
8813	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	29	3.9	Stable	No	Yes or Unknown			No	0	29.67	1	no	no	no
8814	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	40.28	1	no	no	no
8815	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	30	9.8	Stable	No	No	Signature.4		No	1	0.390000000000001	1	no	no	no
8816	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	299	10.5		No	No	Signature.7	PMS1	Yes	0	29.64	1	no	no	no
8817	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	7	6.9	Stable	No	No	Signature.4		No	1	1.84	1	no	no	no
8818	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	47	5.9	Stable	No	No	Signature.4		No	1	1.91	1	no	no	no
8819	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	IV	0	1.8		Yes or Unknown	Yes or Unknown			No	0	33.58	1	no	no	no
8820	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2016	III	585	2.6	Stable	No	Yes or Unknown			No	0	8.31	1	no	no	no
8821	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	3	Stable	No	No			No	1	2.66	1	no	no	no
8822	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2016	IV	0	1	Stable	No	No			No	0	37.06	1	no	no	no
8823	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2016	IV	233	1.8		No	Yes or Unknown			No	1	9.59	1	no	no	no
8824	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	0	20.2		No	No	Signature.4	ARID1A	No	1	6.44	1	no	no	yes
8825	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	219	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.81	1	no	no	no
8826	ICI-treated	ICI as first line	66 - 70	Male	Renal	2016	IV	5	5.3	Indeterminate	No	No			Yes	0	30.82	1	no	no	no
8827	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	20	5.3	Stable	No	No	Signature.7	ARID1A	Yes	0	18.8	1	no	no	yes
8828	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2016		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	14.85	1	no	no	no
8829	ICI-treated	ICI as subsequent line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	9	11.8	Stable	No	Yes or Unknown	Signature.7	ATR	No	0	30.95	1	no	no	no
8830	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2016	IV	54	14		No	No	Signature.4	ATM | MUTYH	No	1	14.32	1	no	no	no
8831	ICI-treated	ICI as subsequent line	21 - 25	Female	Ovarian	2016	IV	0	0.9	Stable	No	No			No	0	8.05	1	no	no	no
8832	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	79	2	Stable	No	No	Signature.4		No	1	17.67	1	no	no	no
8833	ICI-treated	ICI as subsequent line	56 - 60	Male	Sarcoma	2016	IV	360	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	0.879999999999999	1	no	no	no
8834	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2016	II	643	1.8	Stable	No	No			No	1	7.22	1	no	no	no
8835	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2015	IV	0	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	26.61	1	no	no	no
8836	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	38	2	Stable	No	No			No	0	17.02	1	no	no	no
8837	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	0	93.5	Stable	No	No	Signature.7	BRCA2 | MDC1 | PMS2	Yes	0	13.7	1	no	no	no
8838	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	28	2	Stable	No	No			No	0	23.63	1	no	no	no
8839	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	II	0	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM	No	0	39.52	1	no	no	no
8840	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	III	0	15.8		Yes or Unknown	Yes or Unknown	Signature.13		No	1	13.5	1	no	no	no
8841	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2016	IV	124	0	Stable	No	No			Yes	1	2.3	1	no	no	no
8842	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	II	193	88.6		No	No	Signature.7	ATM | BRCA2 | ERCC3 | FANCA | SLX4	No	0	19.45	1	no	no	no
8843	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2016	IV	20	53.1	Stable	No	No	Signature.7	ERCC4 | PALB2	Yes	0	39.36	1	no	no	no
8844	ICI-treated	ICI as subsequent line	71 - 75	Male	CNS	2016		6	6.9	Stable	No	No	Signature.1		No	1	4.83	1	no	no	no
8845	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	46	0	Stable	No	No			No	0	39.26	1	no	no	no
8846	ICI-treated	ICI as first line	61 - 65	Male	Head & Neck	2016	I	542	6.1	Stable	No	Yes or Unknown	Signature.13	SLX4	Yes	0	21.78	1	no	no	no
8847	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	I	968	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	15.28	1	no	no	no
8848	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	9	50.2	Indeterminate	No	No	Signature.4	ATM | BLM | ERCC5	No	0	31.5	1	no	no	no
8849	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	21.6	Stable	No	No	Signature.4	CHEK2	No	0	16.1	1	no	no	no
8850	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	29	3.9	Stable	No	No	Signature.26		No	1	2.92	1	no	no	no
8851	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	I	27	6.9	Stable	No	No			No	0	21.59	1	no	no	no
8852	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	3	Stable	No	No	Signature.8		No	1	8.14	1	no	no	no
8853	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	373	49.2	Stable	No	Yes or Unknown	Signature.4	ARID1A | MUTYH	No	1	14.75	1	no	no	yes
8854	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	26	10.8	Stable	No	No	Signature.4		No	1	2.33	1	no	no	no
8855	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2016	IV	37	3.9	Stable	No	No		ARID1A	No	1	33.02	1	no	no	yes
8856	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.4		No	1	7.16	1	no	no	no
8857	ICI-treated	ICI as first line	21 - 25	Male	Sarcoma	2015	IV	153	0	Stable	No	No			No	1	11.2	1	no	no	no
8858	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016	II	22	30.7		No	No	Signature.7	ATM	No	1	17.8	1	no	no	no
8859	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2016	IV	18	19.7	Stable	No	No	Signature.4	ARID1A | BLM | PALB2	No	1	12.52	1	no	no	yes
8860	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	III	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	15.18	1	no	no	no
8861	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2016	IV	62	0		No	No			No	1	22.27	1	no	no	no
8862	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2016	IV	9	0	Stable	No	Yes or Unknown			Yes	1	0.36	1	no	no	no
8863	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	32	15.7	Stable	No	No	Signature.4	ERCC4	No	0	22.8	1	no	no	no
8864	ICI-treated	ICI as subsequent line	41 - 45	Female	Sarcoma	2016	IV	0	1.8		No	No			No	1	1.28	1	no	no	no
8865	ICI-treated	ICI as subsequent line	31 - 35	Female	Renal	2016	I	17	0	Stable	Yes or Unknown	Yes or Unknown			No	1	0.790000000000003	1	no	no	no
8866	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2016		3	3	Stable	Yes or Unknown	Yes or Unknown			No	1	18.86	1	no	no	no
8867	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	9.8	Stable	No	No	Signature.4		No	0	10.02	1	no	no	no
8868	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	I	59	2.6	Stable	No	No			No	0	28.45	1	no	no	no
8869	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	0	9.8	Stable	No	No	Signature.4		No	1	4.17	1	no	no	no
8870	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	16.59	1	no	no	no
8871	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	57	6.9	Stable	No	No	Signature.4		No	1	0.890000000000001	1	no	no	no
8872	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	30	1	Stable	No	No			Yes	1	0.63	1	no	no	no
8873	ICI-treated	ICI as subsequent line	41 - 45	Female	Renal	2016	IV	0	3	Stable	No	Yes or Unknown		CHEK2	No	0	33.91	1	no	no	no
8874	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2016	III	299	61.4	Unstable	No	Yes or Unknown	Signature.6	BRCA1 | CHEK2 | MDC1 | MSH2 | MSH6 | MUTYH | TP53BP1	No	0	18.83	1	mut-MMRd	mut-MMRd	no
8875	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	III	399	3.5	Stable	No	No		FANCA | RAD50	Yes	0	23.95	1	no	no	no
8876	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	39	41.3	Stable	No	No	Signature.4	ATM | BLM | MLH1 | MRE11A	No	1	5.06	1	no	no	no
8877	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2016	III	12	3	Stable	No	No			No	1	5.94	1	no	no	no
8878	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown		MDC1	No	1	13.14	1	no	no	no
8879	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2016	IV	15	3.9	Stable	No	No			No	1	11.04	1	no	no	no
8880	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	III	12	1	Stable	No	No			No	0	36.76	1	no	no	no
8881	ICI-treated	ICI as first line	56 - 60	Male	Renal	2016	IV	18	2.6		No	Yes or Unknown		ARID1A | BRCA2	No	1	20.3	1	no	no	yes
8882	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	3	Stable	No	No			No	1	11.4	1	no	no	no
8883	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2016	III	25	1.8		No	No			No	0	0.659999999999998	1	no	no	no
8884	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	II	0	0	Stable	No	No			No	1	0.389999999999999	1	no	no	no
8885	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	4.4		No	No		CHEK2	No	0	16.1	1	no	no	no
8886	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	637	3.5	Stable	No	No			No	0	9.6	1	no	no	no
8887	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	4.9	Stable	No	No	Signature.13		No	0	28.29	1	no	no	no
8888	ICI-treated	ICI as subsequent line	76 - 80	Male	SCLC	2016	IV	18	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ERCC2	No	1	19.09	1	no	no	no
8889	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	IV	0	1	Stable	No	No			No	1	2.24	1	no	no	no
8890	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2016	II	0	5.9	Stable	No	No	Signature.18		No	1	23.09	1	no	no	no
8891	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	27	9.8	Indeterminate	No	No	Signature.4		No	0	3.22	1	no	no	no
8892	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	28	3	Stable	No	Yes or Unknown			No	1	2.56	1	no	no	no
8893	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	407	2.6	Stable	No	Yes or Unknown	Signature.2		No	1	3.55	1	no	no	no
8894	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	16	5.9	Stable	No	No	Signature.29	ARID1A	No	1	8.24	1	no	no	yes
8895	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	7	11.8	Stable	No	No	Signature.4	ATM	No	1	4.2	1	no	no	no
8896	ICI-treated	ICI as subsequent line	46 - 50	Female	Cutaneous Melanoma 	2016	IV	0	17.7	Stable	No	Yes or Unknown	Signature.7	ERCC5	No	1	6.87	1	no	no	no
8897	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	2	7.9	Stable	No	No	Signature.2		No	1	6.43	1	no	no	no
8898	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2015	IV	56	0	Stable	No	No			No	1	27.3	1	no	no	no
8899	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	IV	249	6.1	Stable	No	Yes or Unknown			No	1	12.72	1	no	no	no
8900	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	13	3.9	Indeterminate	No	No			No	0	19.98	1	no	no	no
8901	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	III	62	3.9	Stable	No	No	Signature.6		No	1	8.02	1	no	no	no
8902	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	0	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4	PALB2	No	1	19.02	1	no	no	no
8903	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	II	376	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | ATM | BRIP1	No	1	27.53	1	no	no	yes
8904	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2015	III	222	2.6		Yes or Unknown	Yes or Unknown		ATM	No	0	32.59	1	no	no	no
8905	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	IV	121	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	4.83	1	no	no	no
8906	ICI-treated	ICI as first line	71 - 75	Male	Sarcoma	2016	IV	155	1.8		No	No			No	1	19.91	1	no	no	no
8907	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	III	23	5.9	Stable	No	No	Signature.4		No	1	3.62	1	no	no	no
8908	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	434	7		No	Yes or Unknown	Signature.16		No	1	10.58	1	no	no	no
8909	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	16	3.9	Stable	No	No			Yes	0	18.7	1	no	no	no
8910	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	8.9	Stable	No	No	Signature.4		No	1	2.27	1	no	no	no
8911	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2016	I	36	0	Stable	No	Yes or Unknown			No	1	28.32	1	no	no	no
8912	ICI-treated	ICI as first line	51 - 55	Female	SCLC	2016	IV	29	14.8	Stable	No	No	Signature.4		No	0	37.68	1	no	no	no
8913	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	161	9.7		No	Yes or Unknown	Signature.16	SLX4	No	1	7.52	1	no	no	no
8914	ICI-treated	ICI as first line	56 - 60	Female	Sarcoma	2016	III	868	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	10.18	1	no	no	no
8915	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	IV	0	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	13.5	1	no	no	no
8916	ICI-treated	ICI as subsequent line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	0	15.7	Stable	No	No	Signature.7	ATM	No	0	33.78	1	no	no	no
8917	ICI-treated	ICI as subsequent line	0 - 5	Male	Hepatobiliary	2016	IV	0	2	Stable	No	Yes or Unknown			No	1	14.85	1	no	no	no
8918	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2016	IV	27	3.5	Stable	No	No			No	0	4.83	1	no	no	no
8919	ICI-treated	ICI as subsequent line	81 - 85	Female	Endometrial	2016	III	35	56.1	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA1 | ERCC4 | MDC1 | MLH1 | MSH6	No	0	8.09	1	mut-MMRd	mut-MMRd	yes
8920	ICI-treated	ICI as subsequent line	26 - 30	Male	Gastric	2016	IV	3	0		No	No			No	1	2	1	no	no	no
8921	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	161	111.5	Unstable	No	Yes or Unknown	Signature.6	ARID1A | MLH1 | MSH3 | PMS2 | RAD50 | SLX4	No	1	2.96	1	mut-MMRd	mut-MMRd	yes
8922	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2016	IV	121	1.8	Stable	No	No			No	1	4.37	1	no	no	no
8923	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	III	21	7.9	Stable	No	No	Signature.1	CHEK2 | PMS2	No	1	1.97	1	no	no	no
8924	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2016	IV	371	12.3	Stable	No	Yes or Unknown	Signature.16	BRCA2	No	1	5.09	1	no	no	no
8925	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	IV	238	19.3		No	No	Signature.4	ARID1A | MDC1 | NBN	No	1	23.2	1	no	no	yes
8926	ICI-treated	ICI as subsequent line	41 - 45	Female	Hepatobiliary	2016	IV	0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	5.16	1	no	no	no
8927	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	0	4.9	Stable	No	No			No	0	37.36	1	no	no	no
8928	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2016	IV	0	53.1	Unstable	No	No	Signature.6	ARID1A | BRIP1 | MLH1 | RAD54L	No	0	35.42	1	mut-MMRd	mut-MMRd	yes
8929	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	14	22.8		No	No	Signature.2	ATR | FANCA | MDC1 | PMS1	No	1	9.2	1	no	no	no
8930	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	0	5.3		No	No			No	0	23.88	1	no	no	no
8931	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	1	5.9	Stable	No	No		PMS1	No	1	0.65	1	no	no	no
8932	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2016	II	387	5.3	Stable	No	Yes or Unknown		RAD50	No	0	25.14	1	no	no	no
8933	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	26	1	Stable	No	Yes or Unknown			No	0	36.76	1	no	no	no
8934	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2016	IV	39	10.8	Stable	No	No	Signature.4	ATR	No	0	34.17	1	no	no	no
8935	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	241	2.6		No	Yes or Unknown	Signature.1		No	1	0.529999999999998	1	no	no	no
8936	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	15	3	Stable	Yes or Unknown	Yes or Unknown			No	1	4.57	1	no	no	no
8937	ICI-treated	ICI as subsequent line	41 - 45	Male	SCLC	2015	IV	3	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	1	2.7	1	no	no	no
8938	ICI-treated	ICI as subsequent line	21 - 25	Male	Gastric	2016	IV	26	3	Stable	No	No			No	1	0.690000000000001	1	no	no	no
8939	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		5	2		Yes or Unknown	Yes or Unknown			No	1	17.91	1	no	no	no
8940	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	34	11.8	Stable	No	No	Signature.7	PALB2	Yes	0	35.49	1	no	no	no
8941	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	39	4.9		No	No		MLH1	No	1	19.81	1	no	no	no
8942	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	II	358	2	Stable	Yes or Unknown	Yes or Unknown			No	0	27.2	1	no	no	no
8943	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2016	III	146	2.6	Stable	No	Yes or Unknown			No	0	23.43	1	no	no	no
8944	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	I	14	3	Stable	No	No			No	0	15.35	1	no	no	no
8945	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	363	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	23.42	1	no	no	no
8946	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	IV	516	7	Stable	No	Yes or Unknown	Signature.1		No	1	2.6	1	no	no	no
8947	ICI-treated	ICI as subsequent line	71 - 75	Male	Sarcoma	2016	III	273	1.8		No	Yes or Unknown			No	1	17.48	1	no	no	no
8948	ICI-treated	ICI - unknown sequence	46 - 50	Male	Head & Neck	2016	IV	77	7.9	Stable	No	No	Signature.4		No	1	10.48	1	no	no	no
8949	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2016	IV	22	2	Stable	No	Yes or Unknown			No	1	6.18	1	no	no	no
8950	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	438	4.4	Stable	No	Yes or Unknown	Signature.7		No	0	23.46	1	no	no	no
8951	ICI-treated	ICI as subsequent line	26 - 30	Male	Head & Neck	2016	IV	336	4.4	Stable	No	Yes or Unknown	Signature.30		No	1	9.89	1	no	no	no
8952	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	I	0	16.7	Stable	No	No	Signature.4		No	1	9.13	1	no	no	no
8953	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	4	1	Stable	No	Yes or Unknown			No	1	13.83	1	no	no	no
8954	ICI-treated	ICI as subsequent line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	246	13.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BRCA1	No	1	28.13	1	no	no	no
8955	ICI-treated	ICI as subsequent line	66 - 70	Female	Head & Neck	2016	IV	52	10.5	Stable	No	No	Signature.13		No	1	1.57	1	no	no	no
8956	ICI-treated	ICI as subsequent line	41 - 45	Male	Esophageal	2016	IV	553	3.5	Stable	No	Yes or Unknown	Signature.15	FANCA	No	1	15.25	1	no	no	no
8957	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	III	9	5.9	Stable	No	Yes or Unknown	Signature.4		No	1	5.69	1	no	no	no
8958	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015		561	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.72	1	no	no	no
8959	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2016	IV	4	3.5	Stable	No	No			No	1	24.18	1	no	no	no
8960	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	3	Stable	No	No			No	1	4.5	1	no	no	no
8961	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	9	6.9	Stable	No	No			No	1	9.2	1	no	no	no
8962	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.4		No	1	27.17	1	no	no	no
8963	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2016	I	0	0	Stable	No	No			No	0	30.55	1	no	no	no
8964	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	5.9	Stable	No	No		ARID1A | PMS2	No	1	2.79	1	no	no	yes
8965	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	4.9	Stable	No	No			No	1	16.17	1	no	no	no
8966	ICI-treated	ICI - unknown sequence	26 - 30	Female	Sarcoma	2016	I	592	11.4	Stable	No	No	Signature.7	RAD50	No	0	11.27	1	no	no	no
8967	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2016	III	330	7.9	Stable	No	Yes or Unknown	Signature.7		No	0	35.74	1	no	no	no
8968	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	1	3.9	Stable	No	No	Signature.4		No	1	4.73	1	no	no	no
8969	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	1.87	1	no	no	no
8970	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2015	II	686	0	Stable	Yes or Unknown	Yes or Unknown			No	1	2.63	1	no	no	no
8971	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	1	5.9	Stable	No	No	Signature.4	ERCC4	Yes	1	0.49	1	no	no	no
8972	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	21	9.8	Indeterminate	No	No	Signature.1	ERCC4	No	1	6.97	1	no	no	no
8973	ICI-treated	ICI as subsequent line	46 - 50	Male	Bladder	2015	IV	226	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	1.84	1	no	no	no
8974	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	0	12.3		Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	0	22.8	1	no	no	yes
8975	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2016	IV	0	11.8	Stable	No	Yes or Unknown	Signature.7		No	1	3.55	1	no	no	no
8976	ICI-treated	ICI as first line	31 - 35	Female	Cutaneous Melanoma 	2016	III	217	9.7		No	No	Signature.7		Yes	0	28.48	1	no	no	no
8977	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	III	312	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	2.63	1	no	no	no
8978	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		497	3.9	Stable	Yes or Unknown	Yes or Unknown		ERCC5	No	1	3.98	1	no	no	no
8979	ICI-treated	ICI as subsequent line	71 - 75	Male	Sarcoma	2016	III	614	4.4	Stable	No	Yes or Unknown	Signature.3		No	0	10.81	1	no	no	no
8980	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	II	314	1.8	Stable	No	Yes or Unknown			No	1	8.97	1	no	no	no
8981	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	166	41.3		Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | BRCA1 | BRCA2 | FANCA	No	0	28.71	1	no	no	yes
8982	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	0	33.4	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BRCA1 | ERCC3	Yes	1	5.12	1	no	no	no
8983	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	4	5.9	Stable	No	No	Signature.24	BRIP1	Yes	0	3.48	1	no	no	no
8984	ICI-treated	ICI - unknown sequence	66 - 70	Female	Cutaneous Melanoma 	2016	III	35	15.8	Stable	No	No	Signature.7	ERCC4	No	0	31.04	1	no	no	no
8985	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	II	412	0.9		Yes or Unknown	Yes or Unknown			No	1	17.08	1	no	no	no
8986	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	6.1	Stable	No	No		ATM	No	1	4.37	1	no	no	no
8987	ICI-treated	ICI as subsequent line	56 - 60	Male	SCLC	2016	IV	232	8.9		No	Yes or Unknown	Signature.4	PMS1	No	0	29.41	1	no	no	no
8988	ICI-treated	ICI as subsequent line	31 - 35	Female	Ovarian	2015	III	226	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	1	3.81	1	no	no	no
8989	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2016	IV	0	6.1	Indeterminate	No	No	Signature.18		No	1	2.76	1	no	no	no
8990	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	38	8.9	Stable	No	No	Signature.13	BRCA2	No	1	7.82	1	no	no	no
8991	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	IV	0	4.9	Stable	No	No	Signature.4		No	1	8.51	1	no	no	no
8992	ICI-treated	ICI as subsequent line	15-Nov	Female	Sarcoma	2016	IV	0	2	Indeterminate	No	No			No	0	11.5	1	no	no	no
8993	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	231	2.6		No	Yes or Unknown			No	1	23.46	1	no	no	no
8994	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	4.9	Stable	No	Yes or Unknown			No	1	26.09	1	no	no	no
8995	ICI-treated	ICI as subsequent line	16 - 20	Female	Hepatobiliary	2016	IV	9	0	Stable	No	No			No	0	30.03	1	no	no	no
8996	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	0	Stable	No	No			No	1	2.39	1	no	no	no
8997	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	5.3		No	No		MSH6	No	1	5.94	1	no	no	no
8998	ICI-treated	ICI - unknown sequence	56 - 60	Female	Renal	2016	III	61	5.3		No	No			No	0	4.7	1	no	no	no
8999	ICI-treated	ICI as subsequent line	16 - 20	Male	NSCLC	2016	IV	16	2	Stable	No	No			No	0	32.33	1	no	no	no
9000	ICI-treated	ICI as first line	61 - 65	Male	Sarcoma	2016	IV	41	0	Stable	No	No			No	0	6.9	1	no	no	no
9001	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2016	I	276	14	Stable	No	No	Signature.7		No	0	16.1	1	no	no	no
9002	ICI-treated	ICI as subsequent line	56 - 60	Male	Prostatic	2016	IV	747	3.5	Stable	No	Yes or Unknown			No	0	11.83	1	no	no	no
9003	ICI-treated	ICI as subsequent line	86 - 90	Female	NSCLC	2016	IV	20	5.3		No	No			No	0	16	1	no	no	no
9004	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2016	IV	9	9.8	Stable	No	Yes or Unknown	Signature.4	BRCA1 | XRCC2	No	0	34.24	1	no	no	no
9005	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	IV	255	0		Yes or Unknown	Yes or Unknown			No	1	14.26	1	no	no	no
9006	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	39	3.9	Stable	No	No	Signature.6		No	0	18.17	1	no	no	no
9007	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	47.2		No	No	Signature.4	ATM | ERCC4	No	1	1.94	1	no	no	no
9008	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	20	10.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MLH1	No	1	0.460000000000001	1	no	no	no
9009	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.94	1	no	no	no
9010	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	III	0	9.7		No	No	Signature.2		No	1	4.3	1	no	no	no
9011	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	0	11.4		No	No	Signature.4		Yes	1	4.14	1	no	no	no
9012	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	II	586	1.8	Stable	No	No	Signature.7	MSH3	No	0	19.84	1	no	no	no
9013	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	326	21.1	Stable	No	Yes or Unknown	Signature.13	MSH6	No	1	9.79	1	no	no	no
9014	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	16.7		No	No	Signature.30	ARID1A	No	1	1.25	1	no	no	yes
9015	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	I	152	3.5		No	No			No	0	30.59	1	no	no	no
9016	ICI-treated	ICI as subsequent line	41 - 45	Female	Gastric	2016	II	275	3.5	Stable	No	Yes or Unknown			No	1	3.88	1	no	no	no
9017	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2016	IV	0	18.7		No	No	Signature.4	CHEK2 | MDC1	No	1	9.33	1	no	no	no
9018	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	36	5.3		No	No	Signature.25		No	1	1.05	1	no	no	no
9019	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		28	2	Stable	Yes or Unknown	Yes or Unknown			No	1	14.75	1	no	no	no
9020	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	III	132	2.6	Stable	No	Yes or Unknown			No	0	16.56	1	no	no	no
9021	ICI-treated	ICI as subsequent line	36 - 40	Male	Sarcoma	2016	IV	32	0		No	No			No	1	12.78	1	no	no	no
9022	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	III	0	4.4	Stable	No	Yes or Unknown			No	1	11.99	1	no	no	no
9023	ICI-treated	ICI as first line	31 - 35	Female	Cutaneous Melanoma 	2016	III	673	15.8	Stable	No	No	Signature.7	BRCA2	Yes	0	29.31	1	no	no	no
9024	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	1.8		Yes or Unknown	Yes or Unknown			No	1	26.94	1	no	no	no
9025	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2016		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	18.1	1	no	no	no
9026	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	III	162	8.9		Yes or Unknown	Yes or Unknown	Signature.19		No	1	8.08	1	no	no	no
9027	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	94	16.7	Stable	No	No	Signature.4	BRCA2	No	0	11.5	1	no	no	no
9028	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2015	I	360	32.5	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	11.59	1	other-MMRd	mut-MMRd	yes
9029	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	29.44	1	no	no	no
9030	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	III	87	0		No	No			No	0	34.66	1	no	no	no
9031	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2016	IV	0	10.5		Yes or Unknown	Yes or Unknown	Signature.3	FANCA	No	1	3.64	1	no	no	no
9032	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	12	14		No	No	Signature.24	BRCA1	No	1	22.05	1	no	no	no
9033	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	201	3.5	Stable	No	Yes or Unknown			No	1	2.49	1	no	no	no
9034	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2016	II	22	3.5	Stable	No	No			No	0	18.43	1	no	no	no
9035	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2016	II	37	0.9	Stable	No	No			No	1	3.49	1	no	no	no
9036	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	7	5.9	Stable	No	No	Signature.3	PALB2	No	0	17.48	1	no	no	no
9037	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	III	0	4.9		No	No			No	1	7.35	1	no	no	no
9038	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	IV	9	1.8	Stable	No	No			No	1	13.76	1	no	no	no
9039	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2016	IV	0	1.8		No	No			No	0	30.95	1	no	no	no
9040	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	524	3.5	Indeterminate	No	Yes or Unknown	Signature.19	RAD50	No	1	17.38	1	no	no	no
9041	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2016	IV	281	7	Stable	No	Yes or Unknown	Signature.4	MSH3	No	1	10.09	1	no	no	no
9042	ICI-treated	ICI as first line	76 - 80	Female	Bladder	2016	III	0	14	Stable	No	No	Signature.13	ATR | BRIP1	Yes	0	12.09	1	no	no	no
9043	ICI-treated	ICI as subsequent line	46 - 50	Male	CNS	2016		9	3.5		No	No			No	1	5.79	1	no	no	no
9044	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	I	299	7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	3.81	1	no	no	no
9045	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2016	IV	263	5.3	Stable	No	Yes or Unknown			No	1	1.05	1	no	no	no
9046	ICI-treated	ICI as subsequent line	76 - 80	Male	Esophageal	2016	IV	0	4.4		Yes or Unknown	Yes or Unknown	Signature.6	BRCA2	No	1	2.76	1	no	no	no
9047	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2016	III	59	2.6		No	No			No	1	7.62	1	no	no	no
9048	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	15.01	1	no	no	no
9049	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	15.8		No	No	Signature.13	NTHL1	No	1	5.98	1	no	no	no
9050	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	0	57.9	Unstable	No	No	Signature.1	ARID1A | ATM | ATR | MSH2 | MSH3 | MSH6	No	1	7.52	1	mut-MMRd	mut-MMRd	yes
9051	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	III	0	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ERCC4	Yes	0	33.28	1	no	no	no
9052	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2015	III	0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	17.8	1	no	no	no
9053	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	128	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	3.91	1	no	no	no
9054	ICI-treated	ICI - unknown sequence	26 - 30	Male	CNS	2016		13	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	8.54	1	no	no	no
9055	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2016	IV	13	2.6	Stable	No	No			No	1	5.52	1	no	no	no
9056	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	IV	264	11.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	1	8.34	1	no	no	no
9057	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2016	IV	159	8.8	Stable	No	Yes or Unknown			No	0	15.41	1	no	no	no
9058	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	0	6.1		No	No	Signature.9	FANCA	No	1	3.97	1	no	no	no
9059	ICI-treated	ICI as first line	51 - 55	Female	CNS	2016		5	5.3	Stable	No	No			Yes	1	15.15	1	no	no	no
9060	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	IV	16	12.3		No	No	Signature.18		No	0	9.92	1	no	no	no
9061	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	I	572	8.8	Stable	No	Yes or Unknown	Signature.18	ARID1A | MSH6	No	0	14.75	1	no	no	yes
9062	ICI-treated	ICI as subsequent line	26 - 30	Female	Sarcoma	2016	I	0	1.8		Yes or Unknown	Yes or Unknown			No	1	4.01	1	no	no	no
9063	ICI-treated	ICI as subsequent line	31 - 35	Female	CNS	2015		0	3.5		Yes or Unknown	Yes or Unknown			No	1	4.8	1	no	no	no
9064	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	I	208	32.5	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | RAD54L	No	0	25.96	1	no	no	yes
9065	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2016	IV	0	2.6		No	No			No	0	21.06	1	no	no	no
9066	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	III	57	0.9		No	No			No	0	28.25	1	no	no	no
9067	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	495	24.6	Indeterminate	No	Yes or Unknown	Signature.4		No	1	21.36	1	no	no	no
9068	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	I	14	5.3		No	No			Yes	0	25.07	1	no	no	no
9069	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	619	10.5		Yes or Unknown	Yes or Unknown	Signature.4		No	1	17.19	1	no	no	no
9070	ICI-treated	ICI as subsequent line	66 - 70	Male	Cutaneous Melanoma 	2016	III	844	41.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | MRE11A | NBN | SLX4 | TP53BP1	No	0	8.84	1	no	no	yes
9071	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016	IV	0	8.8		No	No	Signature.2		No	0	28.65	1	no	no	no
9072	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2016	IV	264	7	Stable	No	Yes or Unknown			No	1	1.51	1	no	no	no
9073	ICI-treated	ICI as subsequent line	36 - 40	Male	Head & Neck	2016	IV	32	6.1		No	No	Signature.13		No	1	9.46	1	no	no	no
9074	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	9	11.4		No	No	Signature.4	ARID1A	No	1	5.85	1	no	no	yes
9075	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2016	III	23	0		Yes or Unknown	Yes or Unknown			Yes	0	18.43	1	no	no	no
9076	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	19	1.8		No	No			No	1	2.14	1	no	no	no
9077	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	IV	0	7.9		No	No	Signature.4		No	1	1.97	1	no	no	no
9078	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2015	III	409	7	Stable	Yes or Unknown	Yes or Unknown	Signature.6	MSH6	No	1	6.61	1	no	no	no
9079	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	II	364	14	Stable	No	Yes or Unknown	Signature.4	MSH6	No	0	22.11	1	no	no	no
9080	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown	Signature.1		No	1	18.76	1	no	no	no
9081	ICI-treated	ICI as subsequent line	56 - 60	Female	Colorectal	2016	IV	0	91.3	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | CHEK2 | ERCC3 | MSH2 | NTHL1 | PMS2 | RAD52	No	1	7.75	1	mut-MMRd	mut-MMRd	yes
9082	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		185	5.3		Yes or Unknown	Yes or Unknown			No	1	3.65	1	no	no	no
9083	ICI-treated	ICI as first line	66 - 70	Male	CNS	2016		10	5.9		No	No	Signature.5		Yes	1	6.18	1	no	no	no
9084	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	0	6.1	Stable	No	Yes or Unknown			No	1	14.26	1	no	no	no
9085	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2017	II	141	2.6	Stable	No	No			No	0	9.69	1	no	no	no
9086	ICI-treated	ICI as subsequent line	36 - 40	Male	Renal	2016	IV	0	1.8		No	Yes or Unknown			No	0	27.6	1	no	no	no
9087	ICI-treated	ICI as first line	76 - 80	Female	Endometrial	2016	I	36	7	Stable	No	No		ARID1A | SLX4	Yes	0	9.2	1	no	no	yes
9088	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2016	I	407	5.3	Stable	No	No	Signature.13		No	1	7.72	1	no	no	no
9089	ICI-treated	ICI - unknown sequence	76 - 80	Female	CNS	2016		13	3.9		Yes or Unknown	Yes or Unknown		BLM	No	1	5.85	1	no	no	no
9090	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	III	451	11.4		Yes or Unknown	Yes or Unknown	Signature.7		No	0	32.89	1	no	no	no
9091	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2016		0	11.4		No	No	Signature.7	MSH3 | SLX4	No	0	6.64	1	no	no	no
9092	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	IV	701	11.4	Stable	No	No	Signature.4	SLX4	Yes	1	26.32	1	no	no	no
9093	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2016	IV	11	14	Unstable	No	No	Signature.6	BRIP1 | PALB2 | PARP1	No	1	7.78	1	other-MMRd	mut-MMRd	no
9094	ICI-treated	ICI as subsequent line	26 - 30	Male	Sarcoma	2016	IV	0	3.5		Yes or Unknown	Yes or Unknown	Signature.5		No	0	1.58	1	no	no	no
9095	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	202	0.9	Stable	No	Yes or Unknown			No	1	6.9	1	no	no	no
9096	ICI-treated	ICI as first line	66 - 70	Female	Renal	2016	III	58	7		No	No			Yes	0	31.57	1	no	no	no
9097	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	IV	51	1.8		No	No	Signature.6	BRCA1	No	1	10.97	1	no	no	no
9098	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	27	4.4		No	No	Signature.30		No	1	1.48	1	no	no	no
9099	ICI-treated	ICI as first line	41 - 45	Female	NSCLC	2016	IV	167	6.1		No	Yes or Unknown		MSH6	No	1	31.73	1	no	no	no
9100	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	6.1		No	No	Signature.16		No	1	12.35	1	no	no	no
9101	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	15.8		No	No	Signature.25		No	1	14.13	1	no	no	no
9102	ICI-treated	ICI as first line	66 - 70	Male	Renal	2016	IV	0	4.4	Stable	No	Yes or Unknown	Signature.5	TP53BP1	No	0	30.69	1	no	no	no
9103	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	117	6.1		No	Yes or Unknown			No	1	9.1	1	no	no	no
9104	ICI-treated	ICI as subsequent line	51 - 55	Female	CNS	2016		4	4.4		No	No			No	1	1.64	1	no	no	no
9105	ICI-treated	ICI - unknown sequence	56 - 60	Male	Prostatic	2016	IV	0	2.6		No	Yes or Unknown			No	1	2.3	1	no	no	no
9106	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2016	IV	0	7.9		No	No	Signature.13	ARID1A	No	0	22.57	1	no	no	yes
9107	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2016	IV	49	7		No	No	Signature.2	ATM	Yes	0	33.11	1	no	no	no
9108	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	108	1.8		No	No			No	1	0.82	1	no	no	no
9109	ICI-treated	ICI as subsequent line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	10	19.7		No	No	Signature.7	BRIP1 | ERCC2	No	1	1.58	1	no	no	no
9110	ICI-treated	ICI as first line	56 - 60	Male	Colorectal	2016	III	34	30.7	Unstable	No	No	Signature.1	MLH1 | MSH2 | NBN | PARP1	Yes	0	21.39	1	mut-MMRd	mut-MMRd	no
9111	ICI-treated	ICI as subsequent line	81 - 85	Male	SCLC	2016	IV	0	5.9		No	No	Signature.18	ARID1A | ATR | FANCC	No	1	1.28	1	no	no	yes
9112	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	2.6		No	No			No	1	4.34	1	no	no	no
9113	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	III	692	4.4	Stable	No	Yes or Unknown	Signature.16		No	1	11.8	1	no	no	no
9114	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016		112	3.5		No	No		BRCA2	No	1	18.7	1	no	no	no
9115	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	II	193	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	3.35	1	no	no	no
9116	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	I	406	7.9		Yes or Unknown	Yes or Unknown	Signature.24		No	0	18.56	1	no	no	no
9117	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	1	1.8		No	No			No	1	1.84	1	no	no	no
9118	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	IV	0	0.9		No	Yes or Unknown			No	0	25.13	1	no	no	no
9119	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2016	I	19	6.1	Stable	No	No		ARID1A	No	1	7.49	1	no	no	yes
9120	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	5.3		No	No	Signature.5		No	1	0.78	1	no	no	no
9121	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	1	19.64	1	no	no	no
9122	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	III	26	6.1	Stable	No	Yes or Unknown	Signature.2		No	0	17.44	1	no	no	no
9123	ICI-treated	ICI as first line	21 - 25	Male	Cutaneous Melanoma 	2016	IV	17	16.7		No	No	Signature.7	ARID1A	No	0	29.8	1	no	no	yes
9124	ICI-treated	ICI as subsequent line	46 - 50	Male	Gastric	2016	IV	4	8.8	Stable	No	Yes or Unknown	Signature.1	BRCA2	No	1	14.52	1	no	no	no
9125	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2016	IV	361	50.9	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | MSH2 | NBN | SLX4	No	0	20.64	1	mut-MMRd	mut-MMRd	yes
9126	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2016	IV	4	5.3		No	No		MDC1	No	1	0.33	1	no	no	no
9127	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2016	IV	129	7	Stable	Yes or Unknown	Yes or Unknown			No	1	6.67	1	no	no	no
9128	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	432	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	1.35	1	no	no	no
9129	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	IV	19	9.7	Stable	No	No	Signature.4	ARID1A	No	1	18.07	1	no	no	yes
9130	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	44	20.2		No	No	Signature.4	ERCC4	Yes	0	32.13	1	no	no	no
9131	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2016	III	145	5.3	Stable	No	Yes or Unknown	Signature.6	ARID1A	No	1	2.86	1	no	no	yes
9132	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	II	345	1.8		Yes or Unknown	Yes or Unknown			No	1	9.89	1	no	no	no
9133	ICI-treated	ICI as subsequent line	26 - 30	Female	Sarcoma	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	0	12.65	1	no	no	no
9134	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	3	6.1	Stable	No	No	Signature.4		No	1	18.46	1	no	no	no
9135	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	1.8		No	Yes or Unknown			No	0	13.87	1	no	no	no
9136	ICI-treated	ICI as first line	16 - 20	Male	Cutaneous Melanoma 	2016	IV	147	1.8	Stable	No	Yes or Unknown			No	0	29.14	1	no	no	no
9137	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	332	16.7	Stable	No	Yes or Unknown	Signature.4	ATM | ATR | CHEK1 | ERCC3	No	1	12.62	1	no	no	no
9138	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2016	IV	448	7.9	Stable	No	Yes or Unknown	Signature.5		No	0	9.63	1	no	no	no
9139	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2016	IV	261	7.9	Stable	No	Yes or Unknown	Signature.5		No	1	5.29	1	no	no	no
9140	ICI-treated	ICI - unknown sequence	71 - 75	Male	CNS	2016		2	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	15.6	1	no	no	no
9141	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	0	4.4		No	No			No	1	26.05	1	no	no	no
9142	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	IV	0	100.1		No	No	Signature.7	ARID1A | ATR | BLM | ERCC2 | ERCC4 | TP53BP1	Yes	0	31.8	1	no	no	yes
9143	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	0	7.9		No	Yes or Unknown	Signature.4		No	1	0.32	1	no	no	no
9144	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	220	3.5	Stable	No	Yes or Unknown			No	1	3.94	1	no	no	no
9145	ICI-treated	ICI as subsequent line	61 - 65	Female	Bladder	2016	IV	26	6.1	Stable	No	No	Signature.1	BRCA1	No	1	18.27	1	no	no	no
9146	ICI-treated	ICI as first line	46 - 50	Male	Head & Neck	2016	IV	60	8.8		No	No	Signature.24		No	0	32.62	1	no	no	no
9147	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	I	678	51.8	Stable	No	No	Signature.7	ARID1A | BLM | ERCC4 | RAD50 | SLX4	Yes	0	11.33	1	no	no	yes
9148	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	III	0	29	Stable	No	No	Signature.13	ATR | CHEK1 | MDC1 | TP53BP1	No	1	23.55	1	no	no	no
9149	ICI-treated	ICI as subsequent line	16 - 20	Female	Esophageal	2016	III	0	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.2	BLM	No	0	6.5	1	no	no	no
9150	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	41	10.5		No	No	Signature.4		No	1	6.97	1	no	no	no
9151	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	III	34	5.3	Stable	No	No		PALB2	No	0	12.02	1	no	no	no
9152	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	IV	203	0.9		Yes or Unknown	Yes or Unknown			No	1	9.96	1	no	no	no
9153	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	13.2		No	No	Signature.24	ATM	No	1	2.63	1	no	no	no
9154	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	Yes or Unknown		ARID1A	No	0	12.85	1	no	no	yes
9155	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	0	19.3		No	No	Signature.4	ARID1A | CHEK1	No	1	5.88	1	no	no	yes
9156	ICI-treated	ICI as first line	41 - 45	Male	Head & Neck	2016	IV	40	7.9		No	No		ARID1A | ATR | PMS1	No	0	30.03	1	no	no	yes
9157	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	29	69.3		No	No	Signature.7	FANCC | MDC1 | PMS1	No	0	31.74	1	no	no	no
9158	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	II	614	5.3	Stable	No	Yes or Unknown	Signature.3		No	0	3.35	1	no	no	no
9159	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	19.3		Yes or Unknown	Yes or Unknown	Signature.4		No	0	19.48	1	no	no	no
9160	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		15	1.8		Yes or Unknown	Yes or Unknown			No	1	10.31	1	no	no	no
9161	ICI-treated	ICI as subsequent line	36 - 40	Female	Ovarian	2015	IV	0	1.8		Yes or Unknown	Yes or Unknown			No	0	4.17	1	no	no	no
9162	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	2	29.8		No	No	Signature.4	ERCC5	Yes	0	30.88	1	no	no	no
9163	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	10.5		No	No	Signature.4	BRCA1	No	0	17.44	1	no	no	no
9164	ICI-treated	ICI as subsequent line	61 - 65	Male	CNS	2016		8	1.8		No	No			No	1	12.68	1	no	no	no
9165	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		6	4.4		Yes or Unknown	Yes or Unknown			No	1	4.83	1	no	no	no
9166	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	238	8.8	Stable	No	Yes or Unknown	Signature.4	ATR	No	1	8.54	1	no	no	no
9167	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	II	199	2.6	Stable	No	No		BRCA1	Yes	1	0.489999999999998	1	no	no	no
9168	ICI-treated	ICI as first line	41 - 45	Female	Hepatobiliary	2016	II	221	2.6	Stable	No	No			Yes	0	25.69	1	no	no	no
9169	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	616	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA2	No	1	4.5	1	no	no	no
9170	ICI-treated	ICI - unknown sequence	66 - 70	Female	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			No	0	21.39	1	no	no	no
9171	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	0	14.9		No	No	Signature.4	ARID1A | ERCC2	No	1	21.02	1	no	no	yes
9172	ICI-treated	ICI as subsequent line	61 - 65	Male	Prostatic	2016	IV	99	57.1	Unstable	No	Yes or Unknown	Signature.6	ATM | BLM | BRCA2 | ERCC2 | MSH3 | TP53BP1	No	0	18.4	1	other-MMRd	mut-MMRd	no
9173	ICI-treated	ICI as first line	51 - 55	Male	Colorectal	2015	IV	925	4.4	Stable	No	No			No	1	10.05	1	no	no	no
9174	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	IV	1	10.5		No	No	Signature.7	PALB2	Yes	0	20.14	1	no	no	no
9175	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	IV	10	16.7		No	No	Signature.13		No	0	24.38	1	no	no	no
9176	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2016	IV	22	2.6	Stable	No	Yes or Unknown			No	1	2.2	1	no	no	no
9177	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2016	IV	332	0.9	Stable	No	Yes or Unknown			No	0	31.34	1	no	no	no
9178	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	24.6		No	No	Signature.4	BLM	No	1	13.04	1	no	no	no
9179	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2016	IV	138	10.5		No	Yes or Unknown	Signature.4		No	0	31.21	1	no	no	no
9180	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	IV	15	79.9		No	No	Signature.7	BRCA2 | ERCC4 | MLH1 | MSH6 | NBN | PALB2 | PMS1	No	1	4.96	1	no	no	no
9181	ICI-treated	ICI as first line	31 - 35	Female	Ovarian	2016	I	51	33.4	Unstable	No	No	Signature.6	ARID1A | MSH2 | RAD50	Yes	0	21	1	mut-MMRd	mut-MMRd	yes
9182	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	827	3.5	Stable	Yes or Unknown	Yes or Unknown		ATM	No	0	8.73999999999999	1	no	no	no
9183	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	35	10.5	Stable	No	No	Signature.4	ARID1A	No	0	12.95	1	no	no	yes
9184	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	7		No	No	Signature.18	ATR	No	1	2.3	1	no	no	no
9185	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	31	7		No	No			Yes	1	13.77	1	no	no	no
9186	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	24	29.8		No	No	Signature.4	ERCC2 | MRE11A | MSH6	Yes	0	29.8	1	no	no	no
9187	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	7.9		No	No	Signature.14		No	1	4.18	1	no	no	no
9188	ICI-treated	ICI as subsequent line	36 - 40	Male	Renal	2015	I	0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.12		No	1	24.61	1	no	no	no
9189	ICI-treated	ICI as first line	86 - 90	Female	NSCLC	2016	IV	4	5.3		No	No			Yes	0	12.78	1	no	no	no
9190	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2016	II	272	7.9	Stable	No	Yes or Unknown	Signature.19	ARID1A	No	1	3.71	1	no	no	yes
9191	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2016	III	41	15.8		No	Yes or Unknown	Signature.7	FANCA	No	1	7.42	1	no	no	no
9192	ICI-treated	ICI - unknown sequence	21 - 25	Male	CNS	2016		46	2.6		No	No			No	0	32.2	1	no	no	no
9193	ICI-treated	ICI - unknown sequence	76 - 80	Male	NSCLC	2016	III	33	3.5		No	No	Signature.4	PMS1	No	0	26.68	1	no	no	no
9194	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	III	24	51.8		No	Yes or Unknown	Signature.7		Yes	0	31.73	1	no	no	no
9195	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	I	287	131.7	Stable	No	No	Signature.7	ARID1A | BRCA1 | BRCA2 | ERCC2	No	0	23.23	1	no	no	yes
9196	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	196	36.9	Stable	No	No	Signature.7	ARID1A | ATM | BRIP1 | PALB2	Yes	0	26.08	1	no	no	yes
9197	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2016	IV	28	4.4		No	Yes or Unknown	Signature.3		No	0	16.78	1	no	no	no
9198	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2016	IV	46	16.7		No	Yes or Unknown	Signature.13	RAD52	No	1	0.16	1	no	no	no
9199	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	26	9.7		No	No	Signature.5		No	0	19.65	1	no	no	no
9200	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	III	17	2.6		No	No			No	1	4.86	1	no	no	no
9201	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016	IV	0	13.2		No	No	Signature.7		No	0	32.07	1	no	no	no
9202	ICI-treated	ICI as subsequent line	41 - 45	Female	Pancreatic	2016	IV	15	1.8		No	No			No	1	3.38	1	no	no	no
9203	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	IV	19	7	Stable	No	No	Signature.30		No	1	4.53	1	no	no	no
9204	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	70	9.7		No	No	Signature.18	PALB2	Yes	0	27.5	1	no	no	no
9205	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	232	2.6	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	1	0.73	1	no	no	no
9206	ICI-treated	ICI as subsequent line	16 - 20	Female	Head & Neck	2016	IV	0	0.9		No	No			No	1	8.97	1	no	no	no
9207	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	44	4.4		No	No			No	0	31.93	1	no	no	no
9208	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2016	II	175	12.3	Stable	No	No	Signature.7	PALB2	Yes	0	24.77	1	no	no	no
9209	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2016	III	27	0.9	Stable	No	Yes or Unknown			No	0	16.33	1	no	no	no
9210	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	0	4.4		No	No			No	0	27.6	1	no	no	no
9211	ICI-treated	ICI as subsequent line	56 - 60	Female	Hepatobiliary	2015	II	133	4.4		Yes or Unknown	Yes or Unknown		ARID1A	No	0	23.62	1	no	no	yes
9212	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2016	IV	148	2.6	Stable	No	Yes or Unknown			No	0	14.78	1	no	no	no
9213	ICI-treated	ICI as first line	61 - 65	Female	Renal	2016	IV	28	3.5	Stable	No	Yes or Unknown			No	0	31.08	1	no	no	no
9214	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2016	II	208	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	5.1	1	no	no	no
9215	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	16	36.9		No	No	Signature.7	ARID1A | ATM | FANCA | MDC1 | TP53BP1	Yes	1	1.84	1	no	no	yes
9216	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2016	IV	19	26.3		No	Yes or Unknown	Signature.7		No	1	7.42	1	no	no	no
9217	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	18.4		No	No	Signature.4	BRCA1	No	0	26.28	1	no	no	no
9218	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	12	4.4	Stable	No	No	Signature.16		No	0	0.910000000000001	1	no	no	no
9219	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2016	IV	0	2.6		No	No			No	0	1.55	1	no	no	no
9220	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	624	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	13.08	1	no	no	no
9221	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	0	8.9		No	No	Signature.1		Yes	1	3.59	1	no	no	no
9222	ICI-treated	ICI as first line	86 - 90	Female	Cutaneous Melanoma 	2016	III	0	36.9		No	No	Signature.7		No	0	28.28	1	no	no	no
9223	ICI-treated	ICI as subsequent line	61 - 65	Male	Cutaneous Melanoma 	2016	IV	0	14.9		No	No	Signature.7	BRCA2 | NBN	No	1	0.36	1	no	no	no
9224	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2016	IV	210	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	2.07	1	no	no	no
9225	ICI-treated	ICI - unknown sequence	71 - 75	Female	Head & Neck	2016	I	47	23.7		No	No	Signature.2	BLM | NBN | SLX4	No	0	30.88	1	no	no	no
9226	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	IV	9	11.4		No	No	Signature.4	ERCC5 | NBN	No	1	6.18	1	no	no	no
9227	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	0	3.5		No	No	Signature.4	ATR	Yes	1	4.37	1	no	no	no
9228	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2016		1	3.5		No	No		PMS1	No	0	3.68	1	no	no	no
9229	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2016	IV	153	32.5	Stable	No	Yes or Unknown	Signature.6	ARID1A | BLM	No	0	22.37	1	no	no	yes
9230	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	657	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.2	SLX4	No	1	11.3	1	no	no	no
9231	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	I	654	73.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | ATM | BLM | MUTYH | PMS1 | RAD52	Yes	0	19.38	1	no	no	yes
9232	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2016	III	0	22.8	Stable	No	No	Signature.7	RAD50	No	0	27.17	1	no	no	no
9233	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	II	533	7.9		Yes or Unknown	Yes or Unknown	Signature.2	MSH6	No	0	27.59	1	no	no	no
9234	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2016	IV	0	8.8		No	No			No	0	20.73	1	no	no	no
9235	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	14		No	No	Signature.4	ATM	No	0	2.34	1	no	no	no
9236	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016	IV	26	1.8	Stable	No	Yes or Unknown			No	1	12.45	1	no	no	no
9237	ICI-treated	ICI as first line	51 - 55	Male	Renal	2016	IV	53	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	28.88	1	no	no	yes
9238	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	II	0	5.3		No	No	Signature.5		No	1	2.4	1	no	no	no
9239	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	162	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	MSH2	No	1	14.68	1	no	no	no
9240	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	2.5	1	no	no	no
9241	ICI-treated	ICI as subsequent line	81 - 85	Male	Head & Neck	2016	IV	410	8.8	Stable	No	Yes or Unknown	Signature.2		No	0	16.43	1	no	no	no
9242	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	12.3		No	No	Signature.4		No	1	7.13	1	no	no	no
9243	ICI-treated	ICI as subsequent line	56 - 60	Female	Esophageal	2016	III	146	6.1	Stable	No	Yes or Unknown	Signature.1	RAD51C	No	1	2.89	1	no	no	no
9244	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2016	IV	0	7	Stable	No	No		ATM	No	1	7.59	1	no	no	no
9245	ICI-treated	ICI as first line	56 - 60	Female	Hepatobiliary	2016	II	23	11.4	Stable	No	Yes or Unknown	Signature.5	ARID1A | ATM	No	1	17.02	1	no	no	yes
9246	ICI-treated	ICI as first line	61 - 65	Female	Renal	2016	III	51	1.8	Stable	No	No		RAD51C	Yes	0	27.34	1	no	no	no
9247	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2016	IV	0	6.1	Stable	No	No	Signature.15	ARID1A	No	1	18.03	1	no	no	yes
9248	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	III	0	14		No	No	Signature.7		Yes	0	25.79	1	no	no	no
9249	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	II	193	27.2	Stable	No	No	Signature.7		Yes	0	21.16	1	no	no	no
9250	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	II	0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	9.29	1	no	no	no
9251	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	29	9.7		No	No	Signature.4		No	1	7.13	1	no	no	no
9252	ICI-treated	ICI as first line	51 - 55	Male	CNS	2016		0	1.8		No	No			No	1	15.41	1	no	no	no
9253	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	2	5.9		No	No	Signature.15		No	1	0.66	1	no	no	no
9254	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	30	7		No	No			No	1	2.92	1	no	no	no
9255	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2016	IV	553	3.5	Stable	No	Yes or Unknown	Signature.13	PMS1	No	0	12.88	1	no	no	no
9256	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	33	21.9		No	No	Signature.6	MSH2	No	0	3.68	1	no	no	no
9257	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	610	5.3	Stable	No	Yes or Unknown	Signature.18		No	0	21.49	1	no	no	no
9258	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	5.3		No	No		BRCA2	No	1	11.17	1	no	no	no
9259	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	34	2.6		No	Yes or Unknown	Signature.26		No	0	14.72	1	no	no	no
9260	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	31	4.4	Stable	No	No	Signature.1	PALB2	No	1	1.58	1	no	no	no
9261	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2016	IV	0	11.4		No	No	Signature.13	FANCA | RAD51	Yes	0	30.12	1	no	no	no
9262	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2016	IV	0	4.4		No	Yes or Unknown			No	1	7.1	1	no	no	no
9263	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	III	0	8.8		No	No	Signature.24		No	0	0.98	1	no	no	no
9264	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	15	20.2	Stable	No	No	Signature.4	MDC1	No	0	15.87	1	no	no	no
9265	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	III	0	21.6	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | CHEK2 | RAD54L	No	0	29.24	1	no	no	yes
9266	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	0	6.1	Stable	No	No	Signature.2	BRCA2	No	1	14.49	1	no	no	no
9267	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2016	IV	10	4.4		No	No	Signature.19	MDC1	No	0	2.17	1	no	no	no
9268	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	I	0	24.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BRCA2	No	0	25.75	1	other-MMRd	mut-MMRd	yes
9269	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2016	IV	12	2.6		No	No		ARID1A	No	1	1.38	1	no	no	yes
9270	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	8.8		No	No	Signature.4	ATM | MSH6	No	0	2.17	1	no	no	no
9271	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	175	1.8		Yes or Unknown	Yes or Unknown			No	1	8.08	1	no	no	no
9272	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	182	6.1	Stable	No	Yes or Unknown			No	1	1.74	1	no	no	no
9273	ICI-treated	ICI as subsequent line	61 - 65	Female	Gastric	2016	I	627	2.6	Stable	No	Yes or Unknown			No	0	10.71	1	no	no	no
9274	ICI-treated	ICI as first line	56 - 60	Male	Colorectal	2016	II	4	44.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA2 | MRE11A | PMS1	Yes	0	21.32	1	other-MMRd	mut-MMRd	yes
9275	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		209	4.4	Stable	Yes or Unknown	Yes or Unknown		PALB2	No	1	3.42	1	no	no	no
9276	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	IV	0	44.8	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | MSH6	No	1	6.27	1	mut-MMRd	mut-MMRd	yes
9277	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	II	54	21.9		Yes or Unknown	Yes or Unknown	Signature.2		No	0	22.74	1	no	no	no
9278	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	452	7	Stable	No	No	Signature.7		No	0	19.85	1	no	no	no
9279	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2016		0	1.8		Yes or Unknown	Yes or Unknown			No	1	8.58	1	no	no	no
9280	ICI-treated	ICI as subsequent line	76 - 80	Male	Colorectal	2016	III	291	12.3	Stable	No	Yes or Unknown	Signature.1	BRCA1	No	0	15.48	1	no	no	no
9281	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	III	81	5.3	Stable	No	No			No	1	4.04	1	no	no	no
9282	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	III	11	20.2	Unstable	No	No	Signature.1	ARID1A	No	1	9.89	1	other-MMRd	mut-MMRd	yes
9283	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2016		0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	6.31	1	no	no	no
9284	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	18	4.4	Stable	No	No	Signature.4		No	1	2.69	1	no	no	no
9285	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	20	10.5		No	No	Signature.24		No	0	22.14	1	no	no	no
9286	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	0	1.8	Stable	No	No			No	0	14.52	1	no	no	no
9287	ICI-treated	ICI as subsequent line	26 - 30	Male	SCLC	2016	IV	70	5.3		No	Yes or Unknown			No	1	0.82	1	no	no	no
9288	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	73	4.4		No	No			No	1	7.85	1	no	no	no
9289	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	17	8.8	Stable	No	No	Signature.4	ATM | ATR | BRCA2	No	0	23.1	1	no	no	no
9290	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	294	6.1	Stable	No	Yes or Unknown	Signature.16	BRCA1 | MSH3	No	1	3.94	1	no	no	no
9291	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	5.3		No	No	Signature.26	ARID1A	No	0	14.65	1	no	no	yes
9292	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	IV	29	8.8		No	No	Signature.7	MLH1	No	1	9.76	1	no	no	no
9293	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	I	40	4.4	Stable	No	No			No	0	11.2	1	no	no	no
9294	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	15	14.9		No	No	Signature.4	ARID1A	No	1	1.18	1	no	no	yes
9295	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	19	6.1		No	No		ATM	No	1	0.4	1	no	no	no
9296	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	14	1.8		No	Yes or Unknown			No	1	6.37	1	no	no	no
9297	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	0	4.4		No	Yes or Unknown	Signature.8	ATR	No	1	1.51	1	no	no	no
9298	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016		0	21.9	Stable	No	No	Signature.7	ARID1A	No	0	15.4	1	no	no	yes
9299	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	167	14	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	16.88	1	no	no	yes
9300	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	IV	499	2.6	Stable	No	Yes or Unknown		ATM	No	0	8.02	1	no	no	no
9301	ICI-treated	ICI as first line	41 - 45	Male	Sarcoma	2016	III	277	1.8	Stable	No	Yes or Unknown			No	0	20.08	1	no	no	no
9302	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2016	IV	105	37.7	Unstable	No	Yes or Unknown	Signature.1	ARID1A | BRCA1 | BRIP1 | CHEK2 | ERCC3 | MSH3 | RAD54L	No	0	25	1	other-MMRd	mut-MMRd	yes
9303	ICI-treated	ICI as subsequent line	46 - 50	Male	Gastric	2016	IV	301	4.4	Stable	No	Yes or Unknown			No	0	19.03	1	no	no	no
9304	ICI-treated	ICI - unknown sequence	31 - 35	Male	CNS	2016		218	301		Yes or Unknown	Yes or Unknown	Signature.1	ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC2 | ERCC3 | ERCC5 | FANCA | MSH6 | MUTYH | NBN | PMS2 | RAD50 | RAD51C | RAD52 | RAD54L | XRCC2	No	1	6.8	1	no	no	no
9305	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2016	III	423	7	Stable	No	No	Signature.7	ATM	No	0	15.48	1	no	no	no
9306	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	26	7		No	No	Signature.24	ATM	No	1	0.96	1	no	no	no
9307	ICI-treated	ICI as subsequent line	66 - 70	Female	Head & Neck	2016	IV	36	5.3		No	No			No	1	1.51	1	no	no	no
9308	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	III	0	3.5	Stable	No	No			No	1	0.59	1	no	no	no
9309	ICI-treated	ICI as first line	46 - 50	Female	Gastric	2016	IV	31	7.9	Stable	No	No	Signature.1	BRIP1	No	1	24.25	1	no	no	no
9310	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	35	9.7	Stable	No	No	Signature.4		No	1	8.44	1	no	no	no
9311	ICI-treated	ICI as first line	66 - 70	Female	Gastric	2016	IV	15	7	Stable	No	Yes or Unknown	Signature.17	PMS1	No	1	24.54	1	no	no	no
9312	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	IV	39	4.4		No	No			Yes	1	1.15	1	no	no	no
9313	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2016	IV	7	4.4	Stable	No	No		ARID1A	No	1	9.89	1	no	no	yes
9314	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	204.5	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH3 | MSH6 | NBN | NTHL1 | PMS1 | RAD51C | RAD54L | SLX4 | TP53BP1	No	1	20.08	1	no	no	yes
9315	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2016		0	0.9	Stable	No	No			No	1	4.5	1	no	no	no
9316	ICI-treated	ICI as first line	66 - 70	Male	Esophageal	2016	III	44	4.4		No	No	Signature.1		No	0	29.44	1	no	no	no
9317	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2016	IV	0	3.5		No	No			No	0	7.58	1	no	no	no
9318	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	1.35	1	no	no	no
9319	ICI-treated	ICI as first line	81 - 85	Male	CNS	2016		0	1.8	Stable	No	No			No	1	3.87	1	no	no	no
9320	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	218	12.3	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	13.86	1	no	no	no
9321	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	25	1		No	No			No	1	2.66	1	no	no	no
9322	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2016	I	298	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | MRE11A	Yes	0	4.37	1	no	no	yes
9323	ICI-treated	ICI as subsequent line	81 - 85	Female	Gastric	2016	IV	6	9.7	Stable	No	No	Signature.4		No	0	0.919999999999998	1	no	no	no
9324	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	66	2.6		No	No			No	1	5.45	1	no	no	no
9325	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2016	II	196	0		No	No			No	0	21.62	1	no	no	no
9326	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	504	29.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH6	No	0	23.45	1	mut-MMRd	mut-MMRd	yes
9327	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	0	12.3		No	No	Signature.24		No	1	8.64	1	no	no	no
9328	ICI-treated	ICI as first line	66 - 70	Male	Gastric	2016	IV	655	14	Stable	No	Yes or Unknown	Signature.17	ARID1A | MRE11A | TP53BP1	No	1	27.33	1	no	no	yes
9329	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	15	9.7	Stable	No	No	Signature.4		No	1	28.29	1	no	no	no
9330	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	II	42	21.9	Stable	No	No	Signature.7	ATR	Yes	0	18.4	1	no	no	no
9331	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	7.9		No	No			No	1	11.08	1	no	no	no
9332	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	10	31.6	Stable	No	No	Signature.4	BRCA1 | MRE11A | RAD54L	No	1	5.81	1	no	no	no
9333	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	0	0.9		No	No			No	0	19.45	1	no	no	no
9334	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	252	77.2	Stable	No	No	Signature.7	ARID1A | BLM | ERCC4 | SLX4	Yes	0	22.31	1	no	no	yes
9335	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	III	272	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	8.12	1	no	no	no
9336	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2017	IV	7	0.9	Stable	No	No		ERCC4	No	1	9	1	no	no	no
9337	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017		0	0		No	No			No	0	12.91	1	no	no	no
9338	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	138	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	3.35	1	no	no	no
9339	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	0.62	1	no	no	no
9340	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2015	IV	114	4.4	Stable	Yes or Unknown	Yes or Unknown		ERCC5	No	1	17.25	1	no	no	no
9341	ICI-treated	ICI as first line	71 - 75	Male	Hepatobiliary	2017	II	0	4.4	Stable	No	Yes or Unknown	Signature.12	ARID1A	No	0	18.2	1	no	no	yes
9342	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2017	IV	0	10.5		No	No	Signature.4		No	1	1.08	1	no	no	no
9343	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	46	19.3	Stable	No	No	Signature.4	ARID1A | MDC1 | RAD50	No	0	19.91	1	no	no	yes
9344	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	125	30.7	Stable	No	No	Signature.7		Yes	0	15.67	1	no	no	no
9345	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	13	11.4		No	No	Signature.4		No	0	1.91	1	no	no	no
9346	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	I	545	2.6	Stable	No	Yes or Unknown	Signature.9		No	0	11.86	1	no	no	no
9347	ICI-treated	ICI as first line	71 - 75	Female	Esophageal	2017	IV	5	10.5	Stable	No	No	Signature.1	ARID1A	No	0	28.78	1	no	no	yes
9348	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	136	3.5	Stable	No	Yes or Unknown	Signature.24	ARID1A	No	1	3.19	1	no	no	yes
9349	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	0	9.8		No	Yes or Unknown	Signature.4	FANCA	No	1	16.63	1	no	no	no
9350	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	97	42.1	Unstable	No	Yes or Unknown	Signature.6	BRCA1 | CHEK1 | ERCC5 | MLH1 | MSH3 | MSH6 | PMS2	No	1	0.53	1	mut-MMRd	mut-MMRd	no
9351	ICI-treated	ICI as first line	76 - 80	Male	Sarcoma	2016	IV	29	0.9		No	No			No	0	29.53	1	no	no	no
9352	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016		85	15.8	Stable	No	No	Signature.4	ATM | MSH2	No	1	5.59	1	no	no	no
9353	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2017	IV	21	3.5	Stable	No	No			No	0	2.76	1	no	no	no
9354	ICI-treated	ICI as subsequent line	41 - 45	Female	Bladder	2017	III	105	7	Stable	No	No		BRCA1 | TP53BP1	No	1	0.52	1	no	no	no
9355	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	IV	16	2.6		No	No			No	1	12.23	1	no	no	no
9356	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	III	0	1.8		Yes or Unknown	Yes or Unknown			No	1	19.97	1	no	no	no
9357	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	0	16.7		No	No	Signature.5		No	1	5.26	1	no	no	no
9358	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2017	IV	280	6.1	Stable	No	Yes or Unknown		SLX4	No	0	19.88	1	no	no	no
9359	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	0	3.5		No	No	Signature.1		No	1	19.75	1	no	no	no
9360	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	25	6.1		No	No	Signature.4	MRE11A | TP53BP1	No	1	6.37	1	no	no	no
9361	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	5.3		No	No	Signature.3		No	1	3.42	1	no	no	no
9362	ICI-treated	ICI as subsequent line	36 - 40	Female	Endometrial	2016	IV	32	3.5	Stable	No	No		ARID1A | ATM | BRCA2	No	0	19.94	1	no	no	yes
9363	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	II	480	2.6	Stable	No	No			Yes	0	12.91	1	no	no	no
9364	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	18	5.3	Stable	No	No	Signature.1		No	0	28.98	1	no	no	no
9365	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2016	IV	301	3.5		Yes or Unknown	Yes or Unknown			No	1	4.8	1	no	no	no
9366	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	8.8	Stable	No	Yes or Unknown	Signature.24		No	1	2.73	1	no	no	no
9367	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	20	48.3		No	Yes or Unknown	Signature.4	ATM | BLM | MRE11A | RAD51C | RAD54L	No	0	20.79	1	no	no	no
9368	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2016	II	0	9.7	Stable	No	No	Signature.2		No	1	2.07	1	no	no	no
9369	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	41	3.5		No	Yes or Unknown			No	1	1.71	1	no	no	no
9370	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2017	III	42	17.6		No	No	Signature.7	BRCA1 | MDC1 | MSH6 | SLX4	No	0	25.13	1	no	no	no
9371	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	0	10.5		No	No	Signature.13		Yes	1	4.44	1	no	no	no
9372	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2016		1	2.6		Yes or Unknown	Yes or Unknown			No	1	2.99	1	no	no	no
9373	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.1		No	1	13.57	1	no	no	no
9374	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2015	I	459	10.5		Yes or Unknown	Yes or Unknown	Signature.7	BRCA2 | ERCC5 | TP53BP1	No	1	18.3	1	no	no	no
9375	ICI-treated	ICI as subsequent line	51 - 55	Male	SCLC	2017	IV	0	9.7		No	No	Signature.5	RAD52	No	0	25.95	1	no	no	no
9376	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2016	IV	456	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	9.23	1	no	no	no
9377	ICI-treated	ICI as subsequent line	76 - 80	Male	Head & Neck	2017	IV	490	2.6	Stable	No	Yes or Unknown	Signature.2		No	0	12.78	1	no	no	no
9378	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	1	7.9		No	No	Signature.4		Yes	1	0.43	1	no	no	no
9379	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	II	15	7.9	Stable	No	No	Signature.4	ATM | MSH3	No	0	5.06	1	no	no	no
9380	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	I	494	8.8		Yes or Unknown	Yes or Unknown	Signature.7		No	0	27.66	1	no	no	no
9381	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2017	III	6	14		No	No	Signature.4	ERCC5 | NTHL1	No	0	15.6	1	no	no	no
9382	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	1	0.910000000000001	1	no	no	no
9383	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	III	42	0		No	No			No	0	10.71	1	no	no	no
9384	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2016	III	33	0.9	Stable	No	No			Yes	1	3.55	1	no	no	no
9385	ICI-treated	ICI as subsequent line	51 - 55	Female	Breast	2016	II	231	2.6		Yes or Unknown	Yes or Unknown			No	1	6.44	1	no	no	no
9386	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	I	608	8.8	Stable	No	Yes or Unknown	Signature.3		No	1	3.15	1	no	no	no
9387	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	30	7	Stable	No	Yes or Unknown	Signature.13	BLM	No	1	3.45	1	no	no	no
9388	ICI-treated	ICI as subsequent line	31 - 35	Female	Renal	2017	IV	57	0.9	Stable	No	No			No	1	14.42	1	no	no	no
9389	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	III	59	3.5	Stable	No	Yes or Unknown			No	0	12.29	1	no	no	no
9390	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2017	IV	4	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	2.76	1	no	no	no
9391	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2016	IV	419	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	3.29	1	no	no	no
9392	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2017	III	45	17.6	Stable	No	No	Signature.7		Yes	0	5.29	1	no	no	no
9393	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	I	0	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	0.789999999999999	1	no	no	no
9394	ICI-treated	ICI - unknown sequence	56 - 60	Male	Renal	2017	III	73	2.6	Stable	No	No			No	0	28.42	1	no	no	no
9395	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	IV	0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.3	MSH3	No	1	17.29	1	no	no	no
9396	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2017	II	143	3.5	Stable	No	Yes or Unknown			No	1	3.98	1	no	no	no
9397	ICI-treated	ICI as subsequent line	41 - 45	Female	CNS	2017		5	6.1		No	No		PARP1	No	1	8.57	1	no	no	no
9398	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	4	2.6	Stable	No	No			No	1	4.3	1	no	no	no
9399	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.3	MUTYH	No	1	7.39	1	no	no	no
9400	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	18	6.1	Stable	No	Yes or Unknown		ARID1A	No	0	14.71	1	no	no	yes
9401	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2016	I	825	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	1.9	1	no	no	no
9402	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2017	IV	19	1.8	Stable	No	Yes or Unknown			No	0	9.92	1	no	no	no
9403	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	II	465	22.8		Yes or Unknown	Yes or Unknown	Signature.7	BRCA1 | ERCC3 | MDC1 | MSH3	No	1	3.58	1	no	no	no
9404	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	16.16	1	no	no	no
9405	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		7	7		Yes or Unknown	Yes or Unknown		FANCA	No	1	6.8	1	no	no	no
9406	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	ATM	No	1	10.21	1	no	no	no
9407	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	III	0	6.1	Stable	No	No	Signature.29	ATM	No	0	10.38	1	no	no	no
9408	ICI-treated	ICI - unknown sequence	41 - 45	Female	Head & Neck	2017	II	42	4.4	Stable	No	No			No	0	28.09	1	no	no	no
9409	ICI-treated	ICI as first line	56 - 60	Male	Renal	2017	IV	37	7	Stable	No	No		ATM	Yes	0	25.2	1	no	no	no
9410	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2017	III	22	6.1	Stable	No	No		MDC1	No	0	19.42	1	no	no	no
9411	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2017	IV	19	5.3	Stable	No	Yes or Unknown		BRCA1 | BRCA2	No	1	6.34	1	no	no	no
9412	ICI-treated	ICI as first line	46 - 50	Female	CNS	2017		0	2.6	Stable	No	No			No	1	23.23	1	no	no	no
9413	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	221	2.6	Stable	No	Yes or Unknown			No	1	5.82	1	no	no	no
9414	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2017	IV	2	19.3	Stable	No	Yes or Unknown	Signature.4	BLM | MUTYH	No	0	18.9	1	no	no	no
9415	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	74	0		No	No			No	0	11.07	1	no	no	no
9416	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	III	36	6.1	Stable	No	No	Signature.13		No	1	14.29	1	no	no	no
9417	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	27	4.4		No	No		SLX4	Yes	1	0.46	1	no	no	no
9418	ICI-treated	ICI as subsequent line	36 - 40	Male	Pancreatic	2016	II	24	3.5	Stable	No	No			No	0	9.03	1	no	no	no
9419	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2017	IV	11	1.8		No	No			No	1	11.6	1	no	no	no
9420	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	7	10.5		No	No	Signature.1	BRIP1 | MLH1 | MUTYH	No	1	1.54	1	no	no	no
9421	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2017	III	419	5.3	Stable	No	No	Signature.7		No	0	14.29	1	no	no	no
9422	ICI-treated	ICI as first line	81 - 85	Female	Cutaneous Melanoma 	2016	II	290	178.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | ATR | BRCA2 | ERCC3 | ERCC4 | MDC1 | MSH3 | NTHL1 | SLX4 | XRCC2	Yes	0	26.91	1	no	no	no
9423	ICI-treated	ICI as subsequent line	10-Jun	Male	Sarcoma	2017	IV	0	0.9	Indeterminate	No	No			No	1	8.84	1	no	no	no
9424	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	0	7	Stable	No	No	Signature.2	BRCA2	No	1	7.82	1	no	no	no
9425	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2017	IV	28	11.4	Stable	No	No	Signature.2		Yes	1	4.63	1	no	no	no
9426	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	III	0	4.4	Stable	Yes or Unknown	Yes or Unknown		MRE11A	No	1	8.05	1	no	no	no
9427	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2017	IV	34	16.7	Stable	No	No	Signature.4	MDC1 | SLX4	No	1	15.58	1	no	no	no
9428	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	22.17	1	no	no	no
9429	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	1.28	1	no	no	no
9430	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	I	38	7	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	1	16.33	1	no	no	yes
9431	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	11	4.4	Stable	No	No			No	0	27.57	1	no	no	no
9432	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2017	IV	16	8.8	Stable	No	No	Signature.17	ATM	No	1	14.49	1	no	no	no
9433	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	43	55.3	Stable	No	Yes or Unknown	Signature.7	ARID1A | BRCA1 | ERCC4 | MDC1 | MLH1 | PMS1	No	1	11.7	1	no	no	yes
9434	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	13	15.8	Stable	No	Yes or Unknown	Signature.4	CHEK2 | ERCC3	No	1	1.58	1	no	no	no
9435	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2016	IV	0	1.8	Indeterminate	Yes or Unknown	Yes or Unknown			No	1	3.84	1	no	no	no
9436	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	0	26.3	Stable	No	No	Signature.4	ATM | BRCA2 | MDC1 | SLX4	No	0	11.99	1	no	no	no
9437	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2017	III	41	18.4	Stable	No	No	Signature.7		Yes	0	24.61	1	no	no	no
9438	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	IV	701	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	8.35	1	no	no	no
9439	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2017	II	29	37.7	Stable	No	No	Signature.7	ARID1A | MLH1 | TP53BP1	Yes	0	27.5	1	no	no	yes
9440	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	34	0	Stable	No	No			No	1	9.86	1	no	no	no
9441	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	III	259	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.14		No	0	4.89	1	no	no	no
9442	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	III	16	7.9	Stable	No	No	Signature.4	BRCA1	No	1	5.78	1	no	no	no
9443	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2017		0	7	Stable	Yes or Unknown	Yes or Unknown			No	0	14.91	1	no	no	no
9444	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2017		0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	14.23	1	no	no	no
9445	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	29	7	Stable	Yes or Unknown	Yes or Unknown			No	0	27.47	1	no	no	no
9446	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	III	0	0	Stable	No	No			No	0	16.26	1	no	no	no
9447	ICI-treated	ICI as subsequent line	46 - 50	Female	Pancreatic	2016	II	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	7.65	1	no	no	no
9448	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2017	IV	55	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ATM	No	1	9.2	1	no	no	no
9449	ICI-treated	ICI - unknown sequence	56 - 60	Female	Renal	2017	III	70	3.5	Stable	No	No			No	0	26.12	1	no	no	no
9450	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	0	21.1	Stable	No	No	Signature.4	ERCC3	No	0	13.37	1	no	no	no
9451	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017		453	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	11.73	1	no	no	no
9452	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	75	0		No	No			No	0	16.98	1	no	no	no
9453	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2017		14	6.1	Stable	No	No		FANCA	No	0	26.48	1	no	no	no
9454	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2017	II	0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	16.52	1	no	no	no
9455	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2016	IV	0	58.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ATM | ATR | BRCA2 | MLH1 | PMS1	No	1	21.72	1	no	no	yes
9456	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2017	IV	10	14	Stable	No	No	Signature.13		No	0	15.87	1	no	no	no
9457	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2017	IV	279	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	1.94	1	no	no	no
9458	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	I	19	36.9	Stable	No	No	Signature.4		No	0	18.33	1	no	no	no
9459	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	311	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	3.62	1	no	no	no
9460	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2017	IV	22	4.4	Stable	No	No	Signature.2		No	0	9.13	1	no	no	no
9461	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2017	IV	0	7	Stable	No	No	Signature.13	ARID1A	No	1	6.77	1	no	no	yes
9462	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2017	III	0	4.4	Stable	No	No			No	1	9	1	no	no	no
9463	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	0	2.6	Stable	No	No			Yes	1	9.13	1	no	no	no
9464	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	26	23.7	Stable	No	No	Signature.4	ARID1A | BLM	No	0	12.42	1	no	no	yes
9465	ICI-treated	ICI as subsequent line	21 - 25	Female	Renal	2017	IV	0	0.9	Stable	No	Yes or Unknown		ATM	No	1	17.42	1	no	no	no
9466	ICI-treated	ICI as subsequent line	26 - 30	Male	Esophageal	2016	III	0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	22.27	1	no	no	no
9467	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2016	III	0	8.8	Stable	No	No	Signature.4		No	1	0.66	1	no	no	no
9468	ICI-treated	ICI as subsequent line	71 - 75	Female	Renal	2017	IV	36	6.1	Stable	No	Yes or Unknown	Signature.3	SLX4	No	1	5.68	1	no	no	no
9469	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	1	13.2	Stable	No	No	Signature.26		No	1	17.51	1	no	no	no
9470	ICI-treated	ICI as first line	76 - 80	Male	Hepatobiliary	2017	IV	171	3.5	Stable	No	No			Yes	0	23	1	no	no	no
9471	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2017	IV	0	5.3	Stable	No	No	Signature.7	BRCA1	No	0	26.67	1	no	no	no
9472	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2017	IV	209	14	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	5.19	1	no	no	yes
9473	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2017	IV	20	0.9	Stable	No	No			No	1	5.22	1	no	no	no
9474	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		1	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	7.59	1	no	no	no
9475	ICI-treated	ICI as subsequent line	36 - 40	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	1.94	1	no	no	no
9476	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	3	6.1	Stable	No	Yes or Unknown	Signature.4	MDC1	No	0	27.08	1	no	no	no
9477	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	III	274	7	Stable	No	Yes or Unknown			No	0	6.83	1	no	no	no
9478	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	IV	22	55.3	Stable	No	No	Signature.7	ATM | BLM | CHEK1	No	0	10.81	1	no	no	no
9479	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2017	III	56	9.7	Stable	No	No			No	1	4.4	1	no	no	no
9480	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	14	0.9	Stable	No	No			No	1	20.37	1	no	no	no
9481	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	III	0	10.5	Stable	No	No	Signature.4	BRCA2 | MSH2	No	0	21.32	1	no	no	no
9482	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	4	5.3	Stable	No	No			Yes	1	1.08	1	no	no	no
9483	ICI-treated	ICI as first line	66 - 70	Male	Hepatobiliary	2016	II	322	7	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	1	8.48	1	no	no	no
9484	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	32	6.1	Stable	No	No		ARID1A	No	1	2.56	1	no	no	yes
9485	ICI-treated	ICI as first line	61 - 65	Female	Bladder	2017	IV	0	22.8	Stable	No	No	Signature.2	ATM | CHEK2	No	0	25.75	1	no	no	no
9486	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2017	II	131	4.4	Stable	No	Yes or Unknown			No	1	0.92	1	no	no	no
9487	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	II	454	7	Stable	No	Yes or Unknown	Signature.4		No	1	10.58	1	no	no	no
9488	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2017	III	388	1.8	Stable	Yes or Unknown	Yes or Unknown		MDC1	No	0	8.97	1	no	no	no
9489	ICI-treated	ICI as subsequent line	21 - 25	Male	Renal	2017	IV	29	0.9	Stable	No	Yes or Unknown			No	1	5.75	1	no	no	no
9490	ICI-treated	ICI as subsequent line	56 - 60	Female	CNS	2017		17	3.5	Stable	No	No		BRCA1	No	1	8.28	1	no	no	no
9491	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2017	II	27	11.4	Stable	No	No	Signature.4		Yes	0	7.46	1	no	no	no
9492	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	7	13.2	Stable	No	No	Signature.4	XRCC2	No	1	8.01	1	no	no	no
9493	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	277	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.5	BRCA2	No	0	26.91	1	no	no	no
9494	ICI-treated	ICI as subsequent line	66 - 70	Female	Breast	2017	IV	22	4.4	Stable	No	No	Signature.1		No	0	11.04	1	no	no	no
9495	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	14.06	1	no	no	no
9496	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2017	IV	11	12.3	Stable	No	No	Signature.13	ARID1A	No	1	6.47	1	no	no	yes
9497	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2017		5	22.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ATR | MSH2	No	0	15.15	1	mut-MMRd	mut-MMRd	no
9498	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	409	4.4	Stable	No	Yes or Unknown			No	0	12.88	1	no	no	no
9499	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	540	6.1	Stable	Yes or Unknown	Yes or Unknown		BLM	No	0	18.6	1	no	no	no
9500	ICI-treated	ICI as first line	66 - 70	Male	Esophageal	2017	II	15	4.4	Stable	No	No	Signature.1	ARID1A	No	0	26.78	1	no	no	yes
9501	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	21	9.7	Stable	No	No	Signature.4		No	1	12.46	1	no	no	no
9502	ICI-treated	ICI as first line	56 - 60	Male	Esophageal	2017	III	176	9.7	Stable	No	Yes or Unknown			No	0	26.77	1	no	no	no
9503	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	II	0	12.3	Stable	No	No	Signature.4		No	0	10.71	1	no	no	no
9504	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	II	0	13.2	Stable	No	No	Signature.4		No	0	25.3	1	no	no	no
9505	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	186	2.6	Stable	No	Yes or Unknown	Signature.5		No	1	7.03	1	no	no	no
9506	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2017	III	0	8.8	Stable	No	No		ARID1A | PARP1	No	1	7	1	no	no	yes
9507	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	3	21.9	Indeterminate	No	No	Signature.4	TP53BP1	No	1	1.61	1	no	no	no
9508	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2017	II	213	3.5	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	15.34	1	no	no	yes
9509	ICI-treated	ICI as first line	46 - 50	Male	Esophageal	2017	III	0	0.9	Stable	No	No			No	1	14.85	1	no	no	no
9510	ICI-treated	ICI as subsequent line	51 - 55	Female	Gastric	2017	III	15	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	2.14	1	no	no	no
9511	ICI-treated	ICI as subsequent line	21 - 25	Male	Sarcoma	2017	IV	113	0.9	Stable	No	No			No	0	14.35	1	no	no	no
9512	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown			No	1	1.22	1	no	no	no
9513	ICI-treated	ICI as subsequent line	46 - 50	Female	Endometrial	2017	III	19	37.7	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC5 | MLH1 | PARP1	No	0	11.59	1	mut-MMRd	mut-MMRd	yes
9514	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2017	IV	4	4.4	Stable	No	No		BLM | PARP1	No	1	4.17	1	no	no	no
9515	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	IV	110	0		No	Yes or Unknown			No	0	15.41	1	no	no	no
9516	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2017		9	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	2.57	1	no	no	no
9517	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2015	IV	844	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATM | BRCA1	No	0	16.62	1	no	no	yes
9518	ICI-treated	ICI as subsequent line	26 - 30	Male	Renal	2017	IV	15	0.9	Stable	No	Yes or Unknown			No	1	0.889999999999999	1	no	no	no
9519	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	I	46	8.8	Stable	No	No	Signature.4		Yes	0	11.27	1	no	no	no
9520	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.13		No	0	4.73	1	no	no	no
9521	ICI-treated	ICI as first line	61 - 65	Male	Head & Neck	2017	IV	33	1.8	Stable	No	No	Signature.1	ARID1A	No	0	24.84	1	no	no	yes
9522	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	0	12.3	Stable	No	No	Signature.4	ERCC2 | ERCC5	No	1	9.63	1	no	no	no
9523	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	0	15.8	Stable	No	No	Signature.4		No	0	19.05	1	no	no	no
9524	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	32	1.8	Stable	No	No			No	0	1.94	1	no	no	no
9525	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2015	III	582	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ATM | FANCA	No	0	25.99	1	no	no	yes
9526	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2017	III	4	3.5	Stable	No	No			No	0	21.32	1	no	no	no
9527	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	11	5.3	Stable	No	No			No	1	5	1	no	no	no
9528	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	8	3.5	Stable	No	Yes or Unknown			No	1	9.52	1	no	no	no
9529	ICI-treated	ICI as subsequent line	31 - 35	Female	Sarcoma	2016	II	133	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	0.43	1	no	no	no
9530	ICI-treated	ICI as first line	36 - 40	Male	NSCLC	2017	IV	81	3.5	Stable	No	No			No	0	23.92	1	no	no	no
9531	ICI-treated	ICI as subsequent line	51 - 55	Female	SCLC	2017	III	0	7.9	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.20	SLX4	No	0	19.32	1	no	no	no
9532	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	18.4	Stable	No	Yes or Unknown	Signature.4	ATM | BRIP1 | PALB2 | TP53BP1	No	0	25.4	1	no	no	no
9533	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2017	IV	63	1.8	Stable	No	No			No	1	14.46	1	no	no	no
9534	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	21	9.7	Stable	No	No	Signature.3	ARID1A	Yes	1	4.83	1	no	no	yes
9535	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	0	0		No	No			No	0	25.73	1	no	no	no
9536	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2015	III	96	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	1.87	1	no	no	no
9537	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	46	13.2	Stable	No	No	Signature.4	ATM | BRCA1 | CHEK2 | FANCA | PALB2	Yes	0	25.04	1	no	no	no
9538	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	316	7	Stable	No	Yes or Unknown	Signature.16	ATM | BRCA2	No	0	14.25	1	no	no	no
9539	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2017	II	181	3.5	Stable	No	Yes or Unknown	Signature.3	ARID1A	No	1	1.77	1	no	no	yes
9540	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	IV	635	7	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | ATR	No	1	10.88	1	no	no	yes
9541	ICI-treated	ICI as subsequent line	31 - 35	Male	Esophageal	2016	II	109	43	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH2	No	1	0.829999999999998	1	mut-MMRd	mut-MMRd	yes
9542	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	1.8	Stable	No	No			Yes	1	0.99	1	no	no	no
9543	ICI-treated	ICI as subsequent line	26 - 30	Male	NSCLC	2017	IV	31	1.8	Stable	No	No			No	0	17.12	1	no	no	no
9544	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.3	PMS2	No	1	4.08	1	no	no	no
9545	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	0	7	Stable	No	Yes or Unknown		ARID1A | ATM	No	1	3.71	1	no	no	yes
9546	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.3		No	1	9.03	1	no	no	no
9547	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	96	17.6	Stable	Yes or Unknown	Yes or Unknown	Signature.5	ERCC5 | NTHL1	No	1	9.1	1	no	no	no
9548	ICI-treated	ICI as subsequent line	46 - 50	Female	Pancreatic	2016	II	303	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	2.07	1	no	no	no
9549	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	127	9.7	Stable	No	Yes or Unknown	Signature.4	RAD50	No	1	0.95	1	no	no	no
9550	ICI-treated	ICI as subsequent line	71 - 75	Male	SCLC	2016	IV	0	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	SLX4	No	1	14.95	1	no	no	no
9551	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2017	III	45	7.9	Stable	No	No	Signature.2		No	1	19.19	1	no	no	no
9552	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	BRCA2 | MSH2 | NBN | SLX4	No	0	12.81	1	no	no	no
9553	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	231	0.9	Stable	No	Yes or Unknown			No	1	3.15	1	no	no	no
9554	ICI-treated	ICI as subsequent line	26 - 30	Female	Ovarian	2017	IV	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	11.7	1	no	no	no
9555	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2015	II	12	79.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | ATR | ERCC5 | MRE11A | MSH3	Yes	1	6.73	1	no	no	no
9556	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	10	16.7	Stable	No	No	Signature.4	MSH2	No	0	22.43	1	no	no	no
9557	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	431	7	Stable	No	Yes or Unknown	Signature.4		No	1	21.52	1	no	no	no
9558	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	IV	426	6.1	Stable	Yes or Unknown	Yes or Unknown			No	0	14.36	1	no	no	no
9559	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	I	373	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.24		Yes	0	12.52	1	no	no	no
9560	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	0	4.4	Stable	No	No	Signature.8	ATR | MDC1	Yes	1	7.88	1	no	no	no
9561	ICI-treated	ICI as subsequent line	46 - 50	Male	Breast	2017	II	532	36	Stable	No	Yes or Unknown	Signature.7	ATM | ATR | RAD52	No	0	8.77	1	no	no	no
9562	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2017	I	41	1.8	Stable	No	No			Yes	1	3.68	1	no	no	no
9563	ICI-treated	ICI as subsequent line	41 - 45	Female	Head & Neck	2017	II	55	4.4	Stable	No	No	Signature.13		No	0	5.15	1	no	no	no
9564	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	IV	21	44.8	Stable	No	No	Signature.7	MDC1 | MLH1	No	1	10.91	1	no	no	no
9565	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	III	16	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	12.74	1	no	no	no
9566	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	0	1.8	Stable	No	No			No	1	10.28	1	no	no	no
9567	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2017	IV	87	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	24.38	1	no	no	no
9568	ICI-treated	ICI as subsequent line	71 - 75	Male	SCLC	2017	IV	170	15.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	TP53BP1	No	1	0.359999999999999	1	no	no	no
9569	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	II	252	17.6	Stable	No	No	Signature.7	ARID1A | PALB2	No	0	18.92	1	no	no	yes
9570	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	II	93	11.4	Stable	No	No	Signature.13	BRCA1	No	0	18.17	1	no	no	no
9571	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2017	IV	5	43.9	Unstable	No	No	Signature.1	ARID1A | CHEK2 | FANCA | MSH6	No	1	6.37	1	mut-MMRd	mut-MMRd	yes
9572	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	0	21.1	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | TP53BP1	No	0	14.33	1	other-MMRd	mut-MMRd	yes
9573	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2017	I	0	7	Stable	No	No			No	0	21.12	1	no	no	no
9574	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	41	6.1	Stable	No	No	Signature.2	ARID1A	No	1	0.989999999999999	1	no	no	yes
9575	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	III	15	17.6	Stable	No	No	Signature.7	BLM | BRCA2 | ERCC5 | MDC1	Yes	0	22.34	1	no	no	no
9576	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	II	202	31.6	Stable	No	No	Signature.7	ARID1A	Yes	0	15.34	1	no	no	yes
9577	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	II	403	41.3	Stable	No	No	Signature.7	BRCA2 | CHEK2	Yes	0	12.19	1	no	no	no
9578	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	II	453	0	Stable	Yes or Unknown	Yes or Unknown			No	0	10.45	1	no	no	no
9579	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	I	71	7.9	Stable	No	No		ARID1A	No	0	12.59	1	no	no	yes
9580	ICI-treated	ICI as subsequent line	51 - 55	Female	Cutaneous Melanoma 	2017		28	14.9	Stable	No	No	Signature.7	SLX4	No	0	10.12	1	no	no	no
9581	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	I	29	52.7	Unstable	No	No	Signature.6	MLH1	No	0	13.27	1	mut-MMRd	mut-MMRd	no
9582	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	17	0.9	Stable	No	No			No	1	2.23	1	no	no	no
9583	ICI-treated	ICI as subsequent line	51 - 55	Female	Esophageal	2017	III	0	43.9	Unstable	No	No	Signature.6	ARID1A | BRIP1 | RAD50	No	0	19.08	1	other-MMRd	mut-MMRd	yes
9584	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2017		5	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	10.98	1	no	no	no
9585	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	269	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	13.41	1	no	no	no
9586	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2017	III	21	1.8	Stable	No	No			No	0	24.8	1	no	no	no
9587	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	28	5.3	Stable	No	No	Signature.4		No	1	1.81	1	no	no	no
9588	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2017	IV	21	33.4	Unstable	No	Yes or Unknown	Signature.6	BLM | MDC1 | TP53BP1	No	0	1.54	1	other-MMRd	mut-MMRd	no
9589	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	III	88	2.6	Stable	Yes or Unknown	Yes or Unknown		MLH1	No	1	9.59	1	no	no	no
9590	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2017	I	0	7	Stable	No	No	Signature.5		No	0	19.16	1	no	no	no
9591	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	IV	34	3.5	Stable	No	No	Signature.24		No	1	14.42	1	no	no	no
9592	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	II	370	6.1	Stable	No	Yes or Unknown	Signature.24	ATM	No	1	16.17	1	no	no	no
9593	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	0	7.9	Stable	No	No	Signature.18		No	0	18.43	1	no	no	no
9594	ICI-treated	ICI as subsequent line	71 - 75	Female	Pancreatic	2017	IV	0	10.5	Stable	No	No	Signature.1	ARID1A | ERCC3	No	1	4.14	1	no	no	yes
9595	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	0	5.3	Stable	No	No	Signature.7		No	0	24.87	1	no	no	no
9596	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2017	IV	39	52.7	Stable	No	No	Signature.7	ERCC5 | MSH6 | SLX4	Yes	0	23.95	1	no	no	no
9597	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2017	III	28	13.2	Stable	No	No	Signature.7	MLH1	No	0	19.32	1	no	no	no
9598	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	III	344	14.9	Stable	No	Yes or Unknown	Signature.4	MSH2	No	0	15.17	1	no	no	no
9599	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2017	II	0	0	Stable	No	No			No	0	0	1	no	no	no
9600	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	17	7	Stable	No	No	Signature.7		Yes	0	19.55	1	no	no	no
9601	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	613	6.1	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.1		No	0	19.35	1	no	no	no
9602	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	IV	0	6.1	Stable	No	No	Signature.8		No	0	7.92	1	no	no	no
9603	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	26	8.8	Indeterminate	No	No	Signature.4		Yes	1	1.29	1	no	no	no
9604	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	IV	1182	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	3.55	1	no	no	no
9605	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	I	141	29.8	Unstable	No	Yes or Unknown	Signature.6	ARID1A | MRE11A	No	1	11.92	1	other-MMRd	mut-MMRd	yes
9606	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	22	0.9	Stable	No	No			No	1	1.81	1	no	no	no
9607	ICI-treated	ICI as subsequent line	36 - 40	Male	Sarcoma	2017	II	292	0	Stable	No	No			No	1	6.87	1	no	no	no
9608	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	22.63	1	no	no	no
9609	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	22	7.9	Stable	No	No	Signature.4		No	0	10.15	1	no	no	no
9610	ICI-treated	ICI as first line	76 - 80	Female	Bladder	2017	III	78	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	22.37	1	no	no	no
9611	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2017	IV	176	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	20.83	1	no	no	yes
9612	ICI-treated	ICI as first line	46 - 50	Male	Gastric	2017	IV	1	4.4	Stable	No	No			No	1	21.95	1	no	no	no
9613	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	27	75.5	Stable	No	No	Signature.7	ATR | PMS1 | PMS2	No	0	17.01	1	no	no	no
9614	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	26	5.3	Stable	No	No	Signature.24		No	0	20.01	1	no	no	no
9615	ICI-treated	ICI as subsequent line	26 - 30	Female	Head & Neck	2017	IV	2	4.4	Stable	No	No	Signature.3		No	1	4.04	1	no	no	no
9616	ICI-treated	ICI as subsequent line	31 - 35	Male	Cutaneous Melanoma 	2017	III	0	11.4	Indeterminate	No	No	Signature.7		No	1	6.57	1	no	no	no
9617	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2015	III	165	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	4.34	1	no	no	no
9618	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	16	5.3	Stable	No	No	Signature.4		No	1	3.98	1	no	no	no
9619	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2017	IV	46	1.8	Stable	No	Yes or Unknown			No	1	6.21	1	no	no	no
9620	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2017	IV	0	6.1	Indeterminate	No	No	Signature.1		No	1	0.850000000000001	1	no	no	no
9621	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2017	III	67	17.6	Stable	No	No	Signature.4	ATM	No	1	21.03	1	no	no	no
9622	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	I	11	2.6	Stable	No	No			Yes	0	13.44	1	no	no	no
9623	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	10	0.9	Stable	No	No			No	0	14.1	1	no	no	no
9624	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	84	0.9	Stable	No	No	Signature.3		No	0	11.24	1	no	no	no
9625	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2016	II	281	36	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	21.16	1	no	no	no
9626	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2017	IV	0	2.6	Stable	No	No			No	1	10.87	1	no	no	no
9627	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2016	I	530	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	15.9	1	no	no	no
9628	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	I	399	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	4.24	1	no	no	no
9629	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2017	IV	280	5.3	Stable	No	Yes or Unknown		ATR	No	0	8.97	1	no	no	no
9630	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017	III	41	1.8	Stable	No	No	Signature.7		No	0	19.29	1	no	no	no
9631	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	0	6.1	Indeterminate	No	No	Signature.4	ATM	No	1	4.47	1	no	no	no
9632	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.4	CHEK1	No	1	8.01	1	no	no	no
9633	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	22	12.3	Stable	No	No	Signature.4		No	1	1.21	1	no	no	no
9634	ICI-treated	ICI as first line	76 - 80	Female	Gastric	2017	IV	392	2.6	Stable	No	Yes or Unknown		CHEK2	No	0	23.39	1	no	no	no
9635	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	18.4	Stable	No	No	Signature.4		No	1	3.88	1	no	no	no
9636	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	0	48.3	Stable	No	No	Signature.7	BRCA1 | BRCA2 | BRIP1 | PALB2 | RAD50	Yes	0	19.55	1	no	no	no
9637	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	0	23.7	Stable	No	No	Signature.4		No	0	15.41	1	no	no	no
9638	ICI-treated	ICI as subsequent line	16 - 20	Male	Sarcoma	2017	IV	7	0	Stable	No	No			No	1	4.73	1	no	no	no
9639	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	II	15	24.6	Stable	No	No	Signature.4	ARID1A | PMS1	No	0	21.78	1	no	no	yes
9640	ICI-treated	ICI as subsequent line	36 - 40	Male	SCLC	2016	IV	0	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	9.07	1	no	no	no
9641	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	III	13	8.8	Stable	No	No	Signature.4		No	0	22.27	1	no	no	no
9642	ICI-treated	ICI as first line	46 - 50	Male	Bladder	2017	IV	40	0.9	Stable	No	No			Yes	1	1.57	1	no	no	no
9643	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2017	IV	0	2.6	Stable	No	No			No	0	2.16	1	no	no	no
9644	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	14	3.5	Stable	No	No		RAD50	No	0	17.68	1	no	no	no
9645	ICI-treated	ICI as first line	41 - 45	Male	Bladder	2017	IV	38	17.6	Stable	No	No	Signature.13	MDC1	Yes	0	23.06	1	no	no	no
9646	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.4	ARID1A | ATM	No	0	5.69	1	no	no	yes
9647	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	2.53	1	no	no	no
9648	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2016	III	370	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	12.22	1	no	no	no
9649	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	12	14	Stable	No	No	Signature.4	ARID1A | BRCA1 | MSH3	No	0	15.18	1	no	no	yes
9650	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	11	5.3	Stable	No	No		FANCA	No	1	3.58	1	no	no	no
9651	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	I	28	0		Yes or Unknown	Yes or Unknown			No	0	9.88	1	no	no	no
9652	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	44	4.4	Stable	No	No		BRCA1	Yes	1	0.37	1	no	no	no
9653	ICI-treated	ICI as subsequent line	71 - 75	Female	SCLC	2017	I	294	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	1	3.68	1	no	no	no
9654	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2016	IV	49	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	2.53	1	no	no	no
9655	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2017	IV	26	4.4	Stable	No	No			No	0	9.83	1	no	no	no
9656	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2017	III	0	39.5	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | ATM | MRE11A | PARP1	No	0	18.86	1	no	no	yes
9657	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	14	17.6	Stable	No	No	Signature.4		No	0	11.08	1	no	no	no
9658	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ERCC5	No	1	4.99	1	no	no	no
9659	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	248	1.8	Stable	No	Yes or Unknown			No	1	6.54	1	no	no	no
9660	ICI-treated	ICI - unknown sequence	76 - 80	Male	NSCLC	2017	III	0	11.4	Stable	No	No	Signature.24	NBN | SLX4	No	0	22.31	1	no	no	no
9661	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2017	IV	0	8.8	Stable	No	No	Signature.8		No	1	6.67	1	no	no	no
9662	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	5	1.8	Stable	No	No			No	1	5.03	1	no	no	no
9663	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	5	13.2	Stable	No	No	Signature.7		Yes	0	21.39	1	no	no	no
9664	ICI-treated	ICI as subsequent line	56 - 60	Male	SCLC	2017	IV	2	6.1	Stable	No	Yes or Unknown	Signature.24		No	1	1.22	1	no	no	no
9665	ICI-treated	ICI as first line	31 - 35	Female	Gastric	2017	IV	17	2.6	Stable	No	No			No	0	17.25	1	no	no	no
9666	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2017		0	2.6	Stable	No	No			No	1	8.9	1	no	no	no
9667	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	0	36.9	Stable	No	No	Signature.7	BRCA2 | ERCC3 | MLH1 | PMS2	No	1	13.37	1	no	no	no
9668	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	7	4.4	Stable	No	No	Signature.4		No	1	1.28	1	no	no	no
9669	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	10	3.5	Stable	No	No	Signature.17	ATM	No	1	17.61	1	no	no	no
9670	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	16	18.4	Stable	No	No	Signature.4		Yes	0	21.81	1	no	no	no
9671	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	II	33	3.5	Stable	No	No			No	1	10.35	1	no	no	no
9672	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	37	8.8	Stable	No	Yes or Unknown	Signature.4	ARID1A | SLX4	No	0	21.1	1	no	no	yes
9673	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	0	2.6	Indeterminate	No	No	Signature.1	MSH2	No	0	6.73	1	no	no	no
9674	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2017	III	8	1.8	Stable	No	No			No	1	3.19	1	no	no	no
9675	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	II	209	47.4	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATR | BRIP1 | ERCC4 | RAD51	No	0	17.41	1	no	no	no
9676	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.13	ATM | MSH6	No	0	11.57	1	no	no	no
9677	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		3	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	3.97	1	no	no	no
9678	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	IV	2	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	5.52	1	no	no	no
9679	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	III	118	0.9	Stable	No	No			No	0	21.82	1	no	no	no
9680	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	IV	754	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.2	BRCA1 | RAD50	No	1	4.3	1	no	no	no
9681	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	0	11.4	Stable	No	No	Signature.3		No	1	1.88	1	no	no	no
9682	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2017	III	87	4.4	Stable	No	No			No	1	14.29	1	no	no	no
9683	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2017	I	20	1.8	Stable	No	No			No	0	12.09	1	no	no	no
9684	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	II	91	5.3	Stable	No	No	Signature.18	BRCA1	No	0	6.96	1	no	no	no
9685	ICI-treated	ICI as subsequent line	66 - 70	Male	Colorectal	2017	IV	24	22.8	Indeterminate	No	No	Signature.1	ATM	No	0	12.98	1	no	no	no
9686	ICI-treated	ICI as first line	36 - 40	Male	Renal	2017	IV	75	3.5	Stable	No	No			Yes	0	16.59	1	no	no	no
9687	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2017	II	112	14.9	Stable	No	Yes or Unknown	Signature.7		No	0	19.35	1	no	no	no
9688	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	II	239	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ATM | MSH3	No	0	19.78	1	no	no	no
9689	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	IV	43	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	0.230000000000004	1	no	no	no
9690	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	18	2.6	Stable	No	No	Signature.22		No	1	6.5	1	no	no	no
9691	ICI-treated	ICI as first line	71 - 75	Male	Esophageal	2017	IV	0	0.9	Stable	No	No	Signature.5		Yes	0	18.8	1	no	no	no
9692	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	III	18	14	Stable	No	No	Signature.7		No	0	19.62	1	no	no	no
9693	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	IV	162	40.4	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | BRIP1 | SLX4	No	0	21.94	1	other-MMRd	mut-MMRd	yes
9694	ICI-treated	ICI as subsequent line	66 - 70	Female	Breast	2017	II	274	3.5	Indeterminate	No	Yes or Unknown	Signature.5	PMS2	No	0	14.69	1	no	no	no
9695	ICI-treated	ICI as subsequent line	41 - 45	Female	Endometrial	2017	IV	53	0.9	Stable	No	No			No	1	9.03	1	no	no	no
9696	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.24		No	1	7.33	1	no	no	no
9697	ICI-treated	ICI as first line	46 - 50	Male	Renal	2017	III	0	2.6	Stable	No	No			Yes	0	20.66	1	no	no	no
9698	ICI-treated	ICI as subsequent line	86 - 90	Male	Sarcoma	2017	IV	133	1.8	Stable	No	Yes or Unknown			No	0	18.27	1	no	no	no
9699	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2017	IV	1	1.8	Stable	No	Yes or Unknown			No	0	19.78	1	no	no	no
9700	ICI-treated	ICI - unknown sequence	66 - 70	Female	Breast	2017	I	114	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	9.37	1	no	no	no
9701	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2017	IV	24	3.5	Stable	No	No			No	1	5.45	1	no	no	no
9702	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2017	II	194	6.1	Stable	No	No	Signature.7	MDC1	Yes	1	4.53	1	no	no	no
9703	ICI-treated	ICI as first line	76 - 80	Male	Bladder	2017	I	106	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	2.92	1	no	no	no
9704	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017		0	0		Yes or Unknown	Yes or Unknown			No	1	9.07	1	no	no	no
9705	ICI-treated	ICI as subsequent line	66 - 70	Male	Prostatic	2016	IV	342	65.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATM | ERCC4 | ERCC5 | MRE11A | MSH6	No	0	17.41	1	mut-MMRd	mut-MMRd	yes
9706	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	0	7	Stable	No	No	Signature.24		No	0	20.07	1	no	no	no
9707	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2017	II	320	0	Stable	Yes or Unknown	Yes or Unknown			No	1	19.25	1	no	no	no
9708	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2017		23	99.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | BLM | BRCA2 | MDC1 | PALB2	No	0	12.19	1	no	no	yes
9709	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	201	42.1	Stable	No	No	Signature.7	ATM | ATR | BRIP1 | ERCC2	No	0	20.01	1	no	no	no
9710	ICI-treated	ICI as first line	86 - 90	Male	Bladder	2017	IV	138	6.1	Stable	No	Yes or Unknown	Signature.2		Yes	1	4.08	1	no	no	no
9711	ICI-treated	ICI as subsequent line	51 - 55	Female	Pancreatic	2017	II	155	3.5	Stable	No	Yes or Unknown			No	1	5.42	1	no	no	no
9712	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	19.42	1	no	no	no
9713	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	24.6	Stable	No	No	Signature.4		No	1	0.92	1	no	no	no
9714	ICI-treated	ICI as subsequent line	31 - 35	Female	Sarcoma	2017	IV	224	7		No	Yes or Unknown	Signature.5	ERCC2	No	0	15.64	1	no	no	no
9715	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	41	6.1	Stable	No	No			No	0	8.84	1	no	no	no
9716	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	2	6.1		No	No	Signature.26		No	1	2.47	1	no	no	no
9717	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	22	14.9	Stable	No	No	Signature.13	ATM	No	0	19.88	1	no	no	no
9718	ICI-treated	ICI - unknown sequence	36 - 40	Male	Cutaneous Melanoma 	2017	I	348	29	Stable	No	No	Signature.7	ARID1A | ERCC2 | MSH3 | RAD51C	No	0	9.66	1	no	no	yes
9719	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2017	II	0	16.7	Stable	No	No	Signature.4	CHEK2	No	0	17.52	1	no	no	no
9720	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2017	IV	0	5.3	Stable	No	No			No	0	0.819999999999999	1	no	no	no
9721	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2017	II	13	9.7	Stable	No	No	Signature.30		No	1	2.7	1	no	no	no
9722	ICI-treated	ICI as subsequent line	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	2.76	1	no	no	no
9723	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	1	3.68	1	no	no	no
9724	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	13.2	Stable	No	No	Signature.13		No	0	17.7	1	no	no	no
9725	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2017	III	18	4.4	Stable	No	No			No	1	6.8	1	no	no	no
9726	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	21	2.6	Stable	No	Yes or Unknown			No	1	4.53	1	no	no	no
9727	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	1	12.32	1	no	no	no
9728	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2017	IV	0	19.3	Stable	No	No	Signature.4	BRCA2 | ERCC4 | MRE11A	No	1	18.37	1	no	no	no
9729	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	39	15.8	Stable	No	No	Signature.29		No	1	0.99	1	no	no	no
9730	ICI-treated	ICI as first line	31 - 35	Female	NSCLC	2017	IV	3	4.4	Stable	No	No	Signature.5		No	1	7.23	1	no	no	no
9731	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	29	5.3	Stable	No	No	Signature.5	BRCA2 | BRIP1	No	1	0.79	1	no	no	no
9732	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	IV	633	7	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	14.72	1	no	no	yes
9733	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	16	12.3	Stable	No	No	Signature.4	ARID1A | ATM	No	1	2.4	1	no	no	yes
9734	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	14	5.3	Stable	No	No	Signature.2		No	0	11.76	1	no	no	no
9735	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	21	17.6	Stable	Yes or Unknown	Yes or Unknown	Signature.29	NTHL1 | PALB2	No	1	9.46	1	no	no	no
9736	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	III	58	4.4	Stable	No	No			No	0	21.1	1	no	no	no
9737	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	0	8.8	Stable	No	No	Signature.5	CHEK1 | FANCA | PALB2	No	0	14.72	1	no	no	no
9738	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	332	1.8	Stable	No	Yes or Unknown	Signature.1		No	0	11.7	1	no	no	no
9739	ICI-treated	ICI as first line	46 - 50	Male	Gastric	2017	IV	0	13.2	Stable	No	No	Signature.9		Yes	0	5.75	1	no	no	no
9740	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2017	IV	64	16.7	Indeterminate	No	No	Signature.6	ARID1A | PARP1	No	0	15.02	1	no	no	yes
9741	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	III	0	13.2	Stable	No	No	Signature.4	PMS2	No	0	7	1	no	no	no
9742	ICI-treated	ICI as first line	56 - 60	Male	Sarcoma	2017	IV	19	16.7	Stable	No	No	Signature.4	ATR | MRE11A	Yes	0	20.7	1	no	no	no
9743	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2016	II	271	6.1	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.3	ATR | MRE11A	No	0	11.73	1	no	no	no
9744	ICI-treated	ICI - unknown sequence	41 - 45	Female	Cutaneous Melanoma 	2017	III	43	1.8	Stable	No	No			No	0	16.4	1	no	no	no
9745	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	MDC1	No	0	16.4	1	no	no	no
9746	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	16	10.5	Stable	No	No	Signature.4	ARID1A | ERCC4	No	1	7.56	1	no	no	yes
9747	ICI-treated	ICI as subsequent line	76 - 80	Male	Hepatobiliary	2017	III	355	4.4	Stable	No	Yes or Unknown			No	0	14.23	1	no	no	no
9748	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2017	IV	39	7	Stable	No	Yes or Unknown	Signature.4		No	1	11.59	1	no	no	no
9749	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.2	RAD52	No	1	0.559999999999999	1	no	no	no
9750	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	0	3.5	Stable	No	No		CHEK1	No	1	7.98	1	no	no	no
9751	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2017	IV	30	6.1	Stable	No	No	Signature.13		No	1	8.57	1	no	no	no
9752	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	12	5.3	Stable	No	No	Signature.18	ERCC3	No	0	16.53	1	no	no	no
9753	ICI-treated	ICI as first line	26 - 30	Male	NSCLC	2017	IV	8	4.4	Stable	No	No			No	0	19.88	1	no	no	no
9754	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	192	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	6.8	1	no	no	no
9755	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	7	15.8	Stable	No	No	Signature.24	ARID1A | ERCC4	No	0	17.81	1	no	no	yes
9756	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.3	PARP1	No	1	7.16	1	no	no	no
9757	ICI-treated	ICI as first line	56 - 60	Female	Bladder	2017	IV	5	19.3	Stable	No	No	Signature.13	ARID1A	No	0	18.16	1	no	no	yes
9758	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	26	9.7	Stable	No	No	Signature.4	ATM | ERCC2	No	0	19.51	1	no	no	no
9759	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	11	12.3	Stable	No	No	Signature.30		Yes	0	20.27	1	no	no	no
9760	ICI-treated	ICI as first line	36 - 40	Male	Sarcoma	2017		0	0.9	Stable	No	No			No	0	20.34	1	no	no	no
9761	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	133	0		No	Yes or Unknown			No	1	2.53	1	no	no	no
9762	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	7	12.3	Stable	No	No	Signature.4	ERCC5 | MSH2	No	0	13.01	1	no	no	no
9763	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2017	IV	126	2.6	Stable	No	Yes or Unknown			No	0	2.72	1	no	no	no
9764	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2017		5	20.2	Stable	Yes or Unknown	Yes or Unknown	Signature.1	BRCA1	No	0	18.37	1	no	no	no
9765	ICI-treated	ICI as subsequent line	81 - 85	Female	Gastric	2017	IV	0	2.6	Stable	No	Yes or Unknown		PMS1	No	1	5.56	1	no	no	no
9766	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2017	IV	117	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	9.59	1	no	no	no
9767	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	117	24.6	Stable	No	No	Signature.4		Yes	0	14.06	1	no	no	no
9768	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	22	144.8	Stable	No	No	Signature.7	ARID1A | BLM | BRCA2 | MDC1 | PARP1 | SLX4 | TP53BP1	Yes	1	0.23	1	no	no	yes
9769	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2016	IV	416	59.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13	BRCA1 | BRCA2 | ERCC4 | MDC1 | MUTYH | NBN | PALB2 | PMS1 | TP53BP1	No	0	19.61	1	no	no	no
9770	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2017	IV	0	3.5	Stable	No	No			No	1	3.84	1	no	no	no
9771	ICI-treated	ICI as subsequent line	51 - 55	Female	Hepatobiliary	2017	IV	0	10.5	Stable	No	No	Signature.13	ARID1A | CHEK2 | SLX4	No	1	3.09	1	no	no	yes
9772	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2016	III	141	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	19.15	1	no	no	no
9773	ICI-treated	ICI as first line	51 - 55	Male	Gastric	2017	IV	17	47.4	Unstable	No	No	Signature.26	ARID1A | ERCC2 | MSH6 | TP53BP1	Yes	0	19.58	1	mut-MMRd	mut-MMRd	yes
9774	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	392	4.4	Stable	No	No			Yes	0	19.16	1	no	no	no
9775	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	14	6.1	Stable	No	Yes or Unknown	Signature.4		No	1	14.56	1	no	no	no
9776	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2017	IV	9	2.6	Stable	No	Yes or Unknown			No	1	9.01	1	no	no	no
9777	ICI-treated	ICI as subsequent line	61 - 65	Male	Prostatic	2017	II	246	2.6	Stable	No	Yes or Unknown			No	0	9.83	1	no	no	no
9778	ICI-treated	ICI as first line	36 - 40	Male	Cutaneous Melanoma 	2017	IV	111	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	18.86	1	no	no	no
9779	ICI-treated	ICI - unknown sequence	51 - 55	Male	Cutaneous Melanoma 	2017	III	83	0.9	Stable	No	No			No	0	7.81	1	no	no	no
9780	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	7	8.8	Stable	No	No	Signature.5	BRCA2 | MRE11A	No	1	7.36	1	no	no	no
9781	ICI-treated	ICI as first line	31 - 35	Male	Colorectal	2017	III	130	368.6	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | MUTYH | NBN | PALB2 | PARP1 | PMS1 | RAD50 | RAD54L | SLX4 | TP53BP1	Yes	0	16.59	1	mut-MMRd	mut-MMRd	yes
9782	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2017	IV	0	7.9	Stable	No	No	Signature.6	CHEK2	No	0	14.26	1	no	no	no
9783	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2017		132	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.16		No	1	11.8	1	no	no	no
9784	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2017	IV	24	6.1	Indeterminate	No	No	Signature.5	ATM	No	0	0.17	1	no	no	no
9785	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	694	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	6.01	1	no	no	no
9786	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2017	IV	3	1.8	Stable	No	No		FANCA	No	1	8.9	1	no	no	no
9787	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2017		7	1.8	Stable	No	No	Signature.26		No	0	11.27	1	no	no	no
9788	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	28	0	Stable	No	No			No	0	17.15	1	no	no	no
9789	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	III	32	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	11.27	1	no	no	no
9790	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	IV	0	4.4	Stable	No	No			No	1	5.58	1	no	no	no
9791	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	259	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	10.81	1	no	no	no
9792	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2017	IV	397	11.4	Stable	No	Yes or Unknown	Signature.4	MSH3	No	1	15.68	1	no	no	no
9793	ICI-treated	ICI as subsequent line	46 - 50	Female	Breast	2017	III	0	2.6	Stable	No	No			No	1	0.99	1	no	no	no
9794	ICI-treated	ICI as subsequent line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	75	3.5		Yes or Unknown	Yes or Unknown	Signature.1		No	1	1.31	1	no	no	no
9795	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	5.3	Stable	No	No			No	1	17.28	1	no	no	no
9796	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	0	12.3	Stable	No	No	Signature.7	SLX4	Yes	0	19.55	1	no	no	no
9797	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.24	ARID1A | ATM	No	1	12.87	1	no	no	yes
9798	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No			No	1	0.75	1	no	no	no
9799	ICI-treated	ICI - unknown sequence	61 - 65	Female	Renal	2017	III	65	0.9	Stable	No	No			No	0	14.26	1	no	no	no
9800	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	52	25.5	Stable	No	No	Signature.4	MLH1	No	0	14.1	1	no	no	no
9801	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	IV	7	4.4	Stable	No	Yes or Unknown			No	0	8.81	1	no	no	no
9802	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	245	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	14.13	1	no	no	no
9803	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	33	4.4	Stable	No	No	Signature.5	RAD50	No	1	8.08	1	no	no	no
9804	ICI-treated	ICI as subsequent line	46 - 50	Male	Hepatobiliary	2017	IV	0	3.5	Stable	No	No			No	0	2.3	1	no	no	no
9805	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown	Signature.2	ARID1A | BRCA2	No	0	20.17	1	no	no	yes
9806	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2016	II	892	5.3	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.17	BRCA1	No	0	10.71	1	no	no	no
9807	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	FANCC	No	0	15.71	1	no	no	no
9808	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	8	20.2	Stable	No	No	Signature.4	SLX4	No	0	19.68	1	no	no	no
9809	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	189	31.6	Unstable	No	Yes or Unknown	Signature.1	ARID1A | MSH2 | XRCC2	No	0	12.41	1	mut-MMRd	mut-MMRd	yes
9810	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	0	4.4	Stable	No	No	Signature.16		No	0	5.06	1	no	no	no
9811	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	0	51.8	Stable	No	No	Signature.7	PMS1 | TP53BP1	Yes	0	16.1	1	no	no	no
9812	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	203	2.6	Stable	No	Yes or Unknown			No	0	12.22	1	no	no	no
9813	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2017	IV	55	19.3	Stable	No	No	Signature.7		Yes	1	2.4	1	no	no	no
9814	ICI-treated	ICI as subsequent line	76 - 80	Male	Hepatobiliary	2017	IV	0	8.8	Stable	No	No	Signature.5		No	0	0.49	1	no	no	no
9815	ICI-treated	ICI as first line	46 - 50	Male	Renal	2017	III	151	7	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	10.12	1	no	no	no
9816	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	IV	23	4.4	Stable	No	No	Signature.4		No	0	19.38	1	no	no	no
9817	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2017	IV	12	2.6	Stable	No	No			No	1	2.01	1	no	no	no
9818	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	I	0	13.2	Stable	No	No	Signature.2	PMS2	No	0	11.96	1	no	no	no
9819	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	62	13.2	Stable	No	No	Signature.4	CHEK2 | RAD51C	No	1	5.81	1	no	no	no
9820	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	28	5.3	Stable	No	No		RAD50	Yes	1	0.1	1	no	no	no
9821	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	IV	60	11.4	Stable	No	No	Signature.29		Yes	0	14.26	1	no	no	no
9822	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	III	47	8.8	Stable	No	No	Signature.7		No	1	9.76	1	no	no	no
9823	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	15	2.6	Stable	No	Yes or Unknown			No	0	19.09	1	no	no	no
9824	ICI-treated	ICI as first line	71 - 75	Male	Gastric	2017	IV	7	6.1	Stable	No	No	Signature.1		Yes	0	11.04	1	no	no	no
9825	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	III	26	9.7	Stable	No	No	Signature.7		No	0	17.02	1	no	no	no
9826	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2017	IV	67	2.6	Stable	No	No			No	1	2.04	1	no	no	no
9827	ICI-treated	ICI as subsequent line	26 - 30	Male	Head & Neck	2017	IV	464	0	Stable	Yes or Unknown	Yes or Unknown			No	1	0.620000000000001	1	no	no	no
9828	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	II	20	7	Stable	No	No	Signature.29		No	0	17.94	1	no	no	no
9829	ICI-treated	ICI as subsequent line	86 - 90	Male	Bladder	2016	I	618	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	4.14	1	no	no	no
9830	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2016	II	534	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.30		No	0	19.09	1	no	no	no
9831	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2017	IV	0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	1.9	1	no	no	no
9832	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017		2	33.4	Stable	No	No	Signature.7	BLM | RAD52	No	0	12.46	1	no	no	no
9833	ICI-treated	ICI as first line	46 - 50	Male	Head & Neck	2016	IV	411	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	19.35	1	no	no	no
9834	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2017	IV	0	12.3	Stable	No	No	Signature.8	ATM | CHEK2	No	1	0.43	1	no	no	no
9835	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	III	35	6.1	Indeterminate	No	No		BRCA1	No	0	11.96	1	no	no	no
9836	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	818	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	3.51000000000001	1	no	no	no
9837	ICI-treated	ICI as first line	71 - 75	Female	Esophageal	2017	IV	19	4.4	Stable	No	Yes or Unknown	Signature.6		No	0	18.86	1	no	no	no
9838	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	17	7.9	Stable	No	No	Signature.4	ATM	No	1	5.06	1	no	no	no
9839	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	14	24.6	Stable	No	No	Signature.4	BRCA1	No	1	5.85	1	no	no	no
9840	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	13	1.8	Stable	No	No			Yes	1	10.94	1	no	no	no
9841	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	222	32.5	Stable	No	Yes or Unknown	Signature.2	ERCC5 | TP53BP1	No	1	10.42	1	no	no	no
9842	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	IV	0	4.4	Stable	No	No	Signature.1		No	1	0.82	1	no	no	no
9843	ICI-treated	ICI as first line	61 - 65	Female	Hepatobiliary	2016	I	60	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	17.51	1	no	no	no
9844	ICI-treated	ICI as subsequent line	41 - 45	Male	Cutaneous Melanoma 	2017	III	27	0	Stable	No	No			No	0	16.33	1	no	no	no
9845	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2016	IV	0	32.5	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MSH2	No	0	18.56	1	no	no	yes
9846	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2017	I	12	3.5	Stable	No	No		BRCA1	No	0	2.6	1	no	no	no
9847	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	45	2.6	Stable	No	No			No	0	8.87	1	no	no	no
9848	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	II	409	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	18.73	1	no	no	no
9849	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	49	30.7	Indeterminate	No	No	Signature.4	FANCC	No	1	4.43	1	no	no	no
9850	ICI-treated	ICI - unknown sequence	66 - 70	Male	Renal	2017	II	66	1.8	Stable	No	Yes or Unknown		BLM	No	0	17.71	1	no	no	no
9851	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	0	12.3	Stable	No	No	Signature.4	MSH2 | PMS1	No	0	12.39	1	no	no	no
9852	ICI-treated	ICI as subsequent line	76 - 80	Male	Esophageal	2017	II	209	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	1.18	1	no	no	no
9853	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	10	14	Stable	No	No	Signature.4		No	0	13.6	1	no	no	no
9854	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	0	7.9	Stable	No	Yes or Unknown	Signature.6	MDC1	No	0	18.86	1	no	no	no
9855	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	3	0	Stable	No	No			No	1	7.62	1	no	no	no
9856	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2017	I	130	0.9	Stable	Yes or Unknown	Yes or Unknown		CHEK2 | MUTYH	No	0	10.91	1	no	no	no
9857	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	27	3.5	Stable	No	No			No	1	8.28	1	no	no	no
9858	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2017	III	117	5.3	Stable	No	Yes or Unknown	Signature.13		No	0	2.07	1	no	no	no
9859	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	34	3.5	Stable	No	No		ERCC3	No	1	11.27	1	no	no	no
9860	ICI-treated	ICI as subsequent line	91 - 95	Male	NSCLC	2017	IV	18	10.5	Stable	No	Yes or Unknown	Signature.13	RAD52	No	1	0.13	1	no	no	no
9861	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	IV	0	59.7	Stable	No	No	Signature.7	ATR | BRCA2 | CHEK1 | CHEK2 | TP53BP1	Yes	0	17.74	1	no	no	no
9862	ICI-treated	ICI as subsequent line	81 - 85	Male	SCLC	2017	IV	0	10.5	Stable	No	No	Signature.9	ATR	No	1	2.13	1	no	no	no
9863	ICI-treated	ICI as subsequent line	56 - 60	Female	Gastric	2017	IV	80	0	Stable	No	No			No	0	14.72	1	no	no	no
9864	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	III	80	7	Stable	No	No	Signature.5	PALB2	No	0	7.85	1	no	no	no
9865	ICI-treated	ICI as first line	36 - 40	Female	NSCLC	2017	IV	1	1.8	Stable	No	No			No	1	9.4	1	no	no	no
9866	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2017	IV	25	0.9	Stable	No	No	Signature.1		No	1	1.08	1	no	no	no
9867	ICI-treated	ICI - unknown sequence	61 - 65	Male	Prostatic	2017	IV	279	4.4	Stable	No	Yes or Unknown			No	1	6.9	1	no	no	no
9868	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	III	34	31.6	Unstable	No	No	Signature.1	ARID1A | ATR | ERCC2	No	0	11.14	1	other-MMRd	mut-MMRd	yes
9869	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	4	5.3	Indeterminate	No	No			No	1	0.819999999999999	1	no	no	no
9870	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	14	10.5	Stable	No	No	Signature.4	ATM	No	0	18.13	1	no	no	no
9871	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	23.7	Stable	No	No	Signature.4	ARID1A | ATM	No	0	9.1	1	no	no	yes
9872	ICI-treated	ICI as first line	36 - 40	Female	NSCLC	2017	IV	7	5.3	Stable	No	No	Signature.2	NTHL1	Yes	0	17.25	1	no	no	no
9873	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	0	4.4	Stable	No	No	Signature.26		No	1	2.93	1	no	no	no
9874	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	615	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	0.66	1	no	no	yes
9875	ICI-treated	ICI as first line	76 - 80	Female	Ovarian	2017	IV	135	0	Stable	No	Yes or Unknown			Yes	0	18.46	1	no	no	no
9876	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2017	IV	0	7.9	Stable	No	No	Signature.2	MUTYH	No	1	12.94	1	no	no	no
9877	ICI-treated	ICI as first line	56 - 60	Female	Pancreatic	2017	IV	13	2.6	Stable	No	No			No	0	17.05	1	no	no	no
9878	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2017	IV	14	0.9	Stable	No	No			No	1	3.68	1	no	no	no
9879	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	49	12.3	Stable	No	No	Signature.4	ATR	No	1	1.94	1	no	no	no
9880	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2017	IV	0	4.4	Stable	No	No			No	0	1.78	1	no	no	no
9881	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	41	3.5	Stable	No	No		BRIP1 | PALB2	No	0	17.48	1	no	no	no
9882	ICI-treated	ICI as subsequent line	16 - 20	Female	Sarcoma	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	1	1.91	1	no	no	no
9883	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2017	IV	14	19.3	Stable	No	No	Signature.7	ATR | MDC1 | MRE11A	No	1	7.98	1	no	no	no
9884	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	III	160	14.9	Stable	No	Yes or Unknown	Signature.5	PMS1 | TP53BP1	No	1	7.85	1	no	no	no
9885	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	110	15.8	Indeterminate	No	Yes or Unknown	Signature.4	MDC1	No	1	5.94	1	no	no	no
9886	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2017	IV	25	3.5	Stable	No	No			No	1	3.22	1	no	no	no
9887	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	25	4.4	Stable	No	No		BRIP1	No	1	2.96	1	no	no	no
9888	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2017	IV	34	1.8	Stable	No	No		BRCA2	No	0	9.07	1	no	no	no
9889	ICI-treated	ICI as first line	41 - 45	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	0	13.21	1	no	no	no
9890	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	3	3.5	Stable	No	No	Signature.4	TP53BP1	No	1	4.34	1	no	no	no
9891	ICI-treated	ICI as subsequent line	31 - 35	Female	Gastric	2017	IV	0	3.5	Stable	No	No			No	0	3.62	1	no	no	no
9892	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	164	15.8	Stable	No	Yes or Unknown	Signature.4	ARID1A | MDC1	No	1	9.1	1	no	no	yes
9893	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	5	8.8	Stable	No	No	Signature.4	RAD51C	No	1	3.12	1	no	no	no
9894	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2017	IV	79	14	Stable	No	No	Signature.13	ATM | PARP1	No	1	5.68	1	no	no	no
9895	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2017	IV	54	4.4	Indeterminate	No	Yes or Unknown			No	1	4.01	1	no	no	no
9896	ICI-treated	ICI as subsequent line	51 - 55	Female	Hepatobiliary	2017	IV	3	3.5	Stable	No	No			No	1	8.08	1	no	no	no
9897	ICI-treated	ICI - unknown sequence	76 - 80	Male	Cutaneous Melanoma 	2017		94	18.4	Stable	No	No	Signature.7	MSH3	No	1	3.68	1	no	no	no
9898	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2017	III	313	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	11.66	1	no	no	yes
9899	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	23	0		No	No			No	1	3.15	1	no	no	no
9900	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	70	13.2	Stable	No	No	Signature.4	TP53BP1	No	1	4.83	1	no	no	no
9901	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	70	3.5	Stable	No	Yes or Unknown			No	0	6.14	1	no	no	no
9902	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	I	560	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.4		Yes	1	13.44	1	no	no	no
9903	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	I	953	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	7.42	1	no	no	no
9904	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	3	4.4	Stable	No	No	Signature.24		Yes	0	17.15	1	no	no	no
9905	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	III	256	24.6	Stable	No	No	Signature.7	ATR | BLM	No	0	9.36	1	no	no	no
9906	ICI-treated	ICI as first line	91 - 95	Male	Bladder	2017	II	139	18.4	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | FANCA	No	1	5.85	1	no	no	yes
9907	ICI-treated	ICI - unknown sequence	41 - 45	Male	Cutaneous Melanoma 	2017	III	32	27.2	Stable	No	No	Signature.7	FANCA | PARP1 | RAD50	No	0	15.87	1	no	no	no
9908	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		319	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	10.48	1	no	no	no
9909	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	24	0	Stable	Yes or Unknown	Yes or Unknown			No	1	9.03	1	no	no	no
9910	ICI-treated	ICI as subsequent line	51 - 55	Male	Prostatic	2017	IV	0	23.7	Unstable	No	No	Signature.1	MUTYH | PALB2 | PARP1	No	0	8.77	1	other-MMRd	mut-MMRd	no
9911	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	16	5.3	Stable	No	No			No	1	8.15	1	no	no	no
9912	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2017	IV	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	2.66	1	no	no	no
9913	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	72	6.1	Stable	No	No		ATM	No	0	13.54	1	no	no	no
9914	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	667	9.7	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.24		No	1	6.81	1	no	no	no
9915	ICI-treated	ICI as first line	81 - 85	Male	Gastric	2017	IV	62	43	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | FANCC | RAD50 | SLX4	Yes	1	2.63	1	other-MMRd	mut-MMRd	yes
9916	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2018	IV	14	1.8	Stable	No	No			Yes	1	0.95	1	no	no	no
9917	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	7	4.4	Stable	No	No	Signature.24		No	1	3.45	1	no	no	no
9918	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	II	28	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	12.38	1	no	no	no
9919	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	III	0	31.6	Stable	No	No	Signature.4	ERCC2 | PMS1 | PMS2	No	0	14.72	1	no	no	no
9920	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	0	1.8	Stable	No	No			No	1	12.55	1	no	no	no
9921	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	0	17.6	Stable	No	No	Signature.24	SLX4	Yes	0	15.18	1	no	no	no
9922	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2017	IV	19	1.8	Stable	No	No			No	0	9.5	1	no	no	no
9923	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	35	26.3	Unstable	No	No	Signature.6	ARID1A | BLM	No	0	10.81	1	other-MMRd	mut-MMRd	yes
9924	ICI-treated	ICI as subsequent line	71 - 75	Female	Cutaneous Melanoma 	2016	IV	254	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	4.93	1	no	no	no
9925	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	3	7	Indeterminate	Yes or Unknown	Yes or Unknown		ERCC3 | TP53BP1	No	1	1.41	1	no	no	no
9926	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	16	9.7	Stable	No	No	Signature.13		No	0	13.5	1	no	no	no
9927	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2017	IV	112	102.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA2 | BRIP1 | ERCC3 | FANCA | NBN | PMS2 | RAD54L | SLX4	No	1	2.33	1	mut-MMRd	mut-MMRd	yes
9928	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	22	1.8	Stable	No	No	Signature.12		No	1	10.12	1	no	no	no
9929	ICI-treated	ICI as subsequent line	31 - 35	Female	Hepatobiliary	2017	IV	43	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.11	ARID1A	No	1	1.55	1	no	no	yes
9930	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2018	IV	4	26.3	Stable	No	No	Signature.7	ARID1A | PALB2	Yes	0	16.03	1	no	no	yes
9931	ICI-treated	ICI as first line	41 - 45	Male	Esophageal	2017	IV	38	0.9	Stable	No	No	Signature.13		No	0	16.75	1	no	no	no
9932	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	IV	0	4.4	Stable	No	No		BRCA2	No	1	4.89	1	no	no	no
9933	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	0		No	No			No	1	8.21	1	no	no	no
9934	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	12	0.9	Stable	No	No			Yes	0	16.33	1	no	no	no
9935	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	IV	305	2.6	Stable	No	Yes or Unknown			No	0	7.72	1	no	no	no
9936	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	0	7	Stable	No	No	Signature.16		No	1	2.86	1	no	no	no
9937	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2018	II	313	5.3	Stable	No	Yes or Unknown	Signature.7		No	1	9.53	1	no	no	no
9938	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2018	III	24	2.6	Stable	No	No			No	0	7.36	1	no	no	no
9939	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	345	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	15.91	1	no	no	no
9940	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2016	III	100	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	8.32	1	no	no	no
9941	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	344	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	13.66	1	no	no	no
9942	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	10	4.4	Stable	No	No	Signature.5	FANCA	Yes	1	2.66	1	no	no	no
9943	ICI-treated	ICI as first line	36 - 40	Female	Cutaneous Melanoma 	2015	III	837	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	5.41999999999999	1	no	no	no
9944	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	I	892	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	0.519999999999996	1	no	no	no
9945	ICI-treated	ICI as subsequent line	76 - 80	Male	Prostatic	2017	IV	0	74.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATR | BRIP1 | CHEK2 | ERCC3 | MSH3 | NBN | RAD50 | SLX4	No	0	9.2	1	other-MMRd	mut-MMRd	yes
9946	ICI-treated	ICI as first line	46 - 50	Male	NSCLC	2018	IV	4	27.2	Stable	No	No	Signature.4	ATR | BLM | ERCC5 | RAD50	Yes	0	12.94	1	no	no	no
9947	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	21	16.7	Stable	No	No	Signature.4	MSH3 | PMS2	No	0	14.72	1	no	no	no
9948	ICI-treated	ICI - unknown sequence	61 - 65	Female	Endometrial	2016	I	731	28.1	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH3 | MSH6 | SLX4	No	0	0	1	mut-MMRd	mut-MMRd	yes
9949	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	12	8.8	Stable	No	No	Signature.4		Yes	0	15.67	1	no	no	no
9950	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	0	31.6	Stable	No	No	Signature.4	BRIP1 | CHEK1 | CHEK2 | ERCC5 | RAD50 | RAD54L	Yes	0	15.51	1	no	no	no
9951	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2018	IV	22	30.7	Stable	No	No	Signature.7	ATR	Yes	0	15.87	1	no	no	no
9952	ICI-treated	ICI as first line	51 - 55	Male	Renal	2018	III	0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	7.82	1	no	no	no
9953	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	III	61	5.3	Stable	No	No	Signature.4		No	0	15.51	1	no	no	no
9954	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	III	0	13.2	Stable	No	Yes or Unknown	Signature.4	MRE11A	No	1	9.66	1	no	no	no
9955	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	125	7.9	Stable	No	Yes or Unknown	Signature.3	MSH3 | PMS2	No	1	6.01	1	no	no	no
9956	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	13	5.3	Stable	No	No			No	0	13.99	1	no	no	no
9957	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	30	8.8	Stable	No	No	Signature.2		No	0	15.63	1	no	no	no
9958	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	0	7	Stable	No	No	Signature.24		No	1	5.06	1	no	no	no
9959	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2017	IV	185	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	FANCA	No	1	14.59	1	no	no	no
9960	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	27	7.9	Stable	No	No			No	1	6.66	1	no	no	no
9961	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	14	5.3	Stable	No	Yes or Unknown			No	0	14.3	1	no	no	no
9962	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	21	6.1	Stable	No	No	Signature.1		No	1	4.1	1	no	no	no
9963	ICI-treated	ICI as first line	46 - 50	Male	Bladder	2018	IV	329	2.6	Stable	No	Yes or Unknown			No	1	11.96	1	no	no	no
9964	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	4	10.5	Stable	No	No	Signature.13		No	0	15.18	1	no	no	no
9965	ICI-treated	ICI as first line	46 - 50	Male	Renal	2018	III	0	3.5	Stable	No	Yes or Unknown			No	0	10.09	1	no	no	no
9966	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	17	16.7	Stable	No	No	Signature.4	MDC1	No	1	1.35	1	no	no	no
9967	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2015	IV	216	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1	BRIP1	No	1	6.97	1	no	no	no
9968	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2018	IV	0	5.3	Stable	No	No			No	1	5.19	1	no	no	no
9969	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4	PMS1	No	1	5.29	1	no	no	no
9970	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2018	IV	1	3.5	Stable	No	No	Signature.4		Yes	0	15.54	1	no	no	no
9971	ICI-treated	ICI - unknown sequence	61 - 65	Male	NSCLC	2018	III	22	6.1	Stable	No	No	Signature.24		No	1	1.81	1	no	no	no
9972	ICI-treated	ICI as first line	91 - 95	Male	Cutaneous Melanoma 	2018	III	0	158.9	Stable	No	No	Signature.7	ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC4 | ERCC5 | FANCA | MDC1 | PMS2 | SLX4 | TP53BP1	Yes	0	6.87	1	no	no	no
9973	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	III	0	8.8	Stable	No	No	Signature.4	NBN	No	0	11.96	1	no	no	no
9974	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	III	26	22.8	Stable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | PALB2	No	0	15.18	1	no	no	yes
9975	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2016	I	0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	15.15	1	no	no	no
9976	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2018	IV	5	29.8	Stable	No	No	Signature.7	ARID1A | BRCA2 | MDC1 | PALB2	Yes	0	14.52	1	no	no	yes
9977	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	IV	0	7		Yes or Unknown	Yes or Unknown	Signature.5	ARID1A	No	0	13.08	1	no	no	yes
9978	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	58	11.4	Stable	No	No	Signature.4	MRE11A | SLX4	No	0	14.55	1	no	no	no
9979	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2018	IV	13	6.1	Indeterminate	No	Yes or Unknown	Signature.13		No	0	14.94	1	no	no	no
9980	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	15	3.5	Stable	No	No			No	1	9.99	1	no	no	no
9981	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	20	11.4	Stable	No	No	Signature.1	MUTYH	Yes	0	14.95	1	no	no	no
9982	ICI-treated	ICI as subsequent line	71 - 75	Male	Esophageal	2017	IV	0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	1.32	1	no	no	no
9983	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	150	4.4	Stable	No	Yes or Unknown		FANCA	No	1	8.84	1	no	no	no
9984	ICI-treated	ICI as subsequent line	31 - 35	Female	Endometrial	2018	IV	11	15.8	Unstable	No	Yes or Unknown	Signature.6	BRCA2	No	0	8.12	1	other-MMRd	mut-MMRd	no
9985	ICI-treated	ICI as subsequent line	76 - 80	Female	Colorectal	2018	IV	18	44.8	Unstable	No	No	Signature.6	BRCA2 | MUTYH	No	1	8.31	1	other-MMRd	mut-MMRd	no
9986	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2017	IV	235	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	10.25	1	no	no	no
9987	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.18	ARID1A | ATM | BRCA2	No	0	14.72	1	no	no	yes
9988	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2018	IV	15	7.9	Stable	No	Yes or Unknown	Signature.16	BRIP1	No	1	6.93	1	no	no	no
9989	ICI-treated	ICI as subsequent line	21 - 25	Male	Colorectal	2017	III	201	65.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | ERCC3 | ERCC4 | MLH1 | SLX4	No	0	14.49	1	mut-MMRd	mut-MMRd	yes
9990	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	28	8.8	Stable	No	No	Signature.4	BRCA2	Yes	0	13.8	1	no	no	no
9991	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	36	26.3	Stable	No	No	Signature.4	ATR | MUTYH	Yes	0	13.8	1	no	no	no
9992	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	I	0	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	9.79	1	no	no	no
9993	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	6	4.4	Stable	No	No			Yes	1	1.29	1	no	no	no
9994	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	11.4	Stable	No	No	Signature.4	ARID1A | ATM | PALB2	No	1	11.43	1	no	no	yes
9995	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	I	505	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	6.38	1	no	no	no
9996	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	0	25.5	Stable	No	No	Signature.4	TP53BP1	Yes	0	13.86	1	no	no	no
9997	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	10	14.9	Stable	No	No	Signature.24	BRCA1	Yes	0	13.33	1	no	no	no
9998	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	IV	28	5.3	Stable	No	No	Signature.24		No	1	2.14	1	no	no	no
9999	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.24		Yes	0	14.48	1	no	no	no
10000	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2018	III	22	39.5	Stable	No	No	Signature.4	ARID1A | PARP1 | TP53BP1	No	0	10.88	1	no	no	yes
10001	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	20	5.3	Stable	No	No	Signature.3		Yes	0	13.79	1	no	no	no
10002	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	II	111	7	Stable	No	No	Signature.24		No	1	4.14	1	no	no	no
10003	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	13	15.8	Stable	No	No	Signature.13	ATR	No	1	2.6	1	no	no	no
10004	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2018	III	70	21.9	Stable	No	No	Signature.7	BRCA1	Yes	0	5.81	1	no	no	no
10005	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	26	7	Stable	No	No	Signature.8		Yes	1	4.57	1	no	no	no
10006	ICI-treated	ICI as subsequent line	81 - 85	Female	Colorectal	2018	IV	8	78.1	Unstable	No	No	Signature.6	BLM | BRCA2 | FANCA | MLH1 | MSH2 | RAD50 | TP53BP1	No	1	0.88	1	mut-MMRd	mut-MMRd	no
10007	ICI-treated	ICI as first line	71 - 75	Male	Sarcoma	2018	IV	13	6.1	Stable	No	No	Signature.6		No	1	12.12	1	no	no	no
10008	ICI-treated	ICI as subsequent line	61 - 65	Female	Pancreatic	2018	IV	14	2.6	Stable	No	No			No	1	2.5	1	no	no	no
10009	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2018	IV	18	0.9	Stable	No	No			Yes	1	0.49	1	no	no	no
10010	ICI-treated	ICI - unknown sequence	46 - 50	Female	Cutaneous Melanoma 	2016	I	546	23.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	TP53BP1	No	0	13.8	1	no	no	no
10011	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	7	13.2	Stable	No	No	Signature.3		Yes	0	13.54	1	no	no	no
10012	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.24	PALB2	Yes	0	14.03	1	no	no	no
10013	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			Yes	0	13.7	1	no	no	no
10014	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	IV	0	4.4	Stable	No	No			No	1	5.81	1	no	no	no
10015	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	47	0.9	Stable	No	No			No	1	10.71	1	no	no	no
10016	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	2	2.6	Stable	No	No			No	1	6.08	1	no	no	no
10017	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	35	47.4	Unstable	No	No	Signature.1	ARID1A | ATR | BRCA2 | BRIP1 | MLH1 | NBN | PARP1 | PMS1	Yes	1	1.75	1	mut-MMRd	mut-MMRd	yes
10018	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2018	II	0	2.6	Stable	No	No			No	0	8.02	1	no	no	no
10019	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	III	618	38.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BRCA2 | MSH3	No	0	13.14	1	other-MMRd	mut-MMRd	yes
10020	ICI-treated	ICI as first line	61 - 65	Male	Colorectal	2018	IV	0	17.6	Stable	No	No	Signature.1	MSH2	No	1	3.45	1	no	no	no
10021	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	0	3.5	Stable	No	No	Signature.17		No	0	13.34	1	no	no	no
10022	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	0	1.8	Stable	No	No		ARID1A	No	0	12.91	1	no	no	yes
10023	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	8	7.9	Stable	No	No	Signature.3	ATM | NBN	Yes	0	14.03	1	no	no	no
10024	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2018	II	43	2.6	Stable	No	No	Signature.3		No	0	12.02	1	no	no	no
10025	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	5	0	Stable	No	No			Yes	1	0.82	1	no	no	no
10026	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	II	298	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4	FANCA | PARP1	No	0	6.9	1	no	no	no
10027	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	53	12.3	Stable	No	No	Signature.4	PMS1	No	0	10.19	1	no	no	no
10028	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2018	IV	14	9.7	Stable	No	No	Signature.4		Yes	1	1.54	1	no	no	no
10029	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2018	IV	54	7	Stable	No	No	Signature.29	ATM	Yes	0	13.44	1	no	no	no
10030	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	8	3.5	Stable	No	No	Signature.19		No	0	12.81	1	no	no	no
10031	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	0	13.2	Stable	No	No	Signature.4	MDC1 | RAD50	No	0	7.82	1	no	no	no
10032	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	III	657	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.2		No	1	3.15	1	no	no	no
10033	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2018	III	12	8.8	Stable	No	No	Signature.4		No	0	9.82	1	no	no	no
10034	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2017	IV	0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	0	13.47	1	no	no	no
10035	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	III	50	14.9	Stable	No	No	Signature.13	BRCA1	No	0	10.12	1	no	no	no
10036	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	I	738	7.9	Stable	Yes or Unknown	Yes or Unknown			No	1	9.39	1	no	no	no
10037	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.24		No	0	13.34	1	no	no	no
10038	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2018	III	20	17.6	Stable	No	No	Signature.7	ARID1A | MSH2	Yes	0	7.86	1	no	no	yes
10039	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2018	IV	35	0	Stable	No	No			No	0	8.41	1	no	no	no
10040	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	21	13.2	Stable	No	No	Signature.24	ARID1A	Yes	1	4.66	1	no	no	yes
10041	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	9.7	Stable	No	No	Signature.8	ERCC2	Yes	0	11.96	1	no	no	no
10042	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2018	IV	11	2.6	Stable	No	No			No	1	2.79	1	no	no	no
10043	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2018	IV	31	7	Stable	No	No	Signature.2	ATM | BLM | ERCC5	Yes	0	12.12	1	no	no	no
10044	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	127	14	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MLH1 | PMS1	No	0	12.55	1	no	no	no
10045	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2017		460	0	Stable	Yes or Unknown	Yes or Unknown			No	0	12.19	1	no	no	no
10046	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	12.42	1	no	no	no
10047	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	8	3.5	Stable	No	No			No	1	5.98	1	no	no	no
10048	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2018	III	76	8.8		No	Yes or Unknown	Signature.5	TP53BP1	No	0	13.51	1	no	no	no
10049	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	8	12.3	Stable	No	No	Signature.4	ATR	Yes	0	11.56	1	no	no	no
10050	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	37	9.7	Stable	No	No	Signature.18		No	0	12.09	1	no	no	no
10051	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	15	2.6	Stable	No	No			No	0	10.94	1	no	no	no
10052	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1	ATM | MLH1 | PALB2	No	0	3.52	1	no	no	no
10053	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	21	1.8	Stable	No	No			No	0	12.81	1	no	no	no
10054	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	II	969	0	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	6.63	1	no	no	no
10055	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	16	9.7	Stable	No	No		MUTYH	No	1	1.61	1	no	no	no
10056	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.13	MSH6 | TP53BP1	No	1	5.06	1	no	no	no
10057	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	22	5.3	Stable	No	No	Signature.4	RAD51C	Yes	1	3.45	1	no	no	no
10058	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	III	705	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.61	1	no	no	no
10059	ICI-treated	ICI as subsequent line	81 - 85	Female	SCLC	2018	IV	10	7.9	Stable	No	No	Signature.3	ERCC5	No	0	7.1	1	no	no	no
10060	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	I	19	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	11.4	1	no	no	no
10061	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	III	16	0.9	Stable	No	No			No	0	11.31	1	no	no	no
10062	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	II	45	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	1.51	1	no	no	no
10063	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	0	3.5	Stable	No	No	Signature.4		No	0	12.03	1	no	no	no
10064	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2018	IV	0	11.4	Stable	No	No	Signature.4	BRIP1	No	0	1.77	1	no	no	no
10065	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2018	IV	0	2.6	Stable	No	No	Signature.13		No	1	1.71	1	no	no	no
10066	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	19	4.4	Stable	No	No			No	1	8.12	1	no	no	no
10067	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2018	I	27	4.4	Stable	No	No	Signature.29		No	0	9.27	1	no	no	no
10068	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2018	III	0	10.5	Stable	No	No	Signature.4	ARID1A	No	0	12.62	1	no	no	yes
10069	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	1	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	CHEK1	Yes	1	0.13	1	no	no	no
10070	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	19	12.3	Stable	No	No	Signature.8	ATR | NBN	No	0	12.19	1	no	no	no
10071	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	12	16.7	Stable	No	No	Signature.4	ARID1A | ATR | FANCA	Yes	0	11.1	1	no	no	yes
10072	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2018	IV	0	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.4	PALB2	No	0	8.97	1	no	no	no
10073	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2018	III	0	15.8	Stable	No	No	Signature.7		No	0	10.32	1	no	no	no
10074	ICI-treated	ICI as subsequent line	26 - 30	Female	NSCLC	2018	III	28	1.8	Stable	No	No			No	1	10.02	1	no	no	no
10075	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	II	1056	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4	TP53BP1	No	0	9	1	no	no	no
10076	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	19	14.9	Stable	No	No	Signature.4	PALB2	Yes	0	11.69	1	no	no	no
10077	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	71	8.8	Stable	No	No	Signature.6		No	0	10.48	1	no	no	no
10078	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	I	0	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA1	No	1	10.32	1	no	no	no
10079	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			Yes	1	2.66	1	no	no	no
10080	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2016	III	123	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	1.8	1	no	no	no
10081	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	71	3.5	Stable	No	No		BRIP1	Yes	0	11.04	1	no	no	no
10082	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			No	0	11.47	1	no	no	no
10083	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	II	361	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.29		No	0	9.6	1	no	no	no
10084	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2017	II	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	7.2	1	no	no	no
10085	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	71	1.8	Stable	No	Yes or Unknown			No	1	7.62	1	no	no	no
10086	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	52	7	Stable	No	No	Signature.29	ARID1A | ATM	Yes	0	10.38	1	no	no	yes
10087	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2018	IV	0	6.1	Stable	No	No	Signature.1	NBN	Yes	0	11.03	1	no	no	no
10088	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2017	IV	28	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	8.31	1	no	no	no
10089	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	I	13	149.2	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC5 | FANCA | MDC1 | MLH1 | MRE11A | MSH2 | MSH6 | PARP1 | SLX4 | TP53BP1	No	1	7.76	1	mut-MMRd	mut-MMRd	yes
10090	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	7	12.3	Stable	No	No	Signature.4	BRIP1	Yes	0	11.5	1	no	no	no
10091	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	47	0	Stable	No	No			Yes	0	9.79	1	no	no	no
10092	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	0	21.9	Stable	No	No	Signature.2	ATM | PALB2 | RAD51	Yes	0	6.18	1	no	no	no
10093	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	11	15.8	Stable	No	No	Signature.4		Yes	1	2.6	1	no	no	no
10094	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	18	7.9	Stable	No	No	Signature.24	ERCC2	No	0	11.08	1	no	no	no
10095	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	25	7.9	Stable	No	No	Signature.2		No	0	8.74	1	no	no	no
10096	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	0	4.4	Stable	No	No			No	0	10.58	1	no	no	no
10097	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	IV	13	8.8	Stable	No	No	Signature.4	ATR | MDC1	No	0	11.27	1	no	no	no
10098	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	III	0	5.3	Stable	No	No	Signature.20	ERCC4 | FANCA | MSH3	No	0	9.1	1	no	no	no
10099	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	III	0	34.2	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MSH3 | MUTYH | PMS1	No	0	10.75	1	other-MMRd	mut-MMRd	yes
10100	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2018	IV	22	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	1.97	1	no	no	no
10101	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	7	76.4	Stable	No	No	Signature.7	BRCA2 | FANCA	Yes	1	3.65	1	no	no	no
10102	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2016	IV	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	9.73	1	no	no	no
10103	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4	FANCA	No	0	10.42	1	no	no	no
10104	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	358	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	10.54	1	no	no	no
10105	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	I	42	5.3	Stable	Yes or Unknown	Yes or Unknown			No	0	8.94	1	no	no	no
10106	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	III	52	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.18		Yes	0	7.58	1	no	no	no
10107	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	17	7.9	Stable	No	Yes or Unknown	Signature.4		No	0	10.02	1	no	no	no
10108	ICI-treated	ICI - unknown sequence	71 - 75	Female	CNS	2018		0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	7.36	1	no	no	no
10109	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	2	6.1	Stable	No	No	Signature.4	BRCA2	Yes	1	2.43	1	no	no	no
10110	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	76	8.8	Stable	No	No	Signature.4		No	0	8.41	1	no	no	no
10111	ICI-treated	ICI as subsequent line	46 - 50	Male	Pancreatic	2018	IV	3	0	Stable	No	No			No	0	8.05	1	no	no	no
10112	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	0	4.4	Stable	No	No			Yes	0	9.66	1	no	no	no
10113	ICI-treated	ICI as first line	61 - 65	Female	Hepatobiliary	2018	III	0	6.1	Stable	No	No		ARID1A	Yes	1	1.52	1	no	no	yes
10114	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	29	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	0	9.66	1	no	no	no
10115	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	36	20.2	Stable	No	No	Signature.4	ARID1A | ATM | ERCC4 | NBN	No	0	8.5	1	no	no	yes
10116	ICI-treated	ICI - unknown sequence	46 - 50	Female	Cutaneous Melanoma 	2018	III	45	0		No	No			No	0	7.62	1	no	no	no
10117	ICI-treated	ICI as first line	61 - 65	Male	Esophageal	2018	IV	0	5.3	Stable	No	No	Signature.3	ARID1A | BRIP1	No	0	10.25	1	no	no	yes
10118	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	17.6	Stable	No	No	Signature.4	ARID1A	Yes	1	0.96	1	no	no	yes
10119	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	7	9.7	Stable	No	No	Signature.4		No	1	0.89	1	no	no	no
10120	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2018	III	16	5.3	Stable	No	No	Signature.17		No	0	8.31	1	no	no	no
10121	ICI-treated	ICI - unknown sequence	76 - 80	Female	Cutaneous Melanoma 	2018		0	51.8	Stable	No	No	Signature.7	BRIP1 | MDC1 | MSH2	No	0	8.34	1	no	no	no
10122	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.2		Yes	1	2.95	1	no	no	no
10123	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	27	14	Stable	No	No	Signature.24	ATR	No	0	9.66	1	no	no	no
10124	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	0	8.8	Stable	No	No	Signature.1		No	0	8.71	1	no	no	no
10125	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	0	4.4	Stable	No	No	Signature.24		No	0	7.65	1	no	no	no
10126	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	7	2.6	Stable	No	No			No	0	8.51	1	no	no	no
10127	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	30	4.4	Stable	No	No			No	0	8.51	1	no	no	no
10128	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2015	III	27	3	Stable	No	No			No	0	16.56	1	no	no	no
10129	ICI-treated	ICI - unknown sequence	56 - 60	Female	Ovarian	2015	III	0	2	Indeterminate	No	No			No	1	1.32	1	no	no	no
10130	ICI-treated	ICI - unknown sequence	71 - 75	Female	Bladder	2016		15	20.2	Stable	No	No	Signature.13	ARID1A | BRCA1 | BRCA2 | PALB2	No	0	34.89	1	no	no	yes
10131	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	IV	28	8.9	Stable	No	Yes or Unknown	Signature.5		No	1	6.37	1	no	no	no
10132	ICI-treated	ICI - unknown sequence	81 - 85	Male	Bladder	2015	I	32	0	Stable	No	No			No	0	51.74	1	no	no	no
10133	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2018	III	10	2.6	Stable	No	No	Signature.1	BRCA1	No	0	13.37	1	no	no	no
10134	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	I	39	2.6	Stable	No	No			No	0	10.68	1	no	no	no
10135	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		0	9.8	Stable	No	No	Signature.13	ARID1A | PMS1	No	0	18.1	1	no	no	yes
10136	ICI-treated	ICI - unknown sequence	66 - 70	Female	Bladder	2015	I	60	40.3	Stable	No	No	Signature.2	ATM | ATR | ERCC2	No	0	50.63	1	no	no	no
10137	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2015		132	44.8	Stable	No	No	Signature.2	ERCC2 | MRE11A | RAD51C | TP53BP1	Yes	0	32.89	1	no	no	no
10138	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		0	29.8	Stable	No	No	Signature.2	ATR | ERCC2 | MSH6 | RAD51C	No	0	31.7	1	no	no	no
10139	ICI-treated	ICI - unknown sequence	81 - 85	Male	Bladder	2015	I	421	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.2		No	0	48.07	1	no	no	no
10140	ICI-treated	ICI as subsequent line	46 - 50	Female	Bladder	2015		22	6.9	Stable	No	No	Signature.13		No	0	44.42	1	no	no	no
10141	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	No			No	1	11.17	1	no	no	no
10142	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		472	13.2	Stable	No	No	Signature.2	BRCA2	No	0	49.22	1	no	no	no
10143	ICI-treated	ICI - unknown sequence	36 - 40	Female	Breast	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	1	35.18	1	no	no	no
10144	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2015		375	6.1	Stable	No	No	Signature.13		No	0	33.97	1	no	no	no
10145	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2015	IV	132	2	Stable	No	Yes or Unknown			No	1	4.24	1	no	no	no
10146	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2015	IV	0	6.9	Stable	No	No	Signature.3		No	1	0.880000000000001	1	no	no	no
10147	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	IV	28	3.9	Stable	No	Yes or Unknown			No	1	16.26	1	no	no	no
10148	ICI-treated	ICI as subsequent line	61 - 65	Female	Pancreatic	2015	II	14	3.9	Stable	No	No	Signature.3	BRCA2	No	1	0.890000000000001	1	no	no	no
10149	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2017		229	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A	No	0	18.3	1	no	no	yes
10150	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2015		43	0	Stable	No	Yes or Unknown			No	0	43.86	1	no	no	no
10151	ICI-treated	ICI as subsequent line	56 - 60	Male	Prostatic	2015	III	69	0		Yes or Unknown	Yes or Unknown			No	0	21.88	1	no	no	no
10152	ICI-treated	ICI - unknown sequence	71 - 75	Female	Pancreatic	2015	II	9	5.9	Stable	No	Yes or Unknown			No	1	11.96	1	no	no	no
10153	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2015		209	7.9	Stable	No	No	Signature.2	ERCC4	No	0	34.63	1	no	no	no
10154	ICI-treated	ICI - unknown sequence	15-Nov	Female	Sarcoma	2015	II	892	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	23.09	1	no	no	no
10155	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2015	IV	560	0	Stable	No	Yes or Unknown			No	0	23.72	1	no	no	no
10156	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2015	IV	3	4.4	Stable	No	No		ATM	No	1	3.49	1	no	no	no
10157	ICI-treated	ICI - unknown sequence	56 - 60	Female	Pancreatic	2015	IV	7	3	Stable	No	Yes or Unknown			No	1	0.490000000000002	1	no	no	no
10158	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2016		0	35.1	Stable	No	No	Signature.2	BLM | ERCC2 | FANCA | MSH2 | RAD50 | RAD51C	No	0	42.02	1	no	no	no
10159	ICI-treated	ICI - unknown sequence	76 - 80	Male	Bladder	2016		0	10.5	Stable	No	No	Signature.13	SLX4	No	0	40.7	1	no	no	no
10160	ICI-treated	ICI as subsequent line	81 - 85	Male	Prostatic	2015	IV	354	10.5		No	Yes or Unknown	Signature.1		No	1	8.83	1	no	no	no
10161	ICI-treated	ICI as first line	10-Jun	Male	CNS	2016		27	7.9	Stable	No	No			No	1	12.55	1	no	no	no
10162	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2016	II	0	1	Stable	No	No			No	1	4.31	1	no	no	no
10163	ICI-treated	ICI as subsequent line	16 - 20	Male	Sarcoma	2016	IV	0	1	Stable	No	No			No	0	13.73	1	no	no	no
10164	ICI-treated	ICI as first line	41 - 45	Female	Sarcoma	2016	IV	94	2	Stable	No	No			No	1	24.41	1	no	no	no
10165	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016		0	17.6	Stable	No	No	Signature.2	MSH6	No	0	40.74	1	no	no	no
10166	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		105	9.7	Stable	No	No	Signature.13	ATM | MUTYH	No	0	16.79	1	no	no	no
10167	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		0	10.5	Stable	No	No	Signature.13		No	0	36.21	1	no	no	no
10168	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	II	578	2.6		Yes or Unknown	Yes or Unknown			No	1	7.23	1	no	no	no
10169	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		1004	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	38.34	1	no	no	no
10170	ICI-treated	ICI - unknown sequence	46 - 50	Female	Bladder	2016		231	8.8	Stable	No	No	Signature.1	ARID1A	No	0	35.38	1	no	no	yes
10171	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016		452	10.5	Stable	No	Yes or Unknown	Signature.7		No	0	27.17	1	no	no	no
10172	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		195	7	Stable	No	No	Signature.13		No	0	29.63	1	no	no	no
10173	ICI-treated	ICI - unknown sequence	66 - 70	Male	Pancreatic	2015		0	2		Yes or Unknown	Yes or Unknown			No	1	1.68	1	no	no	no
10174	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2016	III	0	2.6	Stable	No	No			No	0	26.71	1	no	no	no
10175	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2016	II	87	1.8		No	Yes or Unknown			No	0	17.97	1	no	no	no
10176	ICI-treated	ICI as subsequent line	26 - 30	Female	Colorectal	2016	IV	2	4.4	Stable	No	No			No	1	4.92	1	no	no	no
10177	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		0	7	Stable	No	No	Signature.2		No	0	32.66	1	no	no	no
10178	ICI-treated	ICI as subsequent line	36 - 40	Male	Colorectal	2016	III	18	5.3	Stable	No	No	Signature.1		No	0	1.12	1	no	no	no
10179	ICI-treated	ICI - unknown sequence	56 - 60	Female	SCLC	2016	IV	541	7.9	Stable	Yes or Unknown	Yes or Unknown			No	1	3.65	1	no	no	no
10180	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2017	III	17	3.5	Stable	No	No		BRCA2	No	0	16.82	1	no	no	no
10181	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		0	6.1	Stable	No	No	Signature.13		No	0	34.63	1	no	no	no
10182	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016	III	17	4.4		No	No	Signature.2	ARID1A	No	0	23.29	1	no	no	yes
10183	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		172	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	32.46	1	no	no	no
10184	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		1045	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13	BRCA2	No	0	33.41	1	no	no	no
10185	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2016		1015	17.6	Stable	No	No	Signature.2	ARID1A | ATM	No	0	33.8	1	no	no	yes
10186	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	636	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	17.09	1	no	no	no
10187	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2016	IV	89	5.3	Stable	No	Yes or Unknown		ARID1A	No	1	5.88	1	no	no	yes
10188	ICI-treated	ICI as first line	15-Nov	Male	Sarcoma	2016	II	637	0.9	Stable	No	No			No	0	13.11	1	no	no	no
10189	ICI-treated	ICI - unknown sequence	51 - 55	Female	Colorectal	2016	IV	0	5.3		Yes or Unknown	Yes or Unknown			No	0	1.91	1	no	no	no
10190	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		0	4.4	Stable	Yes or Unknown	Yes or Unknown		ATR	No	0	28.58	1	no	no	no
10191	ICI-treated	ICI - unknown sequence	41 - 45	Female	Breast	2016	III	279	5.3		Yes or Unknown	Yes or Unknown		SLX4	No	1	0.82	1	no	no	no
10192	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	I	840	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	1	7.49	1	no	no	yes
10193	ICI-treated	ICI - unknown sequence	46 - 50	Female	Bladder	2016		305	7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	28.95	1	no	no	no
10194	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2017	I	43	10.5	Stable	No	No	Signature.13	ERCC3	No	0	23.2	1	no	no	no
10195	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2017		0	78.1	Stable	No	No	Signature.2	BRCA1 | BRCA2 | ERCC2 | ERCC5 | MDC1 | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	26.64	1	no	no	no
10196	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2017	II	46	5.3	Stable	No	No	Signature.1		No	1	0.459999999999999	1	no	no	no
10197	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	III	52	2.6	Stable	No	No			No	0	12.59	1	no	no	no
10198	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2017	I	62	0.9	Stable	No	No			No	0	17.18	1	no	no	no
10199	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017	I	0	3.5	Stable	No	No	Signature.13		No	0	21.78	1	no	no	no
10200	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2017	IV	676	7	Stable	No	Yes or Unknown	Signature.1	ARID1A | ATM	No	0	19.51	1	no	no	yes
10201	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017		142	7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	22.17	1	no	no	no
10202	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	II	140	5.3	Stable	No	Yes or Unknown			No	1	0.720000000000001	1	no	no	no
10203	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	12	3.5	Stable	No	No			No	0	19.45	1	no	no	no
10204	ICI-treated	ICI - unknown sequence	51 - 55	Female	Bladder	2017	IV	25	10.5	Stable	No	No	Signature.2	TP53BP1	No	0	15.54	1	no	no	no
10205	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	6.6	1	no	no	no
10206	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2017	IV	0	0	Stable	No	No			No	0	9.89	1	no	no	no
10207	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2017	IV	91	4.4	Stable	No	Yes or Unknown			No	0	14.75	1	no	no	no
10208	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	4	3.5	Stable	No	No		BRCA1	No	0	15.21	1	no	no	no
10209	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2017	I	463	31.6	Stable	No	No	Signature.13	CHEK2 | MDC1 | TP53BP1	No	0	20.8	1	no	no	no
10210	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2017	IV	18	1.8	Indeterminate	No	No			No	0	13.9	1	no	no	no
10211	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	1	17.52	1	no	no	no
10212	ICI-treated	ICI - unknown sequence	46 - 50	Male	Bladder	2017		0	8.8	Stable	No	No	Signature.13		No	0	18.1	1	no	no	no
10213	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2017	I	47	1.8	Stable	No	No			No	0	11.87	1	no	no	no
10214	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		620	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	17.32	1	no	no	no
10215	ICI-treated	ICI - unknown sequence	76 - 80	Female	Bladder	2017		350	14	Stable	No	No	Signature.2	PALB2	No	0	12.98	1	no	no	no
10216	ICI-treated	ICI - unknown sequence	16 - 20	Male	Sarcoma	2016	IV	453	2.6	Stable	Yes or Unknown	Yes or Unknown		MUTYH	No	0	8.35	1	no	no	no
10217	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2017		0	30.7	Stable	No	No	Signature.2	ERCC2 | ERCC4 | XRCC2	No	0	17.64	1	no	no	no
10218	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2018		0	5.3	Stable	No	No	Signature.19	BRCA1	No	0	12.45	1	no	no	no
10219	ICI-treated	ICI - unknown sequence	46 - 50	Male	Bladder	2018		6	7.9	Stable	No	No	Signature.13	FANCA	No	0	15.31	1	no	no	no
10220	ICI-treated	ICI - unknown sequence	46 - 50	Male	Colorectal	2018	IV	0	5.3	Stable	No	Yes or Unknown	Signature.10		No	1	0.92	1	no	no	no
10221	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2018	III	28	5.3	Stable	No	No		BRCA1	No	0	8.58	1	no	no	no
10222	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2018		35	13.2	Stable	No	No	Signature.2	ARID1A | BRCA2 | PMS2	No	0	12.32	1	no	no	yes
10223	ICI-treated	ICI - unknown sequence	41 - 45	Male	Bladder	2018		71	7.9	Stable	No	No	Signature.13	ARID1A | ATM	No	0	13.77	1	no	no	yes
10224	ICI-treated	ICI - unknown sequence	51 - 55	Male	Bladder	2018	I	0	18.4	Stable	No	No	Signature.2	ARID1A | ATM | ERCC2	No	0	12.82	1	no	no	yes
10225	ICI-treated	ICI as subsequent line	36 - 40	Female	Bladder	2018	I	0	28.1	Stable	No	No	Signature.2	ARID1A | ERCC2 | MDC1 | SLX4	No	0	15.18	1	no	no	yes
10226	ICI-treated	ICI - unknown sequence	36 - 40	Male	Bladder	2017	I	0	4.4	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	11.4	1	no	no	yes
10227	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2018		240	16.7	Stable	No	No	Signature.13	ATR | FANCA | RAD50	No	0	13.37	1	no	no	no
10228	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2018	I	28	6.1	Stable	No	No		ERCC2 | FANCA	No	0	9.17	1	no	no	no
10229	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2018	I	182	7.9	Stable	No	No	Signature.13		No	0	10.77	1	no	no	no
10230	ICI-treated	ICI - unknown sequence	21 - 25	Male	Sarcoma	2015	I	968	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	11.33	1	no	no	no
10231	ICI-treated	ICI - unknown sequence	51 - 55	Male	Bladder	2018		0	37.7	Stable	No	No	Signature.2	ARID1A | ATR | BLM | BRCA1 | BRIP1 | CHEK2 | MDC1 | NBN | TP53BP1	No	0	11.36	1	no	no	yes
10232	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2018	I	262	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	12.19	1	no	no	yes
10233	ICI-treated	ICI - unknown sequence	51 - 55	Male	Pancreatic	2017	IV	224	1.8	Stable	Yes or Unknown	Yes or Unknown		BLM	No	1	1.94	1	no	no	no
